Clustering O 0 0.09571843594312668
of O 0 0.019289351999759674
missense O 1 0.9950001239776611
mutations O 1 0.9884032607078552
in O 0 0.008986222557723522
the O 0 0.015535973943769932
ataxia B-Disease 1 0.9999759197235107
- I-Disease 1 0.9953780174255371
telangiectasia I-Disease 1 0.9999363422393799
gene O 1 0.9656635522842407
in O 0 0.008426059037446976
a O 0 0.01884244568645954
sporadic B-Disease 1 0.9828736186027527
T I-Disease 1 0.9987176656723022
- I-Disease 1 0.9455374479293823
cell I-Disease 1 0.9875183701515198
leukaemia I-Disease 1 0.9998792409896851
. O 0 0.03257472813129425

Ataxia B-Disease 1 0.9999241828918457
- I-Disease 1 0.991378903388977
telangiectasia I-Disease 1 0.9999303817749023
( O 0 0.029959486797451973
A B-Disease 0 0.3352469801902771
- I-Disease 1 0.8615065217018127
T I-Disease 1 0.9963441491127014
) O 0 0.008576211519539356
is O 0 0.006925881374627352
a O 0 0.01740637607872486
recessive B-Disease 1 0.9999136924743652
multi I-Disease 1 0.985008716583252
- I-Disease 1 0.7865412831306458
system I-Disease 0 0.38038647174835205
disorder I-Disease 1 0.999984622001648
caused O 1 0.9867933392524719
by O 0 0.012096105143427849
mutations O 1 0.9955838322639465
in O 0 0.006175716407597065
the O 0 0.009151501581072807
ATM O 0 0.26270419359207153
gene O 1 0.744631290435791
at O 0 0.022176027297973633
11q22 O 1 0.9694618582725525
- O 0 0.14811167120933533
q23 O 1 0.9674060344696045
( O 0 0.027526702731847763
ref O 1 0.6307193636894226
. O 0 0.012652261182665825
3 O 0 0.021089568734169006
) O 0 0.014668104238808155
. O 0 0.018675198778510094

The O 0 0.023012667894363403
risk O 1 0.5960674285888672
of O 0 0.017233358696103096
cancer B-Disease 1 0.9999686479568481
, O 0 0.012132272124290466
especially O 0 0.03208979219198227
lymphoid B-Disease 1 0.9996365308761597
neoplasias I-Disease 1 0.9942821264266968
, O 0 0.005900609772652388
is O 0 0.006246617063879967
substantially O 0 0.02712344378232956
elevated O 0 0.26657021045684814
in O 0 0.005679849535226822
A B-Disease 1 0.8244680762290955
- I-Disease 1 0.9984784722328186
T I-Disease 1 0.9999624490737915
patients O 1 0.9996556043624878
and O 0 0.004279168788343668
has O 0 0.006756147835403681
long O 0 0.01117729302495718
been O 0 0.006677309982478619
associated O 0 0.014119359664618969
with O 0 0.013694437220692635
chromosomal O 1 0.9996709823608398
instability O 1 0.9969490170478821
. O 0 0.029683934524655342

By O 0 0.028606470674276352
analysing O 0 0.45403093099594116
tumour B-Disease 1 0.9998394250869751
DNA O 0 0.11176624149084091
from O 0 0.018681736662983894
patients O 1 0.9973015785217285
with O 0 0.010646069422364235
sporadic B-Disease 1 0.9752272367477417
T I-Disease 1 0.998537540435791
- I-Disease 1 0.6182466745376587
cell I-Disease 1 0.9719247817993164
prolymphocytic I-Disease 1 0.9994706511497498
leukaemia I-Disease 1 0.999975323677063
( O 0 0.17925970256328583
T B-Disease 1 0.9989097118377686
- I-Disease 1 0.7533355355262756
PLL I-Disease 1 0.9976766705513
) O 0 0.010824114084243774
, O 0 0.004868659656494856
a O 0 0.010687624104321003
rare O 0 0.3649466633796692
clonal B-Disease 1 0.9989408850669861
malignancy I-Disease 1 0.9998358488082886
with O 0 0.007476843427866697
similarities O 0 0.01592303067445755
to O 0 0.0042051044292747974
a O 0 0.01426747441291809
mature B-Disease 1 0.9468004107475281
T I-Disease 1 0.9977957010269165
- I-Disease 1 0.5987126231193542
cell I-Disease 1 0.9772496223449707
leukaemia I-Disease 1 0.9999428987503052
seen O 0 0.018497750163078308
in O 0 0.006911034230142832
A B-Disease 0 0.21591803431510925
- I-Disease 1 0.9804810881614685
T I-Disease 1 0.9991247057914734
, O 0 0.004165759775787592
we O 0 0.0033648626413196325
demonstrate O 0 0.008230868726968765
a O 0 0.006571037694811821
high O 0 0.009180455468595028
frequency O 0 0.018657833337783813
of O 0 0.0077063413336873055
ATM O 0 0.37186405062675476
mutations O 1 0.9877197742462158
in O 0 0.019596407189965248
T B-Disease 1 0.994539201259613
- I-Disease 1 0.5697729587554932
PLL I-Disease 1 0.9907970428466797
. O 0 0.038328077644109726

In O 0 0.015713823959231377
marked O 0 0.027988949790596962
contrast O 0 0.015458493493497372
to O 0 0.0048637972213327885
the O 0 0.009264322929084301
ATM O 1 0.6719133257865906
mutation O 1 0.9968454241752625
pattern O 0 0.03413472697138786
in O 0 0.007029400207102299
A B-Disease 0 0.18889884650707245
- I-Disease 1 0.9144434928894043
T I-Disease 1 0.9978148937225342
, O 0 0.004204357508569956
the O 0 0.0041440981440246105
most O 0 0.0059368968941271305
frequent O 0 0.026448726654052734
nucleotide O 0 0.044922009110450745
changes O 0 0.010242504067718983
in O 0 0.005371582694351673
this O 0 0.009919306263327599
leukaemia B-Disease 1 0.9998236298561096
were O 0 0.016259940341114998
missense O 1 0.9982466697692871
mutations O 1 0.9950525164604187
. O 0 0.03478649631142616

These O 0 0.01003379374742508
clustered O 0 0.024479210376739502
in O 0 0.004414050839841366
the O 0 0.004508981481194496
region O 0 0.012012911960482597
corresponding O 0 0.011378149501979351
to O 0 0.003827483858913183
the O 0 0.00715734763070941
kinase O 1 0.8955112099647522
domain O 0 0.016910504549741745
, O 0 0.00319513026624918
which O 0 0.00302405864931643
is O 0 0.0042710499837994576
highly O 0 0.011303559876978397
conserved O 0 0.021098541095852852
in O 0 0.007337222341448069
ATM O 0 0.16902582347393036
- O 0 0.03009740449488163
related O 0 0.02090349607169628
proteins O 0 0.02339586429297924
in O 0 0.007386585231870413
mouse O 1 0.9800196886062622
, O 0 0.010061843320727348
yeast O 0 0.3657868504524231
and O 0 0.01305522583425045
Drosophila O 0 0.1627480685710907
. O 0 0.027099302038550377

The O 0 0.01821793057024479
resulting O 0 0.05179298669099808
amino O 0 0.05438102409243584
- O 0 0.0533050112426281
acid O 0 0.1363370567560196
substitutions O 0 0.02208881266415119
are O 0 0.004679263569414616
predicted O 0 0.014123169705271721
to O 0 0.004871770739555359
interfere O 0 0.022394685074687004
with O 0 0.007898532785475254
ATP O 0 0.18174399435520172
binding O 0 0.02725079469382763
or O 0 0.013498206622898579
substrate O 0 0.05616004019975662
recognition O 0 0.039821378886699677
. O 0 0.021799426525831223

Two O 0 0.010209757834672928
of O 0 0.009022245183587074
seventeen O 0 0.07080947607755661
mutated O 1 0.9972760081291199
T B-Disease 1 0.9966872334480286
- I-Disease 0 0.29504016041755676
PLL I-Disease 1 0.9900319576263428
samples O 0 0.030009884387254715
had O 0 0.007711474318057299
a O 0 0.008129463531076908
previously O 0 0.01005205512046814
reported O 0 0.024532264098525047
A B-Disease 0 0.06248929724097252
- I-Disease 1 0.878376841545105
T I-Disease 1 0.998245120048523
allele O 1 0.9791982173919678
. O 0 0.03887562081217766

In O 0 0.013385340571403503
contrast O 0 0.01942729391157627
, O 0 0.0066337427124381065
no O 0 0.009290607646107674
mutations O 1 0.9937024116516113
were O 0 0.004872124642133713
detected O 0 0.04121938720345497
in O 0 0.004635190591216087
the O 0 0.008539372123777866
p53 O 1 0.9982847571372986
gene O 1 0.9492250084877014
, O 0 0.005436969455331564
suggesting O 0 0.014318779110908508
that O 0 0.0044587538577616215
this O 0 0.010869180783629417
tumour B-Disease 1 0.9999942779541016
suppressor O 1 0.9998476505279541
is O 0 0.007989846169948578
not O 0 0.005004375707358122
frequently O 0 0.01426532119512558
altered O 0 0.022202037274837494
in O 0 0.006097876466810703
this O 0 0.012227410450577736
leukaemia B-Disease 1 0.9998890161514282
. O 0 0.029888542369008064

Occasional O 1 0.5022153258323669
missense O 1 0.9949641227722168
mutations O 1 0.9936188459396362
in O 0 0.009037989191710949
ATM O 0 0.04150231555104256
were O 0 0.0035515502095222473
also O 0 0.003720392007380724
found O 0 0.007446581963449717
in O 0 0.009256653487682343
tumour B-Disease 1 0.9999575614929199
DNA O 0 0.13485603034496307
from O 0 0.011991861276328564
patients O 1 0.9957433342933655
with O 0 0.007810698822140694
B B-Disease 1 0.676037609577179
- I-Disease 0 0.05550314486026764
cell I-Disease 0 0.2635434865951538
non I-Disease 0 0.1335524618625641
- I-Disease 1 0.9943155646324158
Hodgkins I-Disease 1 0.9999970197677612
lymphomas I-Disease 1 0.9999412298202515
( O 0 0.029049130156636238
B B-Disease 1 0.8047569990158081
- I-Disease 0 0.042598698288202286
NHL I-Disease 0 0.04065661504864693
) O 0 0.006313395220786333
and O 0 0.003649553284049034
a O 0 0.011395378969609737
B B-Disease 0 0.27587321400642395
- I-Disease 0 0.048851463943719864
NHL I-Disease 0 0.0864943191409111
cell O 0 0.06324094533920288
line O 0 0.02557709626853466
. O 0 0.01984267309308052

The O 0 0.00786848645657301
evidence O 0 0.00630406616255641
of O 0 0.0032709904480725527
a O 0 0.00609954446554184
significant O 0 0.010482212528586388
proportion O 0 0.015067447908222675
of O 0 0.004909951239824295
loss O 0 0.093358114361763
- O 0 0.01677970588207245
of O 0 0.00511306943371892
- O 0 0.07480815798044205
function O 0 0.050316255539655685
mutations O 1 0.9943367838859558
and O 0 0.0032267512287944555
a O 0 0.004855221603065729
complete O 0 0.007873055525124073
absence O 0 0.009963089600205421
of O 0 0.0028668614104390144
the O 0 0.004507806617766619
normal O 0 0.015357157215476036
copy O 0 0.011244655586779118
of O 0 0.0043779406696558
ATM O 0 0.023756705224514008
in O 0 0.003493688302114606
the O 0 0.00419605290517211
majority O 0 0.011506034061312675
of O 0 0.011846715584397316
mutated O 1 0.9998987913131714
tumours B-Disease 1 0.9999778270721436
establishes O 1 0.9790793657302856
somatic O 1 0.9970734119415283
inactivation O 1 0.9897936582565308
of O 0 0.0054280804470181465
this O 0 0.005342557094991207
gene O 0 0.23371347784996033
in O 0 0.003995745442807674
the O 0 0.007094862870872021
pathogenesis O 1 0.9909494519233704
of O 0 0.0099868793040514
sporadic B-Disease 1 0.992489755153656
T I-Disease 1 0.9992837309837341
- I-Disease 1 0.8981317281723022
PLL I-Disease 1 0.9985246062278748
and O 0 0.00621643615886569
suggests O 0 0.017685506492853165
that O 0 0.005456326529383659
ATM O 0 0.03714042529463768
acts O 0 0.01142055168747902
as O 0 0.00719741266220808
a O 0 0.032658662647008896
tumour B-Disease 1 0.9999524354934692
suppressor O 1 0.9992309808731079
. O 0 0.036160908639431

As O 0 0.013146795332431793
constitutional O 0 0.021981308236718178
DNA O 0 0.028444649651646614
was O 0 0.0058337547816336155
not O 0 0.003050441388040781
available O 0 0.0037704487331211567
, O 0 0.003463894361630082
a O 0 0.012733985669910908
putative O 1 0.9873577356338501
hereditary O 1 0.9997518658638
predisposition O 1 0.999785840511322
to O 0 0.01890411041676998
T B-Disease 1 0.9983508586883545
- I-Disease 1 0.5892668962478638
PLL I-Disease 1 0.9953882694244385
will O 0 0.007280636578798294
require O 0 0.011512771248817444
further O 0 0.0093464944511652
investigation O 0 0.018489176407456398
. O 0 0.00966931227594614
. O 0 0.01741344854235649

Myotonic B-Disease 1 0.9999700784683228
dystrophy I-Disease 1 0.999992847442627
protein O 1 0.946405291557312
kinase O 1 0.9901548624038696
is O 0 0.010446736589074135
involved O 0 0.009232972748577595
in O 0 0.0038430148269981146
the O 0 0.005340299569070339
modulation O 0 0.040378767997026443
of O 0 0.005892101675271988
the O 0 0.014415216632187366
Ca2 O 1 0.9942264556884766
+ O 0 0.4281556010246277
homeostasis O 1 0.9661069512367249
in O 0 0.022452296689152718
skeletal O 1 0.999305009841919
muscle O 1 0.9996474981307983
cells O 1 0.8398425579071045
. O 0 0.02733832411468029

Myotonic B-Disease 1 0.9999773502349854
dystrophy I-Disease 1 0.999996542930603
( O 1 0.5884919762611389
DM B-Disease 1 0.9998865127563477
) O 0 0.01567927375435829
, O 0 0.005245211999863386
the O 0 0.0061851246282458305
most O 0 0.014455458149313927
prevalent O 1 0.999572217464447
muscular B-Disease 1 0.9999971389770508
disorder I-Disease 1 0.9999963045120239
in O 0 0.013949346728622913
adults O 1 0.8925099968910217
, O 0 0.005749730858951807
is O 0 0.007108304649591446
caused O 0 0.48708516359329224
by O 0 0.009024756029248238
( O 0 0.016218269243836403
CTG O 1 0.9730185270309448
) O 0 0.01615210622549057
n O 0 0.030366763472557068
- O 0 0.03164149075746536
repeat O 0 0.03542717546224594
expansion O 0 0.014847885817289352
in O 0 0.006635782774537802
a O 0 0.01535531785339117
gene O 0 0.13346563279628754
encoding O 0 0.04503287747502327
a O 0 0.023009510710835457
protein O 0 0.07972036302089691
kinase O 1 0.9690033793449402
( O 0 0.038025107234716415
DM B-Disease 1 0.9995611310005188
protein O 0 0.234879732131958
kinase O 1 0.981514036655426
; O 0 0.020305544137954712
DMPK O 1 0.9779329299926758
) O 0 0.007870713248848915
and O 0 0.004364666994661093
involves O 0 0.020696774125099182
changes O 0 0.01291272696107626
in O 0 0.008097273297607899
cytoarchitecture O 1 0.9016353487968445
and O 0 0.011912394315004349
ion O 0 0.40586358308792114
homeostasis O 1 0.987672746181488
. O 0 0.026907330378890038

To O 0 0.010540985502302647
obtain O 0 0.015630511566996574
clues O 0 0.015974435955286026
to O 0 0.0034473256673663855
the O 0 0.0047436123713850975
normal O 0 0.016042284667491913
biological O 0 0.012388684786856174
role O 0 0.009787609800696373
of O 0 0.0061284941621124744
DMPK O 1 0.9858530759811401
in O 0 0.010756350122392178
cellular O 1 0.6260194778442383
ion O 1 0.6291518211364746
homeostasis O 1 0.9842907190322876
, O 0 0.005356516223400831
we O 0 0.0029840487986803055
have O 0 0.0034655770286917686
compared O 0 0.010649685747921467
the O 0 0.0079099852591753
resting O 1 0.8733140230178833
[ O 1 0.5211648941040039
Ca2 O 1 0.9944788217544556
+ O 1 0.5563623309135437
] O 0 0.04242046922445297
i O 0 0.007672885432839394
, O 0 0.003720743814483285
the O 0 0.005475581157952547
amplitude O 0 0.0331522636115551
and O 0 0.005048598628491163
shape O 0 0.022088294848799706
of O 0 0.010262017138302326
depolarization O 1 0.998023271560669
- O 1 0.944598376750946
induced O 1 0.9994677901268005
Ca2 O 1 0.9980472326278687
+ O 1 0.7872694134712219
transients O 1 0.7548204064369202
, O 0 0.004863799549639225
and O 0 0.0024942245800048113
the O 0 0.0031619081273674965
content O 0 0.006063510663807392
of O 0 0.004842453636229038
ATP O 0 0.13828526437282562
- O 0 0.033317673951387405
driven O 0 0.04351465031504631
ion O 0 0.06433865427970886
pumps O 0 0.05126051604747772
in O 0 0.012447355315089226
cultured O 1 0.977876603603363
skeletal O 1 0.9996901750564575
muscle O 1 0.9997691512107849
cells O 0 0.11988899111747742
of O 0 0.008045149967074394
wild O 0 0.044686004519462585
- O 0 0.04112711548805237
type O 0 0.04642081260681152
and O 0 0.009699000976979733
DMPK O 1 0.9950534701347351
[ O 0 0.2290092557668686
- O 0 0.1226206123828888
/ O 0 0.2735036015510559
- O 0 0.08865690231323242
] O 0 0.12595878541469574
knockout O 1 0.8928261399269104
mice O 1 0.951772928237915
. O 0 0.03732048720121384

In O 0 0.021328827366232872
vitro O 1 0.63497394323349
- O 0 0.14861708879470825
differentiated O 1 0.9065037369728088
DMPK O 1 0.9951724410057068
[ O 0 0.26357829570770264
- O 0 0.16236943006515503
/ O 1 0.5449841618537903
- O 0 0.07867667824029922
] O 0 0.07152599841356277
myotubes O 1 0.7197010517120361
exhibit O 0 0.02802993170917034
a O 0 0.013213453814387321
higher O 0 0.020601768046617508
resting O 1 0.5147265791893005
[ O 0 0.23879675567150116
Ca2 O 1 0.9942736029624939
+ O 0 0.36699536442756653
] O 0 0.04252098873257637
i O 0 0.009223347529768944
than O 0 0.00544586218893528
do O 0 0.0070993416011333466
wild O 0 0.02906634472310543
- O 0 0.07442129403352737
type O 0 0.1899399310350418
myotubes O 1 0.8633913993835449
because O 0 0.006257080938667059
of O 0 0.002681194571778178
an O 0 0.004421561490744352
altered O 0 0.02131078578531742
open O 0 0.010683552362024784
probability O 0 0.011566846631467342
of O 0 0.005172442179173231
voltage O 0 0.03707181289792061
- O 0 0.04249190166592598
dependent O 0 0.04726723954081535
l O 1 0.6323248147964478
- O 0 0.07538703083992004
type O 0 0.35251298546791077
Ca2 O 1 0.9813951849937439
+ O 0 0.07494375854730606
and O 0 0.013536815531551838
Na O 1 0.9213857054710388
+ O 0 0.08378881961107254
channels O 0 0.03493734076619148
. O 0 0.02225060574710369

The O 0 0.027559708803892136
mutant O 1 0.9765086770057678
myotubes O 1 0.9375152587890625
exhibit O 0 0.037585265934467316
smaller O 0 0.016388453543186188
and O 0 0.007323003839701414
slower O 0 0.05393746867775917
Ca2 O 1 0.9802818298339844
+ O 0 0.0945805087685585
responses O 0 0.03754229098558426
upon O 0 0.01576349139213562
triggering O 1 0.583945095539093
by O 0 0.014422215521335602
acetylcholine O 1 0.7093836665153503
or O 0 0.01117953285574913
high O 0 0.016026996076107025
external O 0 0.03295886144042015
K O 0 0.09238964319229126
+ O 0 0.07585283368825912
. O 0 0.023618310689926147

In O 0 0.011128382757306099
addition O 0 0.009899839758872986
, O 0 0.004409878049045801
we O 0 0.0038090802263468504
observed O 0 0.011594312265515327
that O 0 0.003775347024202347
these O 0 0.008913157507777214
Ca2 O 1 0.9898877739906311
+ O 1 0.7852769494056702
transients O 1 0.9817053079605103
partially O 0 0.05274002626538277
result O 0 0.015954772010445595
from O 0 0.006050994619727135
an O 0 0.005447153467684984
influx O 0 0.03585302457213402
of O 0 0.010602563619613647
extracellular O 0 0.20215070247650146
Ca2 O 1 0.9887626767158508
+ O 0 0.051171332597732544
through O 0 0.012588545680046082
the O 0 0.01555686630308628
l O 0 0.2193497121334076
- O 0 0.08270622789859772
type O 0 0.17955070734024048
Ca2 O 1 0.9675302505493164
+ O 0 0.10572066158056259
channel O 0 0.05994806066155434
. O 0 0.025793278589844704

Neither O 0 0.023163674399256706
the O 0 0.007060036528855562
content O 0 0.011346978135406971
nor O 0 0.01036952156573534
the O 0 0.005459479056298733
activity O 0 0.014404096640646458
of O 0 0.009892009198665619
Na O 1 0.942638635635376
+ O 0 0.33410096168518066
/ O 0 0.2314017415046692
K O 0 0.1162196472287178
+ O 0 0.13995115458965302
ATPase O 1 0.9279358983039856
and O 0 0.030590249225497246
sarcoplasmic O 1 0.9986934065818787
reticulum O 1 0.9966005682945251
Ca2 O 1 0.9938259720802307
+ O 1 0.5896985530853271
- O 0 0.1694841831922531
ATPase O 1 0.9703212976455688
are O 0 0.009500212967395782
affected O 0 0.04322447627782822
by O 0 0.015814539045095444
DMPK O 1 0.9885736703872681
absence O 0 0.07157929986715317
. O 0 0.02823432721197605

In O 0 0.012096189893782139
conclusion O 0 0.01479804702103138
, O 0 0.003656267886981368
our O 0 0.004988923203200102
data O 0 0.006047404371201992
suggest O 0 0.010577966459095478
that O 0 0.0055462755262851715
DMPK O 1 0.9274845719337463
is O 0 0.006353772711008787
involved O 0 0.009729706682264805
in O 0 0.005935850087553263
modulating O 1 0.723724901676178
the O 0 0.006624219473451376
initial O 0 0.01842224970459938
events O 0 0.010114978067576885
of O 0 0.0079467399045825
excitation O 1 0.9222834706306458
- O 0 0.39105355739593506
contraction O 1 0.9553508162498474
coupling O 0 0.19868309795856476
in O 0 0.019819602370262146
skeletal O 1 0.9994927644729614
muscle O 1 0.9991329312324524
. O 0 0.01491106953471899
. O 0 0.019466238096356392

Constitutional O 0 0.21165668964385986
RB1 O 1 0.9990084767341614
- O 1 0.9209548830986023
gene O 1 0.9950309991836548
mutations O 1 0.9982247948646545
in O 0 0.014197430573403835
patients O 1 0.9989328980445862
with O 0 0.013311931863427162
isolated O 1 0.9543112516403198
unilateral B-Disease 1 0.9852227568626404
retinoblastoma I-Disease 1 0.9992152452468872
. O 0 0.03341151028871536

In O 0 0.015707850456237793
most O 0 0.017327044159173965
patients O 1 0.9980999827384949
with O 0 0.0122467540204525
isolated O 1 0.7864108681678772
unilateral B-Disease 1 0.9908339381217957
retinoblastoma I-Disease 1 0.9998685121536255
, O 0 0.018734723329544067
tumor B-Disease 1 0.9996129870414734
development O 0 0.012179810553789139
is O 0 0.007493623998016119
initiated O 0 0.029741249978542328
by O 0 0.012474622577428818
somatic O 1 0.9771630764007568
inactivation O 1 0.9412286281585693
of O 0 0.005971959792077541
both O 0 0.008586377836763859
alleles O 1 0.8440430760383606
of O 0 0.008707696571946144
the O 0 0.01936127431690693
RB1 O 1 0.9993351101875305
gene O 1 0.9407095313072205
. O 0 0.029155055060982704

However O 0 0.013094303198158741
, O 0 0.004112844355404377
some O 0 0.0034796076361089945
of O 0 0.004144243896007538
these O 0 0.006935651879757643
patients O 1 0.9990324974060059
can O 0 0.014056758023798466
transmit O 1 0.987321138381958
retinoblastoma B-Disease 1 0.9999046325683594
predisposition O 1 0.9991511106491089
to O 0 0.008529627695679665
their O 0 0.011756505817174911
offspring O 1 0.743391215801239
. O 0 0.023192785680294037

To O 0 0.008996661752462387
determine O 0 0.00981693435460329
the O 0 0.0056058987975120544
frequency O 0 0.01782945729792118
and O 0 0.0035625663585960865
nature O 0 0.008179658092558384
of O 0 0.006084245163947344
constitutional O 0 0.04479312151670456
RB1 O 1 0.9998354911804199
- O 1 0.8652597069740295
gene O 1 0.9958646297454834
mutations O 1 0.9991210103034973
in O 0 0.013066473416984081
patients O 1 0.9995366334915161
with O 0 0.01001758873462677
isolated O 1 0.7773370146751404
unilateral B-Disease 1 0.9740865230560303
retinoblastoma I-Disease 1 0.9996169805526733
, O 0 0.005878270138055086
we O 0 0.004657804034650326
analyzed O 0 0.020390547811985016
DNA O 0 0.03170649707317352
from O 0 0.012298353016376495
peripheral O 1 0.9989726543426514
blood O 1 0.9864822626113892
and O 0 0.00917784497141838
from O 0 0.02350335568189621
tumor B-Disease 1 0.9999426603317261
tissue O 1 0.9978612065315247
. O 0 0.027236580848693848

The O 0 0.012039415538311005
analysis O 0 0.018347814679145813
of O 0 0.012928442098200321
tumors B-Disease 1 0.9995654225349426
from O 0 0.010554272681474686
54 O 0 0.026748422533273697
( O 0 0.013000263832509518
71 O 0 0.025578830391168594
% O 0 0.009740122593939304
) O 0 0.0064076390117406845
of O 0 0.0060057444497942924
76 O 0 0.05782134830951691
informative O 0 0.13995450735092163
patients O 1 0.9980623126029968
showed O 0 0.021438634023070335
loss O 0 0.02806713990867138
of O 0 0.008429354056715965
constitutional O 0 0.03167310357093811
heterozygosity O 1 0.9980134963989258
( O 0 0.051932767033576965
LOH O 1 0.9993347525596619
) O 0 0.01942267455160618
at O 0 0.018802067264914513
intragenic O 1 0.9818184971809387
loci O 1 0.9738257527351379
. O 0 0.03522033989429474

Three O 0 0.010151203721761703
of O 0 0.008208660408854485
13 O 0 0.03090350329875946
uninformative O 1 0.9984123706817627
patients O 1 0.9992796778678894
had O 0 0.013500072993338108
constitutional O 0 0.028895918279886246
deletions O 1 0.731347382068634
. O 0 0.02612149901688099

For O 0 0.016954144462943077
39 O 0 0.03685968741774559
randomly O 0 0.04694783687591553
selected O 0 0.031801480799913406
tumors B-Disease 1 0.9995591044425964
, O 0 0.016411928460001945
SSCP O 1 0.990256130695343
, O 0 0.017189770936965942
hetero O 1 0.9972087740898132
- O 0 0.06964311003684998
duplex O 0 0.4385696351528168
analysis O 0 0.01705225370824337
, O 0 0.006321229040622711
sequencing O 0 0.027905423194169998
, O 0 0.004173324443399906
and O 0 0.0036818082444369793
Southern O 0 0.01611686311662197
blot O 1 0.7007775902748108
analysis O 0 0.010541258379817009
were O 0 0.0027589681558310986
used O 0 0.003971743397414684
to O 0 0.005449758376926184
identify O 0 0.032863713800907135
mutations O 1 0.9804010987281799
. O 0 0.025352412834763527

Mutations O 1 0.9890254139900208
were O 0 0.009881828911602497
detected O 0 0.04879438877105713
in O 0 0.006659382954239845
21 O 0 0.015617427416145802
( O 0 0.010293186642229557
91 O 0 0.02461072988808155
% O 0 0.008937850594520569
) O 0 0.006077683065086603
of O 0 0.005406366661190987
23 O 0 0.04528171569108963
tumors B-Disease 1 0.9998738765716553
with O 0 0.023574979975819588
LOH O 1 0.9987406134605408
. O 0 0.02948119305074215

In O 0 0.016224823892116547
6 O 0 0.02337433397769928
( O 0 0.012937603518366814
38 O 0 0.021626031026244164
% O 0 0.009163113310933113
) O 0 0.006477755960077047
of O 0 0.005418140906840563
16 O 0 0.025586150586605072
tumors B-Disease 1 0.9999054670333862
without O 0 0.02586384490132332
LOH O 1 0.9997057318687439
, O 0 0.007473574485629797
one O 0 0.010129488073289394
mutation O 1 0.9978697299957275
was O 0 0.010420669801533222
detected O 0 0.2480860948562622
, O 0 0.0032223861198872328
and O 0 0.0021438917610794306
in O 0 0.0033607331570237875
9 O 0 0.011224035173654556
( O 0 0.007053297013044357
56 O 0 0.013335402123630047
% O 0 0.006546498741954565
) O 0 0.004098990932106972
of O 0 0.0040030088275671005
the O 0 0.009674839675426483
tumors B-Disease 1 0.9999467134475708
without O 0 0.02072552591562271
LOH O 1 0.9996671676635742
, O 0 0.00744475657120347
both O 0 0.00785910151898861
mutations O 1 0.9937638640403748
were O 0 0.005263425875455141
found O 0 0.014356632716953754
. O 0 0.016174856573343277

Thus O 0 0.018816251307725906
, O 0 0.004508624318987131
a O 0 0.005628223530948162
total O 0 0.0053283520974218845
of O 0 0.0040252371691167355
45 O 0 0.01481762994080782
mutations O 1 0.9869982004165649
were O 0 0.004028817638754845
identified O 0 0.012908442877233028
in O 0 0.009158291853964329
tumors B-Disease 1 0.9998206496238708
of O 0 0.010065957903862
36 O 0 0.15499743819236755
patients O 1 0.997426450252533
. O 0 0.026460394263267517

Thirty O 0 0.04083668813109398
- O 0 0.024603260681033134
nine O 0 0.008379938080906868
of O 0 0.004382336977869272
the O 0 0.009734242223203182
mutations O 1 0.9979280233383179
- O 0 0.023683924227952957
including O 0 0.008131713606417179
34 O 0 0.020204510539770126
small O 0 0.015342192724347115
mutations O 1 0.9969280362129211
, O 0 0.005611936096101999
2 O 0 0.009210118092596531
large O 0 0.009617170318961143
structural O 0 0.03313904255628586
alterations O 0 0.025311294943094254
, O 0 0.004205802921205759
and O 0 0.006353339180350304
hypermethylation O 1 0.9970871806144714
in O 0 0.009860232472419739
3 O 0 0.05708833411335945
tumors O 1 0.9999740123748779
- O 0 0.025939367711544037
were O 0 0.0033304316457360983
not O 0 0.004148032050579786
detected O 0 0.02781648561358452
in O 0 0.004986143670976162
the O 0 0.007461451925337315
corresponding O 0 0.029260054230690002
peripheral O 1 0.9973856806755066
blood O 1 0.9957972764968872
DNA O 0 0.25931012630462646
. O 0 0.024927975609898567

In O 0 0.01489129476249218
6 O 0 0.02087533101439476
( O 0 0.009733732789754868
17 O 0 0.010714278556406498
% O 0 0.007075975649058819
) O 0 0.004178138915449381
of O 0 0.002255229977890849
the O 0 0.0046311975456774235
36 O 0 0.0532175712287426
patients O 1 0.9988784193992615
, O 0 0.00529452646151185
a O 0 0.01244769524782896
mutation O 1 0.9990370273590088
was O 0 0.008406885899603367
detected O 0 0.03698034584522247
in O 0 0.004507254343479872
constitutional O 0 0.010817954316735268
DNA O 0 0.026083672419190407
, O 0 0.003652712097391486
and O 0 0.002564882393926382
1 O 0 0.005720892455428839
of O 0 0.003810462774708867
these O 0 0.006558098830282688
mutations O 1 0.9901689291000366
is O 0 0.005024285987019539
known O 0 0.005900833290070295
to O 0 0.0026284921914339066
be O 0 0.003214836586266756
associated O 0 0.009918740019202232
with O 0 0.006972924806177616
reduced O 0 0.05683021992444992
expressivity O 1 0.9908015131950378
. O 0 0.029728377237915993

The O 0 0.011378143914043903
presence O 0 0.013175593689084053
of O 0 0.0044234259985387325
a O 0 0.009698685258626938
constitutional O 0 0.022869311273097992
mutation O 1 0.998650848865509
was O 0 0.007152249570935965
not O 0 0.004069202579557896
associated O 0 0.008179282769560814
with O 0 0.002998072188347578
an O 0 0.004004629794508219
early O 0 0.01187374722212553
age O 0 0.018300633877515793
at O 0 0.01422144379466772
treatment O 1 0.8541693687438965
. O 0 0.020517604425549507

In O 0 0.016396017745137215
1 O 0 0.028972765430808067
patient O 1 0.987036406993866
, O 0 0.015021095983684063
somatic O 1 0.9880830645561218
mosaicism O 1 0.9976213574409485
was O 0 0.012042921036481857
demonstrated O 0 0.015548953786492348
by O 0 0.006960033904761076
molecular O 0 0.022503340616822243
analysis O 0 0.008405757136642933
of O 0 0.004593501333147287
DNA O 0 0.028305234387516975
and O 0 0.006715917959809303
RNA O 0 0.05369062349200249
from O 0 0.01704581268131733
peripheral O 1 0.9936489462852478
blood O 1 0.946683943271637
. O 0 0.026608528569340706

In O 0 0.015092519111931324
2 O 0 0.024688251316547394
patients O 1 0.9924464821815491
without O 0 0.013440161012113094
a O 0 0.019475644454360008
detectable O 1 0.9882821440696716
mutation O 1 0.9986345171928406
in O 0 0.016389235854148865
peripheral O 1 0.9994445443153381
blood O 1 0.9981173276901245
, O 0 0.01178177259862423
mosaicism O 1 0.9980547428131104
was O 0 0.009179709479212761
suggested O 0 0.010601122863590717
because O 0 0.006396855693310499
1 O 0 0.006418507546186447
of O 0 0.0034060892648994923
the O 0 0.009017875418066978
patients O 1 0.9998536109924316
showed O 1 0.9734718203544617
multifocal O 1 0.9999969005584717
tumors B-Disease 1 0.9999562501907349
and O 0 0.005400874186307192
the O 0 0.00380369508638978
other O 0 0.003870324930176139
later O 0 0.007926699705421925
developed O 0 0.023911962285637856
bilateral B-Disease 0 0.03951249644160271
retinoblastoma I-Disease 1 0.9975011944770813
. O 0 0.033169347792863846

In O 0 0.010636822320520878
conclusion O 0 0.014311050064861774
, O 0 0.003861319739371538
our O 0 0.006305640563368797
results O 0 0.010447461158037186
emphasize O 0 0.015410725958645344
that O 0 0.0031058252789080143
the O 0 0.005264956504106522
manifestation O 1 0.702117919921875
and O 0 0.007088204380124807
transmissibility O 1 0.9963356256484985
of O 0 0.01038943137973547
retinoblastoma B-Disease 1 0.9997788071632385
depend O 0 0.013132050633430481
on O 0 0.0029229577630758286
the O 0 0.0032017254270613194
nature O 0 0.005914759822189808
of O 0 0.0023246705532073975
the O 0 0.0032690258231014013
first O 0 0.007629657629877329
mutation O 1 0.9960283041000366
, O 0 0.003906324040144682
its O 0 0.003291250439360738
time O 0 0.003295992035418749
in O 0 0.002349566202610731
development O 0 0.004354264587163925
, O 0 0.002333100652322173
and O 0 0.001582403085194528
the O 0 0.002231595804914832
number O 0 0.0034517906606197357
and O 0 0.0028909880202263594
types O 0 0.008466017432510853
of O 0 0.004211978986859322
cells O 0 0.15047411620616913
that O 0 0.003552140900865197
are O 0 0.004623499233275652
affected O 0 0.03715299442410469
. O 0 0.007997613400220871
. O 0 0.015723060816526413

Hereditary B-Disease 1 0.9996129870414734
deficiency I-Disease 1 0.9998524188995361
of I-Disease 0 0.006004130467772484
the I-Disease 0 0.005009267013520002
fifth I-Disease 0 0.015559576451778412
component I-Disease 0 0.018565461039543152
of I-Disease 0 0.005242451094090939
complement I-Disease 0 0.018861887976527214
in O 0 0.008730173110961914
man O 0 0.032389406114816666
. O 0 0.020445583388209343

I O 0 0.05642640218138695
. O 0 0.028845200315117836

Clinical O 1 0.9387251138687134
, O 0 0.015038969926536083
immunochemical O 1 0.9762521982192993
, O 0 0.006422096863389015
and O 0 0.004654235206544399
family O 0 0.017842944711446762
studies O 0 0.021172989159822464
. O 0 0.022203370928764343

The O 0 0.011709761805832386
first O 0 0.010988983325660229
recognized O 0 0.023986011743545532
human O 0 0.029279010370373726
kindred O 1 0.9847003221511841
with O 0 0.01663520745933056
hereditary B-Disease 1 0.9999219179153442
deficiency I-Disease 1 0.9999573230743408
of I-Disease 0 0.005671077407896519
the I-Disease 0 0.005654345266520977
fifth I-Disease 0 0.016815010458230972
component I-Disease 0 0.021824311465024948
of I-Disease 0 0.007495820056647062
complement I-Disease 0 0.029562370851635933
( O 0 0.02308804728090763
C5 O 1 0.9883657693862915
) O 0 0.01159509364515543
is O 0 0.00969008170068264
described O 0 0.026365669444203377
. O 0 0.01712833158671856

The O 0 0.019948892295360565
proband O 1 0.7832731604576111
, O 0 0.007111778948456049
a O 0 0.009847331792116165
20 O 0 0.011685997247695923
- O 0 0.021075936034321785
year O 0 0.012174631468951702
- O 0 0.02642088197171688
old O 0 0.020976869389414787
black O 0 0.0395086333155632
female O 0 0.272450715303421
with O 0 0.3287251591682434
systemic B-Disease 1 0.9999997615814209
lupus I-Disease 1 1.0
erythematosus I-Disease 1 0.9999994039535522
since O 0 0.10619610548019409
age O 0 0.03741036355495453
11 O 0 0.01732129044830799
, O 0 0.010313053615391254
lacked O 0 0.24400976300239563
serum O 1 0.9985548853874207
hemolytic O 1 0.9999837875366211
complement O 0 0.0531608983874321
activity O 0 0.020269477739930153
, O 0 0.005974896252155304
even O 0 0.01053408533334732
during O 0 0.02307162992656231
remission O 1 0.9982196688652039
. O 0 0.031390342861413956

C5 O 1 0.985832691192627
was O 0 0.0232327189296484
undetectable O 1 0.8617805242538452
in O 0 0.00808152835816145
her O 0 0.015517185442149639
serum O 1 0.7217921614646912
by O 0 0.008006162941455841
both O 0 0.010022125206887722
immunodiffusion O 1 0.9906101822853088
and O 0 0.024257265031337738
hemolytic O 1 0.9999703168869019
assays O 0 0.23108668625354767
. O 0 0.03001491166651249

Other O 0 0.009335754439234734
complement O 0 0.02214600145816803
components O 0 0.011081196367740631
were O 0 0.00460383016616106
normal O 0 0.02011973224580288
during O 0 0.016171591356396675
remission O 1 0.9993187189102173
of O 0 0.023426750674843788
lupus O 1 0.9999992847442627
, O 0 0.009741299785673618
but O 0 0.011161630973219872
C1 O 1 0.9970014691352844
, O 0 0.011544652283191681
C4 O 1 0.895260214805603
, O 0 0.01181478425860405
C2 O 1 0.996385931968689
, O 0 0.006650738883763552
and O 0 0.007263478823006153
C3 O 1 0.9775561690330505
levels O 0 0.03039669618010521
fell O 0 0.03924182057380676
during O 0 0.03531123325228691
exacerbations O 1 0.9983034133911133
. O 0 0.033192746341228485

A O 0 0.03169398382306099
younger O 0 0.044252898544073105
half O 0 0.020137667655944824
- O 0 0.04040435701608658
sister O 0 0.040391676127910614
, O 0 0.005116492975503206
who O 0 0.005663059651851654
had O 0 0.00707637844607234
no O 0 0.010055269114673138
underlying O 1 0.9918573498725891
disease O 1 0.9999934434890747
, O 0 0.005527995992451906
was O 0 0.005339387338608503
also O 0 0.003575156908482313
found O 0 0.005909068509936333
to O 0 0.0057643111795187
lack O 0 0.03326450660824776
immunochemically O 1 0.9918462634086609
detectable O 1 0.9830207824707031
C5 O 1 0.982772707939148
. O 0 0.0322985015809536

By O 0 0.0585755817592144
hemolytic O 1 0.9999246597290039
assay O 0 0.29752153158187866
, O 0 0.008069233037531376
she O 0 0.008629520423710346
exhibited O 0 0.017541956156492233
1 O 0 0.009688261896371841
- O 0 0.016574209555983543
2 O 0 0.007058930117636919
% O 0 0.004556641448289156
of O 0 0.002480677329003811
the O 0 0.005958650726824999
normal O 0 0.05623485893011093
serum O 1 0.9867984652519226
C5 O 1 0.9672715067863464
level O 0 0.010430321097373962
and O 0 0.004679516889154911
normal O 0 0.017709361389279366
concentrations O 0 0.017627257853746414
of O 0 0.003446929156780243
other O 0 0.004258792847394943
complement O 0 0.02210664004087448
components O 0 0.017661580815911293
. O 0 0.01548700500279665

C5 O 1 0.9556185603141785
levels O 0 0.024224622175097466
of O 0 0.005015207454562187
other O 0 0.004302763380110264
family O 0 0.00993196852505207
members O 0 0.004210866522043943
were O 0 0.002824739320203662
either O 0 0.006944778375327587
normal O 0 0.015407600440084934
or O 0 0.005283809266984463
approximately O 0 0.008647475391626358
half O 0 0.010356293991208076
- O 0 0.023946650326251984
normal O 0 0.02014743722975254
, O 0 0.005390773992985487
consistent O 0 0.01593560352921486
with O 0 0.01293234247714281
autosomal O 1 0.9999388456344604
codominant O 1 0.9958043694496155
inheritance O 0 0.46848225593566895
of O 0 0.008370614610612392
the O 0 0.012760303914546967
gene O 1 0.9846565127372742
determining O 0 0.20764455199241638
C5 B-Disease 1 0.9995643496513367
deficiency I-Disease 1 0.9999662637710571
. O 0 0.03595981001853943

Normal O 1 0.9667551517486572
hemolytic O 1 0.9999692440032959
titers O 1 0.9850252270698547
were O 0 0.006810775026679039
restored O 0 0.015090519562363625
to O 0 0.004767994862049818
both O 0 0.010425124317407608
homozygous O 1 0.9967882633209229
C5 B-Disease 1 0.9989469647407532
- I-Disease 1 0.8896194696426392
deficient I-Disease 1 0.999009370803833
( O 0 0.03186668083071709
C5D B-Disease 1 0.9972293972969055
) O 0 0.01364127453416586
sera O 0 0.040217846632003784
by O 0 0.006238775793462992
addition O 0 0.007337236311286688
of O 0 0.005963278468698263
highly O 0 0.023988213390111923
purified O 0 0.2285778671503067
human O 0 0.048958756029605865
C5 O 1 0.9707958102226257
. O 0 0.025220969691872597

In O 0 0.01939072087407112
specific O 0 0.03580588102340698
C5 O 1 0.9964045286178589
titrations O 1 0.9874580502510071
, O 0 0.008514571003615856
however O 0 0.006500520743429661
, O 0 0.0029777945019304752
it O 0 0.0026484569534659386
was O 0 0.003512589493766427
noted O 0 0.00514618307352066
that O 0 0.002938221674412489
when O 0 0.00458513293415308
limited O 0 0.007709452882409096
amounts O 0 0.011189626529812813
of O 0 0.006246774457395077
C5 O 1 0.9223975539207458
were O 0 0.004896972794085741
assayed O 0 0.03711698576807976
in O 0 0.0037595208268612623
the O 0 0.004053304437547922
presence O 0 0.010739619843661785
of O 0 0.00436235498636961
low O 0 0.02357020042836666
dilutions O 1 0.9549458026885986
of O 0 0.00710019888356328
either O 0 0.018107611685991287
C5D B-Disease 1 0.9994901418685913
serum O 1 0.9871565103530884
, O 0 0.009410659782588482
curving O 0 0.041096411645412445
rather O 0 0.01110376138240099
than O 0 0.011381378397345543
linear O 0 0.051163844764232635
dose O 1 0.984382688999176
- O 0 0.0375671312212944
response O 0 0.019268425181508064
plots O 0 0.01343145128339529
were O 0 0.0035779657773673534
consistently O 0 0.01195998303592205
obtained O 0 0.007944568060338497
, O 0 0.00532548688352108
suggesting O 0 0.02146141603589058
some O 0 0.011652763932943344
inhibitory O 0 0.1720544397830963
effect O 0 0.045961931347846985
. O 0 0.020781168714165688

Further O 0 0.021458398550748825
studies O 0 0.01773986406624317
suggested O 0 0.014025857672095299
that O 0 0.00741981714963913
low O 0 0.031802427023649216
dilutions O 1 0.899537980556488
of O 0 0.01402126345783472
C5D B-Disease 1 0.9988928437232971
serum O 1 0.9581034779548645
contain O 0 0.019673194736242294
a O 0 0.01238803006708622
factor O 0 0.03551454097032547
( O 0 0.009306807070970535
or O 0 0.007697027176618576
factors O 0 0.015981687232851982
) O 0 0.007264015730470419
interfering O 0 0.016465796157717705
at O 0 0.0051071373745799065
some O 0 0.004011672455817461
step O 0 0.010155555792152882
in O 0 0.005089777521789074
the O 0 0.012042177841067314
hemolytic O 1 0.9999629259109497
assay O 0 0.0683317631483078
of O 0 0.009281902574002743
C5 O 1 0.9875470995903015
, O 0 0.0054852720350027084
rather O 0 0.006595261860638857
than O 0 0.00563266035169363
a O 0 0.009975552558898926
true O 0 0.02887580171227455
C5 O 1 0.9948241710662842
inhibitor O 1 0.9652527570724487
or O 0 0.02899116277694702
inactivator O 1 0.786029040813446
. O 0 0.02986406721174717

Of O 0 0.014561131596565247
clinical O 0 0.38815051317214966
interest O 0 0.010253546759486198
are O 0 0.004098198842257261
( O 0 0.006842497270554304
a O 0 0.006376488599926233
) O 0 0.004867768380790949
the O 0 0.003971588797867298
documentation O 0 0.014873028732836246
of O 0 0.01409138273447752
membranous O 1 0.999893307685852
glomerulonephritis B-Disease 1 0.9999854564666748
, O 0 0.1849176436662674
vasculitis B-Disease 1 0.9999818801879883
, O 0 0.011760594323277473
and O 0 0.014024162665009499
arthritis B-Disease 1 0.999997615814209
in O 0 0.007279812823981047
an O 0 0.006813776213675737
individual O 0 0.01570037752389908
lacking O 0 0.42618614435195923
C5 O 1 0.9963885545730591
( O 0 0.010478236712515354
and O 0 0.004114033654332161
its O 0 0.008016769774258137
biologic O 1 0.6758337020874023
functions O 0 0.013667339459061623
) O 0 0.006316022481769323
, O 0 0.0034539420157670975
and O 0 0.003565665567293763
( O 0 0.008690880611538887
b O 0 0.021469946950674057
) O 0 0.005534479394555092
a O 0 0.008377853780984879
remarkable O 0 0.023133624345064163
propensity O 1 0.9746357202529907
to O 0 0.017734581604599953
bacterial B-Disease 1 0.9999207258224487
infections I-Disease 1 0.999972939491272
in O 0 0.00712163420394063
the O 0 0.008276062086224556
proband O 1 0.9757014513015747
, O 0 0.0056592319160699844
even O 0 0.006089331116527319
during O 0 0.00756997661665082
periods O 0 0.01254293043166399
of O 0 0.005410285200923681
low O 0 0.031002404168248177
- O 0 0.05994084104895592
dose O 1 0.9451349973678589
or O 0 0.010633326135575771
alternate O 0 0.019050877541303635
- O 0 0.044511329382658005
day O 0 0.03449758142232895
corticosteroid O 1 0.9974272847175598
therapy O 1 0.9851412773132324
. O 0 0.035197190940380096

Other O 0 0.013113616034388542
observations O 0 0.022277234122157097
indicate O 0 0.014504398219287395
that O 0 0.0037906793877482414
the O 0 0.0076737720519304276
C5D B-Disease 1 0.9886296987533569
state O 0 0.005018553696572781
is O 0 0.005171264987438917
compatible O 0 0.012200429104268551
with O 0 0.006102436687797308
normal O 0 0.07860830426216125
coagulation O 1 0.9956321120262146
function O 0 0.015091964043676853
and O 0 0.0026213438250124454
the O 0 0.0037488348316401243
capacity O 0 0.00662787863984704
to O 0 0.004273508209735155
mount O 0 0.026542872190475464
a O 0 0.03106987662613392
neutrophilic O 1 0.9995830655097961
leukocytosis O 1 0.9993017911911011
during O 1 0.6159611940383911
pyogenic B-Disease 1 0.9997460246086121
infection I-Disease 1 0.9999544620513916
. O 0 0.021306553855538368
. O 0 0.02580380253493786

Susceptibility O 1 0.9989042282104492
to O 0 0.05246655270457268
ankylosing B-Disease 1 0.999985933303833
spondylitis I-Disease 1 0.9999847412109375
in O 0 0.017893973737955093
twins O 1 0.9189348816871643
: O 0 0.008533503860235214
the O 0 0.0047272271476686
role O 0 0.00960874930024147
of O 0 0.0064764125272631645
genes O 1 0.9475306272506714
, O 0 0.010117212310433388
HLA O 1 0.9990079998970032
, O 0 0.006277039647102356
and O 0 0.0037408489733934402
the O 0 0.006354645825922489
environment O 0 0.019586000591516495
. O 0 0.017248330637812614

OBJECTIVE O 0 0.030102306976914406
To O 0 0.006083781365305185
determine O 0 0.008360311388969421
the O 0 0.005172952078282833
relative O 0 0.016513720154762268
effects O 0 0.03087093122303486
of O 0 0.00593196926638484
genetic O 0 0.217098206281662
and O 0 0.004553410690277815
environmental O 0 0.01606707274913788
factors O 0 0.01630658470094204
in O 0 0.01084824837744236
susceptibility O 1 0.9994139671325684
to O 0 0.03715088590979576
ankylosing B-Disease 1 0.9999973773956299
spondylitis I-Disease 1 0.999997615814209
( O 0 0.03155697137117386
AS B-Disease 0 0.016138456761837006
) O 0 0.013470429927110672
. O 0 0.015029761008918285

METHODS O 0 0.04031526297330856
Twins O 0 0.19374708831310272
with O 0 0.005775913130491972
AS B-Disease 0 0.005543911829590797
were O 0 0.002484910888597369
identified O 0 0.008465119637548923
from O 0 0.003743184497579932
the O 0 0.004386397078633308
Royal O 0 0.017651019617915154
National O 0 0.024502431973814964
Hospital O 1 0.9988996982574463
for O 0 0.03463956341147423
Rheumatic B-Disease 1 0.9999984502792358
Diseases I-Disease 1 0.9999656677246094
database O 0 0.14607442915439606
. O 0 0.030944986268877983

Clinical O 1 0.8920236229896545
and O 0 0.01197605300694704
radiographic O 1 0.9560104012489319
examinations O 0 0.030420754104852676
were O 0 0.003930544946342707
performed O 0 0.009127793833613396
to O 0 0.004024486523121595
establish O 0 0.02013503760099411
diagnoses O 1 0.999338686466217
, O 0 0.007462197449058294
and O 0 0.01274565514177084
disease O 1 0.999997615814209
severity O 1 0.9997710585594177
was O 0 0.00789480097591877
assessed O 0 0.016135022044181824
using O 0 0.005846547428518534
a O 0 0.007232859265059233
combination O 0 0.017137525603175163
of O 0 0.00539790652692318
validated O 0 0.02662651799619198
scoring O 0 0.01798464171588421
systems O 0 0.02465805970132351
. O 0 0.01853194087743759

HLA O 1 0.9952617883682251
typing O 0 0.18949846923351288
for O 0 0.0232760701328516
HLA O 1 0.9989922642707825
- O 0 0.17604808509349823
B27 O 1 0.9567014575004578
, O 0 0.02046351507306099
HLA O 1 0.9991025924682617
- O 0 0.3041943907737732
B60 O 1 0.9295557737350464
, O 0 0.00978520605713129
and O 0 0.010833379812538624
HLA O 1 0.9998055100440979
- O 0 0.4978342056274414
DR1 O 1 0.9937601685523987
was O 0 0.014514659531414509
performed O 0 0.018089184537529945
by O 0 0.012178841046988964
polymerase O 0 0.18408441543579102
chain O 0 0.06582896411418915
reaction O 0 0.02987070009112358
with O 0 0.008155222982168198
sequence O 0 0.02629060484468937
- O 0 0.02580760046839714
specific O 0 0.012190330773591995
primers O 0 0.03692637383937836
, O 0 0.004777663387358189
and O 0 0.00465776864439249
zygosity O 1 0.7506972551345825
was O 0 0.01017824374139309
assessed O 0 0.02889993228018284
using O 0 0.019487686455249786
microsatellite O 1 0.9279571175575256
markers O 0 0.07585039734840393
. O 0 0.02397056110203266

Genetic O 0 0.393826425075531
and O 0 0.007938452996313572
environmental O 0 0.018548287451267242
variance O 0 0.023208292201161385
components O 0 0.009317619726061821
were O 0 0.002873572986572981
assessed O 0 0.011309802532196045
with O 0 0.003072087885811925
the O 0 0.003908555023372173
program O 0 0.012999758124351501
Mx O 1 0.9178805947303772
, O 0 0.003181979525834322
using O 0 0.0033248760737478733
data O 0 0.0036219467874616385
from O 0 0.0029111066833138466
this O 0 0.00237829121761024
and O 0 0.002405468374490738
previous O 0 0.006361300125718117
studies O 0 0.01012230571359396
of O 0 0.006348208989948034
twins O 0 0.24818485975265503
with O 0 0.007957770489156246
AS B-Disease 0 0.01669473573565483
. O 0 0.019032098352909088

RESULTS O 0 0.03148035705089569
Six O 0 0.013426675461232662
of O 0 0.008957566693425179
8 O 0 0.032157909125089645
monozygotic O 1 0.9716230630874634
( O 0 0.04077544063329697
MZ O 1 0.9985830783843994
) O 0 0.022212481126189232
twin O 0 0.2425592541694641
pairs O 0 0.030122341588139534
were O 0 0.009808914735913277
disease O 1 0.9999712705612183
concordant O 1 0.9836564064025879
, O 0 0.007159496657550335
compared O 0 0.013878311030566692
with O 0 0.004786271136254072
4 O 0 0.008048385381698608
of O 0 0.00401347316801548
15 O 0 0.014384295791387558
B27 O 1 0.9409456849098206
- O 0 0.054018452763557434
positive O 0 0.05499088764190674
dizygotic O 1 0.990119218826294
( O 0 0.034787245094776154
DZ O 1 0.9935759902000427
) O 0 0.022707246243953705
twin O 0 0.0687560886144638
pairs O 0 0.02860296331346035
( O 0 0.011372223496437073
27 O 0 0.015291369520127773
% O 0 0.009721742942929268
) O 0 0.005751476157456636
and O 0 0.002858320716768503
4 O 0 0.007983689196407795
of O 0 0.006433687172830105
32 O 0 0.03448881953954697
DZ O 1 0.9939126372337341
twin O 0 0.20175409317016602
pairs O 0 0.030618974938988686
overall O 0 0.021693671122193336
( O 0 0.010423865169286728
12 O 0 0.008857857435941696
. O 0 0.004847051575779915
5 O 0 0.010875863023102283
% O 0 0.010946491733193398
) O 0 0.01236689556390047
. O 0 0.017597660422325134

Nonsignificant O 1 0.9909221529960632
increases O 0 0.041277628391981125
in O 0 0.008522359654307365
similarity O 0 0.02065369300544262
with O 0 0.0037701386027038097
regard O 0 0.008949465118348598
to O 0 0.003944415599107742
age O 0 0.0240628682076931
at O 0 0.07793409377336502
disease O 1 0.9999986886978149
onset O 1 0.9999206066131592
and O 0 0.0028941703494638205
all O 0 0.0020033419132232666
of O 0 0.003374050837010145
the O 0 0.01178058423101902
disease O 1 0.9999979734420776
severity O 1 0.9997833371162415
scores O 0 0.021291906014084816
assessed O 0 0.01947822794318199
were O 0 0.00325102754868567
noted O 0 0.007803397253155708
in O 0 0.009722706861793995
disease O 1 0.9999890327453613
- O 1 0.9815574884414673
concordant O 1 0.9989526271820068
MZ O 1 0.9998219609260559
twins O 1 0.978702187538147
compared O 0 0.03552718833088875
with O 0 0.018959179520606995
concordant O 1 0.9871907234191895
DZ O 1 0.9978415966033936
twins O 1 0.8034626245498657
. O 0 0.037285175174474716

HLA O 1 0.9983030557632446
- O 0 0.2508842945098877
B27 O 1 0.9107546806335449
and O 0 0.013029047288000584
B60 O 0 0.4961588978767395
were O 0 0.004612058401107788
associated O 0 0.009647838771343231
with O 0 0.003995132632553577
the O 0 0.009300939738750458
disease O 1 0.9999809265136719
in O 0 0.008563765324652195
probands O 1 0.992154061794281
, O 0 0.003637826768681407
and O 0 0.002283653477206826
the O 0 0.003261686535552144
rate O 0 0.010219982825219631
of O 0 0.006704641506075859
disease O 1 0.9999877214431763
concordance O 1 0.8881847858428955
was O 0 0.00979053508490324
significantly O 0 0.03370843082666397
increased O 0 0.01916746236383915
among O 0 0.01866939477622509
DZ O 1 0.9986625909805298
twin O 0 0.4374487102031708
pairs O 0 0.018312575295567513
in O 0 0.004307550378143787
which O 0 0.0037658533547073603
the O 0 0.00562732107937336
co O 0 0.027188370004296303
- O 0 0.03872593492269516
twin O 0 0.04831431806087494
was O 0 0.009526935406029224
positive O 0 0.016205811873078346
for O 0 0.00499497028067708
both O 0 0.008966760709881783
B27 O 1 0.9295787811279297
and O 0 0.01598515175282955
DR1 O 1 0.9920575022697449
. O 0 0.03075488656759262

Additive O 1 0.6343937516212463
genetic O 1 0.9719512462615967
effects O 0 0.13002875447273254
were O 0 0.0046851453371346
estimated O 0 0.011937975883483887
to O 0 0.005068626254796982
contribute O 0 0.019717469811439514
97 O 0 0.025807375088334084
% O 0 0.007667415775358677
of O 0 0.004209655802696943
the O 0 0.0071814837865531445
population O 0 0.022214414551854134
variance O 0 0.04520746320486069
. O 0 0.017897101119160652

CONCLUSION O 0 0.07281703501939774
Susceptibility O 1 0.9961249232292175
to O 0 0.0072290427051484585
AS B-Disease 0 0.007956113666296005
is O 0 0.005940483417361975
largely O 0 0.012693304568529129
genetically O 0 0.050131600350141525
determined O 0 0.01124239806085825
, O 0 0.0028220005333423615
and O 0 0.0021791458129882812
the O 0 0.004122590180486441
environmental O 0 0.015421583317220211
trigger O 1 0.8982680439949036
for O 0 0.005361352581530809
the O 0 0.010828178375959396
disease O 1 0.9999808073043823
is O 0 0.01238313689827919
probably O 0 0.023970479145646095
ubiquitous O 0 0.34270358085632324
. O 0 0.01957167498767376

HLA O 1 0.9982909560203552
- O 0 0.10974965244531631
B27 O 0 0.37279635667800903
accounts O 0 0.013061095029115677
for O 0 0.004559891298413277
a O 0 0.007500873878598213
minority O 0 0.012426381930708885
of O 0 0.0035782139748334885
the O 0 0.005719264969229698
overall O 0 0.032197948545217514
genetic O 1 0.9958328604698181
susceptibility O 1 0.9986905455589294
to O 0 0.008523366414010525
AS B-Disease 0 0.014481459744274616
. O 0 0.01677544228732586

Cell O 0 0.20209471881389618
cycle O 0 0.09748529642820358
- O 0 0.05470660328865051
dependent O 0 0.05242115259170532
colocalization O 1 0.6796788573265076
of O 0 0.012709871865808964
BARD1 O 1 0.9976837635040283
and O 0 0.017611689865589142
BRCA1 O 1 0.9994755387306213
proteins O 0 0.03223901614546776
in O 0 0.008482877165079117
discrete O 0 0.036005113273859024
nuclear O 0 0.023113476112484932
domains O 0 0.05568253621459007
. O 0 0.024438727647066116

Germ O 1 0.9750080108642578
- O 0 0.061281442642211914
line O 0 0.027105337008833885
mutations O 1 0.8882333636283875
of O 0 0.006678193341940641
the O 0 0.01507968083024025
BRCA1 O 1 0.9999728202819824
gene O 1 0.998134434223175
predispose O 1 0.9982472658157349
women O 0 0.01621147058904171
to O 0 0.0060991025529801846
early O 0 0.025329556316137314
- O 1 0.9879302978515625
onset O 1 0.9999748468399048
breast B-Disease 1 0.9999853372573853
and I-Disease 1 0.7054035067558289
ovarian I-Disease 1 0.9999994039535522
cancer I-Disease 1 0.9999867677688599
by O 0 0.01378108561038971
compromising O 0 0.04573756828904152
the O 0 0.01175580732524395
genes O 1 0.8321377635002136
presumptive O 1 0.9955393671989441
function O 0 0.02967335842549801
as O 0 0.011017819866538048
a O 0 0.03354986011981964
tumor B-Disease 1 0.9998617172241211
suppressor O 1 0.9974274039268494
. O 0 0.03589196503162384

Although O 0 0.015452558174729347
the O 0 0.010190006345510483
biochemical O 0 0.04616731032729149
properties O 0 0.017631657421588898
of O 0 0.012036427855491638
BRCA1 O 1 0.9999455213546753
polypeptides O 1 0.8937487006187439
are O 0 0.004070319700986147
not O 0 0.0034378604032099247
understood O 0 0.009634006768465042
, O 0 0.003264777595177293
their O 0 0.0037702606059610844
expression O 0 0.02307257056236267
pattern O 0 0.026161862537264824
and O 0 0.005553123075515032
subcellular O 0 0.05778538063168526
localization O 0 0.04289613664150238
suggest O 0 0.01350707933306694
a O 0 0.007145393639802933
role O 0 0.010522346943616867
in O 0 0.00670284079387784
cell O 0 0.12738658487796783
- O 0 0.04966026172041893
cycle O 0 0.0794156864285469
regulation O 0 0.048152439296245575
. O 0 0.027605803683400154

When O 0 0.03624526411294937
resting O 1 0.8507881760597229
cells O 1 0.7151135206222534
are O 0 0.007519678212702274
induced O 1 0.9893940091133118
to O 0 0.006750897970050573
proliferate O 0 0.05634333938360214
, O 0 0.004546413663774729
the O 0 0.005446021910756826
steady O 0 0.023427188396453857
- O 0 0.022570393979549408
state O 0 0.008344142697751522
levels O 0 0.017120692878961563
of O 0 0.01003226824104786
BRCA1 O 1 0.9996566772460938
increase O 0 0.016418054699897766
in O 0 0.006274547893553972
late O 0 0.019662685692310333
G1 O 1 0.9683936238288879
and O 0 0.004268248565495014
reach O 0 0.010473408736288548
a O 0 0.009313962422311306
maximum O 0 0.018348632380366325
during O 0 0.023627648130059242
S O 0 0.18823955953121185
phase O 0 0.058282919228076935
. O 0 0.026283549144864082

Moreover O 0 0.03401394188404083
, O 0 0.006550681311637163
in O 0 0.007454936392605305
S O 0 0.4730012118816376
phase O 0 0.05738481506705284
cells O 0 0.3807971477508545
, O 0 0.014584311284124851
BRCA1 O 1 0.9997267127037048
polypeptides O 0 0.2703409194946289
are O 0 0.008321592584252357
hyperphosphorylated O 1 0.7542693018913269
and O 0 0.007909109815955162
accumulate O 0 0.04412444680929184
into O 0 0.016125554218888283
discrete O 0 0.0530160553753376
subnuclear O 1 0.9559844732284546
foci O 1 0.9005544781684875
termed O 0 0.3936094343662262
" O 0 0.03396519273519516
BRCA1 O 1 0.9979811310768127
nuclear O 0 0.04748568683862686
dots O 0 0.10333335399627686
. O 0 0.03206388279795647

" O 0 0.06040237098932266
BRCA1 O 1 0.9996790885925293
associates O 0 0.04364464059472084
in O 0 0.009936963208019733
vivo O 0 0.06842916458845139
with O 0 0.0074738189578056335
a O 0 0.015626924112439156
structurally O 0 0.06564796715974808
related O 0 0.03596140444278717
protein O 0 0.08153128623962402
termed O 0 0.23842854797840118
BARD1 O 1 0.9625265002250671
. O 0 0.028924651443958282

Here O 0 0.010395933873951435
we O 0 0.00519057409837842
show O 0 0.008141771890223026
that O 0 0.0030384273268282413
the O 0 0.004914146848022938
steady O 0 0.023853279650211334
- O 0 0.020322538912296295
state O 0 0.00617004232481122
levels O 0 0.012940788641571999
of O 0 0.00593536626547575
BARD1 O 1 0.9902614951133728
, O 0 0.005114694591611624
unlike O 0 0.009071392007172108
those O 0 0.004153231158852577
of O 0 0.007355554029345512
BRCA1 O 1 0.9999403953552246
, O 0 0.006241081282496452
remain O 0 0.009797180071473122
relatively O 0 0.01568763330578804
constant O 0 0.02633960358798504
during O 0 0.020863322541117668
cell O 0 0.40942102670669556
cycle O 1 0.7384119629859924
progression O 1 0.9851607084274292
. O 0 0.032953646034002304

However O 0 0.019662726670503616
, O 0 0.011584938503801823
immunostaining O 1 0.9197667241096497
revealed O 0 0.026587726548314095
that O 0 0.008144029416143894
BARD1 O 1 0.989385187625885
resides O 0 0.041211631149053574
within O 0 0.018728362396359444
BRCA1 O 1 0.999554455280304
nuclear O 0 0.020897332578897476
dots O 0 0.0990416407585144
during O 0 0.018311474472284317
S O 0 0.05950820818543434
phase O 0 0.02123372070491314
of O 0 0.004484372679144144
the O 0 0.006740726064890623
cell O 0 0.050270289182662964
cycle O 0 0.036798566579818726
, O 0 0.004574153106659651
but O 0 0.0037058303132653236
not O 0 0.003553560469299555
during O 0 0.00982709415256977
the O 0 0.011535737663507462
G1 O 1 0.9725590944290161
phase O 0 0.06588409841060638
. O 0 0.025919903069734573

Nevertheless O 0 0.054942045360803604
, O 0 0.01845567487180233
BARD1 O 1 0.989029049873352
polypeptides O 0 0.12114815413951874
are O 0 0.004483305849134922
found O 0 0.0059692515060305595
exclusively O 0 0.0054830219596624374
in O 0 0.002485232427716255
the O 0 0.003046864178031683
nuclear O 0 0.007424028590321541
fractions O 0 0.013141927309334278
of O 0 0.004271917976438999
both O 0 0.008129267022013664
G1 O 1 0.9924152493476868
- O 0 0.03287127614021301
and O 0 0.009987407363951206
S O 1 0.6732280254364014
- O 0 0.07186632603406906
phase O 0 0.07631946355104446
cells O 0 0.2527039349079132
. O 0 0.02369638904929161

Therefore O 0 0.021561764180660248
, O 0 0.009835045784711838
progression O 1 0.9209175109863281
to O 0 0.008012350648641586
S O 0 0.10132887214422226
phase O 0 0.02500818856060505
is O 0 0.0065697673708200455
accompanied O 0 0.012547590769827366
by O 0 0.004866865463554859
the O 0 0.00565218273550272
aggregation O 0 0.034580085426568985
of O 0 0.006548874545842409
nuclear O 0 0.02081500180065632
BARD1 O 1 0.9777759909629822
polypeptides O 0 0.13674068450927734
into O 0 0.029086142778396606
BRCA1 O 1 0.998613715171814
nuclear O 0 0.036784905940294266
dots O 0 0.10404153168201447
. O 0 0.026898682117462158

This O 0 0.017285995185375214
cell O 0 0.07263601571321487
cycle O 0 0.07529021054506302
- O 0 0.052117735147476196
dependent O 0 0.050483062863349915
colocalization O 1 0.6600397825241089
of O 0 0.012470182962715626
BARD1 O 1 0.9931011199951172
and O 0 0.01344251912087202
BRCA1 O 1 0.9998224377632141
indicates O 0 0.02995430864393711
a O 0 0.009087407030165195
role O 0 0.0113702192902565
for O 0 0.008232247084379196
BARD1 O 1 0.9812465310096741
in O 0 0.02431299537420273
BRCA1 O 1 0.9998980760574341
- O 1 0.9746928215026855
mediated O 1 0.9953961968421936
tumor B-Disease 1 0.9998921155929565
suppression O 1 0.8371586799621582
. O 0 0.029503455385565758

Ethnic O 0 0.037477292120456696
differences O 0 0.022369656711816788
in O 0 0.009319658391177654
the O 0 0.016353147104382515
HFE O 1 0.9930697083473206
codon O 1 0.6984335780143738
282 O 0 0.31984689831733704
( O 0 0.045948125422000885
Cys O 1 0.9988597631454468
/ O 1 0.9750720262527466
Tyr O 1 0.9959679841995239
) O 0 0.03330596536397934
polymorphism O 0 0.44066083431243896
. O 0 0.02423427812755108

Recent O 0 0.029299894347786903
studies O 0 0.017895692959427834
have O 0 0.007148062810301781
shown O 0 0.01449745986610651
that O 0 0.011889292858541012
hereditary B-Disease 1 0.9999439716339111
hemochromatosis I-Disease 1 0.9999977350234985
( O 0 0.34087127447128296
HH B-Disease 1 0.9999034404754639
) O 0 0.009718961082398891
is O 0 0.004617652855813503
likely O 0 0.007643670774996281
to O 0 0.002888050628826022
be O 0 0.0034216209314763546
caused O 0 0.04284005984663963
by O 0 0.006776837166398764
homozygosity O 0 0.4618273079395294
for O 0 0.0065490179695189
a O 0 0.01722368597984314
Cys282Tyr O 1 0.9943329095840454
mutation O 1 0.9956028461456299
in O 0 0.00943777896463871
the O 0 0.016942959278821945
HFE O 1 0.9991617202758789
gene O 1 0.9669492840766907
located O 0 0.029386740177869797
4 O 0 0.030804749578237534
. O 0 0.023988043889403343

5 O 0 0.05407596379518509
Mb O 1 0.8973800539970398
telomeric O 1 0.9660481810569763
to O 0 0.027134494855999947
HLA O 1 0.9980681538581848
- O 0 0.057220615446567535
A O 0 0.03525330871343613
. O 0 0.024860145524144173

Population O 0 0.028551895171403885
studies O 0 0.01167191844433546
of O 0 0.004126433283090591
this O 0 0.006079250946640968
polymorphism O 0 0.17215363681316376
are O 0 0.003504469059407711
facilitated O 0 0.015969421714544296
by O 0 0.004258410539478064
the O 0 0.0031020138412714005
fact O 0 0.005912823602557182
that O 0 0.003778336104005575
the O 0 0.009074684232473373
Cys282Tyr O 1 0.9939202070236206
mutation O 1 0.9975358247756958
creates O 0 0.0473737008869648
a O 0 0.025278467684984207
Rsal O 1 0.9086089134216309
restriction O 0 0.05361789092421532
site O 0 0.025462331250309944
. O 0 0.02213302068412304

We O 0 0.010194133967161179
have O 0 0.006792331114411354
studied O 0 0.013068472035229206
the O 0 0.012108356691896915
codon O 0 0.17936232686042786
282 O 0 0.12995925545692444
( O 0 0.036544568836688995
Cys O 1 0.9963783621788025
/ O 1 0.9133909344673157
Tyr O 1 0.9954901337623596
) O 0 0.020701361820101738
polymorphism O 0 0.06441418081521988
in O 0 0.004969426430761814
different O 0 0.005932671949267387
ethnic O 0 0.016644658520817757
groups O 0 0.019326619803905487
. O 0 0.021892767399549484

In O 0 0.008358489722013474
agreement O 0 0.0070780436508357525
with O 0 0.004508307669311762
previous O 0 0.010070625692605972
observations O 0 0.014817575924098492
the O 0 0.011452714912593365
Tyr O 1 0.9992454051971436
allele O 1 0.9969747066497803
appeared O 0 0.013747957535088062
to O 0 0.00338885560631752
be O 0 0.00349744176492095
rare O 0 0.016973042860627174
or O 0 0.007470599841326475
absent O 0 0.036554526537656784
in O 0 0.006932447198778391
Asiatic O 1 0.9307035803794861
( O 0 0.010795004665851593
Indian O 0 0.010344687849283218
, O 0 0.004957533907145262
Chinese O 0 0.013026840053498745
) O 0 0.014048137702047825
populations O 0 0.04823281243443489
. O 0 0.022293804213404655

The O 0 0.017117585986852646
highest O 0 0.039769601076841354
allele O 1 0.9514721035957336
frequency O 0 0.05232221633195877
( O 0 0.015066555701196194
7 O 0 0.013906450942158699
. O 0 0.005405873991549015
5 O 0 0.011070729233324528
% O 0 0.008348226547241211
) O 0 0.005693578626960516
was O 0 0.005188314709812403
found O 0 0.008106200955808163
in O 0 0.007906259968876839
Swedes O 0 0.057869866490364075
. O 0 0.024026980623602867

Saamis O 1 0.9496225118637085
( O 0 0.022546669468283653
2 O 0 0.01454179733991623
% O 0 0.011025638319551945
) O 0 0.007055389229208231
and O 0 0.005347768310457468
Mordvinians O 1 0.9156785607337952
( O 0 0.0112720662727952
1 O 0 0.009455770254135132
. O 0 0.005242498125880957
8 O 0 0.009774566628038883
% O 0 0.00800823513418436
) O 0 0.006515176501125097
had O 0 0.0060325078666210175
significantly O 0 0.02119876630604267
lower O 0 0.01539380569010973
frequencies O 0 0.01680106297135353
of O 0 0.005772206466645002
the O 0 0.014779197983443737
Tyr O 1 0.995834231376648
allele O 1 0.9759179353713989
. O 0 0.03479151800274849

Comparisons O 0 0.04413613677024841
with O 0 0.01680295355618
allele O 1 0.8708968162536621
frequencies O 0 0.027691209688782692
based O 0 0.008507376536726952
on O 0 0.00850978959351778
prevalence O 1 0.9569265842437744
estimates O 0 0.019409948959946632
of O 0 0.008282569237053394
HH B-Disease 1 0.9997562766075134
showed O 0 0.017790211364626884
some O 0 0.0056391432881355286
disagreements O 0 0.014461295679211617
with O 0 0.004304943606257439
the O 0 0.006914759520441294
RFLP O 1 0.982012927532196
data O 0 0.008713336661458015
, O 0 0.0042982860468328
particularly O 0 0.010646063834428787
in O 0 0.00714784674346447
Finns O 0 0.09448255598545074
. O 0 0.023424534127116203

The O 0 0.018006712198257446
newly O 0 0.03386755287647247
described O 0 0.04659872502088547
HFE O 1 0.9974225759506226
marker O 0 0.06646492332220078
provides O 0 0.013699485920369625
a O 0 0.007735519669950008
new O 0 0.005489121191203594
approach O 0 0.008928464725613594
to O 0 0.003288284409791231
the O 0 0.006225025746971369
screening O 0 0.03125585988163948
of O 0 0.007603749167174101
HH B-Disease 1 0.9993984699249268
as O 0 0.0049112094566226006
well O 0 0.0032789036631584167
as O 0 0.0030616275034844875
studies O 0 0.005957037676125765
of O 0 0.0029549046885222197
the O 0 0.003919061738997698
relationship O 0 0.014251301996409893
between O 0 0.008163110353052616
the O 0 0.01435832493007183
HFE O 1 0.9997522234916687
Tyr O 1 0.9992805123329163
allele O 1 0.9951462149620056
and O 0 0.009727961383759975
different O 0 0.016676796600222588
disorders O 1 0.9998193383216858
including O 0 0.047439079731702805
cancer B-Disease 1 0.9998273253440857

Autosomal B-Disease 1 0.9998289346694946
dominant I-Disease 1 0.9952219128608704
neurohypophyseal I-Disease 1 0.999840259552002
diabetes I-Disease 1 0.9999977350234985
insipidus I-Disease 1 0.9999290704727173
associated O 0 0.030391862615942955
with O 0 0.008128110319375992
a O 0 0.021169520914554596
missense O 1 0.9924289584159851
mutation O 1 0.9974784255027771
encoding O 0 0.2457478791475296
Gly23 O 1 0.995302677154541
- O 0 0.3136692941188812
- O 0 0.33572933077812195
> O 1 0.976838231086731
Val O 1 0.9752590656280518
in O 0 0.022388581186532974
neurophysin O 1 0.9500494599342346
II O 0 0.40777677297592163
. O 0 0.027343038469552994

Autosomal B-Disease 1 0.9998966455459595
dominant I-Disease 1 0.997082531452179
neurohypophyseal I-Disease 1 0.9999384880065918
diabetes I-Disease 1 0.9999994039535522
insipidus I-Disease 1 0.9999932050704956
( O 0 0.2594338357448578
ADNDI B-Disease 1 0.9977815747261047
) O 0 0.011034990660846233
is O 0 0.007694401312619448
an O 0 0.014283397234976292
inherited B-Disease 1 0.9999828338623047
disease I-Disease 1 0.9999994039535522
caused O 1 0.9987903237342834
by O 0 0.015608851797878742
progressive O 1 0.9986489415168762
degeneration O 1 0.9999539852142334
of O 0 0.00838662963360548
the O 0 0.011218083091080189
magnocellular O 1 0.9972551465034485
neurons O 0 0.43177610635757446
of O 0 0.00624479167163372
the O 0 0.010153542272746563
hypothalamus O 1 0.9950245022773743
leading O 0 0.014451641589403152
to O 0 0.006007506977766752
decreased O 0 0.12762866914272308
ability O 0 0.012469579465687275
to O 0 0.0041146413423120975
produce O 0 0.011216675862669945
the O 0 0.013684894889593124
hormone O 1 0.9880427122116089
arginine O 1 0.8518232703208923
vasopressin O 1 0.9908267855644226
( O 0 0.0386429987847805
AVP O 1 0.9680514335632324
) O 0 0.026152411475777626
. O 0 0.023800484836101532

Affected O 0 0.3958382308483124
individuals O 0 0.01779850386083126
are O 0 0.005040851421654224
not O 0 0.008016363717615604
symptomatic O 1 0.9987051486968994
at O 0 0.010657335631549358
birth O 0 0.4822313189506531
, O 0 0.0041302950121462345
but O 0 0.005423547234386206
usually O 0 0.016694994643330574
develop O 1 0.9347871541976929
diabetes B-Disease 1 0.9999982118606567
insipidus I-Disease 1 0.9999420642852783
at O 0 0.01628703624010086
1 O 0 0.02028176188468933
- O 0 0.03721530735492706
6 O 0 0.028175782412290573
yr O 1 0.9740644693374634
of O 0 0.009848745539784431
age O 0 0.03027506172657013
. O 0 0.021240489557385445

The O 0 0.020846150815486908
genetic O 0 0.3783006966114044
locus O 1 0.6896266937255859
of O 0 0.007870255038142204
the O 0 0.012909628450870514
disease O 1 0.9999464750289917
is O 0 0.01065291278064251
the O 0 0.012192795053124428
AVP O 1 0.9979268312454224
- O 1 0.5950228571891785
neurophysin O 1 0.995572566986084
II O 1 0.8911842703819275
( O 0 0.029679447412490845
NPII O 1 0.9814613461494446
) O 0 0.021992985159158707
gene O 1 0.6606881022453308
, O 0 0.005963761825114489
and O 0 0.00635594641789794
mutations O 1 0.9977505803108215
that O 0 0.007364594377577305
cause O 1 0.9964911341667175
ADNDI B-Disease 1 0.9978674650192261
have O 0 0.005212746560573578
been O 0 0.004267399199306965
found O 0 0.004653760697692633
in O 0 0.0027869425248354673
both O 0 0.0029599848203361034
the O 0 0.003674208652228117
signal O 0 0.01902894489467144
peptide O 0 0.03878803923726082
of O 0 0.004456834401935339
the O 0 0.008836590684950352
prepro O 1 0.9855981469154358
- O 0 0.36542463302612305
AVP O 1 0.9937242865562439
- O 0 0.23520377278327942
NPII O 1 0.9857284426689148
precursor O 0 0.06397788226604462
and O 0 0.009047335013747215
within O 0 0.017933543771505356
NPII O 1 0.9546268582344055
itself O 0 0.03873346373438835
. O 0 0.025162778794765472

An O 0 0.02330620214343071
affected O 0 0.2351156324148178
girl O 0 0.3156248927116394
who O 0 0.010138562880456448
presented O 0 0.008958710357546806
at O 0 0.006708958186209202
9 O 0 0.010027050971984863
months O 0 0.00922772753983736
of O 0 0.0035341023467481136
age O 0 0.011523487977683544
and O 0 0.0041878717020154
her O 0 0.01292120199650526
similarly O 0 0.09345456957817078
affected O 1 0.8037403225898743
younger O 0 0.4577159285545349
brother O 0 0.02627803385257721
and O 0 0.0037616898771375418
father O 0 0.009763565845787525
were O 0 0.002226889133453369
all O 0 0.0021129529923200607
found O 0 0.003912050276994705
to O 0 0.0022244544234126806
have O 0 0.003258161712437868
a O 0 0.009503763169050217
novel O 0 0.03747957944869995
missense O 1 0.9962794184684753
mutation O 1 0.9975578784942627
( O 0 0.030632395297288895
G1758 O 1 0.9915934801101685
- O 1 0.5499491691589355
- O 1 0.5881208777427673
> O 1 0.9854300022125244
T O 1 0.9478316903114319
) O 0 0.011455737985670567
encoding O 0 0.029982635751366615
the O 0 0.008716121315956116
amino O 0 0.03783903270959854
acid O 0 0.07013153284788132
substitution O 0 0.05593224987387657
Gly23 O 1 0.9876629710197449
- O 0 0.23244889080524445
- O 0 0.307839959859848
> O 1 0.9708907604217529
Val O 1 0.9842580556869507
within O 0 0.031953372061252594
NPII O 1 0.9601805806159973
. O 0 0.03237538039684296

The O 0 0.02395191602408886
mutation O 1 0.9916364550590515
was O 0 0.013397840782999992
confirmed O 0 0.020836032927036285
by O 0 0.01202878076583147
restriction O 0 0.05259391665458679
endonuclease O 1 0.8928754925727844
analysis O 0 0.03274327144026756
. O 0 0.021133115515112877

A O 0 0.06713446974754333
T1 O 1 0.8764599561691284
- O 0 0.06126024201512337
weighted O 0 0.053519293665885925
magnetic O 0 0.04655059799551964
resonance O 0 0.06370122730731964
imaging O 0 0.04750639572739601
of O 0 0.005967027507722378
the O 0 0.011678316630423069
fathers O 1 0.6774960160255432
pituitary O 1 0.9992554783821106
gland O 1 0.9968145489692688
demonstrates O 0 0.07062898576259613
an O 0 0.027105117216706276
attenuated O 1 0.9953727126121521
posterior O 1 0.9986017346382141
pituitary O 1 0.9995334148406982
bright O 0 0.3515128791332245
spot O 0 0.06772515177726746
. O 0 0.030963659286499023

This O 0 0.022280845791101456
mutation O 1 0.9966188669204712
may O 0 0.012591959908604622
be O 0 0.003249078057706356
valuable O 0 0.006451219320297241
for O 0 0.003490820759907365
developing O 0 0.013445233926177025
models O 0 0.013421647250652313
of O 0 0.009489495307207108
dominantly B-Disease 1 0.99935382604599
inherited I-Disease 1 0.9999266862869263
neurodegeneration I-Disease 1 0.9999732971191406
, O 0 0.0064160386100411415
as O 0 0.0036540436558425426
the O 0 0.004156829789280891
early O 0 0.009314504452049732
age O 0 0.012892630882561207
of O 0 0.008484797552227974
onset O 1 0.9998865127563477
of O 0 0.016903014853596687
symptoms O 1 0.9999959468841553
suggests O 0 0.04711276665329933
that O 0 0.004664761945605278
this O 0 0.007251440547406673
mutation O 1 0.9994086027145386
may O 0 0.011691036634147167
be O 0 0.004147724248468876
particularly O 0 0.015346703119575977
deleterious O 1 0.9686473608016968
to O 0 0.0067368741147220135
the O 0 0.014238753356039524
magnocellular O 1 0.9955269694328308
neuron O 1 0.9925410747528076
. O 0 0.01359239500015974
. O 0 0.018305979669094086

Frequent O 0 0.14620570838451385
inactivation O 1 0.9741809368133545
of O 0 0.02884688414633274
PTEN O 1 0.9997382760047913
/ O 1 0.9860976934432983
MMAC1 O 1 0.9967097043991089
in O 0 0.023204073309898376
primary O 1 0.9919006824493408
prostate B-Disease 1 0.999998927116394
cancer I-Disease 1 0.9999876022338867
. O 0 0.038101185113191605

Sporadic B-Disease 1 0.9987422823905945
prostate I-Disease 1 0.9999963045120239
carcinoma I-Disease 1 0.9999921321868896
is O 0 0.010588357225060463
the O 0 0.00650964817032218
most O 0 0.007957950234413147
common O 0 0.4122677445411682
male B-Disease 1 0.9978431463241577
cancer I-Disease 1 0.9999479055404663
in O 0 0.004289910662919283
the O 0 0.0037530665285885334
Western O 0 0.007570305839180946
world O 0 0.006006427574902773
, O 0 0.0028212345205247402
yet O 0 0.0038280498702079058
many O 0 0.0019459371687844396
of O 0 0.0018886412726715207
the O 0 0.003624990815296769
major O 0 0.01007825881242752
genetic O 0 0.3825502097606659
events O 0 0.007107934448868036
involved O 0 0.007355721201747656
in O 0 0.003514551091939211
the O 0 0.0053696054965257645
progression O 1 0.8946664333343506
of O 0 0.00526268919929862
this O 0 0.008025124669075012
often O 0 0.11983173340559006
fatal O 1 0.9999831914901733
cancer B-Disease 1 0.9999814033508301
remain O 0 0.012872263789176941
to O 0 0.005547259468585253
be O 0 0.007052763365209103
elucidated O 0 0.47621026635169983
. O 0 0.021607454866170883

Numerous O 0 0.051640260964632034
cytogenetic O 1 0.9665812849998474
and O 0 0.012472579255700111
allelotype O 1 0.8828896880149841
studies O 0 0.016947008669376373
have O 0 0.006622616201639175
reported O 0 0.021195750683546066
frequent O 0 0.03876859322190285
loss O 0 0.034426625818014145
of O 0 0.011133857071399689
heterozygosity O 1 0.9943928718566895
on O 0 0.01919194497168064
chromosomal O 1 0.999349057674408
arm O 1 0.983148455619812
10q O 1 0.9826045632362366
in O 0 0.026806646957993507
sporadic B-Disease 1 0.9983716607093811
prostate I-Disease 1 0.9999992847442627
cancer I-Disease 1 0.9999855756759644
. O 0 0.04012001305818558

Deletion O 1 0.8821319341659546
mapping O 0 0.04764821380376816
studies O 0 0.016369149088859558
have O 0 0.0073588029481470585
unambiguously O 0 0.032971691340208054
identified O 0 0.014997916296124458
a O 0 0.007958274334669113
region O 0 0.01484261266887188
of O 0 0.00931620690971613
chromosome O 1 0.9987364411354065
10q23 O 1 0.8805403113365173
to O 0 0.004050773568451405
be O 0 0.00289416266605258
the O 0 0.0040857018902897835
minimal O 0 0.02158493548631668
area O 0 0.010190332308411598
of O 0 0.0070503330789506435
loss O 0 0.08752162009477615
. O 0 0.019650738686323166

A O 0 0.034835733473300934
new O 0 0.03287363424897194
tumor B-Disease 1 0.9999229907989502
suppressor O 1 0.999785840511322
gene O 1 0.9961807727813721
, O 0 0.02331903576850891
PTEN O 1 0.9998701810836792
/ O 1 0.9874517321586609
MMAC1 O 1 0.9972859621047974
, O 0 0.007514640688896179
was O 0 0.008950745686888695
isolated O 0 0.038465727120637894
recently O 0 0.013852869160473347
at O 0 0.004932540934532881
this O 0 0.0040470934472978115
region O 0 0.014028950594365597
of O 0 0.009433829225599766
chromosome O 1 0.9989904761314392
10q23 O 1 0.9714183211326599
and O 0 0.004763066302984953
found O 0 0.005952485371381044
to O 0 0.002849849872291088
be O 0 0.004580512642860413
inactivated O 0 0.23920926451683044
by O 0 0.009192642755806446
mutation O 1 0.9959659576416016
in O 0 0.010019177570939064
three O 0 0.03624136000871658
prostate B-Disease 1 0.9999995231628418
cancer I-Disease 1 0.999997615814209
cell O 1 0.9118092656135559
lines O 0 0.036493632942438126
. O 0 0.021139010787010193

We O 0 0.01806841790676117
screened O 1 0.6836504340171814
80 O 1 0.8311511278152466
prostate B-Disease 1 0.9999964237213135
tumors I-Disease 1 0.9999276399612427
by O 0 0.01564415730535984
microsatellite O 1 0.9673031568527222
analysis O 0 0.01907188445329666
and O 0 0.006796803791075945
found O 0 0.02085781842470169
chromosome O 1 0.9977891445159912
10q23 O 1 0.8549863696098328
to O 0 0.005386329721659422
be O 0 0.004598209168761969
deleted O 0 0.02388800121843815
in O 0 0.005949179641902447
23 O 0 0.018782077357172966
cases O 0 0.02716143988072872
. O 0 0.018758205696940422

We O 0 0.008306259289383888
then O 0 0.006843178067356348
proceeded O 0 0.011120853945612907
with O 0 0.003481021849438548
sequence O 0 0.013393044471740723
analysis O 0 0.00734313577413559
of O 0 0.0033445085864514112
the O 0 0.007556250784546137
entire O 0 0.04315781965851784
PTEN O 1 0.9994787573814392
/ O 1 0.9367157220840454
MMAC1 O 1 0.9953658580780029
coding O 0 0.15622173249721527
region O 0 0.01873709261417389
and O 0 0.004765162244439125
tested O 0 0.022547699511051178
for O 0 0.007057278882712126
homozygous O 1 0.9877694249153137
deletion O 1 0.7425377368927002
with O 0 0.006284271366894245
new O 0 0.009482555091381073
intragenic O 1 0.9756900072097778
markers O 0 0.027409467846155167
in O 0 0.004930275958031416
these O 0 0.0037862416356801987
23 O 0 0.01319456659257412
cases O 0 0.013636616058647633
with O 0 0.00873798318207264
10q23 O 1 0.9647138118743896
loss O 0 0.10259313136339188
of O 0 0.015481444075703621
heterozygosity O 1 0.9919711351394653
. O 0 0.03289644047617912

The O 0 0.010699470527470112
identification O 0 0.01611345447599888
of O 0 0.0043853046372532845
the O 0 0.006233096122741699
second O 0 0.015421980991959572
mutational O 1 0.9830443263053894
event O 0 0.016804907470941544
in O 0 0.0057737999595701694
10 O 0 0.007972023449838161
( O 0 0.009946678765118122
43 O 0 0.02082536555826664
% O 0 0.01776224561035633
) O 0 0.02507893182337284
tumors B-Disease 1 0.9998733997344971
establishes O 1 0.987436056137085
PTEN O 1 0.9998469352722168
/ O 1 0.955224335193634
MMAC1 O 1 0.9064372181892395
as O 0 0.0067371102049946785
a O 0 0.009329528547823429
main O 0 0.01435814332216978
inactivation O 1 0.829124391078949
target O 0 0.014119412750005722
of O 0 0.007751871831715107
10q O 1 0.9802979826927185
loss O 1 0.6045723557472229
in O 0 0.01669791340827942
sporadic B-Disease 1 0.9990699887275696
prostate I-Disease 1 0.9999996423721313
cancer I-Disease 1 0.9999946355819702
. O 0 0.020527726039290428
. O 0 0.02606818825006485

Risk O 1 0.9636244177818298
reversals O 0 0.38072216510772705
in O 0 0.013176542706787586
predictive O 1 0.6967754364013672
testing O 0 0.06363260746002197
for O 0 0.02141985110938549
Huntington B-Disease 1 0.9999465942382812
disease I-Disease 1 0.9999916553497314
. O 0 0.03425569459795952

The O 0 0.012915972620248795
first O 0 0.015146761201322079
predictive O 0 0.09093472361564636
testing O 0 0.0446096695959568
for O 0 0.018796607851982117
Huntington B-Disease 1 0.9999661445617676
disease I-Disease 1 0.9999974966049194
( O 0 0.04582812637090683
HD B-Disease 1 0.9675427079200745
) O 0 0.007949530147016048
was O 0 0.0044310083612799644
based O 0 0.003820554120466113
on O 0 0.0029674284160137177
analysis O 0 0.00836481899023056
of O 0 0.006744766142219305
linked O 0 0.11572901904582977
polymorphic O 1 0.9920733571052551
DNA O 0 0.07167283445596695
markers O 0 0.024269983172416687
to O 0 0.00404699333012104
estimate O 0 0.010873102582991123
the O 0 0.005643882788717747
likelihood O 0 0.025297090411186218
of O 0 0.006822512950748205
inheriting O 1 0.9194080233573914
the O 0 0.015728715807199478
mutation O 1 0.9888461232185364
for O 0 0.014798326417803764
HD B-Disease 0 0.27473950386047363
. O 0 0.026759231463074684

Limits O 0 0.021043812856078148
to O 0 0.006206881254911423
accuracy O 0 0.014576590619981289
included O 0 0.00994615163654089
recombination O 0 0.056609828025102615
between O 0 0.006252943072468042
the O 0 0.006688692606985569
DNA O 0 0.033579323440790176
markers O 0 0.019564161077141762
and O 0 0.004139881115406752
the O 0 0.007994178682565689
mutation O 1 0.999451220035553
, O 0 0.008169432170689106
pedigree O 0 0.47835999727249146
structure O 0 0.01032604742795229
, O 0 0.003274038899689913
and O 0 0.0025686766020953655
whether O 0 0.006343773566186428
DNA O 0 0.023307565599679947
samples O 0 0.012607812881469727
were O 0 0.0033369259908795357
available O 0 0.004769347608089447
from O 0 0.005367856472730637
family O 0 0.015517925843596458
members O 0 0.01254076324403286
. O 0 0.018727315589785576

With O 0 0.009938383474946022
direct O 0 0.015441413968801498
tests O 0 0.012412580661475658
for O 0 0.004137994721531868
the O 0 0.007876181043684483
HD B-Disease 1 0.9962306618690491
mutation O 1 0.9987195730209351
, O 0 0.0043665324337780476
we O 0 0.003098082495853305
have O 0 0.0035176104865968227
assessed O 0 0.011504635214805603
the O 0 0.00347943720407784
accuracy O 0 0.007162109948694706
of O 0 0.0031698488164693117
results O 0 0.00792202539741993
obtained O 0 0.006406385451555252
by O 0 0.0062380894087255
linkage O 0 0.043427638709545135
approaches O 0 0.022164706140756607
when O 0 0.007795016746968031
requested O 0 0.007859531790018082
to O 0 0.003389316378161311
do O 0 0.004233868792653084
so O 0 0.00391216529533267
by O 0 0.004037939477711916
the O 0 0.005126573611050844
test O 0 0.01576315052807331
individuals O 0 0.017268117517232895
. O 0 0.01877438835799694

For O 0 0.008203701116144657
six O 0 0.007852790877223015
such O 0 0.003975193481892347
individuals O 0 0.007504114415496588
, O 0 0.003561955178156495
there O 0 0.00362186785787344
was O 0 0.005498455837368965
significant O 0 0.011593885719776154
disparity O 0 0.0350353978574276
between O 0 0.006932601798325777
the O 0 0.007394189480692148
tests O 0 0.023408951237797737
. O 0 0.01920434646308422

Three O 0 0.010772409848868847
went O 0 0.010319685563445091
from O 0 0.007395376451313496
a O 0 0.014264551922678947
decreased O 1 0.8096741437911987
risk O 1 0.6185846328735352
to O 0 0.004148209001868963
an O 0 0.005402275826781988
increased O 0 0.021550646051764488
risk O 1 0.8913769125938416
, O 0 0.003030821681022644
while O 0 0.002855198923498392
in O 0 0.002891433658078313
another O 0 0.006014976650476456
three O 0 0.0039646136574447155
the O 0 0.007066869642585516
risk O 0 0.35096946358680725
was O 0 0.014260515570640564
decreased O 0 0.4173685312271118
. O 0 0.021393422037363052

Knowledge O 0 0.015645844861865044
of O 0 0.00477936677634716
the O 0 0.005122603848576546
potential O 0 0.01155779603868723
reasons O 0 0.006986674387007952
for O 0 0.0026558823883533478
these O 0 0.002492171712219715
changes O 0 0.006692413240671158
in O 0 0.002538328990340233
results O 0 0.007931838743388653
and O 0 0.0028303200379014015
impact O 0 0.009877719916403294
of O 0 0.00348449032753706
these O 0 0.004560358822345734
risk O 1 0.9649668335914612
reversals O 1 0.8160086274147034
on O 0 0.004968800116330385
both O 0 0.00631109531968832
patients O 1 0.9989951252937317
and O 0 0.0035590440966188908
the O 0 0.0052780881524086
counseling O 0 0.4435054063796997
team O 0 0.007405274547636509
can O 0 0.0045880889520049095
assist O 0 0.007862350903451443
in O 0 0.0022864551283419132
the O 0 0.0026961055118590593
development O 0 0.004205303732305765
of O 0 0.00257018581032753
strategies O 0 0.01146611012518406
for O 0 0.0026444897521287203
the O 0 0.0049288212321698666
prevention O 1 0.9338264465332031
and O 0 0.002760708099231124
, O 0 0.002740195021033287
where O 0 0.0032601444981992245
necessary O 0 0.004837198182940483
, O 0 0.0028962353244423866
management O 0 0.008928995579481125
of O 0 0.003608415834605694
a O 0 0.010407832451164722
risk O 1 0.9857563376426697
reversal O 0 0.07296107709407806
in O 0 0.004422692582011223
any O 0 0.0069216457195580006
predictive O 0 0.34042155742645264
testing O 0 0.02877873368561268
program O 0 0.01810266450047493
. O 0 0.009271007962524891
. O 0 0.019009778276085854

A O 0 0.033709995448589325
novel O 0 0.04197607934474945
common O 0 0.0492992028594017
missense O 1 0.9967532753944397
mutation O 1 0.9986692667007446
G301C O 1 0.831348717212677
in O 0 0.0070462580770254135
the O 0 0.008726504631340504
N O 0 0.07251031696796417
- O 0 0.08622679114341736
acetylgalactosamine O 1 0.9491434693336487
- O 0 0.05642422288656235
6 O 0 0.036893222481012344
- O 0 0.16835787892341614
sulfate O 1 0.9601942300796509
sulfatase O 1 0.9950662851333618
gene O 1 0.7946484088897705
in O 0 0.024280423298478127
mucopolysaccharidosis B-Disease 1 0.9591890573501587
IVA I-Disease 1 0.9800317287445068
. O 0 0.037900906056165695

Mucopolysaccharidosis B-Disease 1 0.9939303398132324
IVA I-Disease 1 0.997149646282196
( O 0 0.03722653165459633
MPS B-Disease 1 0.9149464964866638
IVA I-Disease 1 0.9990624785423279
) O 0 0.013639003969728947
is O 0 0.009086544625461102
an O 0 0.01795809343457222
autosomal B-Disease 1 0.9999830722808838
recessive I-Disease 1 0.9999955892562866
lysosomal I-Disease 1 0.9999109506607056
storage I-Disease 1 0.9800909161567688
disorder I-Disease 1 0.9999953508377075
caused O 1 0.9855070114135742
by O 0 0.010277392342686653
a O 0 0.020062478259205818
genetic B-Disease 1 0.9965108036994934
defect I-Disease 1 0.9971405267715454
in O 0 0.011645049788057804
N O 0 0.07515259832143784
- O 0 0.07120048999786377
acetylgalactosamine O 1 0.9526471495628357
- O 0 0.055360253900289536
6 O 0 0.039331186562776566
- O 0 0.18135489523410797
sulfate O 1 0.9887632131576538
sulfatase O 1 0.9968987703323364
( O 0 0.048504140228033066
GALNS O 1 0.901418924331665
) O 0 0.025798747316002846
. O 0 0.023173285648226738

In O 0 0.0099656255915761
previous O 0 0.012406198307871819
studies O 0 0.009518034756183624
, O 0 0.002888339338824153
we O 0 0.0022022277116775513
have O 0 0.0023436429910361767
found O 0 0.005247225519269705
two O 0 0.00439327722415328
common O 0 0.020306644961237907
mutations O 1 0.9975730776786804
in O 0 0.007478191517293453
Caucasians O 1 0.8922472596168518
and O 0 0.005027421284466982
Japanese O 0 0.014182454906404018
, O 0 0.006851427257061005
respectively O 0 0.01893409714102745
. O 0 0.01839645393192768

To O 0 0.01566273905336857
characterize O 0 0.051319025456905365
the O 0 0.013871453702449799
mutational O 1 0.9855169653892517
spectrum O 0 0.033949483186006546
in O 0 0.004160040523856878
various O 0 0.003521340899169445
ethnic O 0 0.009403017349541187
groups O 0 0.007807799149304628
, O 0 0.0067094978876411915
mutations O 1 0.9888034462928772
in O 0 0.004799451678991318
the O 0 0.009425767697393894
GALNS O 1 0.9970818161964417
gene O 1 0.7037534713745117
in O 0 0.00876733660697937
Colombian O 0 0.07148705422878265
MPS B-Disease 1 0.9891724586486816
IVA I-Disease 1 0.9999356269836426
patients O 1 0.9996820688247681
were O 0 0.005966878030449152
investigated O 0 0.02006017044186592
, O 0 0.003797340439632535
and O 0 0.004431338980793953
genetic O 1 0.6760480403900146
backgrounds O 0 0.013772767037153244
were O 0 0.0031935011502355337
extensively O 0 0.011668226681649685
analyzed O 0 0.013541808351874352
to O 0 0.003928206395357847
identify O 0 0.014985847286880016
racial O 0 0.017789779230952263
origin O 0 0.011414188891649246
, O 0 0.004021135158836842
based O 0 0.006058963015675545
on O 0 0.006814976688474417
mitochondrial O 0 0.4965490400791168
DNA O 0 0.0647999569773674
( O 0 0.020497459918260574
mtDNA O 0 0.21384689211845398
) O 0 0.023656172677874565
lineages O 0 0.15581519901752472
. O 0 0.02456466481089592

Three O 0 0.018387075513601303
novel O 0 0.07189351320266724
missense O 1 0.9969202280044556
mutations O 1 0.9988130331039429
never O 0 0.017574232071638107
identified O 0 0.014804533682763577
previously O 0 0.006473096553236246
in O 0 0.0030533496756106615
other O 0 0.0034006533678621054
populations O 0 0.01860783062875271
and O 0 0.002710029250010848
found O 0 0.005744554568082094
in O 0 0.003180213738232851
16 O 0 0.006472970824688673
out O 0 0.003758462145924568
of O 0 0.004475527908653021
19 O 0 0.018965333700180054
Colombian O 0 0.05430848151445389
MPS B-Disease 1 0.7779263854026794
IVA I-Disease 1 0.9980744123458862
unrelated O 1 0.5348625183105469
alleles O 1 0.9633935689926147
account O 0 0.01839270442724228
for O 0 0.010026946663856506
84 O 0 0.04818360134959221
. O 0 0.02141345664858818

2 O 0 0.021577829495072365
% O 0 0.009175130166113377
of O 0 0.0046257576905190945
the O 0 0.007107261102646589
alleles O 1 0.9527108669281006
in O 0 0.005742430686950684
this O 0 0.006053844932466745
study O 0 0.019551794975996017
. O 0 0.01729634217917919

The O 0 0.024674516171216965
G301C O 1 0.6054302453994751
and O 0 0.014756117947399616
S162F O 1 0.9924359917640686
mutations O 1 0.9916834831237793
account O 0 0.013676843605935574
for O 0 0.008313325233757496
68 O 0 0.039609115570783615
. O 0 0.01940816454589367

4 O 0 0.028348684310913086
% O 0 0.01428209338337183
and O 0 0.006636880338191986
10 O 0 0.014578528702259064
. O 0 0.016725149005651474

5 O 0 0.027386175468564034
% O 0 0.013326984830200672
of O 0 0.009216168895363808
mutations O 1 0.990996241569519
, O 0 0.005894020665436983
respectively O 0 0.008665583096444607
, O 0 0.004551405552774668
whereas O 0 0.012074921280145645
the O 0 0.005018997006118298
remaining O 0 0.01264211442321539
F69V O 1 0.9450898170471191
is O 0 0.006866144016385078
limited O 0 0.008230791427195072
to O 0 0.0045821042731404305
a O 0 0.013600784353911877
single O 0 0.03388525918126106
allele O 1 0.9615617394447327
. O 0 0.027502289041876793

The O 0 0.02572680078446865
skewed O 0 0.3571559190750122
prevalence O 1 0.9509830474853516
of O 0 0.011806219816207886
G301C O 1 0.7209138870239258
in O 0 0.007164171896874905
only O 0 0.007893847301602364
Colombian O 0 0.12666568160057068
patients O 1 0.9978140592575073
and O 0 0.01012711226940155
haplotype O 1 0.9898848533630371
analysis O 0 0.015780087560415268
by O 0 0.010233515873551369
restriction O 0 0.04036325588822365
fragment O 0 0.07512874156236649
length O 0 0.028656411916017532
polymorphisms O 0 0.10947725176811218
in O 0 0.0070020840503275394
the O 0 0.010996760800480843
GALNS O 1 0.9963822364807129
gene O 1 0.9534023404121399
suggest O 0 0.024381104856729507
that O 0 0.009623875841498375
G301C O 1 0.8018676042556763
originated O 0 0.023798422887921333
from O 0 0.007905256003141403
a O 0 0.013128706254065037
common O 0 0.024452464655041695
ancestor O 0 0.13941268622875214
. O 0 0.023588361218571663

Investigation O 0 0.026582805439829826
of O 0 0.006351136136800051
the O 0 0.006936640944331884
genetic O 0 0.18989567458629608
background O 0 0.01300190482288599
by O 0 0.005505019798874855
means O 0 0.009919198229908943
of O 0 0.0069246781058609486
mtDNA O 1 0.9006833434104919
lineages O 1 0.6458712220191956
indicate O 0 0.014520859345793724
that O 0 0.0031793115194886923
all O 0 0.0031343784648925066
our O 0 0.008926283568143845
patients O 1 0.9984174966812134
are O 0 0.004057254176586866
probably O 0 0.009745901450514793
of O 0 0.00586092472076416
native O 0 0.019365930929780006
American O 0 0.02819276601076126
descent O 0 0.10958238691091537

Low O 0 0.07121496647596359
frequency O 0 0.05648013576865196
of O 0 0.023530500009655952
BRCA1 O 1 0.9997748732566833
germline O 1 0.9994301199913025
mutations O 1 0.9941851496696472
in O 0 0.011226142756640911
45 O 0 0.02762848325073719
German O 1 0.796596884727478
breast B-Disease 1 0.9999970197677612
/ I-Disease 1 0.9999165534973145
ovarian I-Disease 1 0.9999990463256836
cancer I-Disease 1 0.9999967813491821
families O 0 0.11482709646224976
. O 0 0.03008243627846241

In O 0 0.008717778138816357
this O 0 0.005273188464343548
study O 0 0.009981991723179817
we O 0 0.00465815793722868
investigated O 0 0.02627917006611824
45 O 0 0.02300822176039219
German O 1 0.6973350048065186
breast B-Disease 1 0.9999961853027344
/ I-Disease 1 0.9998457431793213
ovarian I-Disease 1 0.9999994039535522
cancer I-Disease 1 0.9999904632568359
families O 0 0.03743744269013405
for O 0 0.01815914548933506
germline O 1 0.9995561242103577
mutations O 1 0.9974871873855591
in O 0 0.012348155491054058
the O 0 0.021777845919132233
BRCA1 O 1 0.9998766183853149
gene O 1 0.9699369072914124
. O 0 0.026650238782167435

We O 0 0.013273038901388645
identified O 0 0.02438643015921116
four O 0 0.015673421323299408
germline O 1 0.998141884803772
mutations O 1 0.9957017302513123
in O 0 0.008794059976935387
three O 0 0.03057396598160267
breast B-Disease 1 0.999996542930603
cancer I-Disease 1 0.9999778270721436
families O 0 0.013315295800566673
and O 0 0.003442127024754882
in O 0 0.004931174218654633
one O 0 0.12688130140304565
breast B-Disease 1 0.9999986886978149
- I-Disease 1 0.9999123811721802
ovarian I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999984502792358
family O 0 0.06830170005559921
. O 0 0.0047749001532793045
among O 0 0.005308777093887329
these O 0 0.002369590802118182
were O 0 0.0029889766592532396
one O 0 0.009216385893523693
frameshift O 1 0.9993522763252258
mutation O 1 0.9992178678512573
, O 0 0.006538586225360632
one O 0 0.009294593706727028
nonsense O 0 0.28329765796661377
mutation O 1 0.9953693747520447
, O 0 0.00581048708409071
one O 0 0.006549948360770941
novel O 0 0.026496198028326035
splice O 1 0.6380149722099304
site O 0 0.024541711434721947
mutation O 1 0.9962408542633057
, O 0 0.004532494582235813
and O 0 0.004212962929159403
one O 0 0.011780495755374432
missense O 1 0.9963067770004272
mutation O 1 0.9986904263496399
. O 0 0.02623322419822216

The O 0 0.033393844962120056
missense O 1 0.9964130520820618
mutation O 1 0.9961828589439392
was O 0 0.010814938694238663
also O 0 0.005777164362370968
found O 0 0.008329341188073158
in O 0 0.006902830675244331
2 O 0 0.019707677885890007
. O 0 0.018405163660645485

8 O 0 0.0279032364487648
% O 0 0.009377770125865936
of O 0 0.0033957387786358595
the O 0 0.004333891905844212
general O 0 0.008410359732806683
population O 0 0.011856929399073124
, O 0 0.004255292005836964
suggesting O 0 0.013916369527578354
that O 0 0.0029370717238634825
it O 0 0.0035200300626456738
is O 0 0.005517004523426294
not O 0 0.00922204926609993
disease O 1 0.9999641180038452
associated O 0 0.03240159898996353
. O 0 0.018823077902197838

The O 0 0.014922377653419971
average O 0 0.029683582484722137
age O 0 0.027489233762025833
of O 0 0.015689747408032417
disease O 1 0.9999943971633911
onset O 1 0.9999302625656128
in O 0 0.007353959605097771
those O 0 0.008135037496685982
families O 0 0.02865566685795784
harbouring O 1 0.9979670643806458
causative O 1 0.9991362690925598
mutations O 1 0.998310923576355
was O 0 0.009996511042118073
between O 0 0.010028812102973461
32 O 0 0.026449088007211685
. O 0 0.01618744246661663

3 O 0 0.03129878640174866
and O 0 0.012838823720812798
37 O 0 0.04085133969783783
. O 0 0.02434968203306198

4 O 0 0.02698521502315998
years O 0 0.011697535403072834
, O 0 0.006037944927811623
whereas O 0 0.015378093346953392
the O 0 0.006347829941660166
family O 0 0.019343974068760872
harbouring O 1 0.6944966912269592
the O 0 0.017916707322001457
missense O 1 0.9987415671348572
mutation O 1 0.9994661211967468
had O 0 0.008378947153687477
an O 0 0.00548939686268568
average O 0 0.014909186400473118
age O 0 0.015492756851017475
of O 0 0.009496943093836308
onset O 1 0.9989946484565735
of O 0 0.012529654428362846
51 O 0 0.0459158830344677
. O 0 0.02226487547159195

2 O 0 0.03811342641711235
years O 0 0.02458929270505905
. O 0 0.024816710501909256

These O 0 0.011508680880069733
findings O 0 0.023665089160203934
show O 0 0.015689682215452194
that O 0 0.010117967613041401
BRCA1 O 1 0.9998180270195007
is O 0 0.008748861029744148
implicated O 0 0.11654417961835861
in O 0 0.004288513213396072
a O 0 0.0070710694417357445
small O 0 0.008771667256951332
fraction O 0 0.03018917515873909
of O 0 0.019785167649388313
breast B-Disease 1 0.9999963045120239
/ I-Disease 1 0.9998866319656372
ovarian I-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999948740005493
families O 0 0.038522008806467056
suggesting O 0 0.023479193449020386
the O 0 0.0066499290987849236
involvement O 0 0.020753586664795876
of O 0 0.006147981621325016
another O 0 0.032059796154499054
susceptibility O 1 0.9993299245834351
gene O 1 0.9890236854553223
( O 0 0.0312935896217823
s O 0 0.12283578515052795
) O 0 0.03714999929070473

Paternal O 1 0.9875916242599487
transmission O 1 0.9601322412490845
of O 0 0.17574425041675568
congenital B-Disease 1 0.9999994039535522
myotonic I-Disease 1 0.9999974966049194
dystrophy I-Disease 1 0.9999974966049194
. O 0 0.06686722487211227

We O 0 0.010170679539442062
report O 0 0.011023812927305698
a O 0 0.011974720284342766
rare O 0 0.023421132937073708
case O 0 0.015200820751488209
of O 0 0.014207905158400536
paternally O 1 0.9995655417442322
transmitted O 1 0.9999057054519653
congenital B-Disease 1 0.9999997615814209
myotonic I-Disease 1 0.9999990463256836
dystrophy I-Disease 1 0.9999992847442627
( O 1 0.9252793192863464
DM B-Disease 1 0.9999369382858276
) O 0 0.035598743706941605
. O 0 0.027492398396134377

The O 0 0.021415503695607185
proband O 0 0.48747891187667847
is O 0 0.008188138715922832
a O 0 0.008724166080355644
23 O 0 0.014805118553340435
year O 0 0.010674968361854553
old O 0 0.01982196979224682
, O 0 0.013354998081922531
mentally B-Disease 1 0.9992110729217529
retarded I-Disease 1 0.9990027546882629
male O 1 0.9659269452095032
who O 0 0.48548099398612976
suffers O 1 0.9999860525131226
severe O 1 0.9999879598617554
muscular B-Disease 1 0.9999527931213379
weakness I-Disease 1 0.9988111257553101
. O 0 0.038480278104543686

He O 0 0.012458867393434048
presented O 0 0.016501424834132195
with O 0 0.01456998847424984
respiratory O 1 0.9999929666519165
and O 0 0.009034116752445698
feeding O 1 0.8646458983421326
difficulties O 0 0.3252604901790619
at O 0 0.01629641465842724
birth O 0 0.49242281913757324
. O 0 0.01827295310795307

His O 0 0.01926581561565399
two O 0 0.017439737915992737
sibs O 1 0.9992926120758057
suffer O 1 0.9983432292938232
from O 0 0.03415674343705177
childhood O 1 0.9995044469833374
onset O 1 0.9999785423278809
DM B-Disease 1 0.9999374151229858
. O 0 0.050309017300605774

Their O 0 0.011571088805794716
late O 0 0.016939185559749603
father O 0 0.017511993646621704
had O 0 0.006339999847114086
the O 0 0.007260377984493971
adult O 0 0.03642326593399048
type O 0 0.02911984734237194
of O 0 0.010022665373980999
DM B-Disease 1 0.9999392032623291
, O 0 0.00815343763679266
with O 0 0.01030889805406332
onset O 1 0.9998433589935303
around O 0 0.012159781530499458
30 O 0 0.014598710462450981
years O 0 0.013580462895333767
. O 0 0.014626537449657917

Only O 0 0.009715071879327297
six O 0 0.00752508919686079
other O 0 0.004278647247701883
cases O 0 0.012679560109972954
of O 0 0.007145440671592951
paternal O 1 0.9907318949699402
transmission O 1 0.9715956449508667
of O 0 0.08490539342164993
congenital B-Disease 1 0.9999992847442627
DM I-Disease 1 0.9999740123748779
have O 0 0.012422872707247734
been O 0 0.012246984988451004
reported O 0 0.027080757543444633
recently O 0 0.034563709050416946
. O 0 0.02354414388537407

We O 0 0.010554671287536621
review O 0 0.012241979129612446
the O 0 0.0057237409055233
sex O 0 0.02176579087972641
related O 0 0.015720227733254433
effects O 0 0.032759889960289
on O 0 0.00693910475820303
transmission O 1 0.6268839240074158
of O 0 0.025362204760313034
congenital B-Disease 1 0.9999990463256836
DM I-Disease 1 0.9999651908874512
. O 0 0.041420090943574905

Decreased O 1 0.676403284072876
fertility O 1 0.5749661922454834
of O 0 0.012595114298164845
males O 0 0.2475256621837616
with O 0 0.013076204806566238
adult O 1 0.9939324259757996
onset O 1 0.9999898672103882
DM B-Disease 1 0.999976396560669
and O 0 0.010949058458209038
contraction O 0 0.3810383975505829
of O 0 0.004344035871326923
the O 0 0.0059753828682005405
repeat O 0 0.0402013435959816
upon O 0 0.011977079324424267
male O 0 0.13511976599693298
transmission O 0 0.13114966452121735
contribute O 0 0.013350926339626312
to O 0 0.0035408358089625835
the O 0 0.004764454439282417
almost O 0 0.011391054838895798
absent O 0 0.03971435874700546
occurrence O 0 0.05514094978570938
of O 0 0.00913995411247015
paternal O 1 0.9805876016616821
transmission O 1 0.86179119348526
of O 0 0.031241193413734436
congenital B-Disease 1 0.999998927116394
DM I-Disease 1 0.9998832941055298
. O 0 0.04250428080558777

Also O 0 0.009274662472307682
the O 0 0.00548209436237812
fathers O 0 0.01766173727810383
of O 0 0.004253871738910675
the O 0 0.00661915959790349
reported O 0 0.04377048462629318
congenitally O 1 0.9997066855430603
affected O 1 0.9726393818855286
children O 0 0.03741968423128128
showed O 0 0.013490824028849602
, O 0 0.0037545468658208847
on O 0 0.0033998112194240093
average O 0 0.012485365383327007
, O 0 0.006712346337735653
shorter O 0 0.040824126452207565
CTG O 1 0.9753519296646118
repeat O 0 0.1181117445230484
lengths O 0 0.02689472585916519
and O 0 0.005730259697884321
hence O 0 0.021125389263033867
less O 0 0.030353626236319542
severe O 1 0.9999415874481201
clinical O 1 0.9996339082717896
symptoms O 1 0.9999762773513794
than O 0 0.008050167001783848
the O 0 0.007179229985922575
mothers O 1 0.7171618938446045
of O 0 0.006476169917732477
children O 0 0.05920953303575516
with O 0 0.04695622995495796
congenital B-Disease 1 0.9999977350234985
DM I-Disease 1 0.9999290704727173
. O 0 0.047861598432064056

We O 0 0.01331012137234211
conclude O 0 0.022235237061977386
that O 0 0.008020357228815556
paternal O 1 0.8800371885299683
transmission O 1 0.8167297840118408
of O 0 0.02902250736951828
congenital B-Disease 1 0.9999996423721313
DM I-Disease 1 0.9999881982803345
is O 0 0.017154455184936523
rare O 0 0.08532504737377167
and O 0 0.006352033466100693
preferentially O 1 0.5695727467536926
occurs O 0 0.06825817376375198
with O 0 0.012577088549733162
onset O 1 0.9992197751998901
of O 0 0.017130788415670395
DM B-Disease 1 0.9998852014541626
past O 0 0.01672479882836342
30 O 0 0.012118512764573097
years O 0 0.007010161876678467
in O 0 0.004537221044301987
the O 0 0.007024415768682957
father O 0 0.022287597879767418
. O 0 0.01088226679712534
. O 0 0.01883665844798088

The O 0 0.041453395038843155
RB1 O 1 0.9994179010391235
gene O 1 0.9879698753356934
mutation O 1 0.9892604351043701
in O 0 0.008650431409478188
a O 0 0.016759179532527924
child O 0 0.10158444195985794
with O 0 0.02676559053361416
ectopic B-Disease 1 0.9998645782470703
intracranial I-Disease 1 0.9999436140060425
retinoblastoma I-Disease 1 0.9991686344146729
. O 0 0.044250037521123886

The O 0 0.04581720009446144
RB1 O 1 0.9995684027671814
gene O 1 0.9959173798561096
mutation O 1 0.9989657402038574
was O 0 0.010007466189563274
investigated O 0 0.017381248995661736
in O 0 0.0048067523166537285
a O 0 0.009401295334100723
child O 0 0.32385748624801636
with O 0 0.021726829931139946
ectopic B-Disease 1 0.9998472929000854
intracranial I-Disease 1 0.9999300241470337
retinoblastoma I-Disease 1 0.9979107975959778
using O 0 0.017350852489471436
DNA O 0 0.029672658070921898
obtained O 0 0.0067764162085950375
from O 0 0.0038875516038388014
both O 0 0.003705832175910473
the O 0 0.007355534005910158
pineal B-Disease 1 0.9991747736930847
and I-Disease 0 0.016064774245023727
retinal I-Disease 1 0.9999653100967407
tumours I-Disease 1 0.9998462200164795
of O 0 0.009119580499827862
the O 0 0.01344551146030426
patient O 1 0.9979454874992371
. O 0 0.023084187880158424

A O 0 0.045077282935380936
nonsense O 0 0.21200932562351227
mutation O 1 0.992897629737854
in O 0 0.013839385472238064
exon O 0 0.2788808345794678
17 O 0 0.024263326078653336
( O 0 0.01759541966021061
codon O 0 0.22646838426589966
556 O 0 0.08399584889411926
) O 0 0.008444988168776035
of O 0 0.006315579172223806
the O 0 0.014761142432689667
RB1 O 1 0.9992156028747559
gene O 1 0.857966959476471
was O 0 0.008799580857157707
found O 0 0.006706083193421364
to O 0 0.0027778190560638905
be O 0 0.0028741878923028708
present O 0 0.006208311300724745
homozygously O 1 0.5029036402702332
in O 0 0.004233609419316053
both O 0 0.004080530721694231
the O 0 0.007516004145145416
retinal B-Disease 1 0.9989834427833557
and I-Disease 0 0.007189610041677952
the I-Disease 0 0.015624958090484142
pineal I-Disease 1 0.9995081424713135
tumours I-Disease 1 0.9997150301933289
. O 0 0.036332275718450546

The O 0 0.017187658697366714
same O 0 0.022979307919740677
mutation O 1 0.9927288293838501
was O 0 0.010469663888216019
present O 0 0.009950205683708191
heterozygously O 1 0.6819654703140259
in O 0 0.004569840617477894
the O 0 0.005954861640930176
DNA O 0 0.020821604877710342
from O 0 0.004114162642508745
the O 0 0.004294287879019976
constitutional O 0 0.011908948421478271
cells O 0 0.026470091193914413
of O 0 0.003862818470224738
the O 0 0.007669346872717142
patient O 1 0.9982232451438904
, O 0 0.0051679047755897045
proving O 0 0.014750766567885876
it O 0 0.0029029794968664646
to O 0 0.002466972451657057
be O 0 0.0032260380685329437
of O 0 0.008706304244697094
germline O 1 0.986929178237915
origin O 0 0.03516168147325516
. O 0 0.02106320671737194

The O 0 0.018059464171528816
initial O 0 0.04723481833934784
mutation O 1 0.9972435235977173
was O 0 0.008462990634143353
shown O 0 0.009044060483574867
to O 0 0.0035557514056563377
have O 0 0.0044783479534089565
occurred O 0 0.014743720181286335
in O 0 0.004919297527521849
the O 0 0.012462574988603592
paternally O 1 0.9671120643615723
derived O 0 0.10289151221513748
RB1 O 1 0.9979616403579712
allele O 1 0.9726905822753906
. O 0 0.036128684878349304

The O 0 0.02097312919795513
mutation O 1 0.9976443648338318
is O 0 0.0057176221162080765
in O 0 0.003365970915183425
an O 0 0.0034464560449123383
area O 0 0.006074181757867336
of O 0 0.003079857910051942
the O 0 0.006142780184745789
gene O 0 0.272717148065567
that O 0 0.005988894030451775
encodes O 0 0.03594524785876274
the O 0 0.00776869198307395
protein O 0 0.04007255285978317
- O 0 0.025617798790335655
binding O 0 0.01708413101732731
region O 0 0.013377024792134762
known O 0 0.007839994505047798
as O 0 0.0036229018587619066
the O 0 0.005159498658031225
pocket O 0 0.2822582721710205
region O 0 0.012295740656554699
and O 0 0.0033056132961064577
has O 0 0.004863905254751444
been O 0 0.006407064851373434
detected O 0 0.04154180362820625
in O 0 0.0042847394943237305
other O 0 0.0042994203977286816
cases O 0 0.014903554692864418
of O 0 0.009724144823849201
retinoblastoma B-Disease 1 0.9995607733726501
. O 0 0.01409975253045559
. O 0 0.0176731925457716

Low O 0 0.052988201379776
levels O 0 0.025966905057430267
of O 0 0.01053340919315815
beta O 0 0.0881495326757431
hexosaminidase O 1 0.8748354315757751
A O 0 0.014367189258337021
in O 0 0.00834621861577034
healthy O 0 0.3890124261379242
individuals O 0 0.012330031022429466
with O 0 0.009929525665938854
apparent O 1 0.9807846546173096
deficiency O 1 0.9999531507492065
of O 0 0.007819350808858871
this O 0 0.010058082640171051
enzyme O 0 0.16670766472816467
. O 0 0.022952338680624962

Appreciable O 1 0.5549097657203674
beta O 0 0.13727255165576935
hexosaminidase O 1 0.8419615626335144
A O 0 0.023334674537181854
( O 0 0.01390392892062664
hex O 0 0.04782058298587799
A O 0 0.014975686557590961
) O 0 0.008031010627746582
activity O 0 0.013039376586675644
has O 0 0.006567807402461767
been O 0 0.00789413508027792
detected O 0 0.04821789264678955
in O 0 0.010395973920822144
cultured O 1 0.9907129406929016
skin O 1 0.9999716281890869
fibroblasts O 1 0.9995952248573303
and O 0 0.19899016618728638
melanoma B-Disease 1 0.9999985694885254
tissue O 1 0.999640941619873
from O 0 0.01333540864288807
healthy O 1 0.9861095547676086
individuals O 0 0.013648930005729198
previously O 0 0.010613052174448967
reported O 0 0.014654610306024551
as O 0 0.0054759131744503975
having O 0 0.018147332593798637
deficiency B-Disease 1 0.9998180270195007
of I-Disease 0 0.007203595247119665
hex I-Disease 0 0.09110778570175171
A I-Disease 0 0.012977968901395798
activity O 0 0.01814415492117405
indistinguishable O 0 0.027264535427093506
from O 0 0.0047417739406228065
that O 0 0.003364707576110959
of O 0 0.006415141746401787
patients O 1 0.9994654059410095
with O 0 0.02660365030169487
Tay B-Disease 1 0.9999734163284302
- I-Disease 1 0.9981718063354492
Sachs I-Disease 1 0.9997853636741638
disease I-Disease 1 0.9999847412109375
( O 0 0.4044773280620575
TSD B-Disease 1 0.9989438652992249
) O 0 0.03032449074089527
. O 0 0.02425219677388668

Identification O 0 0.04080178216099739
and O 0 0.010750344954431057
quantitation O 0 0.3500136137008667
of O 0 0.01127611007541418
hex O 0 0.05512377247214317
A O 0 0.01510105561465025
, O 0 0.006821143440902233
amounting O 0 0.026899032294750214
to O 0 0.007420564070343971
3 O 0 0.018397267907857895
. O 0 0.01833987794816494

5 O 0 0.03543873503804207
% O 0 0.022476118057966232
- O 0 0.047467153519392014
6 O 0 0.030815256759524345
. O 0 0.021743685007095337

9 O 0 0.03403540328145027
% O 0 0.013084743171930313
of O 0 0.006346662994474173
total O 0 0.015386724844574928
beta O 0 0.07023738324642181
hexosaminidase O 1 0.7701813578605652
activity O 0 0.021827364340424538
, O 0 0.005559760611504316
has O 0 0.004783591255545616
been O 0 0.00499978382140398
obtained O 0 0.008180521428585052
by O 0 0.01012172270566225
cellulose O 0 0.10742652416229248
acetate O 0 0.4132148325443268
gel O 1 0.9266176819801331
electrophoresis O 0 0.4472544193267822
, O 0 0.017287565395236015
DEAE O 1 0.9770548343658447
- O 0 0.07870594412088394
cellulose O 0 0.14058823883533478
ion O 0 0.08699402213096619
- O 0 0.04051653668284416
exchange O 0 0.02336065098643303
chromatography O 0 0.06905541568994522
, O 0 0.014613142237067223
radial O 1 0.9328899383544922
immunodiffusion O 1 0.8715761303901672
, O 0 0.01059799175709486
and O 0 0.00923914834856987
radioimmunoassay O 1 0.9635104537010193
. O 0 0.027163801714777946

Previous O 0 0.033217012882232666
family O 0 0.024907201528549194
studies O 0 0.014841734431684017
suggested O 0 0.01066377479583025
that O 0 0.00294509413652122
these O 0 0.002984529361128807
individuals O 0 0.008570603094995022
may O 0 0.007579045370221138
be O 0 0.004502071067690849
compound O 0 0.024792678654193878
heterozygotes O 1 0.6799430251121521
for O 0 0.003930382430553436
the O 0 0.007059946656227112
common O 0 0.03434443846344948
mutant O 1 0.9983983635902405
TSD B-Disease 1 0.9996961355209351
gene O 1 0.9475735425949097
and O 0 0.00664210319519043
a O 0 0.01445078756660223
rare O 0 0.039709173142910004
( O 0 0.022874707356095314
allelic O 1 0.9852942228317261
) O 0 0.028886942192912102
mutant O 1 0.9745426774024963
gene O 1 0.864858090877533
. O 0 0.028020178899168968

Thus O 0 0.01866663619875908
, O 0 0.005688743200153112
the O 0 0.008070209063589573
postulated O 0 0.06511923670768738
rate O 0 0.0378708615899086
mutant O 1 0.9980552196502686
gene O 1 0.9877108931541443
appears O 0 0.019876942038536072
to O 0 0.003882230259478092
code O 0 0.007079192902892828
for O 0 0.0025040965992957354
the O 0 0.003927917219698429
expression O 0 0.0147478636354208
of O 0 0.004154813010245562
low O 0 0.016178324818611145
amounts O 0 0.012499895878136158
of O 0 0.006035584025084972
hex O 0 0.05903704836964607
A O 0 0.023593438789248466
. O 0 0.020563624799251556

Heterozygotes O 1 0.8767269849777222
for O 0 0.00989571399986744
the O 0 0.012208489701151848
rare O 0 0.10231123119592667
mutant O 1 0.9941523671150208
may O 0 0.013449111022055149
be O 0 0.006357401609420776
indistinguishable O 0 0.03892551735043526
from O 0 0.010278793051838875
heterozygotes O 1 0.8078012466430664
for O 0 0.005952676758170128
the O 0 0.009345893748104572
common O 0 0.10535881668329239
TSD B-Disease 1 0.9989633560180664
mutant O 1 0.9885237812995911
. O 0 0.036534618586301804

However O 0 0.01630524732172489
, O 0 0.007486332207918167
direct O 0 0.0159415565431118
visualization O 0 0.03388515114784241
and O 0 0.006524584721773863
quantitation O 0 0.31250640749931335
of O 0 0.006962921470403671
hex O 0 0.040903158485889435
A O 0 0.008048107847571373
by O 0 0.0044902171939611435
the O 0 0.004017325583845377
methods O 0 0.008843746967613697
described O 0 0.013136215507984161
may O 0 0.01107401866465807
prevent O 0 0.02564561367034912
false O 0 0.020053880289196968
- O 0 0.08854202181100845
positive O 0 0.1660269945859909
prenatal O 1 0.9989653825759888
diagnosis O 1 0.9996086955070496
of O 0 0.016317948698997498
TSD B-Disease 1 0.99945467710495
in O 0 0.01415994018316269
fetuses O 1 0.9952658414840698
having O 0 0.010377402417361736
the O 0 0.007143796421587467
incomplete O 0 0.022852009162306786
hex B-Disease 0 0.21594427525997162
A I-Disease 0 0.03229988366365433
deficiency I-Disease 1 0.999785840511322
of O 0 0.005142471753060818
the O 0 0.005927907768636942
type O 0 0.030631791800260544
described O 0 0.010187721811234951
in O 0 0.0032642846927046776
the O 0 0.004983134567737579
four O 0 0.011388875544071198
healthy O 0 0.4007575511932373
individuals O 0 0.0519818440079689

The O 0 0.05514653027057648
tumor B-Disease 1 0.9998311996459961
suppressor O 1 0.9996490478515625
gene O 1 0.9941727519035339
Smad4 O 1 0.9966895580291748
/ O 1 0.9323793649673462
Dpc4 O 1 0.932461142539978
is O 0 0.0071754758246243
required O 0 0.007566892541944981
for O 0 0.006518860347568989
gastrulation O 1 0.9724037051200867
and O 0 0.00502850953489542
later O 0 0.006484775338321924
for O 0 0.006171351298689842
anterior O 1 0.9777407646179199
development O 0 0.007741173729300499
of O 0 0.005205383524298668
the O 0 0.012550431303679943
mouse O 1 0.9788497090339661
embryo O 1 0.9026852250099182
. O 0 0.0315309576690197

Mutations O 1 0.950477123260498
in O 0 0.012238981202244759
the O 0 0.018542300909757614
SMAD4 O 1 0.9978799819946289
/ O 1 0.9933791160583496
DPC4 O 1 0.9997963309288025
tumor B-Disease 1 0.9999710321426392
suppressor O 1 0.999863862991333
gene O 1 0.9829733371734619
, O 0 0.005517854820936918
a O 0 0.0075724306516349316
key O 0 0.010884608142077923
signal O 0 0.023517902940511703
transducer O 0 0.13555340468883514
in O 0 0.006719564087688923
most O 0 0.011838503181934357
TGFbeta O 1 0.9914823770523071
- O 0 0.042359452694654465
related O 0 0.02187645062804222
pathways O 0 0.11524180322885513
, O 0 0.0039505972526967525
are O 0 0.0025190720334649086
involved O 0 0.006915565114468336
in O 0 0.0036400880198925734
50 O 0 0.010109956376254559
% O 0 0.012625738978385925
of O 0 0.01831757090985775
pancreatic B-Disease 1 0.9999858140945435
cancers I-Disease 1 0.9999746084213257
. O 0 0.030732329934835434

Homozygous O 1 0.9954425096511841
Smad4 O 1 0.9968022108078003
mutant O 1 0.9979274272918701
mice O 1 0.9983336329460144
die O 1 0.9776275157928467
before O 0 0.01723703183233738
day O 0 0.016737207770347595
7 O 0 0.025516508147120476
. O 0 0.01911117695271969

5 O 0 0.04070407524704933
of O 0 0.02002011425793171
embryogenesis O 1 0.691392183303833
. O 0 0.037733789533376694

Mutant O 1 0.9873902797698975
embryos O 0 0.056044429540634155
have O 0 0.008705029264092445
reduced O 0 0.021878862753510475
size O 0 0.01284052338451147
, O 0 0.00523275975137949
fail O 0 0.04239446669816971
to O 0 0.00748215988278389
gastrulate O 1 0.7348146438598633
or O 0 0.011386571452021599
express O 0 0.023491302505135536
a O 0 0.01613469049334526
mesodermal O 1 0.9780415892601013
marker O 0 0.0645432397723198
, O 0 0.00602872297167778
and O 0 0.006318045314401388
show O 0 0.0288369320333004
abnormal O 1 0.9966000914573669
visceral O 1 0.9959542751312256
endoderm O 1 0.9818903207778931
development O 0 0.029110856354236603
. O 0 0.02353399060666561

Growth B-Disease 0 0.34448719024658203
retardation I-Disease 1 0.9970905780792236
of O 0 0.009238925762474537
the O 0 0.014579802751541138
Smad4 O 1 0.9974305033683777
- O 0 0.48685938119888306
deficient O 1 0.9835034608840942
embryos O 0 0.04477231204509735
results O 0 0.015140379779040813
from O 0 0.008698505349457264
reduced O 0 0.03410986438393593
cell O 0 0.08370552211999893
proliferation O 0 0.03779836371541023
rather O 0 0.010622279718518257
than O 0 0.010341120883822441
increased O 0 0.037283141165971756
apoptosis O 1 0.9741004109382629
. O 0 0.02764546312391758

Aggregation O 0 0.1005680039525032
of O 0 0.01858990080654621
mutant O 1 0.9874227046966553
Smad4 O 1 0.9950125813484192
ES O 1 0.9640392661094666
cells O 0 0.07255508750677109
with O 0 0.010182260535657406
wild O 0 0.04045494273304939
- O 0 0.07393457740545273
type O 0 0.21654415130615234
tetraploid O 1 0.9855884909629822
morulae O 1 0.9785791039466858
rescues O 1 0.627467691898346
the O 0 0.025353865697979927
gastrulation B-Disease 1 0.997318685054779
defect I-Disease 1 0.9948868155479431
. O 0 0.03793627396225929

These O 0 0.012374630197882652
results O 0 0.016894737258553505
indicate O 0 0.01887260563671589
that O 0 0.0068521928042173386
Smad4 O 1 0.8928697109222412
is O 0 0.007241623941808939
initially O 0 0.008437992073595524
required O 0 0.005040425341576338
for O 0 0.0027323865797370672
the O 0 0.004636094905436039
differentiation O 0 0.028280096128582954
of O 0 0.004473682027310133
the O 0 0.0077978093177080154
visceral O 1 0.9953089356422424
endoderm O 1 0.9742113947868347
and O 0 0.004151484463363886
that O 0 0.003889006795361638
the O 0 0.008637960068881512
gastrulation B-Disease 1 0.9987026453018188
defect I-Disease 1 0.9929078817367554
in O 0 0.006504374090582132
the O 0 0.008762435056269169
epiblast O 1 0.9979074001312256
is O 0 0.009378181770443916
secondary O 0 0.01685270294547081
and O 0 0.004674016032367945
non O 0 0.017599955201148987
- O 0 0.04126289486885071
cell O 0 0.0590556375682354
autonomous O 0 0.0400427021086216
. O 0 0.02300245873630047

Rescued O 1 0.5429494976997375
embryos O 0 0.32596102356910706
show O 0 0.09382209181785583
severe O 1 0.9997569918632507
anterior O 1 0.9997307658195496
truncations O 1 0.993351399898529
, O 0 0.008364316076040268
indicating O 0 0.019714223220944405
a O 0 0.007289774250239134
second O 0 0.006750914268195629
important O 0 0.006063209380954504
role O 0 0.009843803010880947
for O 0 0.007726631127297878
Smad4 O 1 0.9503790140151978
in O 0 0.016513720154762268
anterior O 1 0.9994016885757446
patterning O 1 0.9933433532714844
during O 0 0.045850154012441635
embryogenesis O 1 0.8588066101074219
. O 0 0.03140690550208092

Prevalence O 1 0.9794803857803345
of O 0 0.026448555290699005
p16 O 1 0.9695567488670349
and O 0 0.026725152507424355
CDK4 O 1 0.9978925585746765
germline O 1 0.998608410358429
mutations O 1 0.996345579624176
in O 0 0.014951487071812153
48 O 1 0.6022002100944519
melanoma B-Disease 1 0.9999922513961792
- O 1 0.9237868189811707
prone O 1 0.9871482253074646
families O 0 0.020312994718551636
in O 0 0.008881641551852226
France O 0 0.03222545236349106
. O 0 0.02235197089612484

The O 0 0.03235549479722977
French O 1 0.9144617319107056
Familial B-Disease 1 0.9999792575836182
Melanoma I-Disease 1 0.9999878406524658
Study O 0 0.050084926187992096
Group O 0 0.03301867097616196
. O 0 0.026775656268000603

Germline O 1 0.9968090653419495
mutations O 1 0.9830801486968994
in O 0 0.01032202411442995
the O 0 0.012805291451513767
p16 O 1 0.9950189590454102
and O 0 0.012534086592495441
CDK4 O 1 0.9978997707366943
genes O 1 0.7929462194442749
have O 0 0.00569956935942173
been O 0 0.005100945942103863
reported O 0 0.010504612699151039
in O 0 0.004172734450548887
a O 0 0.010074657388031483
subset O 0 0.03951520845293999
of O 0 0.013158822432160378
melanoma B-Disease 1 0.9999926090240479
pedigrees O 1 0.9749714732170105
, O 0 0.006791817490011454
but O 0 0.004654120188206434
their O 0 0.006548341363668442
prevalence O 1 0.9964516162872314
is O 0 0.005996347405016422
not O 0 0.0036188403610140085
well O 0 0.00494333216920495
known O 0 0.014633666723966599
. O 0 0.014070147648453712

We O 0 0.011250155046582222
searched O 0 0.018977774307131767
for O 0 0.005297468043863773
such O 0 0.01046675443649292
germline O 1 0.9988489151000977
mutations O 1 0.9928290247917175
in O 0 0.00858691893517971
48 O 0 0.029121000319719315
French O 1 0.9566591382026672
melanoma B-Disease 1 0.9999982118606567
- O 1 0.9585627913475037
prone O 1 0.9686393737792969
families O 0 0.01166860107332468
selected O 0 0.006346981972455978
according O 0 0.004237519111484289
to O 0 0.002583470894023776
two O 0 0.003129995195195079
major O 0 0.008367644622921944
criteria O 0 0.00929433386772871
families O 0 0.007031676825135946
with O 0 0.0033809510059654713
at O 0 0.004344893153756857
least O 0 0.007215274963527918
three O 0 0.005327983759343624
affected O 0 0.0273088701069355
members O 0 0.009410683065652847
( O 0 0.013359421864151955
n O 0 0.03319195657968521
= O 0 0.03194740414619446
20 O 0 0.008777141571044922
) O 0 0.005640202201902866
or O 0 0.004344039596617222
families O 0 0.005817658733576536
with O 0 0.002775913802906871
two O 0 0.003407274140045047
affected O 0 0.020022565498948097
members O 0 0.004016816150397062
, O 0 0.0022962617222219706
one O 0 0.002230354119092226
of O 0 0.0021059568971395493
them O 0 0.003331335261464119
affected O 0 0.019122570753097534
before O 0 0.004893140867352486
the O 0 0.0036275750026106834
age O 0 0.009735225699841976
of O 0 0.003949499689042568
50 O 0 0.012939034961163998
( O 0 0.013523741625249386
n O 0 0.03777523338794708
= O 0 0.03649773821234703
28 O 0 0.014557057060301304
) O 0 0.005508868955075741
, O 0 0.00299974181689322
and O 0 0.0021669340785592794
one O 0 0.004021927714347839
additional O 0 0.01039207074791193
minor O 0 0.05016012862324715
criterion O 0 0.045256245881319046
. O 0 0.01980474777519703

Sixteen O 0 0.05988788977265358
different O 0 0.027481431141495705
p16 O 1 0.9943080544471741
germline O 1 0.9990818500518799
mutations O 1 0.9951167106628418
were O 0 0.005631870124489069
found O 0 0.007801806088536978
in O 0 0.00363462558016181
21 O 0 0.009367108345031738
families O 0 0.008122307248413563
, O 0 0.0035679955035448074
while O 0 0.005697003100067377
one O 0 0.012508174404501915
germline O 1 0.9997413754463196
mutation O 1 0.9997058510780334
, O 0 0.00951777771115303
Arg24His O 1 0.9852951765060425
, O 0 0.006078022997826338
was O 0 0.008508406579494476
detected O 0 0.03925182297825813
in O 0 0.0062713343650102615
the O 0 0.013089584186673164
CDK4 O 1 0.9922687411308289
gene O 1 0.9632321000099182
. O 0 0.026685163378715515

The O 0 0.016372378915548325
frequency O 0 0.03898349776864052
of O 0 0.016287503764033318
p16 O 1 0.9945504069328308
gene O 1 0.9816622138023376
mutation O 1 0.9889916181564331
in O 0 0.0066787782125175
our O 0 0.00741462130099535
sample O 0 0.01766197942197323
( O 0 0.008756494149565697
44 O 0 0.011778170242905617
% O 0 0.007761524058878422
) O 0 0.004312379751354456
is O 0 0.002951735630631447
among O 0 0.0043914602138102055
the O 0 0.0038146297447383404
highest O 0 0.012797540985047817
rates O 0 0.016322700306773186
yet O 0 0.008513652719557285
reported O 0 0.011549267917871475
and O 0 0.004142546094954014
the O 0 0.009919853881001472
CDK4 O 1 0.997471809387207
mutation O 1 0.9970681071281433
is O 0 0.0063108643516898155
the O 0 0.005688705947250128
second O 0 0.019582586362957954
mutation O 1 0.9993250370025635
detected O 0 0.23111698031425476
in O 0 0.0060638729482889175
this O 0 0.00934806652367115
gene O 1 0.7313004732131958
worldwide O 0 0.044225163757801056
. O 0 0.023993369191884995

In O 0 0.012563427910208702
summary O 0 0.02227756194770336
, O 0 0.005421463865786791
our O 0 0.006969069596379995
results O 0 0.0131743298843503
show O 0 0.012898876331746578
frequent O 0 0.025540711358189583
involvement O 0 0.023285113275051117
of O 0 0.007255589123815298
the O 0 0.013068496249616146
p16 O 1 0.9981415271759033
gene O 1 0.9944701194763184
in O 0 0.022075477987527847
familial B-Disease 1 0.9999855756759644
melanoma I-Disease 1 0.9999966621398926
and O 0 0.006796079687774181
confirm O 0 0.011309168301522732
the O 0 0.0034449612721800804
role O 0 0.0069784182123839855
of O 0 0.0040161521174013615
the O 0 0.00813504122197628
CDK4 O 1 0.9958946704864502
gene O 1 0.8877301812171936
as O 0 0.009943678975105286
a O 0 0.036433082073926926
melanoma B-Disease 1 0.9999891519546509
- O 1 0.921700656414032
predisposing O 1 0.9980764389038086
gene O 1 0.9642264246940613
. O 0 0.013699336908757687
. O 0 0.020440036430954933

Progression O 1 0.9669631123542786
of O 0 0.021749358624219894
somatic O 1 0.9709406495094299
CTG O 1 0.9832968711853027
repeat O 0 0.23727019131183624
length O 0 0.029499687254428864
heterogeneity O 0 0.08167380839586258
in O 0 0.00622570188716054
the O 0 0.010223118588328362
blood O 1 0.9946257472038269
cells O 1 0.9399112462997437
of O 0 0.07598039507865906
myotonic B-Disease 1 0.9999988079071045
dystrophy I-Disease 1 0.9999996423721313
patients O 1 0.9999072551727295
. O 0 0.04169805347919464

The O 0 0.0167620237916708
genetic O 0 0.06593571603298187
basis O 0 0.014251637272536755
of O 0 0.024396603927016258
myotonic B-Disease 1 0.9999983310699463
dystrophy I-Disease 1 0.9999994039535522
( O 1 0.8660694360733032
DM B-Disease 1 0.9999455213546753
) O 0 0.01150602288544178
is O 0 0.004800847731530666
the O 0 0.003573599737137556
expansion O 0 0.009480212815105915
of O 0 0.0042715249583125114
an O 0 0.00921107642352581
unstable O 1 0.9770688414573669
CTG O 1 0.9859896898269653
repeat O 0 0.04874929040670395
in O 0 0.006562225054949522
the O 0 0.008213374763727188
34 O 0 0.02475029230117798
UTR O 0 0.09053080528974533
of O 0 0.007452166639268398
the O 0 0.016420535743236542
DM B-Disease 1 0.999619722366333
protein O 0 0.4833076000213623
kinase O 1 0.9800657033920288
gene O 0 0.4786752462387085
on O 0 0.016308320686221123
chromosome O 1 0.98332279920578
19 O 0 0.035558197647333145
. O 0 0.022553715854883194

One O 0 0.008899027481675148
of O 0 0.004396181087940931
the O 0 0.004203160293400288
principal O 0 0.00792667269706726
features O 0 0.006702644284814596
of O 0 0.004213194828480482
the O 0 0.012707976624369621
DM B-Disease 1 0.9999872446060181
mutation O 1 0.9997714161872864
is O 0 0.007297621574252844
an O 0 0.0060727824456989765
extraordinarily O 0 0.05448876693844795
high O 0 0.009660006500780582
level O 0 0.009442651644349098
of O 0 0.009640778414905071
somatic O 1 0.9928638339042664
mosaicism O 1 0.9990054965019226
, O 0 0.00774392718449235
due O 0 0.009568595327436924
to O 0 0.003140309127047658
an O 0 0.004662532825022936
extremely O 0 0.01481831818819046
high O 0 0.008159906603395939
degree O 0 0.010483212769031525
of O 0 0.007373590022325516
somatic O 1 0.9834960699081421
instability O 1 0.6582278609275818
both O 0 0.004724493250250816
within O 0 0.004482678137719631
and O 0 0.002984291408210993
between O 0 0.0070467484183609486
different O 0 0.01028699055314064
tissues O 1 0.9667805433273315
. O 0 0.0197287667542696

This O 0 0.017406040802598
instability O 1 0.6493189334869385
appears O 0 0.026451410725712776
to O 0 0.004509747494012117
be O 0 0.003810066496953368
biased O 0 0.017818018794059753
towards O 0 0.008402172476053238
further O 0 0.006325863767415285
expansion O 0 0.008809368126094341
and O 0 0.0032950351014733315
continuous O 0 0.013986846432089806
throughout O 0 0.004972714465111494
the O 0 0.002882875967770815
life O 0 0.005024577025324106
of O 0 0.002189221093431115
an O 0 0.002888701856136322
individual O 0 0.00498133385553956
, O 0 0.003011342603713274
features O 0 0.005249904002994299
that O 0 0.002008285140618682
could O 0 0.003142383648082614
be O 0 0.0022050542756915092
associated O 0 0.006168270483613014
with O 0 0.0022893885616213083
the O 0 0.0044602807611227036
progressive O 0 0.12690040469169617
nature O 0 0.011013149283826351
of O 0 0.0062147811986505985
the O 0 0.01418542955070734
disease O 1 0.9999707937240601
. O 0 0.026438379660248756

Although O 0 0.025582443922758102
increasing O 0 0.03872248902916908
measured O 0 0.042536791414022446
allele O 1 0.9742257595062256
size O 0 0.02529318444430828
between O 0 0.015931207686662674
patients O 1 0.9993882179260254
clearly O 0 0.018916890025138855
correlates O 0 0.16509930789470673
with O 0 0.004914155695587397
an O 0 0.005832507275044918
increased O 0 0.024615125730633736
severity O 1 0.9936922788619995
of O 0 0.011122416704893112
symptoms O 1 0.9999819993972778
and O 0 0.003548716427758336
an O 0 0.003924133721739054
earlier O 0 0.007394378073513508
age O 0 0.013374262489378452
of O 0 0.006984709296375513
onset O 1 0.9996360540390015
, O 0 0.005153888836503029
this O 0 0.004618095234036446
correlation O 0 0.021052464842796326
is O 0 0.0038933907635509968
not O 0 0.002584021305665374
precise O 0 0.009747954085469246
and O 0 0.004356663674116135
measured O 0 0.022561391815543175
allele O 1 0.9887458682060242
length O 0 0.014851497486233711
cannot O 0 0.006146635394543409
be O 0 0.0023035574704408646
used O 0 0.002403341233730316
as O 0 0.002313886536285281
an O 0 0.0031318049877882004
accurate O 0 0.011386878788471222
predictor O 0 0.4101859927177429
of O 0 0.00567217729985714
age O 0 0.017194878309965134
of O 0 0.011208033189177513
onset O 1 0.9996040463447571
. O 0 0.027862926945090294

In O 0 0.010153461247682571
order O 0 0.0066423676908016205
to O 0 0.004064447712153196
further O 0 0.007953017018735409
characterize O 0 0.027749937027692795
the O 0 0.0071879057213664055
dynamics O 0 0.03598003089427948
of O 0 0.016480429098010063
DM B-Disease 1 0.9998575448989868
CTG O 1 0.9983855485916138
repeat O 1 0.9700232744216919
somatic O 1 0.9916471242904663
instability O 1 0.9388250112533569
, O 0 0.0057239956222474575
we O 0 0.0032970746979117393
have O 0 0.0038129037711769342
studied O 0 0.010202508419752121
repeat O 0 0.03253184258937836
length O 0 0.012995878234505653
changes O 0 0.007047896273434162
over O 0 0.003866065526381135
time O 0 0.005512801930308342
in O 0 0.009699307382106781
111 O 1 0.9942834973335266
myotonic B-Disease 1 0.9999974966049194
dystrophy I-Disease 1 0.9999997615814209
patients O 1 0.9998810291290283
with O 0 0.010696006938815117
varying O 0 0.08360790461301804
clinical O 1 0.9950130581855774
severity O 1 0.9990760087966919
and O 0 0.01107966061681509
CTG O 1 0.9966717958450317
repeat O 0 0.1482393890619278
size O 0 0.012736449018120766
over O 0 0.004479466006159782
time O 0 0.004816682543605566
intervals O 0 0.01238261815160513
of O 0 0.004733135458081961
1 O 0 0.013386096805334091
- O 0 0.028683120384812355
7 O 0 0.018552377820014954
years O 0 0.014624117873609066
. O 0 0.01872950978577137

We O 0 0.008188905194401741
have O 0 0.0046287113800644875
found O 0 0.006205528508871794
a O 0 0.007328864187002182
direct O 0 0.01433112844824791
progression O 1 0.7442529797554016
of O 0 0.004018781241029501
the O 0 0.005486558191478252
size O 0 0.01426843274384737
heterogeneity O 0 0.09514293819665909
over O 0 0.005051025655120611
time O 0 0.004942734260112047
related O 0 0.008893733844161034
to O 0 0.004489061888307333
initial O 0 0.025746412575244904
CTG O 1 0.9748716950416565
repeat O 0 0.06884431093931198
size O 0 0.01013320405036211
and O 0 0.0029274653643369675
the O 0 0.003152137156575918
time O 0 0.005686815828084946
interval O 0 0.01713130995631218
and O 0 0.003475398989394307
always O 0 0.0080494936555624
biased O 0 0.017050286754965782
towards O 0 0.010815193876624107
further O 0 0.010186645202338696
expansion O 0 0.0274492334574461
. O 0 0.018278440460562706

Attempts O 0 0.02709689363837242
to O 0 0.006248174700886011
mathematically O 0 0.02312719076871872
model O 0 0.011484609916806221
the O 0 0.005744181107729673
dynamics O 0 0.023143183439970016
have O 0 0.005153566598892212
proved O 0 0.012390965595841408
only O 0 0.005886280909180641
partially O 0 0.028680479153990746
successful O 0 0.015442651696503162
suggesting O 0 0.01345263421535492
that O 0 0.0033099930733442307
individual O 0 0.006937442347407341
specific O 0 0.010630371980369091
genetic O 0 0.40380430221557617
and O 0 0.005662424024194479
/ O 0 0.1884867548942566
or O 0 0.007952042855322361
environmental O 0 0.013265258632600307
factors O 0 0.01099478080868721
also O 0 0.0038919192738831043
play O 0 0.0050105624832212925
a O 0 0.007705878000706434
role O 0 0.013564024120569229
in O 0 0.013055580668151379
somatic O 1 0.9843892455101013
mosaicism O 1 0.994491457939148
. O 0 0.018792271614074707
. O 0 0.02467670664191246

Aspartylglucosaminuria B-Disease 1 0.9669427275657654
among O 0 0.03560018539428711
Palestinian O 0 0.04851602762937546
Arabs O 0 0.06236256659030914
. O 0 0.026928022503852844

Aspartylglucosaminuria B-Disease 1 0.9973437190055847
( O 0 0.06242894381284714
AGU B-Disease 1 0.9993780851364136
) O 0 0.015394282527267933
is O 0 0.007959931157529354
a O 0 0.015640346333384514
rare O 1 0.7582900524139404
disorder B-Disease 1 0.9999418258666992
of I-Disease 0 0.016116024926304817
glycoprotein I-Disease 1 0.9980541467666626
metabolism I-Disease 1 0.9943178296089172
caused O 1 0.6002508997917175
by O 0 0.0076302774250507355
the O 0 0.010172782465815544
deficiency B-Disease 1 0.9997679591178894
of I-Disease 0 0.00700505543500185
the I-Disease 0 0.013572518713772297
lysosomal I-Disease 1 0.999052107334137
enzyme I-Disease 1 0.981338620185852
aspartylglucosaminidase I-Disease 1 0.9949223399162292
( O 0 0.028108038008213043
AGA O 1 0.7940250635147095
) O 0 0.0216594897210598
. O 0 0.020063038915395737

AGU B-Disease 1 0.9994729161262512
is O 0 0.0258259829133749
inherited O 1 0.9888928532600403
as O 0 0.011121252551674843
an O 0 0.02694779634475708
autosomal O 1 0.9999945163726807
recessive O 1 0.9999970197677612
trait O 1 0.9996837377548218
and O 0 0.007954255677759647
occurs O 0 0.10210059583187103
with O 0 0.004321527201682329
a O 0 0.006753559689968824
high O 0 0.009491157718002796
frequency O 0 0.018240690231323242
in O 0 0.004406737629324198
Finland O 0 0.013642813079059124
because O 0 0.006144520826637745
of O 0 0.0038955258205533028
a O 0 0.010869135148823261
founder O 0 0.040031611919403076
effect O 0 0.03713482990860939
. O 0 0.01994764246046543

While O 0 0.015677785500884056
very O 0 0.013393119908869267
few O 0 0.01705876737833023
patients O 1 0.9990025162696838
with O 0 0.01354117039591074
AGU B-Disease 1 0.9997842907905579
have O 0 0.0071052866987884045
been O 0 0.006281815469264984
reported O 0 0.014678123407065868
from O 0 0.006617012899369001
non O 0 0.015856904909014702
- O 0 0.026721149682998657
Finnish O 0 0.03057437762618065
origin O 0 0.015083440579473972
, O 0 0.005988845136016607
we O 0 0.010004687123000622
diagnosed O 1 0.9999922513961792
the O 0 0.01948440819978714
disorder O 1 0.9999829530715942
in O 0 0.01028199028223753
8 O 0 0.05304568633437157
patients O 1 0.9990068078041077
originating O 0 0.03264416754245758
from O 0 0.009566214866936207
3 O 0 0.01640624739229679
unrelated O 0 0.031422633677721024
families O 0 0.01022398192435503
, O 0 0.0032299673184752464
all O 0 0.0026918291114270687
Palestinian O 0 0.01175388041883707
Arabs O 0 0.01460280455648899
from O 0 0.004630421753972769
the O 0 0.004718118812888861
region O 0 0.012737139128148556
of O 0 0.005987099837511778
Jerusalem O 0 0.02776258811354637
. O 0 0.02046462520956993

The O 0 0.030148807913064957
clinical O 1 0.9953911304473877
diagnosis O 1 0.999419093132019
of O 0 0.01700981706380844
AGU B-Disease 1 0.9999374151229858
is O 0 0.010390333831310272
often O 0 0.009153489954769611
difficult O 0 0.009087488986551762
, O 0 0.0032160242553800344
in O 0 0.002934770192950964
particular O 0 0.005970117170363665
early O 0 0.005938726477324963
in O 0 0.0025707969907671213
the O 0 0.0027318019419908524
course O 0 0.00642611738294363
of O 0 0.003550376044586301
the O 0 0.008204209618270397
disease O 1 0.99998939037323
, O 0 0.0032748731318861246
and O 0 0.002287390874698758
most O 0 0.002748136641457677
of O 0 0.0029500997625291348
the O 0 0.007316105533391237
patients O 1 0.9998182654380798
are O 0 0.009942471981048584
diagnosed O 1 0.9999852180480957
after O 0 0.012273791246116161
the O 0 0.005192493554204702
age O 0 0.012193603441119194
of O 0 0.004952511750161648
5 O 0 0.014844085089862347
years O 0 0.015169368125498295
. O 0 0.018235117197036743

However O 0 0.016369039192795753
, O 0 0.006616213824599981
since O 0 0.012026643380522728
these O 0 0.009054348804056644
patients O 1 0.9997624754905701
excrete O 1 0.9891855716705322
early O 0 0.012514065019786358
large O 0 0.00904424861073494
amounts O 0 0.01004865299910307
of O 0 0.005468043498694897
aspartylglucosamine O 1 0.9720513820648193
in O 0 0.008093787357211113
urine O 1 0.7826527953147888
, O 0 0.009017645381391048
biochemical O 0 0.09847014397382736
screening O 0 0.04312931373715401
is O 0 0.0076250298880040646
easy O 0 0.013951144181191921
by O 0 0.011818526312708855
urine O 0 0.21724984049797058
chromatography O 0 0.06959261000156403
. O 0 0.012810584157705307
. O 0 0.01937940903007984

Detection O 0 0.0758846178650856
of O 0 0.015610918402671814
heterozygous O 1 0.9242796897888184
carriers O 0 0.05361860617995262
of O 0 0.008181809447705746
the O 0 0.018476959317922592
ataxia B-Disease 1 0.999957799911499
- I-Disease 1 0.9856162071228027
telangiectasia I-Disease 1 0.9998397827148438
( O 0 0.03076811693608761
ATM O 0 0.2562285363674164
) O 0 0.020641429349780083
gene O 0 0.16832095384597778
by O 0 0.02004760503768921
G2 O 1 0.9684388637542725
phase O 0 0.12193283438682556
chromosomal O 1 0.990225613117218
radiosensitivity O 1 0.9620415568351746
of O 0 0.022145885974168777
peripheral O 1 0.9992617964744568
blood O 1 0.998775064945221
lymphocytes O 1 0.9983682036399841
. O 0 0.04128759726881981

In O 0 0.039625972509384155
ataxia B-Disease 1 0.9998985528945923
- I-Disease 1 0.9825191497802734
telangiectasia I-Disease 1 0.9999067783355713
( O 0 0.03145868703722954
A B-Disease 1 0.6196170449256897
- I-Disease 1 0.983604371547699
T I-Disease 1 0.9996764659881592
) O 0 0.022008134052157402
patients O 1 0.9988559484481812
, O 0 0.008316737599670887
mutations O 1 0.9940855503082275
in O 0 0.0044278171844780445
a O 0 0.008826839737594128
single O 0 0.0168936587870121
gene O 1 0.5799545645713806
, O 0 0.007142852991819382
ATM O 0 0.05523637309670448
, O 0 0.004776212852448225
result O 0 0.010405671782791615
in O 0 0.005817973054945469
an O 0 0.05679088458418846
autosomal B-Disease 1 0.9999994039535522
recessive I-Disease 1 0.9999997615814209
syndrome I-Disease 1 0.9999998807907104
that O 0 0.01161108911037445
embraces O 0 0.3188570439815521
a O 0 0.008681721054017544
variety O 0 0.0077793775126338005
of O 0 0.005062493495643139
clinical O 1 0.9199990034103394
features O 0 0.009767056442797184
and O 0 0.005421959795057774
manifests O 1 0.9269696474075317
extreme O 1 0.5767925977706909
radiosensitivity O 1 0.9723395705223083
and O 0 0.0045372359454631805
a O 0 0.008588537573814392
strong O 0 0.013485152274370193
pre O 0 0.053996965289115906
- O 0 0.05329763889312744
disposition O 0 0.2825433909893036
to O 0 0.016829773783683777
malignancy B-Disease 1 0.9990159273147583
. O 0 0.03331637755036354

Heterozygotes O 1 0.9380911588668823
for O 0 0.0086017195135355
the O 0 0.010476681403815746
ATM O 1 0.8212572932243347
gene O 1 0.9043596982955933
have O 0 0.006089767441153526
no O 0 0.006409171968698502
clinical O 0 0.1572585254907608
expression O 0 0.017997827380895615
of O 0 0.0051190112717449665
A B-Disease 0 0.46434488892555237
- I-Disease 1 0.9887592792510986
T I-Disease 1 0.9993942975997925
but O 0 0.007377919740974903
may O 0 0.014833390712738037
be O 0 0.010185221210122108
cancer B-Disease 1 0.9999908208847046
prone O 1 0.9391055107116699
with O 0 0.0058473930694162846
a O 0 0.00996906403452158
moderate O 0 0.04500998184084892
increase O 0 0.01363951526582241
in O 0 0.005530092865228653
in O 0 0.010123278945684433
vitro O 1 0.8485839366912842
radiosensitivity O 1 0.9763200283050537
. O 0 0.0295543409883976

We O 0 0.014357352629303932
performed O 0 0.019743220880627632
a O 0 0.018207602202892303
blind O 1 0.7975371479988098
chromosomal O 1 0.9710232615470886
analysis O 0 0.021526068449020386
on O 0 0.01309447642415762
G2 O 1 0.98899906873703
- O 0 0.0913153886795044
phase O 0 0.07600521296262741
lymphocytes O 1 0.9926445484161377
from O 0 0.01073151733726263
7 O 0 0.020168717950582504
unrelated O 0 0.059220295399427414
A B-Disease 0 0.3785717189311981
- I-Disease 1 0.9925047159194946
T I-Disease 1 0.9998575448989868
patients O 1 0.9983465671539307
, O 0 0.007325721438974142
13 O 0 0.013635942712426186
obligate O 1 0.780691921710968
A B-Disease 0 0.3263331353664398
- I-Disease 1 0.9839202761650085
T I-Disease 1 0.9996771812438965
heterozygotes O 1 0.9985356330871582
( O 0 0.013409986160695553
parents O 0 0.014795642346143723
of O 0 0.005059225484728813
the O 0 0.008450907655060291
patients O 1 0.9993281364440918
) O 0 0.006323948502540588
, O 0 0.0027173515409231186
and O 0 0.0026007399428635836
14 O 0 0.009254300966858864
normal O 0 0.019532620906829834
controls O 0 0.02255372144281864
following O 0 0.017386266961693764
X O 0 0.2546984851360321
- O 0 0.03910677880048752
irradiation O 0 0.10470475256443024
with O 0 0.007371423300355673
1 O 0 0.016529541462659836
Gy O 1 0.9500466585159302
in O 0 0.005096101202070713
order O 0 0.00603414885699749
to O 0 0.00396204786375165
evaluate O 0 0.02074754424393177
this O 0 0.006770838052034378
cytogenetic O 1 0.6387709379196167
method O 0 0.013663182035088539
as O 0 0.004217473790049553
a O 0 0.005693536251783371
tool O 0 0.0133378179743886
for O 0 0.00441365223377943
detection O 0 0.03368459641933441
of O 0 0.008815336972475052
ATM O 1 0.5185492634773254
carriers O 0 0.11750064045190811
. O 0 0.023252135142683983

Both O 0 0.018193397670984268
A B-Disease 0 0.05475199222564697
- I-Disease 1 0.9364213943481445
T I-Disease 1 0.9994156360626221
homozygotes O 1 0.9970491528511047
and O 0 0.012525767087936401
heterozygotes O 1 0.9960378408432007
showed O 0 0.0267543476074934
significantly O 0 0.028897883370518684
increased O 0 0.015578754246234894
levels O 0 0.01700790412724018
of O 0 0.009197560139000416
radiation O 1 0.9931502938270569
- O 1 0.959355354309082
induced O 1 0.9992411136627197
chromatid O 1 0.9996036887168884
damage O 1 0.9444783926010132
relative O 0 0.01562448125332594
to O 0 0.003390285884961486
that O 0 0.0031300249975174665
of O 0 0.004933672957122326
normal O 0 0.030451921746134758
controls O 0 0.03651633858680725
. O 0 0.02214864082634449

These O 0 0.008792449720203876
results O 0 0.012037754990160465
show O 0 0.007776967249810696
that O 0 0.003347056219354272
the O 0 0.008153374306857586
G2 O 1 0.9965954422950745
- O 0 0.1805560439825058
phase O 0 0.4498806297779083
chromosomal O 1 0.9993225336074829
radiosensitivity O 1 0.9951306581497192
assay O 0 0.1302058845758438
can O 0 0.004901473876088858
be O 0 0.0020026392303407192
used O 0 0.00234705931507051
for O 0 0.002285443479195237
the O 0 0.004595623351633549
detection O 0 0.02394932322204113
of O 0 0.006921625696122646
A B-Disease 0 0.13117961585521698
- I-Disease 1 0.9485822916030884
T I-Disease 1 0.9976230263710022
heterozygotes O 1 0.9756903648376465
. O 0 0.045493997633457184

In O 0 0.014033329673111439
combination O 0 0.037090517580509186
with O 0 0.00986169371753931
molecular O 0 0.04856359586119652
genetic O 1 0.6246031522750854
analyses O 0 0.016007335856556892
, O 0 0.003438324434682727
this O 0 0.0031515981536358595
test O 0 0.008817878551781178
may O 0 0.004570288117974997
be O 0 0.0016462227795273066
of O 0 0.001762665924616158
value O 0 0.0033628337550908327
in O 0 0.0026849103160202503
studies O 0 0.006838657893240452
of O 0 0.005952372681349516
familial B-Disease 1 0.999737560749054
and I-Disease 0 0.009712828323245049
sporadic I-Disease 1 0.9905635118484497
cancers I-Disease 1 0.9999147653579712
aimed O 0 0.018754957243800163
at O 0 0.006803432479500771
determination O 0 0.012691061943769455
of O 0 0.003396358573809266
the O 0 0.00461593410000205
potential O 0 0.013411272317171097
involvement O 0 0.020433630794286728
of O 0 0.008186849765479565
ATM O 1 0.9813817739486694
mutations O 1 0.9993034601211548
in O 0 0.018372396007180214
tumor B-Disease 1 0.9999591112136841
risk O 1 0.9896321296691895
or O 0 0.01027034129947424
development O 0 0.010603179223835468
. O 0 0.008779564872384071
. O 0 0.01712096482515335

Ataxia B-Disease 1 0.9999276399612427
- I-Disease 1 0.9861414432525635
telangiectasia I-Disease 1 0.9996957778930664
: O 0 0.019842717796564102
identification O 0 0.0172595027834177
and O 0 0.005131523124873638
detection O 0 0.023223979398608208
of O 0 0.00549415173009038
founder O 0 0.04300033673644066
- O 0 0.17591111361980438
effect O 0 0.05976531654596329
mutations O 1 0.9923093318939209
in O 0 0.005217942409217358
the O 0 0.008024455979466438
ATM O 0 0.3218725323677063
gene O 0 0.4963390529155731
in O 0 0.009846461936831474
ethnic O 0 0.027500394731760025
populations O 0 0.07344923168420792
. O 0 0.020294632762670517

To O 0 0.010763201862573624
facilitate O 0 0.015603181906044483
the O 0 0.006508890073746443
evaluation O 0 0.022811053320765495
of O 0 0.009179417975246906
ATM O 0 0.4781184196472168
heterozygotes O 1 0.9885677099227905
for O 0 0.010701503604650497
susceptibility O 1 0.9964675903320312
to O 0 0.005717809312045574
other O 0 0.007765443529933691
diseases O 1 0.9999443292617798
, O 0 0.004519355017691851
such O 0 0.005100635811686516
as O 0 0.14531899988651276
breast B-Disease 1 0.9999990463256836
cancer I-Disease 1 0.9999936819076538
, O 0 0.0054113478399813175
we O 0 0.0032195784151554108
have O 0 0.003302491270005703
attempted O 0 0.00942241121083498
to O 0 0.003973131999373436
define O 0 0.011264458298683167
the O 0 0.004597643855959177
most O 0 0.0065957303158938885
common O 0 0.020803149789571762
mutations O 1 0.9933561086654663
and O 0 0.0039098248817026615
their O 0 0.005665347911417484
frequencies O 0 0.0254417285323143
in O 0 0.013682449236512184
ataxia B-Disease 1 0.9999302625656128
- I-Disease 1 0.9883700609207153
telangiectasia I-Disease 1 0.9999401569366455
( O 0 0.024814113974571228
A B-Disease 1 0.547051727771759
- I-Disease 1 0.9580114483833313
T I-Disease 1 0.9979810118675232
) O 0 0.021434640511870384
homozygotes O 1 0.9538317918777466
from O 0 0.011198066174983978
10 O 0 0.013793925754725933
ethnic O 0 0.027178816497325897
populations O 0 0.060823772102594376
. O 0 0.0231493953615427

Both O 0 0.025569681078195572
genomic O 1 0.9031739234924316
mutations O 1 0.9915561676025391
and O 0 0.00688357837498188
their O 0 0.007811955641955137
effects O 0 0.03298326954245567
on O 0 0.00838540866971016
cDNA O 0 0.05802319571375847
were O 0 0.008297983556985855
characterized O 0 0.07395520806312561
. O 0 0.020673392340540886

Protein O 0 0.13568849861621857
- O 0 0.06873279809951782
truncation O 0 0.20609450340270996
testing O 0 0.023652993142604828
of O 0 0.0059427423402667046
the O 0 0.00749480864033103
entire O 0 0.03034847602248192
ATM O 0 0.1033615842461586
cDNA O 0 0.13204523921012878
detected O 0 0.1343311369419098
92 O 0 0.044115450233221054
( O 0 0.015437418594956398
66 O 0 0.028241746127605438
% O 0 0.015559256076812744
) O 0 0.015324095264077187
truncating O 1 0.973070502281189
mutations O 1 0.9861180186271667
in O 0 0.013279959559440613
140 O 0 0.05741778016090393
mutant O 1 0.9855538010597229
alleles O 1 0.9861474633216858
screened O 0 0.09849239885807037
. O 0 0.027401695027947426

The O 0 0.019679754972457886
haplotyping O 1 0.719072163105011
of O 0 0.012122424319386482
patients O 1 0.998357355594635
with O 0 0.008365306071937084
identical O 0 0.08069656789302826
mutations O 1 0.9993821382522583
indicates O 0 0.020987603813409805
that O 0 0.0029505768325179815
almost O 0 0.004135008901357651
all O 0 0.0013876606244593859
of O 0 0.001898036221973598
these O 0 0.0024056481197476387
represent O 0 0.005737219005823135
common O 0 0.010460692457854748
ancestry O 0 0.02745867893099785
and O 0 0.002823151182383299
that O 0 0.0032974707428365946
very O 0 0.007237250450998545
few O 0 0.011435549706220627
spontaneously O 1 0.858831524848938
recurring O 1 0.9949464201927185
ATM O 1 0.9731467962265015
mutations O 1 0.996351957321167
exist O 0 0.024803880602121353
. O 0 0.01970236748456955

Assays O 0 0.13478122651576996
requiring O 0 0.04845702648162842
minimal O 0 0.037763286381959915
amounts O 0 0.01885158009827137
of O 0 0.008013252168893814
genomic O 0 0.43886375427246094
DNA O 0 0.030016489326953888
were O 0 0.0033955180551856756
designed O 0 0.006147993262857199
to O 0 0.0031807986088097095
allow O 0 0.009580809623003006
rapid O 0 0.03347634896636009
screening O 0 0.032594066113233566
for O 0 0.005852043628692627
common O 0 0.01775534078478813
ethnic O 0 0.03763287514448166
mutations O 1 0.9951608777046204
. O 0 0.027383126318454742

These O 0 0.017121784389019012
rapid O 0 0.07403010129928589
assays O 0 0.18139207363128662
detected O 1 0.6796362996101379
mutations O 1 0.9589043259620667
in O 0 0.0087418919429183
76 O 0 0.02972317487001419
% O 0 0.010563170537352562
of O 0 0.007187933195382357
Costa O 0 0.04601016268134117
Rican O 1 0.7368223071098328
patients O 1 0.9988106489181519
( O 0 0.015119262039661407
3 O 0 0.011971618048846722
) O 0 0.005788239650428295
, O 0 0.003731850069016218
50 O 0 0.007774229161441326
% O 0 0.006475295405834913
of O 0 0.0052186064422130585
Norwegian O 0 0.039525069296360016
patients O 1 0.9987112283706665
( O 0 0.011884129606187344
1 O 0 0.009783663786947727
) O 0 0.0055983951315283775
, O 0 0.003401323687285185
25 O 0 0.007065169513225555
% O 0 0.005953459069132805
of O 0 0.005244652274996042
Polish O 0 0.37008023262023926
patients O 1 0.9995811581611633
( O 0 0.010699640959501266
4 O 0 0.010713359341025352
) O 0 0.004673084709793329
, O 0 0.0022907627280801535
and O 0 0.0023614608217030764
14 O 0 0.0059070102870464325
% O 0 0.004849611781537533
of O 0 0.00459381565451622
Italian O 0 0.49493110179901123
patients O 1 0.9997485280036926
( O 0 0.010939509607851505
1 O 0 0.008779187686741352
) O 0 0.004450004082173109
, O 0 0.0022422047331929207
as O 0 0.0021608304232358932
well O 0 0.0025058446917682886
as O 0 0.0029459313955157995
in O 0 0.00507491547614336
patients O 1 0.9951983094215393
of O 0 0.00801797304302454
Amish O 1 0.6374793648719788
/ O 0 0.28137412667274475
Mennonite O 0 0.050321631133556366
and O 0 0.006299327127635479
Irish O 0 0.025610629469156265
English O 0 0.018731551244854927
backgrounds O 0 0.037765294313430786
. O 0 0.023371201008558273

Additional O 0 0.041645877063274384
mutations O 1 0.9842049479484558
were O 0 0.006224913988262415
observed O 0 0.015111396089196205
in O 0 0.0046739899553358555
Japanese O 0 0.010476290248334408
, O 0 0.005485383793711662
Utah O 0 0.016729559749364853
Mormon O 0 0.023429369553923607
, O 0 0.004394269548356533
and O 0 0.004744505975395441
African O 0 0.029995689168572426
American O 0 0.034552011638879776
patients O 1 0.9980687499046326
. O 0 0.028342608362436295

These O 0 0.013089096173644066
assays O 0 0.0405314564704895
should O 0 0.007614116184413433
facilitate O 0 0.01639723964035511
screening O 0 0.029081277549266815
for O 0 0.006707582622766495
A B-Disease 0 0.06384680420160294
- I-Disease 1 0.9568368792533875
T I-Disease 1 0.9993282556533813
heterozygotes O 1 0.9699233174324036
in O 0 0.007452766411006451
the O 0 0.008153325878083706
populations O 0 0.042891573160886765
studied O 0 0.015255732461810112
. O 0 0.009636305272579193
. O 0 0.016167929396033287

The O 0 0.0266459621489048
von B-Disease 1 0.9798027873039246
Hippel I-Disease 1 0.9992376565933228
- I-Disease 1 0.9920559525489807
Lindau I-Disease 1 0.9998445510864258
tumor I-Disease 1 0.9999892711639404
suppressor O 1 0.9998880624771118
gene O 1 0.972672164440155
is O 0 0.006309323012828827
required O 0 0.005913366563618183
for O 0 0.0044777593575417995
cell O 0 0.0470053032040596
cycle O 0 0.05159485712647438
exit O 0 0.04249976575374603
upon O 0 0.02386418543756008
serum O 1 0.9720893502235413
withdrawal O 0 0.07682547718286514
. O 0 0.026086583733558655

The O 0 0.017189817503094673
inactivation O 1 0.6547604203224182
of O 0 0.007485574577003717
the O 0 0.012352901510894299
von B-Disease 1 0.979340672492981
Hippel I-Disease 1 0.9990766048431396
- I-Disease 1 0.6935325860977173
Lindau I-Disease 1 0.9969252943992615
( I-Disease 0 0.06278300285339355
VHL I-Disease 1 0.9994614720344543
) I-Disease 0 0.08994334936141968
tumor I-Disease 1 0.9999752044677734
suppressor O 1 0.9999357461929321
gene O 1 0.9994301199913025
predisposes O 1 0.9996857643127441
affected O 1 0.6317588686943054
individuals O 0 0.010562232695519924
to O 0 0.004216257017105818
the O 0 0.008795289322733879
human O 1 0.9777092933654785
VHL B-Disease 1 0.9999977350234985
cancer I-Disease 1 0.9999997615814209
syndrome I-Disease 1 0.9999998807907104
and O 0 0.007550087757408619
is O 0 0.006635210011154413
associated O 0 0.013009550981223583
with O 0 0.010882728733122349
sporadic B-Disease 1 0.9984038472175598
renal I-Disease 1 0.9999983310699463
cell I-Disease 1 0.9988499879837036
carcinomas I-Disease 1 0.9999676942825317
( O 0 0.10486844927072525
RCC B-Disease 1 0.9984685778617859
) O 0 0.01597408391535282
and O 0 0.01354575902223587
brain B-Disease 1 0.9996503591537476
hemangioblastomas I-Disease 1 0.9872651100158691
. O 0 0.034375544637441635

VHL O 1 0.997318685054779
- O 0 0.19347794353961945
negative O 0 0.18949538469314575
786 O 1 0.9667770862579346
- O 0 0.26713237166404724
0 O 0 0.06706660985946655
RCC B-Disease 1 0.9974052309989929
cells O 0 0.34772607684135437
are O 0 0.007889177650213242
tumorigenic O 1 0.9398791790008545
in O 0 0.011398853734135628
nude O 1 0.962243378162384
mice O 1 0.9911782145500183
which O 0 0.007788941729813814
is O 0 0.00781912263482809
suppressed O 0 0.03532474488019943
by O 0 0.007543284446001053
the O 0 0.008549769409000874
reintroduction O 0 0.1632588505744934
of O 0 0.02052099071443081
VHL B-Disease 1 0.9980530738830566
. O 0 0.03611364588141441

Remarkably O 0 0.07450759410858154
, O 0 0.0074782948940992355
this O 0 0.006887752562761307
occurs O 0 0.028936417773365974
without O 0 0.008613417856395245
affecting O 0 0.057687219232320786
the O 0 0.005187399219721556
growth O 0 0.012656152248382568
rate O 0 0.011262563057243824
and O 0 0.004714304581284523
cell O 0 0.07774868607521057
cycle O 0 0.043747153133153915
profile O 0 0.024929124861955643
of O 0 0.00482551334425807
these O 0 0.005534878466278315
cells O 0 0.044978830963373184
in O 0 0.009055837988853455
culture O 0 0.028128428384661674
. O 0 0.019025469198822975

The O 0 0.025822920724749565
786 O 1 0.9550063014030457
- O 0 0.07915034890174866
0 O 0 0.034398894757032394
cell O 0 0.044934455305337906
line O 0 0.013227874413132668
, O 0 0.005013325251638889
like O 0 0.01057779137045145
many O 0 0.013632879592478275
cancer B-Disease 1 0.9999830722808838
cells O 1 0.9333797693252563
, O 0 0.00641278363764286
fails O 0 0.029204873368144035
to O 0 0.005038651637732983
exit O 0 0.023730840533971786
the O 0 0.009156336076557636
cell O 0 0.054490793496370316
cycle O 0 0.057958073914051056
upon O 0 0.025187982246279716
serum O 1 0.9245436191558838
withdrawal O 0 0.07354497909545898
. O 0 0.02602255344390869

Here O 0 0.012231039814651012
, O 0 0.004869355354458094
it O 0 0.0032581123523414135
is O 0 0.0038936128839850426
shown O 0 0.007023894228041172
that O 0 0.002953467657789588
reintroduction O 0 0.030761830508708954
of O 0 0.0033695846796035767
the O 0 0.0050919512286782265
wild O 0 0.03646654635667801
- O 0 0.381027489900589
type O 1 0.7366918325424194
VHL B-Disease 1 0.9995694756507874
gene O 1 0.9660152792930603
restores O 0 0.06887856870889664
the O 0 0.0072943586856126785
ability O 0 0.016643274575471878
of O 0 0.01185542717576027
VHL O 1 0.9998791217803955
- O 1 0.9703503847122192
negative O 1 0.9918588995933533
RCC B-Disease 1 0.9999469518661499
cancer I-Disease 1 0.999983549118042
cells O 1 0.7042344808578491
to O 0 0.006932023912668228
exit O 0 0.0216752327978611
the O 0 0.007306256797164679
cell O 0 0.036883991211652756
cycle O 0 0.0337587334215641
and O 0 0.0072779543697834015
enter O 0 0.03385544195771217
G0 O 1 0.998968243598938
/ O 1 0.9200695157051086
quiescence O 1 0.9827067852020264
in O 0 0.015898168087005615
low O 0 0.050873346626758575
serum O 1 0.8621903657913208
. O 0 0.03129066899418831

Both O 0 0.03463416546583176
VHL O 1 0.9987998008728027
- O 0 0.06381260603666306
positive O 0 0.03283344954252243
and O 0 0.014139371924102306
VHL O 1 0.9995481371879578
- O 0 0.32686904072761536
negative O 1 0.5313230752944946
RCC B-Disease 1 0.9981681108474731
cells O 1 0.6079992055892944
exit O 0 0.03508559986948967
the O 0 0.009805669076740742
cell O 0 0.050084881484508514
cycle O 0 0.0429011695086956
by O 0 0.01287400908768177
contact O 0 0.04947255924344063
inhibition O 1 0.8878917694091797
. O 0 0.02770008146762848

The O 0 0.04279523342847824
cyclin O 1 0.9779148101806641
- O 0 0.10731704533100128
dependent O 0 0.1067403256893158
kinase O 1 0.98252272605896
inhibitor O 1 0.9873262047767639
, O 0 0.019061459228396416
p27 O 1 0.9913228750228882
, O 0 0.01227492280304432
accumulates O 1 0.730681836605072
upon O 0 0.01894374191761017
serum O 1 0.9914748668670654
withdrawal O 0 0.06639792770147324
, O 0 0.004017415456473827
only O 0 0.002743598073720932
in O 0 0.002760490169748664
the O 0 0.0038068299181759357
presence O 0 0.013288503512740135
of O 0 0.007106204982846975
VHL B-Disease 1 0.9998376369476318
, O 0 0.004477076698094606
as O 0 0.0030246556270867586
a O 0 0.004983064252883196
result O 0 0.0069921184331178665
of O 0 0.002662253100425005
the O 0 0.00420188857242465
stabilization O 0 0.026492061093449593
of O 0 0.004792744293808937
the O 0 0.01002490147948265
protein O 0 0.0538409948348999
. O 0 0.0180064644664526

We O 0 0.010212162509560585
propose O 0 0.019129615277051926
that O 0 0.0036163206677883863
the O 0 0.004319379571825266
loss O 0 0.01735612004995346
of O 0 0.0066116987727582455
wild O 0 0.12259312719106674
- O 1 0.7355260252952576
type O 1 0.9756608605384827
VHL B-Disease 1 0.9998569488525391
gene O 1 0.9847407937049866
results O 0 0.012904451228678226
in O 0 0.004213443025946617
a O 0 0.007901286706328392
specific O 0 0.012340993620455265
cellular O 0 0.4507601857185364
defect O 1 0.9895637631416321
in O 0 0.010671895928680897
serum O 1 0.9806021451950073
- O 0 0.04708050563931465
dependent O 0 0.03241916373372078
growth O 0 0.01918509416282177
control O 0 0.019900355488061905
, O 0 0.005026954226195812
which O 0 0.007574760355055332
may O 0 0.02478567138314247
initiate O 1 0.9063814878463745
tumor B-Disease 1 0.9996486902236938
formation O 0 0.0779547169804573
. O 0 0.02555052936077118

This O 0 0.013740931637585163
is O 0 0.009885091334581375
corrected O 0 0.037014301866292953
by O 0 0.006091563031077385
the O 0 0.006110108457505703
reintroduction O 0 0.0688142254948616
of O 0 0.007839445024728775
wild O 0 0.04024672508239746
- O 0 0.11793500185012817
type O 0 0.4071015417575836
VHL B-Disease 1 0.999215841293335
, O 0 0.016169894486665726
implicating O 1 0.9395951628684998
VHL B-Disease 1 0.9989722967147827
as O 0 0.006571323610842228
the O 0 0.00697858352214098
first O 0 0.016805078834295273
tumor B-Disease 1 0.9999686479568481
suppressor O 1 0.9995689988136292
involved O 0 0.014520096592605114
in O 0 0.003699065186083317
the O 0 0.004250970669090748
regulation O 0 0.013964052312076092
of O 0 0.005550229921936989
cell O 0 0.16895024478435516
cycle O 0 0.10953950136899948
exit O 0 0.028949527069926262
, O 0 0.0036926812026649714
which O 0 0.002938808174803853
is O 0 0.0036028516478836536
consistent O 0 0.007735037244856358
with O 0 0.0040086405351758
its O 0 0.00794193334877491
gatekeeper O 1 0.9945172667503357
function O 0 0.015910647809505463
in O 0 0.005068895407021046
the O 0 0.01179017499089241
kidney O 1 0.9999815225601196
. O 0 0.013049161061644554
. O 0 0.017702404409646988

Piebaldism B-Disease 1 0.9984809756278992
with O 0 0.03606289252638817
deafness B-Disease 1 0.9999798536300659
: O 0 0.01440017856657505
molecular O 0 0.02555469609797001
evidence O 0 0.00697265425696969
for O 0 0.0042869579046964645
an O 0 0.008918403647840023
expanded O 0 0.07596255838871002
syndrome O 1 0.9999884366989136
. O 0 0.03439386188983917

In O 0 0.00862202513962984
a O 0 0.011334553360939026
South O 0 0.012389128096401691
African O 0 0.02857673540711403
girl O 0 0.11230146139860153
of O 0 0.009717282839119434
Xhosa O 1 0.9908488988876343
stock O 0 0.03567802906036377
with O 0 0.013449509628117085
severe O 1 0.9998807907104492
piebaldism B-Disease 1 0.9989922642707825
and O 0 0.020905746147036552
profound O 1 0.9998202919960022
congenital O 1 0.9999998807907104
sensorineural B-Disease 1 0.9999940395355225
deafness I-Disease 1 0.9999964237213135
we O 0 0.009766134433448315
identified O 0 0.01813090220093727
a O 0 0.012831454165279865
novel O 0 0.03749954700469971
missense O 1 0.9653657078742981
substitution O 0 0.02992621622979641
at O 0 0.006419106852263212
a O 0 0.009120413102209568
highly O 0 0.015699515119194984
conserved O 0 0.028627971187233925
residue O 0 0.028815848752856255
in O 0 0.004414464347064495
the O 0 0.007522818632423878
intracellular O 0 0.2775861620903015
kinase O 0 0.22090117633342743
domain O 0 0.020670777186751366
of O 0 0.0052799261175096035
the O 0 0.011335126124322414
KIT O 1 0.9296790957450867
proto O 1 0.994820237159729
- O 1 0.7502098083496094
oncogene O 1 0.9986409544944763
, O 0 0.02462610974907875
R796G O 1 0.6871952414512634
. O 0 0.02802399732172489

Though O 0 0.051799919456243515
auditory B-Disease 1 0.9886389970779419
anomalies I-Disease 1 0.7830725312232971
have O 0 0.008062328211963177
been O 0 0.008215751498937607
observed O 0 0.019166389480233192
in O 0 0.007805948611348867
mice O 1 0.9514986276626587
with O 0 0.010312090627849102
dominant O 0 0.2852948009967804
white O 0 0.06755479425191879
spotting O 1 0.9858176112174988
( O 0 0.025445813313126564
W O 1 0.9720869660377502
) O 0 0.008807041682302952
due O 0 0.011021432466804981
to O 0 0.0076728276908397675
KIT O 1 0.9900658130645752
mutations O 1 0.9994004964828491
, O 0 0.018757717683911324
deafness B-Disease 1 0.9999719858169556
is O 0 0.00705596012994647
not O 0 0.004514033906161785
typical O 0 0.019701391458511353
in O 0 0.006373534444719553
human O 0 0.03692770004272461
piebaldism B-Disease 1 0.9808635711669922
. O 0 0.025141088292002678

Thus O 0 0.0213504359126091
, O 0 0.0062237572856247425
the O 0 0.009007645770907402
occurrence O 0 0.204570472240448
of O 0 0.015959743410348892
sensorineural B-Disease 1 0.9998968839645386
deafness I-Disease 1 0.9999868869781494
in O 0 0.0095891784876585
this O 0 0.010369673371315002
patient O 1 0.9974955916404724
extends O 0 0.05250399559736252
considerably O 0 0.03530074283480644
the O 0 0.011497901752591133
phenotypic O 1 0.7775449752807617
range O 0 0.012006117962300777
of O 0 0.006424917373806238
piebaldism B-Disease 1 0.8841790556907654
due O 0 0.018281495198607445
to O 0 0.009162671864032745
KIT O 1 0.98475581407547
gene O 1 0.9976677298545837
mutation O 1 0.9989407658576965
in O 0 0.009227709844708443
humans O 0 0.0597936287522316
and O 0 0.007066019345074892
tightens O 1 0.9740427136421204
the O 0 0.011076275259256363
clinical O 1 0.8482087254524231
similarity O 0 0.03584600239992142
between O 0 0.010428544133901596
piebaldism B-Disease 1 0.6077059507369995
and O 0 0.003512391122058034
the O 0 0.004198281094431877
various O 0 0.005251056980341673
forms O 0 0.01639612577855587
of O 0 0.01931053400039673
Waardenburg B-Disease 1 0.9999920129776001
syndrome I-Disease 1 0.9999984502792358
. O 0 0.01907248981297016
. O 0 0.02125309407711029

Cycloheximide O 1 0.9070656299591064
facilitates O 0 0.059398189187049866
the O 0 0.010682977735996246
identification O 0 0.016490254551172256
of O 0 0.007689524907618761
aberrant O 0 0.32945936918258667
transcripts O 0 0.02195107936859131
resulting O 0 0.024947158992290497
from O 0 0.006916082929819822
a O 0 0.011247566901147366
novel O 0 0.034903693944215775
splice O 1 0.7809610962867737
- O 0 0.046841830015182495
site O 0 0.028225336223840714
mutation O 1 0.9871163964271545
in O 0 0.009861634112894535
COL17A1 O 1 0.9327097535133362
in O 0 0.007154383230954409
a O 0 0.015357963740825653
patient O 1 0.9945195317268372
with O 0 0.02225368097424507
generalized O 1 0.9997503161430359
atrophic B-Disease 1 0.9999935626983643
benign I-Disease 1 0.9999642372131348
epidermolysis I-Disease 1 0.9999628067016602
bullosa I-Disease 1 0.9997102618217468
. O 0 0.057792048901319504

Patients O 1 0.9987677335739136
with O 0 0.03291889652609825
generalized O 1 0.9996092915534973
atrophic B-Disease 1 0.9999871253967285
benign I-Disease 1 0.9999809265136719
epidermolysis I-Disease 1 0.9999943971633911
bullosa I-Disease 1 0.9999685287475586
often O 0 0.029726574197411537
show O 0 0.019958388060331345
decreased O 0 0.20979876816272736
expression O 0 0.03176690265536308
of O 0 0.008794966153800488
type O 1 0.9850972890853882
XVII O 1 0.9998237490653992
collagen O 1 0.999291181564331
, O 0 0.0087783457711339
a O 0 0.017117658630013466
transmembrane O 1 0.935851514339447
hemidesmosomal O 1 0.9166289567947388
protein O 0 0.06092990189790726
encoded O 0 0.036220237612724304
by O 0 0.017124943435192108
COL17A1 O 1 0.9696722030639648
. O 0 0.026265205815434456

This O 0 0.009843477047979832
report O 0 0.009043773636221886
documents O 0 0.0064908885397017
a O 0 0.011683155782520771
novel O 0 0.03707505762577057
splice O 1 0.7485391497612
- O 0 0.04672010615468025
site O 0 0.025959322229027748
mutation O 1 0.9681554436683655
in O 0 0.010117490775883198
COL17A1 O 1 0.856116533279419
in O 0 0.006472243927419186
a O 0 0.016541531309485435
patient O 1 0.9916165471076965
with O 0 0.022292207926511765
generalized O 1 0.999478280544281
atrophic B-Disease 1 0.9999957084655762
benign I-Disease 1 0.9999856948852539
epidermolysis I-Disease 1 0.9999858140945435
bullosa I-Disease 1 0.9999327659606934
, O 0 0.009610876441001892
and O 0 0.0044050393626093864
applies O 0 0.01058921217918396
a O 0 0.005199845880270004
new O 0 0.004658319056034088
methodology O 0 0.011124882847070694
to O 0 0.0034982236102223396
define O 0 0.011156663298606873
and O 0 0.004124019294977188
characterize O 0 0.03309047594666481
the O 0 0.008947530761361122
resulting O 0 0.048949163407087326
mRNA O 0 0.08884801715612411
splice O 1 0.539159893989563
variants O 0 0.08359742164611816
. O 0 0.02707948163151741

Mutational O 1 0.8838484287261963
analysis O 0 0.028571931645274162
of O 0 0.01089415978640318
COL17A1 O 1 0.9790375232696533
identified O 0 0.029522253200411797
a O 0 0.021556388586759567
maternally O 1 0.990176260471344
inherited O 1 0.9980694651603699
G O 1 0.9554135203361511
- O 0 0.03523913025856018
to O 0 0.011718870140612125
- O 0 0.21629448235034943
T O 1 0.9843164682388306
transversion O 0 0.33417949080467224
at O 0 0.007557280361652374
the O 0 0.0063844965770840645
- O 0 0.02038707584142685
1 O 0 0.010739178396761417
position O 0 0.0076742107048630714
of O 0 0.007201931905001402
exon O 0 0.4115358293056488
32 O 0 0.03850914165377617
. O 0 0.019250912591814995

This O 0 0.023014454171061516
acceptor O 1 0.5279550552368164
splice O 1 0.8843143582344055
- O 0 0.05354280024766922
site O 0 0.02956540696322918
mutation O 1 0.9905982613563538
led O 0 0.011473425664007664
to O 0 0.0034707977902144194
the O 0 0.004578990861773491
formation O 0 0.01888437755405903
of O 0 0.005913067609071732
aberrant O 0 0.4127804636955261
transcripts O 0 0.016603941097855568
present O 0 0.008296508342027664
at O 0 0.009353529661893845
extremely O 0 0.026770275086164474
low O 0 0.03545631468296051
levels O 0 0.030195485800504684
. O 0 0.020871251821517944

Based O 0 0.01269625499844551
on O 0 0.005299802869558334
our O 0 0.006581480149179697
recent O 0 0.010985533706843853
finding O 0 0.01564081571996212
that O 0 0.010325024835765362
cycloheximide O 1 0.985866367816925
stabilized O 1 0.9774858951568604
mutant O 1 0.9783952236175537
COL17A1 O 1 0.9553514719009399
transcripts O 0 0.03229377046227455
in O 0 0.013433335348963737
keratinocytes O 1 0.9874366521835327
homozygous O 1 0.9291113018989563
for O 0 0.00915286224335432
a O 0 0.025693411007523537
frameshift O 1 0.9986463189125061
mutation O 1 0.9969668984413147
, O 0 0.006060255225747824
the O 0 0.005460029933601618
effects O 0 0.019666237756609917
of O 0 0.0037347530014812946
the O 0 0.007481313776224852
splice O 1 0.7822102904319763
- O 0 0.03804321587085724
site O 0 0.022708887234330177
mutation O 1 0.8782834410667419
on O 0 0.007150056306272745
splicing O 0 0.04848221689462662
of O 0 0.007846317254006863
COL17A1 O 1 0.8882083296775818
transcripts O 0 0.01603732444345951
were O 0 0.0037770222406834364
determined O 0 0.013592023402452469
using O 0 0.011459669098258018
reverse O 0 0.06701163947582245
transcriptase O 1 0.9763675332069397
polymerase O 1 0.6086363196372986
chain O 0 0.05882124602794647
reaction O 0 0.025626299902796745
of O 0 0.0064937337301671505
total O 0 0.015668222680687904
RNA O 0 0.06076965853571892
from O 0 0.014341962523758411
keratinocytes O 1 0.9708473086357117
incubated O 0 0.06375180929899216
for O 0 0.009286516346037388
2 O 0 0.020636623725295067
. O 0 0.01895917020738125

5 O 0 0.03460126370191574
h O 0 0.045088544487953186
in O 0 0.004756396170705557
the O 0 0.0048798383213579655
presence O 0 0.013485938310623169
or O 0 0.008244827389717102
absence O 0 0.015042586252093315
of O 0 0.0070287310518324375
10 O 0 0.018510974943637848
microg O 1 0.9216609001159668
cycloheximide O 1 0.9135194420814514
per O 0 0.031644225120544434
ml O 1 0.8270531296730042
. O 0 0.030846092849969864

Using O 0 0.01248688343912363
this O 0 0.006140905432403088
approach O 0 0.011977001093327999
, O 0 0.004435419570654631
an O 0 0.0071592992171645164
abnormally O 1 0.9823455214500427
spliced O 0 0.2232271283864975
transcript O 0 0.03021472878754139
was O 0 0.0076363543048501015
identified O 0 0.010761851444840431
that O 0 0.003176942700520158
contains O 0 0.006117030046880245
an O 0 0.0043819500133395195
extra O 0 0.014543149620294571
264 O 0 0.036974214017391205
bases O 0 0.01754327118396759
upstream O 0 0.0312635637819767
from O 0 0.010621347464621067
exon O 0 0.09616503119468689
32 O 0 0.018060725182294846
, O 0 0.0054483781568706036
resulting O 0 0.019963225349783897
in O 0 0.005266202613711357
a O 0 0.015877770259976387
premature O 1 0.991181492805481
termination O 1 0.9505852460861206
codon O 0 0.3587852418422699
27 O 0 0.02806769870221615
bp O 0 0.044088058173656464
downstream O 0 0.029247663915157318
from O 0 0.007898147217929363
the O 0 0.010391511023044586
cryptic O 0 0.47670888900756836
splice O 1 0.613426923751831
site O 0 0.03318116068840027
. O 0 0.024851424619555473

Three O 0 0.013311706483364105
other O 0 0.009144222363829613
splice O 1 0.7328488826751709
variants O 0 0.03702537342905998
, O 0 0.004397772252559662
including O 0 0.003936513792723417
one O 0 0.004658420570194721
derived O 0 0.010226665996015072
from O 0 0.004427555948495865
the O 0 0.0056467605754733086
skipping O 0 0.0309292059391737
of O 0 0.0075934878550469875
exon O 0 0.19546547532081604
32 O 0 0.017759500071406364
, O 0 0.003924903459846973
were O 0 0.002782507101073861
also O 0 0.004823606926947832
identified O 0 0.019599737599492073
. O 0 0.016844945028424263

These O 0 0.009369626641273499
results O 0 0.015944287180900574
indicate O 0 0.011527996510267258
the O 0 0.006042480003088713
usefulness O 0 0.028053048998117447
of O 0 0.007660732604563236
cycloheximide O 1 0.9985122084617615
treatment O 1 0.618914008140564
in O 0 0.006153881549835205
evaluating O 0 0.02341446466743946
the O 0 0.009533443488180637
abnormal O 1 0.6336992383003235
processing O 0 0.012598080560564995
of O 0 0.00531285535544157
mRNA O 0 0.030442440882325172
due O 0 0.011460404843091965
to O 0 0.005659406539052725
splice O 1 0.7002381682395935
- O 0 0.04477030411362648
site O 0 0.027199333533644676
mutations O 1 0.9898284673690796
, O 0 0.007139299996197224
because O 0 0.010149871930480003
( O 0 0.010660785250365734
i O 0 0.011646910570561886
) O 0 0.01503201387822628
aberrant O 1 0.5219822525978088
splicing O 0 0.07960668951272964
often O 0 0.015062933787703514
generates O 0 0.038335226476192474
a O 0 0.026106661185622215
premature O 1 0.9946634769439697
termination O 1 0.972931444644928
codon O 1 0.5795510411262512
, O 0 0.010264905169606209
( O 0 0.013370701111853123
ii O 0 0.02813921682536602
) O 0 0.00796013418585062
transcripts O 0 0.016835803166031837
with O 0 0.011675795540213585
premature O 1 0.995978832244873
termination O 1 0.976671040058136
codons O 1 0.6327618956565857
can O 0 0.0122979786247015
occur O 0 0.020899657160043716
at O 0 0.007339486852288246
low O 0 0.018296748399734497
or O 0 0.01157250627875328
undetectable O 1 0.9678611159324646
levels O 0 0.01599196344614029
due O 0 0.008968723937869072
to O 0 0.004471724387258291
nonsense O 0 0.08198191225528717
- O 0 0.04524728283286095
mediated O 0 0.13991113007068634
mRNA O 0 0.055658526718616486
decay O 0 0.05301458388566971
, O 0 0.005902962293475866
and O 0 0.00471996795386076
( O 0 0.009314236231148243
iii O 0 0.02945677563548088
) O 0 0.004700811579823494
the O 0 0.0032451862934976816
levels O 0 0.006674066185951233
of O 0 0.0025310800410807133
these O 0 0.0024803222622722387
transcripts O 0 0.009272869676351547
can O 0 0.004369713366031647
be O 0 0.0034565934911370277
increased O 0 0.014191771857440472
by O 0 0.01292671449482441
cycloheximide O 1 0.8971801996231079
. O 0 0.026241686195135117

A O 0 0.06974420696496964
deletion O 1 0.9763007164001465
mutation O 1 0.9943475127220154
in O 0 0.015000319108366966
COL17A1 O 1 0.7681640386581421
in O 0 0.008881902322173119
five O 0 0.010572073981165886
Austrian O 0 0.0349748358130455
families O 0 0.017800286412239075
with O 0 0.015744555741548538
generalized O 1 0.9995055198669434
atrophic B-Disease 1 0.9999768733978271
benign I-Disease 1 0.9999486207962036
epidermolysis I-Disease 1 0.9999462366104126
bullosa I-Disease 1 0.9998409748077393
represents O 0 0.04586241394281387
propagation O 0 0.03373442590236664
of O 0 0.005220331251621246
an O 0 0.009747862815856934
ancestral O 0 0.21132656931877136
allele O 1 0.9909363389015198
. O 0 0.03323426470160484

Patients O 1 0.9972080588340759
with O 0 0.032567307353019714
generalized O 1 0.9994491934776306
atrophic B-Disease 1 0.999987006187439
benign I-Disease 1 0.9999707937240601
epidermolysis I-Disease 1 0.9999722242355347
bullosa I-Disease 1 0.9999279975891113
, O 0 0.01383805088698864
a O 0 0.014708525501191616
usually O 0 0.014932614751160145
nonlethal O 0 0.05047537386417389
form O 0 0.01647181250154972
of O 0 0.014298832975327969
junctional B-Disease 1 0.9998149275779724
epidermolysis I-Disease 1 0.9999672174453735
bullosa I-Disease 1 0.9999250173568726
, O 0 0.011202321387827396
have O 0 0.009230129420757294
generalized O 1 0.9952764511108398
blistering B-Disease 1 0.9905502796173096
, O 0 0.025925835594534874
nail B-Disease 1 0.9998788833618164
dystrophy I-Disease 1 0.9999957084655762
, O 0 0.04759230464696884
patchy B-Disease 1 0.9996433258056641
alopecia I-Disease 1 0.9999903440475464
, O 0 0.014522559940814972
and O 0 0.01453413162380457
dental B-Disease 1 0.9996745586395264
abnormalities I-Disease 1 0.999777615070343
. O 0 0.027276109904050827

Skin B-Disease 1 0.9999233484268188
fragility I-Disease 1 0.994877815246582
in O 0 0.007709839381277561
most O 0 0.00804354902356863
cases O 0 0.017290988937020302
is O 0 0.005306851118803024
due O 0 0.009320969693362713
to O 0 0.004917026963084936
mutations O 1 0.9809545278549194
in O 0 0.003952245227992535
the O 0 0.007022626232355833
gene O 1 0.8915930986404419
encoding O 0 0.11752719432115555
type O 1 0.9443944096565247
XVII O 1 0.9995728135108948
collagen O 1 0.9993481040000916
( O 0 0.03776232898235321
COL17A1 O 1 0.9832010269165039
) O 0 0.024417735636234283
. O 0 0.019549336284399033

Recently O 0 0.03260808810591698
, O 0 0.006609228439629078
we O 0 0.004690081812441349
reported O 0 0.013950927183032036
five O 0 0.008525357581675053
Austrian O 0 0.03447751700878143
families O 0 0.018002469092607498
with O 0 0.016146017238497734
generalized O 1 0.9995480179786682
atrophic B-Disease 1 0.9999704360961914
benign I-Disease 1 0.9999688863754272
epidermolysis I-Disease 1 0.9999843835830688
bullosa I-Disease 1 0.9999247789382935
who O 0 0.019604533910751343
share O 0 0.016138426959514618
the O 0 0.009904482401907444
same O 0 0.020174385979771614
COL17A1 O 1 0.9952389001846313
mutation O 1 0.9970701932907104
. O 0 0.030907630920410156

Affected O 0 0.14825113117694855
individuals O 0 0.01251902710646391
in O 0 0.0047098989598453045
three O 0 0.004132392350584269
families O 0 0.009042509831488132
are O 0 0.004866812843829393
homozygous O 1 0.9752814173698425
for O 0 0.0067085325717926025
4003delTC O 1 0.9875656962394714
, O 0 0.005381905008107424
whereas O 0 0.009450839832425117
those O 0 0.0027639816980808973
in O 0 0.0026022507809102535
two O 0 0.0029261349700391293
others O 0 0.006597523577511311
are O 0 0.005876484327018261
compound O 0 0.04524931311607361
heterozygotes O 1 0.9744747281074524
. O 0 0.02924845740199089

To O 0 0.009964876808226109
determine O 0 0.01351112686097622
if O 0 0.0070373257622122765
the O 0 0.006781993433833122
occurrence O 0 0.04100563004612923
of O 0 0.006824691779911518
4003delTC O 1 0.9523460865020752
in O 0 0.005706924479454756
these O 0 0.005974023602902889
unrelated O 0 0.03155453875660896
families O 0 0.0161709263920784
signifies O 0 0.06556399166584015
propagation O 0 0.03082737885415554
of O 0 0.004899678751826286
an O 0 0.007422848138958216
ancestral O 0 0.15858425199985504
allele O 1 0.9926504492759705
or O 0 0.011093336157500744
a O 0 0.01678924448788166
mutational O 1 0.9917913675308228
hot O 0 0.052171286195516586
spot O 0 0.022552641108632088
, O 0 0.007710328791290522
haplotypes O 1 0.9238419532775879
were O 0 0.003934454172849655
determined O 0 0.009655932895839214
for O 0 0.005171900149434805
polymorphisms O 0 0.4390885829925537
both O 0 0.004635799676179886
within O 0 0.007151701953262091
and O 0 0.007163867820054293
flanking O 1 0.923842191696167
COL17A1 O 1 0.9935367703437805
. O 0 0.03211929649114609

Five O 0 0.03810791298747063
intragenic O 1 0.9748749732971191
polymorphisms O 1 0.8567155003547668
were O 0 0.005727946292608976
chosen O 0 0.007382313720881939
based O 0 0.004682493861764669
on O 0 0.004444976802915335
their O 0 0.009760463610291481
informativeness O 1 0.835517406463623
. O 0 0.024533618241548538

One O 0 0.010310766287147999
of O 0 0.004667151253670454
these O 0 0.003124217502772808
, O 0 0.0026867249980568886
not O 0 0.002830502111464739
previously O 0 0.007125610485672951
reported O 0 0.010929820127785206
, O 0 0.004054331686347723
was O 0 0.007565324194729328
2988 O 1 0.8339805006980896
A O 0 0.01275849062949419
or O 0 0.01044074073433876
C O 0 0.027480583637952805
that O 0 0.004219589754939079
introduces O 0 0.020606499165296555
a O 0 0.007471554912626743
new O 0 0.006029817275702953
restriction O 0 0.02058153599500656
site O 0 0.01085828710347414
for O 0 0.007688247598707676
Eco0109 O 1 0.8727933764457703
I O 0 0.026358768343925476
. O 0 0.020895667374134064

All O 0 0.009494094178080559
the O 0 0.013275104574859142
4003delTC O 1 0.9934864044189453
alleles O 1 0.9923962950706482
showed O 0 0.016415514051914215
the O 0 0.006055254489183426
same O 0 0.00929062906652689
haplotype O 1 0.8737295866012573
for O 0 0.00477406894788146
these O 0 0.0045531434006989
five O 0 0.014568708837032318
polymorphic O 1 0.9834421277046204
markers O 0 0.07588183134794235
. O 0 0.026606034487485886

Fourteen O 0 0.08375048637390137
microsatellite O 1 0.980097770690918
polymorphisms O 1 0.7761557698249817
were O 0 0.005672857630997896
selected O 0 0.006854938808828592
based O 0 0.004107695538550615
on O 0 0.0030076296534389257
their O 0 0.004428743850439787
high O 0 0.01187453605234623
heterozygosity O 1 0.8003792762756348
and O 0 0.004570761229842901
their O 0 0.004273086320608854
location O 0 0.011148831807076931
within O 0 0.014304131269454956
10q23 O 1 0.9461811184883118
- O 0 0.095584936439991
q25 O 1 0.7812470197677612
near O 0 0.05835592746734619
COL17A1 O 1 0.961731493473053
. O 0 0.03819622844457626

Three O 0 0.017222046852111816
families O 0 0.02639438770711422
shared O 0 0.03446132317185402
microsatellite O 1 0.9793857336044312
polymorphisms O 1 0.9465723037719727
covering O 0 0.02746046893298626
at O 0 0.010500216856598854
most O 0 0.008294770494103432
19 O 0 0.02043924480676651
cM O 0 0.03654813766479492
, O 0 0.004969719331711531
whereas O 0 0.009712561964988708
the O 0 0.003820096841081977
others O 0 0.005837804172188044
shared O 0 0.00808224268257618
smaller O 0 0.010400178842246532
regions O 0 0.013522978872060776
consistent O 0 0.010953603312373161
with O 0 0.004583650268614292
cross O 0 0.013357862830162048
- O 0 0.01671692728996277
over O 0 0.005942296702414751
events O 0 0.0077985660172998905
during O 0 0.007757661398500204
passage O 0 0.010120823979377747
of O 0 0.0034993672743439674
this O 0 0.00616881949827075
mutation O 1 0.9824549555778503
through O 0 0.00880784448236227
several O 0 0.008045870810747147
generations O 0 0.036962732672691345
. O 0 0.020591171458363533

These O 0 0.009907189756631851
results O 0 0.016811132431030273
indicate O 0 0.015248176641762257
that O 0 0.00672306539490819
4003delTC O 1 0.9681477546691895
occurs O 0 0.02663452737033367
on O 0 0.004480455070734024
a O 0 0.01006926130503416
single O 0 0.021023975685238838
ancestral O 0 0.11063403636217117
allele O 1 0.9780594110488892
. O 0 0.013814306817948818
. O 0 0.01931263692677021

The O 0 0.032668810337781906
haptoglobin O 1 0.9859058856964111
- O 0 0.32229021191596985
gene O 1 0.9464208483695984
deletion O 1 0.9177221059799194
responsible O 0 0.028682265430688858
for O 0 0.014433830976486206
anhaptoglobinemia B-Disease 1 0.8623783588409424
. O 0 0.02659357711672783

We O 0 0.009626048617064953
have O 0 0.005525742191821337
found O 0 0.008433432318270206
an O 0 0.008762559853494167
allelic O 1 0.9423714280128479
deletion O 0 0.45319095253944397
of O 0 0.007408212870359421
the O 0 0.010866929776966572
haptoglobin O 1 0.9854200482368469
( O 0 0.018357619643211365
Hp O 0 0.0490199439227581
) O 0 0.01320742443203926
gene O 0 0.0962052047252655
from O 0 0.006036654580384493
an O 0 0.005257679149508476
individual O 0 0.011331913061439991
with O 0 0.010769509710371494
anhaptoglobinemia B-Disease 1 0.8538535237312317
. O 0 0.026762377470731735

The O 0 0.025930115953087807
Hp O 0 0.1692579984664917
gene O 1 0.8780712485313416
cluster O 0 0.0473836250603199
consists O 0 0.01215741690248251
of O 0 0.005935403518378735
coding O 0 0.04468050226569176
regions O 0 0.012329298071563244
of O 0 0.0034680115059018135
the O 0 0.006762159988284111
alpha O 0 0.052970096468925476
chain O 0 0.03376903384923935
and O 0 0.0062700179405510426
beta O 0 0.04126310721039772
chain O 0 0.028246112167835236
of O 0 0.005395654123276472
the O 0 0.009580048732459545
haptoglobin O 1 0.9928407669067383
gene O 1 0.9589547514915466
( O 0 0.017687875777482986
Hp O 0 0.035477470606565475
) O 0 0.005316060967743397
and O 0 0.0018685385584831238
of O 0 0.002637745812535286
the O 0 0.00550360232591629
alpha O 0 0.04274050518870354
chain O 0 0.032565049827098846
and O 0 0.005297493655234575
beta O 0 0.03452623635530472
chain O 0 0.023172907531261444
of O 0 0.004713091533631086
the O 0 0.009253977797925472
haptoglobin O 1 0.9791387915611267
- O 0 0.11330633610486984
related O 0 0.045557860285043716
gene O 1 0.9651906490325928
( O 0 0.027603795751929283
Hpr O 1 0.9942346215248108
) O 0 0.0093411048874259
, O 0 0.004088122397661209
in O 0 0.004505776800215244
tandem O 0 0.02097105234861374
from O 0 0.005381014198064804
the O 0 0.006571106147021055
5 O 0 0.015554610639810562
side O 0 0.01837179809808731
. O 0 0.01882338337600231

Southern O 0 0.05890108644962311
blot O 1 0.6868353486061096
and O 0 0.01164888683706522
PCR O 0 0.4259258508682251
analyses O 0 0.018808817490935326
have O 0 0.004871761426329613
indicated O 0 0.00873204693198204
that O 0 0.002312772674486041
the O 0 0.003367161378264427
individual O 0 0.005397589411586523
with O 0 0.004601691849529743
anhaptoglobinemia B-Disease 1 0.9433633089065552
was O 0 0.009305242449045181
homozygous O 1 0.8213489055633545
for O 0 0.004660227335989475
the O 0 0.006543206050992012
gene O 1 0.9881747961044312
deletion O 1 0.9325469136238098
and O 0 0.003231484442949295
that O 0 0.0031266820151358843
the O 0 0.007291665766388178
gene O 1 0.9402563571929932
deletion O 1 0.9762160778045654
was O 0 0.005614951252937317
included O 0 0.004233315587043762
at O 0 0.004562869668006897
least O 0 0.005701078101992607
from O 0 0.004564980510622263
the O 0 0.006857909262180328
promoter O 0 0.1900283396244049
region O 0 0.015568351373076439
of O 0 0.0069733611308038235
Hp O 0 0.04972214996814728
to O 0 0.012633772566914558
Hpr O 1 0.9897560477256775
alpha O 0 0.04568113014101982
but O 0 0.006653373595327139
not O 0 0.0048040361143648624
to O 0 0.008989837020635605
Hpr O 1 0.9824926853179932
beta O 0 0.10384118556976318
( O 0 0.029257837682962418
Hpdel O 1 0.9321914315223694
) O 0 0.021636610850691795
. O 0 0.0202622152864933

In O 0 0.01099926047027111
addition O 0 0.00942496582865715
, O 0 0.00363881210796535
we O 0 0.0028661007527261972
found O 0 0.005169746465981007
seven O 0 0.004936900455504656
individuals O 0 0.007836048491299152
with O 0 0.005425559356808662
hypohaptoglobinemia B-Disease 1 0.9086635112762451
in O 0 0.004151204135268927
three O 0 0.004319340921938419
families O 0 0.007833035662770271
, O 0 0.0029176550451666117
and O 0 0.002425877610221505
the O 0 0.004512735176831484
genotypes O 1 0.9183586239814758
of O 0 0.002839410677552223
six O 0 0.0037073446437716484
of O 0 0.00245234789326787
the O 0 0.003095368156209588
seven O 0 0.0054071745835244656
individuals O 0 0.006995936390012503
were O 0 0.002697739750146866
found O 0 0.00531006371602416
to O 0 0.004539465997368097
be O 0 0.008868797682225704
Hp2 O 1 0.9850364923477173
/ O 1 0.8203596472740173
Hpdel O 1 0.9030382633209229
. O 0 0.03361950069665909

The O 0 0.02392747439444065
phenotypes O 1 0.9961481094360352
and O 0 0.00966324657201767
genotypes O 1 0.964694619178772
in O 0 0.004384798463433981
one O 0 0.003314444562420249
of O 0 0.002630148781463504
these O 0 0.002308871131390333
three O 0 0.0034542030189186335
families O 0 0.008500698953866959
showed O 0 0.009794256649911404
the O 0 0.004609038587659597
father O 0 0.012107034213840961
to O 0 0.00455716485157609
be O 0 0.006435601972043514
hypohaptoglobinemic B-Disease 1 0.9584495425224304
( O 0 0.01947227492928505
Hp2 O 1 0.9681050777435303
) O 0 0.01036516297608614
and O 0 0.007587315980345011
Hp2 O 1 0.9960594177246094
/ O 1 0.9281653165817261
Hpdel O 1 0.9760887026786804
, O 0 0.0051741572096943855
the O 0 0.005964092444628477
mother O 0 0.01863785833120346
to O 0 0.004226222168654203
be O 0 0.006034771911799908
Hp2 O 1 0.9357214570045471
- O 0 0.02938797138631344
1 O 0 0.013462233357131481
and O 0 0.007872414775192738
Hp1 O 1 0.9936655163764954
/ O 1 0.8015815615653992
Hp2 O 1 0.9710100293159485
, O 0 0.0036143935285508633
one O 0 0.002383710816502571
of O 0 0.0017476317007094622
the O 0 0.0022480215411633253
two O 0 0.0023601287975907326
children O 0 0.007384214550256729
to O 0 0.003416366409510374
be O 0 0.00559184979647398
hypohaptoglobinemic B-Disease 1 0.963187038898468
( O 0 0.01751352846622467
Hp2 O 1 0.9379568696022034
) O 0 0.011304034851491451
and O 0 0.007440987974405289
Hp2 O 1 0.9973142743110657
/ O 1 0.9659593105316162
Hpdel O 1 0.972875714302063
, O 0 0.004521779716014862
and O 0 0.0025709413457661867
the O 0 0.0028802095912396908
other O 0 0.0027847939636558294
child O 0 0.01768086850643158
to O 0 0.004271062556654215
be O 0 0.005853566806763411
Hp1 O 1 0.8599799275398254
and O 0 0.01003972627222538
Hp1 O 1 0.9976142644882202
/ O 1 0.8756638169288635
Hpdel O 1 0.9864975810050964
, O 0 0.007749476935714483
showing O 0 0.017333485186100006
an O 0 0.008889368735253811
anomalous O 1 0.5963293313980103
inheritance O 0 0.27889275550842285
of O 0 0.008087879046797752
Hp O 1 0.8549230098724365
phenotypes O 1 0.9947443008422852
in O 0 0.006098599173128605
the O 0 0.007064952049404383
child O 0 0.05915490910410881
with O 0 0.014318895526230335
Hp1 O 1 0.9637448787689209
. O 0 0.0316653773188591

The O 0 0.03134182468056679
Hp2 O 1 0.9959509372711182
/ O 1 0.9774327278137207
Hpdel O 1 0.9935239553451538
individuals O 0 0.013341376557946205
had O 0 0.007005550432950258
an O 0 0.006024378351867199
extremely O 0 0.017037849873304367
low O 0 0.015335243195295334
level O 0 0.007778652012348175
of O 0 0.005888388026505709
Hp O 0 0.05128997936844826
( O 0 0.015079260803759098
mean O 0 0.026936249807476997
+ O 0 0.2070917785167694
/ O 0 0.12009257078170776
- O 0 0.08005998283624649
SD O 1 0.9694441556930542
= O 0 0.0673055648803711
0 O 0 0.03607191890478134
. O 0 0.017259841784834862
049 O 1 0.9874979257583618
+ O 0 0.27236926555633545
/ O 0 0.14466409385204315
- O 0 0.048965491354465485
0 O 0 0.03456723690032959
. O 0 0.01561166625469923
043 O 1 0.9840102791786194
mg O 1 0.9842265248298645
/ O 1 0.8284266591072083
ml O 1 0.9778333306312561
; O 0 0.017678115516901016
n O 0 0.038012709468603134
= O 0 0.04118076711893082
6 O 0 0.013181683607399464
) O 0 0.005132866092026234
, O 0 0.00303191551938653
compared O 0 0.007736511062830687
with O 0 0.00261555053293705
the O 0 0.0034743817523121834
level O 0 0.0077574597671628
( O 0 0.007555077318102121
1 O 0 0.007321181241422892
. O 0 0.0048193372786045074
64 O 0 0.020975738763809204
+ O 0 0.0870606079697609
/ O 0 0.05557743087410927
- O 0 0.028947489336133003
1 O 0 0.014295117929577827
. O 0 0.010344473645091057
07 O 1 0.7816007137298584
mg O 1 0.9896998405456543
/ O 0 0.46878018975257874
ml O 1 0.5092474818229675
) O 0 0.01033873949199915
obtained O 0 0.009237244725227356
from O 0 0.00832688994705677
52 O 0 0.028105614706873894
healthy O 1 0.5841665863990784
volunteers O 0 0.05061839893460274
having O 0 0.05613035336136818
phenotype O 1 0.9996272325515747
Hp2 O 1 0.9944816827774048
, O 0 0.008659563958644867
whereas O 0 0.016201093792915344
the O 0 0.007935050874948502
serum O 1 0.9404458999633789
Hp O 0 0.03223336488008499
level O 0 0.007499538362026215
of O 0 0.0037387488409876823
an O 0 0.00486725103110075
individual O 0 0.00938502885401249
with O 0 0.009821133688092232
Hp1 O 1 0.9959069490432739
/ O 1 0.961479663848877
Hpdel O 1 0.9831320643424988
was O 0 0.020494449883699417
0 O 0 0.03735823184251785
. O 0 0.01755117066204548

50 O 0 0.06696917861700058
mg O 1 0.9912324547767639
/ O 1 0.9219315052032471
ml O 1 0.9451420307159424
, O 0 0.005181305576115847
which O 0 0.0036394556518644094
was O 0 0.004508273210376501
approximately O 0 0.0067713381722569466
half O 0 0.006308894604444504
the O 0 0.0035977831576019526
level O 0 0.006454847753047943
of O 0 0.004836501087993383
Hp O 0 0.030725961551070213
in O 0 0.006475937087088823
control O 0 0.02251141518354416
sera O 0 0.05320212244987488
from O 0 0.009319535456597805
the O 0 0.013202814385294914
Hp1 O 1 0.9977300763130188
phenotype O 1 0.9991893172264099
( O 0 0.016672182828187943
1 O 0 0.012512427754700184
. O 0 0.0075531937181949615
26 O 0 0.02119344472885132
+ O 0 0.13769234716892242
/ O 0 0.06504757702350616
- O 0 0.03550403192639351
0 O 0 0.025168605148792267
. O 0 0.008549717254936695
33 O 0 0.033705633133649826
mg O 1 0.9337682723999023
/ O 0 0.2915872037410736
ml O 1 0.8516772389411926
; O 0 0.019602466374635696
n O 0 0.04145590588450432
= O 0 0.03966367989778519
9 O 0 0.014790243469178677
) O 0 0.006254937499761581
, O 0 0.003831961192190647
showing O 0 0.013924779370427132
a O 0 0.015876058489084244
gene O 1 0.9818867444992065
- O 0 0.26321303844451904
dosage O 1 0.9858684539794922
effect O 0 0.04262637346982956
. O 0 0.02170022577047348

The O 0 0.015954846516251564
other O 0 0.013988149352371693
allele O 1 0.9706634879112244
( O 0 0.02302558533847332
Hp2 O 1 0.764659583568573
) O 0 0.007481236010789871
of O 0 0.0037726364098489285
individuals O 0 0.009142706170678139
with O 0 0.008537045679986477
Hp2 O 1 0.9978468418121338
/ O 1 0.9522271752357483
Hpdel O 1 0.992914080619812
was O 0 0.007122271228581667
found O 0 0.0055315252393484116
to O 0 0.0025157853960990906
have O 0 0.002257507760077715
, O 0 0.0021105867344886065
in O 0 0.002274321625009179
all O 0 0.0031348716001957655
exons O 0 0.04790716990828514
, O 0 0.004956736229360104
no O 0 0.008056430146098137
mutation O 1 0.9957977533340454
, O 0 0.005511011462658644
by O 0 0.01023291889578104
DNA O 0 0.054431088268756866
sequencing O 0 0.07132770866155624
. O 0 0.021310333162546158

On O 0 0.007219309918582439
the O 0 0.004941671621054411
basis O 0 0.004423971753567457
of O 0 0.0028748491313308477
the O 0 0.003713778452947736
present O 0 0.0051888711750507355
study O 0 0.006857568398118019
, O 0 0.0027888386975973845
the O 0 0.00353208277374506
mechanism O 0 0.014346298761665821
of O 0 0.0056115188635885715
anhaptoglobinemia B-Disease 1 0.5979838371276855
and O 0 0.0031399615108966827
the O 0 0.004108327440917492
mechanism O 0 0.016972480341792107
of O 0 0.006249171681702137
anomalous O 1 0.5898388028144836
inheritance O 1 0.6096459627151489
of O 0 0.009787536226212978
Hp O 1 0.8477295637130737
phenotypes O 1 0.9946840405464172
were O 0 0.00545715494081378
well O 0 0.00858303438872099
explained O 0 0.024009890854358673
. O 0 0.01840055361390114

However O 0 0.011991686187684536
, O 0 0.00505864666774869
the O 0 0.00489068916067481
mechanism O 0 0.020099278539419174
of O 0 0.009236472658813
hypohaptoglobinemia B-Disease 1 0.9695968627929688
remains O 0 0.042457569390535355
unknown O 0 0.06919462233781815

ATM O 1 0.7969604730606079
mutations O 1 0.9909645318984985
and O 0 0.014516828581690788
phenotypes O 1 0.9954909682273865
in O 0 0.020778344944119453
ataxia B-Disease 1 0.9999936819076538
- I-Disease 1 0.9980112314224243
telangiectasia I-Disease 1 0.9999678134918213
families O 0 0.01622781530022621
in O 0 0.004115744028240442
the O 0 0.005236344877630472
British O 0 0.016210222616791725
Isles O 0 0.49955862760543823
: O 0 0.008558896370232105
expression O 0 0.019875502213835716
of O 0 0.006186856422573328
mutant O 1 0.992010235786438
ATM O 0 0.05326855555176735
and O 0 0.00426368648186326
the O 0 0.006975708529353142
risk O 1 0.9102150201797485
of O 0 0.017246415838599205
leukemia B-Disease 1 0.9999992847442627
, O 1 0.6207343935966492
lymphoma B-Disease 1 0.9999997615814209
, O 0 0.02041173353791237
and O 0 0.08965243399143219
breast B-Disease 1 0.9999977350234985
cancer I-Disease 1 0.9999903440475464
. O 0 0.033220551908016205

We O 0 0.010323610156774521
report O 0 0.01136269886046648
the O 0 0.0070264083333313465
spectrum O 0 0.026903295889496803
of O 0 0.008570099249482155
59 O 0 0.03669667989015579
ATM O 0 0.4996767044067383
mutations O 1 0.9899058938026428
observed O 0 0.03166450187563896
in O 0 0.017800571396946907
ataxia B-Disease 1 0.9999569654464722
- I-Disease 1 0.9883637428283691
telangiectasia I-Disease 1 0.9999059438705444
( O 0 0.02823023870587349
A B-Disease 1 0.6862347722053528
- I-Disease 1 0.9876933693885803
T I-Disease 1 0.9996801614761353
) O 0 0.017102878540754318
patients O 1 0.9810202717781067
in O 0 0.004613998346030712
the O 0 0.007206127047538757
British O 0 0.02604769356548786
Isles O 1 0.6706283092498779
. O 0 0.02464507892727852

Of O 0 0.018552517518401146
51 O 0 0.05840058997273445
ATM O 1 0.7752891182899475
mutations O 1 0.995311439037323
identified O 0 0.018922576680779457
in O 0 0.005262352526187897
families O 0 0.010472988709807396
native O 0 0.008450372144579887
to O 0 0.003289931919425726
the O 0 0.004743887111544609
British O 0 0.013456040062010288
Isles O 0 0.23868460953235626
, O 0 0.00488312728703022
11 O 0 0.008149600587785244
were O 0 0.00441367132589221
founder O 0 0.16281332075595856
mutations O 1 0.9949460625648499
, O 0 0.003907275851815939
and O 0 0.0031246477738022804
2 O 0 0.005020391661673784
of O 0 0.002567589282989502
these O 0 0.003197459736838937
11 O 0 0.009630831889808178
conferred O 0 0.02442271076142788
a O 0 0.017810946330428123
milder O 1 0.9966543912887573
clinical O 1 0.998157799243927
phenotype O 1 0.9998323917388916
with O 0 0.004683987237513065
respect O 0 0.0060207415372133255
to O 0 0.0037010442465543747
both O 0 0.009914063848555088
cerebellar B-Disease 1 0.9999326467514038
degeneration I-Disease 1 0.9999924898147583
and O 0 0.011472993530333042
cellular O 0 0.3359498679637909
features O 0 0.02337292954325676
. O 0 0.021207261830568314

We O 0 0.008681364357471466
report O 0 0.007400211878120899
, O 0 0.002989931730553508
in O 0 0.0030757966451346874
two O 0 0.004510203376412392
A B-Disease 0 0.04885290563106537
- I-Disease 1 0.9526025056838989
T I-Disease 1 0.9986613988876343
families O 0 0.016222434118390083
, O 0 0.0063044363632798195
an O 0 0.01098582986742258
ATM O 0 0.42647552490234375
mutation O 1 0.997441291809082
( O 0 0.025090765208005905
7271T O 1 0.9948552846908569
- O 0 0.4096558392047882
- O 1 0.6781163215637207
> O 1 0.9880637526512146
G O 1 0.672141432762146
) O 0 0.0073199402540922165
that O 0 0.0029965629801154137
may O 0 0.006042285356670618
be O 0 0.002878807485103607
associated O 0 0.00731076393276453
with O 0 0.003044967306777835
an O 0 0.004960794933140278
increased O 0 0.021219588816165924
risk O 1 0.9417474865913391
of O 0 0.024484101682901382
breast B-Disease 1 0.9999982118606567
cancer I-Disease 1 0.9999828338623047
in O 0 0.008226051926612854
both O 0 0.009729926474392414
homozygotes O 1 0.9970276951789856
and O 0 0.011091159656643867
heterozygotes O 1 0.9958767890930176
( O 0 0.014179442077875137
relative O 0 0.026155197992920876
risk O 1 0.6326912641525269
12 O 0 0.010917861945927143
. O 0 0.005347388796508312
7 O 0 0.014042986556887627
; O 0 0.01237572729587555
P O 0 0.49966463446617126
= O 0 0.05499749258160591
. O 0 0.01365957036614418
0025 O 1 0.9956122636795044
) O 0 0.00825479906052351
, O 0 0.003347749589011073
although O 0 0.004540815018117428
there O 0 0.002833146369084716
is O 0 0.003461505053564906
a O 0 0.006121983751654625
less O 0 0.015554419718682766
severe O 1 0.9998582601547241
A B-Disease 1 0.8067713379859924
- I-Disease 1 0.9978038668632507
T I-Disease 1 0.9998883008956909
phenotype O 1 0.9995918869972229
in O 0 0.0046033975668251514
terms O 0 0.0038292023818939924
of O 0 0.0024587216321378946
the O 0 0.004325550515204668
degree O 0 0.012326481752097607
of O 0 0.014294404536485672
cerebellar B-Disease 1 0.9997418522834778
degeneration I-Disease 1 0.9999402761459351
. O 0 0.03450871258974075

This O 0 0.028375888243317604
mutation O 1 0.9941920638084412
( O 0 0.027476297691464424
7271T O 1 0.9883132576942444
- O 0 0.43877947330474854
- O 0 0.4621753990650177
> O 1 0.9743937253952026
G O 0 0.1930268555879593
) O 0 0.006434486247599125
also O 0 0.003096721600741148
allows O 0 0.008162593469023705
expression O 0 0.013051084242761135
of O 0 0.003240688471123576
full O 0 0.010227641090750694
- O 0 0.02787391096353531
length O 0 0.02211504615843296
ATM O 0 0.05941791087388992
protein O 0 0.027719827368855476
at O 0 0.004608237650245428
a O 0 0.006531135644763708
level O 0 0.007640073075890541
comparable O 0 0.01134523469954729
with O 0 0.003348840633407235
that O 0 0.003331179032102227
in O 0 0.0070343343541026115
unaffected O 1 0.7963994741439819
individuals O 0 0.021855980157852173
. O 0 0.019345564767718315

In O 0 0.01030663587152958
addition O 0 0.009369409643113613
, O 0 0.0032855018507689238
we O 0 0.00229470431804657
have O 0 0.0030097835697233677
studied O 0 0.007446546573191881
18 O 0 0.010649354197084904
A B-Disease 0 0.3004467785358429
- I-Disease 1 0.9947216510772705
T I-Disease 1 0.9999412298202515
patients O 1 0.9996077418327332
, O 0 0.00417671911418438
in O 0 0.00374389230273664
15 O 0 0.007035963237285614
families O 0 0.007569750305265188
, O 0 0.004097171127796173
who O 0 0.009556037373840809
developed O 1 0.9650792479515076
leukemia B-Disease 1 0.9999992847442627
, O 0 0.3644023835659027
lymphoma B-Disease 1 0.9999996423721313
, O 0 0.02704646810889244
preleukemic O 1 0.999870777130127
T O 1 0.9996272325515747
- O 0 0.41240474581718445
cell O 1 0.5364392995834351
proliferation O 0 0.24530255794525146
, O 0 0.010430709458887577
or O 1 0.5519967675209045
Hodgkin B-Disease 1 0.9999995231628418
lymphoma I-Disease 1 0.9999995231628418
, O 0 0.011179923079907894
mostly O 0 0.011541512794792652
in O 0 0.011306673288345337
childhood O 1 0.8735539317131042
. O 0 0.02039690874516964

A O 0 0.024852197617292404
wide O 0 0.022501857951283455
variety O 0 0.012519081123173237
of O 0 0.008472071029245853
ATM O 1 0.6338333487510681
mutation O 1 0.9977884292602539
types O 0 0.01907949522137642
, O 0 0.0054617165587842464
including O 0 0.008311965502798557
missense O 1 0.9991251826286316
mutations O 1 0.9980015158653259
and O 0 0.00401039095595479
in O 0 0.00514130387455225
- O 0 0.02624836377799511
frame O 0 0.025289205834269524
deletions O 0 0.15443281829357147
, O 0 0.0035533735062927008
were O 0 0.002680283272638917
seen O 0 0.009350655600428581
in O 0 0.005166574381291866
these O 0 0.009515706449747086
patients O 1 0.9954244494438171
. O 0 0.022246530279517174

We O 0 0.007801119238138199
also O 0 0.004427236504852772
show O 0 0.006527756806463003
that O 0 0.0024410979822278023
25 O 0 0.005238123703747988
% O 0 0.004028348717838526
of O 0 0.00253210193477571
all O 0 0.0035801695194095373
A B-Disease 0 0.10127057135105133
- I-Disease 1 0.9954754710197449
T I-Disease 1 0.9997701048851013
patients O 1 0.9986526966094971
carried O 0 0.012232760898768902
in O 0 0.006921232677996159
- O 0 0.030192546546459198
frame O 0 0.03270247206091881
deletions O 1 0.563233494758606
or O 0 0.02278832718729973
missense O 1 0.9988403916358948
mutations O 1 0.9969853758811951
, O 0 0.004320189356803894
many O 0 0.002624668413773179
of O 0 0.0021206531673669815
which O 0 0.002440094016492367
were O 0 0.0019546293187886477
also O 0 0.0031497511081397533
associated O 0 0.0077873533591628075
with O 0 0.003926245961338282
expression O 0 0.01977108046412468
of O 0 0.008192268200218678
mutant O 1 0.9859619736671448
ATM O 1 0.5972400903701782
protein O 0 0.07728909701108932
. O 0 0.02046249248087406

The O 0 0.025535162538290024
DMPK O 1 0.975913405418396
gene O 1 0.765028178691864
of O 0 0.02008039504289627
severely O 1 0.9994518160820007
affected O 1 0.9994613528251648
myotonic B-Disease 1 0.9999990463256836
dystrophy I-Disease 1 0.9999998807907104
patients O 1 0.9999523162841797
is O 0 0.035284463316202164
hypermethylated O 1 0.999193012714386
proximal O 1 0.9980497360229492
to O 0 0.006515492685139179
the O 0 0.007250397466123104
largely O 0 0.0202194694429636
expanded O 0 0.03323012962937355
CTG O 1 0.9769382476806641
repeat O 0 0.13787108659744263
. O 0 0.028144177049398422

Using O 0 0.032394103705883026
methylation O 0 0.09573686122894287
- O 0 0.04040847718715668
sensitive O 0 0.034770503640174866
restriction O 0 0.039651188999414444
enzymes O 0 0.03538312762975693
, O 0 0.005431505385786295
we O 0 0.005002882797271013
characterized O 0 0.025979287922382355
the O 0 0.00702633848413825
methylation O 0 0.04753434658050537
pattern O 0 0.020313983783125877
on O 0 0.0035424139350652695
the O 0 0.003716785926371813
5 O 0 0.007409001234918833
side O 0 0.005802927538752556
of O 0 0.0033591664396226406
the O 0 0.007183551322668791
CTG O 1 0.9869307279586792
repeat O 0 0.0374569296836853
in O 0 0.005785356741398573
the O 0 0.009316329844295979
DMPK O 1 0.9944056272506714
gene O 1 0.7756677865982056
of O 0 0.006601738277822733
normal O 0 0.02074548229575157
individuals O 0 0.00775129534304142
and O 0 0.003269496839493513
of O 0 0.006974262651056051
patients O 1 0.9997202754020691
affected O 1 0.982554018497467
with O 0 0.13854095339775085
myotonic B-Disease 1 0.9999986886978149
dystrophy I-Disease 1 0.9999983310699463
, O 0 0.012695557437837124
showing O 0 0.0257501732558012
expansions O 0 0.02822805941104889
of O 0 0.006619210354983807
the O 0 0.013435275293886662
repetitive O 1 0.9781056642532349
sequence O 0 0.06058986112475395
. O 0 0.024574941024184227

The O 0 0.02429606392979622
gene O 0 0.4710218608379364
segment O 0 0.04393450915813446
analyzed O 0 0.025949496775865555
corresponds O 0 0.02143734134733677
to O 0 0.005646428093314171
the O 0 0.009928423911333084
genomic O 1 0.5304115414619446
SacI O 1 0.9830390214920044
- O 0 0.08643847703933716
HindIII O 1 0.9348326921463013
fragment O 0 0.07000669091939926
carrying O 0 0.02423405461013317
exons O 0 0.0758148804306984
11 O 0 0.020900700241327286
- O 0 0.03843843191862106
15 O 0 0.023829245939850807
. O 0 0.0234278105199337

There O 0 0.015530104748904705
is O 0 0.014210323803126812
constitutive O 0 0.07802858203649521
methylation O 0 0.06667661666870117
in O 0 0.012551538646221161
intron O 1 0.7888523936271667
12 O 0 0.01352276373654604
at O 0 0.00719692837446928
restriction O 0 0.018878217786550522
sites O 0 0.008926182053983212
of O 0 0.006251826416701078
SacII O 1 0.9554312229156494
and O 0 0.007814350537955761
HhaI O 1 0.9901817440986633
, O 0 0.009057639166712761
localized O 1 0.823093056678772
1 O 0 0.011565614491701126
, O 0 0.00610539922490716
159 O 0 0.03240514174103737
- O 0 0.02521771565079689
1 O 0 0.01262209564447403
, O 0 0.00728821475058794
232 O 0 0.042654577642679214
bp O 0 0.04028284177184105
upstream O 0 0.02108158729970455
of O 0 0.0043546101078391075
the O 0 0.009456447325646877
CTG O 1 0.9894647598266602
repeat O 0 0.19774922728538513
, O 0 0.006674164440482855
whereas O 0 0.014368045143783092
most O 0 0.004393689334392548
, O 0 0.0027313849423080683
if O 0 0.0030377483926713467
not O 0 0.0017117398092523217
all O 0 0.0015530200907960534
, O 0 0.001702865120023489
of O 0 0.0017205437179654837
the O 0 0.002248890232294798
other O 0 0.0021474065724760294
sites O 0 0.005276228301227093
of O 0 0.005218439735472202
SacII O 1 0.9940681457519531
, O 0 0.008549700491130352
HhaI O 1 0.9920943379402161
, O 0 0.005300481803715229
and O 0 0.004309244453907013
HpaII O 1 0.8848403692245483
in O 0 0.00427622813731432
this O 0 0.004100887570530176
region O 0 0.012766271829605103
are O 0 0.0045243301428854465
unmethylated O 1 0.9710421562194824
, O 0 0.004425885621458292
in O 0 0.004312111530452967
normal O 0 0.01636112481355667
individuals O 0 0.0063685146160423756
and O 0 0.0022928384132683277
most O 0 0.003452658886089921
of O 0 0.0044505298137664795
the O 0 0.010455441661179066
patients O 1 0.9988107681274414
. O 0 0.0233750082552433

In O 0 0.007642578799277544
a O 0 0.007117245811969042
number O 0 0.005295486189424992
of O 0 0.004538987297564745
young O 0 0.020326538011431694
and O 0 0.0077554709278047085
severely O 1 0.9995806813240051
affected O 1 0.9960940480232239
patients O 1 0.999884843826294
, O 0 0.00407397048547864
however O 0 0.00448235496878624
, O 0 0.00270514702424407
complete O 0 0.007427828386425972
methylation O 0 0.02696334198117256
of O 0 0.0031226687133312225
these O 0 0.0035299721639603376
restriction O 0 0.016614340245723724
sites O 0 0.006286189425736666
was O 0 0.005121338181197643
found O 0 0.0062460582703351974
in O 0 0.0044805617071688175
the O 0 0.013281852006912231
mutated O 1 0.9934737086296082
allele O 1 0.9818369746208191
. O 0 0.03158041834831238

In O 0 0.008354343473911285
most O 0 0.006027757655829191
of O 0 0.003656113287433982
these O 0 0.005528135225176811
patients O 1 0.9987586736679077
, O 0 0.004794946406036615
the O 0 0.007086356170475483
onset O 1 0.9994263648986816
of O 0 0.007436002139002085
the O 0 0.02514604665338993
disease O 1 0.9999978542327881
was O 1 0.7852456569671631
congenital O 1 0.9999978542327881
. O 0 0.027904439717531204

Preliminary O 0 0.034722909331321716
in O 0 0.016416987404227257
vivo O 1 0.8003937005996704
footprinting O 1 0.9768868088722229
data O 0 0.009176951833069324
gave O 0 0.007529271766543388
evidence O 0 0.005956187844276428
for O 0 0.0046676271595060825
protein O 0 0.03246181085705757
- O 0 0.02951047383248806
DNA O 0 0.03753604739904404
contact O 0 0.018118998035788536
in O 0 0.006208913400769234
normal O 0 0.028499741107225418
genes O 0 0.16259823739528656
at O 0 0.006284194067120552
an O 0 0.007122473791241646
Sp1 O 1 0.9490271806716919
consensus O 0 0.016471147537231445
binding O 0 0.016948755830526352
site O 0 0.009716309607028961
upstream O 0 0.015660516917705536
of O 0 0.003960791043937206
the O 0 0.006908423267304897
CTG O 1 0.9849306344985962
repeat O 0 0.04236619547009468
and O 0 0.002605532296001911
for O 0 0.002398286247625947
a O 0 0.006149908062070608
significant O 0 0.009527178481221199
reduction O 0 0.01346015464514494
of O 0 0.0029940372332930565
this O 0 0.00369284232147038
interaction O 0 0.011873572133481503
in O 0 0.004956545773893595
cells O 0 0.03474818542599678
with O 0 0.0059834858402609825
a O 0 0.01942805014550686
hypermethylated O 1 0.9960888624191284
DMPK O 1 0.9957734942436218
gene O 1 0.8886028528213501
. O 0 0.014121330343186855
. O 0 0.019801702350378036

The O 0 0.05612507835030556
hemochromatosis B-Disease 1 0.9998103976249695
gene O 1 0.9648587107658386
product O 0 0.03121846169233322
complexes O 0 0.030857140198349953
with O 0 0.00782417505979538
the O 0 0.012559430673718452
transferrin O 1 0.9673823714256287
receptor O 1 0.5836492776870728
and O 0 0.01068596076220274
lowers O 0 0.4047588109970093
its O 0 0.014285720884799957
affinity O 0 0.045913707464933395
for O 0 0.011189436540007591
ligand O 0 0.07515047490596771
binding O 0 0.047405075281858444
. O 0 0.023211749270558357

We O 0 0.01167749147862196
recently O 0 0.018293876200914383
reported O 0 0.016344912350177765
the O 0 0.00663631409406662
positional O 0 0.051465194672346115
cloning O 0 0.02945011481642723
of O 0 0.004191018640995026
a O 0 0.00952550396323204
candidate O 0 0.026805728673934937
gene O 1 0.962924599647522
for O 0 0.018211930990219116
hereditary B-Disease 1 0.9999295473098755
hemochromatosis I-Disease 1 0.9999943971633911
called O 0 0.4039990305900574
HFE O 1 0.998554527759552
. O 0 0.033886924386024475

The O 0 0.021504048258066177
gene O 1 0.5863460302352905
product O 0 0.013219940476119518
, O 0 0.003536759875714779
a O 0 0.005498001351952553
member O 0 0.005109044257551432
of O 0 0.002965151332318783
the O 0 0.005638506729155779
major O 0 0.02925005927681923
histocompatibility O 1 0.9997109770774841
complex O 0 0.021284842863678932
class O 0 0.02470042183995247
I O 0 0.014763426035642624
- O 0 0.020672723650932312
like O 0 0.008049280382692814
family O 0 0.011105106212198734
, O 0 0.003298892406746745
was O 0 0.0035401375498622656
found O 0 0.004115662071853876
to O 0 0.0023052403703331947
have O 0 0.0032193674705922604
a O 0 0.01073769386857748
mutation O 1 0.9971349239349365
, O 0 0.011162999086081982
Cys O 1 0.9948362112045288
- O 0 0.06808491051197052
282 O 0 0.24003423750400543
- O 0 0.24737603962421417
- O 0 0.43303748965263367
> O 1 0.9847680926322937
Tyr O 1 0.9952399730682373
( O 0 0.028092125430703163
C282Y O 1 0.8646073341369629
) O 0 0.009583071805536747
, O 0 0.003352450905367732
in O 0 0.004306399263441563
85 O 0 0.022072015330195427
% O 0 0.010824236087501049
of O 0 0.011928277090191841
patient O 1 0.9923691749572754
chromosomes O 1 0.5039533376693726
. O 0 0.032241448760032654

This O 0 0.028016164898872375
mutation O 1 0.9948425889015198
eliminates O 0 0.07198914140462875
the O 0 0.007664652541279793
ability O 0 0.015376468189060688
of O 0 0.0069349524565041065
HFE O 1 0.9982142448425293
to O 0 0.006403395906090736
associate O 0 0.015430666506290436
with O 0 0.009091748856008053
beta2 O 1 0.9886916875839233
- O 1 0.5483600497245789
microglobulin O 1 0.9884570240974426
( O 0 0.02541463077068329
beta2m O 1 0.9283996820449829
) O 0 0.01137740258127451
and O 0 0.007328420411795378
prevents O 1 0.5194862484931946
cell O 0 0.2370595782995224
- O 0 0.043660327792167664
surface O 0 0.03624088689684868
expression O 0 0.04856955632567406
. O 0 0.022517159581184387

A O 0 0.027402669191360474
second O 0 0.024097101762890816
mutation O 1 0.994206428527832
that O 0 0.005045349709689617
has O 0 0.005723467096686363
no O 0 0.005607682280242443
effect O 0 0.014401286840438843
on O 0 0.007644004188477993
beta2m O 1 0.9801830053329468
association O 0 0.018123388290405273
, O 0 0.007619871757924557
H63D O 1 0.993633508682251
, O 0 0.004459389019757509
was O 0 0.004293141886591911
found O 0 0.004380926489830017
in O 0 0.0022069034166634083
eight O 0 0.0033473214134573936
out O 0 0.003544323146343231
of O 0 0.0036850329488515854
nine O 0 0.015339571982622147
patients O 1 0.9984129667282104
heterozygous O 1 0.9096660017967224
for O 0 0.008145801723003387
the O 0 0.013451902195811272
C282Y O 1 0.9918648600578308
mutant O 1 0.971592128276825
. O 0 0.032520946115255356

In O 0 0.009646567516028881
this O 0 0.005356643348932266
report O 0 0.00636314507573843
, O 0 0.0028857942670583725
we O 0 0.003284930717200041
demonstrate O 0 0.009897137992084026
in O 0 0.005935810040682554
cultured O 0 0.4738596975803375
293 O 1 0.9187285304069519
cells O 1 0.9246535897254944
overexpressing O 1 0.9979671835899353
wild O 0 0.08257931470870972
- O 0 0.089788056910038
type O 0 0.06472350656986237
or O 0 0.018272453919053078
mutant O 1 0.9950245022773743
HFE O 1 0.9988784193992615
proteins O 0 0.02893146313726902
that O 0 0.003953420091420412
both O 0 0.0032915256451815367
the O 0 0.005708781071007252
wild O 0 0.027991998940706253
- O 0 0.03975651040673256
type O 0 0.04159211367368698
and O 0 0.01223019789904356
H63D O 1 0.9973612427711487
HFE O 1 0.9985573887825012
proteins O 0 0.04899017512798309
form O 0 0.018438078463077545
stable O 0 0.04424376040697098
complexes O 0 0.02490430697798729
with O 0 0.006638010963797569
the O 0 0.012263891287147999
transferrin O 1 0.9916734099388123
receptor O 1 0.973055899143219
( O 0 0.033337708562612534
TfR O 1 0.9632185697555542
) O 0 0.023660840466618538
. O 0 0.021289538592100143

The O 0 0.028447218239307404
C282Y O 1 0.9917392730712891
mutation O 1 0.9983906745910645
nearly O 0 0.03149713948369026
completely O 0 0.023961544036865234
prevents O 0 0.03687376156449318
the O 0 0.004999987315386534
association O 0 0.00942876935005188
of O 0 0.004224382806569338
the O 0 0.010307366028428078
mutant O 1 0.9943407773971558
HFE O 1 0.9987636804580688
protein O 0 0.056428395211696625
with O 0 0.007774671074002981
the O 0 0.013077306561172009
TfR O 1 0.9841214418411255
. O 0 0.0258316770195961

Studies O 0 0.027199825271964073
on O 0 0.010885757394134998
cell O 0 0.05346468836069107
- O 0 0.04069766402244568
associated O 0 0.025646600872278214
transferrin O 1 0.5009555220603943
at O 0 0.01034651417285204
37 O 0 0.02138577587902546
degrees O 0 0.015448649413883686
C O 0 0.027460182085633278
suggest O 0 0.010271009989082813
that O 0 0.003560432465746999
the O 0 0.007170218508690596
overexpressed O 1 0.9413789510726929
wild O 0 0.050230786204338074
- O 0 0.14291977882385254
type O 0 0.45362815260887146
HFE O 1 0.9971728324890137
protein O 0 0.09390982985496521
decreases O 0 0.046999525278806686
the O 0 0.007102407980710268
affinity O 0 0.024954717606306076
of O 0 0.004888331983238459
the O 0 0.010423599742352962
TfR O 1 0.9755299091339111
for O 0 0.017806651070713997
transferrin O 1 0.8474228978157043
. O 0 0.025304993614554405

The O 0 0.03303823620080948
overexpressed O 1 0.9951804876327515
H63D O 1 0.9973629117012024
protein O 0 0.15840911865234375
does O 0 0.009059552103281021
not O 0 0.002960074692964554
have O 0 0.0029713870026171207
this O 0 0.0032827425748109818
effect O 0 0.009852451272308826
, O 0 0.0024464335292577744
providing O 0 0.004199391230940819
the O 0 0.002773582236841321
first O 0 0.0037124096415936947
direct O 0 0.006901821121573448
evidence O 0 0.004792498424649239
for O 0 0.003794024931266904
a O 0 0.00830767396837473
functional O 0 0.02632170543074608
consequence O 0 0.025067321956157684
of O 0 0.005518891382962465
the O 0 0.01196579821407795
H63D O 1 0.9987970590591431
mutation O 1 0.9980100989341736
. O 0 0.02673347108066082

Addition O 0 0.022407537326216698
of O 0 0.012050214223563671
soluble O 0 0.08910093456506729
wild O 0 0.053743019700050354
- O 0 0.21421898901462555
type O 1 0.8282729983329773
HFE O 1 0.9996720552444458
/ O 1 0.9870122075080872
beta2m O 1 0.99482262134552
heterodimers O 1 0.987873375415802
to O 0 0.01229405589401722
cultured O 0 0.47833263874053955
cells O 0 0.21463680267333984
also O 0 0.007821896113455296
decreased O 0 0.03754164278507233
the O 0 0.007556772790849209
apparent O 0 0.056435152888298035
affinity O 0 0.024668527767062187
of O 0 0.004120112396776676
the O 0 0.006483272649347782
TfR O 1 0.9347178936004639
for O 0 0.004181207157671452
its O 0 0.005893034860491753
ligand O 0 0.03637385740876198
under O 0 0.007040595170110464
steady O 0 0.022315004840493202
- O 0 0.021062348037958145
state O 0 0.006664191372692585
conditions O 0 0.01050806324928999
, O 0 0.0033792799804359674
both O 0 0.004108296241611242
in O 0 0.006278411019593477
293 O 0 0.27984949946403503
cells O 0 0.09093108028173447
and O 0 0.006543403957039118
in O 0 0.013774859718978405
HeLa O 1 0.9972986578941345
cells O 1 0.5871367454528809
. O 0 0.029409779235720634

Furthermore O 0 0.03814828768372536
, O 0 0.005839727818965912
at O 0 0.006903328001499176
4 O 0 0.012571013532578945
degrees O 0 0.014015396125614643
C O 0 0.021655628457665443
, O 0 0.003501195227727294
the O 0 0.004243809729814529
added O 0 0.00858311913907528
soluble O 0 0.04091992601752281
complex O 0 0.015054700896143913
of O 0 0.012590330094099045
HFE O 1 0.9994115829467773
/ O 1 0.9205093383789062
beta2m O 1 0.9785862565040588
inhibited O 0 0.4421849250793457
binding O 0 0.025752291083335876
of O 0 0.008940786123275757
transferrin O 1 0.8880652189254761
to O 0 0.011179644614458084
HeLa O 1 0.997930645942688
cell O 1 0.5173091888427734
TfR O 1 0.9769734740257263
in O 0 0.008004955016076565
a O 0 0.011620664969086647
concentration O 0 0.048241037875413895
- O 0 0.03776612505316734
dependent O 0 0.040135882794857025
manner O 0 0.03091244585812092
. O 0 0.020619992166757584

Scatchard O 0 0.12766607105731964
plots O 0 0.030713196843862534
of O 0 0.006140795070677996
these O 0 0.0038034042809158564
data O 0 0.005737988743931055
indicate O 0 0.010174727998673916
that O 0 0.0026939972303807735
the O 0 0.004703122191131115
added O 0 0.010940567590296268
heterodimer O 1 0.9869601726531982
substantially O 0 0.032857462763786316
reduced O 0 0.020263073965907097
the O 0 0.007561029400676489
affinity O 0 0.03416787460446358
of O 0 0.0103656817227602
TfR O 1 0.9863228797912598
for O 0 0.014189817011356354
transferrin O 1 0.9242761135101318
. O 0 0.026967134326696396

These O 0 0.010354462079703808
results O 0 0.016056779772043228
establish O 0 0.014027124270796776
a O 0 0.012672733515501022
molecular O 0 0.03219181299209595
link O 0 0.02185678668320179
between O 0 0.011586107313632965
HFE O 1 0.997395396232605
and O 0 0.0045523373410105705
a O 0 0.007778184488415718
key O 0 0.011797361075878143
protein O 0 0.02993619814515114
involved O 0 0.008877922780811787
in O 0 0.004996579606086016
iron O 0 0.026179131120443344
transport O 0 0.010897103697061539
, O 0 0.004449137952178717
the O 0 0.007301060017198324
TfR O 1 0.9868214726448059
, O 0 0.004406950436532497
and O 0 0.0026146797463297844
raise O 0 0.007678645197302103
the O 0 0.0036984835751354694
possibility O 0 0.009412020444869995
that O 0 0.0031128295231610537
alterations O 0 0.01269068568944931
in O 0 0.0028556417673826218
this O 0 0.0035416483879089355
regulatory O 0 0.06306080520153046
mechanism O 0 0.03713631629943848
may O 0 0.008258125744760036
play O 0 0.004449078813195229
a O 0 0.00523356394842267
role O 0 0.0069168126210570335
in O 0 0.003810933092609048
the O 0 0.007088718470185995
pathogenesis O 1 0.9988179802894592
of O 0 0.0202570129185915
hereditary B-Disease 1 0.9999892711639404
hemochromatosis I-Disease 1 0.9999974966049194
. O 0 0.020121632143855095
. O 0 0.02311621978878975

Genomic O 0 0.1467551440000534
organization O 0 0.018169473856687546
of O 0 0.007099459879100323
the O 0 0.013108963146805763
UBE3A O 1 0.9995589852333069
/ O 1 0.9439430832862854
E6 O 1 0.9632713198661804
- O 0 0.07670554518699646
AP O 0 0.08398997038602829
gene O 1 0.7188142538070679
and O 0 0.00889300275593996
related O 0 0.03228689730167389
pseudogenes O 1 0.9439617991447449
. O 0 0.02566412277519703

The O 0 0.04538195952773094
UBE3A O 1 0.9891378283500671
gene O 1 0.7975054979324341
encodes O 0 0.0823477953672409
the O 0 0.01699811778962612
E6 O 1 0.9335850477218628
- O 0 0.05861705541610718
AP O 0 0.07026343792676926
ubiquitin O 0 0.11123114824295044
- O 0 0.05061592534184456
protein O 0 0.05338190495967865
ligase O 0 0.03906293958425522
and O 0 0.0041369725950062275
has O 0 0.005000903736799955
recently O 0 0.009647712111473083
been O 0 0.004582280293107033
shown O 0 0.006576876621693373
to O 0 0.002949735149741173
be O 0 0.0064790635369718075
mutated O 1 0.9988635778427124
in O 0 0.1436162292957306
Angelman B-Disease 1 0.9999991655349731
syndrome I-Disease 1 1.0
patients O 1 0.9999674558639526
who O 0 0.028576694428920746
lack O 1 0.5367895364761353
15q11 O 1 0.999107301235199
- O 1 0.8533455729484558
q13 O 1 0.9920097589492798
deletions O 1 0.8658387660980225
or O 0 0.02582952380180359
chromosome O 1 0.9959366321563721
15 O 0 0.0435623973608017
paternal O 1 0.9787814021110535
uniparental B-Disease 1 0.9985743761062622
disomy I-Disease 1 0.9739856123924255
. O 0 0.040204789489507675

Previous O 0 0.061967480927705765
UBE3A O 1 0.9872807860374451
cDNA O 0 0.10763338208198547
analysis O 0 0.02072751149535179
has O 0 0.009494894184172153
shown O 0 0.012321839109063148
a O 0 0.010416385717689991
coding O 0 0.047178901731967926
region O 0 0.01605868525803089
of O 0 0.006185206118971109
approximately O 0 0.01749972440302372
2 O 0 0.020912570878863335
. O 0 0.017015719786286354

6 O 0 0.03644387423992157
kb O 0 0.06322582811117172
and O 0 0.005728894378989935
a O 0 0.011590919457376003
3 O 0 0.02038949728012085
- O 0 0.04821380227804184
untranslated O 0 0.3771061599254608
region O 0 0.034027788788080215
( O 0 0.020869147032499313
UTR O 0 0.33158838748931885
) O 0 0.010106473229825497
of O 0 0.007342975586652756
< O 1 0.6714101433753967
50 O 0 0.015269098803400993
bp O 0 0.03177256137132645
, O 0 0.0068133240565657616
whereas O 0 0.014829397201538086
Northern O 0 0.012416298501193523
analysis O 0 0.011795333586633205
has O 0 0.007789225317537785
indicated O 0 0.02022762969136238
mRNA O 0 0.03587121143937111
sizes O 0 0.016589000821113586
of O 0 0.005829066038131714
5 O 0 0.01663590408861637
- O 0 0.03413727506995201
8 O 0 0.03176511451601982
kb O 0 0.11570748686790466
. O 0 0.024878809228539467

We O 0 0.010308629833161831
have O 0 0.007470621261745691
analyzed O 0 0.02187187597155571
additional O 0 0.013637591153383255
cDNA O 0 0.07811097800731659
clones O 0 0.2141558676958084
and O 0 0.004358178004622459
provide O 0 0.004936574958264828
evidence O 0 0.004531231243163347
for O 0 0.002753930864855647
an O 0 0.0044259969145059586
additional O 0 0.012560665607452393
0 O 0 0.03251447156071663
. O 0 0.017742089927196503

5 O 0 0.035105593502521515
kb O 0 0.06098645552992821
of O 0 0.008912529796361923
5 O 0 0.01959267258644104
- O 0 0.04932833090424538
UTR O 0 0.35235321521759033
and O 0 0.011142315343022346
> O 0 0.124170683324337
2 O 0 0.014615753665566444
kb O 0 0.05026692524552345
of O 0 0.00852930173277855
3 O 0 0.02163347601890564
- O 0 0.058317288756370544
UTR O 0 0.36413058638572693
. O 0 0.02984778583049774

We O 0 0.009170372039079666
have O 0 0.005398204084485769
established O 0 0.008350868709385395
the O 0 0.006656979210674763
genomic O 0 0.07411002367734909
organization O 0 0.013516250997781754
of O 0 0.008634546771645546
UBE3A O 1 0.9979467988014221
and O 0 0.004910701420158148
the O 0 0.005261505953967571
sequence O 0 0.01851043663918972
of O 0 0.01030276995152235
intron O 1 0.9866666197776794
- O 0 0.1117272898554802
exon O 0 0.23363542556762695
borders O 0 0.047382570803165436
. O 0 0.027355089783668518

We O 0 0.00819939561188221
have O 0 0.005404702853411436
also O 0 0.004632351454347372
mapped O 0 0.020486870780587196
two O 0 0.006721989251673222
highly O 0 0.024065399542450905
homologous O 0 0.11419771611690521
processed O 0 0.036896806210279465
pseudogenes O 1 0.880926787853241
, O 0 0.012028926983475685
UBE3AP1 O 1 0.9725067615509033
and O 0 0.007872690446674824
UBE3AP2 O 1 0.9816827774047852
, O 0 0.0054395766928792
to O 0 0.005626494064927101
chromosomes O 0 0.045504726469516754
2 O 0 0.007615387439727783
and O 0 0.0029263156466186047
21 O 0 0.00870946142822504
, O 0 0.003307816106826067
respectively O 0 0.00670733442530036
, O 0 0.0031378217972815037
and O 0 0.0028203628025949
determined O 0 0.011118264868855476
their O 0 0.007364800199866295
genomic O 0 0.19498546421527863
organization O 0 0.027863172814249992
. O 0 0.02121901884675026

These O 0 0.007959185168147087
results O 0 0.00943745393306017
will O 0 0.003078520530834794
form O 0 0.0054002320393919945
the O 0 0.002323736436665058
basis O 0 0.0033462699502706528
for O 0 0.0026358836330473423
studies O 0 0.0073980363085865974
of O 0 0.006560692563652992
mutation O 1 0.996204674243927
and O 0 0.009498301893472672
imprinting O 1 0.9159137010574341
of O 0 0.018049336969852448
UBE3A O 1 0.9983433485031128
. O 0 0.03619517758488655

Mutation O 1 0.9971543550491333
spectrum O 0 0.12091083824634552
and O 0 0.01577773317694664
genotype O 1 0.9984341263771057
- O 1 0.9040547013282776
phenotype O 1 0.9987587928771973
analyses O 0 0.038415420800447464
in O 0 0.01899433322250843
Cowden B-Disease 1 0.9999555349349976
disease I-Disease 1 0.9999899864196777
and O 0 0.020855525508522987
Bannayan B-Disease 1 0.9996980428695679
- I-Disease 1 0.9977229237556458
Zonana I-Disease 1 0.9999552965164185
syndrome I-Disease 1 0.9999991655349731
, O 0 0.018766818568110466
two O 0 0.025821935385465622
hamartoma B-Disease 1 0.9998828172683716
syndromes I-Disease 1 0.9999096393585205
with O 0 0.05338432639837265
germline O 1 0.9996963739395142
PTEN O 1 0.9998812675476074
mutation O 1 0.9991922974586487
. O 0 0.03790784254670143

The O 0 0.05626598373055458
tumour B-Disease 1 0.9999697208404541
suppressor O 1 0.999804675579071
gene O 1 0.9988467693328857
PTEN O 1 0.9993001222610474
, O 0 0.009150938130915165
which O 0 0.00618296442553401
maps O 0 0.012090790085494518
to O 0 0.010634985752403736
10q23 O 1 0.6359162330627441
. O 0 0.027820343151688576

3 O 0 0.02512212097644806
and O 0 0.008916025049984455
encodes O 0 0.05029349401593208
a O 0 0.017637331038713455
403 O 0 0.060980312526226044
amino O 0 0.053363919258117676
acid O 0 0.08037509024143219
dual O 0 0.05523398891091347
specificity O 0 0.08300510793924332
phosphatase O 1 0.9690780639648438
( O 0 0.03072616271674633
protein O 0 0.08446808159351349
tyrosine O 1 0.9087377190589905
phosphatase O 1 0.9902352690696716
; O 0 0.022484349086880684
PTPase O 1 0.9586445689201355
) O 0 0.00954598281532526
, O 0 0.003974332939833403
was O 0 0.004980797413736582
shown O 0 0.008764203637838364
recently O 0 0.00827229768037796
to O 0 0.0026965606957674026
play O 0 0.004422778729349375
a O 0 0.006944653578102589
broad O 0 0.018442539498209953
role O 0 0.014675350859761238
in O 0 0.00938030332326889
human O 0 0.06535916775465012
malignancy B-Disease 1 0.9997463822364807
. O 0 0.031036416068673134

Somatic O 1 0.9924994111061096
PTEN O 1 0.9994760155677795
deletions O 1 0.9134836196899414
and O 0 0.01381407305598259
mutations O 1 0.9910118579864502
were O 0 0.005974080413579941
observed O 0 0.01764112338423729
in O 0 0.008647259324789047
sporadic B-Disease 1 0.9932873845100403
breast I-Disease 1 0.9999911785125732
, I-Disease 0 0.07773607224225998
brain I-Disease 1 0.9999703168869019
, I-Disease 0 0.40031543374061584
prostate I-Disease 1 0.9999995231628418
and I-Disease 1 0.8386943936347961
kidney I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999985694885254
cell O 1 0.8788281679153442
lines O 0 0.012581192888319492
and O 0 0.0027629577089101076
in O 0 0.0032088446896523237
several O 0 0.004899525083601475
primary O 0 0.11880208551883698
tumours B-Disease 1 0.999872088432312
such O 0 0.008197471499443054
as O 0 0.018555106595158577
endometrial B-Disease 1 0.9999978542327881
carcinomas I-Disease 1 0.999994158744812
, O 1 0.9817337989807129
malignant B-Disease 1 0.9999997615814209
melanoma I-Disease 1 0.9999998807907104
and O 1 0.9270426630973816
thyroid B-Disease 1 0.9999972581863403
tumours I-Disease 1 0.9999532699584961
. O 0 0.038018885999917984

In O 0 0.011686166748404503
addition O 0 0.015995195135474205
, O 0 0.011922692880034447
PTEN O 1 0.9980525970458984
was O 0 0.011960686184465885
identified O 0 0.013981509022414684
as O 0 0.004609865602105856
the O 0 0.00897311232984066
susceptibility O 1 0.9986131191253662
gene O 1 0.7229100465774536
for O 0 0.007949032820761204
two O 0 0.019271308556199074
hamartoma B-Disease 1 0.9999697208404541
syndromes I-Disease 1 0.999998927116394
Cowden B-Disease 1 0.9999933242797852
disease I-Disease 1 0.9999961853027344
( O 0 0.03702781721949577
CD B-Disease 0 0.10577550530433655
; O 0 0.022480254992842674
MIM O 1 0.9979996085166931
158350 O 1 0.9313758611679077
) O 0 0.014621376991271973
and O 0 0.010293220169842243
Bannayan B-Disease 1 0.988138735294342
- I-Disease 0 0.4760338068008423
Zonana I-Disease 1 0.9960436820983887
( I-Disease 0 0.033029258251190186
BZS I-Disease 1 0.9571307897567749
) I-Disease 0 0.015441978350281715
or I-Disease 0 0.016786009073257446
Ruvalcaba I-Disease 1 0.9956058859825134
- I-Disease 1 0.5692390203475952
Riley I-Disease 1 0.9864792227745056
- I-Disease 1 0.9705963730812073
Smith I-Disease 1 0.9944416880607605
syndrome I-Disease 1 0.9999974966049194
( O 0 0.07604943960905075
MIM O 1 0.9990905523300171
153480 O 1 0.9745824337005615
) O 0 0.025721538811922073
. O 0 0.021093355491757393

Constitutive O 1 0.6345517039299011
DNA O 0 0.06203225255012512
from O 0 0.011187068186700344
37 O 0 0.023326043039560318
CD B-Disease 0 0.024776622653007507
families O 0 0.013164475560188293
and O 0 0.005793334916234016
seven O 0 0.015543464571237564
BZS B-Disease 1 0.9730851650238037
families O 0 0.02028488740324974
was O 0 0.012827238999307156
screened O 0 0.04789463430643082
for O 0 0.023216789588332176
germline O 1 0.9988529682159424
PTEN O 1 0.9996198415756226
mutations O 1 0.9981034994125366
. O 0 0.033848024904727936

PTEN O 1 0.9996976852416992
mutations O 1 0.9949581027030945
were O 0 0.007111189421266317
identified O 0 0.012668062932789326
in O 0 0.003631508443504572
30 O 0 0.00681681651622057
of O 0 0.0038411093410104513
37 O 0 0.01803595758974552
( O 0 0.011391044594347477
81 O 0 0.025676870718598366
% O 0 0.010241943411529064
) O 0 0.006743155885487795
CD B-Disease 0 0.01906832866370678
families O 0 0.009147683158516884
, O 0 0.004032833501696587
including O 0 0.007280353456735611
missense O 1 0.965247392654419
and O 0 0.006832718383520842
nonsense O 0 0.03544018045067787
point O 0 0.01593349315226078
mutations O 1 0.9950647950172424
, O 0 0.007268890272825956
deletions O 0 0.41254860162734985
, O 0 0.007246591616421938
insertions O 0 0.09242511540651321
, O 0 0.007347350008785725
a O 0 0.017705431208014488
deletion O 1 0.9902390241622925
/ O 1 0.6925775408744812
insertion O 0 0.3948213458061218
and O 0 0.01205290388315916
splice O 1 0.7942224740982056
site O 0 0.04582413658499718
mutations O 1 0.9863944053649902
. O 0 0.0272222813218832

These O 0 0.015607343055307865
mutations O 1 0.8776612281799316
were O 0 0.0046110753901302814
scattered O 0 0.009844737127423286
over O 0 0.0038581278640776873
the O 0 0.004078874364495277
entire O 0 0.014168035238981247
length O 0 0.01595715992152691
of O 0 0.007864869199693203
PTEN O 1 0.9991334080696106
, O 0 0.004262640606611967
with O 0 0.0026196062099188566
the O 0 0.003069591708481312
exception O 0 0.007846320979297161
of O 0 0.002136922674253583
the O 0 0.002851382829248905
first O 0 0.0034598044585436583
, O 0 0.003076709108427167
fourth O 0 0.008983043022453785
and O 0 0.004976264201104641
last O 0 0.018478048965334892
exons O 0 0.11421790719032288
. O 0 0.023568373173475266

A O 0 0.033623430877923965
hot O 0 0.04528293013572693
spot O 0 0.030921127647161484
for O 0 0.014654645696282387
PTEN O 1 0.9993170499801636
mutation O 1 0.9980319142341614
in O 0 0.009367754682898521
CD B-Disease 0 0.021042732521891594
was O 0 0.007284407503902912
identified O 0 0.013439668342471123
in O 0 0.006030511576682329
exon O 0 0.15537570416927338
5 O 0 0.009617955423891544
that O 0 0.0031257248483598232
contains O 0 0.006877876352518797
the O 0 0.0063108885660767555
PTPase O 1 0.7063566446304321
core O 0 0.02224765159189701
motif O 0 0.03790079802274704
, O 0 0.003766338573768735
with O 0 0.0033527074847370386
13 O 0 0.00657045841217041
of O 0 0.003828905988484621
30 O 0 0.01014030072838068
( O 0 0.008942907676100731
43 O 0 0.01748616062104702
% O 0 0.011731043457984924
) O 0 0.010931380093097687
CD B-Disease 0 0.04352764040231705
mutations O 1 0.9822730422019958
identified O 0 0.01684913970530033
in O 0 0.005847224034368992
this O 0 0.009995539672672749
exon O 0 0.25566956400871277
. O 0 0.02257867529988289

Seven O 0 0.014164687134325504
of O 0 0.006786479149013758
30 O 0 0.01340777799487114
( O 0 0.010504812002182007
23 O 0 0.011284795589745045
% O 0 0.007298676297068596
) O 0 0.004259342327713966
were O 0 0.0022186930291354656
within O 0 0.004350863862782717
the O 0 0.00483707943931222
core O 0 0.015385063365101814
motif O 0 0.03157973289489746
, O 0 0.00420073326677084
the O 0 0.004470595624297857
majority O 0 0.009300794452428818
( O 0 0.004992717411369085
five O 0 0.003154253587126732
of O 0 0.0024748174473643303
seven O 0 0.004380934406071901
) O 0 0.003521307837218046
of O 0 0.002438104245811701
which O 0 0.0039034567307680845
were O 0 0.007027017418295145
missense O 1 0.9983839988708496
mutations O 1 0.9983202815055847
, O 0 0.0061675915494561195
possibly O 0 0.014578877948224545
pointing O 0 0.013226170092821121
to O 0 0.0031506710220128298
the O 0 0.005005940794944763
functional O 0 0.017859073355793953
significance O 0 0.007630678825080395
of O 0 0.0033887235913425684
this O 0 0.00568088935688138
region O 0 0.0236788522452116
. O 0 0.01702728681266308

Germline O 1 0.9991515874862671
PTEN O 1 0.9997290968894958
mutations O 1 0.9968041181564331
were O 0 0.005513422191143036
identified O 0 0.010226882994174957
in O 0 0.0023777110036462545
four O 0 0.002798847621306777
of O 0 0.0030518174171447754
seven O 0 0.0071194469928741455
( O 0 0.01072850450873375
57 O 0 0.024680422618985176
% O 0 0.014320234768092632
) O 0 0.016314204782247543
BZS B-Disease 1 0.9649207592010498
families O 0 0.022146878764033318
studied O 0 0.020563799887895584
. O 0 0.01826530322432518

Interestingly O 0 0.0964813232421875
, O 0 0.007346326485276222
none O 0 0.009248410351574421
of O 0 0.003795395139604807
these O 0 0.0057887909933924675
mutations O 1 0.9876965880393982
was O 0 0.008791743777692318
observed O 0 0.01436901930719614
in O 0 0.004951971583068371
the O 0 0.008818216621875763
PTPase O 1 0.8718055486679077
core O 0 0.04420044273138046
motif O 0 0.08424364775419235
. O 0 0.02365926094353199

It O 0 0.010009421966969967
is O 0 0.007107638753950596
also O 0 0.0045006973668932915
worthy O 0 0.01559630036354065
of O 0 0.004079191945493221
note O 0 0.010036887601017952
that O 0 0.0029043820686638355
a O 0 0.006993988994508982
single O 0 0.012477702461183071
nonsense O 0 0.0327116958796978
point O 0 0.015154769644141197
mutation O 1 0.9988256096839905
, O 0 0.009013560600578785
R233X O 1 0.7880489230155945
, O 0 0.004546780604869127
was O 0 0.005420142784714699
observed O 0 0.011048544198274612
in O 0 0.004063282161951065
the O 0 0.008554816246032715
germline O 1 0.9975208640098572
DNA O 0 0.03626064211130142
from O 0 0.006591632030904293
two O 0 0.005407238379120827
unrelated O 0 0.03240586444735527
CD B-Disease 0 0.03008636087179184
families O 0 0.01539140660315752
and O 0 0.007146252319216728
one O 0 0.01562751829624176
BZS B-Disease 1 0.9751861691474915
family O 0 0.043183814734220505
. O 0 0.025706039741635323

Genotype O 1 0.9985143542289734
- O 1 0.932590663433075
phenotype O 1 0.9989223480224609
studies O 0 0.014145676977932453
were O 0 0.0026636815164238214
not O 0 0.0026730275712907314
performed O 0 0.006189936306327581
on O 0 0.0023363803047686815
this O 0 0.003316093934699893
small O 0 0.006752386223524809
group O 0 0.010218281298875809
of O 0 0.010946745984256268
BZS B-Disease 1 0.9626800417900085
families O 0 0.03834217041730881
. O 0 0.025321973487734795

However O 0 0.018789142370224
, O 0 0.015081868506968021
genotype O 1 0.9968743324279785
- O 1 0.526155948638916
phenotype O 1 0.9990876913070679
analysis O 0 0.030072249472141266
inthe O 1 0.8865691423416138
group O 0 0.011465375311672688
of O 0 0.005800925195217133
CD B-Disease 0 0.022730883210897446
families O 0 0.01122599933296442
revealed O 0 0.01337146945297718
two O 0 0.004201994277536869
possible O 0 0.00862414576113224
associations O 0 0.013918017037212849
worthy O 0 0.016592055559158325
of O 0 0.004199032671749592
follow O 0 0.009862038306891918
- O 0 0.01582532748579979
up O 0 0.005560147576034069
in O 0 0.004923608619719744
independent O 0 0.013785598799586296
analyses O 0 0.03283796086907387
. O 0 0.02062024176120758

The O 0 0.009982307441532612
first O 0 0.00775096146389842
was O 0 0.005755597725510597
an O 0 0.005510319024324417
association O 0 0.012515938840806484
noted O 0 0.006394201423972845
in O 0 0.0025981080252677202
the O 0 0.0027266843244433403
group O 0 0.005701474379748106
of O 0 0.00399819016456604
CD B-Disease 0 0.02639896050095558
families O 0 0.021392468363046646
with O 0 0.03615836054086685
breast B-Disease 1 0.9999914169311523
disease I-Disease 1 0.9999842643737793
. O 0 0.03253943473100662

A O 0 0.027482150122523308
correlation O 0 0.03587020933628082
was O 0 0.009094185195863247
observed O 0 0.013472851365804672
between O 0 0.004305409267544746
the O 0 0.005369119346141815
presence O 0 0.020574359223246574
/ O 0 0.12704096734523773
absence O 0 0.016570735722780228
of O 0 0.0063711488619446754
a O 0 0.024529004469513893
PTEN O 1 0.9997754693031311
mutation O 1 0.9978598952293396
and O 0 0.005520063918083906
the O 0 0.006428681313991547
type O 0 0.02883998490869999
of O 0 0.010396145284175873
breast O 1 0.9999582767486572
involvement O 0 0.3423926532268524
( O 0 0.0319196991622448
unaffected O 1 0.9980167150497437
versus O 1 0.9936556816101074
benign O 1 0.9998148083686829
versus O 1 0.9948441982269287
malignant O 1 0.9999589920043945
) O 0 0.028654184192419052
. O 0 0.02114803157746792

Specifically O 0 0.021661322563886642
and O 0 0.0050811548717319965
more O 0 0.004186231642961502
directly O 0 0.005997884087264538
, O 0 0.0033992105163633823
an O 0 0.004085521679371595
association O 0 0.009297904558479786
was O 0 0.004520742688328028
also O 0 0.003243053797632456
observed O 0 0.00980660691857338
between O 0 0.003275760682299733
the O 0 0.003426122944802046
presence O 0 0.009683473035693169
of O 0 0.0052413372322916985
a O 0 0.023819560185074806
PTEN O 1 0.9999574422836304
mutation O 1 0.9999487400054932
and O 1 0.7307617664337158
malignant B-Disease 1 0.9999992847442627
breast I-Disease 1 0.999998927116394
disease I-Disease 1 0.999993085861206
. O 0 0.04016098380088806

Secondly O 0 0.1433737576007843
, O 0 0.005094897001981735
there O 0 0.003740807995200157
appeared O 0 0.00684125954285264
to O 0 0.0023206991609185934
be O 0 0.0024026986211538315
an O 0 0.004585093352943659
interdependent O 0 0.11494794487953186
association O 0 0.02003983035683632
between O 0 0.014716869220137596
mutations O 1 0.9947463870048523
upstream O 0 0.024793274700641632
and O 0 0.0038725826889276505
within O 0 0.006543044466525316
the O 0 0.007230668794363737
PTPase O 1 0.9553707242012024
core O 0 0.02553357556462288
motif O 0 0.04152023047208786
, O 0 0.004277556668967009
the O 0 0.005519644822925329
core O 0 0.018200460821390152
motif O 0 0.03188787028193474
containing O 0 0.009464151225984097
the O 0 0.004518680740147829
majority O 0 0.01086543407291174
of O 0 0.00863613560795784
missense O 1 0.9992877840995789
mutations O 1 0.9981579184532166
, O 0 0.0035333416890352964
and O 0 0.0020728015806525946
the O 0 0.0030692971777170897
involvement O 0 0.01217738352715969
of O 0 0.002691893372684717
all O 0 0.002756119705736637
major O 0 0.011944125406444073
organ O 1 0.7628036737442017
systems O 0 0.01687537506222725
( O 0 0.01030701957643032
central O 0 0.012559972703456879
nervous O 1 0.9982944130897522
system O 0 0.018846333026885986
, O 0 0.016645977273583412
thyroid O 1 0.9999879598617554
, O 0 0.05129162594676018
breast O 1 0.9999933242797852
, O 0 0.14711058139801025
skin O 1 0.9999927282333374
and O 0 0.19380933046340942
gastrointestinal O 1 0.9999990463256836
tract O 1 0.9998620748519897
) O 0 0.026098478585481644
. O 0 0.021876949816942215

However O 0 0.014952147379517555
, O 0 0.004408210515975952
these O 0 0.0037005979102104902
observations O 0 0.008438489399850368
would O 0 0.0027589888777583838
need O 0 0.0035760083701461554
to O 0 0.001944424700923264
be O 0 0.002297846134752035
confirmed O 0 0.007296023890376091
by O 0 0.003542089369148016
studying O 0 0.006228180136531591
a O 0 0.005996219348162413
larger O 0 0.008166415616869926
number O 0 0.004875107668340206
of O 0 0.004584384150803089
CD B-Disease 0 0.031182916834950447
families O 0 0.023632679134607315
. O 0 0.01955188624560833

Molecular O 0 0.4791986644268036
defects O 1 0.9940881729125977
leading O 0 0.019606202840805054
to O 0 0.007330938708037138
human O 0 0.025108736008405685
complement B-Disease 0 0.047166548669338226
component I-Disease 1 0.8426653742790222
C6 I-Disease 1 0.999954104423523
deficiency I-Disease 1 0.9999799728393555
in O 0 0.00739445211365819
an O 0 0.007185384631156921
African O 0 0.0285235196352005
- O 0 0.04023037105798721
American O 0 0.021383188664913177
family O 0 0.034269824624061584
. O 0 0.02035299316048622

Complement B-Disease 0 0.13687822222709656
component I-Disease 1 0.8765364289283752
C6 I-Disease 1 0.9998340606689453
deficiency I-Disease 1 0.999984622001648
( O 0 0.053237780928611755
C6D B-Disease 1 0.9956831932067871
) O 0 0.01699656993150711
was O 0 0.016924478113651276
diagnosed O 1 0.9999133348464966
in O 0 0.005241098813712597
a O 0 0.008392678573727608
16 O 0 0.011741993948817253
- O 0 0.022122899070382118
year O 0 0.010862094350159168
- O 0 0.0257791206240654
old O 0 0.02044939622282982
African O 0 0.02851334773004055
- O 0 0.038561541587114334
American O 0 0.02271517924964428
male O 0 0.21086764335632324
with O 0 0.0367589108645916
meningococcal B-Disease 1 0.99998939037323
meningitis I-Disease 1 0.9999855756759644
. O 0 0.05071840435266495

The O 0 0.026430265977978706
patients O 1 0.9982463121414185
father O 0 0.023256652057170868
and O 0 0.0043455143459141254
two O 0 0.0049287062138319016
brothers O 0 0.01737755909562111
also O 0 0.005426798947155476
had O 0 0.008106118999421597
C6D B-Disease 1 0.992447018623352
, O 0 0.00477357255294919
but O 0 0.003299943171441555
gave O 0 0.005899065639823675
no O 0 0.004259276203811169
history O 0 0.006750000640749931
of O 0 0.008264290168881416
meningitis B-Disease 1 0.9999879598617554
or O 0 0.01317683421075344
other O 0 0.012112537398934364
neisserial B-Disease 1 0.9996969699859619
infection I-Disease 1 0.9999809265136719
. O 0 0.030524984002113342

By O 0 0.01872154511511326
using O 0 0.020178144797682762
exon O 0 0.11969158798456192
- O 0 0.04809810593724251
specific O 0 0.0265812985599041
polymerase O 0 0.24563050270080566
chain O 0 0.09356860816478729
reaction O 0 0.045748431235551834
( O 0 0.018231913447380066
PCR O 0 0.12672924995422363
) O 0 0.013604149222373962
/ O 0 0.04462430253624916
single O 0 0.022133182734251022
- O 0 0.04125077649950981
strand O 0 0.08500829339027405
conformation O 0 0.40572649240493774
polymorphism O 0 0.13607677817344666
as O 0 0.006280857138335705
a O 0 0.009984366595745087
screening O 0 0.03317699581384659
step O 0 0.013710573315620422
and O 0 0.00448301387950778
nucleotide O 0 0.03670390322804451
sequencing O 0 0.02478053979575634
of O 0 0.0041590966284275055
target O 0 0.01545023638755083
exons O 0 0.04336332157254219
, O 0 0.0036717031616717577
we O 0 0.002966766944155097
determined O 0 0.00733122369274497
that O 0 0.003055744571611285
the O 0 0.005287850741297007
proband O 0 0.4798268675804138
was O 0 0.007854249328374863
a O 0 0.01028414536267519
compound O 0 0.031005486845970154
heterozygote O 1 0.5842999219894409
for O 0 0.009358701296150684
two O 0 0.016991160809993744
C6 O 1 0.9981178045272827
gene O 1 0.9801405072212219
mutations O 1 0.9929481744766235
. O 0 0.0318705253303051

The O 0 0.010220914147794247
first O 0 0.008894394151866436
, O 0 0.007766626309603453
1195delC O 1 0.5042509436607361
located O 0 0.011688579805195332
in O 0 0.006776266265660524
exon O 1 0.7063387036323547
7 O 0 0.012066273018717766
, O 0 0.0035244079772382975
is O 0 0.004404397215694189
a O 0 0.009148871526122093
novel O 0 0.03178662434220314
mutation O 1 0.9983872175216675
, O 0 0.004165100399404764
while O 0 0.003936740104109049
the O 0 0.004406197927892208
second O 0 0.009503412991762161
, O 0 0.007476199418306351
1936delG O 1 0.761050283908844
in O 0 0.009151993319392204
exon O 1 0.595363974571228
12 O 0 0.010790185071527958
, O 0 0.0037475619465112686
has O 0 0.004743133205920458
been O 0 0.005474339704960585
described O 0 0.010234931483864784
before O 0 0.006181425880640745
to O 0 0.006156247109174728
cause O 1 0.5508235692977905
C6D B-Disease 1 0.9806134700775146
in O 0 0.005848386324942112
an O 0 0.007519707083702087
unrelated O 0 0.03754435107111931
African O 0 0.030304614454507828
- O 0 0.03388945013284683
American O 0 0.017223799601197243
individual O 0 0.01938062347471714
. O 0 0.01909095235168934

Both O 0 0.03318694606423378
mutations O 1 0.9875989556312561
result O 0 0.024779170751571655
in O 0 0.014394405297935009
premature O 1 0.9961977601051331
termination O 1 0.9626840353012085
codons O 1 0.5135197639465332
and O 0 0.023214098066091537
C6 O 1 0.9956947565078735
null O 0 0.3743475377559662
alleles O 1 0.985602080821991
. O 0 0.030776893720030785

Allele O 1 0.9866895079612732
- O 0 0.0663667842745781
specific O 0 0.026432357728481293
PCR O 0 0.1952272355556488
indicated O 0 0.014553778804838657
that O 0 0.0036347690038383007
the O 0 0.005960192531347275
probands O 0 0.40415963530540466
two O 0 0.005767971742898226
brothers O 0 0.021137604489922523
also O 0 0.007295466493815184
inherited O 1 0.9293205738067627
the O 0 0.011840738356113434
1195delC O 1 0.9943742752075195
mutation O 1 0.9967643022537231
from O 0 0.009151982143521309
their O 0 0.009158927947282791
heterozygous O 1 0.9727684259414673
mother O 0 0.032375480979681015
and O 0 0.00495766568928957
the O 0 0.009693543426692486
1936delG O 1 0.9919192790985107
mutation O 1 0.9954525828361511
from O 0 0.010636893101036549
their O 0 0.011846152134239674
homozygous O 1 0.9822355508804321
father O 0 0.027911754325032234
. O 0 0.01001028623431921
. O 0 0.01555921882390976

PAX6 O 1 0.9974867105484009
mutations O 1 0.9897088408470154
reviewed O 0 0.06669354438781738
. O 0 0.03775278106331825

Mutations O 1 0.989189624786377
in O 0 0.02255081571638584
PAX6 O 1 0.9966367483139038
are O 0 0.007054526824504137
responsible O 0 0.014444539323449135
for O 0 0.005488376133143902
human O 0 0.028723690658807755
aniridia B-Disease 1 0.9952991008758545
and O 0 0.003746643429622054
have O 0 0.0032092109322547913
also O 0 0.002777433255687356
been O 0 0.004059935454279184
found O 0 0.006216924637556076
in O 0 0.006121136248111725
patients O 1 0.9989338517189026
with O 0 0.008889805525541306
Peters B-Disease 1 0.9968692660331726
anomaly I-Disease 1 0.9988594055175781
, O 0 0.009195544756948948
with O 0 0.09475430101156235
congenital B-Disease 1 0.9999998807907104
cataracts I-Disease 1 0.9999990463256836
, O 0 0.012634575366973877
with O 0 0.021459316834807396
autosomal B-Disease 1 0.999993085861206
dominant I-Disease 1 0.9995825886726379
keratitis I-Disease 1 0.999980092048645
, O 0 0.009776265360414982
and O 0 0.006266104057431221
with O 0 0.012337355874478817
isolated B-Disease 1 0.9550504088401794
foveal I-Disease 1 0.9988135099411011
hypoplasia I-Disease 1 0.9994826316833496
. O 0 0.04343406856060028

No O 0 0.02337249554693699
locus O 1 0.8108558058738708
other O 0 0.008465736173093319
than O 0 0.01588032767176628
chromosome O 1 0.9977571368217468
11p13 O 1 0.9145421981811523
has O 0 0.009884633123874664
been O 0 0.009662927128374577
implicated O 0 0.32014361023902893
in O 0 0.010909410193562508
aniridia B-Disease 1 0.9969180822372437
, O 0 0.007395421154797077
and O 0 0.007494652643799782
PAX6 O 1 0.9993946552276611
is O 0 0.006571946665644646
clearly O 0 0.008067594841122627
the O 0 0.003592188935726881
major O 0 0.00877747405320406
, O 0 0.003304884070530534
if O 0 0.004403249826282263
not O 0 0.0030414762441068888
only O 0 0.004308915231376886
, O 0 0.008231592364609241
gene O 1 0.7087767124176025
responsible O 0 0.028531083837151527
. O 0 0.020049186423420906

Twenty O 0 0.03906529024243355
- O 0 0.02441505156457424
eight O 0 0.009545832872390747
percent O 0 0.01075156033039093
of O 0 0.007186047732830048
identified O 0 0.06029604747891426
PAX6 O 1 0.9996782541275024
mutations O 1 0.9990590214729309
are O 0 0.00961045827716589
C O 1 0.7149602174758911
- O 0 0.39340364933013916
T O 1 0.9765962362289429
changes O 0 0.01628286764025688
at O 0 0.011990120634436607
CpG O 1 0.9713996052742004
dinucleotides O 1 0.9782454371452332
, O 0 0.005611574277281761
20 O 0 0.008134882897138596
% O 0 0.007155942264944315
are O 0 0.004280961584299803
splicing O 0 0.05849607288837433
errors O 0 0.015393703244626522
, O 0 0.0026842232327908278
and O 0 0.0020233611576259136
more O 0 0.0028860261663794518
than O 0 0.004206578712910414
30 O 0 0.00826838705688715
% O 0 0.008100485429167747
are O 0 0.005862714257091284
deletion O 1 0.9000459909439087
or O 0 0.017317289486527443
insertion O 0 0.10456575453281403
events O 0 0.022951345890760422
. O 0 0.01968628540635109

There O 0 0.010321141220629215
is O 0 0.007060948759317398
a O 0 0.013842014595866203
noticeably O 1 0.5621052384376526
elevated O 0 0.1449306458234787
level O 0 0.008841616101562977
of O 0 0.0067008985206484795
mutation O 1 0.9963471293449402
in O 0 0.004040369763970375
the O 0 0.005299093667417765
paired O 0 0.027153020724654198
domain O 0 0.020383283495903015
compared O 0 0.00986147578805685
with O 0 0.0028926944360136986
the O 0 0.0035090476740151644
rest O 0 0.007906901650130749
of O 0 0.0048708622343838215
the O 0 0.010460720397531986
gene O 1 0.6704660058021545
. O 0 0.02865993045270443

Increased O 0 0.079898402094841
mutation O 1 0.9887575507164001
in O 0 0.00796118937432766
the O 0 0.008777257986366749
homeodomain O 1 0.9507671594619751
is O 0 0.008111094124615192
accounted O 0 0.013597968965768814
for O 0 0.0034274691715836525
by O 0 0.005568842403590679
the O 0 0.010961447842419147
hypermutable O 1 0.9782660603523254
CpG O 1 0.9747684597969055
dinucleotide O 1 0.5581461787223816
in O 0 0.021996652707457542
codon O 0 0.15708006918430328
240 O 0 0.0578664131462574
. O 0 0.027433374896645546

Very O 0 0.0197975505143404
nearly O 0 0.020698733627796173
all O 0 0.008991995826363564
mutations O 1 0.9979848861694336
appear O 0 0.012277559377253056
to O 0 0.0058657219633460045
cause O 1 0.7236261367797852
loss O 0 0.02406987175345421
of O 0 0.0036490922793745995
function O 0 0.009463146328926086
of O 0 0.003773866221308708
the O 0 0.007504505570977926
mutant O 1 0.999083399772644
allele O 1 0.9918096661567688
, O 0 0.004886634182184935
and O 0 0.0026014596223831177
more O 0 0.003604340832680464
than O 0 0.004787654150277376
80 O 0 0.010859889909625053
% O 0 0.007401563227176666
of O 0 0.006523970514535904
exonic O 1 0.9208029508590698
substitutions O 0 0.031070197001099586
result O 0 0.016734743490815163
in O 0 0.010909105651080608
nonsense O 0 0.07195959985256195
codons O 0 0.2784896492958069
. O 0 0.025302555412054062

In O 0 0.012882166542112827
a O 0 0.017416229471564293
gene O 0 0.12852242588996887
with O 0 0.005905767437070608
such O 0 0.00552093842998147
extraordinarily O 0 0.03504955396056175
high O 0 0.01319971028715372
sequence O 0 0.023618826642632484
conservation O 0 0.016083674505352974
throughout O 0 0.009097086265683174
evolution O 0 0.016061602160334587
, O 0 0.003209747839719057
there O 0 0.0033731129951775074
are O 0 0.003503835992887616
presumed O 0 0.0682709738612175
undiscovered O 1 0.9852480888366699
missense O 1 0.9989936947822571
mutations O 1 0.9981589913368225
, O 0 0.00417008763179183
these O 0 0.0026221664156764746
are O 0 0.002563769929111004
hypothesized O 0 0.044045474380254745
to O 0 0.002773734275251627
exist O 0 0.004765202756971121
in O 0 0.0028998616617172956
as O 0 0.005148659460246563
- O 0 0.024082941934466362
yet O 0 0.01476992480456829
unidentified O 0 0.059030089527368546
phenotypes O 1 0.9847676157951355
. O 0 0.012425797060132027
. O 0 0.02075672149658203

Genetic O 1 0.9499119520187378
heterogeneity O 1 0.6807250380516052
and O 0 0.012325821444392204
penetrance O 1 0.8206409811973572
analysis O 0 0.01581989787518978
of O 0 0.006070451810956001
the O 0 0.011426080949604511
BRCA1 O 1 0.999756395816803
and O 0 0.021260961890220642
BRCA2 O 1 0.9999783039093018
genes O 1 0.994810938835144
in O 0 0.07364264130592346
breast B-Disease 1 0.9999974966049194
cancer I-Disease 1 0.9999862909317017
families O 0 0.054746270179748535
. O 0 0.024385295808315277

The O 0 0.3129565119743347
Breast B-Disease 1 0.9999971389770508
Cancer I-Disease 1 0.9999922513961792
Linkage O 1 0.9798123836517334
Consortium O 0 0.10873329639434814
. O 0 0.03134838864207268

The O 0 0.014355100691318512
contribution O 0 0.024707959964871407
of O 0 0.014076114632189274
BRCA1 O 1 0.9998284578323364
and O 0 0.015720006078481674
BRCA2 O 1 0.9999772310256958
to O 0 0.048659175634384155
inherited B-Disease 1 0.9999949932098389
breast I-Disease 1 0.9999992847442627
cancer I-Disease 1 0.9999972581863403
was O 0 0.014360249042510986
assessed O 0 0.024865102022886276
by O 0 0.00791520718485117
linkage O 0 0.0838366374373436
and O 0 0.008148329332470894
mutation O 1 0.9951139092445374
analysis O 0 0.013476209715008736
in O 0 0.005895351059734821
237 O 0 0.03179696574807167
families O 0 0.009755432605743408
, O 0 0.0030306875705718994
each O 0 0.002995589282363653
with O 0 0.0025138775818049908
at O 0 0.0037595760077238083
least O 0 0.005916352849453688
four O 0 0.005310167092829943
cases O 0 0.016529394313693047
of O 0 0.015438209287822247
breast B-Disease 1 0.9999988079071045
cancer I-Disease 1 0.9999891519546509
, O 0 0.005182347260415554
collected O 0 0.007012602407485247
by O 0 0.007906004786491394
the O 0 0.027378283441066742
Breast B-Disease 1 0.9999982118606567
Cancer I-Disease 1 0.9999957084655762
Linkage O 1 0.9533634781837463
Consortium O 0 0.0958022028207779
. O 0 0.028127217665314674

Families O 0 0.021674869582057
were O 0 0.004242153838276863
included O 0 0.0056679160334169865
without O 0 0.005830099806189537
regard O 0 0.007076478563249111
to O 0 0.0028858312871307135
the O 0 0.0053759729489684105
occurrence O 0 0.4765838384628296
of O 0 0.013818608596920967
ovarian B-Disease 1 0.9999874830245972
or I-Disease 0 0.018911363556981087
other I-Disease 0 0.01568140648305416
cancers I-Disease 1 0.9999006986618042
. O 0 0.026953767985105515

Overall O 0 0.059948284178972244
, O 0 0.02013481594622135
disease O 1 0.9999308586120605
was O 0 0.011896610260009766
linked O 0 0.05733805149793625
to O 0 0.010513086803257465
BRCA1 O 1 0.9995941519737244
in O 0 0.00637461245059967
an O 0 0.005105332471430302
estimated O 0 0.014346756972372532
52 O 0 0.016152849420905113
% O 0 0.006930146366357803
of O 0 0.0037026326172053814
families O 0 0.009180442430078983
, O 0 0.00426465691998601
to O 0 0.007086590863764286
BRCA2 O 1 0.9997227787971497
in O 0 0.006477906834334135
32 O 0 0.012297606095671654
% O 0 0.0062019177712500095
of O 0 0.0033994039986282587
families O 0 0.007728496100753546
, O 0 0.0026889173313975334
and O 0 0.002411362947896123
to O 0 0.003736568382009864
neither O 0 0.016531387344002724
gene O 0 0.22160425782203674
in O 0 0.004962805192917585
16 O 0 0.009837701916694641
% O 0 0.008869200944900513
( O 0 0.0073537202551960945
95 O 0 0.013800063170492649
% O 0 0.009260857477784157
confidence O 0 0.02297910489141941
interval O 0 0.04589102417230606
[ O 0 0.05977068841457367
CI O 1 0.9848076105117798
] O 0 0.041762612760066986
6 O 0 0.018044685944914818
% O 0 0.012784017249941826
- O 0 0.024236449971795082
28 O 0 0.01745874620974064
% O 0 0.010047880932688713
) O 0 0.007809476461261511
, O 0 0.005530455615371466
suggesting O 0 0.020496318116784096
other O 0 0.010764039121568203
predisposition O 1 0.996665894985199
genes O 1 0.8842670917510986
. O 0 0.031612470746040344

The O 0 0.01581686921417713
majority O 0 0.023026105016469955
( O 0 0.013533002696931362
81 O 0 0.02289532870054245
% O 0 0.009466668590903282
) O 0 0.005606444086879492
of O 0 0.004773509223014116
the O 0 0.02218170277774334
breast B-Disease 1 0.999997615814209
- I-Disease 1 0.9998921155929565
ovarian I-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999961853027344
families O 0 0.024292511865496635
were O 0 0.004499904345721006
due O 0 0.012287590652704239
to O 0 0.007555542513728142
BRCA1 O 1 0.9999204874038696
, O 0 0.004545856267213821
with O 0 0.003833665046840906
most O 0 0.0049360813573002815
others O 0 0.007250465918332338
( O 0 0.008404500782489777
14 O 0 0.009879622608423233
% O 0 0.009737162850797176
) O 0 0.007702907547354698
due O 0 0.013329875655472279
to O 0 0.01247939933091402
BRCA2 O 1 0.9994450211524963
. O 0 0.030694300308823586

Conversely O 0 0.06686612963676453
, O 0 0.005294529255479574
the O 0 0.003980766050517559
majority O 0 0.008237258531153202
of O 0 0.003829376772046089
families O 0 0.008542889729142189
with O 0 0.0055028279311954975
male B-Disease 0 0.07461830973625183
and I-Disease 0 0.00963327381759882
female I-Disease 1 0.9959002137184143
breast I-Disease 1 0.9999971389770508
cancer I-Disease 1 0.9999642372131348
were O 0 0.006227138452231884
due O 0 0.01661357656121254
to O 0 0.012105852365493774
BRCA2 O 1 0.9997944235801697
( O 0 0.02407645434141159
76 O 0 0.050497427582740784
% O 0 0.01976270042359829
) O 0 0.014729693531990051
. O 0 0.016487400978803635

The O 0 0.015142286196351051
largest O 0 0.028249843046069145
proportion O 0 0.03412839397788048
( O 0 0.013811929151415825
67 O 0 0.01959243416786194
% O 0 0.008275983855128288
) O 0 0.004429768305271864
of O 0 0.002757800742983818
families O 0 0.007428235374391079
due O 0 0.007583209779113531
to O 0 0.002638000762090087
other O 0 0.003379839239642024
genes O 0 0.2654738426208496
was O 0 0.0044423253275454044
found O 0 0.0043004779145121574
in O 0 0.002360415179282427
families O 0 0.004999558441340923
with O 0 0.0023217746056616306
four O 0 0.002762491349130869
or O 0 0.004428695421665907
five O 0 0.0053994073532521725
cases O 0 0.012522011063992977
of O 0 0.010139299556612968
female O 1 0.9940841794013977
breast B-Disease 1 0.9999977350234985
cancer I-Disease 1 0.9999685287475586
only O 0 0.0168225709348917
. O 0 0.01988384872674942

These O 0 0.009831485338509083
estimates O 0 0.015297948382794857
were O 0 0.004017069470137358
not O 0 0.004980832803994417
substantially O 0 0.028458580374717712
affected O 0 0.02696172520518303
either O 0 0.007088097278028727
by O 0 0.004541211761534214
changing O 0 0.011418720707297325
the O 0 0.006653688848018646
assumed O 0 0.03482774272561073
penetrance O 1 0.9955617189407349
model O 0 0.021481186151504517
for O 0 0.010722518898546696
BRCA1 O 1 0.9998244643211365
or O 0 0.0076857563108205795
by O 0 0.005877740681171417
including O 0 0.005868745502084494
or O 0 0.012495741248130798
excluding O 0 0.04678988456726074
BRCA1 O 1 0.9997126460075378
mutation O 1 0.9894988536834717
data O 0 0.027817394584417343
. O 0 0.022169003263115883

Among O 0 0.018291033804416656
those O 0 0.008363760076463223
families O 0 0.015635017305612564
with O 0 0.013470468111336231
disease O 1 0.9999880790710449
due O 0 0.04898877069354057
to O 0 0.010788870975375175
BRCA1 O 1 0.9998360872268677
that O 0 0.004768881481140852
were O 0 0.003047334961593151
tested O 0 0.01268147211521864
by O 0 0.0025804019533097744
one O 0 0.00244180322624743
of O 0 0.002277845051139593
the O 0 0.004167910199612379
standard O 0 0.011864514090120792
screening O 0 0.03366062045097351
methods O 0 0.012712039053440094
, O 0 0.008046653121709824
mutations O 1 0.9929587841033936
were O 0 0.005446481518447399
detected O 0 0.028245897963643074
in O 0 0.004098009783774614
the O 0 0.005658832378685474
coding O 0 0.041072748601436615
sequence O 0 0.02221631072461605
or O 0 0.009225779213011265
splice O 0 0.06402914971113205
sites O 0 0.008102248422801495
in O 0 0.0036266925744712353
an O 0 0.004792379681020975
estimated O 0 0.016652090474963188
63 O 0 0.02317618764936924
% O 0 0.011430558748543262
( O 0 0.010649365372955799
95 O 0 0.019766880199313164
% O 0 0.018066687509417534
CI O 1 0.8533821105957031
51 O 0 0.03862335905432701
% O 0 0.01886872947216034
- O 0 0.037521567195653915
77 O 0 0.03979553282260895
% O 0 0.020780857652425766
) O 0 0.01707742176949978
. O 0 0.020006977021694183

The O 0 0.014087860472500324
estimated O 0 0.02436850592494011
sensitivity O 0 0.0362081341445446
was O 0 0.007525816094130278
identical O 0 0.011977683752775192
for O 0 0.004429528024047613
direct O 0 0.011720029637217522
sequencing O 0 0.03045160509645939
and O 0 0.004094300325959921
other O 0 0.004578636027872562
techniques O 0 0.020466966554522514
. O 0 0.017469244077801704

The O 0 0.024121835827827454
penetrance O 1 0.9422225952148438
of O 0 0.017304668202996254
BRCA2 O 1 0.9998549222946167
was O 0 0.012156820856034756
estimated O 0 0.016346752643585205
by O 0 0.007609850727021694
maximizing O 0 0.03561868146061897
the O 0 0.00977142434567213
LOD O 1 0.5098381638526917
score O 0 0.01619519665837288
in O 0 0.014158261939883232
BRCA2 O 1 0.9999585151672363
- O 1 0.9382879734039307
mutation O 1 0.9990888833999634
families O 0 0.014886812306940556
, O 0 0.00437755836173892
over O 0 0.005029683001339436
all O 0 0.00466948002576828
possible O 0 0.015493759885430336
penetrance O 1 0.9759585857391357
functions O 0 0.023260783404111862
. O 0 0.01939622312784195

The O 0 0.015674011781811714
estimated O 0 0.036558520048856735
cumulative O 0 0.4488027095794678
risk O 1 0.9460614919662476
of O 0 0.026894422248005867
breast B-Disease 1 0.9999979734420776
cancer I-Disease 1 0.9999856948852539
reached O 0 0.021825594827532768
28 O 0 0.020066438242793083
% O 0 0.01023581251502037
( O 0 0.009533091448247433
95 O 0 0.020078439265489578
% O 0 0.016164205968379974
CI O 1 0.8700631856918335
9 O 0 0.01802060566842556
% O 0 0.01199444942176342
- O 0 0.022913197055459023
44 O 0 0.01536933146417141
% O 0 0.009150463156402111
) O 0 0.005154932849109173
by O 0 0.004934623837471008
age O 0 0.012175468727946281
50 O 0 0.008634809404611588
years O 0 0.006850090809166431
and O 0 0.004733229987323284
84 O 0 0.02232581563293934
% O 0 0.010775872506201267
( O 0 0.008921345695853233
95 O 0 0.017546920105814934
% O 0 0.01700150966644287
CI O 1 0.9312362670898438
43 O 0 0.023274628445506096
% O 0 0.013182987459003925
- O 0 0.026923663914203644
95 O 0 0.0211311187595129
% O 0 0.011426830664277077
) O 0 0.0076089040376245975
by O 0 0.00633271923288703
age O 0 0.01572304591536522
70 O 0 0.02013861946761608
years O 0 0.014248514547944069
. O 0 0.019542472437024117

The O 0 0.03259342163801193
corresponding O 1 0.8999435901641846
ovarian B-Disease 1 0.9999982118606567
cancer I-Disease 1 0.9999947547912598
risks O 1 0.9779102206230164
were O 0 0.009664883837103844
0 O 0 0.03538806736469269
. O 0 0.01881500892341137

4 O 0 0.03358268365263939
% O 0 0.01636480912566185
( O 0 0.012204056605696678
95 O 0 0.019310513511300087
% O 0 0.015802200883626938
CI O 1 0.9297019839286804
0 O 0 0.024903299286961555
% O 0 0.012333213351666927
- O 0 0.02011473849415779
1 O 0 0.01070582028478384
% O 0 0.007512749172747135
) O 0 0.005275600124150515
by O 0 0.0051219891756772995
age O 0 0.012461742386221886
50 O 0 0.008888166397809982
years O 0 0.006298933178186417
and O 0 0.004053217824548483
27 O 0 0.012824581936001778
% O 0 0.010050124488770962
( O 0 0.009043167345225811
95 O 0 0.018001863732933998
% O 0 0.017030391842126846
CI O 1 0.947536289691925
0 O 0 0.030510099604725838
% O 0 0.013888312503695488
- O 0 0.02611587382853031
47 O 0 0.02296748012304306
% O 0 0.011370990425348282
) O 0 0.007133278995752335
by O 0 0.006542660761624575
age O 0 0.018705448135733604
70 O 0 0.022574203088879585
years O 0 0.01879003830254078
. O 0 0.021849429234862328

The O 0 0.023446738719940186
lifetime O 0 0.39853838086128235
risk O 1 0.9555180668830872
of O 0 0.03893326595425606
breast B-Disease 1 0.9999979734420776
cancer I-Disease 1 0.999994158744812
appears O 0 0.16215717792510986
similar O 0 0.010493798181414604
to O 0 0.003432949772104621
the O 0 0.006600364577025175
risk O 1 0.9043903946876526
in O 0 0.012610686011612415
BRCA1 O 1 0.9999836683273315
carriers O 1 0.9003337621688843
, O 0 0.00494209211319685
but O 0 0.0035225865431129932
there O 0 0.002720816759392619
was O 0 0.0032972563058137894
some O 0 0.0028817548882216215
suggestion O 0 0.008369254879653454
of O 0 0.003144211834296584
a O 0 0.007830078713595867
lower O 0 0.02050863206386566
risk O 1 0.8706026077270508
in O 0 0.01545430812984705
BRCA2 O 1 0.9999775886535645
carriers O 1 0.9951992630958557
< O 1 0.977452278137207
50 O 0 0.01468962337821722
years O 0 0.009108716621994972
of O 0 0.007818721234798431
age O 0 0.02991001307964325
. O 0 0.01923050545156002

Eye B-Disease 1 0.9978246688842773
movement I-Disease 1 0.5313606858253479
abnormalities I-Disease 1 0.999640941619873
correlate O 0 0.1585122048854828
with O 0 0.017566626891493797
genotype O 1 0.996191143989563
in O 0 0.02388267032802105
autosomal O 1 0.9999436140060425
dominant O 1 0.9965672492980957
cerebellar B-Disease 1 0.9999158382415771
ataxia I-Disease 1 0.9999794960021973
type I-Disease 1 0.9765719175338745
I I-Disease 0 0.042895130813121796
. O 0 0.026018531993031502

We O 0 0.014935926534235477
compared O 0 0.03300555795431137
horizontal O 0 0.36951589584350586
eye O 1 0.9853401780128479
movements O 0 0.03169345483183861
( O 0 0.0170532688498497
visually O 0 0.055721215903759
guided O 0 0.039383381605148315
saccades O 1 0.9984839558601379
, O 0 0.013600068166851997
antisaccades O 1 0.939545214176178
, O 0 0.006411212962120771
and O 0 0.0054424903355538845
smooth O 0 0.03275268152356148
pursuit O 0 0.029190558940172195
) O 0 0.0075771622359752655
in O 0 0.004597606603056192
control O 0 0.01563001051545143
subjects O 0 0.016543803736567497
( O 0 0.011740637943148613
n O 0 0.0299067385494709
= O 0 0.03625871241092682
14 O 0 0.01034536212682724
) O 0 0.005683674942702055
and O 0 0.004349655006080866
patients O 1 0.9891040325164795
with O 0 0.0031522917561233044
three O 0 0.00373684405349195
forms O 0 0.011368599720299244
of O 0 0.011149028316140175
autosomal O 1 0.9999657869338989
dominant O 1 0.9940192699432373
cerebellar B-Disease 1 0.9999146461486816
ataxias I-Disease 1 0.9994076490402222
type I-Disease 1 0.968616247177124
I I-Disease 1 0.5066778063774109
spinocerebellar B-Disease 1 0.9998598098754883
ataxias I-Disease 1 0.9906704425811768
1 I-Disease 0 0.014674460515379906
and I-Disease 0 0.004655242431908846
2 I-Disease 0 0.01160765253007412
( O 0 0.012640091590583324
SCA1 B-Disease 1 0.9788594245910645
, O 0 0.009261639788746834
n O 0 0.03568829596042633
= O 0 0.037243276834487915
11 O 0 0.014774896204471588
; O 0 0.01084812544286251
SCA2 B-Disease 1 0.9552416205406189
, O 0 0.008238213136792183
n O 0 0.0333070270717144
= O 0 0.03285812959074974
10 O 0 0.010051637887954712
) O 0 0.008079956285655499
and O 0 0.007769081741571426
SCA3 B-Disease 1 0.9981343150138855
/ O 1 0.8016812205314636
Machado B-Disease 1 0.8916391730308533
- I-Disease 0 0.2579863369464874
Joseph I-Disease 1 0.943716287612915
disease I-Disease 1 0.9999898672103882
( O 0 0.048078753054142
MJD B-Disease 1 0.9985228180885315
) O 0 0.015730634331703186
( O 0 0.01610519364476204
n O 0 0.0383220873773098
= O 0 0.04504474252462387
16 O 0 0.016776449978351593
) O 0 0.012952286750078201
. O 0 0.016687599942088127

In O 0 0.028716938570141792
SCA1 B-Disease 1 0.9744393229484558
, O 0 0.019428566098213196
saccade O 1 0.977919340133667
amplitude O 0 0.07754940539598465
was O 0 0.013983705081045628
significantly O 0 0.035374198108911514
increased O 0 0.02181355282664299
, O 0 0.008926980197429657
resulting O 0 0.03460853174328804
in O 0 0.014479936100542545
hypermetria B-Disease 1 0.8062388300895691
. O 0 0.028754327446222305

The O 0 0.021593106910586357
smooth O 0 0.05101773887872696
pursuit O 0 0.04477822035551071
gain O 0 0.027680348604917526
was O 0 0.017910517752170563
decreased O 0 0.17458024621009827
. O 0 0.02438409812748432

In O 0 0.028347371146082878
SCA2 B-Disease 1 0.9449334740638733
, O 0 0.020705077797174454
saccade O 1 0.9434946179389954
velocity O 0 0.06044870242476463
was O 0 0.02080450765788555
markedly O 0 0.2957233190536499
decreased O 0 0.4123404324054718
. O 0 0.029001569375395775

The O 0 0.012814988382160664
percentage O 0 0.016937199980020523
of O 0 0.006093661766499281
errors O 0 0.020843274891376495
in O 0 0.009112376719713211
antisaccades O 1 0.8400430679321289
was O 0 0.010442109778523445
greatly O 0 0.021048901602625847
increased O 0 0.011498812586069107
and O 0 0.0037508655805140734
was O 0 0.007774715311825275
significantly O 0 0.02943487837910652
correlated O 0 0.04835290461778641
with O 0 0.008223317563533783
age O 0 0.028404168784618378
at O 0 0.028948118910193443
disease O 1 0.9999850988388062
onset O 1 0.9997493624687195
. O 0 0.03559612110257149

In O 0 0.011149521917104721
addition O 0 0.009823638014495373
, O 0 0.0047046104446053505
a O 0 0.00889085978269577
correlation O 0 0.03108745440840721
between O 0 0.010557718575000763
smooth O 0 0.026998914778232574
pursuit O 0 0.026424892246723175
gain O 0 0.012221859768033028
and O 0 0.0027913630474358797
the O 0 0.0035626208409667015
number O 0 0.00544757442548871
of O 0 0.007283300627022982
trinucleotide O 1 0.996127188205719
repeats O 0 0.08160971850156784
was O 0 0.011569731868803501
found O 0 0.013206878677010536
. O 0 0.016603855416178703

In O 0 0.027508346363902092
SCA3 B-Disease 1 0.9976784586906433
, O 0 0.015658922493457794
gaze B-Disease 1 0.9839659929275513
- I-Disease 1 0.79510098695755
evoked I-Disease 1 0.994419515132904
nystagmus I-Disease 1 0.9998388290405273
was O 0 0.01155092753469944
often O 0 0.009455282241106033
present O 0 0.006507500074803829
as O 0 0.005186406895518303
was O 0 0.010484232567250729
saccade O 1 0.9901896119117737
hypometria O 1 0.8372451663017273
and O 0 0.008749349042773247
smooth O 0 0.038552507758140564
pursuit O 0 0.035203564912080765
gain O 0 0.024908117949962616
was O 0 0.01776532270014286
markedly O 1 0.7753896713256836
decreased O 0 0.3673332631587982
. O 0 0.02491612918674946

Three O 0 0.01391796488314867
major O 0 0.01879793033003807
criteria O 0 0.019587039947509766
, O 0 0.0111016146838665
saccade O 1 0.9378975033760071
amplitude O 0 0.09084975719451904
, O 0 0.012745367363095284
saccade O 1 0.8935264945030212
velocity O 0 0.03638719767332077
, O 0 0.004590436816215515
and O 0 0.003995018545538187
presence O 0 0.013051558285951614
of O 0 0.0077467793598771095
gaze B-Disease 1 0.9833022952079773
- I-Disease 1 0.8863297700881958
evoked I-Disease 1 0.9942605495452881
nystagmus I-Disease 1 0.9995799660682678
, O 0 0.007192838005721569
permitted O 0 0.00981136504560709
the O 0 0.005758419632911682
correct O 0 0.020202767103910446
assignment O 0 0.01870175637304783
of O 0 0.004096768330782652
90 O 0 0.012354264035820961
% O 0 0.0064018224366009235
of O 0 0.0031147939153015614
the O 0 0.006624668370932341
SCA1 B-Disease 1 0.990420401096344
, O 0 0.005137527361512184
90 O 0 0.010371297597885132
% O 0 0.005664945114403963
of O 0 0.0028385899495333433
the O 0 0.006882783025503159
SCA2 B-Disease 1 0.9909399747848511
, O 0 0.0046943663619458675
and O 0 0.0034839403815567493
93 O 0 0.014440642669796944
% O 0 0.006962272338569164
of O 0 0.004071311093866825
the O 0 0.009357237257063389
patients O 1 0.9988803267478943
with O 0 0.009834209457039833
SCA3 B-Disease 1 0.9960023760795593
to O 0 0.006044619716703892
their O 0 0.007497444748878479
genetically O 0 0.4581219255924225
confirmed O 0 0.2843268811702728
patient O 1 0.9973656535148621
group O 0 0.009127982892096043
and O 0 0.003190115327015519
, O 0 0.0030749328434467316
therefore O 0 0.005194907542318106
, O 0 0.003621441312134266
may O 0 0.007392702624201775
help O 0 0.012602304108440876
orient O 0 0.07261792570352554
diagnoses O 1 0.9954394698143005
of O 0 0.011974247172474861
SCA1 B-Disease 1 0.9982362985610962
, O 0 0.011757918633520603
SCA2 B-Disease 1 0.9951280355453491
, O 0 0.006497460417449474
and O 0 0.006490224506705999
SCA3 B-Disease 1 0.9933010339736938
at O 0 0.009235450997948647
early O 0 0.013910132460296154
clinical O 1 0.6956239938735962
stages O 0 0.021313948556780815
of O 0 0.005766661837697029
the O 0 0.010816407389938831
diseases O 1 0.9999442100524902
. O 0 0.011714452877640724
. O 0 0.016483575105667114

Genetic O 0 0.2081328183412552
basis O 0 0.010628259740769863
and O 0 0.00602775439620018
molecular O 0 0.037136729806661606
mechanism O 0 0.0401400551199913
for O 0 0.026989152655005455
idiopathic B-Disease 1 0.9999955892562866
ventricular I-Disease 1 0.9999886751174927
fibrillation I-Disease 1 0.9999709129333496
. O 0 0.047773320227861404

Ventricular B-Disease 1 0.9999545812606812
fibrillation I-Disease 1 0.9999774694442749
causes O 1 0.9971039891242981
more O 0 0.007912829518318176
than O 0 0.007586713880300522
300 O 0 0.014298832975327969
, O 0 0.007267238572239876
000 O 0 0.08606377989053726
sudden O 1 0.9935944676399231
deaths O 1 0.5729443430900574
each O 0 0.006311881821602583
year O 0 0.007019215729087591
in O 0 0.005104369018226862
the O 0 0.007337437942624092
USA O 0 0.03545187786221504
alone O 0 0.02731734700500965
. O 0 0.021328214555978775

In O 0 0.011543907225131989
approximately O 0 0.017477087676525116
5 O 0 0.015255681239068508
- O 0 0.01729385368525982
12 O 0 0.00838693417608738
% O 0 0.005377031862735748
of O 0 0.0026061285752803087
these O 0 0.002985690487548709
cases O 0 0.009366684593260288
, O 0 0.0024922736920416355
there O 0 0.0023633793462067842
are O 0 0.002359763951972127
no O 0 0.007004952989518642
demonstrable O 1 0.9993701577186584
cardiac O 1 0.9999774694442749
or O 0 0.01483343355357647
non O 0 0.2513984143733978
- O 1 0.9954421520233154
cardiac O 1 0.9999912977218628
causes O 1 0.9968710541725159
to O 0 0.003724142210558057
account O 0 0.006367702968418598
for O 0 0.003085422096773982
the O 0 0.0044480254873633385
episode O 0 0.017472043633461
, O 0 0.0034173130989074707
which O 0 0.003341347211971879
is O 0 0.004386680666357279
therefore O 0 0.007858133874833584
classified O 0 0.019128920510411263
as O 0 0.021548232063651085
idiopathic B-Disease 1 0.9999972581863403
ventricular I-Disease 1 0.9999914169311523
fibrillation I-Disease 1 0.9999923706054688
( O 0 0.41252243518829346
IVF B-Disease 1 0.9989640712738037
) O 0 0.03185516595840454
. O 0 0.027971535921096802

A O 0 0.024371715262532234
distinct O 0 0.02480141632258892
group O 0 0.013641184195876122
of O 0 0.010173100046813488
IVF B-Disease 1 0.9999613761901855
patients O 1 0.9998849630355835
has O 0 0.007096945773810148
been O 0 0.0041353642009198666
found O 0 0.004585298243910074
to O 0 0.002180876675993204
present O 0 0.004222836345434189
with O 0 0.004548609256744385
a O 0 0.013089817948639393
characteristic O 0 0.2883656919002533
electrocardiographic O 1 0.9881606101989746
pattern O 0 0.09998879581689835
. O 0 0.024662815034389496

Because O 0 0.015380960889160633
of O 0 0.004126278217881918
the O 0 0.00492323050275445
small O 0 0.00740162655711174
size O 0 0.0077738030813634396
of O 0 0.0034293222706764936
most O 0 0.005331514403223991
pedigrees O 0 0.06906843185424805
and O 0 0.0031154006719589233
the O 0 0.004912267439067364
high O 0 0.01421863492578268
incidence O 1 0.9967824220657349
of O 0 0.010399590246379375
sudden B-Disease 1 0.9993684887886047
death I-Disease 1 0.6630828380584717
, O 0 0.004933408927172422
however O 0 0.0058011459186673164
, O 0 0.005354118999093771
molecular O 0 0.03300771117210388
genetic O 0 0.22209875285625458
studies O 0 0.01003756932914257
of O 0 0.005479531828314066
IVF B-Disease 1 0.9992082715034485
have O 0 0.004235857632011175
not O 0 0.003217601915821433
yet O 0 0.006925291381776333
been O 0 0.006561072077602148
done O 0 0.012014513835310936
. O 0 0.014929515309631824

Because O 0 0.10228566080331802
IVF B-Disease 1 0.999516487121582
causes O 1 0.9998273849487305
cardiac O 1 0.9999780654907227
rhythm O 1 0.9976835250854492
disturbance O 1 0.9579373002052307
, O 0 0.006235429085791111
we O 0 0.00514525081962347
investigated O 0 0.02158774808049202
whether O 0 0.011484631337225437
malfunction O 1 0.8686213493347168
of O 0 0.007025626953691244
ion O 0 0.05105733871459961
channels O 0 0.018949933350086212
could O 0 0.00957550760358572
cause O 1 0.7551824450492859
the O 0 0.011707411147654057
disorder O 1 0.999936580657959
by O 0 0.009206147864460945
studying O 0 0.017775578424334526
mutations O 1 0.9925311207771301
in O 0 0.006996966898441315
the O 0 0.012260361574590206
cardiac O 1 0.9997395873069763
sodium O 1 0.7449894547462463
channel O 0 0.07048779726028442
gene O 1 0.9321559071540833
SCN5A O 1 0.9520485997200012
. O 0 0.034299544990062714

We O 0 0.009344437159597874
have O 0 0.005449801683425903
now O 0 0.0070138536393642426
identified O 0 0.016964716836810112
a O 0 0.016926661133766174
missense O 1 0.9941423535346985
mutation O 1 0.9952455163002014
, O 0 0.007762262597680092
a O 0 0.01627372018992901
splice O 1 0.9637190699577332
- O 0 0.26340383291244507
donor O 1 0.9855339527130127
mutation O 1 0.9981398582458496
, O 0 0.005690745078027248
and O 0 0.003665560856461525
a O 0 0.01477015484124422
frameshift O 1 0.9995056390762329
mutation O 1 0.998100221157074
in O 0 0.0048385970294475555
the O 0 0.005997844971716404
coding O 0 0.04363401606678963
region O 0 0.013442899100482464
of O 0 0.0064661758951842785
SCN5A O 1 0.988315999507904
in O 0 0.008467544801533222
three O 0 0.014113029465079308
IVF B-Disease 1 0.9953193068504333
families O 0 0.03789565712213516
. O 0 0.0238018985837698

We O 0 0.009270061738789082
show O 0 0.011570647358894348
that O 0 0.0051774499006569386
sodium O 0 0.03764114901423454
channels O 0 0.012448263354599476
with O 0 0.004811450839042664
the O 0 0.01129692792892456
missense O 1 0.9984984397888184
mutation O 1 0.9995706677436829
recover O 1 0.9251509308815002
from O 0 0.015779057517647743
inactivation O 1 0.9879717230796814
more O 0 0.008676481433212757
rapidly O 0 0.022031119093298912
than O 0 0.005527379922568798
normal O 0 0.01102200336754322
and O 0 0.0023439996875822544
that O 0 0.003022722201421857
the O 0 0.009742675349116325
frameshift O 1 0.9998589754104614
mutation O 1 0.9998682737350464
causes O 1 0.990330696105957
the O 0 0.008645149879157543
sodium O 0 0.144647479057312
channel O 0 0.014351957477629185
to O 0 0.0032557097729295492
be O 0 0.004278755281120539
non O 0 0.0199965201318264
- O 0 0.03677248954772949
functional O 0 0.048676006495952606
. O 0 0.018684053793549538

Our O 0 0.01697458140552044
results O 0 0.021358532831072807
indicate O 0 0.017828436568379402
that O 0 0.007952171377837658
mutations O 1 0.9961857199668884
in O 0 0.012942152097821236
cardiac O 1 0.9999139308929443
ion O 1 0.5724217891693115
- O 0 0.047352034598588943
channel O 0 0.03490302711725235
genes O 0 0.0633430927991867
contribute O 0 0.01585341803729534
to O 0 0.003646586090326309
the O 0 0.0056983912363648415
risk O 0 0.20731063187122345
of O 0 0.007802536711096764
developing O 0 0.09462232142686844
IVF B-Disease 1 0.9965527057647705
. O 0 0.015044423751533031
. O 0 0.01878686621785164

Molecular O 0 0.10323118418455124
heterogeneity O 1 0.5001592636108398
in O 0 0.013611195608973503
mucopolysaccharidosis B-Disease 1 0.9941942095756531
IVA I-Disease 1 0.9968752861022949
in O 0 0.005858041811734438
Australia O 0 0.007627996616065502
and O 0 0.0036517546977847815
Northern O 0 0.010923140682280064
Ireland O 0 0.01482805423438549
: O 0 0.00787716917693615
nine O 0 0.010805075988173485
novel O 0 0.03911518678069115
mutations O 1 0.9964714050292969
including O 0 0.010206473059952259
T312S O 1 0.9462921023368835
, O 0 0.005572643131017685
a O 0 0.00883450172841549
common O 0 0.02098148874938488
allele O 1 0.9940696954727173
that O 0 0.009111018851399422
confers O 1 0.8584816455841064
a O 0 0.04709702730178833
mild O 1 0.9996844530105591
phenotype O 1 0.9997574687004089
. O 0 0.029882090166211128

Mucopolysaccharidosis B-Disease 1 0.9841070175170898
IVA I-Disease 1 0.9969022274017334
( O 0 0.039744455367326736
MPS B-Disease 1 0.9269587993621826
IVA I-Disease 1 0.9986127614974976
) O 0 0.013713628984987736
is O 0 0.008872667327523232
an O 0 0.01792425848543644
autosomal B-Disease 1 0.9999864101409912
recessive I-Disease 1 0.9999933242797852
lysosomal I-Disease 1 0.9998939037322998
storage I-Disease 1 0.9523344039916992
disorder I-Disease 1 0.9999908208847046
caused O 1 0.9827510714530945
by O 0 0.00839942041784525
a O 0 0.015816856175661087
genetic B-Disease 1 0.9968928098678589
defect I-Disease 1 0.9985893368721008
in O 0 0.011072050780057907
N O 0 0.12074863910675049
- O 0 0.13696734607219696
acetylgalactosamine O 1 0.9902355074882507
- O 0 0.06875253468751907
6 O 0 0.04005327820777893
- O 0 0.14529865980148315
sulfate O 1 0.9723787903785706
sulfatase O 1 0.9958156943321228
( O 0 0.048863451927900314
GALNS O 1 0.9678086042404175
) O 0 0.029032176360487938
. O 0 0.024712923914194107

Previous O 0 0.023163089528679848
studies O 0 0.015385279431939125
of O 0 0.008518898859620094
patients O 1 0.9944713115692139
from O 0 0.0075699398294091225
a O 0 0.010847936384379864
British O 0 0.01925765536725521
- O 0 0.030223669484257698
Irish O 0 0.03107895515859127
population O 0 0.01751687563955784
showed O 0 0.014553839340806007
that O 0 0.004722244571894407
the O 0 0.008037896826863289
I113F O 1 0.9932758808135986
mutation O 1 0.9955820441246033
is O 0 0.0057303281500935555
the O 0 0.004266578704118729
most O 0 0.005598453339189291
common O 0 0.013893994502723217
single O 0 0.023179983720183372
mutation O 1 0.9990636706352234
among O 0 0.02231343276798725
MPS B-Disease 1 0.9945974349975586
IVA I-Disease 1 0.9999401569366455
patients O 1 0.9996364116668701
and O 0 0.00941756647080183
produces O 0 0.050685346126556396
a O 0 0.03694964572787285
severe O 1 0.9997842907905579
clinical O 1 0.9970455765724182
phenotype O 1 0.9993815422058105
. O 0 0.03185495734214783

We O 0 0.01654147356748581
studied O 0 0.024544715881347656
mutations O 1 0.8381425738334656
in O 0 0.006522202864289284
the O 0 0.010568185709416866
GALNS O 1 0.9929468035697937
gene O 0 0.3662818372249603
from O 0 0.010523766279220581
23 O 0 0.01921723410487175
additional O 0 0.017952097579836845
MPS B-Disease 1 0.932693600654602
IVA I-Disease 1 0.9998593330383301
patients O 1 0.999407172203064
( O 0 0.01238490454852581
15 O 0 0.008169417269527912
from O 0 0.005072103813290596
Australia O 0 0.00803651288151741
, O 0 0.003936672583222389
8 O 0 0.00791303999722004
from O 0 0.0048986137844622135
Northern O 0 0.011425137519836426
Ireland O 0 0.013584360480308533
) O 0 0.006798902526497841
, O 0 0.003267747350037098
with O 0 0.0037756231613457203
various O 0 0.007227242924273014
clinical O 1 0.9960948824882507
phenotypes O 1 0.9995788931846619
( O 0 0.08854705840349197
severe O 1 0.9997691512107849
, O 0 0.0055631413124501705
16 O 0 0.011693566106259823
cases O 0 0.01788964308798313
; O 0 0.006911597680300474
intermediate O 0 0.01562286727130413
, O 0 0.004904218949377537
4 O 0 0.011359497904777527
cases O 0 0.02041609399020672
; O 0 0.012300791218876839
mild O 1 0.9933912754058838
, O 0 0.007626495789736509
3 O 0 0.01621687225997448
cases O 0 0.02160361222922802
) O 0 0.011282098479568958
. O 0 0.015275854617357254

We O 0 0.009445618838071823
found O 0 0.00838763639330864
two O 0 0.004872623365372419
common O 0 0.01914723962545395
mutations O 1 0.9941871166229248
that O 0 0.0032039068173617125
together O 0 0.004708250053226948
accounted O 0 0.013845471665263176
for O 0 0.003997195977717638
32 O 0 0.01017012819647789
% O 0 0.0059922304935753345
of O 0 0.0029733325354754925
the O 0 0.005148571450263262
44 O 0 0.019457243382930756
unrelated O 0 0.10739157348871231
alleles O 1 0.9769456386566162
in O 0 0.008949738927185535
these O 0 0.010913733392953873
patients O 1 0.9981303811073303
. O 0 0.022681448608636856

One O 0 0.013631564565002918
is O 0 0.00862109661102295
the O 0 0.011510117910802364
T312S O 1 0.9945259690284729
mutation O 1 0.9978592991828918
, O 0 0.007209177128970623
a O 0 0.013913501985371113
novel O 0 0.04589694365859032
mutation O 1 0.9966155886650085
found O 0 0.016013292595744133
exclusively O 0 0.016317006200551987
in O 0 0.014052774757146835
milder O 1 0.996067225933075
patients O 1 0.9976502060890198
. O 0 0.030414702370762825

The O 0 0.009471799246966839
other O 0 0.004122666548937559
is O 0 0.004160757642239332
the O 0 0.004411601927131414
previously O 0 0.009478382766246796
described O 0 0.019660765305161476
I113F O 1 0.7507089376449585
that O 0 0.008489970117807388
produces O 0 0.04141829162836075
a O 0 0.03148610517382622
severe O 1 0.9995019435882568
phenotype O 1 0.9996449947357178
. O 0 0.030956773087382317

The O 0 0.022775281220674515
I113F O 1 0.8462451100349426
and O 0 0.012969635426998138
T312S O 1 0.992510199546814
mutations O 1 0.9973037242889404
accounted O 0 0.0251458752900362
for O 0 0.00581160606816411
8 O 0 0.011295287869870663
( O 0 0.007954180240631104
18 O 0 0.008578681387007236
% O 0 0.008252169005572796
) O 0 0.005664526019245386
and O 0 0.003693214152008295
6 O 0 0.010901623405516148
( O 0 0.007871639914810658
14 O 0 0.008548492565751076
% O 0 0.00666638882830739
) O 0 0.0043599288910627365
of O 0 0.003964622970670462
44 O 0 0.02190380170941353
unrelated O 0 0.10572901368141174
alleles O 1 0.9826337695121765
, O 0 0.011845901608467102
respectively O 0 0.023069363087415695
. O 0 0.01850752905011177

The O 0 0.016735481098294258
relatively O 0 0.025191493332386017
high O 0 0.019968735054135323
residual O 1 0.8780511021614075
GALNS O 1 0.9920126795768738
activity O 0 0.02469380758702755
seen O 0 0.01682521589100361
when O 0 0.009084808640182018
the O 0 0.01209685206413269
T312S O 1 0.9487689733505249
mutant O 1 0.8916449546813965
cDNA O 0 0.09926252067089081
is O 0 0.018256688490509987
overexpressed O 1 0.9136310815811157
in O 0 0.013654593378305435
mutant O 1 0.9742608666419983
cells O 0 0.07243464142084122
provides O 0 0.010813387110829353
an O 0 0.0050817676819860935
explanation O 0 0.01108982227742672
for O 0 0.004786261823028326
the O 0 0.009792938828468323
mild O 1 0.9995915293693542
phenotype O 1 0.9999233484268188
in O 0 0.012367069721221924
patients O 1 0.9992941617965698
with O 0 0.0072942026890814304
this O 0 0.011574339121580124
mutation O 1 0.9982144832611084
. O 0 0.02359950914978981

The O 0 0.011137183755636215
distribution O 0 0.012341480702161789
and O 0 0.004207928199321032
relative O 0 0.014139744453132153
frequencies O 0 0.014160074293613434
of O 0 0.003882242599502206
the O 0 0.00763365114107728
I113F O 1 0.853204071521759
and O 0 0.010412214323878288
T312S O 1 0.9980695843696594
mutations O 1 0.998072624206543
in O 0 0.005916653200984001
Australia O 0 0.008466941304504871
corresponded O 0 0.018314732238650322
to O 0 0.003315071575343609
those O 0 0.0034006000496447086
observed O 0 0.010141654871404171
in O 0 0.0030434478539973497
Northern O 0 0.00800937507301569
Ireland O 0 0.007861465215682983
and O 0 0.0022287480533123016
are O 0 0.0020008657593280077
unique O 0 0.004218453541398048
to O 0 0.0017320273909717798
these O 0 0.0020108502358198166
two O 0 0.002669811947271228
populations O 0 0.01975226402282715
, O 0 0.003551364876329899
suggesting O 0 0.011762866750359535
that O 0 0.0030672538559883833
both O 0 0.005332703702151775
mutations O 1 0.9841152429580688
were O 0 0.003967700991779566
probably O 0 0.009214596822857857
introduced O 0 0.00754935946315527
to O 0 0.0028360416181385517
Australia O 0 0.006703538820147514
by O 0 0.005522058345377445
Irish O 0 0.02039237692952156
migrants O 0 0.01754908077418804
during O 0 0.008766904473304749
the O 0 0.005772740114480257
19th O 0 0.016241537407040596
century O 0 0.019487900659441948
. O 0 0.019231434911489487

Haplotype O 1 0.9725339412689209
analysis O 0 0.02721044421195984
using O 0 0.01289072073996067
6 O 0 0.021635711193084717
RFLPs O 0 0.25809040665626526
provides O 0 0.012613862752914429
additional O 0 0.00684955483302474
data O 0 0.005320195574313402
that O 0 0.004487419500946999
the O 0 0.01034982968121767
I113F O 1 0.9923382997512817
mutation O 1 0.9957677125930786
originated O 0 0.02843097597360611
from O 0 0.007877299562096596
a O 0 0.014240768738090992
common O 0 0.0256666149944067
ancestor O 0 0.2347269207239151
. O 0 0.023979127407073975

The O 0 0.009496871381998062
other O 0 0.0061285728588700294
9 O 0 0.020143939182162285
novel O 0 0.03722579777240753
mutations O 1 0.9927156567573547
identified O 0 0.014565751887857914
in O 0 0.0038010713178664446
these O 0 0.004454372450709343
23 O 0 0.020237604156136513
patients O 1 0.9911989569664001
were O 0 0.0026617860421538353
each O 0 0.0036825970746576786
limited O 0 0.005091255996376276
to O 0 0.0027054224628955126
a O 0 0.007175486069172621
single O 0 0.01738998293876648
family O 0 0.026872938498854637
. O 0 0.019427871331572533

These O 0 0.007811704184859991
data O 0 0.006994744762778282
provide O 0 0.005903211887925863
further O 0 0.005222679581493139
evidence O 0 0.0055806394666433334
for O 0 0.005192961078137159
extensive O 0 0.031063100323081017
allelic O 1 0.9708775281906128
heterogeneity O 1 0.6647908687591553
in O 0 0.011971155181527138
MPS B-Disease 1 0.7117397785186768
IVA I-Disease 1 0.9986028075218201
in O 0 0.011250505223870277
British O 0 0.02793600596487522
- O 0 0.1738511323928833
Irish O 1 0.6736231446266174
patients O 1 0.9991436004638672
and O 0 0.003820093348622322
provide O 0 0.005033094901591539
evidence O 0 0.00391450384631753
for O 0 0.0025105078238993883
their O 0 0.0035614289809018373
transmission O 0 0.024063602089881897
to O 0 0.003055847715586424
Australia O 0 0.006254024803638458
by O 0 0.00605024304240942
British O 0 0.019033918157219887
- O 0 0.03144851326942444
Irish O 0 0.03536125645041466
migrants O 0 0.030253848060965538
. O 0 0.0109767597168684
. O 0 0.018642107024788857

Identification O 0 0.03853229805827141
of O 0 0.012452485039830208
constitutional O 0 0.05112219229340553
WT1 O 1 0.999883770942688
mutations O 1 0.9990653395652771
, O 0 0.007685428950935602
in O 0 0.008729752153158188
patients O 1 0.9995582699775696
with O 0 0.012048181146383286
isolated O 1 0.9984839558601379
diffuse B-Disease 1 0.9999682903289795
mesangial I-Disease 1 0.9999947547912598
sclerosis I-Disease 1 0.999998927116394
, O 0 0.009862219914793968
and O 0 0.0052021099254488945
analysis O 0 0.012671563774347305
of O 0 0.010836798697710037
genotype O 1 0.9995810389518738
/ O 1 0.9960430860519409
phenotype O 1 0.99953293800354
correlations O 0 0.03878436237573624
by O 0 0.00553561607375741
use O 0 0.004726258106529713
of O 0 0.0044778697192668915
a O 0 0.014045879244804382
computerized O 1 0.7842389941215515
mutation O 1 0.990947425365448
database O 0 0.05642121285200119
. O 0 0.028743168339133263

Constitutional O 0 0.054224997758865356
mutations O 1 0.8806617856025696
of O 0 0.009057797491550446
the O 0 0.016677124425768852
WT1 O 1 0.9990007281303406
gene O 1 0.6949203014373779
, O 0 0.00889174547046423
encoding O 0 0.03163173422217369
a O 0 0.016747096553444862
zinc O 1 0.551707923412323
- O 0 0.06474246829748154
finger O 1 0.7981956601142883
transcription O 0 0.16552506387233734
factor O 0 0.04016686603426933
involved O 0 0.019257070496678352
in O 0 0.01265272032469511
renal O 1 0.9999936819076538
and O 0 0.01098750252276659
gonadal O 1 0.9994544386863708
development O 0 0.010269004851579666
, O 0 0.0033318516798317432
are O 0 0.002528921002522111
found O 0 0.0053626783192157745
in O 0 0.004160278011113405
most O 0 0.008571570739150047
patients O 1 0.9976162910461426
with O 0 0.015490603633224964
Denys B-Disease 1 0.9997019171714783
- I-Disease 1 0.9968351721763611
Drash I-Disease 1 0.9998804330825806
syndrome I-Disease 1 0.9999991655349731
( O 0 0.16026388108730316
DDS B-Disease 1 0.9994397759437561
) O 0 0.01600266806781292
, O 0 0.009209283627569675
or O 0 0.030126294121146202
diffuse B-Disease 1 0.9998341798782349
mesangial I-Disease 1 0.9999946355819702
sclerosis I-Disease 1 0.9999995231628418
( O 0 0.39228126406669617
DMS B-Disease 1 0.9991372227668762
) O 0 0.012792035937309265
associated O 0 0.013756482861936092
with O 0 0.007429163902997971
pseudohermaphroditism B-Disease 1 0.9955857992172241
and O 0 0.010814719833433628
/ O 1 0.8789626955986023
or O 0 0.06967366486787796
Wilms B-Disease 1 0.999957799911499
tumor I-Disease 1 0.9999731779098511
( O 0 0.05690332129597664
WT B-Disease 1 0.9970408082008362
) O 0 0.025055281817913055
. O 0 0.020358750596642494

Most O 0 0.03093811869621277
mutations O 1 0.9960926175117493
in O 0 0.022779086604714394
DDS B-Disease 1 0.999909520149231
patients O 1 0.999503493309021
lie O 0 0.026137886568903923
in O 0 0.010203509591519833
exon O 0 0.21843774616718292
8 O 0 0.020300766453146935
or O 0 0.01367584802210331
exon O 0 0.08671101927757263
9 O 0 0.01803649216890335
, O 0 0.007062166463583708
encoding O 0 0.0434265062212944
zinc O 1 0.6063908338546753
finger O 0 0.4238818883895874
2 O 0 0.017117995768785477
or O 0 0.014294431544840336
zinc O 1 0.7495301961898804
finger O 1 0.6465958952903748
3 O 0 0.01321765873581171
, O 0 0.0038666019681841135
respectively O 0 0.006716904230415821
, O 0 0.0023253674153238535
with O 0 0.002877640537917614
a O 0 0.007650951389223337
hot O 0 0.029784444719552994
spot O 0 0.026359643787145615
( O 0 0.015874573960900307
R394W O 1 0.8058770298957825
) O 0 0.010231604799628258
in O 0 0.00978571455925703
exon O 0 0.11350224167108536
9 O 0 0.028912903741002083
. O 0 0.019728492945432663

We O 0 0.011249487288296223
analyzed O 0 0.02234545722603798
a O 0 0.008900836110115051
series O 0 0.00987810268998146
of O 0 0.00507903890684247
24 O 0 0.019480708986520767
patients O 1 0.9983267188072205
, O 0 0.0046165394596755505
10 O 0 0.007906166836619377
with O 0 0.007594374939799309
isolated B-Disease 1 0.8474844694137573
DMS I-Disease 1 0.9995836615562439
( O 0 0.03293726220726967
IDMS B-Disease 1 0.9995061159133911
) O 0 0.009580959565937519
, O 0 0.004455632995814085
10 O 0 0.007709810044616461
with O 0 0.007343204692006111
DDS B-Disease 1 0.9977694749832153
, O 0 0.0053826323710381985
and O 0 0.004351218696683645
4 O 0 0.011807393282651901
with O 0 0.010659800842404366
urogenital B-Disease 1 0.999799907207489
abnormalities I-Disease 1 0.9998611211776733
and O 0 0.0136863486841321
/ O 1 0.8162485957145691
or O 0 0.027663880959153175
WT B-Disease 1 0.9926691055297852
. O 0 0.03204890713095665

We O 0 0.02426466904580593
report O 0 0.04108336195349693
WT1 O 1 0.996325671672821
heterozygous O 1 0.9906749129295349
mutations O 1 0.9930751323699951
in O 0 0.010312956757843494
16 O 0 0.027232207357883453
patients O 1 0.9991341233253479
, O 0 0.004927811212837696
4 O 0 0.00800328515470028
of O 0 0.003960473462939262
whom O 0 0.013382142409682274
presented O 0 0.011252494528889656
with O 0 0.014105526730418205
IDMS B-Disease 1 0.9988264441490173
. O 0 0.027821850031614304

One O 0 0.017866868525743484
male O 0 0.032663099467754364
and O 0 0.004822899121791124
two O 0 0.007961135357618332
female O 1 0.6953752636909485
IDMS B-Disease 1 0.9999221563339233
patients O 1 0.9996364116668701
with O 0 0.03513979911804199
WT1 O 1 0.9999343156814575
mutations O 1 0.9998030066490173
underwent O 1 0.9993985891342163
normal O 1 0.8211647868156433
puberty O 1 0.9975455403327942
. O 0 0.033254336565732956

Two O 0 0.024046534672379494
mutations O 1 0.994412362575531
associated O 0 0.023623565211892128
with O 0 0.010428637266159058
IDMS B-Disease 1 0.9994620680809021
are O 0 0.0036035189405083656
different O 0 0.0030230889096856117
from O 0 0.004511353559792042
those O 0 0.005327015183866024
described O 0 0.019083071500062943
in O 0 0.016771573573350906
DDS B-Disease 1 0.9998703002929688
patients O 1 0.9988652467727661
. O 0 0.030498147010803223

No O 0 0.04950817674398422
WT1 O 1 0.999355137348175
mutations O 1 0.9971603155136108
were O 0 0.007332722656428814
detected O 0 0.03424587845802307
in O 0 0.0029897214844822884
the O 0 0.004016469232738018
six O 0 0.0074678147211670876
other O 0 0.010025684721767902
IDMS B-Disease 1 0.9999040365219116
patients O 1 0.9993832111358643
, O 0 0.011108669452369213
suggesting O 0 0.04264353960752487
genetic O 1 0.9033723473548889
heterogeneity O 1 0.7943005561828613
of O 0 0.008692191913723946
this O 0 0.016873294487595558
disease O 1 0.999977707862854
. O 0 0.026547357439994812

We O 0 0.025536827743053436
analyzed O 0 0.08630646765232086
genotype O 1 0.9980829954147339
/ O 1 0.9900205135345459
phenotype O 1 0.9983683228492737
correlations O 0 0.05301697924733162
, O 0 0.0044321403838694096
on O 0 0.0028788214549422264
the O 0 0.0028899989556521177
basis O 0 0.003629369894042611
of O 0 0.003183188382536173
the O 0 0.0038310433737933636
constitution O 0 0.008713879622519016
of O 0 0.005620861891657114
a O 0 0.017254626378417015
WT1 O 1 0.9994696974754333
mutation O 1 0.9940869808197021
database O 0 0.027262145653367043
of O 0 0.007469723932445049
84 O 0 0.1080867275595665
germ O 1 0.9891654849052429
- O 0 0.060195330530405045
line O 0 0.025563383474946022
mutations O 1 0.9951215386390686
, O 0 0.0043960269540548325
to O 0 0.0033943969756364822
compare O 0 0.012303833849728107
the O 0 0.0035541937686502934
distribution O 0 0.00763075053691864
and O 0 0.004056321457028389
type O 0 0.017939895391464233
of O 0 0.005623272154480219
mutations O 1 0.9986231327056885
, O 0 0.0034547215327620506
according O 0 0.003934478387236595
to O 0 0.0026126212906092405
the O 0 0.004876081831753254
different O 0 0.0123877739533782
symptoms O 1 0.999944806098938
. O 0 0.02350655198097229

This O 0 0.014958083629608154
demonstrated O 0 0.027858620509505272
( O 0 0.012654894031584263
1 O 0 0.010570270009338856
) O 0 0.005476175807416439
the O 0 0.004177214577794075
association O 0 0.012193030677735806
between O 0 0.010490495711565018
mutations O 1 0.9870179295539856
in O 0 0.006543196737766266
exons O 0 0.08887214213609695
8 O 0 0.012010009028017521
and O 0 0.004018044099211693
9 O 0 0.012814370915293694
and O 0 0.007175590842962265
DMS B-Disease 1 0.998494029045105
; O 0 0.010696765035390854
( O 0 0.008766291663050652
2 O 0 0.009354816749691963
) O 0 0.006823912728577852
among O 0 0.010860355570912361
patients O 1 0.998225748538971
with O 0 0.009017718024551868
DMS B-Disease 1 0.9976521134376526
, O 0 0.004459966905415058
a O 0 0.006971373222768307
higher O 0 0.009778707288205624
frequency O 0 0.01993878185749054
of O 0 0.006499048788100481
exon O 1 0.7072768807411194
8 O 0 0.027084071189165115
mutations O 1 0.9878756999969482
among O 0 0.014962398447096348
46 O 0 0.028790118172764778
, O 0 0.01651422306895256
XY O 1 0.9996581077575684
patients O 1 0.9984194040298462
with O 0 0.010999453254044056
female O 0 0.3974092900753021
phenotype O 1 0.9996384382247925
than O 0 0.007800373714417219
among O 0 0.01051714550703764
46 O 0 0.023093199357390404
, O 0 0.01283170748502016
XY O 1 0.9999147653579712
patients O 1 0.9993791580200195
with O 0 0.007648033555597067
sexual O 0 0.03221679478883743
ambiguity O 0 0.029642820358276367
or O 0 0.01546650193631649
male O 1 0.9403762817382812
phenotype O 1 0.9997933506965637
; O 0 0.00813813041895628
and O 0 0.003505298402160406
( O 0 0.007395077496767044
3 O 0 0.008283077739179134
) O 0 0.0070128971710801125
statistically O 0 0.017811045050621033
significant O 0 0.007888107560575008
evidence O 0 0.006253805477172136
that O 0 0.006290009710937738
mutations O 1 0.9809592366218567
in O 0 0.00775489816442132
exons O 0 0.06802710890769958
8 O 0 0.014111530035734177
and O 0 0.006126786582171917
9 O 0 0.02078992873430252
preferentially O 0 0.0969509556889534
affect O 0 0.03829353302717209
amino O 0 0.03414493054151535
acids O 0 0.020711297169327736
with O 0 0.003739157458767295
different O 0 0.004632100462913513
functions O 0 0.009405967779457569
. O 0 0.006679423153400421
. O 0 0.014054493047297001

The O 0 0.03999895229935646
185delAG O 1 0.9972272515296936
BRCA1 O 1 0.9999277591705322
mutation O 1 0.9991011619567871
originated O 0 0.028955494984984398
before O 0 0.007382565177977085
the O 0 0.005654651205986738
dispersion O 0 0.027811184525489807
of O 0 0.00378714082762599
Jews O 0 0.007911089807748795
in O 0 0.002968038199469447
the O 0 0.003808255074545741
diaspora O 0 0.016183234751224518
and O 0 0.0029935957863926888
is O 0 0.0038775340653955936
not O 0 0.0033660701010376215
limited O 0 0.008573982864618301
to O 0 0.008440668694674969
Ashkenazim O 1 0.7778632640838623
. O 0 0.027995992451906204

The O 0 0.029156357049942017
185delAG O 1 0.9914848208427429
mutation O 1 0.99748295545578
in O 0 0.020051077008247375
BRCA1 O 1 0.9998430013656616
is O 0 0.015695638954639435
detected O 0 0.10183081030845642
in O 0 0.007598415482789278
Ashkenazi O 0 0.35930705070495605
Jews O 0 0.011446281336247921
both O 0 0.006696220953017473
in O 0 0.0127152344211936
familial B-Disease 1 0.9999905824661255
breast I-Disease 1 0.9999992847442627
and I-Disease 1 0.978670060634613
ovarian I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999966621398926
and O 0 0.005975540727376938
in O 0 0.004171854350715876
the O 0 0.004967477638274431
general O 0 0.011477464810013771
population O 0 0.022655444219708443
. O 0 0.018792839720845222

All O 0 0.01705637015402317
tested O 0 0.38224032521247864
Ashkenazi O 1 0.9971826076507568
mutation O 1 0.9995606541633606
carriers O 0 0.2425181120634079
share O 0 0.01270557101815939
the O 0 0.00627128453925252
same O 0 0.012316177599132061
allelic O 1 0.9095268249511719
pattern O 0 0.03750855103135109
at O 0 0.012722505256533623
the O 0 0.019905252382159233
BRCA1 O 1 0.999722421169281
locus O 1 0.9897134304046631
. O 0 0.036561377346515656

Our O 0 0.01490623690187931
previous O 0 0.01420661062002182
study O 0 0.01545666716992855
showed O 0 0.01423631701618433
that O 0 0.004839499481022358
this O 0 0.009820535778999329
Ashkenazi O 1 0.9897124767303467
mutation O 1 0.9992169141769409
also O 0 0.008562907576560974
occurs O 0 0.02200750634074211
in O 0 0.003641340648755431
Iraqi O 0 0.010550607927143574
Jews O 0 0.008072221651673317
with O 0 0.004384384024888277
a O 0 0.011946454644203186
similar O 0 0.023821353912353516
allelic O 1 0.9679529070854187
pattern O 0 0.09955797344446182
. O 0 0.025835590437054634

We O 0 0.010473952628672123
extended O 0 0.013461599126458168
our O 0 0.0065864394418895245
analysis O 0 0.007626502774655819
to O 0 0.0028816121630370617
other O 0 0.003502143546938896
non O 0 0.019486481323838234
- O 0 0.04175962507724762
Ashkenazi O 1 0.5642368793487549
subsets O 0 0.04258827120065689
354 O 0 0.03394506126642227
of O 0 0.006253064144402742
Moroccan O 0 0.031020598486065865
origin O 0 0.015198295935988426
, O 0 0.0059887426905334
200 O 0 0.016316311433911324
Yemenites O 1 0.7179055213928223
and O 0 0.005534607917070389
150 O 0 0.015243366360664368
Iranian O 0 0.01936623826622963
Jews O 0 0.02483263611793518
. O 0 0.02494109235703945

Heteroduplex O 1 0.5866748690605164
analysis O 0 0.0321015790104866
complemented O 0 0.030436396598815918
by O 0 0.008301123976707458
direct O 0 0.01598132587969303
DNA O 0 0.03773833066225052
sequencing O 0 0.041535548865795135
of O 0 0.011235561221837997
abnormally O 1 0.9789505004882812
migrating O 0 0.15545554459095
bands O 0 0.026721470057964325
were O 0 0.006351271644234657
employed O 0 0.024626141414046288
. O 0 0.02015974372625351

Four O 0 0.01179835107177496
of O 0 0.008103382773697376
Moroccan O 0 0.04021045193076134
origin O 0 0.018476013094186783
( O 0 0.009178434498608112
1 O 0 0.007891535758972168
. O 0 0.0039589861407876015
1 O 0 0.007373904809355736
% O 0 0.005833104718476534
) O 0 0.004042872693389654
and O 0 0.002135437447577715
none O 0 0.005641448777168989
of O 0 0.0033077597618103027
the O 0 0.00660979188978672
Yemenites O 1 0.9412286281585693
or O 0 0.007229125127196312
Iranians O 0 0.010036290623247623
was O 0 0.005629189778119326
a O 0 0.00823729857802391
carrier O 0 0.02650132216513157
of O 0 0.006282729096710682
the O 0 0.013832014054059982
185delAG O 1 0.9900727272033691
mutation O 1 0.9977964162826538
. O 0 0.0304633229970932

BRCA1 O 1 0.9998306035995483
allelic O 1 0.9870957136154175
patterns O 0 0.033968258649110794
were O 0 0.004257715307176113
determined O 0 0.00664913933724165
for O 0 0.002002513501793146
four O 0 0.002356941346079111
of O 0 0.002144429599866271
these O 0 0.0024477888364344835
individuals O 0 0.004894515033811331
and O 0 0.002036113990470767
for O 0 0.002610372146591544
12 O 0 0.006619291380047798
additional O 0 0.007773512043058872
non O 0 0.022489303722977638
- O 0 0.0792311280965805
Ashkenazi O 1 0.9887130260467529
185delAG O 1 0.9986905455589294
mutation O 1 0.9994520545005798
carriers O 1 0.8616681098937988
who O 0 0.01965566724538803
had O 0 0.14880958199501038
breast B-Disease 1 0.9999902248382568
/ I-Disease 1 0.999836802482605
ovarian I-Disease 1 0.9999992847442627
cancer I-Disease 1 0.999991774559021
. O 0 0.03928753733634949

Six O 0 0.029501119628548622
non O 0 0.04017897695302963
- O 0 0.055381279438734055
Ashkenazi O 0 0.42956599593162537
individuals O 0 0.014155793935060501
shared O 0 0.011229868046939373
the O 0 0.007128117606043816
common O 0 0.027274806052446365
Ashkenazi O 1 0.9980104565620422
haplotype O 1 0.9979903697967529
, O 0 0.004587213508784771
four O 0 0.0037034836132079363
had O 0 0.004770542494952679
a O 0 0.0058304560370743275
closely O 0 0.00861659087240696
related O 0 0.013731452636420727
pattern O 0 0.027227599173784256
, O 0 0.0034736848901957273
and O 0 0.002380120102316141
the O 0 0.003829395165666938
rest O 0 0.012056669220328331
( O 0 0.011604338884353638
n O 0 0.030456289649009705
= O 0 0.03449752926826477
6 O 0 0.014141040854156017
) O 0 0.007295760791748762
displayed O 0 0.014019805938005447
a O 0 0.01732376590371132
distinct O 0 0.0751265436410904
BRCA1 O 1 0.9997066855430603
allelic O 1 0.9912121891975403
pattern O 0 0.13400620222091675
. O 0 0.029554929584264755

We O 0 0.01017225906252861
conclude O 0 0.01865054853260517
that O 0 0.005244734231382608
the O 0 0.010846458375453949
185delAG O 1 0.9991772770881653
BRCA1 O 1 0.9999791383743286
mutation O 1 0.9997580647468567
occurs O 0 0.07330795377492905
in O 0 0.005925951525568962
some O 0 0.006612664088606834
non O 0 0.021213756874203682
- O 0 0.10018406063318253
Ashkenazi O 1 0.9743676781654358
populations O 0 0.11230432242155075
at O 0 0.008893696591258049
rates O 0 0.017106857150793076
comparable O 0 0.0156900342553854
with O 0 0.004753963090479374
that O 0 0.004811081103980541
of O 0 0.009696930646896362
Ashkenazim O 1 0.9738547801971436
. O 0 0.0278110820800066

The O 0 0.010386290028691292
majority O 0 0.014544222503900528
of O 0 0.006267906166613102
Jewish O 0 0.03366091102361679
185delAG O 1 0.9983090162277222
mutation O 1 0.9995865225791931
carriers O 0 0.47488078474998474
have O 0 0.006264838390052319
a O 0 0.009894555434584618
common O 0 0.02149610035121441
allelic O 1 0.9932168126106262
pattern O 0 0.14576150476932526
, O 0 0.00577704980969429
supporting O 0 0.010529895313084126
the O 0 0.00575290247797966
founder O 0 0.02669868804514408
effect O 0 0.020448897033929825
notion O 0 0.014477002434432507
, O 0 0.0038324485067278147
but O 0 0.004641235340386629
dating O 0 0.015293826349079609
the O 0 0.008105303160846233
mutations O 1 0.9907433390617371
origin O 0 0.009583230130374432
to O 0 0.0029537805821746588
an O 0 0.003689412260428071
earlier O 0 0.006820833310484886
date O 0 0.00846817810088396
than O 0 0.006505776196718216
currently O 0 0.010407027788460255
estimated O 0 0.025169311091303825
. O 0 0.01911369524896145

However O 0 0.013331555761396885
, O 0 0.00467270752415061
the O 0 0.004660072270780802
different O 0 0.008115937002003193
allelic O 1 0.8637179732322693
pattern O 0 0.033175043761730194
at O 0 0.00909408275038004
the O 0 0.013860857114195824
BRCA1 O 1 0.9998855590820312
locus O 1 0.9947423934936523
even O 0 0.008646557107567787
in O 0 0.005292041227221489
some O 0 0.005750696174800396
Jewish O 0 0.04305948317050934
mutation O 1 0.9996606111526489
carriers O 0 0.4362812042236328
, O 0 0.005133646074682474
might O 0 0.009711525402963161
suggest O 0 0.010927540250122547
that O 0 0.004361137747764587
the O 0 0.010569925419986248
mutation O 1 0.9951451420783997
arose O 0 0.03912537172436714
independently O 0 0.021886073052883148
. O 0 0.009432220831513405
. O 0 0.016834665089845657

Crystal O 0 0.04327317699790001
structure O 0 0.016452325507998466
of O 0 0.006627668626606464
the O 0 0.016147077083587646
hemochromatosis B-Disease 1 0.9999544620513916
protein O 1 0.9255788326263428
HFE O 1 0.9982917904853821
and O 0 0.007464751601219177
characterization O 0 0.01877976581454277
of O 0 0.0037302295677363873
its O 0 0.006143015809357166
interaction O 0 0.020004738122224808
with O 0 0.013272300362586975
transferrin O 1 0.983407199382782
receptor O 1 0.9194932579994202
. O 0 0.027949584648013115

HFE O 1 0.9941374063491821
is O 0 0.02054314874112606
an O 0 0.018249832093715668
MHC O 1 0.9977936744689941
- O 0 0.0515064001083374
related O 0 0.026189642027020454
protein O 0 0.03545306995511055
that O 0 0.005604878067970276
is O 0 0.007886244915425777
mutated O 1 0.724926233291626
in O 0 0.005863420199602842
the O 0 0.008373663760721684
iron B-Disease 1 0.5480466485023499
- I-Disease 1 0.9818806648254395
overload I-Disease 1 0.9997989535331726
disease I-Disease 1 0.9999984502792358
hereditary B-Disease 1 0.9999839067459106
hemochromatosis I-Disease 1 0.9999933242797852
. O 0 0.054758988320827484

HFE O 1 0.9929156303405762
binds O 0 0.1590961217880249
to O 0 0.02205955982208252
transferrin O 1 0.9707182049751282
receptor O 1 0.9721723794937134
( O 0 0.0287946704775095
TfR O 1 0.9715255498886108
) O 0 0.011784536764025688
and O 0 0.0062004136852920055
reduces O 0 0.04907112196087837
its O 0 0.0074006421491503716
affinity O 0 0.028889155015349388
for O 0 0.0063576907850801945
iron O 0 0.03823946416378021
- O 0 0.038291215896606445
loaded O 0 0.03794097155332565
transferrin O 1 0.5594415068626404
, O 0 0.015189804136753082
implicating O 0 0.474833220243454
HFE O 1 0.9964514970779419
in O 0 0.019314773380756378
iron O 0 0.2058214545249939
metabolism O 1 0.882413923740387
. O 0 0.030473751947283745

The O 0 0.024666402488946915
2 O 0 0.03227744996547699
. O 0 0.023247230798006058

6 O 0 0.03171916306018829
A O 0 0.0191012192517519
crystal O 0 0.02764730527997017
structure O 0 0.015194105915725231
of O 0 0.009920111857354641
HFE O 1 0.9984862208366394
reveals O 0 0.03618210181593895
the O 0 0.0058718291111290455
locations O 0 0.01132870838046074
of O 0 0.01132051832973957
hemochromatosis B-Disease 1 0.9999915361404419
mutations O 1 0.9992177486419678
and O 0 0.00596967525780201
a O 0 0.014283276163041592
patch O 1 0.9953130483627319
of O 0 0.008499512448906898
histidines O 1 0.9836795926094055
that O 0 0.004258924629539251
could O 0 0.004650417249649763
be O 0 0.003039218718186021
involved O 0 0.00943487323820591
in O 0 0.009593320079147816
pH O 1 0.8685222268104553
- O 0 0.0479232594370842
dependent O 0 0.049398504197597504
interactions O 0 0.05032413452863693
. O 0 0.024588443338871002

We O 0 0.00987377017736435
also O 0 0.006790980231016874
demonstrate O 0 0.015484873205423355
that O 0 0.008884471841156483
soluble O 0 0.2582491338253021
TfR O 1 0.9915937185287476
and O 0 0.014260333962738514
HFE O 1 0.9989778995513916
bind O 0 0.06482374668121338
tightly O 0 0.02253696694970131
at O 0 0.005815387703478336
the O 0 0.004775920417159796
basic O 0 0.011038628406822681
pH O 0 0.2337373048067093
of O 0 0.003470189403742552
the O 0 0.00520962243899703
cell O 0 0.14830774068832397
surface O 0 0.012404265813529491
, O 0 0.0034052052069455385
but O 0 0.0029022672679275274
not O 0 0.0022581652738153934
at O 0 0.004696994088590145
the O 0 0.007313477341085672
acidic O 1 0.6763789057731628
pH O 1 0.7113051414489746
of O 0 0.013151466846466064
intracellular O 1 0.8815389275550842
vesicles O 1 0.5368086099624634
. O 0 0.028452200815081596

TfR O 1 0.9881270527839661
HFE O 1 0.9984928369522095
stoichiometry O 1 0.9086896181106567
( O 0 0.02306940220296383
2 O 0 0.017770584672689438
1 O 0 0.015908945351839066
) O 0 0.010803823359310627
differs O 0 0.0295929666608572
from O 0 0.01583748124539852
TfR O 1 0.9936144351959229
transferrin O 1 0.9851114153862
stoichiometry O 1 0.75042724609375
( O 0 0.015938617289066315
2 O 0 0.012565994635224342
2 O 0 0.011244062334299088
) O 0 0.005846409127116203
, O 0 0.004023994784802198
implying O 0 0.017721286043524742
a O 0 0.00623909430578351
different O 0 0.0049659148789942265
mode O 0 0.016634248197078705
of O 0 0.004591951612383127
binding O 0 0.018052110448479652
for O 0 0.007941209711134434
HFE O 1 0.9985684156417847
and O 0 0.009721999987959862
transferrin O 1 0.9829033017158508
to O 0 0.008505976758897305
TfR O 1 0.9896590113639832
, O 0 0.005364619195461273
consistent O 0 0.009962727315723896
with O 0 0.0038292882964015007
our O 0 0.007195950485765934
demonstration O 0 0.020965605974197388
that O 0 0.010619414038956165
HFE O 1 0.9977735877037048
, O 0 0.012928045354783535
transferrin O 1 0.8574953675270081
, O 0 0.0065387943759560585
and O 0 0.006878273095935583
TfR O 1 0.9726865291595459
form O 0 0.019743992015719414
a O 0 0.016705360263586044
ternary O 0 0.09266530722379684
complex O 0 0.03266528248786926
. O 0 0.021093543618917465

Identification O 0 0.023401526734232903
of O 0 0.005096009466797113
three O 0 0.00779389962553978
novel O 0 0.03729036822915077
mutations O 1 0.9946796298027039
and O 0 0.003837079042568803
a O 0 0.007195262238383293
high O 0 0.007896958850324154
frequency O 0 0.015506341122090816
of O 0 0.004284257534891367
the O 0 0.01001732423901558
Arg778Leu O 1 0.9965732097625732
mutation O 1 0.9984620809555054
in O 0 0.009461300447583199
Korean O 0 0.10542494058609009
patients O 1 0.99959796667099
with O 0 0.017167501151561737
Wilson B-Disease 1 0.995206892490387
disease I-Disease 1 0.999974250793457
. O 0 0.02760414220392704

Four O 0 0.036161210387945175
mutations O 1 0.9937485456466675
- O 0 0.15645141899585724
- O 0 0.18022869527339935
R778L O 1 0.9762440323829651
, O 0 0.014158947393298149
A874V O 1 0.94337397813797
, O 0 0.010099959559738636
L1083F O 1 0.7883931994438171
, O 0 0.005994842853397131
and O 0 0.0060999090783298016
2304delC O 1 0.9910616874694824
- O 0 0.03453703224658966
- O 0 0.02066170983016491
in O 0 0.005080624483525753
the O 0 0.006357365287840366
copper O 0 0.029546333476901054
- O 0 0.03211520239710808
transporting O 0 0.03413975611329079
enzyme O 0 0.06368175894021988
, O 0 0.011027254164218903
P O 0 0.4004836976528168
- O 0 0.0684969574213028
type O 0 0.13508683443069458
ATPase O 1 0.9789305925369263
( O 0 0.026750218123197556
ATP7B O 1 0.9855471849441528
) O 0 0.008472559973597527
, O 0 0.0032097690273076296
were O 0 0.0031858282163739204
identified O 0 0.0111553855240345
in O 0 0.006501283962279558
Korean O 0 0.04481545463204384
Patients O 1 0.999243974685669
with O 0 0.017221063375473022
Wilson B-Disease 1 0.9967538714408875
disease I-Disease 1 0.9999860525131226
. O 0 0.031901538372039795

Arg778Leu O 1 0.9061088562011719
, O 0 0.00755352945998311
the O 0 0.0059176040813326836
most O 0 0.00777050107717514
frequently O 0 0.017418066039681435
reported O 0 0.02822139300405979
mutation O 1 0.9922322034835815
of O 0 0.005544019863009453
this O 0 0.005478341598063707
enzyme O 0 0.04641703516244888
, O 0 0.0038348035886883736
was O 0 0.00368203385733068
found O 0 0.004240098875015974
in O 0 0.002197761321440339
six O 0 0.0037611518055200577
of O 0 0.0032805560622364283
eight O 0 0.011323732323944569
unrelated O 1 0.6756488680839539
patients O 1 0.9989317059516907
studied O 0 0.013430939055979252
, O 0 0.005458019208163023
an O 0 0.008903569541871548
allele O 1 0.9812504649162292
frequency O 0 0.028086774051189423
of O 0 0.0067752450704574585
37 O 0 0.02902986854314804
. O 0 0.017410609871149063

5 O 0 0.027867348864674568
% O 0 0.0121997632086277
, O 0 0.004190819803625345
which O 0 0.00376518489792943
is O 0 0.004954246804118156
considerably O 0 0.018304476514458656
higher O 0 0.007128613535314798
than O 0 0.00393236568197608
those O 0 0.002865379909053445
in O 0 0.003213264513760805
other O 0 0.004331907257437706
Asian O 0 0.02505047619342804
populations O 0 0.057779308408498764
. O 0 0.020857764407992363

The O 0 0.01606922224164009
novel O 0 0.037111032754182816
single O 0 0.03249002620577812
nucleotide O 0 0.10803184658288956
deletion O 1 0.9476219415664673
, O 0 0.009672810323536396
2304delC O 1 0.8984813094139099
, O 0 0.005408715922385454
was O 0 0.005744006484746933
found O 0 0.006846272852271795
in O 0 0.005773629527539015
one O 0 0.011291373521089554
patient O 1 0.984347939491272
. O 0 0.02399173006415367

Since O 0 0.03548074886202812
a O 0 0.028478002175688744
mutation O 1 0.9780325889587402
at O 0 0.022282812744379044
cDNA O 0 0.13080072402954102
nucleotide O 0 0.3376787602901459
2302 O 1 0.9891286492347717
( O 0 0.02893509343266487
2302insC O 1 0.7157192230224609
) O 0 0.012067859061062336
had O 0 0.006338092498481274
been O 0 0.006013556849211454
previously O 0 0.008278325200080872
described O 0 0.009491145610809326
, O 0 0.0028509695548564196
this O 0 0.002768367063254118
region O 0 0.008529574610292912
of O 0 0.004384784027934074
the O 0 0.009339348413050175
ATP7B O 1 0.9993684887886047
gene O 1 0.996688187122345
may O 0 0.01661352999508381
be O 0 0.006429269444197416
susceptible O 1 0.993881106376648
to O 0 0.011359278112649918
gene O 1 0.9895861744880676
rearrangements O 1 0.9965113997459412
causing O 1 0.9986761212348938
Wilson B-Disease 1 0.9945582151412964
disease I-Disease 1 0.9999661445617676
. O 0 0.032424196600914

Disruption O 0 0.10839942842721939
of O 0 0.016068294644355774
splicing O 0 0.09385839849710464
regulated O 0 0.03164994716644287
by O 0 0.009313448332250118
a O 0 0.020206626504659653
CUG O 1 0.9871709942817688
- O 0 0.06625386327505112
binding O 0 0.053177282214164734
protein O 0 0.06493590027093887
in O 0 0.028183121234178543
myotonic B-Disease 1 0.9999520778656006
dystrophy I-Disease 1 0.9999871253967285
. O 0 0.04298243671655655

Myotonic B-Disease 1 0.9999719858169556
dystrophy I-Disease 1 0.9999947547912598
( O 1 0.677818775177002
DM B-Disease 1 0.9999091625213623
) O 0 0.015892811119556427
is O 0 0.00813726894557476
caused O 0 0.28249379992485046
by O 0 0.007913852110505104
a O 0 0.012646638788282871
CTG O 1 0.8234478235244751
expansion O 0 0.015907464548945427
in O 0 0.004815701395273209
the O 0 0.005108546931296587
3 O 0 0.012761896476149559
untranslated O 0 0.06463123112916946
region O 0 0.016550792381167412
of O 0 0.0072031449526548386
the O 0 0.01969357579946518
DM B-Disease 1 0.9998643398284912
gene O 1 0.9667313098907471
. O 0 0.03418721631169319

One O 0 0.019083112478256226
model O 0 0.025799071416258812
of O 0 0.020028967410326004
DM B-Disease 1 0.9999659061431885
pathogenesis O 1 0.9995978474617004
suggests O 0 0.03423871472477913
that O 0 0.007290671579539776
RNAs O 0 0.0394265353679657
from O 0 0.004670978058129549
the O 0 0.004219214431941509
expanded O 0 0.014837265014648438
allele O 1 0.742567777633667
create O 0 0.010420835576951504
a O 0 0.008410555310547352
gain O 0 0.01564483903348446
- O 0 0.02035430446267128
of O 0 0.007009600754827261
- O 0 0.037333931773900986
function O 0 0.03429149463772774
mutation O 1 0.9828794598579407
by O 0 0.006485871970653534
the O 0 0.0056305937469005585
inappropriate O 0 0.021981792524456978
binding O 0 0.012976082973182201
of O 0 0.004009836353361607
proteins O 0 0.017595533281564713
to O 0 0.004998754244297743
the O 0 0.011486758477985859
CUG O 1 0.981291651725769
repeats O 0 0.16221663355827332
. O 0 0.02438667230308056

Data O 0 0.01672547124326229
presented O 0 0.010690509341657162
here O 0 0.005639689043164253
indicate O 0 0.009852344170212746
that O 0 0.0027638371102511883
the O 0 0.005602720193564892
conserved O 0 0.03212651237845421
heterogeneous O 0 0.055701736360788345
nuclear O 0 0.026843659579753876
ribonucleoprotein O 1 0.7942269444465637
, O 0 0.015363537706434727
CUG O 1 0.9728050827980042
- O 0 0.04477626457810402
binding O 0 0.03663251921534538
protein O 0 0.04696832224726677
( O 0 0.01849653199315071
CUG O 1 0.9925359487533569
- O 0 0.10442597419023514
BP O 0 0.08014709502458572
) O 0 0.008047951385378838
, O 0 0.004125650972127914
may O 0 0.00963677279651165
mediate O 0 0.029163289815187454
the O 0 0.009243953973054886
trans O 0 0.37899455428123474
- O 0 0.03873571753501892
dominant O 0 0.04207449033856392
effect O 0 0.016035623848438263
of O 0 0.005663531832396984
the O 0 0.009308398701250553
RNA O 0 0.07192403078079224
. O 0 0.01855677366256714

CUG O 1 0.9943601489067078
- O 0 0.10578913241624832
BP O 0 0.08542784303426743
was O 0 0.008054662495851517
found O 0 0.006811272352933884
to O 0 0.003806567518040538
bind O 0 0.019906865432858467
to O 0 0.004107792861759663
the O 0 0.007685618009418249
human O 0 0.48197251558303833
cardiac O 1 0.9999850988388062
troponin O 1 0.9998657703399658
T O 1 0.9982280135154724
( O 0 0.026869889348745346
cTNT O 1 0.8516067862510681
) O 0 0.015564076602458954
pre O 0 0.046240076422691345
- O 0 0.043983928859233856
messenger O 0 0.06216112896800041
RNA O 0 0.05335814878344536
and O 0 0.007917536422610283
regulate O 0 0.03582556173205376
its O 0 0.010106578469276428
alternative O 0 0.03404149413108826
splicing O 0 0.12321566045284271
. O 0 0.031075291335582733

Splicing O 0 0.12737008929252625
of O 0 0.017461469396948814
cTNT O 1 0.9007403254508972
was O 0 0.019664667546749115
disrupted O 0 0.22092071175575256
in O 0 0.02711597830057144
DM B-Disease 1 0.9999794960021973
striated O 1 0.9998739957809448
muscle O 1 0.9993270635604858
and O 0 0.006933225318789482
in O 0 0.008299938403069973
normal O 0 0.04958527162671089
cells O 0 0.4318954050540924
expressing O 0 0.03283112868666649
transcripts O 0 0.019690513610839844
that O 0 0.007608331274241209
contain O 0 0.03133968263864517
CUG O 1 0.9815331101417542
repeats O 0 0.1354595571756363
. O 0 0.024986138567328453

Altered O 0 0.08024758845567703
expression O 0 0.04300600662827492
of O 0 0.010223056189715862
genes O 0 0.16930197179317474
regulated O 0 0.052782997488975525
posttranscriptionally O 1 0.9389989376068115
by O 0 0.016525952145457268
CUG O 1 0.9981685876846313
- O 0 0.12010703980922699
BP O 0 0.08218737691640854
therefore O 0 0.012789556756615639
may O 0 0.012050304561853409
contribute O 0 0.02386815845966339
to O 0 0.016440756618976593
DM B-Disease 1 0.9998384714126587
pathogenesis O 1 0.9989933371543884
. O 0 0.016513774171471596
. O 0 0.01962072029709816

Identification O 0 0.030082250013947487
of O 0 0.00705993315204978
a O 0 0.012012358754873276
novel O 0 0.033873774111270905
nonsense O 1 0.6984183192253113
mutation O 1 0.9958027005195618
and O 0 0.006614433601498604
a O 0 0.01498605776578188
missense O 1 0.933122992515564
substitution O 0 0.03561519831418991
in O 0 0.006484575569629669
the O 0 0.011057530529797077
vasopressin O 1 0.9934549927711487
- O 0 0.45373401045799255
neurophysin O 1 0.9863775968551636
II O 0 0.48510006070137024
gene O 0 0.11781572550535202
in O 0 0.005580552387982607
two O 0 0.005258968099951744
Spanish O 0 0.0269533172249794
kindreds O 1 0.9847877025604248
with O 0 0.02538272738456726
familial B-Disease 1 0.9999098777770996
neurohypophyseal I-Disease 1 0.9999257326126099
diabetes I-Disease 1 0.9999983310699463
insipidus I-Disease 1 0.9998931884765625
. O 0 0.05509350448846817

Familial B-Disease 1 0.9998935461044312
neurohypophyseal I-Disease 1 0.9998754262924194
diabetes I-Disease 1 0.9999986886978149
insipidus I-Disease 1 0.9999573230743408
( O 0 0.09045204520225525
FNDI B-Disease 1 0.9984859824180603
) O 0 0.013078992255032063
is O 0 0.007677203975617886
an O 0 0.01525497529655695
autosomal B-Disease 1 0.9999687671661377
dominant I-Disease 1 0.9996366500854492
disease I-Disease 1 0.9999982118606567
caused O 1 0.9993805885314941
by O 0 0.03389660269021988
deficiency O 1 0.9999781847000122
in O 0 0.01014241948723793
the O 0 0.018259253352880478
antidiuretic O 1 0.9990922212600708
hormone O 1 0.9977231621742249
arginine O 1 0.9742564558982849
vasopressin O 1 0.9930914640426636
( O 0 0.03380024805665016
AVP O 1 0.9698148965835571
) O 0 0.012731167487800121
encoded O 0 0.021442819386720657
by O 0 0.00809541530907154
the O 0 0.013529723510146141
AVP O 1 0.9805085062980652
- O 0 0.1496826559305191
neurophysin O 1 0.9728294610977173
II O 0 0.40120503306388855
( O 0 0.03317885845899582
AVP O 1 0.9884240031242371
- O 0 0.19804413616657257
NPII O 1 0.9739219546318054
) O 0 0.028871024027466774
gene O 0 0.29202619194984436
on O 0 0.02115105837583542
chromosome O 1 0.9942161440849304
20p13 O 1 0.8321970701217651
. O 0 0.03514659032225609

In O 0 0.008520119823515415
this O 0 0.004858721978962421
study O 0 0.007613391615450382
, O 0 0.0027718390338122845
we O 0 0.002667628927156329
analyzed O 0 0.010712004266679287
two O 0 0.003453236073255539
families O 0 0.009796750731766224
with O 0 0.0073517742566764355
FNDI B-Disease 1 0.9761956334114075
using O 0 0.009376255795359612
direct O 0 0.014925440773367882
automated O 0 0.03150478005409241
fluorescent O 0 0.0833924189209938
, O 0 0.005422623828053474
solid O 0 0.01376208383589983
phase O 0 0.021214397624135017
, O 0 0.004912209697067738
single O 0 0.0158101674169302
- O 0 0.03419426456093788
stranded O 0 0.07035937160253525
DNA O 0 0.055475227534770966
sequencing O 0 0.05196982994675636
of O 0 0.013562403619289398
PCR O 0 0.1635185033082962
- O 0 0.06474081426858902
amplified O 0 0.3841022551059723
AVP O 1 0.9754907488822937
- O 0 0.14421945810317993
NPII O 1 0.9592504501342773
DNA O 0 0.11272544413805008
. O 0 0.03675135597586632

In O 0 0.008404619991779327
one O 0 0.0049532377161085606
of O 0 0.0036503770388662815
the O 0 0.004530827049165964
families O 0 0.010183049365878105
, O 0 0.005528425332158804
affected O 0 0.035038962960243225
individuals O 0 0.009300477802753448
presented O 0 0.007949802093207836
a O 0 0.009464513510465622
novel O 0 0.029434651136398315
nonsense O 1 0.632643461227417
mutation O 1 0.9977153539657593
in O 0 0.008987960405647755
exon O 0 0.1738235354423523
3 O 0 0.010078110732138157
of O 0 0.0035919449292123318
the O 0 0.006191393360495567
gene O 1 0.5223841667175293
, O 0 0.0038782821502536535
consisting O 0 0.006796514615416527
in O 0 0.0038444094825536013
a O 0 0.01092474814504385
G O 0 0.286262571811676
to O 0 0.008486495353281498
T O 1 0.9370549917221069
transition O 0 0.030384374782443047
at O 0 0.0133573729544878
nucleotide O 0 0.0978599488735199
2101 O 1 0.8389450311660767
, O 0 0.007030708249658346
which O 0 0.005941199138760567
produces O 0 0.018996048718690872
a O 0 0.009070385247468948
stop O 0 0.018962975591421127
signal O 0 0.024155693128705025
in O 0 0.01107727736234665
codon O 0 0.12005272507667542
82 O 0 0.054402101784944534
( O 0 0.027932679280638695
Glu O 1 0.985248863697052
) O 0 0.015238887630403042
of O 0 0.014980330131947994
NPII O 1 0.9577920436859131
. O 0 0.0308957789093256

The O 0 0.02970457449555397
premature O 1 0.9952757358551025
termination O 1 0.9040613174438477
eliminates O 0 0.06445132195949554
part O 0 0.008006272837519646
of O 0 0.003975193481892347
the O 0 0.007679162081331015
C O 0 0.11420398205518723
- O 0 0.03909093514084816
terminal O 0 0.046131622046232224
domain O 0 0.023404739797115326
of O 0 0.007761248853057623
NPII O 1 0.9377033710479736
, O 0 0.00432363897562027
including O 0 0.004768664482980967
a O 0 0.008774147368967533
cysteine O 0 0.041464872658252716
residue O 0 0.03867461159825325
in O 0 0.004686638247221708
position O 0 0.007374413311481476
85 O 0 0.01307941135019064
, O 0 0.0030223887879401445
which O 0 0.0026682494208216667
could O 0 0.003203124273568392
be O 0 0.0021176591981202364
involved O 0 0.004778486676514149
in O 0 0.002471406012773514
the O 0 0.004450867418199778
correct O 0 0.020282339304685593
folding O 0 0.03389547020196915
of O 0 0.008151929825544357
the O 0 0.01576896943151951
prohormone O 1 0.9848616123199463
. O 0 0.03129791468381882

In O 0 0.008889024145901203
the O 0 0.007540322840213776
second O 0 0.012226535938680172
family O 0 0.01550314575433731
, O 0 0.005927022080868483
a O 0 0.013615747913718224
G279A O 1 0.788033664226532
substitution O 0 0.028883349150419235
at O 0 0.007399097550660372
position O 0 0.007333396468311548
- O 0 0.01510618906468153
1 O 0 0.006705726962536573
of O 0 0.002726254053413868
the O 0 0.0053146700374782085
signal O 0 0.02550947666168213
peptide O 0 0.061795104295015335
was O 0 0.008339058607816696
observed O 0 0.01380421593785286
in O 0 0.0038285658229142427
all O 0 0.004995210096240044
affected O 0 0.11885134130716324
individuals O 0 0.019783398136496544
. O 0 0.01677803136408329

This O 0 0.032153576612472534
missense O 1 0.9960579872131348
mutation O 1 0.997265100479126
, O 0 0.010424038395285606
which O 0 0.009359059855341911
replaces O 1 0.6262350678443909
Ala O 1 0.9858249425888062
with O 0 0.01497952826321125
Thr O 1 0.9984512329101562
, O 0 0.008200380019843578
is O 0 0.009051102213561535
frequent O 0 0.05746176466345787
among O 0 0.05741632357239723
FNDI B-Disease 1 0.9999603033065796
patients O 1 0.9998667240142822
and O 0 0.004423388279974461
is O 0 0.0048426007851958275
thought O 0 0.0073623256757855415
to O 0 0.002850797027349472
reduce O 0 0.011865716427564621
the O 0 0.0037724035792052746
efficiency O 0 0.01088570524007082
of O 0 0.006086002103984356
cleavage O 1 0.9616584181785583
by O 0 0.010219496674835682
signal O 0 0.03443045914173126
peptidases O 1 0.7174060344696045
. O 0 0.014187037013471127
. O 0 0.019757112488150597

Genetic O 1 0.6099988222122192
heterogeneity O 0 0.24864976108074188
of O 0 0.020198879763484
Saethre B-Disease 1 0.9977685213088989
- I-Disease 1 0.9918907880783081
Chotzen I-Disease 1 0.9996755123138428
syndrome I-Disease 1 0.9999969005584717
, O 0 0.009475423023104668
due O 0 0.015485996380448341
to O 0 0.006793933920562267
TWIST O 1 0.8010212779045105
and O 0 0.014161603525280952
FGFR O 1 0.9976094961166382
mutations O 1 0.9952366352081299
. O 0 0.027230849489569664

Thirty O 0 0.05112871900200844
- O 0 0.03417119011282921
two O 0 0.011339593678712845
unrelated O 0 0.35460802912712097
patients O 1 0.9954376816749573
with O 0 0.005942460615187883
features O 0 0.010028443299233913
of O 0 0.00808190181851387
Saethre B-Disease 1 0.9987794756889343
- I-Disease 1 0.9927339553833008
Chotzen I-Disease 1 0.9997947812080383
syndrome I-Disease 1 0.9999985694885254
, O 0 0.010057603940367699
a O 0 0.015812674537301064
common O 1 0.5215796232223511
autosomal B-Disease 1 0.9999736547470093
dominant I-Disease 1 0.9745708703994751
condition I-Disease 1 0.8387251496315002
of O 0 0.013681290671229362
craniosynostosis B-Disease 1 0.9999545812606812
and O 0 0.035755667835474014
limb B-Disease 1 0.9999804496765137
anomalies I-Disease 1 0.9945507645606995
, O 0 0.004664323292672634
were O 0 0.0034663525875657797
screened O 0 0.023034974932670593
for O 0 0.007931478321552277
mutations O 1 0.9946570992469788
in O 0 0.008578446693718433
TWIST O 1 0.5966808795928955
, O 0 0.009917072020471096
FGFR2 O 1 0.9891720414161682
, O 0 0.007957973517477512
and O 0 0.009451175108551979
FGFR3 O 1 0.9846920371055603
. O 0 0.025639139115810394

Nine O 0 0.023681635037064552
novel O 0 0.02624194324016571
and O 0 0.006294928956776857
three O 0 0.012472801841795444
recurrent O 1 0.9987881779670715
TWIST O 1 0.9970417618751526
mutations O 1 0.9975984692573547
were O 0 0.004711105953902006
found O 0 0.007045171223580837
in O 0 0.0049612936563789845
12 O 0 0.01417054608464241
families O 0 0.0201960951089859
. O 0 0.020108826458454132

Seven O 0 0.014874021522700787
families O 0 0.01139461062848568
were O 0 0.003110544290393591
found O 0 0.005419808439910412
to O 0 0.002764093456789851
have O 0 0.0034858614671975374
the O 0 0.008283725939691067
FGFR3 O 1 0.9990537762641907
P250R O 1 0.9992983341217041
mutation O 1 0.9993067979812622
, O 0 0.0041175344958901405
and O 0 0.002577579813078046
one O 0 0.004094092641025782
individual O 0 0.005439880769699812
was O 0 0.0039430237375199795
found O 0 0.004968842025846243
to O 0 0.002829748671501875
have O 0 0.004102864768356085
an O 0 0.009292046539485455
FGFR2 O 1 0.9896961450576782
VV269 O 1 0.9805482625961304
- O 0 0.07849138230085373
270 O 0 0.09725454449653625
deletion O 1 0.9490708112716675
. O 0 0.03392920643091202

To O 0 0.009781621396541595
date O 0 0.011177361942827702
, O 0 0.003569705178961158
our O 0 0.006878124084323645
detection O 0 0.02770741656422615
rate O 0 0.011282254010438919
for O 0 0.005912789609283209
TWIST O 0 0.4627196490764618
or O 0 0.017100000753998756
FGFR O 1 0.9990260601043701
mutations O 1 0.9978976249694824
is O 0 0.00862656719982624
68 O 0 0.017830459401011467
% O 0 0.007225416135042906
in O 0 0.004877493251115084
our O 0 0.015072990208864212
Saethre B-Disease 1 0.9985408782958984
- I-Disease 1 0.9982807636260986
Chotzen I-Disease 1 0.9999761581420898
syndrome I-Disease 1 0.9999998807907104
patients O 1 0.9999504089355469
, O 0 0.004360551945865154
including O 0 0.0036611612886190414
our O 0 0.006321183871477842
five O 0 0.010507984086871147
patients O 1 0.9991984963417053
elsewhere O 0 0.02146371454000473
reported O 0 0.020694652572274208
with O 0 0.01353511493653059
TWIST O 1 0.9747897982597351
mutations O 1 0.9962055683135986
. O 0 0.030050495639443398

More O 0 0.010283615440130234
than O 0 0.008093619719147682
35 O 0 0.01720302924513817
different O 0 0.010528678074479103
TWIST O 1 0.966451108455658
mutations O 1 0.9978651404380798
are O 0 0.004396915901452303
now O 0 0.006139223929494619
known O 0 0.0067876167595386505
in O 0 0.002966312924399972
the O 0 0.005452333018183708
literature O 0 0.017144346609711647
. O 0 0.014924326911568642

The O 0 0.012067686766386032
most O 0 0.011244062334299088
common O 0 0.02390545792877674
phenotypic O 1 0.9959433674812317
features O 0 0.010612692683935165
, O 0 0.0030517911072820425
present O 0 0.0037844793405383825
in O 0 0.0026573578361421824
more O 0 0.0026154895313084126
than O 0 0.0033363390248268843
a O 0 0.004280849825590849
third O 0 0.006382457446306944
of O 0 0.003971430007368326
our O 0 0.010702968575060368
patients O 1 0.9977948665618896
with O 0 0.010675673373043537
TWIST O 1 0.9921343326568604
mutations O 1 0.9978843331336975
, O 0 0.006134971510618925
are O 0 0.0067985872738063335
coronal B-Disease 1 0.9332420825958252
synostosis I-Disease 1 0.9767027497291565
, O 0 0.01266042422503233
brachycephaly B-Disease 1 0.8127906322479248
, O 0 0.013137144036591053
low B-Disease 0 0.44099628925323486
frontal I-Disease 1 0.9998575448989868
hairline I-Disease 1 0.9999823570251465
, O 0 0.043718621134757996
facial B-Disease 1 0.9999524354934692
asymmetry I-Disease 1 0.99869304895401
, O 0 0.02502957172691822
ptosis B-Disease 1 0.9999449253082275
, O 0 0.018340714275836945
hypertelorism B-Disease 1 0.998818576335907
, O 0 0.010274017229676247
broad B-Disease 0 0.03199194744229317
great I-Disease 0 0.02272418700158596
toes I-Disease 1 0.9927213788032532
, O 0 0.00788543839007616
and O 0 0.008830870501697063
clinodactyly B-Disease 1 0.819230318069458
. O 0 0.025886958464980125

Significant O 0 0.04846324771642685
intra O 0 0.3246169090270996
- O 0 0.054277125746011734
and O 0 0.015620095655322075
interfamilial O 1 0.9832073450088501
phenotypic O 1 0.9953494668006897
variability O 0 0.360707551240921
is O 0 0.0056072198785841465
present O 0 0.0050788563676178455
for O 0 0.004481730982661247
either O 0 0.012950480915606022
TWIST O 1 0.9792979955673218
mutations O 1 0.9992213249206543
or O 0 0.026415618136525154
FGFR O 1 0.9983295798301697
mutations O 1 0.9970465302467346
. O 0 0.029988739639520645

The O 0 0.014788101427257061
overlap O 0 0.033216580748558044
in O 0 0.00838191993534565
clinical O 1 0.7088683843612671
features O 0 0.008173154667019844
and O 0 0.0023613586090505123
the O 0 0.0032555987127125263
presence O 0 0.00911187194287777
, O 0 0.002565791131928563
in O 0 0.0022974221501499414
the O 0 0.0034941232297569513
same O 0 0.006268627941608429
genes O 0 0.11221296340227127
, O 0 0.0039060311391949654
of O 0 0.0045753587037324905
mutations O 1 0.9551440477371216
for O 0 0.002918871818110347
more O 0 0.0032378064934164286
than O 0 0.004856765270233154
one O 0 0.007826878689229488
craniosynostotic B-Disease 1 0.9973535537719727
condition I-Disease 1 0.7349345088005066
- O 0 0.01901371404528618
such O 0 0.004682209342718124
as O 0 0.007733843754976988
Saethre B-Disease 1 0.994931161403656
- I-Disease 0 0.16827960312366486
Chotzen I-Disease 1 0.9809644818305969
, I-Disease 0 0.010428942739963531
Crouzon I-Disease 1 0.9635193943977356
, I-Disease 0 0.007067873142659664
and I-Disease 0 0.010004526935517788
Pfeiffer I-Disease 1 0.9991472959518433
syndromes I-Disease 1 0.999948263168335
- O 0 0.032819319516420364
support O 0 0.01097647100687027
the O 0 0.0068147252313792706
hypothesis O 0 0.028676316142082214
that O 0 0.00541516812518239
TWIST O 0 0.45942050218582153
and O 0 0.005913083907216787
FGFRs O 1 0.8995144963264465
are O 0 0.0030909657943993807
components O 0 0.005018716212362051
of O 0 0.0023970662150532007
the O 0 0.0035216526594012976
same O 0 0.007945281453430653
molecular O 0 0.03235451132059097
pathway O 0 0.04461101070046425
involved O 0 0.008819229900836945
in O 0 0.0038053167518228292
the O 0 0.004904984496533871
modulation O 0 0.14578984677791595
of O 0 0.008083886466920376
craniofacial O 1 0.9999492168426514
and O 0 0.011732442304491997
limb O 1 0.9999284744262695
development O 0 0.01175661664456129
in O 0 0.007818958722054958
humans O 0 0.10066023468971252
. O 0 0.009742717258632183
. O 0 0.014546936377882957

Mutation O 1 0.9770970940589905
analysis O 0 0.036232467740774155
of O 0 0.02100859023630619
UBE3A O 1 0.9997010231018066
in O 1 0.7502121925354004
Angelman B-Disease 1 0.9999994039535522
syndrome I-Disease 1 0.9999998807907104
patients O 1 0.999874472618103
. O 0 0.04382562264800072

Angelman B-Disease 1 0.9999945163726807
syndrome I-Disease 1 0.9999991655349731
( O 0 0.028932804241776466
AS B-Disease 0 0.013875073753297329
) O 0 0.008922314271330833
is O 0 0.007286041975021362
caused O 0 0.13195346295833588
by O 0 0.01644418016076088
chromosome O 1 0.9983144998550415
15q11 O 1 0.994765043258667
- O 0 0.4621773362159729
q13 O 1 0.9831148386001587
deletions O 0 0.2363012135028839
of O 0 0.009405318647623062
maternal O 1 0.9043471813201904
origin O 0 0.015311744064092636
, O 0 0.006322148721665144
by O 0 0.011942202225327492
paternal O 1 0.9978618025779724
uniparental B-Disease 1 0.9998107552528381
disomy I-Disease 1 0.9961045980453491
( O 0 0.04326927661895752
UPD B-Disease 1 0.9989338517189026
) O 0 0.01340593583881855
15 O 0 0.009360438212752342
, O 0 0.004383280873298645
by O 0 0.009556637145578861
imprinting O 1 0.9982068538665771
defects O 1 0.999115526676178
, O 0 0.0049468050710856915
and O 0 0.0032710586674511433
by O 0 0.006969822570681572
mutations O 1 0.9873576164245605
in O 0 0.00645645335316658
the O 0 0.014815394766628742
UBE3A O 1 0.999667763710022
gene O 1 0.9823403358459473
. O 0 0.028786292299628258

UBE3A O 1 0.9881383776664734
encodes O 0 0.1178259551525116
a O 0 0.030210861936211586
ubiquitin O 0 0.10340647399425507
- O 0 0.05826164409518242
protein O 0 0.053776949644088745
ligase O 0 0.05077208951115608
and O 0 0.008521780371665955
shows O 0 0.02628706581890583
brain O 1 0.9989443421363831
- O 0 0.054240524768829346
specific O 0 0.03384729474782944
imprinting O 1 0.954882800579071
. O 0 0.03204327076673508

Here O 0 0.016139009967446327
we O 0 0.010508093051612377
describe O 0 0.041318465024232864
UBE3A O 1 0.9972647428512573
coding O 0 0.38671132922172546
- O 0 0.07175255566835403
region O 0 0.06391532719135284
mutations O 1 0.9981149435043335
detected O 1 0.6271820068359375
by O 0 0.012135045602917671
SSCP O 1 0.9527676105499268
analysis O 0 0.013423941098153591
in O 0 0.0049732220359146595
13 O 0 0.009730038233101368
AS B-Disease 0 0.007527743931859732
individuals O 0 0.010639558546245098
or O 0 0.009905384853482246
families O 0 0.020636659115552902
. O 0 0.01935018226504326

Two O 0 0.015040496364235878
identical O 0 0.03427016735076904
de O 0 0.05197921022772789
novo O 0 0.07569529861211777
5 O 0 0.02453988417983055
- O 0 0.04159729555249214
bp O 0 0.057902611792087555
duplications O 0 0.10490337014198303
in O 0 0.011002346873283386
exon O 0 0.14905881881713867
16 O 0 0.016129937022924423
were O 0 0.006424908526241779
found O 0 0.017470454797148705
. O 0 0.018163319677114487

Among O 0 0.013072025962173939
the O 0 0.00523742800578475
other O 0 0.003610919462516904
11 O 0 0.012433301657438278
unique O 0 0.016801612451672554
mutations O 1 0.9967128038406372
, O 0 0.005203756503760815
8 O 0 0.008074181154370308
were O 0 0.003393016057088971
small O 0 0.010273212566971779
deletions O 0 0.09393595904111862
or O 0 0.012140105478465557
insertions O 0 0.30343204736709595
predicted O 0 0.028539828956127167
to O 0 0.009386798366904259
cause O 1 0.925527036190033
frameshifts O 1 0.9481589794158936
, O 0 0.005613155197352171
1 O 0 0.008164966478943825
was O 0 0.005677006673067808
a O 0 0.01049001608043909
mutation O 1 0.9778900742530823
to O 0 0.004975235555320978
a O 0 0.010070639662444592
stop O 0 0.021827956661581993
codon O 0 0.0745580717921257
, O 0 0.00596569012850523
1 O 0 0.009638525545597076
was O 0 0.008260766044259071
a O 0 0.01729159988462925
missense O 1 0.9947848916053772
mutation O 1 0.997788667678833
, O 0 0.004780643619596958
and O 0 0.003568605985492468
1 O 0 0.007891267538070679
was O 0 0.005414149258285761
predicted O 0 0.0136356670409441
to O 0 0.005277151707559824
cause O 0 0.1291317194700241
insertion O 0 0.044053561985492706
of O 0 0.004047269932925701
an O 0 0.005513679701834917
isoleucine O 0 0.44278863072395325
in O 0 0.005186513531953096
the O 0 0.006803112104535103
hect O 1 0.5306922197341919
domain O 0 0.01859155111014843
of O 0 0.00512472540140152
the O 0 0.011684387922286987
UBE3A O 1 0.9988037347793579
protein O 0 0.05058186128735542
, O 0 0.004987427964806557
which O 0 0.004228144884109497
functions O 0 0.007617550436407328
in O 0 0.006786029320210218
E2 O 1 0.8664184808731079
binding O 0 0.022515790536999702
and O 0 0.007320484146475792
ubiquitin O 0 0.06320177018642426
transfer O 0 0.0209541954100132
. O 0 0.021331744268536568

Eight O 0 0.013302910141646862
of O 0 0.004649333655834198
the O 0 0.0059334589168429375
cases O 0 0.01704546995460987
were O 0 0.005465800408273935
familial O 1 0.9998455047607422
, O 0 0.003822267521172762
and O 0 0.0025951366405934095
five O 0 0.005201106425374746
were O 0 0.0062782359309494495
sporadic O 0 0.058806631714105606
. O 0 0.01949523761868477

In O 0 0.012911329977214336
two O 0 0.0144365718588233
familial O 1 0.9992824196815491
cases O 0 0.024815702810883522
and O 0 0.004562876187264919
one O 0 0.007579052355140448
sporadic O 0 0.0891403779387474
case O 0 0.014197750017046928
, O 0 0.010808542370796204
mosaicism O 1 0.998047947883606
for O 0 0.017429128289222717
UBE3A O 1 0.9998745918273926
mutations O 1 0.9992994070053101
was O 0 0.012112087570130825
detected O 0 0.07191421836614609
in O 0 0.003913225140422583
the O 0 0.003843562211841345
mother O 0 0.012847148813307285
of O 0 0.0028650162275880575
three O 0 0.003667459823191166
AS B-Disease 0 0.006918421480804682
sons O 0 0.01899116300046444
, O 0 0.003594302572309971
in O 0 0.0031825366895645857
the O 0 0.00615908345207572
maternal O 1 0.9819392561912537
grandfather O 0 0.03342624753713608
of O 0 0.003393205115571618
two O 0 0.002894599922001362
AS B-Disease 0 0.005260495003312826
first O 0 0.005616744048893452
cousins O 0 0.11566272377967834
, O 0 0.0029450994916260242
and O 0 0.0019397460855543613
in O 0 0.0023617325350642204
the O 0 0.0035420286003500223
mother O 0 0.013864527456462383
of O 0 0.003093877574428916
an O 0 0.005209019873291254
AS B-Disease 0 0.013063732534646988
daughter O 0 0.4047083258628845
. O 0 0.02331138402223587

The O 0 0.013234779238700867
frequencies O 0 0.018932919949293137
with O 0 0.00425285380333662
which O 0 0.004546618554741144
we O 0 0.0068209171295166016
detected O 1 0.577002227306366
mutations O 1 0.9644128680229187
were O 0 0.004879442509263754
5 O 0 0.011127342469990253
( O 0 0.008743147365748882
14 O 0 0.009094439446926117
% O 0 0.0070618088357150555
) O 0 0.0042777108028531075
of O 0 0.00280465604737401
35 O 0 0.008069881238043308
in O 0 0.005374777130782604
sporadic O 0 0.17315445840358734
cases O 0 0.016679977998137474
and O 0 0.0046621570363640785
8 O 0 0.013171316124498844
( O 0 0.008577043190598488
80 O 0 0.013455933891236782
% O 0 0.00892830453813076
) O 0 0.005406663753092289
of O 0 0.0035053850151598454
10 O 0 0.008146502077579498
in O 0 0.00833183340728283
familial O 1 0.9997473359107971
cases O 0 0.03920693323016167
. O 0 0.010694049298763275
. O 0 0.016641510650515556

The O 0 0.046241339296102524
hemochromatosis B-Disease 1 0.9998726844787598
845 O 1 0.9931898713111877
G O 1 0.9617423415184021
- O 0 0.10978573560714722
- O 0 0.08100685477256775
> O 0 0.22709812223911285
A O 0 0.013617286458611488
and O 0 0.005957060027867556
187 O 0 0.04366162046790123
C O 0 0.06399810314178467
- O 0 0.061860211193561554
- O 0 0.23785001039505005
> O 1 0.9646719694137573
G O 1 0.9707911014556885
mutations O 1 0.9970393180847168
: O 0 0.018866054713726044
prevalence O 1 0.9845582842826843
in O 0 0.008751031942665577
non O 0 0.027284586802124977
- O 0 0.09906687587499619
Caucasian O 1 0.9332022070884705
populations O 0 0.1831083446741104
. O 0 0.02982696332037449

Hemochromatosis B-Disease 1 0.9997071623802185
, O 0 0.01466758269816637
the O 0 0.01645062118768692
inherited B-Disease 1 0.999953031539917
disorder I-Disease 1 0.9999938011169434
of I-Disease 0 0.010777309536933899
iron I-Disease 1 0.9666224718093872
metabolism I-Disease 1 0.9969383478164673
, O 0 0.006155538372695446
leads O 0 0.03221305087208748
, O 0 0.004570541437715292
if O 0 0.007937494665384293
untreated O 1 0.9978678226470947
, O 0 0.005162379704415798
to O 0 0.0059290737845003605
progressive O 1 0.9599553346633911
iron B-Disease 1 0.6162816882133484
overload I-Disease 1 0.9962846040725708
and O 0 0.013142893090844154
premature B-Disease 1 0.9984962940216064
death I-Disease 0 0.2784632742404938
. O 0 0.02362980879843235

The O 0 0.04433548450469971
hemochromatosis B-Disease 1 0.9999759197235107
gene O 1 0.9960681200027466
, O 0 0.0184672512114048
HFE O 1 0.9995495676994324
, O 0 0.00807501282542944
recently O 0 0.012639347463846207
has O 0 0.005351747386157513
been O 0 0.004572286270558834
identified O 0 0.010314790531992912
, O 0 0.00302610220387578
and O 0 0.0025816871784627438
characterization O 0 0.014565005898475647
of O 0 0.0034249427262693644
this O 0 0.005742519628256559
gene O 1 0.7158234715461731
has O 0 0.005428158212453127
shown O 0 0.0073927054181694984
that O 0 0.0020611274521797895
it O 0 0.002580848755314946
contains O 0 0.0053220936097204685
two O 0 0.00489442003890872
mutations O 1 0.9337752461433411
that O 0 0.004213977139443159
result O 0 0.008934669196605682
in O 0 0.00534408213570714
amino O 0 0.03198518231511116
acid O 0 0.057854149490594864
substitutions O 0 0.03644544258713722
- O 0 0.044625841081142426
cDNA O 0 0.10291942954063416
nucleotides O 0 0.07477366924285889
845 O 1 0.959396481513977
G O 1 0.8826391696929932
- O 0 0.07284072041511536
- O 0 0.09129441529512405
> O 0 0.4842125475406647
A O 0 0.01993626356124878
( O 0 0.01796153374016285
C282Y O 0 0.4228247404098511
) O 0 0.009550739079713821
and O 0 0.006115890108048916
187 O 0 0.04250754043459892
C O 0 0.06381385773420334
- O 0 0.0582694411277771
- O 0 0.1912194788455963
> O 1 0.9524445533752441
G O 0 0.4611037075519562
( O 0 0.028133437037467957
H63D O 1 0.8530848026275635
) O 0 0.022120259702205658
. O 0 0.021305449306964874

Although O 0 0.056332942098379135
hemochromatosis B-Disease 1 0.9998846054077148
is O 0 0.013285808265209198
common O 0 0.01622321829199791
in O 0 0.00881408341228962
Caucasians O 1 0.9327632784843445
, O 0 0.012741775251924992
affecting O 1 0.961310863494873
> O 1 0.9938437938690186
= O 0 0.07034087926149368
1 O 0 0.019451579079031944
/ O 0 0.04717960208654404
300 O 0 0.012745649553835392
individuals O 0 0.007472732570022345
of O 0 0.003209727816283703
northern O 0 0.009119883179664612
European O 0 0.007273515686392784
origin O 0 0.008677166886627674
, O 0 0.002679676515981555
it O 0 0.0022765754256397486
has O 0 0.002973527880385518
not O 0 0.0024486808106303215
been O 0 0.0037634840700775385
recognized O 0 0.008647153154015541
in O 0 0.004218697547912598
other O 0 0.005660058464854956
populations O 0 0.049822475761175156
. O 0 0.019852876663208008

The O 0 0.013934217393398285
present O 0 0.011578508652746677
study O 0 0.013076813891530037
used O 0 0.00806341040879488
PCR O 0 0.05981322005391121
and O 0 0.007317979354411364
restriction O 0 0.030351268127560616
- O 0 0.03925616294145584
enzyme O 0 0.10129896551370621
digestion O 0 0.31292295455932617
to O 0 0.004978762473911047
analyze O 0 0.016408788040280342
the O 0 0.005191618576645851
frequency O 0 0.016132129356265068
of O 0 0.004531898070126772
the O 0 0.009595534764230251
845 O 1 0.9761365652084351
G O 1 0.8655655980110168
- O 0 0.06732772290706635
- O 0 0.06458178162574768
> O 0 0.11404725164175034
A O 0 0.012239315547049046
and O 0 0.006033808458596468
187 O 0 0.04057430475950241
C O 0 0.08260367065668106
- O 0 0.07026994228363037
- O 0 0.3254949450492859
> O 1 0.9466533660888672
G O 1 0.8543412089347839
mutations O 1 0.9722909927368164
in O 0 0.016235684975981712
HLA O 1 0.9977709054946899
- O 0 0.04238962009549141
typed O 0 0.04633578285574913
samples O 0 0.022206738591194153
from O 0 0.009089506231248379
non O 0 0.026127934455871582
- O 0 0.06382282078266144
Caucasian O 1 0.9585339426994324
populations O 0 0.05779207870364189
, O 0 0.006096975412219763
comprising O 0 0.013303385116159916
Australian O 0 0.019050121307373047
Aboriginal O 0 0.025368327274918556
, O 0 0.004301746375858784
Chinese O 0 0.006682872772216797
, O 0 0.004724701400846243
and O 0 0.005725971423089504
Pacific O 0 0.029620375484228134
Islanders O 0 0.0836956799030304
. O 0 0.02623007632791996

Results O 0 0.03278271108865738
showed O 0 0.01705835945904255
that O 0 0.005520641803741455
the O 0 0.009924927726387978
845 O 1 0.9881600141525269
G O 1 0.8656986951828003
- O 0 0.06935256719589233
- O 0 0.093857042491436
> O 1 0.7766192555427551
A O 0 0.025347845628857613
mutation O 1 0.9963856935501099
was O 0 0.006354980170726776
present O 0 0.005508072208613157
in O 0 0.0036907147150486708
these O 0 0.004841318819671869
populations O 0 0.051389794796705246
( O 0 0.01783771626651287
allele O 1 0.9830307364463806
frequency O 0 0.03997448831796646
0 O 0 0.021246399730443954
. O 0 0.005081634968519211
32 O 0 0.011528017930686474
% O 0 0.007009205874055624
) O 0 0.004219056572765112
, O 0 0.002710050204768777
and O 0 0.0021388940513134003
, O 0 0.0028887237422168255
furthermore O 0 0.009433267638087273
, O 0 0.0028622744139283895
it O 0 0.002610632684081793
was O 0 0.003956207539886236
always O 0 0.00582890585064888
seen O 0 0.008151274174451828
in O 0 0.004904214292764664
conjunction O 0 0.022385798394680023
with O 0 0.013720015063881874
HLA O 1 0.9997101426124573
haplotypes O 1 0.9928580522537231
common O 0 0.023825714364647865
in O 0 0.008923958986997604
Caucasians O 1 0.9756149053573608
, O 0 0.006235831417143345
suggesting O 0 0.020046265795826912
that O 0 0.007895001210272312
845 O 1 0.994163453578949
G O 1 0.9824001789093018
- O 0 0.3549709916114807
- O 0 0.37734925746917725
> O 1 0.9043376445770264
A O 0 0.013277148827910423
may O 0 0.008828801102936268
have O 0 0.003460766514763236
been O 0 0.004454184323549271
introduced O 0 0.007069500163197517
into O 0 0.004911659751087427
these O 0 0.004678217228502035
populations O 0 0.028675638139247894
by O 0 0.015643516555428505
Caucasian O 1 0.9651051163673401
admixture O 1 0.9695214629173279
. O 0 0.03572846204042435

187 O 0 0.10807837545871735
C O 0 0.22396697103977203
- O 0 0.1967356950044632
- O 0 0.3869335353374481
> O 1 0.9292436838150024
G O 0 0.10260316729545593
was O 0 0.006950075272470713
present O 0 0.0064729126170277596
at O 0 0.005823795683681965
an O 0 0.007798719685524702
allele O 1 0.9055197238922119
frequency O 0 0.026066603139042854
of O 0 0.006488079205155373
2 O 0 0.015126948244869709
. O 0 0.015196125954389572

68 O 0 0.044951096177101135
% O 0 0.01135930884629488
in O 0 0.004140807315707207
the O 0 0.0043893237598240376
two O 0 0.005192534998059273
populations O 0 0.031189128756523132
analyzed O 0 0.020809462293982506
( O 0 0.011094074696302414
Australian O 0 0.014897347427904606
Aboriginal O 0 0.025453606620430946
and O 0 0.004677464719861746
Chinese O 0 0.013184996321797371
) O 0 0.012912003323435783
. O 0 0.016799863427877426

In O 0 0.009257791563868523
the O 0 0.007431562524288893
Australian O 0 0.017396176233887672
Aboriginal O 0 0.02752681076526642
samples O 0 0.017343955114483833
, O 0 0.005754127167165279
187 O 0 0.04314202815294266
C O 0 0.266969233751297
- O 0 0.11104674637317657
- O 0 0.2735207676887512
> O 1 0.9524601697921753
G O 0 0.14743493497371674
was O 0 0.005022403318434954
found O 0 0.004760510753840208
to O 0 0.0025778424460440874
be O 0 0.002824243623763323
associated O 0 0.010616740211844444
with O 0 0.010353821329772472
HLA O 1 0.9998369216918945
haplotypes O 1 0.9964936375617981
common O 0 0.021140076220035553
in O 0 0.009247631765902042
Caucasians O 1 0.9652575254440308
, O 0 0.006050093565136194
suggesting O 0 0.012943406589329243
that O 0 0.002715272130444646
it O 0 0.0026260653976351023
was O 0 0.004655543249100447
introduced O 0 0.010293521918356419
by O 0 0.008244180120527744
recent O 0 0.023727046325802803
admixture O 1 0.8970658183097839
. O 0 0.024303874000906944

In O 0 0.007859431207180023
the O 0 0.006120898295193911
Chinese O 0 0.008817058056592941
samples O 0 0.019633736461400986
analyzed O 0 0.020923761650919914
, O 0 0.007555181160569191
187 O 0 0.04661700874567032
C O 0 0.07972769439220428
- O 0 0.10859090089797974
- O 0 0.38970232009887695
> O 1 0.9748791456222534
G O 0 0.2897176742553711
was O 0 0.0059304931201040745
present O 0 0.0052096000872552395
in O 0 0.0034294540528208017
association O 0 0.00841874722391367
with O 0 0.0031890871468931437
a O 0 0.0064941891469061375
wide O 0 0.012767431326210499
variety O 0 0.009629194624722004
of O 0 0.008967654779553413
HLA O 1 0.9998530149459839
haplotypes O 1 0.9964307546615601
, O 0 0.006928928662091494
showing O 0 0.0160329919308424
this O 0 0.007018158677965403
mutation O 1 0.9980862140655518
to O 0 0.003811914473772049
be O 0 0.0033044242300093174
widespread O 0 0.018621724098920822
and O 0 0.0034226421266794205
likely O 0 0.008233181200921535
to O 0 0.004155913833528757
predate O 0 0.04503733664751053
the O 0 0.0054970248602330685
more O 0 0.007790160831063986
genetically O 0 0.049053315073251724
restricted O 0 0.036787740886211395
845 O 1 0.9929077625274658
G O 1 0.9502918124198914
- O 0 0.10395968705415726
- O 0 0.19344785809516907
> O 1 0.7574414610862732
A O 0 0.041343387216329575
mutation O 1 0.9871905446052551
. O 0 0.03149646148085594

Genotype O 1 0.9978804588317871
- O 1 0.8870269656181335
phenotype O 1 0.9971946477890015
correlations O 0 0.4362563192844391
in O 0 0.03665284812450409
attenuated B-Disease 1 0.9998601675033569
adenomatous I-Disease 1 0.9999985694885254
polyposis I-Disease 1 0.9999983310699463
coli I-Disease 1 0.9999496936798096
. O 0 0.0683279037475586

Germ O 1 0.9709928035736084
- O 0 0.07487718760967255
line O 0 0.03143402934074402
mutations O 1 0.9113788604736328
of O 0 0.008852553553879261
the O 0 0.02081742137670517
tumor B-Disease 1 0.9999306201934814
suppressor O 1 0.9997050166130066
APC O 1 0.9919443130493164
are O 0 0.011379526928067207
implicated O 1 0.7040662169456482
in O 0 0.03014908917248249
attenuated B-Disease 1 0.9998291730880737
adenomatous I-Disease 1 0.999998927116394
polyposis I-Disease 1 0.9999986886978149
coli I-Disease 1 0.9999874830245972
( O 1 0.5303439497947693
AAPC B-Disease 1 0.999289870262146
) O 0 0.013183439150452614
, O 0 0.005727299489080906
a O 0 0.014009526930749416
variant O 1 0.934185266494751
of O 0 0.03234688192605972
familial B-Disease 1 0.9999910593032837
adenomatous I-Disease 1 0.999998927116394
polyposis I-Disease 1 0.999998927116394
( O 1 0.9326578378677368
FAP B-Disease 1 0.9997847676277161
) O 0 0.032490503042936325
. O 0 0.02661578170955181

AAPC B-Disease 1 0.995133101940155
is O 0 0.014612160623073578
recognized O 0 0.013041354715824127
by O 0 0.005767101887613535
the O 0 0.006159530021250248
occurrence O 0 0.07598255574703217
of O 0 0.010799187235534191
< O 1 0.8944648504257202
100 O 0 0.02817700244486332
colonic B-Disease 1 0.9993756413459778
adenomas I-Disease 1 0.9985892176628113
and O 0 0.005537062883377075
a O 0 0.011436260305345058
later O 0 0.01816076971590519
onset O 1 0.9997872710227966
of O 0 0.38863030076026917
colorectal B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.999998927116394
( O 0 0.053805239498615265
age O 0 0.25570860505104065
> O 1 0.9716193675994873
40 O 0 0.019231829792261124
years O 0 0.014551528729498386
) O 0 0.015163848176598549
. O 0 0.018085375428199768

The O 0 0.011791924946010113
aim O 0 0.01600349135696888
of O 0 0.0042532216757535934
this O 0 0.004200658295303583
study O 0 0.007716561201959848
was O 0 0.005718717351555824
to O 0 0.0064516994170844555
assess O 0 0.1209104135632515
genotype O 1 0.9978018403053284
- O 1 0.7812964916229248
phenotype O 1 0.9990997314453125
correlations O 0 0.22491012513637543
in O 0 0.019050398841500282
AAPC B-Disease 1 0.9990193843841553
families O 0 0.04463893920183182
. O 0 0.02593030408024788

By O 0 0.03214810788631439
protein O 0 0.0794517770409584
- O 0 0.05951978638768196
truncation O 1 0.5433958768844604
test O 0 0.03205473721027374
( O 0 0.018489589914679527
PTT O 0 0.08779437094926834
) O 0 0.010353674180805683
assay O 0 0.028071170672774315
, O 0 0.003678997978568077
the O 0 0.004517578519880772
entire O 0 0.01691228151321411
coding O 0 0.043234121054410934
region O 0 0.011973598040640354
of O 0 0.005325565580278635
the O 0 0.011749012395739555
APC B-Disease 1 0.9968264102935791
gene O 1 0.9395339488983154
was O 0 0.0105291111394763
screened O 0 0.029953226447105408
in O 0 0.007185544352978468
affected O 0 0.03221093863248825
individuals O 0 0.012192524038255215
from O 0 0.009905622340738773
11 O 0 0.030787963420152664
AAPC B-Disease 1 0.9989168643951416
kindreds O 1 0.9847197532653809
, O 0 0.006100998725742102
and O 0 0.0038033900782465935
their O 0 0.0069699217565357685
phenotypic O 1 0.9661834836006165
differences O 0 0.017241621389985085
were O 0 0.006787385791540146
examined O 0 0.041841328144073486
. O 0 0.017988892272114754

Five O 0 0.031642135232686996
novel O 0 0.06550147384405136
germ O 1 0.9338987469673157
- O 0 0.08426742255687714
line O 0 0.04390167444944382
APC B-Disease 1 0.9934921860694885
mutations O 1 0.9763031005859375
were O 0 0.007092572282999754
identified O 0 0.01742069609463215
in O 0 0.007674945052713156
seven O 0 0.01707479916512966
kindreds O 1 0.9297183752059937
. O 0 0.026581069454550743

Mutations O 1 0.9884989857673645
were O 0 0.005741289351135492
located O 0 0.007080908864736557
in O 0 0.0031242785044014454
three O 0 0.003068630350753665
different O 0 0.0034746360033750534
regions O 0 0.009646457619965076
of O 0 0.004399533849209547
the O 0 0.010659286752343178
APC B-Disease 1 0.998462438583374
gene O 1 0.9489675164222717
( O 0 0.01226421445608139
1 O 0 0.011263731867074966
) O 0 0.00589487561956048
at O 0 0.0038270424120128155
the O 0 0.005341243930160999
5 O 0 0.011039571836590767
end O 0 0.014980146661400795
spanning O 0 0.034583352506160736
exons O 0 0.08067331463098526
4 O 0 0.013162518851459026
and O 0 0.004102571867406368
5 O 0 0.009029828011989594
, O 0 0.00456438260152936
( O 0 0.0077525656670331955
2 O 0 0.007924569770693779
) O 0 0.0062544927932322025
within O 0 0.00896227452903986
exon O 0 0.2695673406124115
9 O 0 0.015119164250791073
, O 0 0.0039795455522835255
and O 0 0.0031736467499285936
( O 0 0.007091480772942305
3 O 0 0.008012994192540646
) O 0 0.004412240348756313
at O 0 0.0041936347261071205
the O 0 0.004793078638613224
3 O 0 0.016419997438788414
distal O 1 0.9933950304985046
end O 0 0.012043977156281471
of O 0 0.006222525145858526
the O 0 0.010743727907538414
gene O 1 0.7687309980392456
. O 0 0.021842366084456444

Variability O 0 0.09122417122125626
in O 0 0.007228730712085962
the O 0 0.0062171779572963715
number O 0 0.009442429058253765
of O 0 0.017610857263207436
colorectal B-Disease 1 0.9999997615814209
adenomas I-Disease 1 0.9999746084213257
was O 0 0.011997726745903492
most O 0 0.007644726894795895
apparent O 0 0.026608478277921677
in O 0 0.0042644767090678215
individuals O 0 0.008734849281609058
with O 0 0.007138494867831469
mutations O 1 0.9954291582107544
in O 0 0.005050595849752426
region O 0 0.013089645653963089
1 O 0 0.008112712763249874
, O 0 0.0035854692105203867
and O 0 0.005416082218289375
upper O 1 0.8899734020233154
- O 1 0.9939684867858887
gastrointestinal O 1 0.9999830722808838
manifestations O 1 0.9901944994926453
were O 0 0.0049474504776299
more O 0 0.0071579948998987675
severe O 1 0.9995400905609131
in O 0 0.005491948686540127
them O 0 0.007427012547850609
. O 0 0.015841344371438026

In O 0 0.012746058404445648
individuals O 0 0.014754640869796276
with O 0 0.009492238983511925
mutations O 1 0.9786362051963806
in O 0 0.005761655978858471
either O 0 0.008779228664934635
region O 0 0.014463837258517742
2 O 0 0.008313746191561222
or O 0 0.00555837107822299
region O 0 0.010405200533568859
3 O 0 0.006737090647220612
, O 0 0.0025610998272895813
the O 0 0.0033234336879104376
average O 0 0.009420618414878845
number O 0 0.005478250794112682
of O 0 0.006889615207910538
adenomas B-Disease 1 0.9994879961013794
tended O 0 0.024830607697367668
to O 0 0.0031342606525868177
be O 0 0.002429598243907094
lower O 0 0.006817148998379707
than O 0 0.002842365298420191
those O 0 0.00261619477532804
in O 0 0.0026420848444104195
individuals O 0 0.008063173852860928
with O 0 0.005743157118558884
mutations O 1 0.9917986392974854
in O 0 0.005354801658540964
region O 0 0.013139202259480953
1 O 0 0.00824467558413744
, O 0 0.0038314422126859426
although O 0 0.006691335700452328
age O 0 0.015563915483653545
at O 0 0.011175080202519894
diagnosis O 1 0.9995599389076233
was O 0 0.010599612258374691
similar O 0 0.0192958265542984
. O 0 0.017725858837366104

In O 0 0.017174536362290382
all O 0 0.01817093789577484
AAPC B-Disease 1 0.9990546107292175
kindreds O 1 0.984114408493042
, O 0 0.007300288882106543
a O 0 0.012669011019170284
predominance O 0 0.15680034458637238
of O 0 0.01065617986023426
right O 0 0.07935547083616257
- O 1 0.893161416053772
sided O 1 0.996229350566864
colorectal B-Disease 1 0.9999973773956299
adenomas I-Disease 1 0.9999487400054932
and O 0 0.1545431911945343
rectal B-Disease 1 0.9999786615371704
polyp I-Disease 1 0.9999411106109619
sparing O 1 0.9722445011138916
was O 0 0.023133181035518646
observed O 0 0.04312526062130928
. O 0 0.01922968216240406

No O 0 0.04428224265575409
desmoid B-Disease 1 0.9993797540664673
tumors I-Disease 1 0.9999117851257324
were O 0 0.005761958658695221
found O 0 0.007702302653342485
in O 0 0.005606419872492552
these O 0 0.008153070695698261
kindreds O 1 0.763302206993103
. O 0 0.028398655354976654

Our O 0 0.014786353334784508
data O 0 0.009325863793492317
suggest O 0 0.012402927502989769
that O 0 0.004064762033522129
, O 0 0.004620697814971209
in O 0 0.008352294564247131
AAPC B-Disease 1 0.9994373917579651
families O 0 0.011628054082393646
, O 0 0.003013394307345152
the O 0 0.0028395631816238165
location O 0 0.005823801271617413
of O 0 0.0035446619149297476
the O 0 0.009234525263309479
APC B-Disease 1 0.9992374181747437
mutation O 1 0.9993388056755066
may O 0 0.022183800116181374
partially O 0 0.07890191674232483
predict O 0 0.03980741277337074
specific O 0 0.024037115275859833
phenotypic O 1 0.9691948294639587
expression O 0 0.06775862723588943
. O 0 0.02094288542866707

This O 0 0.00947495736181736
should O 0 0.005864532198756933
help O 0 0.006822723429650068
in O 0 0.003281886223703623
the O 0 0.0033710391726344824
design O 0 0.0057930112816393375
of O 0 0.0049385190941393375
tailored O 1 0.6751897931098938
clinical O 1 0.9922609925270081
- O 0 0.06295869499444962
management O 0 0.016743386164307594
protocols O 0 0.017364254221320152
in O 0 0.004219693597406149
this O 0 0.005648433696478605
subset O 0 0.037853140383958817
of O 0 0.015104204416275024
FAP B-Disease 1 0.9999682903289795
patients O 1 0.9994139671325684
. O 0 0.014161411672830582
. O 0 0.01680171489715576

Wilms B-Disease 1 0.9995951056480408
' I-Disease 1 0.8174351453781128
tumor I-Disease 1 0.9997361302375793
1 O 0 0.020204542204737663
and O 0 0.008202051743865013
Dax O 1 0.8665464520454407
- O 0 0.03645318001508713
1 O 0 0.01798834465444088
modulate O 0 0.28151676058769226
the O 0 0.010282530449330807
orphan O 1 0.9890817403793335
nuclear O 0 0.03457305580377579
receptor O 1 0.9758694767951965
SF O 1 0.9933167695999146
- O 0 0.0374501571059227
1 O 0 0.012597505003213882
in O 0 0.006496143061667681
sex O 0 0.029713785275816917
- O 0 0.035337891429662704
specific O 0 0.023623673245310783
gene O 1 0.6113519072532654
expression O 0 0.05658494308590889
. O 0 0.02043852210044861

Products O 0 0.02676542103290558
of O 0 0.014395825564861298
steroidogenic O 1 0.9977672100067139
factor O 0 0.06787782907485962
1 O 0 0.021596059203147888
( O 0 0.020421702414751053
SF O 1 0.9953672885894775
- O 0 0.03381314128637314
1 O 0 0.016651425510644913
) O 0 0.01166392769664526
and O 0 0.012190388515591621
Wilms B-Disease 1 0.9999587535858154
tumor I-Disease 1 0.9999113082885742
1 O 0 0.03001008741557598
( O 0 0.022410303354263306
WT1 O 1 0.9984989166259766
) O 0 0.014539017342031002
genes O 0 0.04982590675354004
are O 0 0.0034634710755199194
essential O 0 0.00795135460793972
for O 0 0.006247768644243479
mammalian O 1 0.9162794351577759
gonadogenesis O 1 0.9468376040458679
prior O 0 0.014764710329473019
to O 0 0.008516600355505943
sexual O 0 0.043346770107746124
differentiation O 0 0.1359962373971939
. O 0 0.02326427958905697

In O 0 0.017521586269140244
males O 1 0.5795345902442932
, O 0 0.013293012045323849
SF O 1 0.9977666139602661
- O 0 0.04406839981675148
1 O 0 0.01475943811237812
participates O 0 0.02805241383612156
in O 0 0.0071358634158968925
sexual O 0 0.0179289523512125
development O 0 0.00932118110358715
by O 0 0.007438903208822012
regulating O 0 0.03611506149172783
expression O 0 0.02221429906785488
of O 0 0.005939365364611149
the O 0 0.013043041341006756
polypeptide O 1 0.9841496348381042
hormone O 1 0.995882511138916
Mullerian O 1 0.9955300688743591
inhibiting O 1 0.9769271612167358
substance O 0 0.2853173613548279
( O 0 0.04082302376627922
MIS O 1 0.9878009557723999
) O 0 0.02204647846519947
. O 0 0.021894283592700958

Here O 0 0.012722336687147617
, O 0 0.005912738852202892
we O 0 0.004414325580000877
show O 0 0.01186235062777996
that O 0 0.01013909000903368
WT1 O 1 0.9987785220146179
- O 1 0.7205204963684082
KTS O 1 0.9967474937438965
isoforms O 0 0.13434068858623505
associate O 0 0.021726010367274284
and O 0 0.008072083815932274
synergize O 1 0.983534038066864
with O 0 0.015320338308811188
SF O 1 0.9968777894973755
- O 0 0.034827105700969696
1 O 0 0.013657118193805218
to O 0 0.007406624034047127
promote O 0 0.032745007425546646
MIS O 1 0.9790111184120178
expression O 0 0.07521016895771027
. O 0 0.02589106373488903

In O 0 0.017380043864250183
contrast O 0 0.035310354083776474
, O 0 0.022191572934389114
WT1 O 1 0.9990465044975281
missense O 1 0.9990793466567993
mutations O 1 0.9983385801315308
, O 0 0.00956475455313921
associated O 0 0.014463483355939388
with O 0 0.0075464509427547455
male B-Disease 0 0.1639961153268814
pseudohermaphroditism I-Disease 1 0.9947512745857239
in O 0 0.019539549946784973
Denys B-Disease 1 0.9995763897895813
- I-Disease 1 0.9961864352226257
Drash I-Disease 1 0.9997695088386536
syndrome I-Disease 1 0.9999982118606567
, O 0 0.014944558031857014
fail O 0 0.06883782148361206
to O 0 0.011545316316187382
synergize O 1 0.9368635416030884
with O 0 0.01919541135430336
SF O 1 0.9961968660354614
- O 0 0.055330391973257065
1 O 0 0.03157311677932739
. O 0 0.02400094084441662

Additionally O 0 0.03247690200805664
, O 0 0.006357185076922178
the O 0 0.008033226244151592
X O 0 0.40912801027297974
- O 0 0.03385717794299126
linked O 0 0.03515348955988884
, O 0 0.008243431337177753
candidate O 0 0.031029794365167618
dosage O 1 0.8695051074028015
- O 0 0.045198652893304825
sensitive O 0 0.03533988073468208
sex O 0 0.04560466110706329
- O 0 0.06701605767011642
reversal O 1 0.5910831093788147
gene O 1 0.85866779088974
, O 0 0.009197691455483437
Dax O 1 0.9078237414360046
- O 0 0.031559526920318604
1 O 0 0.014482507482171059
, O 0 0.00967311579734087
antagonizes O 1 0.940020740032196
synergy O 0 0.2926125228404999
between O 0 0.020493732765316963
SF O 1 0.9979578256607056
- O 0 0.041727080941200256
1 O 0 0.016660165041685104
and O 0 0.008568025194108486
WT1 O 1 0.9978355765342712
, O 0 0.005043669603765011
most O 0 0.004742354154586792
likely O 0 0.008878124877810478
through O 0 0.005235848017036915
a O 0 0.007738301996141672
direct O 0 0.013464214280247688
interaction O 0 0.02086627297103405
with O 0 0.012446517124772072
SF O 1 0.9919931888580322
- O 0 0.050483088940382004
1 O 0 0.028760472312569618
. O 0 0.02267508953809738

We O 0 0.015050585381686687
propose O 0 0.03383606672286987
that O 0 0.013384043239057064
WT1 O 1 0.9969622492790222
and O 0 0.012847857549786568
Dax O 1 0.8933045864105225
- O 0 0.0434274785220623
1 O 0 0.022385720163583755
functionally O 0 0.11657214164733887
oppose O 0 0.01736314594745636
each O 0 0.005258976016193628
other O 0 0.003502611070871353
in O 0 0.006404756102710962
testis O 1 0.9821339249610901
development O 0 0.013641217723488808
by O 0 0.01594368740916252
modulating O 1 0.9964337348937988
SF O 1 0.996394693851471
- O 0 0.062449321150779724
1 O 0 0.03231852129101753
- O 0 0.07437620311975479
mediated O 1 0.7631826400756836
transactivation O 1 0.9867554306983948
. O 0 0.015547473914921284
. O 0 0.019949907436966896

A O 0 0.05158398672938347
mouse O 1 0.599122941493988
model O 0 0.03154081106185913
for O 0 0.02048867754638195
Prader B-Disease 1 0.9997556805610657
- I-Disease 1 0.9981369972229004
Willi I-Disease 1 0.9999796152114868
syndrome I-Disease 1 0.9999992847442627
imprinting O 1 0.999566376209259
- O 1 0.8707168698310852
centre O 0 0.17228484153747559
mutations O 1 0.9921140670776367
. O 0 0.03261750191450119

Imprinting O 1 0.833886981010437
in O 0 0.01168186217546463
the O 0 0.01346585527062416
15q11 O 1 0.966429591178894
- O 0 0.11599034070968628
q13 O 1 0.9397633671760559
region O 0 0.025658736005425453
involves O 0 0.032626520842313766
an O 0 0.013563079759478569
imprinting O 1 0.9832965135574341
centre O 0 0.03402606025338173
( O 0 0.019062798470258713
IC O 1 0.7917482852935791
) O 0 0.00892891176044941
, O 0 0.003992361482232809
mapping O 0 0.012925155460834503
in O 0 0.00288582150824368
part O 0 0.004230942111462355
to O 0 0.0029523700941354036
the O 0 0.005755921825766563
promoter O 0 0.04593275487422943
and O 0 0.0052117034792900085
first O 0 0.010554571636021137
exon O 0 0.08310005813837051
of O 0 0.013670754618942738
SNRPN O 1 0.9705075025558472
. O 0 0.026133770123124123

Deletion O 1 0.6800415515899658
of O 0 0.011281220242381096
this O 0 0.013629358261823654
IC O 1 0.8731257319450378
abolishes O 1 0.9762752652168274
local O 0 0.023590954020619392
paternally O 1 0.974643349647522
derived O 0 0.04470854997634888
gene O 1 0.8981542587280273
expression O 0 0.026785802096128464
and O 0 0.0054470752365887165
results O 0 0.016483450308442116
in O 0 0.016121257096529007
Prader B-Disease 1 0.999948263168335
- I-Disease 1 0.9995576739311218
Willi I-Disease 1 0.9999961853027344
syndrome I-Disease 1 0.9999997615814209
( O 1 0.5844365358352661
PWS B-Disease 1 0.9998216032981873
) O 0 0.0344376415014267
. O 0 0.022619500756263733

We O 0 0.00818056333810091
have O 0 0.006152575369924307
created O 0 0.011705839075148106
two O 0 0.00940216425806284
deletion O 1 0.9884977340698242
mutations O 1 0.9977218508720398
in O 0 0.011612288653850555
mice O 1 0.9932689070701599
to O 0 0.007634149398654699
understand O 0 0.028754254803061485
PWS B-Disease 1 0.9988164901733398
and O 0 0.0042633251287043095
the O 0 0.004834101069718599
mechanism O 0 0.016841944307088852
of O 0 0.006271180231124163
this O 0 0.011265955865383148
IC O 1 0.8272231817245483
. O 0 0.02527971938252449

Mice O 1 0.9875304698944092
harbouring O 1 0.8463374972343445
an O 0 0.02286973036825657
intragenic O 1 0.9860526323318481
deletion O 1 0.9365564584732056
in O 0 0.011565624736249447
Snrpn O 1 0.9610483050346375
are O 0 0.009110404178500175
phenotypically O 1 0.9963984489440918
normal O 0 0.03221364691853523
, O 0 0.0057426695711910725
suggesting O 0 0.017940618097782135
that O 0 0.007078113500028849
mutations O 1 0.9908588528633118
of O 0 0.00789069663733244
SNRPN O 1 0.9934501051902771
are O 0 0.004192599561065435
not O 0 0.004088261630386114
sufficient O 0 0.012351691722869873
to O 0 0.011283078230917454
induce O 1 0.9617406725883484
PWS B-Disease 1 0.9986101388931274
. O 0 0.03898673504590988

Mice O 1 0.9744040966033936
with O 0 0.010601602494716644
a O 0 0.014462756924331188
larger O 0 0.028456201776862144
deletion O 1 0.8059058785438538
involving O 0 0.023353781551122665
both O 0 0.009109404869377613
Snrpn O 1 0.6654722690582275
and O 0 0.006408558692783117
the O 0 0.013167778961360455
putative O 1 0.9812330007553101
PWS O 1 0.9997275471687317
- O 0 0.34596988558769226
IC O 1 0.8589817881584167
lack O 0 0.02718466892838478
expression O 0 0.02254379540681839
of O 0 0.0056566777639091015
the O 0 0.010602333582937717
imprinted O 1 0.9960998296737671
genes O 1 0.9883134365081787
Zfp127 O 1 0.9970782995223999
( O 0 0.03111705183982849
mouse O 1 0.9782978892326355
homologue O 1 0.8671348690986633
of O 0 0.014165632426738739
ZNF127 O 1 0.9952083230018616
) O 0 0.014179788529872894
, O 0 0.009912814013659954
Ndn O 1 0.9921697974205017
and O 0 0.007877451367676258
Ipw O 1 0.8796535134315491
, O 0 0.004996342584490776
and O 0 0.004595150239765644
manifest O 0 0.03314419090747833
several O 0 0.009122434072196484
phenotypes O 1 0.9851213693618774
common O 0 0.027638526633381844
to O 0 0.0163603276014328
PWS B-Disease 1 0.9999169111251831
infants O 1 0.999211311340332
. O 0 0.030121829360723495

These O 0 0.007474695332348347
data O 0 0.005872482433915138
demonstrate O 0 0.008374575525522232
that O 0 0.0021371799521148205
both O 0 0.002239051042124629
the O 0 0.002448126208037138
position O 0 0.0035146784503012896
of O 0 0.002513471059501171
the O 0 0.005195811856538057
IC O 0 0.3975493311882019
and O 0 0.0032648181077092886
its O 0 0.0040177046321332455
role O 0 0.007780853193253279
in O 0 0.0033920826390385628
the O 0 0.0050431666895747185
coordinate O 0 0.019213706254959106
expression O 0 0.020237604156136513
of O 0 0.006016414146870375
genes O 0 0.24128003418445587
is O 0 0.006302223540842533
conserved O 0 0.02220429852604866
between O 0 0.00870603695511818
mouse O 1 0.9550417065620422
and O 0 0.004524334333837032
human O 0 0.010888868942856789
, O 0 0.002864216919988394
and O 0 0.0023809310514479876
indicate O 0 0.007787260692566633
that O 0 0.0024879942648112774
the O 0 0.005195314064621925
mouse O 1 0.8490479588508606
is O 0 0.0055170911364257336
a O 0 0.006572002079337835
suitable O 0 0.011546849273145199
model O 0 0.008788012899458408
system O 0 0.0060140276327729225
in O 0 0.002275806851685047
which O 0 0.0022858090233057737
to O 0 0.0025676139630377293
investigate O 0 0.011120781302452087
the O 0 0.0056768748909235
molecular O 0 0.021996714174747467
mechanisms O 0 0.016940178349614143
of O 0 0.005810183938592672
imprinting O 1 0.9061437845230103
in O 0 0.0042558033019304276
this O 0 0.0037505519576370716
region O 0 0.009112848900258541
of O 0 0.0041285185143351555
the O 0 0.007607301697134972
genome O 0 0.3068925738334656
. O 0 0.009824260137975216
. O 0 0.015301195904612541

Mutations O 1 0.9685007333755493
of O 0 0.00859847478568554
the O 0 0.013831350952386856
ATM O 1 0.6010045409202576
gene O 1 0.881780207157135
detected O 0 0.07072455435991287
in O 0 0.011484219692647457
Japanese O 0 0.10532840341329575
ataxia B-Disease 1 0.9999872446060181
- I-Disease 1 0.9989043474197388
telangiectasia I-Disease 1 0.9999945163726807
patients O 1 0.9998408555984497
: O 0 0.013437815010547638
possible O 0 0.01188522670418024
preponderance O 0 0.04924677684903145
of O 0 0.0034757559187710285
the O 0 0.004127358086407185
two O 0 0.006216153036803007
founder O 0 0.2554350197315216
mutations O 1 0.9986287355422974
4612del165 O 1 0.9846189618110657
and O 0 0.014397066086530685
7883del5 O 1 0.9310230612754822
. O 0 0.022182779386639595

The O 0 0.021210262551903725
ATM O 0 0.10103330761194229
( O 0 0.015180419199168682
A O 0 0.052722156047821045
- O 1 0.7761589288711548
T O 1 0.998219907283783
, O 0 0.014536740258336067
mutated O 1 0.9962911605834961
) O 0 0.015437912195920944
gene O 0 0.1428840458393097
on O 0 0.009854535572230816
human O 0 0.059065863490104675
chromosome O 1 0.9977326393127441
11q22 O 1 0.9481634497642517
. O 0 0.030262716114521027

3 O 0 0.023793265223503113
has O 0 0.00912277027964592
recently O 0 0.013317118398845196
been O 0 0.006195396650582552
identified O 0 0.011410086415708065
as O 0 0.0032091988250613213
the O 0 0.005879000760614872
gene O 0 0.311908483505249
responsible O 0 0.011952371336519718
for O 0 0.004209611099213362
the O 0 0.008713418617844582
human O 1 0.9894565939903259
recessive B-Disease 1 0.9999991655349731
disease I-Disease 1 0.9999995231628418
ataxia B-Disease 1 0.9999960660934448
- I-Disease 1 0.9991899132728577
telangiectasia I-Disease 1 0.9999828338623047
( O 0 0.05170596018433571
A B-Disease 0 0.42706209421157837
- I-Disease 1 0.943973183631897
T I-Disease 1 0.9979446530342102
) O 0 0.0274081751704216
. O 0 0.024244818836450577

In O 0 0.00865220744162798
order O 0 0.006683220621198416
to O 0 0.0033034710213541985
define O 0 0.008960661478340626
the O 0 0.004593106918036938
types O 0 0.013111524283885956
of O 0 0.009493575431406498
disease O 1 0.9999921321868896
- O 1 0.8575946092605591
causing O 1 0.9944992065429688
ATM O 1 0.9583455920219421
mutations O 1 0.9960512518882751
in O 0 0.007937949150800705
Japanese O 0 0.01976695843040943
A B-Disease 0 0.3462790548801422
- I-Disease 1 0.9957941770553589
T I-Disease 1 0.9998419284820557
patients O 1 0.9982573390007019
as O 0 0.004420497454702854
well O 0 0.003427306655794382
as O 0 0.0029765081126242876
to O 0 0.002970130182802677
look O 0 0.008067812770605087
for O 0 0.004594890400767326
possible O 0 0.01908753626048565
mutational O 1 0.9947028756141663
hotspots O 1 0.5772110819816589
, O 0 0.010900727473199368
reverse O 0 0.0448169931769371
- O 0 0.0371197871863842
transcribed O 0 0.05087578296661377
RNA O 0 0.05333743989467621
derived O 0 0.016308682039380074
from O 0 0.006666173692792654
ten O 0 0.013679553754627705
patients O 1 0.9877091646194458
belonging O 0 0.013450965285301208
to O 0 0.004172097891569138
eight O 0 0.008033359423279762
unrelated O 0 0.02646677754819393
Japanese O 0 0.017914868891239166
A B-Disease 0 0.10466837882995605
- I-Disease 1 0.9192548990249634
T I-Disease 1 0.9981675148010254
families O 0 0.013292468152940273
was O 0 0.006989420857280493
analyzed O 0 0.01672031357884407
for O 0 0.005891548935323954
mutations O 1 0.9125909209251404
by O 0 0.006049875169992447
the O 0 0.009113851934671402
restriction O 0 0.06575556844472885
endonuclease O 1 0.9773564338684082
fingerprinting O 0 0.06597328931093216
method O 0 0.03353920578956604
. O 0 0.02033131755888462

As O 0 0.010401332750916481
has O 0 0.00840306282043457
been O 0 0.007175152190029621
reported O 0 0.013685209676623344
by O 0 0.005129772704094648
others O 0 0.008178929798305035
, O 0 0.006308996584266424
mutations O 1 0.9832335114479065
that O 0 0.0037594102323055267
lead O 0 0.010248572565615177
to O 0 0.006500612944364548
exon O 0 0.3504464626312256
skipping O 0 0.066578209400177
or O 0 0.018682288005948067
premature O 1 0.9907479286193848
protein O 0 0.059030044823884964
truncation O 0 0.23407478630542755
were O 0 0.003980375826358795
also O 0 0.004763524513691664
predominant O 0 0.024215934798121452
in O 0 0.007106333039700985
our O 0 0.014251516200602055
mutants O 1 0.7244774103164673
. O 0 0.0258331298828125

Six O 0 0.02230396866798401
different O 0 0.014755272306501865
mutations O 1 0.8941971063613892
were O 0 0.004501883406192064
identified O 0 0.010888622142374516
on O 0 0.0029838148038834333
12 O 0 0.0058862897567451
of O 0 0.0033615236170589924
the O 0 0.006280910689383745
16 O 0 0.02281913533806801
alleles O 1 0.9870821237564087
examined O 0 0.07772571593523026
. O 0 0.02306019887328148

Four O 0 0.011099238879978657
were O 0 0.006739177741110325
deletions O 0 0.05680549889802933
involving O 0 0.0187740009278059
a O 0 0.01028214581310749
loss O 0 0.019004350528120995
of O 0 0.004901115316897631
a O 0 0.01165827363729477
single O 0 0.023522766306996346
exon O 1 0.5727853775024414
exon O 0 0.3348308801651001
7 O 0 0.02356022037565708
, O 0 0.010353229939937592
exon O 0 0.08388850092887878
16 O 0 0.016589118167757988
, O 0 0.009111729450523853
exon O 0 0.08357693254947662
33 O 0 0.028655800968408585
or O 0 0.017262406647205353
exon O 0 0.20371569693088531
35 O 0 0.036997634917497635
. O 0 0.022984476760029793

The O 0 0.010540736839175224
others O 0 0.009927510283887386
were O 0 0.004938961938023567
minute O 0 0.019439788535237312
deletions O 0 0.08286476135253906
, O 0 0.009601435624063015
4649delA O 1 0.7299706935882568
in O 0 0.01016965787857771
exon O 0 0.4760948121547699
33 O 0 0.024150583893060684
and O 0 0.007765281014144421
7883del5 O 0 0.46450331807136536
in O 0 0.01461150124669075
exon O 0 0.17907142639160156
55 O 0 0.048914868384599686
. O 0 0.028277363628149033

The O 0 0.03357972577214241
mutations O 1 0.9970191717147827
4612del165 O 1 0.9752998948097229
and O 0 0.010647234506905079
7883del5 O 1 0.6994231343269348
were O 0 0.00441373698413372
found O 0 0.005132866092026234
in O 0 0.002993274014443159
more O 0 0.003105500480160117
than O 0 0.004229442216455936
two O 0 0.004879484418779612
unrelated O 0 0.02887149341404438
families O 0 0.014862818643450737
; O 0 0.009173098020255566
44 O 0 0.016620665788650513
% O 0 0.011670767329633236
( O 0 0.00865716952830553
7 O 0 0.0086377477273345
of O 0 0.00348943960852921
16 O 0 0.008020563051104546
) O 0 0.004119740333408117
of O 0 0.002951615024358034
the O 0 0.0077162547968328
mutant O 1 0.992161214351654
alleles O 1 0.9856394529342651
had O 0 0.005283115431666374
one O 0 0.0033433453645557165
of O 0 0.0026419770438224077
the O 0 0.004533789586275816
two O 0 0.009718063287436962
mutations O 1 0.9960370659828186
. O 0 0.021540675312280655

The O 0 0.02484535612165928
4612del165 O 1 0.9929898977279663
mutations O 1 0.9858925938606262
in O 0 0.004905736539512873
three O 0 0.0033872066996991634
different O 0 0.0033339126966893673
families O 0 0.0062738521955907345
were O 0 0.002102320082485676
all O 0 0.002515466185286641
ascribed O 0 0.016445400193333626
to O 0 0.0027454188093543053
the O 0 0.004512994550168514
same O 0 0.012031937949359417
T O 1 0.9899880290031433
- O 0 0.07973264902830124
- O 0 0.0764174684882164
> O 0 0.2548147141933441
A O 0 0.015323087573051453
substitution O 0 0.025985045358538628
at O 0 0.007346438709646463
the O 0 0.009327732026576996
splice O 0 0.444219172000885
donor O 0 0.08915946632623672
site O 0 0.021378930658102036
in O 0 0.01601783186197281
intron O 1 0.8116990923881531
33 O 0 0.05332394689321518
. O 0 0.029500525444746017

Microsatellite O 1 0.9767658710479736
genotyping O 1 0.7719208002090454
around O 0 0.019019681960344315
the O 0 0.011422112584114075
ATM O 0 0.4538233280181885
locus O 1 0.9716171026229858
also O 0 0.00723270932212472
indicated O 0 0.011542829684913158
that O 0 0.004045526962727308
a O 0 0.007891984656453133
common O 0 0.021937251091003418
haplotype O 1 0.9897165894508362
was O 0 0.006002992391586304
shared O 0 0.00781941693276167
by O 0 0.00497063621878624
the O 0 0.007836144417524338
mutant O 1 0.9958985447883606
alleles O 1 0.9880883097648621
in O 0 0.008971203118562698
both O 0 0.013865584507584572
mutations O 1 0.9890528321266174
. O 0 0.022925952449440956

This O 0 0.011789947748184204
suggests O 0 0.014453794807195663
that O 0 0.0033359304070472717
these O 0 0.0029149458277970552
two O 0 0.00402633473277092
founder O 0 0.2645259499549866
mutations O 1 0.9988930821418762
may O 0 0.011777016334235668
be O 0 0.00515371048822999
predominant O 0 0.031133010983467102
among O 0 0.011957592330873013
Japanese O 0 0.03020896390080452
ATM O 1 0.740135133266449
mutant O 1 0.9831516742706299
alleles O 1 0.9690746665000916
. O 0 0.03299298509955406

W474C O 1 0.8537557721138
amino O 0 0.09972771257162094
acid O 0 0.139241024851799
substitution O 0 0.06650201976299286
affects O 0 0.45331695675849915
early O 0 0.012491564266383648
processing O 0 0.009314575232565403
of O 0 0.003801867365837097
the O 0 0.007544833701103926
alpha O 0 0.04172275587916374
- O 0 0.03282606974244118
subunit O 0 0.05169401690363884
of O 0 0.007927858270704746
beta O 0 0.05701422318816185
- O 0 0.050692204385995865
hexosaminidase O 1 0.7528144121170044
A O 0 0.013019582256674767
and O 0 0.0044638896360993385
is O 0 0.0062237572856247425
associated O 0 0.015169075690209866
with O 0 0.014142351225018501
subacute O 1 0.9997609257698059
G B-Disease 1 0.9632357358932495
( I-Disease 0 0.027927406132221222
M2 I-Disease 0 0.45888984203338623
) I-Disease 0 0.0254362840205431
gangliosidosis I-Disease 0 0.37273406982421875
. O 0 0.02785482257604599

Mutations O 1 0.9522756934165955
in O 0 0.014314339496195316
the O 0 0.02152428776025772
HEXA O 1 0.9989854693412781
gene O 1 0.7796707153320312
, O 0 0.008773976936936378
encoding O 0 0.030785592272877693
the O 0 0.008097732439637184
alpha O 0 0.0457986481487751
- O 0 0.03688586875796318
subunit O 0 0.05936943739652634
of O 0 0.009905247949063778
beta O 0 0.056077878922224045
- O 0 0.043380025774240494
hexosaminidase O 0 0.48130902647972107
A O 0 0.02035016007721424
( O 0 0.013762526214122772
Hex O 0 0.0528319850564003
A O 0 0.011702429503202438
) O 0 0.006204566452652216
, O 0 0.003212705720216036
that O 0 0.003889858489856124
abolish O 0 0.040140967816114426
Hex O 0 0.05821342021226883
A O 0 0.022883525118231773
enzyme O 0 0.0886000320315361
activity O 0 0.04117046669125557
cause O 1 0.9977317452430725
Tay B-Disease 1 0.9999637603759766
- I-Disease 1 0.9974555373191833
Sachs I-Disease 1 0.9997538924217224
disease I-Disease 1 0.9999853372573853
( O 0 0.06392940878868103
TSD B-Disease 1 0.9991098046302795
) O 0 0.012555420398712158
, O 0 0.00598777225241065
the O 0 0.011602571234107018
fatal O 1 0.9999387264251709
infantile B-Disease 1 0.9999107122421265
form I-Disease 0 0.02472979575395584
of I-Disease 0 0.012316659092903137
G I-Disease 1 0.872016966342926
( I-Disease 0 0.023569568991661072
M2 I-Disease 0 0.3081147372722626
) I-Disease 0 0.01885886862874031
gangliosidosis I-Disease 1 0.7450843453407288
, I-Disease 0 0.010746688582003117
Type I-Disease 0 0.0421011857688427
1 I-Disease 0 0.02172957733273506
. O 0 0.01967228390276432

Less O 0 0.06499721854925156
severe O 1 0.9990172386169434
, O 0 0.02197643183171749
subacute O 1 0.9999223947525024
( O 0 0.0955490991473198
juvenile O 1 0.9988111257553101
- O 1 0.9909294247627258
onset O 1 0.999903678894043
) O 0 0.016135765239596367
and O 0 0.012916678562760353
chronic O 1 0.9999926090240479
( O 0 0.03993596136569977
adult O 1 0.9583654403686523
- O 1 0.9283750057220459
onset O 1 0.9998294115066528
) O 0 0.014651698060333729
variants O 0 0.03049282543361187
are O 0 0.0041731009259819984
characterized O 0 0.025299260392785072
by O 0 0.004223644267767668
a O 0 0.0075105163268744946
broad O 0 0.023748820647597313
spectrum O 0 0.02992098405957222
of O 0 0.005256122909486294
clinical O 1 0.9807526469230652
manifestations O 1 0.8597615957260132
and O 0 0.0028051414992660284
are O 0 0.0023335355799645185
associated O 0 0.007922755554318428
with O 0 0.004213199019432068
residual O 0 0.09581398218870163
levels O 0 0.014061782509088516
of O 0 0.0056459601037204266
Hex O 0 0.07318577915430069
A O 0 0.023708684369921684
enzyme O 0 0.08429787307977676
activity O 0 0.03249348700046539
. O 0 0.02198658511042595

We O 0 0.014538229443132877
identified O 0 0.03148065134882927
a O 0 0.026687027886509895
1422 O 1 0.9899162650108337
G O 1 0.8071519732475281
- O 0 0.09636788815259933
- O 0 0.1339477002620697
> O 1 0.9177814722061157
C O 0 0.05818367749452591
( O 0 0.018280986696481705
amino O 0 0.04949056729674339
acid O 0 0.3642015755176544
W474C O 1 0.8360218405723572
) O 0 0.010238845832645893
substitution O 0 0.01706000789999962
in O 0 0.0028524838853627443
the O 0 0.0025709366891533136
first O 0 0.0037022999022156
position O 0 0.005081777460873127
of O 0 0.004468630533665419
exon O 0 0.06552305072546005
13 O 0 0.01314693782478571
of O 0 0.007834581658244133
HEXA O 1 0.9962493777275085
of O 0 0.00587701378390193
a O 0 0.011348973959684372
non O 0 0.02141113393008709
- O 0 0.03605193272233009
Jewish O 0 0.030094891786575317
proband O 1 0.9798852205276489
who O 0 0.019385572522878647
manifested O 1 0.9209285974502563
a O 0 0.03700536862015724
subacute O 1 0.999605119228363
variant O 1 0.9701516032218933
of O 0 0.017210429534316063
G B-Disease 1 0.8100932836532593
( I-Disease 0 0.024118246510624886
M2 I-Disease 1 0.7281087636947632
) I-Disease 0 0.024720074608922005
gangliosidosis I-Disease 1 0.7537161707878113
. O 0 0.028332507237792015

On O 0 0.009657478891313076
the O 0 0.009208264760673046
second O 0 0.02503444068133831
maternally O 1 0.9930686950683594
inherited O 1 0.9976828098297119
allele O 1 0.9979689717292786
, O 0 0.005557917524129152
we O 0 0.00365647510625422
identified O 0 0.008837614208459854
the O 0 0.006751061882823706
common O 1 0.9524174332618713
infantile O 1 0.9999988079071045
disease O 1 0.9999991655349731
- O 1 0.9893494844436646
causing O 1 0.9967466592788696
4 O 0 0.02346087247133255
- O 0 0.0502823106944561
bp O 0 0.07404396682977676
insertion O 0 0.23223184049129486
, O 0 0.01504774484783411
+ O 0 0.4216115474700928
TATC O 1 0.991658627986908
1278 O 1 0.9787259101867676
, O 0 0.009265142492949963
in O 0 0.01151510514318943
exon O 0 0.23961098492145538
11 O 0 0.030597887933254242
. O 0 0.02247765101492405

Pulse O 1 0.6663399338722229
- O 0 0.056846410036087036
chase O 0 0.0586920827627182
analysis O 0 0.024369001388549805
using O 0 0.021055517718195915
proband O 1 0.9746227264404297
fibroblasts O 1 0.9826632738113403
revealed O 0 0.02216826193034649
that O 0 0.004601447377353907
the O 0 0.008020767942070961
W474C O 1 0.7089662551879883
- O 0 0.03332183137536049
containing O 0 0.024761192500591278
alpha O 0 0.06348584592342377
- O 0 0.05025437846779823
subunit O 0 0.08002878725528717
precursor O 0 0.03797430172562599
was O 0 0.009036123752593994
normally O 0 0.013934576883912086
synthesized O 0 0.0238327756524086
, O 0 0.0037159351631999016
but O 0 0.0037454080302268267
not O 0 0.004680977668613195
phosphorylated O 0 0.3115467429161072
or O 0 0.008619858883321285
secreted O 0 0.03993896022439003
, O 0 0.004275184590369463
and O 0 0.0036641701590269804
the O 0 0.007707409560680389
mature O 1 0.5796722173690796
lysosomal O 1 0.992540180683136
alpha O 0 0.10210885852575302
- O 0 0.05582278594374657
subunit O 0 0.08025269955396652
was O 0 0.011850065551698208
not O 0 0.00889552105218172
detected O 0 0.061350900679826736
. O 0 0.019982656463980675

When O 0 0.02118309587240219
the O 0 0.013859685510396957
W474C O 1 0.5101363062858582
- O 0 0.046985357999801636
containing O 0 0.02615470066666603
alpha O 0 0.06311944127082825
- O 0 0.05113944038748741
subunit O 0 0.08126288652420044
was O 0 0.016531039029359818
transiently O 1 0.7115345597267151
co O 0 0.03544899448752403
- O 0 0.02616165205836296
expressed O 0 0.01172706950455904
with O 0 0.0045350659638643265
the O 0 0.0073293703608214855
beta O 0 0.048505596816539764
- O 0 0.032694488763809204
subunit O 0 0.0485813207924366
to O 0 0.005933456122875214
produce O 0 0.01318097673356533
Hex O 0 0.0488143116235733
A O 0 0.018580837175250053
( O 0 0.01632513664662838
alphabeta O 0 0.4350918233394623
) O 0 0.009386332705616951
in O 0 0.009112793020904064
COS O 1 0.984877347946167
- O 0 0.033908817917108536
7 O 0 0.020816145464777946
cells O 0 0.05088227242231369
, O 0 0.004082911182194948
the O 0 0.0063647255301475525
mature O 0 0.11340584605932236
alpha O 0 0.05767600238323212
- O 0 0.03348385542631149
subunit O 0 0.047479625791311264
was O 0 0.006088661961257458
present O 0 0.005602702032774687
, O 0 0.0028598487842828035
but O 0 0.002684463281184435
its O 0 0.003458525752648711
level O 0 0.005132647696882486
was O 0 0.004267749842256308
much O 0 0.005478315521031618
lower O 0 0.009019683115184307
than O 0 0.0032274294644594193
that O 0 0.00252679199911654
from O 0 0.005278906784951687
normal O 0 0.026661882176995277
alpha O 0 0.05283917486667633
- O 0 0.051028281450271606
subunit O 0 0.17758585512638092
transfections O 1 0.9271335601806641
, O 0 0.005563537590205669
although O 0 0.00622172886505723
higher O 0 0.006714702118188143
than O 0 0.0041386429220438
in O 0 0.00402314867824316
those O 0 0.007338635623455048
cells O 0 0.4174460768699646
transfected O 1 0.9030864238739014
with O 0 0.007582568097859621
an O 0 0.010702104307711124
alpha O 0 0.05526086315512657
- O 0 0.04607471078634262
subunit O 0 0.0909133180975914
associated O 0 0.026691846549510956
with O 0 0.022230012342333794
infantile O 1 0.999816358089447
TSD B-Disease 1 0.9987878203392029
. O 0 0.04012184962630272

Furthermore O 0 0.034555867314338684
, O 0 0.006377626676112413
the O 0 0.005666927434504032
precursor O 0 0.02439635992050171
level O 0 0.0065117888152599335
of O 0 0.003469254123046994
the O 0 0.007494936231523752
W474C O 1 0.9228625297546387
alpha O 0 0.10216391086578369
- O 0 0.04275085777044296
subunit O 0 0.05817699804902077
was O 0 0.006439743097871542
found O 0 0.005921792704612017
to O 0 0.0037277142982929945
accumulate O 0 0.02161637879908085
in O 0 0.003964901901781559
comparison O 0 0.009938351809978485
to O 0 0.003159100189805031
the O 0 0.005700786132365465
normal O 0 0.030317703261971474
alpha O 0 0.05655358359217644
- O 0 0.05063775181770325
subunit O 0 0.11342599242925644
precursor O 0 0.07079684734344482
levels O 0 0.039297524839639664
. O 0 0.023029794916510582

We O 0 0.011834921315312386
conclude O 0 0.021116318181157112
that O 0 0.005375256761908531
the O 0 0.010321302339434624
1422 O 1 0.9984620809555054
G O 1 0.981052815914154
- O 0 0.3421212434768677
- O 0 0.32933443784713745
> O 1 0.973249077796936
C O 0 0.2992231547832489
mutation O 1 0.9851131439208984
is O 0 0.005989620462059975
the O 0 0.005232650320976973
cause O 0 0.03878115490078926
of O 0 0.006308664567768574
Hex B-Disease 1 0.7461316585540771
A I-Disease 0 0.046505432575941086
enzyme I-Disease 1 0.9950333833694458
deficiency I-Disease 1 0.9999649524688721
in O 0 0.010045252740383148
the O 0 0.013782719150185585
proband O 1 0.9807150363922119
. O 0 0.030328771099448204

The O 0 0.020288849249482155
resulting O 0 0.06885699182748795
W474C O 1 0.8085510730743408
substitution O 0 0.05283060297369957
clearly O 0 0.021536238491535187
interferes O 0 0.08090974390506744
with O 0 0.009698976762592793
alpha O 0 0.05289735272526741
- O 0 0.04063372686505318
subunit O 0 0.060819853097200394
processing O 0 0.01368428859859705
, O 0 0.003799885045737028
but O 0 0.0034042668994516134
because O 0 0.004713892936706543
the O 0 0.004340821411460638
base O 0 0.01195475459098816
substitution O 0 0.02647334523499012
falls O 0 0.02579842507839203
at O 0 0.004561583511531353
the O 0 0.0031328010372817516
first O 0 0.0038795091677457094
position O 0 0.005186609458178282
of O 0 0.005683130584657192
exon O 0 0.3775602877140045
13 O 0 0.019288556650280952
, O 0 0.010110309347510338
aberrant O 1 0.9622384309768677
splicing O 0 0.18841245770454407
may O 0 0.011895311996340752
also O 0 0.004628109745681286
contribute O 0 0.012666541151702404
to O 0 0.006644863169640303
Hex B-Disease 0 0.19662758708000183
A I-Disease 0 0.0417545884847641
deficiency I-Disease 1 0.9998061060905457
in O 0 0.007850654423236847
this O 0 0.009202508255839348
proband O 1 0.941652238368988
. O 0 0.010789060033857822
. O 0 0.01826436258852482

Two O 0 0.022937320172786713
frequent O 0 0.15163952112197876
missense O 1 0.9956465363502502
mutations O 1 0.9971766471862793
in O 0 0.04203534871339798
Pendred B-Disease 1 0.9998652935028076
syndrome I-Disease 1 0.9999978542327881
. O 0 0.04365283250808716

Pendred B-Disease 1 0.999739944934845
syndrome I-Disease 1 0.999998927116394
is O 0 0.03475258871912956
an O 0 0.43741700053215027
autosomal B-Disease 1 0.9999994039535522
recessive I-Disease 1 0.9999997615814209
disorder I-Disease 1 0.9999996423721313
characterized O 1 0.991841197013855
by O 0 0.019214900210499763
early O 0 0.13693378865718842
childhood O 1 0.9996435642242432
deafness B-Disease 1 0.9999905824661255
and O 0 0.047584954649209976
goiter B-Disease 1 0.9999200105667114
. O 0 0.03628436475992203

A O 0 0.01945846527814865
century O 0 0.012928416952490807
after O 0 0.009760573506355286
its O 0 0.005962171126157045
recognition O 0 0.015426108613610268
as O 0 0.007158855441957712
a O 0 0.03400591015815735
syndrome O 1 0.9999955892562866
by O 0 0.01516131404787302
Vaughan O 1 0.9719188213348389
Pendred O 1 0.9788486957550049
, O 0 0.0081471037119627
the O 0 0.01515731867402792
disease O 1 0.9999942779541016
gene O 1 0.9988163709640503
( O 0 0.028839245438575745
PDS O 1 0.9975765347480774
) O 0 0.010244752280414104
was O 0 0.008177321404218674
mapped O 0 0.02885732427239418
to O 0 0.014446495100855827
chromosome O 1 0.9945545196533203
7q22 O 1 0.9773748517036438
- O 0 0.1519917994737625
q31 O 1 0.9140172600746155
. O 0 0.030287915840744972

1 O 0 0.01881248876452446
and O 0 0.005369707476347685
, O 0 0.004638172686100006
recently O 0 0.010484701953828335
, O 0 0.0034528307151049376
found O 0 0.005721640773117542
to O 0 0.004224787931889296
encode O 0 0.024678807705640793
a O 0 0.02129664085805416
putative O 1 0.8939981460571289
sulfate O 1 0.9778385758399963
transporter O 1 0.9100242257118225
. O 0 0.03561604395508766

We O 0 0.018407344818115234
performed O 0 0.030720068141818047
mutation O 1 0.8295033574104309
analysis O 0 0.011914028786122799
of O 0 0.005052377004176378
the O 0 0.010933547280728817
PDS B-Disease 1 0.9985843896865845
gene O 1 0.9788640141487122
in O 0 0.012220649980008602
patients O 1 0.998708963394165
from O 0 0.010276650078594685
14 O 0 0.018654851242899895
Pendred B-Disease 1 0.9927186965942383
families O 0 0.015374967828392982
originating O 0 0.020398888736963272
from O 0 0.004848022013902664
seven O 0 0.005143071990460157
countries O 0 0.0036968200001865625
and O 0 0.0035773299168795347
identified O 0 0.013684906996786594
all O 0 0.009505435824394226
mutations O 1 0.9880645871162415
. O 0 0.02349759079515934

The O 0 0.02116904780268669
mutations O 1 0.9795631766319275
include O 0 0.007905926555395126
three O 0 0.005699807312339544
single O 0 0.013772410340607166
base O 0 0.01953454688191414
deletions O 0 0.054453909397125244
, O 0 0.006221516523510218
one O 0 0.009646731428802013
splice O 0 0.3765048086643219
site O 0 0.029880141839385033
mutation O 1 0.990536630153656
and O 0 0.009648713283240795
10 O 0 0.024380570277571678
missense O 1 0.9919497966766357
mutations O 1 0.992653489112854
. O 0 0.029391281306743622

One O 0 0.03612068295478821
missense O 1 0.9962236881256104
mutation O 1 0.9990336894989014
( O 0 0.02635766565799713
L236P O 1 0.9576269388198853
) O 0 0.009116311557590961
was O 0 0.005720171146094799
found O 0 0.006892368663102388
in O 0 0.004000336863100529
a O 0 0.010209941305220127
homozygous O 1 0.6013171672821045
state O 0 0.005538874305784702
in O 0 0.004033146426081657
two O 0 0.007009909488260746
consanguineous O 1 0.9637634754180908
families O 0 0.010612658224999905
and O 0 0.0033228571992367506
in O 0 0.0036264907103031874
a O 0 0.009501626715064049
heterozygous O 0 0.47114378213882446
state O 0 0.003675263375043869
in O 0 0.0031808833591639996
five O 0 0.0049337600357830524
additional O 0 0.010526503436267376
non O 0 0.025064827874302864
- O 0 0.13754123449325562
consanguineous O 1 0.9599681496620178
families O 0 0.04194150120019913
. O 0 0.02775369957089424

Another O 0 0.06517129391431808
missense O 1 0.992324709892273
mutation O 1 0.9978406429290771
( O 0 0.030519938096404076
T416P O 1 0.9662408232688904
) O 0 0.009491750039160252
was O 0 0.005351737141609192
found O 0 0.005653331987559795
in O 0 0.00321635277941823
a O 0 0.0076217143796384335
homozygous O 1 0.7159300446510315
state O 0 0.004391362424939871
in O 0 0.0031565995886921883
one O 0 0.003762599313631654
family O 0 0.007286128122359514
and O 0 0.0022682661656290293
in O 0 0.003517660778015852
a O 0 0.008570144884288311
heterozygous O 1 0.6950864195823669
state O 0 0.004915196448564529
in O 0 0.004065849352627993
four O 0 0.005911997053772211
families O 0 0.018217304721474648
. O 0 0.019492626190185547

Pendred B-Disease 1 0.9949811100959778
patients O 1 0.9943880438804626
in O 0 0.007903053425252438
three O 0 0.007940348237752914
non O 0 0.027415504679083824
- O 0 0.14563380181789398
consanguineous O 1 0.992961585521698
families O 0 0.014864543452858925
were O 0 0.0034225869458168745
shown O 0 0.007098481524735689
to O 0 0.0031768660992383957
be O 0 0.0039960118010640144
compound O 0 0.02612246572971344
heterozygotes O 1 0.9143404960632324
for O 0 0.011199861764907837
L236P O 1 0.7778354287147522
and O 0 0.012536512687802315
T416P O 1 0.975574254989624
. O 0 0.027135375887155533

In O 0 0.008720464073121548
total O 0 0.00889446958899498
, O 0 0.003335925517603755
one O 0 0.0033897915855050087
or O 0 0.0036239128094166517
both O 0 0.0024350236635655165
of O 0 0.0026830085553228855
these O 0 0.004134004004299641
mutations O 1 0.9805834293365479
were O 0 0.0029260790906846523
found O 0 0.004548771306872368
in O 0 0.0024473881348967552
nine O 0 0.0045037297531962395
of O 0 0.0026565981097519398
the O 0 0.004543195012956858
14 O 0 0.013086277060210705
families O 0 0.017733434215188026
analyzed O 0 0.03670644760131836
. O 0 0.019738834351301193

The O 0 0.01045003067702055
identification O 0 0.015508204698562622
of O 0 0.004961726721376181
two O 0 0.006240531802177429
frequent O 1 0.6967943906784058
PDS B-Disease 1 0.9997425675392151
mutations O 1 0.9985612034797668
will O 0 0.005888187792152166
facilitate O 0 0.013435469940304756
the O 0 0.009205221198499203
molecular O 0 0.2409612387418747
diagnosis O 1 0.999360978603363
of O 0 0.027103418484330177
Pendred B-Disease 1 0.9999358654022217
syndrome I-Disease 1 0.9999991655349731
. O 0 0.05057672783732414

Insertional O 1 0.994067907333374
mutation O 1 0.9964967370033264
by O 0 0.020552514120936394
transposable O 1 0.8456916809082031
element O 0 0.03320872783660889
, O 0 0.010299318470060825
L1 O 1 0.7362591624259949
, O 0 0.006264002062380314
in O 0 0.006227173376828432
the O 0 0.01441796775907278
DMD B-Disease 1 0.9999457597732544
gene O 1 0.9773744940757751
results O 0 0.02037336863577366
in O 0 0.010961268097162247
X B-Disease 1 0.7961310744285583
- I-Disease 0 0.34799009561538696
linked I-Disease 1 0.9667786955833435
dilated I-Disease 1 0.9997852444648743
cardiomyopathy I-Disease 1 0.999976634979248
. O 0 0.043650105595588684

X B-Disease 1 0.7615599036216736
- I-Disease 0 0.2899768352508545
linked I-Disease 1 0.9659098982810974
dilated I-Disease 1 0.9997784495353699
cardiomyopathy I-Disease 1 0.9999860525131226
( O 0 0.055825378745794296
XLDCM B-Disease 1 0.9978399276733398
) O 0 0.011242164298892021
is O 0 0.007534250617027283
a O 0 0.014245515689253807
clinical O 1 0.9411665201187134
phenotype O 1 0.9983416795730591
of O 0 0.009487581439316273
dystrophinopathy B-Disease 1 0.9696114659309387
which O 0 0.006759517826139927
is O 0 0.007272166665643454
characterized O 0 0.15255150198936462
by O 0 0.011933590285480022
preferential O 1 0.9566836357116699
myocardial B-Disease 1 0.9999375343322754
involvement I-Disease 0 0.08608346432447433
without O 0 0.010972455143928528
any O 0 0.009792592376470566
overt O 0 0.31951671838760376
clinical O 1 0.9759154319763184
signs O 0 0.08921030908823013
of O 0 0.020196083933115005
skeletal B-Disease 1 0.9999561309814453
myopathy I-Disease 1 0.9999854564666748
. O 0 0.03963809832930565

To O 0 0.009477750398218632
date O 0 0.010927639901638031
, O 0 0.0046986667439341545
several O 0 0.007161174435168505
mutations O 1 0.9745542407035828
in O 0 0.008375469595193863
the O 0 0.025347355753183365
Duchenne B-Disease 1 0.9999940395355225
muscular I-Disease 1 0.9999949932098389
dystrophy I-Disease 1 0.9999979734420776
gene O 1 0.9993720650672913
, O 0 0.11863527446985245
DMD O 1 0.999980092048645
, O 0 0.007048784289509058
have O 0 0.00439634220674634
been O 0 0.00511641800403595
identified O 0 0.0108643164858222
in O 0 0.005892788991332054
patients O 1 0.999196469783783
with O 0 0.007341925986111164
XLDCM B-Disease 1 0.9988465309143066
, O 0 0.0055829561315476894
but O 0 0.004931763745844364
a O 0 0.01115946751087904
pathogenic O 1 0.9810422658920288
correlation O 0 0.02800801396369934
of O 0 0.00535623449832201
these O 0 0.008380869403481483
cardiospecific O 1 0.997904896736145
mutations O 1 0.9986028075218201
in O 0 0.015552218072116375
DMD O 1 0.9999125003814697
with O 0 0.009336300194263458
the O 0 0.015293027274310589
XLDCM B-Disease 1 0.9996682405471802
phenotype O 1 0.9997984766960144
has O 0 0.009830811992287636
remained O 0 0.010072746314108372
to O 0 0.0046204435639083385
be O 0 0.007056167349219322
elucidated O 0 0.13691161572933197
. O 0 0.024632614105939865

We O 0 0.010160906240344048
report O 0 0.00798079650849104
here O 0 0.004091490060091019
the O 0 0.0034043658524751663
identification O 0 0.009083706885576248
of O 0 0.0035026082769036293
a O 0 0.008828412741422653
unique O 0 0.014799138531088829
de O 0 0.04395909607410431
novo O 0 0.22930385172367096
L1 O 1 0.886155903339386
insertion O 0 0.11330575495958328
in O 0 0.007986210286617279
the O 0 0.012173231691122055
muscle O 1 0.9955556988716125
exon O 1 0.8361088037490845
1 O 0 0.01974235661327839
in O 0 0.012413551099598408
DMD O 1 0.9997900128364563
in O 0 0.009776164777576923
three O 0 0.013933733105659485
XLDCM B-Disease 1 0.9996292591094971
patients O 1 0.9992144107818604
from O 0 0.007885647937655449
two O 0 0.006328771822154522
unrelated O 0 0.03962036222219467
Japanese O 0 0.026444198563694954
families O 0 0.02883433736860752
. O 0 0.024275261908769608

The O 0 0.024195773527026176
insertion O 0 0.08915359526872635
was O 0 0.011208080686628819
a O 0 0.012582524679601192
5 O 0 0.016535356640815735
- O 0 0.03332960233092308
truncated O 0 0.05173636972904205
form O 0 0.013270740397274494
of O 0 0.007620333228260279
human O 0 0.032511062920093536
L1 O 1 0.9154289960861206
inversely O 0 0.07317681610584259
integrated O 0 0.025781502947211266
in O 0 0.004948286339640617
the O 0 0.006408813409507275
5 O 0 0.01553941611200571
- O 0 0.0341927707195282
untranslated O 0 0.1964442878961563
region O 0 0.017751766368746758
in O 0 0.007415807340294123
the O 0 0.013210444711148739
muscle O 1 0.9981927275657654
exon O 1 0.8900386691093445
1 O 0 0.013837960548698902
, O 0 0.004128622356802225
which O 0 0.004312832374125719
affected O 0 0.020968731492757797
the O 0 0.005472190678119659
transcription O 0 0.03255404531955719
or O 0 0.005216308869421482
the O 0 0.00416184077039361
stability O 0 0.010138284415006638
of O 0 0.0037022295873612165
the O 0 0.007459746208041906
muscle O 1 0.9979602098464966
form O 0 0.013977565802633762
of O 0 0.008798453956842422
dystrophin O 1 0.9985741376876831
transcripts O 0 0.015472042374312878
but O 0 0.003525148145854473
not O 0 0.001968547236174345
that O 0 0.001684854389168322
of O 0 0.0027162611950188875
the O 0 0.0073435939848423
brain O 1 0.9999253749847412
or O 0 0.01668582297861576
Purkinje O 1 0.9984539747238159
cell O 0 0.22769039869308472
form O 0 0.012800541706383228
, O 0 0.004576239734888077
probably O 0 0.00901411846280098
due O 0 0.0075418995693326
to O 0 0.0025408680085092783
its O 0 0.004329725634306669
unique O 0 0.007845601066946983
site O 0 0.008435784839093685
of O 0 0.005875108763575554
integration O 0 0.028450850397348404
. O 0 0.022693917155265808

We O 0 0.01227265689522028
speculate O 0 0.027803365141153336
that O 0 0.004855560138821602
this O 0 0.005623280070722103
insertion O 0 0.03643428534269333
of O 0 0.004538050387054682
an O 0 0.008853781037032604
L1 O 1 0.9105494618415833
sequence O 0 0.030036266893148422
in O 0 0.012559364549815655
DMD O 1 0.9999446868896484
is O 0 0.007433366030454636
responsible O 0 0.01065830048173666
for O 0 0.00281537976115942
some O 0 0.0024599628522992134
of O 0 0.0024650052655488253
the O 0 0.0037798043340444565
population O 0 0.0093380780890584
of O 0 0.005094490945339203
Japanese O 0 0.03133252635598183
patients O 1 0.9994621872901917
with O 0 0.012137480080127716
XLDCM B-Disease 1 0.9966111779212952
. O 0 0.013208544813096523
. O 0 0.017297623679041862

Severe O 1 0.9990918636322021
early O 0 0.06989888846874237
- O 1 0.9907761216163635
onset O 1 0.9999749660491943
obesity B-Disease 1 0.9999819993972778
, O 0 0.05181482434272766
adrenal B-Disease 1 0.999948263168335
insufficiency I-Disease 1 0.9999319314956665
and O 0 0.018457630649209023
red O 1 0.9856083393096924
hair O 1 0.9997363686561584
pigmentation O 1 0.9999655485153198
caused O 1 0.9973715543746948
by O 0 0.03483084216713905
POMC O 1 0.9998960494995117
mutations O 1 0.9990850687026978
in O 0 0.017260482534766197
humans O 0 0.11840689927339554
. O 0 0.025917913764715195

Sequential O 0 0.10210783034563065
cleavage O 0 0.13057848811149597
of O 0 0.006620784755796194
the O 0 0.008284171111881733
precursor O 0 0.049179550260305405
protein O 0 0.051054175943136215
pre O 0 0.05376734584569931
- O 0 0.050487909466028214
pro O 0 0.05501765385270119
- O 0 0.09409856051206589
opiomelanocortin O 1 0.978367805480957
( O 0 0.03561192750930786
POMC O 1 0.9977834820747375
) O 0 0.017175275832414627
generates O 0 0.039756521582603455
the O 0 0.016887221485376358
melanocortin O 1 0.9903528094291687
peptides O 1 0.5253605246543884
adrenocorticotrophin O 1 0.9793599843978882
( O 0 0.034201715141534805
ACTH O 1 0.9832350015640259
) O 0 0.01772177591919899
, O 0 0.015029923990368843
melanocyte O 1 0.9966642260551453
- O 0 0.3594718873500824
stimulating O 1 0.9848944544792175
hormones O 1 0.9950414299964905
( O 0 0.03978179767727852
MSH O 1 0.9987080097198486
) O 0 0.018878810107707977
alpha O 0 0.043068110942840576
, O 0 0.007494248449802399
beta O 0 0.03354249894618988
and O 0 0.005258893594145775
gamma O 0 0.038589611649513245
as O 0 0.004435091745108366
well O 0 0.004168401472270489
as O 0 0.005896991118788719
the O 0 0.01240016520023346
opioid O 1 0.9728009104728699
- O 0 0.11043936014175415
receptor O 1 0.6188188195228577
ligand O 0 0.13168421387672424
beta O 0 0.128959059715271
- O 0 0.13365918397903442
endorphin O 1 0.9387637376785278
. O 0 0.04284883290529251

While O 0 0.011225618422031403
a O 0 0.008959755301475525
few O 0 0.008844252675771713
cases O 0 0.013829179108142853
of O 0 0.008736522868275642
isolated O 1 0.9934468865394592
ACTH B-Disease 1 0.9999631643295288
deficiency I-Disease 1 0.9999874830245972
have O 0 0.008899418637156487
been O 0 0.010143022984266281
reported O 0 0.028966089710593224
( O 0 0.030008815228939056
OMIM O 1 0.9996727705001831
201400 O 1 0.992159366607666
) O 0 0.011353635229170322
, O 0 0.005521179176867008
an O 0 0.010074743069708347
inherited O 1 0.999618411064148
POMC O 1 0.9999804496765137
defect O 1 0.9995182752609253
has O 0 0.009775504469871521
not O 0 0.004162696655839682
been O 0 0.005822525825351477
described O 0 0.014193247072398663
so O 0 0.008811825886368752
far O 0 0.01443429384380579
. O 0 0.017993129789829254

Recent O 0 0.031992629170417786
studies O 0 0.0186343751847744
in O 0 0.008228179067373276
animal O 0 0.033669304102659225
models O 0 0.018048059195280075
elucidated O 0 0.05615801736712456
a O 0 0.00815854873508215
central O 0 0.00814532395452261
role O 0 0.010639477521181107
of O 0 0.006560898385941982
alpha O 0 0.2578725814819336
- O 0 0.22435824573040009
MSH O 1 0.9983147382736206
in O 0 0.006739260163158178
the O 0 0.005536175332963467
regulation O 0 0.014321714639663696
of O 0 0.004968516528606415
food O 0 0.01671271212399006
intake O 0 0.05171781778335571
by O 0 0.008717019110918045
activation O 0 0.04106191545724869
of O 0 0.00561430724337697
the O 0 0.01241135410964489
brain O 1 0.9994680285453796
melanocortin O 1 0.9966422319412231
- O 0 0.10155102610588074
4 O 0 0.030907446518540382
- O 0 0.09153083711862564
receptor O 1 0.8953725099563599
( O 0 0.03325491398572922
MC4 O 1 0.9970968961715698
- O 0 0.18477529287338257
R O 0 0.10622435063123703
; O 0 0.014494680799543858
refs O 0 0.06836450845003128
3 O 0 0.01651088334619999
- O 0 0.022060740739107132
5 O 0 0.010815969668328762
) O 0 0.0046850768849253654
and O 0 0.0020133855286985636
the O 0 0.003955640364438295
linkage O 0 0.02576494961977005
of O 0 0.005573618691414595
human O 0 0.20797409117221832
obesity B-Disease 1 0.9999650716781616
to O 0 0.011097930371761322
chromosome O 1 0.9958835244178772
2 O 0 0.009571044705808163
in O 0 0.004196785856038332
close O 0 0.008736873976886272
proximity O 0 0.01479499600827694
to O 0 0.0043146368116140366
the O 0 0.01049939077347517
POMC O 1 0.9995715022087097
locus O 1 0.9957171082496643
, O 0 0.0062150717712938786
led O 0 0.009213591925799847
to O 0 0.0029771802946925163
the O 0 0.0037399353459477425
proposal O 0 0.006694404408335686
of O 0 0.003043417353183031
an O 0 0.005405643954873085
association O 0 0.01630375348031521
of O 0 0.010125350207090378
POMC O 1 0.9994964599609375
with O 0 0.01557654608041048
human O 1 0.6293640732765198
obesity B-Disease 1 0.999771773815155
. O 0 0.03462808579206467

The O 0 0.014672324061393738
dual O 0 0.029949745163321495
role O 0 0.015163855627179146
of O 0 0.009751580655574799
alpha O 0 0.16258211433887482
- O 0 0.4585464596748352
MSH O 1 0.9985199570655823
in O 0 0.010922052897512913
regulating O 0 0.044327929615974426
food O 0 0.026308657601475716
intake O 0 0.17091670632362366
and O 0 0.009614299051463604
influencing O 1 0.8361574411392212
hair O 1 0.9996408224105835
pigmentation O 1 0.9999359846115112
predicts O 0 0.4736368656158447
that O 0 0.006140818353742361
the O 0 0.010351026430726051
phenotype O 1 0.9991112351417542
associated O 0 0.014182976447045803
with O 0 0.0050973366014659405
a O 0 0.013162803836166859
defect O 1 0.9929595589637756
in O 0 0.01265296433120966
POMC O 1 0.9991063475608826
function O 0 0.027344712987542152
would O 0 0.0069837565533816814
include O 0 0.015939731150865555
obesity B-Disease 1 0.9999372959136963
, O 0 0.01148245483636856
alteration O 1 0.646552324295044
in O 0 0.017255177721381187
pigmentation O 1 0.9998899698257446
and O 0 0.04143025726079941
ACTH B-Disease 1 0.9998199343681335
deficiency I-Disease 1 0.9999771118164062
. O 0 0.03407709673047066

The O 0 0.010685507208108902
observation O 0 0.020679300650954247
of O 0 0.005046991631388664
these O 0 0.006651438307017088
symptoms O 1 0.999870777130127
in O 0 0.005555314477533102
two O 0 0.006596530321985483
probands O 1 0.9935839772224426
prompted O 0 0.04021663963794708
us O 0 0.011026854626834393
to O 0 0.0047361645847558975
search O 0 0.012209679000079632
for O 0 0.009039868600666523
mutations O 1 0.9660601019859314
within O 0 0.013877032324671745
their O 0 0.020715350285172462
POMC O 1 0.9971008896827698
genes O 1 0.59686678647995
. O 0 0.029142063111066818

Patient O 1 0.9965125918388367
1 O 0 0.016420098021626472
was O 0 0.0067692408338189125
found O 0 0.006029208656400442
to O 0 0.002627394627779722
be O 0 0.003363422118127346
a O 0 0.008578896522521973
compound O 0 0.026885123923420906
heterozygote O 1 0.6065151691436768
for O 0 0.006119807716459036
two O 0 0.0069039626978337765
mutations O 1 0.913794994354248
in O 0 0.009663335978984833
exon O 0 0.3998154401779175
3 O 0 0.02196747437119484
( O 0 0.01593877375125885
G7013T O 1 0.9158446788787842
, O 0 0.01094788033515215
C7133delta O 1 0.9611251354217529
) O 0 0.009044624865055084
which O 0 0.005034214351326227
interfere O 0 0.01568402722477913
with O 0 0.00408130930736661
appropriate O 0 0.00841902568936348
synthesis O 0 0.02129603736102581
of O 0 0.007328870706260204
ACTH O 1 0.9927566647529602
and O 0 0.011798739433288574
alpha O 0 0.11935485154390335
- O 0 0.3187078833580017
MSH O 1 0.9972692131996155
. O 0 0.03680552914738655

Patient O 1 0.98490971326828
2 O 0 0.0216875821352005
was O 0 0.012842589989304543
homozygous O 0 0.20599202811717987
for O 0 0.0068098753690719604
a O 0 0.014869912527501583
mutation O 1 0.989274799823761
in O 0 0.01132519543170929
exon O 0 0.4927063584327698
2 O 0 0.02080754190683365
( O 0 0.018829211592674255
C3804A O 1 0.8047450184822083
) O 0 0.01636062003672123
which O 0 0.01417513843625784
abolishes O 1 0.984307587146759
POMC O 1 0.9913169145584106
translation O 0 0.05143902450799942
. O 0 0.029955780133605003

These O 0 0.007835044525563717
findings O 0 0.012795601040124893
represent O 0 0.0060301003977656364
the O 0 0.0029313371051102877
first O 0 0.003642793744802475
examples O 0 0.0058614471927285194
of O 0 0.0037789964117109776
a O 0 0.012628532946109772
genetic B-Disease 1 0.9972397089004517
defect I-Disease 1 0.9981868863105774
within O 0 0.012044413015246391
the O 0 0.014012477360665798
POMC O 1 0.9997708201408386
gene O 1 0.9569948315620422
and O 0 0.00562150776386261
define O 0 0.013876575045287609
a O 0 0.011910330504179
new O 0 0.019104283303022385
monogenic B-Disease 1 0.999715268611908
endocrine I-Disease 1 0.9999864101409912
disorder I-Disease 1 0.9999905824661255
resulting O 0 0.20148181915283203
in O 0 0.009380188770592213
early O 0 0.026916351169347763
- O 1 0.994097113609314
onset O 1 0.9999889135360718
obesity B-Disease 1 0.9999909400939941
, O 0 0.10146747529506683
adrenal B-Disease 1 0.9999667406082153
insufficiency I-Disease 1 0.999961256980896
and O 0 0.01776529848575592
red O 1 0.9911885261535645
hair O 1 0.9995554089546204
pigmentation O 1 0.9998788833618164
. O 0 0.016365256160497665
. O 0 0.020009435713291168

A O 0 0.03618453070521355
European O 0 0.03478828817605972
multicenter O 1 0.9545360803604126
study O 0 0.025849251076579094
of O 0 0.01727248914539814
phenylalanine B-Disease 1 0.9971455931663513
hydroxylase I-Disease 1 0.9987994432449341
deficiency I-Disease 1 0.9999809265136719
: O 0 0.016537806019186974
classification O 0 0.02173248864710331
of O 0 0.005773194599896669
105 O 0 0.029560893774032593
mutations O 1 0.9912961721420288
and O 0 0.0033526248298585415
a O 0 0.005848507862538099
general O 0 0.007906850427389145
system O 0 0.00955917313694954
for O 0 0.007125448435544968
genotype O 1 0.9946660995483398
- O 0 0.026795262470841408
based O 0 0.010114463977515697
prediction O 0 0.03126159682869911
of O 0 0.014883427880704403
metabolic O 1 0.9992644190788269
phenotype O 1 0.998601496219635
. O 0 0.03237336501479149

Phenylketonuria B-Disease 1 0.9997695088386536
( O 0 0.12914688885211945
PKU B-Disease 1 0.9996401071548462
) O 0 0.018867863342165947
and O 0 0.012180723249912262
mild B-Disease 1 0.9993547797203064
hyperphenylalaninemia I-Disease 1 0.9996552467346191
( O 0 0.10681991279125214
MHP B-Disease 1 0.9999334812164307
) O 0 0.015986155718564987
are O 0 0.012193495407700539
allelic B-Disease 1 0.9997473359107971
disorders I-Disease 1 0.99998939037323
caused O 1 0.9908415079116821
by O 0 0.012906213290989399
mutations O 1 0.9969582557678223
in O 0 0.0057800463400781155
the O 0 0.009326722472906113
gene O 1 0.7333809733390808
encoding O 0 0.0919169932603836
phenylalanine O 1 0.978278398513794
hydroxylase O 1 0.9821165204048157
( O 0 0.05303950980305672
PAH O 1 0.9988440275192261
) O 0 0.02490856871008873
. O 0 0.026296304538846016

Previous O 0 0.026222379878163338
studies O 0 0.01613294705748558
have O 0 0.0054478771053254604
suggested O 0 0.008033305406570435
that O 0 0.0028487457893788815
the O 0 0.005281844642013311
highly O 0 0.023396983742713928
variable O 1 0.6320800185203552
metabolic O 1 0.9991931319236755
phenotypes O 1 0.9984893798828125
of O 0 0.028760308399796486
PAH B-Disease 1 0.9999839067459106
deficiency I-Disease 1 0.9999891519546509
correlate O 1 0.9598251581192017
with O 0 0.03427036851644516
PAH O 1 0.9998297691345215
genotypes O 1 0.9985600113868713
. O 0 0.038810767233371735

We O 0 0.013869882561266422
identified O 0 0.024533966556191444
both O 0 0.012994215823709965
causative O 1 0.9945693016052246
mutations O 1 0.9980168342590332
in O 0 0.014167936518788338
686 O 1 0.9966040849685669
patients O 1 0.997481644153595
from O 0 0.008462278172373772
seven O 0 0.009226780384778976
European O 0 0.0149992685765028
centers O 0 0.02728365547955036
. O 0 0.02097599394619465

On O 0 0.006935379933565855
the O 0 0.004223582800477743
basis O 0 0.004899016115814447
of O 0 0.003387126140296459
the O 0 0.007747196592390537
phenotypic O 1 0.9313207268714905
characteristics O 0 0.020365765318274498
of O 0 0.008213934488594532
297 O 1 0.9846039414405823
functionally O 1 0.998584508895874
hemizygous O 1 0.9997521042823792
patients O 1 0.9993770718574524
, O 0 0.005982124246656895
105 O 0 0.01284618116915226
of O 0 0.003460409352555871
the O 0 0.007030578330159187
mutations O 1 0.9856809377670288
were O 0 0.0032478137873113155
assigned O 0 0.0065735154785215855
to O 0 0.00204246724024415
one O 0 0.0029101823456585407
of O 0 0.0026733821723610163
four O 0 0.006288069300353527
arbitrary O 0 0.027875687927007675
phenotype O 1 0.9959503412246704
categories O 0 0.03132086992263794
. O 0 0.01896190457046032

We O 0 0.00941008236259222
proposed O 0 0.01098865270614624
and O 0 0.004760561976581812
tested O 0 0.021033598110079765
a O 0 0.007705157157033682
simple O 0 0.009345571510493755
model O 0 0.011386706493794918
for O 0 0.00561379361897707
correlation O 0 0.039261721074581146
between O 0 0.01798710972070694
genotype O 1 0.9808969497680664
and O 0 0.014570962637662888
phenotypic O 1 0.9703759551048279
outcome O 0 0.05172019451856613
. O 0 0.026198022067546844

The O 0 0.019486315548419952
observed O 0 0.05123170092701912
phenotype O 1 0.9990058541297913
matched O 0 0.03410721197724342
the O 0 0.010426163673400879
predicted O 0 0.05525678023695946
phenotype O 1 0.9973658919334412
in O 0 0.007382659241557121
79 O 0 0.020573288202285767
% O 0 0.006199507974088192
of O 0 0.003011823631823063
the O 0 0.004285167437046766
cases O 0 0.011472338810563087
, O 0 0.0025306681636720896
and O 0 0.0019221407128497958
in O 0 0.002388118067756295
only O 0 0.0030008116737008095
5 O 0 0.006397558841854334
of O 0 0.004550619050860405
184 O 0 0.31614771485328674
patients O 1 0.9970454573631287
was O 0 0.006273391656577587
the O 0 0.006624015513807535
observed O 0 0.04572364687919617
phenotype O 1 0.9993392825126648
more O 0 0.004397220443934202
than O 0 0.0038010329008102417
one O 0 0.004063073545694351
category O 0 0.010953272692859173
away O 0 0.006632454227656126
from O 0 0.00493965158239007
that O 0 0.005463542882353067
expected O 0 0.012835700064897537
. O 0 0.016835203394293785

Among O 0 0.01515552494674921
the O 0 0.006377874873578548
seven O 0 0.009147399105131626
contributing O 0 0.019260285422205925
centers O 0 0.012665611691772938
, O 0 0.0033834243658930063
the O 0 0.0037493370473384857
proportion O 0 0.014199873432517052
of O 0 0.005949720740318298
patients O 1 0.9993277788162231
for O 0 0.004291055258363485
whom O 0 0.012385021895170212
the O 0 0.00789441168308258
observed O 0 0.07293415069580078
phenotype O 1 0.9996587038040161
did O 0 0.006557499058544636
not O 0 0.003171355929225683
match O 0 0.007564974017441273
the O 0 0.007175546605139971
predicted O 0 0.03516334667801857
phenotype O 1 0.9951856732368469
was O 0 0.009589527733623981
4 O 0 0.013010253198444843
% O 0 0.01153996866196394
- O 0 0.02314217947423458
23 O 0 0.017082715407013893
% O 0 0.013639412820339203
( O 0 0.021366853266954422
P O 1 0.7929549813270569
< O 1 0.7925424575805664
. O 0 0.013740912079811096
0001 O 1 0.9803335070610046
) O 0 0.009725508280098438
, O 0 0.003988169599324465
suggesting O 0 0.010844877921044827
that O 0 0.0025502850767225027
differences O 0 0.006514880806207657
in O 0 0.0024040662683546543
methods O 0 0.004735513124614954
used O 0 0.003988063894212246
for O 0 0.005960419308394194
mutation O 1 0.9993762373924255
detection O 0 0.4290127158164978
or O 0 0.019646313041448593
phenotype O 1 0.99983811378479
classification O 0 0.18774810433387756
may O 0 0.007737760432064533
account O 0 0.005231841001659632
for O 0 0.0029471921734511852
a O 0 0.006088061723858118
considerable O 0 0.01613178290426731
proportion O 0 0.02276216819882393
of O 0 0.012464911676943302
genotype O 1 0.9995163679122925
- O 1 0.9693710207939148
phenotype O 1 0.9983178377151489
inconsistencies O 0 0.07190268486738205
. O 0 0.026999441906809807

Our O 0 0.015391435474157333
data O 0 0.01082327589392662
indicate O 0 0.015482969582080841
that O 0 0.005460059270262718
the O 0 0.013438341207802296
PAH O 1 0.999904990196228
- O 1 0.9796521067619324
mutation O 1 0.999284565448761
genotype O 1 0.99538654088974
is O 0 0.006209022831171751
the O 0 0.005185824818909168
main O 0 0.010853898711502552
determinant O 0 0.09406676143407822
of O 0 0.01145761739462614
metabolic O 1 0.9995768666267395
phenotype O 1 0.9992368221282959
in O 0 0.00937113631516695
most O 0 0.017387766391038895
patients O 1 0.9997555613517761
with O 0 0.2567164897918701
PAH B-Disease 1 0.9999853372573853
deficiency I-Disease 1 0.999982476234436
. O 0 0.03694719076156616

In O 0 0.010467159561812878
the O 0 0.007289526052772999
present O 0 0.007845516316592693
study O 0 0.008926325477659702
, O 0 0.0033726654946804047
the O 0 0.0038345667999237776
classification O 0 0.01541918609291315
of O 0 0.007222064770758152
105 O 1 0.7473194003105164
PAH O 1 0.9999823570251465
mutations O 1 0.9993472695350647
may O 0 0.011969475075602531
allow O 0 0.005888774059712887
the O 0 0.0036437842063605785
prediction O 0 0.015163135714828968
of O 0 0.003976007457822561
the O 0 0.007066511083394289
biochemical O 1 0.8527469038963318
phenotype O 1 0.9996334314346313
in O 0 0.009914010763168335
> O 1 0.7503594756126404
10 O 0 0.00890247244387865
, O 0 0.006618369836360216
000 O 0 0.03596547618508339
genotypes O 1 0.9962953925132751
, O 0 0.005468522198498249
which O 0 0.0036708395928144455
may O 0 0.006010727491229773
be O 0 0.002303611021488905
useful O 0 0.005019816104322672
for O 0 0.0023310338146984577
the O 0 0.0040252795442938805
management O 0 0.012562149204313755
of O 0 0.007802705746144056
hyperphenylalaninemia B-Disease 1 0.9951680898666382
in O 0 0.017087504267692566
newborns O 1 0.9972800016403198
. O 0 0.030601680278778076

Somatic O 1 0.9536480903625488
instability O 0 0.14505091309547424
of O 0 0.007667161989957094
the O 0 0.011205650866031647
CTG O 1 0.991424024105072
repeat O 0 0.08141567558050156
in O 0 0.010949410498142242
mice O 1 0.9851764440536499
transgenic O 0 0.05699458718299866
for O 0 0.0078895203769207
the O 0 0.023039374500513077
myotonic B-Disease 1 0.9999896287918091
dystrophy I-Disease 1 0.9999963045120239
region O 0 0.07539138942956924
is O 0 0.008357785642147064
age O 0 0.0198378749191761
dependent O 0 0.019678937271237373
but O 0 0.0040361639112234116
not O 0 0.003969729412347078
correlated O 0 0.026401933282613754
to O 0 0.003352490719407797
the O 0 0.00511439424008131
relative O 0 0.023602765053510666
intertissue O 1 0.9400034546852112
transcription O 0 0.2595674991607666
levels O 0 0.030072512105107307
and O 0 0.014038114808499813
proliferative O 1 0.9976698756217957
capacities O 0 0.055826034396886826
. O 0 0.022858494892716408

A O 0 0.04423575848340988
( O 0 0.03210650756955147
CTG O 1 0.8636638522148132
) O 0 0.018673887476325035
nexpansion O 0 0.16018983721733093
in O 0 0.005696889478713274
the O 0 0.006580874789506197
3 O 0 0.018005330115556717
- O 0 0.038977500051259995
untranslated O 0 0.12190625071525574
region O 0 0.031044742092490196
( O 0 0.018735792487859726
UTR O 0 0.26288512349128723
) O 0 0.008193887770175934
of O 0 0.004775936249643564
the O 0 0.012864806689321995
DM O 1 0.9998805522918701
protein O 0 0.4320231080055237
kinase O 1 0.9893772602081299
gene O 1 0.9705750346183777
( O 0 0.025046836584806442
DMPK O 1 0.9730244278907776
) O 0 0.009916961193084717
is O 0 0.007019564975053072
responsible O 0 0.017389453947544098
for O 0 0.015437585301697254
causing O 1 0.999224066734314
myotonic B-Disease 1 0.9999933242797852
dystrophy I-Disease 1 0.9999974966049194
( O 1 0.7134432196617126
DM B-Disease 1 0.9998363256454468
) O 0 0.034119460731744766
. O 0 0.026728341355919838

Major O 0 0.04077757149934769
instability O 1 0.7639289498329163
, O 0 0.00598025880753994
with O 0 0.004256340675055981
very O 0 0.005983318202197552
large O 0 0.006423600018024445
expansions O 0 0.019601894542574883
between O 0 0.005642641335725784
generations O 0 0.01286995504051447
and O 0 0.0032786321826279163
high O 0 0.0069920155219733715
levels O 0 0.013391097076237202
of O 0 0.00808759592473507
somatic O 1 0.9901413321495056
mosaicism O 1 0.9992144107818604
, O 0 0.00789905060082674
is O 0 0.00983247347176075
observed O 0 0.023121938109397888
in O 0 0.013218964450061321
patients O 1 0.9982548356056213
. O 0 0.020661478862166405

There O 0 0.010350137948989868
is O 0 0.006171919405460358
a O 0 0.007214502897113562
good O 0 0.009835360571742058
correlation O 0 0.028905659914016724
between O 0 0.01035294122993946
repeat O 0 0.043967630714178085
size O 0 0.016193965449929237
( O 0 0.007554211653769016
at O 0 0.004796912893652916
least O 0 0.007674000691622496
in O 0 0.006463247817009687
leucocytes O 1 0.9818198680877686
) O 0 0.009049373678863049
, O 0 0.007074871100485325
clinical O 1 0.9888302683830261
severity O 1 0.9983254075050354
and O 0 0.005694710183888674
age O 0 0.021733587607741356
of O 0 0.01216572243720293
onset O 1 0.999798595905304
. O 0 0.030820975080132484

The O 0 0.036619603633880615
trinucleotide O 1 0.9900286793708801
repeat O 1 0.7719100117683411
instability O 1 0.8915783762931824
mechanisms O 0 0.055482715368270874
involved O 0 0.02124330960214138
in O 0 0.012063004076480865
DM B-Disease 1 0.9996895790100098
and O 0 0.0058260210789740086
other O 0 0.00599880563095212
human O 0 0.1645154356956482
genetic B-Disease 1 0.9998729228973389
diseases I-Disease 1 0.9999856948852539
are O 0 0.011222814209759235
unknown O 0 0.03419780731201172
. O 0 0.01994398795068264

We O 0 0.014994732104241848
studied O 0 0.02677835151553154
somatic O 1 0.7906983494758606
instability O 0 0.27315759658813477
by O 0 0.009950895793735981
measuring O 0 0.02546645887196064
the O 0 0.012193755246698856
CTG O 1 0.9847919940948486
repeat O 0 0.1399412900209427
length O 0 0.016269413754343987
at O 0 0.00538588548079133
several O 0 0.004819389898329973
ages O 0 0.016231492161750793
in O 0 0.004437883850187063
various O 0 0.006702589802443981
tissues O 1 0.6688610911369324
of O 0 0.008146017789840698
transgenic O 1 0.8134860396385193
mice O 1 0.9893863201141357
carrying O 0 0.019782450050115585
a O 0 0.015426965430378914
( O 0 0.02169972099363804
CTG O 1 0.8662599921226501
) O 0 0.018295541405677795
55expansion O 1 0.6337703466415405
surrounded O 0 0.019877977669239044
by O 0 0.007275558076798916
45 O 0 0.011618062853813171
kb O 0 0.03581516817212105
of O 0 0.004810645245015621
the O 0 0.006619993597269058
human O 0 0.056132420897483826
DM B-Disease 1 0.9996548891067505
region O 0 0.0221553985029459
, O 0 0.005364107899367809
using O 0 0.007804953958839178
small O 0 0.012968652881681919
- O 0 0.04288848489522934
pool O 0 0.05734281986951828
PCR O 0 0.14811211824417114
. O 0 0.030817005783319473

These O 0 0.01717361807823181
mice O 1 0.935416042804718
have O 0 0.005837372969835997
been O 0 0.005167878232896328
shown O 0 0.008272258564829826
to O 0 0.003970609977841377
reproduce O 0 0.0234677717089653
the O 0 0.007638066075742245
intergenerational O 1 0.5321048498153687
and O 0 0.008592038415372372
somatic O 1 0.8464210033416748
instability O 0 0.09544666111469269
of O 0 0.005404648836702108
the O 0 0.007243440020829439
55 O 0 0.030862700194120407
CTG O 1 0.9883919358253479
repeat O 0 0.21446740627288818
suggesting O 0 0.01946120895445347
that O 0 0.004076455254107714
surrounding O 0 0.010452264919877052
sequences O 0 0.014541973359882832
and O 0 0.0027545448392629623
the O 0 0.005175144877284765
chromatin O 0 0.053350780159235
environment O 0 0.010874539613723755
are O 0 0.0036662996280938387
involved O 0 0.01057062391191721
in O 0 0.008160736411809921
instability O 1 0.8088287711143494
mechanisms O 0 0.06447676569223404
. O 0 0.02357395365834236

As O 0 0.010383707471191883
observed O 0 0.01480557769536972
in O 0 0.003473922610282898
some O 0 0.0032360986806452274
of O 0 0.0029241321608424187
the O 0 0.006599462125450373
tissues O 1 0.9975876808166504
of O 0 0.021046152338385582
DM B-Disease 1 0.9999988079071045
patients O 1 0.9999394416809082
, O 0 0.004584444686770439
there O 0 0.0036516659893095493
is O 0 0.004002210684120655
a O 0 0.00778465298935771
tendency O 0 0.034861695021390915
for O 0 0.00485726073384285
repeat O 0 0.05223687365651131
length O 0 0.015960268676280975
and O 0 0.00677598686888814
somatic O 1 0.9957863688468933
mosaicism O 1 0.9977019429206848
to O 0 0.006018371321260929
increase O 0 0.00862334668636322
with O 0 0.0036291710566729307
the O 0 0.004313190467655659
age O 0 0.0111145731061697
of O 0 0.004481895361095667
the O 0 0.010947469621896744
mouse O 1 0.9803823232650757
. O 0 0.023859264329075813

Furthermore O 0 0.037239376455545425
, O 0 0.006135488860309124
we O 0 0.004455958493053913
observed O 0 0.014188437722623348
no O 0 0.005617217626422644
correlation O 0 0.019210193306207657
between O 0 0.006362662650644779
the O 0 0.009065937250852585
somatic O 1 0.9904194474220276
mutation O 1 0.9990999698638916
rate O 0 0.022678039968013763
and O 0 0.010339788161218166
tissue O 1 0.9988625049591064
proliferation O 0 0.14000195264816284
capacity O 0 0.02140415646135807
. O 0 0.019520657137036324

The O 0 0.026460256427526474
somatic O 1 0.9912885427474976
mutation O 1 0.9966842532157898
rates O 0 0.02475389651954174
in O 0 0.005926634185016155
different O 0 0.00848893541842699
tissues O 1 0.9005513787269592
were O 0 0.002917257370427251
also O 0 0.002869987627491355
not O 0 0.0030181400943547487
correlated O 0 0.019364409148693085
to O 0 0.0024768372531980276
the O 0 0.004244714044034481
relative O 0 0.017402200028300285
inter O 0 0.03388970345258713
- O 0 0.18733106553554535
tissue O 1 0.9953523874282837
difference O 0 0.015720833092927933
in O 0 0.005608493462204933
transcriptional O 0 0.05725342035293579
levels O 0 0.010808741673827171
of O 0 0.002940553706139326
the O 0 0.0036498913541436195
three O 0 0.007060454227030277
genes O 1 0.8509547114372253
( O 0 0.01651463285088539
DMAHP O 1 0.9976291060447693
, O 0 0.010348902083933353
DMPK O 1 0.993871808052063
and O 0 0.007049705367535353
59 O 0 0.02295696549117565
) O 0 0.008283548057079315
surrounding O 0 0.013698462396860123
the O 0 0.00851429719477892
repeat O 0 0.05785888433456421
. O 0 0.009813078679144382
. O 0 0.017704710364341736

A O 0 0.03906495124101639
novel O 0 0.0771946832537651
missense O 1 0.9979665279388428
mutation O 1 0.9985437393188477
in O 0 0.018184149637818336
patients O 1 0.9943952560424805
from O 0 0.011198003776371479
a O 0 0.02119296044111252
retinoblastoma B-Disease 1 0.9996539354324341
pedigree O 1 0.9577282071113586
showing O 0 0.030082056298851967
only O 0 0.012104222550988197
mild O 1 0.9739570021629333
expression O 0 0.03125259652733803
of O 0 0.007927648723125458
the O 0 0.022632881999015808
tumor B-Disease 1 0.9999572038650513
phenotype O 1 0.9994199275970459
. O 0 0.03355513885617256

We O 0 0.008505172096192837
have O 0 0.005733211059123278
used O 0 0.006343506276607513
single O 0 0.019006110727787018
strand O 0 0.0682908222079277
conformation O 1 0.5784772038459778
polymorphism O 0 0.14246848225593567
analysis O 0 0.011475995182991028
to O 0 0.003384837880730629
study O 0 0.007349446881562471
the O 0 0.004864420276135206
27 O 0 0.014749123714864254
exons O 0 0.0468156673014164
of O 0 0.006388350855559111
the O 0 0.015092709101736546
RB1 O 1 0.9995730519294739
gene O 1 0.8936465382575989
in O 0 0.006017766427248716
individuals O 0 0.008768106810748577
from O 0 0.0056276037357747555
a O 0 0.009905178099870682
family O 0 0.01952533982694149
showing O 0 0.050192173570394516
mild O 1 0.9949488639831543
expression O 0 0.02959786169230938
of O 0 0.006746654398739338
the O 0 0.016031553968787193
retinoblastoma B-Disease 1 0.9997846484184265
phenotype O 1 0.999401330947876
. O 0 0.03390071913599968

In O 0 0.012170377187430859
this O 0 0.009162208996713161
family O 0 0.02272866480052471
affected O 0 0.27271318435668945
individuals O 0 0.019246505573391914
developed O 0 0.3191630244255066
unilateral B-Disease 1 0.999046266078949
tumors I-Disease 1 0.9999762773513794
and O 0 0.003279645461589098
, O 0 0.0025382735766470432
as O 0 0.0022669315803796053
a O 0 0.0048725800588727
result O 0 0.00798819586634636
of O 0 0.004322323016822338
linkage O 0 0.04612908512353897
analysis O 0 0.013223481364548206
, O 0 0.009853473864495754
unaffected O 1 0.9976094961166382
mutation O 1 0.999384880065918
carriers O 0 0.25451144576072693
were O 0 0.0034269189927726984
also O 0 0.003799682715907693
identified O 0 0.010661515407264233
within O 0 0.007123074494302273
the O 0 0.009068669751286507
pedigree O 1 0.534389853477478
. O 0 0.023063339293003082

A O 0 0.028242701664566994
single O 0 0.025470010936260223
band O 0 0.030788183212280273
shift O 0 0.034813206642866135
using O 0 0.015290687792003155
SSCP O 1 0.8386836051940918
was O 0 0.00855997670441866
identified O 0 0.01415991224348545
in O 0 0.006080933380872011
exon O 0 0.1632140874862671
21 O 0 0.014553998596966267
which O 0 0.005736813880503178
resulted O 0 0.017523735761642456
in O 0 0.0052423616871237755
a O 0 0.015777701511979103
missense O 1 0.9836627244949341
mutation O 1 0.9942612648010254
converting O 0 0.030023885890841484
a O 0 0.0279405377805233
cys O 1 0.9962084293365479
- O 0 0.2935832440853119
- O 0 0.19584955275058746
> O 1 0.9152345657348633
arg O 1 0.8572679758071899
at O 0 0.013539298437535763
nucleotide O 0 0.05011952295899391
position O 0 0.010466883890330791
28 O 0 0.011473339051008224
in O 0 0.0047978730872273445
the O 0 0.009418371133506298
exon O 0 0.17456625401973724
. O 0 0.023970186710357666

The O 0 0.029326574876904488
mutation O 1 0.9960795044898987
destroyed O 0 0.03563540428876877
an O 0 0.017595285549759865
NdeI O 1 0.9758751392364502
restriction O 0 0.06338217854499817
enzyme O 0 0.08684750646352768
site O 0 0.02840748429298401
. O 0 0.022386785596609116

Analysis O 0 0.018010172992944717
of O 0 0.0044777886942029
all O 0 0.0037821070291101933
family O 0 0.008978934027254581
members O 0 0.005533597897738218
demonstrated O 0 0.011194624938070774
that O 0 0.003652924206107855
the O 0 0.008963588625192642
missense O 1 0.9989198446273804
mutation O 1 0.999518632888794
co O 0 0.25199612975120544
- O 0 0.05911535024642944
segregated O 0 0.11410364508628845
with O 0 0.013860492967069149
patients O 1 0.9998224377632141
with O 0 0.019779354333877563
tumors B-Disease 1 0.9999629259109497
or O 0 0.009616602212190628
who O 0 0.004710786510258913
, O 0 0.00245227781124413
as O 0 0.0026134587824344635
a O 0 0.004708562511950731
result O 0 0.008357659913599491
of O 0 0.004108698107302189
linkage O 0 0.16359075903892517
analysis O 0 0.010196957737207413
had O 0 0.005604691803455353
been O 0 0.005084772128611803
predicted O 0 0.012450103648006916
to O 0 0.0036421383265405893
carry O 0 0.011019077152013779
the O 0 0.01277117058634758
predisposing O 1 0.9960924983024597
mutation O 1 0.996813952922821
. O 0 0.026692083105444908

These O 0 0.007304973900318146
observations O 0 0.00983639806509018
point O 0 0.0058578914031386375
to O 0 0.003231668844819069
another O 0 0.006923523731529713
region O 0 0.010154581628739834
of O 0 0.005694283172488213
the O 0 0.014351733960211277
RB1 O 1 0.9997413754463196
gene O 1 0.9824203252792358
where O 0 0.015376598574221134
mutations O 1 0.9859374165534973
only O 0 0.004983492195606232
modify O 0 0.01816694438457489
the O 0 0.00361735001206398
function O 0 0.007540636695921421
of O 0 0.002780802082270384
the O 0 0.005677591077983379
gene O 1 0.7156908512115479
and O 0 0.003102236893028021
raise O 0 0.00974445603787899
important O 0 0.004872145131230354
questions O 0 0.008118193596601486
for O 0 0.006938848178833723
genetic O 1 0.9065874814987183
counseling O 0 0.35016804933547974
in O 0 0.005433494690805674
families O 0 0.009731415659189224
with O 0 0.005170256365090609
these O 0 0.006846007890999317
distinctive O 0 0.35330772399902344
phenotypes O 1 0.9926108717918396
. O 0 0.014022323302924633
. O 0 0.019222892820835114

Maternal B-Disease 1 0.9929404258728027
disomy I-Disease 1 0.9841565489768982
and O 0 0.031547848135232925
Prader B-Disease 1 0.9998400211334229
- I-Disease 1 0.9985187649726868
Willi I-Disease 1 0.9999825954437256
syndrome I-Disease 1 0.9999983310699463
consistent O 0 0.05450005829334259
with O 0 0.01565377600491047
gamete O 1 0.9828687906265259
complementation O 1 0.994492769241333
in O 0 0.007444203831255436
a O 0 0.00959188211709261
case O 0 0.011878659948706627
of O 0 0.010678059421479702
familial O 1 0.9997605681419373
translocation O 1 0.9953778982162476
( O 0 0.016506487503647804
3 O 0 0.013802943751215935
; O 0 0.007999829947948456
15 O 0 0.011498345993459225
) O 0 0.012028253637254238
( O 0 0.015768663957715034
p25 O 1 0.9745070338249207
; O 0 0.018605098128318787
q11 O 1 0.6761809587478638
. O 0 0.00867546908557415
2 O 0 0.015296036377549171
) O 0 0.012544093653559685
. O 0 0.015687577426433563

Maternal B-Disease 1 0.9965705871582031
uniparental I-Disease 1 0.9996829032897949
disomy I-Disease 1 0.9972931742668152
( I-Disease 0 0.050654198974370956
UPD I-Disease 1 0.9976392984390259
) I-Disease 0 0.015439346432685852
for I-Disease 0 0.009914741851389408
chromosome I-Disease 1 0.9895254373550415
15 I-Disease 0 0.010767712257802486
is O 0 0.004616918042302132
responsible O 0 0.008921429514884949
for O 0 0.0032350895926356316
an O 0 0.003572131274268031
estimated O 0 0.010622200556099415
30 O 0 0.007011260371655226
% O 0 0.005608023144304752
of O 0 0.0036739155184477568
cases O 0 0.01556070800870657
of O 0 0.013548429124057293
Prader B-Disease 1 0.9999836683273315
- I-Disease 1 0.9998019337654114
Willi I-Disease 1 0.9999979734420776
syndrome I-Disease 1 0.9999998807907104
( O 1 0.7894574999809265
PWS B-Disease 1 0.9998190999031067
) O 0 0.031503476202487946
. O 0 0.026396919041872025

We O 0 0.008273957297205925
report O 0 0.007812033407390118
on O 0 0.0035699286963790655
an O 0 0.003960106056183577
unusual O 0 0.01077377237379551
case O 0 0.008344320580363274
of O 0 0.005819054786115885
maternal B-Disease 1 0.9991670846939087
disomy I-Disease 1 0.9975361824035645
15 I-Disease 0 0.015690159052610397
in O 0 0.00943511351943016
PWS B-Disease 1 0.9995461106300354
that O 0 0.0049345348961651325
is O 0 0.0036762100644409657
most O 0 0.00363390170969069
consistent O 0 0.008359876461327076
with O 0 0.003843893064185977
adjacent O 0 0.013203858397901058
- O 0 0.020102431997656822
1 O 0 0.011975584551692009
segregation O 0 0.02573496662080288
of O 0 0.0054196747951209545
a O 0 0.01830667443573475
paternal O 1 0.9947584271430969
t O 1 0.9619397521018982
( O 0 0.015005046501755714
3 O 0 0.01363824587315321
; O 0 0.008885100483894348
15 O 0 0.012617764994502068
) O 0 0.011114605702459812
( O 0 0.013417419977486134
p25 O 1 0.9721280932426453
; O 0 0.014603190124034882
q11 O 1 0.6602205634117126
. O 0 0.006725098006427288
2 O 0 0.008679271675646305
) O 0 0.005235284101217985
with O 0 0.005341649521142244
simultaneous O 0 0.03848806768655777
maternal O 1 0.9905564785003662
meiotic O 1 0.9949470162391663
nondisjunction O 1 0.9605309963226318
for O 0 0.021374143660068512
chromosome O 1 0.9933879375457764
15 O 0 0.030768513679504395
. O 0 0.023143555968999863

The O 0 0.033217448741197586
patient O 1 0.9973184466362
( O 0 0.03244514763355255
J O 1 0.9940404295921326
. O 0 0.01041786652058363
B O 0 0.0697549507021904
. O 0 0.004288423340767622
) O 0 0.004442875273525715
, O 0 0.002674152608960867
a O 0 0.005805277731269598
17 O 0 0.01064187753945589
- O 0 0.019496414810419083
year O 0 0.009049523621797562
- O 0 0.022741811349987984
old O 0 0.016591357067227364
white O 0 0.023633772507309914
male O 0 0.13480636477470398
with O 0 0.011293402872979641
PWS B-Disease 1 0.9998291730880737
, O 0 0.0060742562636733055
was O 0 0.004808828234672546
found O 0 0.005241126287728548
to O 0 0.0029519121162593365
have O 0 0.004984099883586168
47 O 0 0.019446002319455147
chromosomes O 0 0.03716304898262024
with O 0 0.005422096233814955
a O 0 0.010741397738456726
supernumerary O 1 0.9632948040962219
, O 0 0.01130525954067707
paternal O 1 0.993937611579895
der O 1 0.758368968963623
( O 0 0.010982289910316467
15 O 0 0.009454179555177689
) O 0 0.005785019136965275
consisting O 0 0.005884024314582348
of O 0 0.002876558341085911
the O 0 0.0043665217235684395
short O 0 0.013251385651528835
arm O 0 0.08137452602386475
and O 0 0.0039833467453718185
the O 0 0.00898854248225689
proximal O 1 0.9982389211654663
long O 0 0.027346760034561157
arm O 0 0.1465000957250595
of O 0 0.009030916728079319
chromosome O 1 0.995840847492218
15 O 0 0.012980754487216473
, O 0 0.006198274437338114
and O 0 0.010632919147610664
distal O 1 0.999703586101532
chromosome O 1 0.9993711113929749
arm O 1 0.9875792860984802
3p O 1 0.9186748266220093
. O 0 0.034556448459625244

The O 0 0.02888166531920433
t O 1 0.7769314646720886
( O 0 0.014679605141282082
3 O 0 0.01220715418457985
; O 0 0.006229723803699017
15 O 0 0.007037818897515535
) O 0 0.004007250536233187
was O 0 0.003245602361857891
present O 0 0.0035348832607269287
in O 0 0.0021281263325363398
the O 0 0.003221341874450445
balanced O 0 0.00996931828558445
state O 0 0.004285203758627176
in O 0 0.0036863007117062807
the O 0 0.008000466041266918
patients O 1 0.9995602965354919
father O 0 0.01966835744678974
and O 0 0.004699204117059708
a O 0 0.012204268015921116
sister O 0 0.0691768079996109
. O 0 0.02092142216861248

Fluorescent O 0 0.11649207025766373
in O 0 0.020515253767371178
situ O 0 0.3421761393547058
hybridization O 0 0.06680320203304291
analysis O 0 0.018745914101600647
demonstrated O 0 0.016765544191002846
that O 0 0.004401627462357283
the O 0 0.010778342373669147
PWS B-Disease 1 0.999197781085968
critical O 0 0.03353271260857582
region O 0 0.021590881049633026
resided O 0 0.02353791333734989
on O 0 0.004766867961734533
the O 0 0.008608129806816578
derivative O 0 0.32343894243240356
chromosome O 1 0.9925185441970825
3 O 0 0.009519076906144619
and O 0 0.0024576610885560513
that O 0 0.0020206565968692303
there O 0 0.0028589852154254913
was O 0 0.004379776306450367
no O 0 0.0059769186191260815
deletion O 0 0.23744885623455048
of O 0 0.004965353757143021
the O 0 0.009437574073672295
PWS B-Disease 1 0.9995571970939636
region O 0 0.016239367425441742
on O 0 0.004123001359403133
the O 0 0.005273472983390093
normal O 0 0.019229937344789505
pair O 0 0.013087254948914051
of O 0 0.008689259178936481
15s O 1 0.9193751811981201
present O 0 0.01513685379177332
in O 0 0.01395388599485159
J O 1 0.9743423461914062
. O 0 0.025929491966962814

B O 0 0.14966434240341187
. O 0 0.03777139261364937

Methylation O 0 0.09444961696863174
analysis O 0 0.02107524871826172
at O 0 0.011628963984549046
exon O 0 0.07673462480306625
alpha O 0 0.02837742678821087
of O 0 0.004200322553515434
the O 0 0.005026801489293575
small O 0 0.009797864593565464
nuclear O 0 0.020469868555665016
ribonucleoprotein O 1 0.852874219417572
- O 0 0.04776765778660774
associated O 0 0.03387491777539253
polypeptide O 1 0.9263353943824768
N O 0 0.07733884453773499
( O 0 0.025949575006961823
SNRPN O 1 0.9290666580200195
) O 0 0.019528036937117577
gene O 0 0.23441022634506226
showed O 0 0.01670866645872593
a O 0 0.010841578245162964
pattern O 0 0.026768820360302925
characteristic O 0 0.018644964322447777
of O 0 0.003302312223240733
only O 0 0.003951892256736755
the O 0 0.006798445247113705
maternal O 1 0.9988706707954407
chromosome O 1 0.9986555576324463
15 O 0 0.018305998295545578
in O 0 0.012639133259654045
J O 1 0.9768022894859314
. O 0 0.022383272647857666

B O 0 0.1654723733663559
. O 0 0.03733532875776291

Maternal B-Disease 1 0.9937105178833008
disomy I-Disease 1 0.9157726168632507
was O 0 0.018873179331421852
confirmed O 0 0.022557754069566727
by O 0 0.013168652541935444
polymerase O 0 0.16569474339485168
chain O 0 0.0577874593436718
reaction O 0 0.027656305581331253
analysis O 0 0.012468961998820305
of O 0 0.007904470898211002
microsatellite O 1 0.8995314240455627
repeats O 0 0.05048097297549248
at O 0 0.010121255181729794
the O 0 0.009931306354701519
gamma O 0 0.22886043787002563
- O 0 0.10595618188381195
aminobutyric O 1 0.9606049060821533
acid O 1 0.7772462964057922
receptor O 1 0.9128835201263428
beta3 O 1 0.9260320067405701
subunit O 0 0.22304768860340118
( O 0 0.03971771150827408
GABRB3 O 1 0.9387507438659668
) O 0 0.03515395149588585
locus O 1 0.8786662220954895
. O 0 0.03010108880698681

A O 0 0.04341265559196472
niece O 1 0.9439794421195984
( O 0 0.02481083944439888
B O 0 0.12424590438604355
. O 0 0.009979710914194584
B O 0 0.03655928745865822
. O 0 0.005274111405014992
) O 0 0.005181260872632265
with O 0 0.0039576212875545025
45 O 0 0.012839719653129578
chromosomes O 0 0.03875045105814934
and O 0 0.003719566622748971
the O 0 0.0051656621508300304
derivative O 0 0.02780613861978054
3 O 0 0.009560342878103256
but O 0 0.004621564876288176
without O 0 0.006983294151723385
the O 0 0.0073541309684515
der O 0 0.28533920645713806
( O 0 0.009983816184103489
15 O 0 0.009239239618182182
) O 0 0.007025965955108404
demonstrated O 0 0.01740269735455513
a O 0 0.012906153686344624
phenotype O 1 0.9991162419319153
consistent O 0 0.014274846762418747
with O 0 0.004102571867406368
that O 0 0.0035888145212084055
reported O 0 0.01198101881891489
for O 0 0.006387739442288876
haploinsufficiency O 1 0.8136402368545532
of O 0 0.015408325009047985
distal O 1 0.9987586736679077
3 O 0 0.044823113828897476
p O 0 0.09136804938316345
. O 0 0.024375515058636665

Uniparental B-Disease 1 0.9994778037071228
disomy I-Disease 1 0.9942016005516052
associated O 0 0.03444288671016693
with O 0 0.01122666709125042
unbalanced O 0 0.08561036735773087
segregation O 0 0.03608405590057373
of O 0 0.006423539016395807
non O 0 0.029987329617142677
- O 1 0.8055879473686218
Robertsonian O 1 0.9985378980636597
translocations O 1 0.9972398281097412
has O 0 0.008464488200843334
been O 0 0.006480411626398563
reported O 0 0.012538672424852848
previously O 0 0.00610762694850564
but O 0 0.0031666746363043785
has O 0 0.003479189705103636
not O 0 0.001927984063513577
, O 0 0.001743367058224976
to O 0 0.0016075607854872942
our O 0 0.0032987394370138645
knowledge O 0 0.005428214557468891
, O 0 0.002483774209395051
been O 0 0.0035201250575482845
observed O 0 0.008413068950176239
in O 0 0.002616121666505933
a O 0 0.005528540816158056
case O 0 0.011778086423873901
of O 0 0.012620094232261181
PWS B-Disease 1 0.9995187520980835
. O 0 0.0300417710095644

Furthermore O 0 0.03136282041668892
, O 0 0.004811389371752739
our O 0 0.006272139959037304
findings O 0 0.011563635431230068
are O 0 0.0030184288043528795
best O 0 0.006826663389801979
interpreted O 0 0.010459230281412601
as O 0 0.006623849738389254
true O 0 0.022837050259113312
gamete O 1 0.9646109342575073
complementation O 1 0.9961877465248108
resulting O 0 0.10300884395837784
in O 0 0.02187572792172432
maternal B-Disease 1 0.9952108263969421
UPD I-Disease 1 0.9978819489479065
15 I-Disease 0 0.04895079508423805
and O 0 0.032299626618623734
PWS B-Disease 1 0.9967216849327087

Schwartz B-Disease 1 0.9809881448745728
- I-Disease 1 0.9740662574768066
Jampel I-Disease 1 0.9994553923606873
syndrome I-Disease 1 0.999997615814209
type I-Disease 0 0.3170734643936157
2 I-Disease 0 0.01736636273562908
and O 0 0.009906960651278496
Stuve B-Disease 1 0.9986473917961121
- I-Disease 1 0.9960695505142212
Wiedemann I-Disease 1 0.9997650980949402
syndrome I-Disease 1 0.999997615814209
: O 0 0.014232209883630276
a O 0 0.010913428850471973
case O 0 0.01124449260532856
for O 0 0.006108121480792761
" O 0 0.013903796672821045
lumping O 0 0.07166564464569092
" O 0 0.020759232342243195
. O 0 0.019068174064159393

Recent O 0 0.031058568507432938
studies O 0 0.01729513518512249
demonstrated O 0 0.01589238829910755
the O 0 0.004231003113090992
existence O 0 0.00779865775257349
of O 0 0.003346298821270466
a O 0 0.008886516094207764
genetically O 0 0.23783880472183228
distinct O 0 0.018826628103852272
, O 0 0.0042680962942540646
usually O 0 0.010446791537106037
lethal O 0 0.10553386062383652
form O 0 0.008042064495384693
of O 0 0.0036652872804552317
the O 0 0.009080629795789719
Schwartz B-Disease 1 0.9956430196762085
- I-Disease 1 0.9920401573181152
Jampel I-Disease 1 0.9998476505279541
syndrome I-Disease 1 0.9999994039535522
( O 0 0.2613126337528229
SJS B-Disease 1 0.9998376369476318
) O 0 0.014985445886850357
of O 0 0.012674326077103615
myotonia B-Disease 1 0.9999332427978516
and O 0 0.04008154943585396
skeletal B-Disease 1 0.9999698400497437
dysplasia I-Disease 1 0.9999932050704956
, O 0 0.006244856398552656
which O 0 0.0043467385694384575
we O 0 0.005993993952870369
called O 0 0.028518233448266983
SJS B-Disease 1 0.9997738003730774
type I-Disease 0 0.1870678812265396
2 I-Disease 0 0.02920464240014553
. O 0 0.018054790794849396

This O 0 0.03458711877465248
disorder O 1 0.9998326301574707
is O 0 0.011517731472849846
reminiscent O 0 0.03041183203458786
of O 0 0.005243517458438873
another O 0 0.013494758866727352
rare O 0 0.360584557056427
condition O 0 0.3429815173149109
, O 0 0.005311036016792059
the O 0 0.010251861996948719
Stuve B-Disease 1 0.999211311340332
- I-Disease 1 0.9955167174339294
Wiedemann I-Disease 1 0.9999059438705444
syndrome I-Disease 1 0.9999995231628418
( O 0 0.37336674332618713
SWS B-Disease 1 0.999664306640625
) O 0 0.010130287148058414
, O 0 0.0040039862506091595
which O 0 0.0045453584752976894
comprises O 0 0.016289910301566124
campomelia B-Disease 1 0.9252395033836365
at O 0 0.010768300853669643
birth O 0 0.48616114258766174
with O 0 0.01842804253101349
skeletal B-Disease 1 0.999970555305481
dysplasia I-Disease 1 0.9999970197677612
, O 0 0.02144109085202217
contractures B-Disease 1 0.9997170567512512
, O 0 0.006252714432775974
and O 0 0.005098182242363691
early B-Disease 0 0.014204045757651329
death I-Disease 0 0.20505094528198242
. O 0 0.01985945925116539

To O 0 0.009981393814086914
test O 0 0.015093454159796238
for O 0 0.005316354334354401
possible O 0 0.014190230518579483
nosologic O 1 0.9174711108207703
identity O 0 0.02187812514603138
between O 0 0.008598621003329754
these O 0 0.008642763830721378
disorders O 1 0.9999380111694336
, O 0 0.00457348208874464
we O 0 0.0029592555947601795
reviewed O 0 0.00741924811154604
the O 0 0.003594881622120738
literature O 0 0.004743029363453388
and O 0 0.0020540496334433556
obtained O 0 0.0051573398523032665
a O 0 0.005436597857624292
follow O 0 0.008851754479110241
- O 0 0.012244613841176033
up O 0 0.003703897353261709
of O 0 0.002199152484536171
the O 0 0.0031616478227078915
only O 0 0.00325747299939394
two O 0 0.005650930572301149
surviving O 0 0.3839479684829712
patients O 1 0.9989503026008606
, O 0 0.005071585066616535
one O 0 0.006662972737103701
with O 0 0.011477125808596611
SJS B-Disease 1 0.9998488426208496
type I-Disease 0 0.07421097904443741
2 I-Disease 0 0.011309067718684673
at O 0 0.006045083981007338
age O 0 0.011883413419127464
10 O 0 0.005769085604697466
years O 0 0.004091921262443066
and O 0 0.0025392768438905478
another O 0 0.00782184861600399
with O 0 0.008405748754739761
SWS B-Disease 1 0.998526930809021
at O 0 0.011967732571065426
age O 0 0.01974097639322281
7 O 0 0.01694955863058567
years O 0 0.016139457002282143
. O 0 0.018161501735448837

Patients O 1 0.9984937906265259
reported O 0 0.02821354754269123
as O 0 0.007105962838977575
having O 0 0.01680055819451809
either O 0 0.0394170880317688
neonatal O 1 0.9999728202819824
SJS B-Disease 1 0.999956488609314
or O 0 0.042173925787210464
SWS B-Disease 1 0.9994400143623352
presented O 0 0.013837193138897419
a O 0 0.010959974490106106
combination O 0 0.019608648493885994
of O 0 0.0048755863681435585
a O 0 0.01607002131640911
severe O 1 0.9996953010559082
, O 0 0.019138142466545105
prenatal O 1 0.9998699426651001
- O 1 0.9995187520980835
onset O 1 0.9999967813491821
neuromuscular B-Disease 1 0.9999994039535522
disorder I-Disease 1 0.9999980926513672
( O 0 0.1298891007900238
with O 0 0.21809299290180206
congenital B-Disease 1 0.999998927116394
joint I-Disease 1 0.9973114728927612
contractures I-Disease 1 0.9999901056289673
, O 0 0.3756895363330841
respiratory O 1 0.9999972581863403
and O 0 0.008678323589265347
feeding O 1 0.9796568751335144
difficulties O 1 0.8185726404190063
, O 0 0.007753460202366114
tendency O 1 0.6287941336631775
to O 0 0.007895397953689098
hyperthermia B-Disease 1 0.9996521472930908
, O 0 0.005062272306531668
and O 0 0.004272145219147205
frequent O 0 0.04371335729956627
death O 0 0.10157471895217896
in O 0 0.00808173418045044
infancy O 1 0.9472131729125977
) O 0 0.008141379803419113
with O 0 0.004892787430435419
a O 0 0.011947406455874443
distinct O 0 0.04235278069972992
campomelic B-Disease 1 0.9950634837150574
- I-Disease 1 0.9251385927200317
metaphyseal I-Disease 1 0.9981461763381958
skeletal I-Disease 1 0.9997373223304749
dysplasia I-Disease 1 0.9999630451202393
. O 0 0.04264024272561073

The O 0 0.011486785486340523
similarity O 0 0.024692019447684288
of O 0 0.004959434270858765
the O 0 0.007515068165957928
clinical O 1 0.6875815391540527
and O 0 0.005794128868728876
radiographic O 1 0.9649208784103394
findings O 0 0.017207486554980278
is O 0 0.004591799341142178
so O 0 0.004691828042268753
extensive O 0 0.010221440345048904
that O 0 0.0036907608155161142
these O 0 0.007190015632659197
disorders O 1 0.9999322891235352
appear O 0 0.01091006863862276
to O 0 0.0023348447866737843
be O 0 0.002286531263962388
a O 0 0.006544746458530426
single O 0 0.01476967055350542
entity O 0 0.034207411110401154
. O 0 0.020425327122211456

The O 0 0.012928089126944542
follow O 0 0.015567541122436523
- O 0 0.020733647048473358
up O 0 0.0072988346219062805
observation O 0 0.013387596234679222
of O 0 0.003323000855743885
an O 0 0.004225533921271563
identical O 0 0.011399059556424618
and O 0 0.004245314747095108
unique O 0 0.012356573715806007
pattern O 0 0.029553044587373734
of O 0 0.010473675094544888
progressive O 1 0.999678373336792
bone B-Disease 1 0.9999951124191284
dysplasia I-Disease 1 0.999993085861206
in O 0 0.00537261925637722
the O 0 0.005873354617506266
two O 0 0.007585758809000254
patients O 1 0.9989436268806458
( O 0 0.0095220897346735
one O 0 0.00726310396566987
with O 0 0.011768766678869724
SJS B-Disease 1 0.999923825263977
type I-Disease 0 0.12033113837242126
2 I-Disease 0 0.012919256463646889
, O 0 0.004299628548324108
one O 0 0.0054639652371406555
with O 0 0.009714392013847828
SWS B-Disease 1 0.9985795021057129
) O 0 0.012852096930146217
surviving O 0 0.0360158234834671
beyond O 0 0.026923516765236855
infancy O 1 0.8662666082382202
adds O 0 0.020887665450572968
to O 0 0.003376811509951949
the O 0 0.004150526598095894
evidence O 0 0.005827568005770445
in O 0 0.004480661358684301
favor O 0 0.010151621885597706
of O 0 0.007066645193845034
identity O 0 0.03590157628059387
. O 0 0.024098429828882217

The O 0 0.01988191157579422
hypothesis O 0 0.0526914969086647
that O 0 0.015621635131537914
SWS B-Disease 1 0.9977567791938782
and O 0 0.02000175043940544
SJS B-Disease 1 0.9998891353607178
type I-Disease 0 0.07829226553440094
2 I-Disease 0 0.009962562471628189
are O 0 0.0026308007072657347
the O 0 0.004563459195196629
same O 0 0.012906431220471859
disorder O 1 0.9999693632125854
should O 0 0.007126878947019577
be O 0 0.004817735869437456
testable O 0 0.030647575855255127
by O 0 0.009947250597178936
molecular O 0 0.029850240796804428
methods O 0 0.015442420728504658
. O 0 0.0095956576988101
. O 0 0.01525204349309206

A O 0 0.04163737967610359
mouse O 1 0.8427914977073669
model O 0 0.02665845863521099
of O 0 0.015561572276055813
severe O 1 0.9999765157699585
von B-Disease 1 0.9999489784240723
Willebrand I-Disease 1 0.9999986886978149
disease I-Disease 1 0.9999991655349731
: O 0 0.3465850353240967
defects O 1 0.9998266100883484
in O 0 0.01721961796283722
hemostasis O 1 0.9998738765716553
and O 0 0.030825071036815643
thrombosis B-Disease 1 0.9999734163284302
. O 0 0.03445442020893097

von B-Disease 1 0.9801682233810425
Willebrand I-Disease 1 0.9994491934776306
factor I-Disease 0 0.44968393445014954
( I-Disease 0 0.051502857357263565
vWf I-Disease 1 0.9954608082771301
) I-Disease 0 0.18451978266239166
deficiency I-Disease 1 0.999992847442627
causes O 1 0.9999305009841919
severe O 1 0.999995231628418
von B-Disease 1 0.9999650716781616
Willebrand I-Disease 1 0.999998927116394
disease I-Disease 1 0.9999984502792358
in O 0 0.025112319737672806
humans O 1 0.8598123788833618
. O 0 0.025108927860856056

We O 0 0.010107447393238544
generated O 0 0.01756521873176098
a O 0 0.0137000922113657
mouse O 1 0.7165034413337708
model O 0 0.012933626770973206
for O 0 0.005046163685619831
this O 0 0.009175572544336319
disease O 1 0.9998093247413635
by O 0 0.00826059840619564
using O 0 0.015597829595208168
gene O 0 0.40367645025253296
targeting O 0 0.039076223969459534
. O 0 0.020297277718782425

vWf B-Disease 1 0.9960512518882751
- I-Disease 1 0.924339771270752
deficient I-Disease 1 0.997111439704895
mice O 1 0.9976025223731995
appeared O 0 0.022773943841457367
normal O 0 0.02659992128610611
at O 0 0.008387398906052113
birth O 0 0.3037218749523163
; O 0 0.006253781262785196
they O 0 0.0026520579122006893
were O 0 0.0034714110661298037
viable O 0 0.022549942135810852
and O 0 0.00808790884912014
fertile O 0 0.12198226898908615
. O 0 0.022897835820913315

Neither O 0 0.09648832678794861
vWf O 1 0.9856675863265991
nor O 0 0.09064164012670517
vWf O 1 0.9894144535064697
propolypeptide O 1 0.9895386695861816
( O 0 0.05155506357550621
von B-Disease 1 0.9910867810249329
Willebrand I-Disease 1 0.9999669790267944
antigen O 1 0.9995548129081726
II O 1 0.6190699338912964
) O 0 0.009991991333663464
were O 0 0.005188383627682924
detectable O 0 0.39822864532470703
in O 0 0.007016511168330908
plasma O 0 0.04884357750415802
, O 0 0.009823193773627281
platelets O 1 0.9925884008407593
, O 0 0.008052638731896877
or O 0 0.012724673375487328
endothelial O 1 0.9958555102348328
cells O 0 0.08417988568544388
of O 0 0.007555582094937563
the O 0 0.013877044431865215
homozygous O 1 0.9934604167938232
mutant O 1 0.9961571097373962
mice O 1 0.9884472489356995
. O 0 0.03177311643958092

The O 0 0.0318463034927845
mutant O 1 0.9926977753639221
mice O 1 0.9971803426742554
exhibited O 1 0.7567615509033203
defects O 1 0.9991090893745422
in O 0 0.010668371804058552
hemostasis O 1 0.9989292025566101
with O 0 0.007615643087774515
a O 0 0.013599728234112263
highly O 0 0.22421281039714813
prolonged O 1 0.9998619556427002
bleeding O 1 0.9999793767929077
time O 0 0.012665343470871449
and O 0 0.009747304953634739
spontaneous O 1 0.9968690276145935
bleeding O 1 0.9999567270278931
events O 0 0.01128515787422657
in O 0 0.005176925100386143
approximately O 0 0.011408950202167034
10 O 0 0.008240737952291965
% O 0 0.010745326057076454
of O 0 0.011127515695989132
neonates O 1 0.9882442951202393
. O 0 0.028743382543325424

As O 0 0.010355633683502674
in O 0 0.0066998982802033424
the O 0 0.009074636735022068
human O 0 0.3713257908821106
disease O 1 0.9999672174453735
, O 0 0.005318555980920792
the O 0 0.006736726965755224
factor O 0 0.2201722115278244
VIII O 1 0.9592714309692383
level O 0 0.008301155641674995
in O 0 0.004100227262824774
these O 0 0.005710378289222717
mice O 1 0.9922811388969421
was O 0 0.007749931886792183
reduced O 0 0.0169767364859581
strongly O 0 0.00819456484168768
as O 0 0.002873262856155634
a O 0 0.004363606218248606
result O 0 0.006477937567979097
of O 0 0.0028581072110682726
the O 0 0.0035720104351639748
lack O 0 0.008597157895565033
of O 0 0.004025344271212816
protection O 0 0.016492530703544617
provided O 0 0.010411964729428291
by O 0 0.016025468707084656
vWf O 1 0.9904958009719849
. O 0 0.02247512713074684

Defective O 1 0.9991362690925598
thrombosis B-Disease 1 0.9999802112579346
in O 0 0.029107140377163887
mutant O 1 0.9992114305496216
mice O 1 0.9971766471862793
was O 0 0.008760995231568813
also O 0 0.005097491201013327
evident O 0 0.014175698161125183
in O 0 0.0034498737659305334
an O 0 0.004124860279262066
in O 0 0.005597176495939493
vivo O 0 0.29143568873405457
model O 0 0.01889071799814701
of O 0 0.01585773192346096
vascular B-Disease 1 0.9999889135360718
injury I-Disease 1 0.9996176958084106
. O 0 0.02706298604607582

In O 0 0.008793484419584274
this O 0 0.006139175035059452
model O 0 0.011056945659220219
, O 0 0.004586965311318636
the O 0 0.009115178138017654
exteriorized O 1 0.9893772602081299
mesentery O 1 0.9931815266609192
was O 0 0.020380821079015732
superfused O 1 0.9819574356079102
with O 0 0.01588483527302742
ferric O 1 0.9914283156394958
chloride O 0 0.057524316012859344
and O 0 0.004861457739025354
the O 0 0.00727940583601594
accumulation O 0 0.04445994645357132
of O 0 0.012678963132202625
fluorescently O 1 0.9892703294754028
labeled O 1 0.6359549164772034
platelets O 1 0.9922148585319519
was O 0 0.01647057756781578
observed O 0 0.026260074228048325
by O 0 0.016804829239845276
intravital O 1 0.9695409536361694
microscopy O 0 0.09449057281017303
. O 0 0.02675432711839676

We O 0 0.011908875778317451
conclude O 0 0.021982351318001747
that O 0 0.004505260847508907
these O 0 0.006833513732999563
mice O 1 0.9658660888671875
very O 0 0.009643930941820145
closely O 0 0.019834468141198158
mimic O 1 0.9986269474029541
severe O 1 0.9999344348907471
human O 1 0.995114803314209
von B-Disease 1 0.9999425411224365
Willebrand I-Disease 1 0.9999996423721313
disease I-Disease 1 0.9999988079071045
and O 0 0.005578760989010334
will O 0 0.0030611923430114985
be O 0 0.002307734452188015
very O 0 0.004185672849416733
useful O 0 0.005253321956843138
for O 0 0.00260995258577168
investigating O 0 0.010119209066033363
the O 0 0.004053352400660515
role O 0 0.009015464223921299
of O 0 0.006655885372310877
vWf O 1 0.969801664352417
in O 0 0.009367099963128567
normal O 0 0.08185344189405441
physiology O 1 0.7830634713172913
and O 0 0.004945861175656319
in O 0 0.010735644027590752
disease O 1 0.9999885559082031
models O 0 0.020365502685308456
. O 0 0.009361076168715954
. O 0 0.015530978329479694

Oral O 0 0.38593217730522156
contraceptives O 0 0.30067023634910583
and O 0 0.005517734680324793
the O 0 0.008373133838176727
risk O 1 0.9329125881195068
of O 0 0.01889302022755146
hereditary B-Disease 1 0.9999904632568359
ovarian I-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999923706054688
. O 0 0.04393738880753517

Hereditary B-Disease 1 0.9999032020568848
Ovarian I-Disease 1 0.9999992847442627
Cancer I-Disease 1 0.9999940395355225
Clinical O 1 0.9970658421516418
Study O 0 0.0367281474173069
Group O 0 0.026038160547614098
. O 0 0.021210717037320137

BACKGROUND O 0 0.0577726848423481
Women O 0 0.029408344998955727
with O 0 0.011800491251051426
mutations O 1 0.9928004741668701
in O 0 0.005460147745907307
either O 0 0.00880060438066721
the O 0 0.009439160116016865
BRCA1 O 1 0.9996665716171265
or O 0 0.011062662117183208
the O 0 0.015260898508131504
BRCA2 O 1 0.9999598264694214
gene O 1 0.9640657305717468
have O 0 0.00618972722440958
a O 0 0.010686879977583885
high O 0 0.016876958310604095
lifetime O 0 0.42604270577430725
risk O 1 0.9843445420265198
of O 0 0.08092151582241058
ovarian B-Disease 1 0.9999991655349731
cancer I-Disease 1 0.9999905824661255
. O 0 0.04013584554195404

Oral O 1 0.9132322669029236
contraceptives O 1 0.9900632500648499
protect O 1 0.7953155040740967
against O 1 0.8690226674079895
ovarian B-Disease 1 0.9999996423721313
cancer I-Disease 1 0.9999969005584717
in O 0 0.008718865923583508
general O 0 0.008055122569203377
, O 0 0.0032513414043933153
but O 0 0.003044453449547291
it O 0 0.002797018038108945
is O 0 0.0032598471734672785
not O 0 0.002571313176304102
known O 0 0.006403984501957893
whether O 0 0.003940378315746784
they O 0 0.0024588443338871002
also O 0 0.0033044912852346897
protect O 0 0.013638027012348175
against O 0 0.010774056427180767
hereditary B-Disease 1 0.9962989687919617
forms I-Disease 0 0.03033987618982792
of I-Disease 0 0.14925412833690643
ovarian I-Disease 1 0.9999996423721313
cancer I-Disease 1 0.9999918937683105
. O 0 0.036198683083057404

METHODS O 0 0.033641815185546875
We O 0 0.011744678020477295
enrolled O 0 0.03882179781794548
207 O 0 0.30816784501075745
women O 0 0.025620246306061745
with O 0 0.021848903968930244
hereditary B-Disease 1 0.9999939203262329
ovarian I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999966621398926
and O 0 0.007758216466754675
161 O 0 0.02312900498509407
of O 0 0.004283474758267403
their O 0 0.004959159065037966
sisters O 0 0.016826072707772255
as O 0 0.004464224446564913
controls O 0 0.012737463228404522
in O 0 0.004171448294073343
a O 0 0.00793810747563839
case O 0 0.013650194741785526
- O 0 0.03009401448071003
control O 0 0.029417777433991432
study O 0 0.024538399651646614
. O 0 0.02308778278529644

All O 0 0.011979088187217712
the O 0 0.012372861616313457
patients O 1 0.9870522022247314
carried O 0 0.015792282298207283
a O 0 0.020160449668765068
pathogenic O 1 0.9968673586845398
mutation O 1 0.9975399971008301
in O 0 0.010581206530332565
either O 0 0.02619771473109722
BRCA1 O 1 0.9997417330741882
( O 0 0.0220622755587101
179 O 0 0.052070315927267075
women O 0 0.021891511976718903
) O 0 0.011587385088205338
or O 0 0.01685590110719204
BRCA2 O 1 0.9997643828392029
( O 0 0.02035682462155819
28 O 0 0.020574789494276047
women O 0 0.019989140331745148
) O 0 0.012689510360360146
. O 0 0.01630871742963791

The O 0 0.01206639688462019
control O 0 0.02319357730448246
women O 0 0.011399365961551666
were O 0 0.003227946115657687
enrolled O 0 0.01761963590979576
regardless O 0 0.009890785440802574
of O 0 0.0028788200579583645
whether O 0 0.004799908958375454
or O 0 0.004157252609729767
not O 0 0.0024858899414539337
they O 0 0.0030311760492622852
had O 0 0.0069833663292229176
either O 0 0.019546473398804665
mutation O 1 0.9906013011932373
. O 0 0.02346056140959263

Lifetime O 0 0.0845552533864975
histories O 0 0.04637527093291283
of O 0 0.009405172429978848
oral O 1 0.7964054346084595
- O 0 0.4872470498085022
contraceptive O 1 0.9628363847732544
use O 0 0.006056756246834993
were O 0 0.0028213378973305225
obtained O 0 0.005400169640779495
by O 0 0.0045753950253129005
interview O 0 0.009857184253633022
or O 0 0.004611649084836245
by O 0 0.0048879096284508705
written O 0 0.006082385778427124
questionnaire O 0 0.023191621527075768
and O 0 0.003130906028673053
were O 0 0.0031168144196271896
compared O 0 0.01258082501590252
between O 0 0.009811860509216785
patients O 1 0.9986960291862488
and O 0 0.004635808523744345
control O 0 0.01890133135020733
women O 0 0.010735070332884789
, O 0 0.0039026704616844654
after O 0 0.008082054555416107
adjustment O 0 0.017809009179472923
for O 0 0.004007677547633648
year O 0 0.006265249103307724
of O 0 0.005819890182465315
birth O 0 0.13373138010501862
and O 0 0.007718317676335573
parity O 0 0.06583018600940704
. O 0 0.02268635295331478

RESULTS O 0 0.03647688031196594
The O 0 0.011934315785765648
adjusted O 0 0.041289474815130234
odds O 0 0.08207617700099945
ratio O 0 0.07627939432859421
for O 0 0.03632882237434387
ovarian B-Disease 1 0.9999991655349731
cancer I-Disease 1 0.999992847442627
associated O 0 0.02111941948533058
with O 0 0.0047657727263867855
any O 0 0.00418356666341424
past O 0 0.007159878965467215
use O 0 0.0048026638105511665
of O 0 0.005571575835347176
oral O 0 0.15814898908138275
contraceptives O 1 0.7730445861816406
was O 0 0.01397640909999609
0 O 0 0.03283162787556648
. O 0 0.019212448969483376

5 O 0 0.03186646103858948
( O 0 0.01653590425848961
95 O 0 0.021660342812538147
percent O 0 0.015839071944355965
confidence O 0 0.02123037725687027
interval O 0 0.03047327511012554
, O 0 0.00570877268910408
0 O 0 0.017028914764523506
. O 0 0.0047272806987166405
3 O 0 0.00839513260871172
to O 0 0.005519687198102474
0 O 0 0.01944776624441147
. O 0 0.006699016783386469
8 O 0 0.014376780949532986
) O 0 0.01268845796585083
. O 0 0.01451458502560854

The O 0 0.020760197192430496
risk O 1 0.9344132542610168
decreased O 0 0.43607914447784424
with O 0 0.007458476349711418
increasing O 0 0.02038007415831089
duration O 0 0.028233518823981285
of O 0 0.004640647675842047
use O 0 0.008355146273970604
( O 0 0.013320183381438255
P O 0 0.039419837296009064
for O 0 0.006779118906706572
trend O 0 0.03489780053496361
, O 0 0.012074978090822697
< O 1 0.8321811556816101
0 O 0 0.027875376865267754
. O 0 0.009823165833950043
001 O 1 0.5280247926712036
) O 0 0.007476528640836477
; O 0 0.00404374860227108
use O 0 0.002861855085939169
for O 0 0.0021844918373972178
six O 0 0.004088689107447863
or O 0 0.00420505041256547
more O 0 0.003350407350808382
years O 0 0.0051253968849778175
was O 0 0.005014883819967508
associated O 0 0.00908402819186449
with O 0 0.0036265014205127954
a O 0 0.0082239406183362
60 O 0 0.014380693435668945
percent O 0 0.015374080277979374
reduction O 0 0.025620045140385628
in O 0 0.00966670922935009
risk O 1 0.8678447604179382
. O 0 0.017515545710921288

Oral O 0 0.3576459586620331
- O 0 0.10690241307020187
contraceptive O 1 0.9224452972412109
use O 0 0.015268209390342236
protected O 0 0.0364915132522583
against O 0 0.1782347410917282
ovarian B-Disease 1 0.9999986886978149
cancer I-Disease 1 0.9999798536300659
both O 0 0.007043609861284494
for O 0 0.005184319335967302
carriers O 0 0.03267711400985718
of O 0 0.005612047389149666
the O 0 0.015683364123106003
BRCA1 O 1 0.9999637603759766
mutation O 1 0.9994909763336182
( O 0 0.020958399400115013
odds O 0 0.0722939521074295
ratio O 0 0.030020589008927345
, O 0 0.006687644403427839
0 O 0 0.016614729538559914
. O 0 0.004452829249203205
5 O 0 0.010252868756651878
; O 0 0.0053702956065535545
95 O 0 0.012332377023994923
percent O 0 0.011200405657291412
confidence O 0 0.01833188906311989
interval O 0 0.028928473591804504
, O 0 0.005678191315382719
0 O 0 0.01416382659226656
. O 0 0.0039205402135849
3 O 0 0.00663991691544652
to O 0 0.003543446073308587
0 O 0 0.01261173002421856
. O 0 0.004127976950258017
9 O 0 0.008063971064984798
) O 0 0.003615856869146228
and O 0 0.0020765906665474176
for O 0 0.003739578416571021
carriers O 0 0.01994200050830841
of O 0 0.0044029210694134235
the O 0 0.014499396085739136
BRCA2 O 1 0.9999808073043823
mutation O 1 0.9996945858001709
( O 0 0.021196333691477776
odds O 0 0.10075540840625763
ratio O 0 0.03450189158320427
, O 0 0.006845022086054087
0 O 0 0.01551053300499916
. O 0 0.005365629214793444
4 O 0 0.009363256394863129
; O 0 0.006662468425929546
95 O 0 0.013417558744549751
percent O 0 0.012588640674948692
confidence O 0 0.020664695650339127
interval O 0 0.02868211828172207
, O 0 0.006116786506026983
0 O 0 0.014806580729782581
. O 0 0.0040162368677556515
2 O 0 0.0058814059011638165
to O 0 0.0031473939307034016
1 O 0 0.0077483258210122585
. O 0 0.0050992765463888645
1 O 0 0.010651757940649986
) O 0 0.010175265371799469
. O 0 0.013026691973209381

CONCLUSIONS O 0 0.06146515905857086
Oral O 0 0.4699374735355377
- O 0 0.20602867007255554
contraceptive O 1 0.978501558303833
use O 0 0.010203735902905464
may O 0 0.010759820230305195
reduce O 0 0.016855934634804726
the O 0 0.008147839456796646
risk O 1 0.9907438158988953
of O 0 0.13700444996356964
ovarian B-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999940395355225
in O 0 0.01039836835116148
women O 0 0.018820449709892273
with O 0 0.011641385033726692
pathogenic O 1 0.9975247979164124
mutations O 1 0.9964768290519714
in O 0 0.008946473710238934
the O 0 0.01897682063281536
BRCA1 O 1 0.9998974800109863
or O 0 0.15307994186878204
BRCA2 O 1 0.9999094009399414
gene O 1 0.9842638373374939

A O 0 0.0294550359249115
Japanese O 0 0.021886982023715973
family O 0 0.020811406895518303
with O 0 0.013708522543311119
adrenoleukodystrophy B-Disease 1 0.9998606443405151
with O 0 0.010293410159647465
a O 0 0.01909591071307659
codon O 1 0.5952482223510742
291 O 0 0.3320068418979645
deletion O 1 0.8500241637229919
: O 0 0.011752938851714134
a O 0 0.01279343944042921
clinical O 1 0.7790471911430359
, O 0 0.006936746183782816
biochemical O 0 0.1969229131937027
, O 0 0.0069883218966424465
pathological O 1 0.9873296022415161
, O 0 0.004540000110864639
and O 0 0.004809481091797352
genetic O 1 0.7097271084785461
report O 0 0.014852342195808887
. O 0 0.015050281770527363

We O 0 0.008839279413223267
report O 0 0.01053179893642664
a O 0 0.01095400657504797
Japanese O 0 0.019039582461118698
family O 0 0.024112075567245483
with O 0 0.01888313516974449
adrenoleukodystrophy B-Disease 1 0.9999892711639404
( O 0 0.3402096629142761
ALD B-Disease 1 0.9999421834945679
) O 0 0.00923934392631054
with O 0 0.004276208579540253
a O 0 0.006900785956531763
three O 0 0.006127143744379282
base O 0 0.015939610078930855
pair O 0 0.029232030734419823
deletion O 1 0.9625337719917297
( O 0 0.025062136352062225
delGAG O 1 0.961219310760498
291 O 0 0.13323582708835602
) O 0 0.009286991320550442
in O 0 0.007682491093873978
the O 0 0.01820804364979267
ALD B-Disease 1 0.9998728036880493
gene O 1 0.9667706489562988
. O 0 0.03217557817697525

A O 0 0.021543558686971664
variety O 0 0.013466475531458855
of O 0 0.00720989378169179
phenotypes O 1 0.9897937774658203
were O 0 0.004390849266201258
observed O 0 0.014616569504141808
within O 0 0.006041503045707941
this O 0 0.005650738254189491
family O 0 0.02102494053542614
. O 0 0.01763772964477539

While O 0 0.016850672662258148
the O 0 0.015680404379963875
proband O 1 0.9919208288192749
( O 0 0.025064991787075996
patient O 1 0.9948822259902954
1 O 0 0.014124385081231594
) O 0 0.006630469113588333
was O 0 0.004688953515142202
classified O 0 0.00946615356951952
as O 0 0.003368428675457835
having O 0 0.007066394202411175
a O 0 0.007910850457847118
rare O 0 0.02424054592847824
intermediate O 0 0.023567426949739456
type O 0 0.02293832041323185
of O 0 0.0072589414194226265
adult O 1 0.9491371512413025
cerebral O 1 0.9998798370361328
and O 0 0.013601629063487053
cerebello O 1 0.9989351630210876
- O 1 0.9907845258712769
brain O 1 0.9998370409011841
stem O 1 0.8656908869743347
forms O 0 0.01503843255341053
, O 0 0.004704749211668968
his O 0 0.008111641742289066
younger O 1 0.7295333743095398
brother O 0 0.21688337624073029
( O 0 0.01811882108449936
patient O 1 0.9856179356575012
2 O 0 0.012463008984923363
) O 0 0.007971955463290215
and O 0 0.00451322365552187
nephew O 1 0.8692138195037842
( O 0 0.01914372108876705
patient O 1 0.992055356502533
3 O 0 0.01387820579111576
) O 0 0.008159049786627293
had O 0 0.00845525972545147
a O 0 0.021123256534337997
childhood O 1 0.998971700668335
ALD B-Disease 1 0.9999749660491943
type O 1 0.8540298938751221
. O 0 0.029096776619553566

Another O 0 0.04685243219137192
nephew O 1 0.6739464402198792
( O 0 0.02897528186440468
patient O 1 0.9917886853218079
4 O 0 0.018763603642582893
) O 0 0.007454689126461744
of O 0 0.006092284806072712
patient O 1 0.9822190999984741
1 O 0 0.011679230257868767
was O 0 0.006507151760160923
classified O 0 0.011270685121417046
as O 0 0.004506634082645178
having O 0 0.010813765227794647
an O 0 0.010380248539149761
adolescent O 1 0.9930033087730408
form O 0 0.02631417289376259
. O 0 0.021654939278960228

The O 0 0.01856864057481289
tau O 0 0.23097646236419678
level O 0 0.010559204034507275
in O 0 0.005541459657251835
the O 0 0.010397054255008698
cerebrospinal O 1 0.9991211295127869
fluid O 1 0.9849536418914795
( O 0 0.02664361149072647
CSF O 1 0.9974740147590637
) O 0 0.011994471773505211
in O 0 0.00842431839555502
patient O 1 0.9827349781990051
1 O 0 0.008927904069423676
was O 0 0.004595337901264429
as O 0 0.0027535418048501015
high O 0 0.004615417681634426
as O 0 0.002483285265043378
that O 0 0.0024276587646454573
of O 0 0.005842981394380331
patients O 1 0.9998723268508911
with O 0 0.44949978590011597
Alzheimers B-Disease 1 0.9999992847442627
disease I-Disease 1 0.9999985694885254
( O 0 0.04802838712930679
AD B-Disease 0 0.3418717086315155
) O 0 0.022685328498482704
. O 0 0.022992834448814392

His O 0 0.041215475648641586
brain O 1 0.9980186223983765
magnetic O 0 0.06316161155700684
resonance O 0 0.30297160148620605
image O 0 0.14579184353351593
( O 0 0.023696519434452057
MRI O 1 0.9902973771095276
) O 0 0.013174045830965042
showed O 0 0.026255248114466667
abnormalities B-Disease 1 0.9954562187194824
in I-Disease 0 0.0048182071186602116
the I-Disease 0 0.006437965203076601
bilateral I-Disease 0 0.025633027777075768
cerebellar I-Disease 1 0.999631404876709
hemispheres I-Disease 1 0.996862530708313
and O 0 0.02376433275640011
brain O 1 0.9999643564224243
stem O 1 0.9668641090393066
, O 0 0.0048433588817715645
but O 0 0.003273123875260353
not O 0 0.0023792574647814035
in O 0 0.003962584771215916
the O 0 0.00962325744330883
cerebral O 1 0.9999538660049438
white O 0 0.029046785086393356
matter O 0 0.008140590973198414
, O 0 0.003541341982781887
where O 0 0.005294823087751865
marked O 0 0.01404545083642006
reductions O 0 0.0165809765458107
of O 0 0.004396458622068167
the O 0 0.011804940178990364
cerebral O 1 0.9999775886535645
blood O 1 0.992743730545044
flow O 0 0.028224434703588486
and O 0 0.008142376318573952
oxygen O 1 0.6863933205604553
metabolism O 1 0.8418192267417908
were O 0 0.005349189043045044
clearly O 0 0.012871608138084412
demonstrated O 0 0.019429653882980347
by O 0 0.013643801212310791
positron O 1 0.9936730861663818
emission O 0 0.41559404134750366
tomography O 1 0.918752908706665
( O 0 0.02919665537774563
PET O 1 0.7872666716575623
) O 0 0.019621074199676514
. O 0 0.018877465277910233

In O 0 0.026482684537768364
patients O 1 0.9922851324081421
2 O 0 0.012206579558551311
and O 0 0.004269983619451523
3 O 0 0.007747369352728128
, O 0 0.0033057716209441423
the O 0 0.005552433896809816
autopsy O 0 0.16906338930130005
findings O 0 0.023969752714037895
showed O 0 0.02481100894510746
massive O 1 0.6718136668205261
demyelination B-Disease 1 0.999823272228241
of I-Disease 0 0.009222893975675106
the I-Disease 0 0.01610066182911396
cerebral I-Disease 1 0.9999030828475952
white I-Disease 0 0.02682422660291195
matter I-Disease 0 0.010435533709824085
with O 0 0.0054594529792666435
sparing O 0 0.055435989052057266
of O 0 0.00484752980992198
the O 0 0.008751987479627132
U O 1 0.8250215649604797
- O 0 0.15960176289081573
fibers O 0 0.20567598938941956
, O 0 0.005056715104728937
compatible O 0 0.011722085997462273
with O 0 0.0037095060106366873
the O 0 0.004776176065206528
findings O 0 0.01831801049411297
of O 0 0.013221346773207188
childhood O 1 0.9955660700798035
ALD B-Disease 1 0.9999277591705322
. O 0 0.04192494601011276

Oleic O 1 0.9020962119102478
and O 0 0.022885849699378014
erucic O 1 0.9728996157646179
acids O 0 0.06459120661020279
( O 0 0.0194286797195673
Lorenzos O 1 0.8872478604316711
Oil O 0 0.013757050037384033
) O 0 0.006488401908427477
were O 0 0.0036600916646420956
administered O 0 0.023942871019244194
to O 0 0.007204475812613964
patients O 1 0.9949892163276672
1 O 0 0.009971107356250286
and O 0 0.00400845380499959
4 O 0 0.008104652166366577
, O 0 0.0034801713190972805
but O 0 0.004451214801520109
sufficient O 0 0.01106132660061121
effectiveness O 0 0.032383427023887634
was O 0 0.006072900723665953
not O 0 0.004491375293582678
obtained O 0 0.0123677346855402
. O 0 0.015119229443371296

The O 0 0.012878499925136566
findings O 0 0.016406256705522537
in O 0 0.004751396365463734
this O 0 0.004387282766401768
family O 0 0.01169821247458458
suggest O 0 0.01315167173743248
that O 0 0.005673089064657688
delGAG291 O 1 0.8266899585723877
is O 0 0.004568092990666628
part O 0 0.005302384961396456
of O 0 0.0032049696892499924
the O 0 0.0051248399540781975
cause O 0 0.17812800407409668
of O 0 0.008106530643999577
Japanese O 0 0.05738823488354683
ALD B-Disease 1 0.9998842477798462
with O 0 0.019729316234588623
phenotypic O 1 0.9965026378631592
variations O 0 0.048648521304130554
. O 0 0.025008752942085266

Moreover O 0 0.03049500286579132
, O 0 0.006144285202026367
although O 0 0.004852072801440954
the O 0 0.0036071762442588806
scale O 0 0.008660922758281231
of O 0 0.002417611889541149
the O 0 0.003103545168414712
study O 0 0.007653409615159035
is O 0 0.00405264412984252
limited O 0 0.006083487533032894
, O 0 0.002573183970525861
there O 0 0.002365462016314268
is O 0 0.0027355393394827843
a O 0 0.004979656543582678
possibility O 0 0.01112289447337389
that O 0 0.005807925947010517
PET O 1 0.9913101196289062
can O 0 0.011156495660543442
detect O 0 0.12217437475919724
an O 0 0.014457926154136658
insidious B-Disease 1 0.9991443157196045
lesion I-Disease 1 0.9996738433837891
which O 0 0.009205438196659088
is O 0 0.012038138695061207
undetectable O 1 0.6145811676979065
by O 0 0.014375354163348675
computed O 0 0.1080363318324089
tomogram O 1 0.9844346642494202
( O 0 0.033210258930921555
CT O 1 0.9971367120742798
) O 0 0.011362935416400433
or O 0 0.01164744421839714
MRI O 1 0.9724012613296509
analysis O 0 0.008163094520568848
, O 0 0.0024375265929847956
and O 0 0.0016318859998136759
that O 0 0.0017455269116908312
the O 0 0.002629279624670744
higher O 0 0.006734873168170452
level O 0 0.006492943037301302
of O 0 0.005751666612923145
tau O 1 0.6381709575653076
reflects O 0 0.015382721088826656
the O 0 0.004680855665355921
process O 0 0.009069900028407574
of O 0 0.011211812496185303
neuronal B-Disease 1 0.9935637712478638
degeneration I-Disease 1 0.9999614953994751
in O 0 0.03414706885814667
ALD B-Disease 1 0.9999058246612549
. O 0 0.03471020609140396

Lorenzos O 1 0.8850828409194946
Oil O 0 0.019938766956329346
should O 0 0.005483745131641626
be O 0 0.0029810722917318344
given O 0 0.00404835632070899
in O 0 0.0033836625516414642
the O 0 0.005123889539390802
early O 0 0.013241936452686787
stage O 0 0.02831875905394554
. O 0 0.010979680344462395
. O 0 0.01850738748908043

Nonsense O 0 0.4879561960697174
mutation O 1 0.9815389513969421
in O 0 0.011265235021710396
exon O 0 0.09778276830911636
4 O 0 0.013141600415110588
of O 0 0.005386266391724348
human O 0 0.02346573770046234
complement O 0 0.12491357326507568
C9 O 1 0.9995953440666199
gene O 1 0.9107838273048401
is O 0 0.006500283721834421
the O 0 0.005376050248742104
major O 0 0.012144790962338448
cause O 0 0.10224507749080658
of O 0 0.007009331602603197
Japanese O 0 0.030441967770457268
complement B-Disease 0 0.3917275667190552
C9 I-Disease 1 0.9988435506820679
deficiency I-Disease 1 0.999843955039978
. O 0 0.04864215478301048

Deficiency B-Disease 1 0.9993565678596497
of I-Disease 0 0.007567891851067543
the I-Disease 0 0.007021442987024784
ninth I-Disease 0 0.02587120607495308
component I-Disease 0 0.01893172413110733
of I-Disease 0 0.005134137813001871
human I-Disease 0 0.02059748023748398
complement I-Disease 0 0.031131532043218613
( O 0 0.01892421580851078
C9 O 1 0.9978663325309753
) O 0 0.008881213143467903
is O 0 0.004253909923136234
the O 0 0.004220286849886179
most O 0 0.006405153311789036
common O 0 0.02493254467844963
complement B-Disease 1 0.9526301622390747
deficiency I-Disease 1 0.9999874830245972
in O 0 0.006736963056027889
Japan O 0 0.00810838583856821
but O 0 0.0040079206228256226
is O 0 0.004658225923776627
rare O 0 0.014428447000682354
in O 0 0.0034595660399645567
other O 0 0.003579234005883336
countries O 0 0.007659848779439926
. O 0 0.014539609663188457

We O 0 0.009971803985536098
studied O 0 0.01133829914033413
the O 0 0.005949879065155983
molecular O 0 0.023964814841747284
basis O 0 0.008101523853838444
of O 0 0.012276576831936836
C9 B-Disease 1 0.9994981288909912
deficiency I-Disease 1 0.9998300075531006
in O 0 0.007928439415991306
four O 0 0.008395843207836151
Japanese O 0 0.03640465438365936
C9 B-Disease 1 0.9998226761817932
- I-Disease 1 0.9935855269432068
deficient I-Disease 1 0.9996877908706665
patients O 1 0.9998373985290527
who O 0 0.017657693475484848
had O 0 0.022602643817663193
suffered O 1 0.9998236298561096
from O 0 0.1860203891992569
meningococcal B-Disease 1 0.9999972581863403
meningitis I-Disease 1 0.9999903440475464
. O 0 0.05159604176878929

Direct O 0 0.04273035377264023
sequencing O 0 0.056518301367759705
of O 0 0.012823676690459251
amplified O 0 0.17589236795902252
C9 O 1 0.9886617660522461
cDNA O 0 0.08139584958553314
and O 0 0.008358015678822994
DNA O 0 0.03564503416419029
revealed O 0 0.022624386474490166
a O 0 0.01222739927470684
nonsense O 0 0.042166776955127716
substitution O 0 0.04195508733391762
( O 0 0.01986737549304962
CGA O 0 0.2005835473537445
- O 0 0.14997044205665588
- O 0 0.4296090304851532
> O 1 0.9381670951843262
TGA O 1 0.9869872331619263
) O 0 0.012525300495326519
at O 0 0.01037556678056717
codon O 0 0.07607796043157578
95 O 0 0.017879124730825424
in O 0 0.007523597218096256
exon O 0 0.06066010892391205
4 O 0 0.009705028496682644
in O 0 0.004148569423705339
the O 0 0.0054905004799366
four O 0 0.012283134274184704
C9 B-Disease 1 0.9985742568969727
- I-Disease 1 0.7132318615913391
deficient I-Disease 1 0.9847357273101807
individuals O 0 0.029466496780514717
. O 0 0.022179605439305305

An O 0 0.031521618366241455
allele O 1 0.9761512875556946
- O 0 0.05914544314146042
specific O 0 0.028223156929016113
polymerase O 1 0.7276725769042969
chain O 0 0.10302165150642395
reaction O 0 0.03173842281103134
system O 0 0.010814724490046501
designed O 0 0.007957743480801582
to O 0 0.00438302755355835
detect O 0 0.025031663477420807
exclusively O 0 0.006233802065253258
only O 0 0.002439187839627266
one O 0 0.0023315015714615583
of O 0 0.0019050952978432178
the O 0 0.003548739943653345
normal O 0 0.017373288050293922
and O 0 0.006684509105980396
mutant O 1 0.9979876279830933
alleles O 1 0.9969960451126099
indicated O 0 0.013584597036242485
that O 0 0.0027789815794676542
all O 0 0.0022668540477752686
the O 0 0.0039044804871082306
four O 0 0.007377287372946739
patients O 1 0.9956377148628235
were O 0 0.005419820547103882
homozygous O 1 0.7543792724609375
for O 0 0.004495167639106512
the O 0 0.008301857858896255
mutation O 1 0.9957564473152161
in O 0 0.008504907600581646
exon O 0 0.3265324831008911
4 O 0 0.009405159391462803
and O 0 0.0023717584554105997
that O 0 0.002087775617837906
the O 0 0.003720278851687908
parents O 0 0.01185984630137682
of O 0 0.006348942872136831
patient O 1 0.9916254878044128
2 O 0 0.013650297187268734
were O 0 0.008928034454584122
heterozygous O 1 0.8437482118606567
. O 0 0.024789389222860336

The O 0 0.019889244809746742
common O 0 0.03978317975997925
mutation O 1 0.991555392742157
at O 0 0.01607479527592659
codon O 0 0.1257970929145813
95 O 0 0.018417317420244217
in O 0 0.007964933291077614
exon O 0 0.23714618384838104
4 O 0 0.013236554339528084
might O 0 0.007184258196502924
be O 0 0.0029290998354554176
responsible O 0 0.010266565717756748
for O 0 0.0038150702603161335
most O 0 0.009341277182102203
Japanese O 0 0.07230985164642334
C9 B-Disease 1 0.9997227787971497
deficiency I-Disease 1 0.999964714050293
. O 0 0.019087152555584908
. O 0 0.021920111030340195

BRCA1 O 1 0.9985688924789429
required O 0 0.01967187039554119
for O 0 0.01082802563905716
transcription O 0 0.10234443098306656
- O 0 0.05526963248848915
coupled O 0 0.06346946209669113
repair O 0 0.2651602029800415
of O 0 0.016111133620142937
oxidative O 1 0.9952933192253113
DNA O 1 0.557955801486969
damage O 0 0.43426886200904846
. O 0 0.02928164228796959

The O 0 0.04812149703502655
breast B-Disease 1 0.9999338388442993
and I-Disease 0 0.46607956290245056
ovarian I-Disease 1 0.9999991655349731
cancer I-Disease 1 0.9999970197677612
susceptibility O 1 0.9998979568481445
gene O 1 0.9981017708778381
BRCA1 O 1 0.9996906518936157
encodes O 0 0.37100404500961304
a O 0 0.026977190747857094
zinc O 1 0.8764125108718872
finger O 1 0.6040039658546448
protein O 0 0.03937891870737076
of O 0 0.007793302647769451
unknown O 0 0.02693890780210495
function O 0 0.030566494911909103
. O 0 0.019857274368405342

Association O 0 0.03106054663658142
of O 0 0.00843255128711462
the O 0 0.015588205307722092
BRCA1 O 1 0.9997255206108093
protein O 0 0.04118392616510391
with O 0 0.005337878130376339
the O 0 0.007317712530493736
DNA O 0 0.06061745062470436
repair O 1 0.9672611355781555
protein O 0 0.345695823431015
Rad51 O 1 0.9882566332817078
and O 0 0.005262437276542187
changes O 0 0.008112161420285702
in O 0 0.0030615576542913914
the O 0 0.004759056027978659
phosphorylation O 0 0.0271838940680027
and O 0 0.005464286543428898
cellular O 0 0.03025529347360134
localization O 0 0.026656024158000946
of O 0 0.0038047363050282
the O 0 0.0055405739694833755
protein O 0 0.03157899156212807
after O 0 0.012872355058789253
exposure O 0 0.17127065360546112
to O 0 0.0066581107676029205
DNA O 0 0.06456322968006134
- O 0 0.04077211767435074
damaging O 0 0.0707920491695404
agents O 0 0.011559838429093361
are O 0 0.0026113679632544518
consistent O 0 0.008122933097183704
with O 0 0.003427189541980624
a O 0 0.006935970392078161
role O 0 0.011158966459333897
for O 0 0.00915544480085373
BRCA1 O 1 0.9997005462646484
in O 0 0.012650343589484692
DNA O 0 0.2212013453245163
repair O 1 0.6918960213661194
. O 0 0.02264748513698578

Here O 0 0.011066830717027187
, O 0 0.004682458005845547
it O 0 0.0032439306378364563
is O 0 0.004680200945585966
shown O 0 0.011269239708781242
that O 0 0.008826088160276413
mouse O 1 0.9959995746612549
embryonic O 1 0.993701696395874
stem O 1 0.9920476078987122
cells O 1 0.9873133301734924
deficient B-Disease 1 0.9919863939285278
in I-Disease 0 0.014671897515654564
BRCA1 I-Disease 1 0.9999009370803833
are O 0 0.006492614280432463
defective O 1 0.9589038491249084
in O 0 0.00403765169903636
the O 0 0.003828089451417327
ability O 0 0.00810810923576355
to O 0 0.0029995879158377647
carry O 0 0.007590354420244694
out O 0 0.008661025203764439
transcription O 0 0.05268438532948494
- O 0 0.03951430320739746
coupled O 0 0.04183154180645943
repair O 0 0.17286142706871033
of O 0 0.010135930962860584
oxidative O 1 0.9971478581428528
DNA O 1 0.6843095421791077
damage O 1 0.8087731599807739
, O 0 0.004431223496794701
and O 0 0.003128226613625884
are O 0 0.004687861073762178
hypersensitive O 1 0.9827339053153992
to O 0 0.012031574733555317
ionizing O 1 0.9785053730010986
radiation O 1 0.713476300239563
and O 0 0.01118576992303133
hydrogen O 0 0.04780866950750351
peroxide O 0 0.1190386712551117
. O 0 0.02876271866261959

These O 0 0.009152418933808804
results O 0 0.016099201515316963
suggest O 0 0.017085108906030655
that O 0 0.009347911924123764
BRCA1 O 1 0.9998476505279541
participates O 0 0.0383731946349144
, O 0 0.004529960453510284
directly O 0 0.008255803026258945
or O 0 0.006518180947750807
indirectly O 0 0.01954568922519684
, O 0 0.00364698120392859
in O 0 0.005763797089457512
transcription O 0 0.07657985389232635
- O 0 0.04542037472128868
coupled O 0 0.062084946781396866
repair O 0 0.3026867210865021
of O 0 0.013139906339347363
oxidative O 1 0.9977691173553467
DNA O 1 0.625567615032196
damage O 1 0.7604723572731018
. O 0 0.01185554452240467
. O 0 0.017006834968924522

Truncation O 1 0.9759699106216431
mutations O 1 0.9746096730232239
in O 0 0.009148077107965946
the O 0 0.010967048816382885
transactivation O 1 0.9547807574272156
region O 0 0.023194367066025734
of O 0 0.010568235069513321
PAX6 O 1 0.9993029832839966
result O 0 0.02146466076374054
in O 0 0.009728609584271908
dominant O 0 0.14561524987220764
- O 0 0.06839309632778168
negative O 0 0.09303472936153412
mutants O 1 0.7730013728141785
. O 0 0.030128804966807365

PAX6 O 1 0.9947446584701538
is O 0 0.012359516695141792
a O 0 0.015775127336382866
transcription O 0 0.056222692131996155
factor O 0 0.02418644353747368
with O 0 0.004931483417749405
two O 0 0.005897031165659428
DNA O 0 0.04313815012574196
- O 0 0.03419129177927971
binding O 0 0.032898783683776855
domains O 0 0.039923422038555145
( O 0 0.01499800756573677
paired O 0 0.03886046260595322
box O 0 0.028391852974891663
and O 0 0.010362423025071621
homeobox O 1 0.9923825860023499
) O 0 0.009933323599398136
and O 0 0.004328656941652298
a O 0 0.01438034139573574
proline O 0 0.44684335589408875
- O 0 0.06282816082239151
serine O 0 0.13535815477371216
- O 0 0.06404859572649002
threonine O 0 0.2525363862514496
( O 0 0.028700895607471466
PST O 1 0.6718151569366455
) O 0 0.019111698493361473
- O 0 0.05003450810909271
rich O 0 0.05409406125545502
transactivation O 1 0.9718120694160461
domain O 0 0.06955164670944214
. O 0 0.026682570576667786

PAX6 O 1 0.9962995648384094
regulates O 1 0.9518774151802063
eye O 1 0.9957542419433594
development O 0 0.011094330810010433
in O 0 0.005608562845736742
animals O 0 0.022532455623149872
ranging O 0 0.0146947605535388
from O 0 0.010234825313091278
jellyfish O 1 0.794507622718811
to O 0 0.00819409266114235
Drosophila O 0 0.09679180383682251
to O 0 0.009613028727471828
humans O 0 0.048692937940359116
. O 0 0.019542938098311424

Heterozygous O 1 0.9894911050796509
mutations O 1 0.9853554964065552
in O 0 0.009387245401740074
the O 0 0.009200586006045341
human O 0 0.10763620585203171
PAX6 O 1 0.9997461438179016
gene O 1 0.9852789640426636
result O 0 0.01516205258667469
in O 0 0.005288952030241489
various O 0 0.007871654815971851
phenotypes O 1 0.9880393147468567
, O 0 0.006823679897934198
including O 0 0.011463245376944542
aniridia B-Disease 1 0.9947795867919922
, O 0 0.014375409111380577
Peters B-Disease 1 0.9933493733406067
anomaly I-Disease 1 0.9962087869644165
, O 0 0.0227823369204998
autosomal B-Disease 1 0.9999449253082275
dominant I-Disease 1 0.9986806511878967
keratitis I-Disease 1 0.9999793767929077
, O 0 0.01451062224805355
and O 0 0.018438518047332764
familial B-Disease 1 0.9999408721923828
foveal I-Disease 1 0.9998019337654114
dysplasia I-Disease 1 0.9999818801879883
. O 0 0.04615393280982971

It O 0 0.009594478644430637
is O 0 0.006722715217620134
believed O 0 0.010955989360809326
that O 0 0.004620471969246864
the O 0 0.009598948061466217
mutated O 1 0.9940833449363708
allele O 1 0.9745158553123474
of O 0 0.01724923588335514
PAX6 O 1 0.9991476535797119
produces O 0 0.043514009565114975
an O 0 0.010364546440541744
inactive O 0 0.2994421124458313
protein O 0 0.03959640488028526
and O 0 0.0074115474708378315
aniridia B-Disease 1 0.9936385750770569
is O 0 0.011368031613528728
caused O 1 0.6319040060043335
due O 0 0.015633217990398407
to O 0 0.009890883229672909
genetic O 1 0.93729567527771
haploinsufficiency O 1 0.9719593524932861
. O 0 0.02794158086180687

However O 0 0.014468235895037651
, O 0 0.007777099497616291
several O 0 0.010812769643962383
truncation O 1 0.9870291948318481
mutations O 1 0.9985805749893188
have O 0 0.004939998034387827
been O 0 0.004703954793512821
found O 0 0.005375588778406382
to O 0 0.0034280167892575264
occur O 0 0.011573215946555138
in O 0 0.003404598915949464
the O 0 0.006405881606042385
C O 0 0.06672752648591995
- O 0 0.03280485048890114
terminal O 0 0.04113544896245003
half O 0 0.011867684312164783
of O 0 0.009584927931427956
PAX6 O 1 0.9993821382522583
in O 0 0.014031345956027508
patients O 1 0.9980497360229492
with O 0 0.012783044017851353
Aniridia B-Disease 1 0.9976333379745483
resulting O 0 0.05929932743310928
in O 0 0.009596378542482853
mutant O 1 0.9759082794189453
proteins O 0 0.02284693717956543
that O 0 0.004249692894518375
retain O 0 0.014404090121388435
the O 0 0.0067891343496739864
DNA O 0 0.04732948914170265
- O 0 0.029799269512295723
binding O 0 0.024370089173316956
domains O 0 0.021735742688179016
but O 0 0.004374882206320763
have O 0 0.003815282369032502
lost O 0 0.00997533556073904
most O 0 0.0037222658284008503
of O 0 0.0036952272057533264
the O 0 0.010275030508637428
transactivation O 1 0.972602367401123
domain O 0 0.054770320653915405
. O 0 0.025105945765972137

It O 0 0.009212595410645008
is O 0 0.006224470678716898
not O 0 0.0033027143217623234
clear O 0 0.006554951425641775
whether O 0 0.0056247105821967125
such O 0 0.0061124940402805805
mutants O 1 0.8621751070022583
really O 0 0.017244618386030197
behave O 0 0.022368935868144035
as O 0 0.005167936906218529
loss O 0 0.023547543212771416
- O 0 0.016694117337465286
of O 0 0.005960557609796524
- O 0 0.03569400683045387
function O 0 0.029984556138515472
mutants O 0 0.40533047914505005
as O 0 0.007800447288900614
predicted O 0 0.027483196929097176
by O 0 0.015560191124677658
haploinsufficiency O 1 0.8571527600288391
. O 0 0.028034187853336334

Contrary O 0 0.018166381865739822
to O 0 0.003970544319599867
this O 0 0.003153255209326744
theory O 0 0.006058566737920046
, O 0 0.002340358681976795
our O 0 0.003275164170190692
data O 0 0.00463918037712574
showed O 0 0.008078580722212791
that O 0 0.0028406924102455378
these O 0 0.0039009356405586004
mutants O 0 0.44866883754730225
are O 0 0.005676662549376488
dominant O 0 0.0435931533575058
- O 0 0.03516135737299919
negative O 0 0.0427217110991478
in O 0 0.015432855114340782
transient O 1 0.9681921005249023
transfection O 1 0.9899137020111084
assays O 0 0.06991120427846909
when O 0 0.00956841092556715
they O 0 0.004030815791338682
are O 0 0.004349413327872753
coexpressed O 1 0.6119388937950134
with O 0 0.008719434030354023
wild O 0 0.05763951689004898
- O 0 0.2409905344247818
type O 1 0.6846929788589478
PAX6 O 1 0.9973629117012024
. O 0 0.03221188113093376

We O 0 0.010613564401865005
found O 0 0.00847207847982645
that O 0 0.003994166851043701
the O 0 0.0068437485024333
dominant O 0 0.13168329000473022
- O 0 0.12308626621961594
negative O 0 0.10411843657493591
effects O 0 0.09321721643209457
result O 0 0.011750445701181889
from O 0 0.005193507298827171
the O 0 0.0059665474109351635
enhanced O 0 0.03428272157907486
DNA O 0 0.03964462876319885
binding O 0 0.01990111917257309
ability O 0 0.013461713679134846
of O 0 0.004992570262402296
these O 0 0.007401946000754833
mutants O 1 0.6530308127403259
. O 0 0.020695054903626442

Kinetic O 0 0.053324341773986816
studies O 0 0.015619229525327682
of O 0 0.005480512045323849
binding O 0 0.016551941633224487
and O 0 0.005852729547768831
dissociation O 0 0.44203487038612366
revealed O 0 0.0172409750521183
that O 0 0.004297375679016113
various O 0 0.007382488343864679
truncation O 1 0.9252701997756958
mutants O 1 0.9047016501426697
have O 0 0.0072082215920090675
3 O 0 0.01289300061762333
- O 0 0.027864638715982437
5 O 0 0.01691930741071701
- O 0 0.029293689876794815
fold O 0 0.0381639339029789
higher O 0 0.014651312492787838
affinity O 0 0.023012647405266762
to O 0 0.0037385534960776567
various O 0 0.006242412608116865
DNA O 0 0.03244771435856819
- O 0 0.02590191923081875
binding O 0 0.018153272569179535
sites O 0 0.007733334321528673
when O 0 0.006730472669005394
compared O 0 0.010560543276369572
with O 0 0.004088411573320627
the O 0 0.006747591309249401
wild O 0 0.045807257294654846
- O 0 0.1278788149356842
type O 0 0.4627518057823181
PAX6 O 1 0.9963769316673279
. O 0 0.03231574222445488

These O 0 0.009646057151257992
results O 0 0.013262619264423847
provide O 0 0.006978302262723446
a O 0 0.0064606089144945145
new O 0 0.0060685304924845695
insight O 0 0.018296487629413605
into O 0 0.0059831030666828156
the O 0 0.005073098465800285
role O 0 0.01227909792214632
of O 0 0.009878437966108322
mutant O 1 0.9970544576644897
PAX6 O 1 0.9979950189590454
in O 0 0.023013418540358543
causing O 1 0.9885823726654053
aniridia B-Disease 1 0.9971099495887756
. O 0 0.016852179542183876
. O 0 0.019198501482605934

Reversal O 1 0.5705591440200806
of O 0 0.030061397701501846
severe O 1 0.9999690055847168
hypertrophic B-Disease 1 0.9999977350234985
cardiomyopathy I-Disease 1 0.9999978542327881
and O 0 0.011920119635760784
excellent O 0 0.05373150110244751
neuropsychologic O 1 0.9850388765335083
outcome O 0 0.019589601084589958
in O 0 0.006320638582110405
very B-Disease 0 0.009534338489174843
- I-Disease 0 0.03373629227280617
long I-Disease 0 0.026542142033576965
- I-Disease 0 0.09988036751747131
chain I-Disease 1 0.653144121170044
acyl I-Disease 1 0.9661011695861816
- I-Disease 0 0.13384659588336945
coenzyme I-Disease 1 0.953163743019104
A I-Disease 0 0.3228076994419098
dehydrogenase I-Disease 1 0.9987140893936157
deficiency I-Disease 1 0.9998295307159424
. O 0 0.04094291105866432

Very B-Disease 0 0.032049331814050674
- I-Disease 0 0.055971451103687286
long I-Disease 0 0.031558483839035034
- I-Disease 0 0.07424215227365494
chain I-Disease 0 0.387221097946167
acyl I-Disease 1 0.9794687032699585
- I-Disease 0 0.08225758373737335
coenzyme I-Disease 1 0.892561674118042
A I-Disease 0 0.04733036458492279
dehydrogenase I-Disease 1 0.9951112866401672
( I-Disease 0 0.037720415741205215
VLCAD I-Disease 1 0.99600750207901
) I-Disease 0 0.031658779829740524
deficiency I-Disease 1 0.999860405921936
is O 0 0.012454267591238022
a O 0 0.02363324537873268
disorder O 1 0.9999006986618042
of O 0 0.01595791056752205
fatty O 1 0.9984539747238159
acid O 1 0.9560999870300293
beta O 0 0.2946997582912445
oxidation O 0 0.05280085653066635
that O 0 0.004809750709682703
reportedly O 0 0.014927110634744167
has O 0 0.006308392621576786
high O 0 0.0095189418643713
rates O 0 0.01583707332611084
of O 0 0.008351747877895832
morbidity O 1 0.9983413219451904
and O 0 0.01218777522444725
mortality O 1 0.9929786324501038
. O 0 0.023190876469016075

We O 0 0.009612747468054295
describe O 0 0.0159855168312788
the O 0 0.005024498328566551
outcome O 0 0.01224280335009098
of O 0 0.0041159153915941715
a O 0 0.009234032593667507
5 O 0 0.013452572748064995
- O 0 0.02639251947402954
year O 0 0.012698778882622719
- O 0 0.031022854149341583
old O 0 0.028215141966938972
girl O 1 0.7805460691452026
with O 0 0.021707285195589066
VLCAD B-Disease 1 0.9999113082885742
deficiency I-Disease 1 0.9999837875366211
who O 0 0.012101149186491966
was O 0 0.006896463688462973
first O 0 0.00589995551854372
seen O 0 0.010942352935671806
at O 0 0.005250346846878529
5 O 0 0.008981782011687756
months O 0 0.00885008554905653
of O 0 0.004368120338767767
age O 0 0.02404208667576313
with O 0 0.024144859984517097
severe O 1 0.9999951124191284
hypertrophic B-Disease 1 0.9999996423721313
cardiomyopathy I-Disease 1 0.9999994039535522
, O 1 0.8070114254951477
hepatomegaly B-Disease 1 0.9999951124191284
, O 1 0.6689668297767639
encephalopathy B-Disease 1 0.9999984502792358
, O 0 0.013710889033973217
and O 0 0.013993462547659874
hypotonia B-Disease 1 0.9989243149757385
. O 0 0.027705837041139603

Biochemical O 0 0.23681940138339996
studies O 0 0.04418529197573662
indicated O 0 0.34506505727767944
VLCAD B-Disease 1 0.9999269247055054
deficiency I-Disease 1 0.999995231628418
caused O 1 0.9829869270324707
by O 0 0.008061354048550129
a O 0 0.013369977474212646
stable O 0 0.07011502981185913
yet O 0 0.02072293870151043
inactive O 0 0.2776556611061096
enzyme O 0 0.19882631301879883
. O 0 0.021950751543045044

Molecular O 0 0.09410587698221207
genetic O 0 0.11975045502185822
analysis O 0 0.01689484715461731
of O 0 0.007314993999898434
her O 0 0.0257252249866724
VLCAD O 1 0.997105062007904
gene O 1 0.9789886474609375
revealed O 0 0.04243745654821396
a O 0 0.02396700344979763
T1372C O 1 0.8409366607666016
( O 0 0.02863381803035736
F458L O 1 0.9440879821777344
) O 0 0.026722988113760948
missense O 1 0.9953137636184692
mutation O 1 0.9932050704956055
and O 0 0.007837452925741673
a O 0 0.020129313692450523
1668 O 1 0.9951602816581726
ACAG O 1 0.9964849948883057
1669 O 1 0.9874846339225769
splice O 1 0.9398552775382996
site O 0 0.06371772289276123
mutation O 1 0.9838737845420837
. O 0 0.030840443447232246

After O 0 0.03958798572421074
initial O 0 0.04567313566803932
treatment O 1 0.5842012166976929
with O 0 0.015713417902588844
intravenous O 1 0.9931312203407288
glucose O 1 0.9473087787628174
and O 0 0.010917934589087963
carnitine O 1 0.9969678521156311
, O 0 0.005969316698610783
the O 0 0.00788854993879795
patient O 1 0.9960886240005493
has O 0 0.009033801034092903
thrived O 0 0.03796245902776718
on O 0 0.005480288062244654
a O 0 0.011501631699502468
low O 0 0.03437094762921333
- O 0 0.07324784994125366
fat O 0 0.45064792037010193
diet O 0 0.1336713582277298
supplemented O 0 0.02677919715642929
with O 0 0.008421940729022026
medium O 0 0.021419288590550423
- O 0 0.04579345881938934
chain O 0 0.11362428218126297
triglyceride O 0 0.343388170003891
oil O 0 0.018607934936881065
and O 0 0.01081897784024477
carnitine O 1 0.9860320091247559
and O 0 0.009941307827830315
avoidance O 0 0.3018559217453003
of O 0 0.013657412491738796
fasting O 1 0.7953921556472778
. O 0 0.0301103126257658

Her O 1 0.6770574450492859
ventricular O 1 0.9997456669807434
hypertrophy O 1 0.9997599720954895
resolved O 0 0.06577575206756592
significantly O 0 0.03078075312077999
over O 0 0.007009205874055624
1 O 0 0.009764709509909153
year O 0 0.007387944497168064
, O 0 0.004458235576748848
and O 0 0.005393991246819496
cognitively O 1 0.98463374376297
, O 0 0.005023859441280365
she O 0 0.005264351610094309
is O 0 0.003707640105858445
in O 0 0.003014105139300227
the O 0 0.005010978318750858
superior O 0 0.01750772073864937
range O 0 0.010121488943696022
for O 0 0.0067303418181836605
age O 0 0.022797252982854843
. O 0 0.01624278724193573

Clinical O 1 0.9038389325141907
recognition O 0 0.04197947680950165
of O 0 0.01810830645263195
VLCAD B-Disease 1 0.9999880790710449
deficiency I-Disease 1 0.999997615814209
is O 0 0.00796301569789648
important O 0 0.005611816421151161
because O 0 0.004739923868328333
it O 0 0.002353062853217125
is O 0 0.0027964382898062468
one O 0 0.002194148488342762
of O 0 0.0023655544500797987
the O 0 0.00462962593883276
few O 0 0.010233656503260136
directly O 0 0.026235656812787056
treatable O 1 0.9999443292617798
causes O 1 0.9975035786628723
of O 0 0.01837778277695179
cardiomyopathy B-Disease 1 0.999993085861206
in O 0 0.013233103789389133
children O 0 0.026662098243832588
. O 0 0.011554865166544914
. O 0 0.01925436407327652

Cloning O 0 0.05718906596302986
of O 0 0.006111918017268181
a O 0 0.01052836049348116
novel O 0 0.016681862995028496
member O 0 0.006916258949786425
of O 0 0.004100947640836239
the O 0 0.006886454299092293
low O 0 0.027743369340896606
- O 0 0.05177619680762291
density O 0 0.05639408156275749
lipoprotein O 1 0.9958609938621521
receptor O 1 0.956062376499176
family O 0 0.04194987565279007
. O 0 0.02378402277827263

A O 0 0.04476475715637207
gene O 0 0.1815025508403778
encoding O 0 0.050894200801849365
a O 0 0.018375173211097717
novel O 0 0.038991935551166534
transmembrane O 0 0.4002453684806824
protein O 0 0.04286236688494682
was O 0 0.007630950305610895
identified O 0 0.013935593888163567
by O 0 0.007217751815915108
DNA O 0 0.0284233670681715
sequence O 0 0.0191509909927845
analysis O 0 0.01018128078430891
within O 0 0.0070972745306789875
the O 0 0.010393040254712105
insulin B-Disease 1 0.997148334980011
- I-Disease 1 0.8615912199020386
dependent I-Disease 1 0.9838674068450928
diabetes I-Disease 1 0.9999986886978149
mellitus I-Disease 1 0.9999810457229614
( O 0 0.04782963544130325
IDDM B-Disease 1 0.9959557056427002
) O 0 0.02781219594180584
locus O 1 0.9949855804443359
IDDM4 O 1 0.9931440353393555
on O 0 0.02349819242954254
chromosome O 1 0.9976518750190735
11q13 O 1 0.9421387314796448
. O 0 0.02937755174934864

Based O 0 0.014492707327008247
on O 0 0.006817355286329985
its O 0 0.011644802987575531
chromosomal O 1 0.9837136268615723
position O 0 0.009748746640980244
, O 0 0.004410737194120884
this O 0 0.005817336030304432
gene O 0 0.35842302441596985
is O 0 0.006299339234828949
a O 0 0.008106384426355362
candidate O 0 0.014243640005588531
for O 0 0.00789364892989397
conferring O 1 0.735537588596344
susceptibility O 1 0.9993306398391724
to O 0 0.021954525262117386
diabetes B-Disease 1 0.999976634979248
. O 0 0.027272982522845268

The O 0 0.02549131214618683
gene O 0 0.3078780174255371
, O 0 0.012237511575222015
termed O 0 0.05537554249167442
low O 0 0.0412571094930172
- O 0 0.0537882074713707
density O 0 0.056838374584913254
lipoprotein O 1 0.9935709238052368
receptor O 1 0.8288321495056152
related O 0 0.037296004593372345
protein O 0 0.05547107756137848
5 O 0 0.02116141840815544
( O 0 0.017968902364373207
LRP5 O 1 0.9640063643455505
) O 0 0.009356124326586723
, O 0 0.005723615642637014
encodes O 0 0.037140630185604095
a O 0 0.011653943918645382
protein O 0 0.03246580436825752
of O 0 0.007877511903643608
1615 O 0 0.12745818495750427
amino O 0 0.03644581139087677
acids O 0 0.023251766338944435
that O 0 0.0037149572744965553
contains O 0 0.0070976209826767445
conserved O 0 0.018422110006213188
modules O 0 0.010429853573441505
which O 0 0.00282585178501904
are O 0 0.0023727540392428637
characteristic O 0 0.010789538733661175
of O 0 0.0030155100394040346
the O 0 0.00476532056927681
low O 0 0.026216091588139534
- O 0 0.07683969289064407
density O 0 0.06808259338140488
lipoprotein O 1 0.9975758194923401
( O 0 0.04264437034726143
LDL O 1 0.9996009469032288
) O 0 0.029221149161458015
receptor O 1 0.8283479809761047
family O 0 0.03598436713218689
. O 0 0.01931966282427311

These O 0 0.00964172650128603
modules O 0 0.01632901094853878
include O 0 0.007558621931821108
a O 0 0.012066186405718327
putative O 0 0.1735452115535736
signal O 0 0.0347791388630867
peptide O 0 0.05453687906265259
for O 0 0.004986876621842384
protein O 0 0.023409288376569748
export O 0 0.007572810165584087
, O 0 0.00447820732370019
four O 0 0.00822431966662407
epidermal O 1 0.9878534078598022
growth O 0 0.03563328832387924
factor O 0 0.06195702776312828
( O 0 0.02284935489296913
EGF O 1 0.9902029037475586
) O 0 0.01623716577887535
repeats O 0 0.03532223030924797
with O 0 0.007917255163192749
associated O 0 0.023624368011951447
spacer O 0 0.23156297206878662
domains O 0 0.04172879830002785
, O 0 0.009641307406127453
three O 0 0.017639225348830223
LDL O 1 0.9988821148872375
- O 0 0.48373669385910034
receptor O 1 0.9710782766342163
( O 0 0.02543436363339424
LDLR O 1 0.9469451308250427
) O 0 0.012599959969520569
repeats O 0 0.029485130682587624
, O 0 0.004486987367272377
a O 0 0.008606962859630585
single O 0 0.018825316801667213
transmembrane O 0 0.17098113894462585
spanning O 0 0.03222964331507683
domain O 0 0.02206147275865078
, O 0 0.004338223487138748
and O 0 0.003813674906268716
a O 0 0.014059852808713913
cytoplasmic O 0 0.25928714871406555
domain O 0 0.05095510184764862
. O 0 0.021469563245773315

The O 0 0.01591978780925274
encoded O 0 0.03832831606268883
protein O 0 0.03433464840054512
has O 0 0.0056350515224039555
a O 0 0.007377682253718376
unique O 0 0.010069540701806545
organization O 0 0.010096980258822441
of O 0 0.007780234795063734
EGF O 1 0.9975059628486633
and O 0 0.01410920824855566
LDLR O 1 0.9982185959815979
repeats O 0 0.14774900674819946
; O 0 0.009005305357277393
therefore O 0 0.008836548775434494
, O 0 0.006317964289337397
LRP5 O 1 0.9923727512359619
likely O 0 0.01611291617155075
represents O 0 0.012749849818646908
a O 0 0.0068575916811823845
new O 0 0.005903648678213358
category O 0 0.013599511235952377
of O 0 0.005390871316194534
the O 0 0.01164560578763485
LDLR O 1 0.9906845092773438
family O 0 0.042320482432842255
. O 0 0.02420392632484436

Both O 0 0.014602298848330975
human O 0 0.0240493081510067
and O 0 0.009848400950431824
mouse O 1 0.9988610744476318
LRP5 O 1 0.9994028806686401
cDNAs O 1 0.9917124509811401
have O 0 0.006240807007998228
been O 0 0.00652665738016367
isolated O 0 0.020002735778689384
and O 0 0.002675440162420273
the O 0 0.004685766063630581
encoded O 0 0.02312682382762432
mature O 0 0.05527940392494202
proteins O 0 0.015365038067102432
are O 0 0.003099268302321434
95 O 0 0.010924402624368668
% O 0 0.007923505268990993
identical O 0 0.01085099671036005
, O 0 0.003998226951807737
indicating O 0 0.01288405992090702
a O 0 0.006023795809596777
high O 0 0.006482020020484924
degree O 0 0.00890613067895174
of O 0 0.005404379218816757
evolutionary O 0 0.03417055681347847
conservation O 0 0.023903554305434227
. O 0 0.009869003668427467
. O 0 0.017064638435840607

The O 0 0.03182034566998482
APC B-Disease 1 0.9611257910728455
variants O 0 0.09837278723716736
I1307K O 1 0.8501230478286743
and O 0 0.009531186893582344
E1317Q O 1 0.8884307742118835
are O 0 0.00651352945715189
associated O 0 0.02011709474027157
with O 0 0.16178905963897705
colorectal B-Disease 1 0.9999998807907104
tumors I-Disease 1 0.9999986886978149
, O 0 0.0058339424431324005
but O 0 0.0035352359991520643
not O 0 0.0025894022546708584
always O 0 0.004559475928544998
with O 0 0.003478954778984189
a O 0 0.008454025723040104
family O 0 0.019376493990421295
history O 0 0.01863483153283596
. O 0 0.020495090633630753

Classical O 0 0.24691520631313324
familial B-Disease 1 0.9999830722808838
adenomatous I-Disease 1 0.9999991655349731
polyposis I-Disease 1 0.9999990463256836
( O 1 0.8778116703033447
FAP B-Disease 1 0.9998134970664978
) O 0 0.01382447686046362
is O 0 0.007075621280819178
a O 0 0.011007817462086678
high O 0 0.021397635340690613
- O 1 0.6725119948387146
penetrance O 1 0.9994633793830872
autosomal B-Disease 1 0.9999926090240479
dominant I-Disease 1 0.9993508458137512
disease I-Disease 1 0.9999954700469971
that O 0 0.010833103209733963
predisposes O 1 0.9993671774864197
to O 0 0.005377296824008226
hundreds O 0 0.011933976784348488
or O 0 0.0064820111729204655
thousands O 0 0.015761198475956917
of O 0 0.0244253221899271
colorectal B-Disease 1 0.9999997615814209
adenomas I-Disease 1 0.9999901056289673
and I-Disease 0 0.04528191685676575
carcinoma I-Disease 1 0.9999960660934448
and O 0 0.004202465061098337
that O 0 0.003798928577452898
results O 0 0.010125205852091312
from O 0 0.010084068402647972
truncating O 1 0.9933962821960449
mutations O 1 0.996819257736206
in O 0 0.009525229223072529
the O 0 0.015933014452457428
APC B-Disease 1 0.9932863116264343
gene O 1 0.9592511057853699
. O 0 0.03028004616498947

A O 0 0.0472603514790535
variant O 1 0.5268653631210327
of O 0 0.022767448797822
FAP B-Disease 1 0.9997270703315735
is O 0 0.10050857812166214
attenuated B-Disease 1 0.9998156428337097
adenomatous I-Disease 1 0.999998927116394
polyposis I-Disease 1 0.9999988079071045
coli I-Disease 1 0.9999836683273315
, O 0 0.010647155344486237
which O 0 0.006146239582449198
results O 0 0.012305027805268764
from O 0 0.00907169096171856
germ O 1 0.9592326879501343
- O 0 0.04915399104356766
line O 0 0.023809967562556267
mutations O 1 0.9781515598297119
in O 0 0.00382650806568563
the O 0 0.0035813876893371344
5 O 0 0.007296043913811445
and O 0 0.0028002052567899227
3 O 0 0.007197006605565548
regions O 0 0.009819932281970978
of O 0 0.0043978216126561165
the O 0 0.012834020890295506
APC B-Disease 1 0.9961148500442505
gene O 1 0.8103412389755249
. O 0 0.029321039095520973

Attenuated B-Disease 1 0.9998408555984497
adenomatous I-Disease 1 0.9999978542327881
polyposis I-Disease 1 0.9999992847442627
coli I-Disease 1 0.9999957084655762
patients O 1 0.999832272529602
have O 0 0.010929546318948269
" O 0 0.01329481229186058
multiple O 0 0.12610770761966705
" O 0 0.4706922173500061
colorectal B-Disease 1 0.9999990463256836
adenomas I-Disease 1 0.9999806880950928
( O 0 0.01834705099463463
typically O 0 0.01295626163482666
fewer O 0 0.011889774352312088
than O 0 0.0046194372698664665
100 O 0 0.006276513449847698
) O 0 0.0047650267370045185
without O 0 0.006855402607470751
the O 0 0.007965784519910812
florid O 1 0.9915347695350647
phenotype O 1 0.9985871315002441
of O 0 0.013148133642971516
classical O 0 0.03497225418686867
FAP B-Disease 1 0.9982835054397583
. O 0 0.03893489018082619

Another O 0 0.0242731012403965
group O 0 0.015728943049907684
of O 0 0.007769129704684019
patients O 1 0.9974192380905151
with O 0 0.008815431967377663
multiple O 0 0.3970320224761963
adenomas B-Disease 1 0.9997885823249817
has O 0 0.011575578711926937
no O 0 0.010882281698286533
mutations O 1 0.990450918674469
in O 0 0.005349037703126669
the O 0 0.00920640304684639
APC B-Disease 1 0.9984315037727356
gene O 1 0.911437451839447
, O 0 0.004349564667791128
and O 0 0.003224540501832962
their O 0 0.006826288066804409
phenotype O 1 0.999439537525177
probably O 0 0.015115401707589626
results O 0 0.010803873650729656
from O 0 0.005543822888284922
variation O 0 0.01974175125360489
at O 0 0.0056054601445794106
a O 0 0.011860316619277
locus O 1 0.9829813838005066
, O 0 0.008013910613954067
or O 0 0.011775566264986992
loci O 1 0.9509921073913574
, O 0 0.005696684587746859
elsewhere O 0 0.010791854001581669
in O 0 0.004777534399181604
the O 0 0.010320723056793213
genome O 0 0.17521682381629944
. O 0 0.023179223760962486

Recently O 0 0.0294652096927166
, O 0 0.006623353809118271
however O 0 0.005977212451398373
, O 0 0.004817350301891565
a O 0 0.014741689898073673
missense O 1 0.9886052012443542
variant O 1 0.8271703124046326
of O 0 0.015496596693992615
APC B-Disease 1 0.9987574815750122
( O 0 0.022033710032701492
I1307K O 1 0.9625582098960876
) O 0 0.00963603612035513
was O 0 0.005690095014870167
described O 0 0.010480853728950024
that O 0 0.003871532855555415
confers O 0 0.07370267808437347
an O 0 0.00653783418238163
increased O 0 0.026866551488637924
risk O 1 0.9901028871536255
of O 0 0.06282752007246017
colorectal B-Disease 1 0.9999997615814209
tumors I-Disease 1 0.9999955892562866
, O 0 0.008899052627384663
including O 0 0.009435050189495087
multiple O 0 0.36514416337013245
adenomas B-Disease 1 0.9998063445091248
, O 0 0.009503811597824097
in O 0 0.01349333580583334
Ashkenazim O 1 0.9666987061500549
. O 0 0.032087542116642

We O 0 0.010189631022512913
have O 0 0.005540004465728998
studied O 0 0.007886923849582672
a O 0 0.005533188581466675
set O 0 0.004194924607872963
of O 0 0.005416909698396921
164 O 1 0.5048549771308899
patients O 1 0.999097466468811
with O 0 0.01312091201543808
multiple O 1 0.9952518939971924
colorectal B-Disease 1 0.9999996423721313
adenomas I-Disease 1 0.9999803304672241
and I-Disease 0 0.014456234872341156
/ I-Disease 1 0.9925289154052734
or I-Disease 0 0.047894611954689026
carcinoma I-Disease 1 0.9999856948852539
and O 0 0.012203095480799675
analyzed O 0 0.049415163695812225
codons O 1 0.7209430932998657
1263 O 1 0.9789550304412842
- O 0 0.15149463713169098
1377 O 1 0.8829405307769775
( O 0 0.03377183899283409
exon O 0 0.46436548233032227
15G O 1 0.7522759437561035
) O 0 0.010571066290140152
of O 0 0.004781907889991999
the O 0 0.010822879150509834
APC B-Disease 1 0.9944308400154114
gene O 1 0.8417627215385437
for O 0 0.012416496872901917
germ O 1 0.8631759285926819
- O 0 0.04255625978112221
line O 0 0.024741413071751595
variants O 0 0.058041635900735855
. O 0 0.019251590594649315

Three O 0 0.02336934395134449
patients O 1 0.9952428936958313
with O 0 0.00726319057866931
the O 0 0.010626479983329773
I1307K O 1 0.9912999272346497
allele O 1 0.993640124797821
were O 0 0.007346577476710081
detected O 0 0.04083766043186188
, O 0 0.0038370646070688963
each O 0 0.004992351867258549
of O 0 0.007560767233371735
Ashkenazi O 1 0.9118728041648865
descent O 0 0.07458416372537613
. O 0 0.02385592646896839

Four O 0 0.025158707052469254
patients O 1 0.9943540096282959
had O 0 0.011711440049111843
a O 0 0.017371008172631264
germ O 1 0.9602644443511963
- O 0 0.05823152884840965
line O 0 0.034286051988601685
E1317Q O 1 0.9756169319152832
missense O 1 0.9942557215690613
variant O 1 0.8864513635635376
of O 0 0.01171132829040289
APC O 1 0.9958266615867615
that O 0 0.0039737592451274395
was O 0 0.004231003113090992
not O 0 0.0027138879522681236
present O 0 0.004025166854262352
in O 0 0.003317113732919097
controls O 0 0.012934710830450058
; O 0 0.004484257660806179
one O 0 0.0022134401369839907
of O 0 0.0020990478806197643
these O 0 0.002560629742220044
individuals O 0 0.006270208396017551
had O 0 0.004937289282679558
an O 0 0.005458961706608534
unusually O 0 0.024468177929520607
large O 0 0.007983778603374958
number O 0 0.006703345570713282
of O 0 0.009028305299580097
metaplastic B-Disease 1 0.9967769980430603
polyps I-Disease 1 0.9987055063247681
of I-Disease 0 0.008984622545540333
the I-Disease 0 0.016513338312506676
colorectum I-Disease 1 0.9687897562980652
. O 0 0.02605118602514267

There O 0 0.01034677866846323
is O 0 0.006156547460705042
increasing O 0 0.01088432502001524
evidence O 0 0.005445552058517933
that O 0 0.0026395590975880623
there O 0 0.0036012940108776093
exist O 0 0.01015927642583847
germ O 1 0.875921905040741
- O 0 0.024182656779885292
line O 0 0.01234155148267746
variants O 0 0.020095130428671837
of O 0 0.00423532584682107
the O 0 0.009147671051323414
APC B-Disease 1 0.9971606731414795
gene O 1 0.8887335062026978
that O 0 0.0064257788471877575
predispose O 1 0.7954285740852356
to O 0 0.00343899754807353
the O 0 0.0036911519709974527
development O 0 0.006430832203477621
of O 0 0.007365490775555372
multiple O 1 0.9904284477233887
colorectal B-Disease 1 0.9999997615814209
adenomas I-Disease 1 0.9999934434890747
and I-Disease 0 0.21768590807914734
carcinoma I-Disease 1 0.9999983310699463
, O 0 0.0062083168886601925
but O 0 0.004536206368356943
without O 0 0.007062755059450865
the O 0 0.009244084358215332
florid O 1 0.9824557304382324
phenotype O 1 0.9973948001861572
of O 0 0.008456392213702202
classical O 0 0.0219863448292017
FAP B-Disease 1 0.9998223185539246
, O 0 0.005181890446692705
and O 0 0.003051898442208767
possibly O 0 0.010200057178735733
with O 0 0.0036677264142781496
importance O 0 0.012135577388107777
for O 0 0.13511939346790314
colorectal B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999997615814209
risk O 1 0.9983950257301331
in O 0 0.005385691300034523
the O 0 0.005141173955053091
general O 0 0.009308834560215473
population O 0 0.01694086194038391
. O 0 0.008576350286602974
. O 0 0.016737906262278557

Genomic O 0 0.12467937916517258
structure O 0 0.01680651493370533
of O 0 0.005639319773763418
the O 0 0.011452152393758297
human O 1 0.9408277869224548
congenital B-Disease 1 0.9999994039535522
chloride I-Disease 1 0.999796450138092
diarrhea I-Disease 1 0.9999992847442627
( O 1 0.7774282693862915
CLD B-Disease 1 0.9998321533203125
) O 0 0.04195991903543472
gene O 1 0.9350175261497498
. O 0 0.02854711189866066

Congenital B-Disease 1 0.9999970197677612
chloride I-Disease 1 0.998921275138855
diarrhea I-Disease 1 0.9999967813491821
( O 0 0.3449106812477112
CLD B-Disease 1 0.9996123909950256
) O 0 0.017224259674549103
is O 0 0.009871955960988998
caused O 1 0.5213099718093872
by O 0 0.010095807723701
mutations O 1 0.9809577465057373
in O 0 0.005413553211838007
a O 0 0.013561898842453957
gene O 0 0.35586094856262207
which O 0 0.010129617527127266
encodes O 0 0.09737930446863174
an O 0 0.026174049824476242
intestinal O 1 0.9999799728393555
anion O 1 0.995080828666687
transporter O 1 0.954413890838623
. O 0 0.033179257065057755

We O 0 0.0082273930311203
report O 0 0.008459258824586868
here O 0 0.0046747042797505856
the O 0 0.005040514282882214
complete O 0 0.01263949740678072
genomic O 0 0.05746354162693024
organization O 0 0.009881543926894665
of O 0 0.004478609189391136
the O 0 0.007780617568641901
human O 0 0.08057869225740433
CLD B-Disease 1 0.9998059868812561
gene O 1 0.966471254825592
which O 0 0.012218509800732136
spans O 0 0.047930747270584106
approximately O 0 0.017345011234283447
39kb O 1 0.8914941549301147
, O 0 0.00508083263412118
and O 0 0.004402607213705778
comprises O 0 0.01442725956439972
21 O 0 0.022974759340286255
exons O 0 0.1980389803647995
. O 0 0.023470697924494743

All O 0 0.021189874038100243
exon O 1 0.7201492190361023
/ O 0 0.3731864094734192
intron O 1 0.8110882639884949
boundaries O 0 0.013326289132237434
conform O 0 0.016562363132834435
to O 0 0.005278168246150017
the O 0 0.01098919752985239
GT O 1 0.9860981702804565
/ O 1 0.715983510017395
AG O 1 0.954410195350647
rule O 0 0.04150114208459854
. O 0 0.025924071669578552

An O 0 0.011663856916129589
analysis O 0 0.012267704121768475
of O 0 0.004559103399515152
the O 0 0.008349360898137093
putative O 1 0.685969889163971
promoter O 0 0.2431902140378952
region O 0 0.020960155874490738
sequence O 0 0.02326956018805504
shows O 0 0.013319399207830429
a O 0 0.014056376181542873
putative O 1 0.7998545169830322
TATA O 1 0.9485074877738953
box O 0 0.03162470459938049
and O 0 0.007646456826478243
predicts O 0 0.056109458208084106
multiple O 0 0.0333809070289135
transcription O 0 0.07962098717689514
factor O 0 0.04008840397000313
binding O 0 0.027242794632911682
sites O 0 0.015474571846425533
. O 0 0.015123716555535793

The O 0 0.01686580665409565
genomic O 0 0.14557215571403503
structure O 0 0.012752420268952847
was O 0 0.006213664542883635
determined O 0 0.009661917574703693
using O 0 0.006192764732986689
DNA O 0 0.019495228305459023
from O 0 0.004332509823143482
several O 0 0.003494877368211746
sources O 0 0.005372848827391863
including O 0 0.004681725054979324
multiple O 0 0.016868334263563156
large O 0 0.014176096767187119
- O 0 0.04930528625845909
insert O 0 0.2195093333721161
libaries O 0 0.4928123950958252
and O 0 0.013122722506523132
genomic O 0 0.1323973387479782
DNA O 0 0.0472177192568779
from O 0 0.01491637248545885
Finnish O 1 0.9010335803031921
CLD B-Disease 1 0.9999157190322876
patients O 1 0.9992125034332275
and O 0 0.011026729829609394
controls O 0 0.041655320674180984
. O 0 0.020683711394667625

Exon O 1 0.6945977210998535
- O 0 0.05260181427001953
specific O 0 0.018271666020154953
primers O 0 0.054605208337306976
developed O 0 0.013231640681624413
in O 0 0.0032071154564619064
this O 0 0.0036688153631985188
study O 0 0.008168316446244717
will O 0 0.004919384140521288
facilitate O 0 0.0256528090685606
mutation O 1 0.9968395233154297
screening O 0 0.15396083891391754
studies O 0 0.014573781751096249
of O 0 0.008699541911482811
patients O 1 0.9976523518562317
with O 0 0.010077006183564663
the O 0 0.018467960879206657
disease O 1 0.9999492168426514
. O 0 0.02961982600390911

Genomic O 0 0.1507200449705124
sequencing O 0 0.060108285397291183
of O 0 0.011339123360812664
a O 0 0.02909393608570099
BAC O 1 0.9982670545578003
clone O 1 0.9978911280632019
H O 1 0.9943692088127136
_ O 0 0.026921745389699936
RG364P16 O 1 0.8883056640625
revealed O 0 0.02017052099108696
the O 0 0.005169903393834829
presence O 0 0.009782985784113407
of O 0 0.0032834182493388653
another O 0 0.007868044078350067
, O 0 0.005368683487176895
highly O 0 0.021177249029278755
homologous O 1 0.7897494435310364
gene O 1 0.555976927280426
3 O 0 0.01070966012775898
of O 0 0.004780525341629982
the O 0 0.012449453584849834
CLD B-Disease 1 0.999502420425415
gene O 1 0.9568379521369934
, O 0 0.005019285250455141
with O 0 0.003998422063887119
a O 0 0.008759714663028717
similar O 0 0.013698405586183071
genomic O 0 0.11632347851991653
structure O 0 0.012138722464442253
, O 0 0.004677964840084314
recently O 0 0.012259865179657936
identified O 0 0.013318967074155807
as O 0 0.005271410569548607
the O 0 0.012898118235170841
Pendred B-Disease 1 0.9999408721923828
syndrome I-Disease 1 0.9999995231628418
gene O 1 0.999046266078949
( O 0 0.05987642705440521
PDS B-Disease 1 0.9992389678955078
) O 0 0.015532823279500008
. O 0 0.009235520847141743
. O 0 0.015587297268211842

The O 0 0.034096233546733856
APCI1307K O 1 0.9978093504905701
allele O 1 0.9986847043037415
and O 0 0.02815098501741886
cancer B-Disease 1 0.9999858140945435
risk O 1 0.9482018351554871
in O 0 0.006124438252300024
a O 0 0.009641234762966633
community O 0 0.011222622357308865
- O 0 0.020041348412632942
based O 0 0.007575566414743662
study O 0 0.010835750959813595
of O 0 0.00883345864713192
Ashkenazi O 1 0.6407844424247742
Jews O 0 0.03110969252884388
. O 0 0.023210136219859123

Mutations O 1 0.9834127426147461
in O 0 0.02487275004386902
APC O 1 0.9512008428573608
are O 0 0.00962403416633606
classically O 1 0.6995030045509338
associated O 0 0.03244867920875549
with O 0 0.032058075070381165
familial B-Disease 1 0.9999959468841553
adenomatous I-Disease 1 0.9999988079071045
polyposis I-Disease 1 0.9999994039535522
( O 1 0.7200104594230652
FAP B-Disease 1 0.9996836185455322
) O 0 0.014802239835262299
, O 0 0.0067339101806283
a O 0 0.01532786525785923
highly O 0 0.09678351134061813
penetrant O 1 0.9998810291290283
autosomal B-Disease 1 0.9999960660934448
dominant I-Disease 1 0.9997742772102356
disorder I-Disease 1 0.9999985694885254
characterized O 1 0.9942660927772522
by O 0 0.023178962990641594
multiple O 1 0.9986525774002075
intestinal O 1 0.9999995231628418
polyps B-Disease 1 0.9999890327453613
and O 0 0.00680637126788497
, O 0 0.005572648718953133
without O 0 0.012758105993270874
surgical O 1 0.9990131855010986
intervention O 0 0.07386936992406845
, O 0 0.004218719899654388
the O 0 0.00413586525246501
development O 0 0.010761323384940624
of O 0 0.03355306014418602
colorectal B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999988079071045
( O 0 0.10834307223558426
CRC B-Disease 1 0.9796074628829956
) O 0 0.023794889450073242
. O 0 0.022318337112665176

APC B-Disease 1 0.9382688999176025
is O 0 0.019605953246355057
a O 0 0.03345146402716637
tumour O 1 0.9999113082885742
- O 1 0.9373061656951904
suppressor O 1 0.999254047870636
gene O 1 0.9747110605239868
, O 0 0.007393352687358856
and O 0 0.007988439872860909
somatic O 1 0.9836888313293457
loss O 1 0.8678200244903564
occurs O 0 0.42344820499420166
in O 0 0.015824828296899796
tumours B-Disease 1 0.999772846698761
. O 0 0.026152905076742172

The O 0 0.03845832869410515
germline O 1 0.9975268244743347
T O 1 0.9872739315032959
- O 0 0.03300900012254715
to O 0 0.007603202946484089
- O 0 0.02579214796423912
A O 0 0.01872849464416504
transversion O 1 0.6558217406272888
responsible O 0 0.014557369984686375
for O 0 0.005364764016121626
the O 0 0.01174211036413908
APC O 1 0.9965441823005676
I1307K O 1 0.9814117550849915
allele O 1 0.9780951738357544
converts O 0 0.03194276615977287
the O 0 0.00907275453209877
wild O 0 0.03333846852183342
- O 0 0.03651496767997742
type O 0 0.029150323942303658
sequence O 0 0.01848744787275791
to O 0 0.005252576898783445
a O 0 0.017110977321863174
homopolymer O 1 0.997035026550293
tract O 1 0.9993688464164734
( O 0 0.02774459682404995
A8 O 1 0.9871178269386292
) O 0 0.007875429466366768
that O 0 0.0035409885458648205
is O 0 0.007074596360325813
genetically O 0 0.3106757402420044
unstable O 1 0.8264330625534058
and O 0 0.007935808971524239
prone O 1 0.841728925704956
to O 0 0.015033976174890995
somatic O 1 0.9850389957427979
mutation O 1 0.9964750409126282
. O 0 0.034425050020217896

The O 0 0.028735479339957237
I1307K O 1 0.9873842000961304
allele O 1 0.9899245500564575
was O 0 0.011396447196602821
found O 0 0.011080924421548843
in O 0 0.007939435541629791
6 O 0 0.02311044931411743
. O 0 0.019020061939954758

1 O 0 0.02874028868973255
% O 0 0.016141608357429504
of O 0 0.01007294561713934
unselected O 1 0.9385026693344116
Ashkenazi O 1 0.7667416334152222
Jews O 0 0.01454582903534174
and O 0 0.004803728312253952
higher O 0 0.011896862648427486
proportions O 0 0.10488536953926086
of O 0 0.0066263098269701
Ashkenazim O 1 0.9779092073440552
with O 0 0.005579274147748947
family O 0 0.013339869678020477
or O 0 0.006751509383320808
personal O 0 0.01361147128045559
histories O 0 0.033131569623947144
of O 0 0.009591448120772839
CRC B-Disease 1 0.9865899085998535
( O 0 0.025708939880132675
ref O 1 0.9120392799377441
. O 0 0.008647103793919086
2 O 0 0.014661174267530441
) O 0 0.013705550692975521
. O 0 0.015963368117809296

To O 0 0.012768212705850601
evaluate O 0 0.02522106282413006
the O 0 0.00593477813526988
role O 0 0.012463074177503586
of O 0 0.008028685115277767
I1307K O 1 0.9905139207839966
in O 0 0.01568753831088543
cancer B-Disease 1 0.9999507665634155
, O 0 0.006930468138307333
we O 0 0.006735438480973244
genotyped O 1 0.9463669657707214
5 O 0 0.0161274541169405
, O 0 0.009890777058899403
081 O 1 0.9961839318275452
Ashkenazi O 1 0.9546346664428711
volunteers O 0 0.024735942482948303
in O 0 0.005585949867963791
a O 0 0.008903713896870613
community O 0 0.016443902626633644
survey O 0 0.028072161599993706
. O 0 0.019338712096214294

Risk O 0 0.48137691617012024
of O 0 0.017267610877752304
developing O 1 0.9509062767028809
colorectal B-Disease 1 0.9999969005584717
, I-Disease 0 0.05161414295434952
breast I-Disease 1 0.9999830722808838
and I-Disease 0 0.005713492166250944
other I-Disease 0 0.006753204856067896
cancers I-Disease 1 0.9998559951782227
were O 0 0.0036755360197275877
compared O 0 0.013662335462868214
between O 0 0.010761242359876633
genotyped O 1 0.9980024695396423
I1307K O 1 0.9976664781570435
carriers O 0 0.4129008650779724
and O 0 0.006537585984915495
non O 0 0.02137221023440361
- O 0 0.039888523519039154
carriers O 0 0.034601904451847076
and O 0 0.0034819329157471657
their O 0 0.003910189028829336
first O 0 0.00758181419223547
- O 0 0.028794066980481148
degree O 0 0.022487424314022064
relatives O 0 0.041520945727825165
. O 0 0.021237149834632874

Sperm O 0 0.12122346460819244
DNA O 0 0.06160122901201248
analysis O 0 0.02302386239171028
in O 0 0.011143872514367104
a O 0 0.036099500954151154
Friedreich B-Disease 1 0.9984564781188965
ataxia I-Disease 1 0.999855637550354
premutation O 1 0.9970523118972778
carrier O 1 0.6150861978530884
suggests O 0 0.03857757896184921
both O 0 0.013723951764404774
meiotic O 1 0.9845051169395447
and O 0 0.009064305573701859
mitotic O 0 0.2260061800479889
expansion O 0 0.02187504805624485
in O 0 0.007871543988585472
the O 0 0.01505353394895792
FRDA B-Disease 1 0.9935963153839111
gene O 1 0.8419621586799622
. O 0 0.030488820746541023

Friedreich B-Disease 1 0.9994418025016785
ataxia I-Disease 1 0.9998369216918945
is O 0 0.020080361515283585
usually O 0 0.019322475418448448
caused O 0 0.24562592804431915
by O 0 0.00487150764092803
an O 0 0.00414655264467001
expansion O 0 0.010326124727725983
of O 0 0.00399944419041276
a O 0 0.015120408497750759
GAA O 0 0.15980862081050873
trinucleotide O 1 0.9905713796615601
repeat O 0 0.06892495602369308
in O 0 0.013765204697847366
intron O 0 0.4865817427635193
1 O 0 0.014991281554102898
of O 0 0.006888942327350378
the O 0 0.013798439875245094
FRDA B-Disease 1 0.9888851642608643
gene O 1 0.7454124689102173
. O 0 0.026366522535681725

Occasionally O 0 0.0387415774166584
, O 0 0.006372661329805851
a O 0 0.008694542571902275
fully O 0 0.016990311443805695
expanded O 0 0.01999598741531372
allele O 1 0.961653470993042
has O 0 0.007142241112887859
been O 0 0.005205471999943256
found O 0 0.0053053661249578
to O 0 0.0036683587823063135
arise O 0 0.015759987756609917
from O 0 0.005298350006341934
a O 0 0.010022612288594246
premutation O 0 0.12319815903902054
of O 0 0.0055355955846607685
100 O 0 0.00972097646445036
or O 0 0.009409019723534584
less O 0 0.021447909995913506
triplet O 1 0.9681442975997925
repeats O 0 0.1404666006565094
. O 0 0.029265332967042923

We O 0 0.010930689983069897
have O 0 0.007111664861440659
examined O 0 0.02091039903461933
the O 0 0.00759027898311615
sperm O 0 0.048600032925605774
DNA O 0 0.030927425250411034
of O 0 0.007845351472496986
a O 0 0.021461043506860733
premutation O 1 0.9871384501457214
carrier O 0 0.15164196491241455
. O 0 0.029450329020619392

This O 0 0.020764581859111786
mans O 0 0.3168286681175232
leucocyte O 1 0.9330834746360779
DNA O 0 0.052726078778505325
showed O 0 0.01925671473145485
one O 0 0.009601037949323654
normal O 0 0.035309482365846634
allele O 1 0.9665524363517761
and O 0 0.005558568984270096
one O 0 0.008915520273149014
allele O 0 0.2904433310031891
of O 0 0.006681878585368395
approximately O 0 0.01600976288318634
100 O 0 0.018885115161538124
repeats O 0 0.06286831945180893
. O 0 0.021115215495228767

His O 0 0.02056271955370903
sperm O 0 0.07118906080722809
showed O 0 0.01848582923412323
an O 0 0.00651845196262002
expanded O 0 0.01814316213130951
allele O 1 0.7934033274650574
in O 0 0.00513972295448184
a O 0 0.009668690152466297
tight O 0 0.01897634193301201
range O 0 0.010868668556213379
centering O 0 0.01944253034889698
on O 0 0.004182899836450815
a O 0 0.006698984652757645
size O 0 0.011340288445353508
of O 0 0.005582548212260008
approximately O 0 0.024373147636651993
320 O 0 0.09583009034395218
trinucleotide O 1 0.9911221265792847
repeats O 0 0.17797690629959106
. O 0 0.034792639315128326

His O 0 0.027060676366090775
affected O 0 0.22710107266902924
son O 0 0.10103758424520493
has O 0 0.012313648127019405
repeat O 0 0.0492589958012104
sizes O 0 0.02201106771826744
of O 0 0.008567387238144875
1040 O 1 0.828095555305481
and O 0 0.011244306340813637
540 O 0 0.07848062366247177
. O 0 0.02191944047808647

These O 0 0.008529821410775185
data O 0 0.008495205081999302
suggest O 0 0.011699783615767956
that O 0 0.004366140812635422
expansion O 0 0.016325756907463074
occurs O 0 0.01712947152554989
in O 0 0.002956294221803546
two O 0 0.003032003529369831
stages O 0 0.013164792209863663
, O 0 0.0024327647406607866
the O 0 0.0028922995552420616
first O 0 0.0054573253728449345
during O 0 0.012868513353168964
meiosis O 0 0.42518091201782227
followed O 0 0.010286116041243076
by O 0 0.005538840312510729
a O 0 0.009871648624539375
second O 0 0.017880840227007866
mitotic O 0 0.1965438723564148
expansion O 0 0.044871825724840164
. O 0 0.026026206091046333

We O 0 0.009212843142449856
also O 0 0.005217984318733215
show O 0 0.007744282949715853
that O 0 0.002508335979655385
in O 0 0.0029230371583253145
all O 0 0.004430272616446018
informative O 0 0.025903373956680298
carrier O 0 0.1359546035528183
father O 0 0.020927298814058304
to O 0 0.00722037348896265
affected O 0 0.17015479505062103
child O 0 0.200652614235878
transmissions O 0 0.03695819154381752
, O 0 0.0037011674139648676
with O 0 0.003213591640815139
the O 0 0.0036522941663861275
notable O 0 0.007822029292583466
exception O 0 0.009409375488758087
of O 0 0.003493272000923753
the O 0 0.007879598997533321
premutation O 1 0.9970500469207764
carrier O 0 0.22491829097270966
, O 0 0.005517086014151573
the O 0 0.006450247019529343
expansion O 0 0.02202933467924595
size O 0 0.023414045572280884
decreases O 0 0.10327658802270889
. O 0 0.011403927579522133
. O 0 0.017122888937592506

The O 0 0.030173633247613907
R496H O 1 0.9856283664703369
mutation O 1 0.9901769757270813
of O 0 0.014159978367388248
arylsulfatase O 1 0.9049770832061768
A O 0 0.02140287682414055
does O 0 0.014244752004742622
not O 0 0.011954219080507755
cause O 1 0.9887495040893555
metachromatic B-Disease 1 0.9977510571479797
leukodystrophy I-Disease 1 0.9993201494216919
. O 0 0.04174460843205452

Deficiency B-Disease 1 0.9992096424102783
of I-Disease 0 0.020352136343717575
arylsulfatase I-Disease 1 0.9745619297027588
A I-Disease 0 0.03355540707707405
( O 0 0.03454640135169029
ARSA O 1 0.9951640367507935
) O 0 0.028077011927962303
enzyme O 0 0.1618890017271042
activity O 0 0.06356033682823181
causes O 1 0.9977654218673706
metachromatic B-Disease 1 0.9990020394325256
leukodystrophy I-Disease 1 0.9998421669006348
( O 0 0.08393248915672302
MLD B-Disease 1 0.997481644153595
) O 0 0.03172226622700691
. O 0 0.025202564895153046

A O 0 0.02520216442644596
number O 0 0.014766143634915352
of O 0 0.015564880333840847
ARSA O 1 0.9991146922111511
gene O 1 0.9962306618690491
mutations O 1 0.9970777034759521
responsible O 0 0.02711535431444645
for O 0 0.01170308142900467
MLD B-Disease 1 0.9991512298583984
have O 0 0.008467773906886578
been O 0 0.008574184961616993
identified O 0 0.02572116255760193
. O 0 0.01631275750696659

Recently O 0 0.04202711582183838
, O 0 0.008664026856422424
the O 0 0.013648338615894318
R496H O 1 0.9774038791656494
mutation O 1 0.9929331541061401
of O 0 0.012216202914714813
ARSA O 1 0.9986251592636108
was O 0 0.008055138401687145
proposed O 0 0.007355895824730396
to O 0 0.0029150720220059156
be O 0 0.0029859645292162895
a O 0 0.00823727436363697
cause O 0 0.08836597204208374
of O 0 0.011569473892450333
MLD B-Disease 1 0.9996302127838135
( O 0 0.031070146709680557
Draghia O 1 0.9883946180343628
et O 0 0.2215528041124344
al O 0 0.027366915717720985
. O 0 0.006608244962990284
, O 0 0.005746085196733475
1997 O 0 0.021503634750843048
) O 0 0.01354315783828497
. O 0 0.015247397124767303

We O 0 0.012171621434390545
have O 0 0.008420976810157299
investigated O 0 0.024029837921261787
the O 0 0.010999721474945545
R496H O 1 0.9962918758392334
mutation O 1 0.9978958368301392
and O 0 0.005528294946998358
found O 0 0.008898316882550716
this O 0 0.006667728535830975
mutation O 1 0.9919022917747498
at O 0 0.006480226758867502
a O 0 0.00776310358196497
relatively O 0 0.01300601102411747
high O 0 0.009491323493421078
frequency O 0 0.016212567687034607
in O 0 0.003692941041663289
an O 0 0.004556031432002783
African O 0 0.01491568610072136
American O 0 0.011973191052675247
population O 0 0.016653573140501976
( O 0 0.015620124526321888
f O 0 0.0471065379679203
= O 0 0.04421977326273918
0 O 0 0.0231363233178854
. O 0 0.008106817491352558
09 O 0 0.057183995842933655
, O 0 0.009724047966301441
n O 0 0.04071153327822685
= O 0 0.050807349383831024
61 O 0 0.03324650973081589
subjects O 0 0.02412947081029415
) O 0 0.015764407813549042
. O 0 0.016505930572748184

The O 0 0.03824697807431221
ARSA O 1 0.9963265061378479
enzyme O 0 0.2491568624973297
activity O 0 0.018330439925193787
in O 0 0.005573864094913006
subjects O 0 0.009571000002324581
with O 0 0.0032841768115758896
and O 0 0.0028890492394566536
without O 0 0.006651577074080706
the O 0 0.009940867312252522
R496H O 1 0.9979755282402039
mutation O 1 0.999450147151947
was O 0 0.0070916288532316685
determined O 0 0.011018532328307629
and O 0 0.003518203739076853
found O 0 0.0054665207862854
to O 0 0.0036643489729613066
be O 0 0.004855619743466377
normal O 0 0.02966073527932167
. O 0 0.016809264197945595

It O 0 0.008702441118657589
is O 0 0.006836537271738052
therefore O 0 0.008831045590341091
concluded O 0 0.013054247945547104
that O 0 0.003948484547436237
the O 0 0.008419337682425976
R496H O 1 0.9965201616287231
mutation O 1 0.9987896084785461
of O 0 0.012981433421373367
ARSA O 1 0.9990478157997131
does O 0 0.01189824752509594
not O 0 0.005940165836364031
negatively O 0 0.02535051293671131
influence O 0 0.009608916938304901
the O 0 0.005043408367782831
activity O 0 0.01313109789043665
of O 0 0.00806225836277008
ARSA O 1 0.9984153509140015
and O 0 0.005421831272542477
is O 0 0.005259065888822079
not O 0 0.004685443826019764
a O 0 0.012108903378248215
cause O 0 0.08336076140403748
of O 0 0.02432169020175934
MLD B-Disease 1 0.9974486231803894

Down O 0 0.03973782807588577
- O 0 0.04131712391972542
regulation O 0 0.029530389234423637
of O 0 0.01215680968016386
transmembrane O 1 0.8909240961074829
carbonic O 1 0.9955174326896667
anhydrases O 1 0.990153968334198
in O 0 0.03217226639389992
renal B-Disease 1 0.9999978542327881
cell I-Disease 1 0.999409556388855
carcinoma I-Disease 1 0.9999974966049194
cell O 1 0.6053407788276672
lines O 0 0.02104589156806469
by O 0 0.011145385913550854
wild O 0 0.07494533061981201
- O 0 0.2346848100423813
type O 0 0.39519163966178894
von B-Disease 1 0.9654061198234558
Hippel I-Disease 1 0.9960674047470093
- I-Disease 1 0.7084524035453796
Lindau I-Disease 1 0.9839500188827515
transgenes O 1 0.9316529631614685
. O 0 0.047556307166814804

To O 0 0.021997584030032158
discover O 0 0.06697078049182892
genes O 0 0.07976645976305008
involved O 0 0.02041284739971161
in O 0 0.012646072544157505
von B-Disease 1 0.9279807209968567
Hippel I-Disease 1 0.9982157945632935
- I-Disease 1 0.9079945087432861
Lindau I-Disease 1 0.9981750249862671
( O 0 0.05180702358484268
VHL B-Disease 1 0.9994551539421082
) O 0 0.020814092829823494
- O 0 0.09541061520576477
mediated O 1 0.9490430951118469
carcinogenesis O 1 0.9957072138786316
, O 0 0.007620965130627155
we O 0 0.007166104856878519
used O 0 0.01831565797328949
renal B-Disease 1 0.9999909400939941
cell I-Disease 1 0.9978777170181274
carcinoma I-Disease 1 0.9999971389770508
cell O 1 0.7839706540107727
lines O 0 0.04767385497689247
stably O 1 0.8722320199012756
transfected O 1 0.965111255645752
with O 0 0.019127726554870605
wild O 0 0.0551941879093647
- O 0 0.15762729942798615
type O 1 0.6955388784408569
VHL O 1 0.9992532134056091
- O 0 0.1555090993642807
expressing O 0 0.16036352515220642
transgenes O 1 0.9203333258628845
. O 0 0.040274545550346375

Large O 0 0.03882761672139168
- O 0 0.055011454969644547
scale O 0 0.04183543846011162
RNA O 0 0.0743580162525177
differential O 0 0.04054930806159973
display O 0 0.012771759182214737
technology O 0 0.008065824396908283
applied O 0 0.006960544269531965
to O 0 0.0032640239223837852
these O 0 0.004412146285176277
cell O 0 0.02747979387640953
lines O 0 0.014022864401340485
identified O 0 0.013144259341061115
several O 0 0.007668422069400549
differentially O 1 0.8594819903373718
expressed O 0 0.017105741426348686
genes O 0 0.27846601605415344
, O 0 0.004210218787193298
including O 0 0.004399931523948908
an O 0 0.00895183626562357
alpha O 0 0.11710251867771149
carbonic O 1 0.9951607584953308
anhydrase O 1 0.9981226325035095
gene O 1 0.9585323929786682
, O 0 0.01695493794977665
termed O 1 0.5195488333702087
CA12 O 1 0.9865019917488098
. O 0 0.03097306564450264

The O 0 0.018652815371751785
deduced O 0 0.05305247753858566
protein O 0 0.04525671526789665
sequence O 0 0.017291991040110588
was O 0 0.005637733731418848
classified O 0 0.008875250816345215
as O 0 0.0032709436491131783
a O 0 0.00539844436571002
one O 0 0.006049554795026779
- O 0 0.02384161204099655
pass O 0 0.025135980919003487
transmembrane O 1 0.7650793790817261
CA O 0 0.03476788476109505
possessing O 0 0.019547024741768837
an O 0 0.007448901422321796
apparently O 0 0.02382419817149639
intact O 0 0.03831179440021515
catalytic O 0 0.0526624470949173
domain O 0 0.018595311790704727
in O 0 0.005216612946242094
the O 0 0.008388331159949303
extracellular O 0 0.0911930501461029
CA O 0 0.0674210637807846
module O 0 0.058453191071748734
. O 0 0.022509628906846046

Reintroduced O 1 0.5672327280044556
wild O 0 0.08795665204524994
- O 0 0.21663735806941986
type O 1 0.8212523460388184
VHL B-Disease 1 0.9989854693412781
strongly O 0 0.039787404239177704
inhibited O 0 0.14633910357952118
the O 0 0.00971627701073885
overexpression O 1 0.549285888671875
of O 0 0.005319823976606131
the O 0 0.010447950102388859
CA12 O 1 0.9934666752815247
gene O 1 0.5616803169250488
in O 0 0.007810018956661224
the O 0 0.014506933279335499
parental O 1 0.9982072114944458
renal B-Disease 1 0.9999978542327881
cell I-Disease 1 0.9996516704559326
carcinoma I-Disease 1 0.9999983310699463
cell O 1 0.9580370783805847
lines O 0 0.04394346475601196
. O 0 0.0243605338037014

Similar O 0 0.023552531376481056
results O 0 0.015297403559088707
were O 0 0.0038581625558435917
obtained O 0 0.008129983209073544
with O 0 0.00803921278566122
CA9 O 1 0.9972143769264221
, O 0 0.008365413174033165
encoding O 0 0.036574311554431915
another O 0 0.02394741214811802
transmembrane O 1 0.8995996117591858
CA O 0 0.026585258543491364
with O 0 0.004977398086339235
an O 0 0.007551338989287615
intact O 0 0.04208832234144211
catalytic O 0 0.09445744007825851
domain O 0 0.0484967902302742
. O 0 0.01999128982424736

Although O 0 0.015825951471924782
both O 0 0.007006827276200056
domains O 0 0.021333595737814903
of O 0 0.006004574242979288
the O 0 0.01231443788856268
VHL B-Disease 1 0.9994899034500122
protein O 0 0.0646924078464508
contribute O 0 0.021458731964230537
to O 0 0.006102329585701227
regulation O 0 0.017694272100925446
of O 0 0.00817070435732603
CA12 O 1 0.9971944093704224
expression O 0 0.036491669714450836
, O 0 0.006090428214520216
the O 0 0.0075520179234445095
elongin O 1 0.9481607675552368
binding O 0 0.030005469918251038
domain O 0 0.029285285621881485
alone O 0 0.018287120386958122
could O 0 0.01213871594518423
effectively O 0 0.04158689081668854
regulate O 0 0.4823685884475708
CA9 O 1 0.9970216155052185
expression O 0 0.1427101194858551
. O 0 0.03301090747117996

We O 0 0.018020866438746452
mapped O 0 0.06502524763345718
CA12 O 1 0.9849225282669067
and O 0 0.02196144312620163
CA9 O 1 0.9974627494812012
loci O 1 0.9780375957489014
to O 0 0.019454481080174446
chromosome O 1 0.992135763168335
bands O 0 0.04573672637343407
15q22 O 1 0.7693260312080383
and O 0 0.014134787023067474
17q21 O 1 0.9589196443557739
. O 0 0.02712402492761612

2 O 0 0.024030733853578568
respectively O 0 0.01771273836493492
, O 0 0.007283690385520458
regions O 0 0.02276459150016308
prone O 1 0.8082026243209839
to O 0 0.006227303296327591
amplification O 0 0.04150519520044327
in O 0 0.006391890347003937
some O 0 0.009778357110917568
human O 0 0.25750532746315
cancers B-Disease 1 0.9998922348022461
. O 0 0.023788508027791977

Additional O 0 0.01891944371163845
experiments O 0 0.01639305055141449
are O 0 0.003497771453112364
needed O 0 0.006449168082326651
to O 0 0.0026503228582441807
define O 0 0.009214252233505249
the O 0 0.0036959347780793905
role O 0 0.008290893398225307
of O 0 0.005485553294420242
CA O 1 0.7444522380828857
IX O 1 0.9965559244155884
and O 0 0.008054658770561218
CA O 1 0.5139729380607605
XII O 1 0.970731258392334
enzymes O 0 0.033953819423913956
in O 0 0.0043172514997422695
the O 0 0.005225823726505041
regulation O 0 0.016953235492110252
of O 0 0.007020136341452599
pH O 1 0.7329936623573303
in O 0 0.004904046189039946
the O 0 0.007617853116244078
extracellular O 0 0.34979939460754395
microenvironment O 1 0.9891001582145691
and O 0 0.004989851266145706
its O 0 0.006976660341024399
potential O 0 0.017720988020300865
impact O 0 0.02530021034181118
on O 0 0.013550856150686741
cancer B-Disease 1 0.9998644590377808
cell O 0 0.3790844678878784
growth O 0 0.03958427160978317
. O 0 0.022440822795033455

A O 0 0.049626290798187256
gene O 0 0.24599412083625793
encoding O 0 0.05673515424132347
a O 0 0.02059931866824627
transmembrane O 0 0.28950071334838867
protein O 0 0.046914905309677124
is O 0 0.012140362523496151
mutated O 1 0.9971556663513184
in O 0 0.011768256314098835
patients O 1 0.9997571110725403
with O 0 0.19833707809448242
diabetes B-Disease 1 0.9999997615814209
mellitus I-Disease 1 0.9999964237213135
and O 0 0.3940817415714264
optic B-Disease 1 0.9999697208404541
atrophy I-Disease 1 0.9999880790710449
( O 1 0.9711116552352905
Wolfram B-Disease 1 0.9999808073043823
syndrome I-Disease 1 0.9999995231628418
) O 0 0.031843386590480804
. O 0 0.022794635966420174

Wolfram B-Disease 1 0.9997524619102478
syndrome I-Disease 1 0.9999988079071045
( O 0 0.44538038969039917
WFS B-Disease 1 0.9994000196456909
; O 0 0.06350119411945343
OMIM O 1 0.999767005443573
222300 O 1 0.992440938949585
) O 0 0.014366683550179005
is O 0 0.0097954785451293
an O 0 0.02643480896949768
autosomal B-Disease 1 0.9999985694885254
recessive I-Disease 1 0.9999995231628418
neurodegenerative I-Disease 1 0.9999995231628418
disorder I-Disease 1 0.9999964237213135
defined O 0 0.034142281860113144
by O 0 0.011396076530218124
young O 0 0.35662975907325745
- O 1 0.9412766695022583
onset O 1 0.9999516010284424
non O 1 0.7153311371803284
- O 1 0.9933300614356995
immune O 1 0.9999439716339111
insulin B-Disease 1 0.9998917579650879
- I-Disease 1 0.9926127195358276
dependent I-Disease 1 0.9947576522827148
diabetes I-Disease 1 0.9999994039535522
mellitus I-Disease 1 0.999981164932251
and O 0 0.02799641713500023
progressive O 1 0.9995067119598389
optic B-Disease 1 0.9998923540115356
atrophy I-Disease 1 0.9999054670333862
. O 0 0.040120501071214676

Linkage O 0 0.10080790519714355
to O 0 0.013441002927720547
markers O 0 0.042966317385435104
on O 0 0.015665840357542038
chromosome O 1 0.9965907335281372
4p O 1 0.9891370534896851
was O 0 0.013062623329460621
confirmed O 0 0.018155334517359734
in O 0 0.005758028943091631
five O 0 0.009481940418481827
families O 0 0.02293245866894722
. O 0 0.020642410963773727

On O 0 0.006769061554223299
the O 0 0.004468995612114668
basis O 0 0.006480546668171883
of O 0 0.009092560969293118
meiotic O 1 0.9987190961837769
recombinants O 1 0.9976430535316467
and O 0 0.01940450817346573
disease O 1 0.999977707862854
- O 0 0.36706972122192383
associated O 0 0.03398072347044945
haplotypes O 1 0.9795106053352356
, O 0 0.0077062686905264854
the O 0 0.013658338226377964
WFS B-Disease 1 0.999512791633606
gene O 1 0.9751307368278503
was O 0 0.013983519747853279
localized O 0 0.32890573143959045
to O 0 0.007514203432947397
a O 0 0.022849049419164658
BAC O 1 0.9964356422424316
/ O 1 0.7830629348754883
P1 O 1 0.8475205898284912
contig O 1 0.6390230655670166
of O 0 0.008569330908358097
less O 0 0.011310308240354061
than O 0 0.009716123342514038
250 O 0 0.033728260546922684
kb O 0 0.15475574135780334
. O 0 0.028504567220807076

Mutations O 1 0.9799736738204956
in O 0 0.011157720349729061
a O 0 0.015734193846583366
novel O 0 0.05464187636971474
gene O 1 0.9487860202789307
( O 0 0.02433413825929165
WFS1 O 1 0.9524240493774414
) O 0 0.012510060332715511
encoding O 0 0.031865399330854416
a O 0 0.016358133405447006
putative O 1 0.8123326301574707
transmembrane O 1 0.7397969365119934
protein O 0 0.03219880908727646
were O 0 0.003022554097697139
found O 0 0.004432809539139271
in O 0 0.002712778514251113
all O 0 0.003316915361210704
affected O 0 0.03080587647855282
individuals O 0 0.008059738203883171
in O 0 0.005331580527126789
six O 0 0.012473718263208866
WFS B-Disease 1 0.9993126392364502
families O 0 0.015148104168474674
, O 0 0.0040562329813838005
and O 0 0.0031611165031790733
these O 0 0.005681883543729782
mutations O 1 0.9878661632537842
were O 0 0.004396948963403702
associated O 0 0.01185508631169796
with O 0 0.0060535212978720665
the O 0 0.017525281757116318
disease O 1 0.9999884366989136
phenotype O 1 0.9997313618659973
. O 0 0.034367598593235016

WFS1 O 1 0.9865846633911133
appears O 0 0.03989291563630104
to O 0 0.006951865274459124
function O 0 0.015593898482620716
in O 0 0.005871681030839682
survival O 0 0.045274730771780014
of O 0 0.009478610940277576
islet O 1 0.987649142742157
beta O 1 0.6525735259056091
- O 0 0.2069191038608551
cells O 0 0.1901344358921051
and O 0 0.010208274237811565
neurons O 1 0.534112274646759
. O 0 0.012272205203771591
. O 0 0.01946995221078396

Stable O 0 0.06645887345075607
interaction O 0 0.02209414727985859
between O 0 0.005767654627561569
the O 0 0.003487176960334182
products O 0 0.006569836288690567
of O 0 0.0038769354578107595
the O 0 0.010503171011805534
BRCA1 O 1 0.9999457597732544
and O 0 0.038214534521102905
BRCA2 O 1 0.9999934434890747
tumor B-Disease 1 0.9999799728393555
suppressor O 1 0.9995608925819397
genes O 1 0.7946991920471191
in O 0 0.0140467444434762
mitotic O 1 0.7555587887763977
and O 0 0.018101032823324203
meiotic O 1 0.9933508038520813
cells O 1 0.6937363743782043
. O 0 0.03439541161060333

BRCA1 O 1 0.9995782971382141
and O 0 0.02101924456655979
BRCA2 O 1 0.999747097492218
account O 0 0.010874883271753788
for O 0 0.004562902729958296
most O 0 0.005808842834085226
cases O 0 0.01294249389320612
of O 0 0.007580207195132971
familial O 1 0.9998335838317871
, O 0 0.010424774140119553
early O 0 0.13245084881782532
onset O 1 0.9999929666519165
breast B-Disease 1 0.999993085861206
and I-Disease 0 0.01880713552236557
/ I-Disease 1 0.9964063763618469
or I-Disease 1 0.9145811796188354
ovarian I-Disease 1 0.9999996423721313
cancer I-Disease 1 0.9999961853027344
and O 0 0.007081231568008661
encode O 0 0.024733861908316612
products O 0 0.00868164747953415
that O 0 0.0035318394657224417
each O 0 0.005883293692022562
interact O 0 0.026467666029930115
with O 0 0.012231499888002872
hRAD51 O 1 0.7117739319801331
. O 0 0.025777041912078857

Results O 0 0.02491927333176136
presented O 0 0.011328693479299545
here O 0 0.006525403819978237
show O 0 0.012701055966317654
that O 0 0.010664448142051697
BRCA1 O 1 0.9996260404586792
and O 0 0.01517706923186779
BRCA2 O 1 0.9999369382858276
coexist O 0 0.05655011534690857
in O 0 0.006875248160213232
a O 0 0.012294860556721687
biochemical O 0 0.057974427938461304
complex O 0 0.015122855082154274
and O 0 0.005689898505806923
colocalize O 1 0.6399043798446655
in O 0 0.011879712343215942
subnuclear O 1 0.9939150214195251
foci O 1 0.9576012492179871
in O 0 0.011873775161802769
somatic O 1 0.9948862195014954
cells O 0 0.1387096345424652
and O 0 0.0037100929766893387
on O 0 0.0036637606099247932
the O 0 0.00641384394839406
axial O 0 0.053136568516492844
elements O 0 0.007995516993105412
of O 0 0.006687850691378117
developing O 0 0.04297933727502823
synaptonemal O 1 0.9728931784629822
complexes O 0 0.08217878639698029
. O 0 0.027383169159293175

Like O 0 0.06356775015592575
BRCA1 O 1 0.998955249786377
and O 0 0.023469651117920876
RAD51 O 1 0.9987627267837524
, O 0 0.02579599991440773
BRCA2 O 1 0.9997850060462952
relocates O 1 0.8670055270195007
to O 0 0.022225992754101753
PCNA O 1 0.9927030801773071
+ O 0 0.09979227930307388
replication O 0 0.08764421194791794
sites O 0 0.015314937569200993
following O 0 0.015985826030373573
exposure O 0 0.1459779590368271
of O 0 0.008624263107776642
S O 1 0.5845641493797302
phase O 0 0.05530950427055359
cells O 0 0.2983866035938263
to O 0 0.014660031534731388
hydroxyurea O 1 0.9899463057518005
or O 0 0.045042604207992554
UV O 1 0.9957212209701538
irradiation O 1 0.527901828289032
. O 0 0.03165619075298309

Thus O 0 0.03416827693581581
, O 0 0.019192125648260117
BRCA1 O 1 0.9998264908790588
and O 0 0.015051258727908134
BRCA2 O 1 0.9998857975006104
participate O 0 0.013967971317470074
, O 0 0.00462898425757885
together O 0 0.0045073674991726875
, O 0 0.0030327746644616127
in O 0 0.0037266607396304607
a O 0 0.009978726506233215
pathway O 0 0.25301608443260193
( O 0 0.01502864621579647
s O 0 0.04463552311062813
) O 0 0.007620430551469326
associated O 0 0.009189464151859283
with O 0 0.0029373106081038713
the O 0 0.004427238367497921
activation O 0 0.03747032582759857
of O 0 0.004914977587759495
double O 0 0.024228565394878387
- O 0 0.04530144855380058
strand O 0 0.0832868441939354
break O 0 0.037176795303821564
repair O 1 0.5634435415267944
and O 0 0.009634758345782757
/ O 0 0.10657201707363129
or O 0 0.022670915350317955
homologous O 0 0.46238192915916443
recombination O 0 0.24165944755077362
. O 0 0.03127247095108032

Dysfunction O 1 0.9983225464820862
of O 0 0.010452640242874622
this O 0 0.009568947367370129
pathway O 0 0.3850265145301819
may O 0 0.010889922268688679
be O 0 0.003780441591516137
a O 0 0.006607613526284695
general O 0 0.010238077491521835
phenomenon O 0 0.03204895183444023
in O 0 0.0030893334187567234
the O 0 0.0038097493816167116
majority O 0 0.008693704381585121
of O 0 0.004056044388562441
cases O 0 0.014131173491477966
of O 0 0.008970372378826141
hereditary B-Disease 1 0.9999662637710571
breast I-Disease 1 0.9999914169311523
and I-Disease 0 0.017107656225562096
/ I-Disease 1 0.9969461560249329
or I-Disease 1 0.9390907287597656
ovarian I-Disease 1 0.9999992847442627
cancer I-Disease 1 0.9999924898147583
. O 0 0.018709827214479446
. O 0 0.020827144384384155

A O 0 0.047548506408929825
novel O 0 0.06777171790599823
Arg362Ser O 1 0.992653489112854
mutation O 1 0.9920114874839783
in O 0 0.008687522262334824
the O 0 0.010136104188859463
sterol O 1 0.905566930770874
27 O 0 0.04033350571990013
- O 0 0.12095236033201218
hydroxylase O 1 0.9793661236763
gene O 1 0.9520977735519409
( O 0 0.021393554285168648
CYP27 O 1 0.9834436178207397
) O 0 0.009068512357771397
: O 0 0.006838609930127859
its O 0 0.005503897089511156
effects O 0 0.02532786689698696
on O 0 0.005832919385284185
pre O 0 0.038398418575525284
- O 0 0.04147862270474434
mRNA O 0 0.056306663900613785
splicing O 0 0.06733302772045135
and O 0 0.011167316697537899
enzyme O 0 0.07353176921606064
activity O 0 0.03379353880882263
. O 0 0.02117106132209301

A O 0 0.03254032880067825
novel O 0 0.040865857154130936
C O 0 0.038915351033210754
to O 0 0.00654736440628767
A O 0 0.01764082908630371
mutation O 1 0.9712692499160767
in O 0 0.00558046018704772
the O 0 0.008442149497568607
sterol O 1 0.9031683802604675
27 O 0 0.03317762538790703
- O 0 0.10939760506153107
hydroxylase O 1 0.9765466451644897
gene O 1 0.9689925312995911
( O 0 0.02280564419925213
CYP27 O 1 0.9503909945487976
) O 0 0.010098062455654144
was O 0 0.008083951659500599
identified O 0 0.015656856819987297
by O 0 0.010992908850312233
sequencing O 0 0.06768634170293808
amplified O 1 0.5489442348480225
CYP27 O 1 0.9946700930595398
gene O 1 0.8170093297958374
products O 0 0.015013295225799084
from O 0 0.00831361673772335
a O 0 0.015997199341654778
patient O 1 0.9829250574111938
with O 0 0.02121523767709732
cerebrotendinous B-Disease 1 0.9993593096733093
xanthomatosis I-Disease 1 0.9971680045127869
( O 0 0.05277727544307709
CTX B-Disease 1 0.9975583553314209
) O 0 0.03005911037325859
. O 0 0.02676616981625557

The O 0 0.027517685666680336
mutation O 1 0.9894315004348755
changed O 0 0.024791385978460312
the O 0 0.0138413580134511
adrenodoxin O 1 0.9711374044418335
cofactor O 1 0.5765381455421448
binding O 0 0.04936900734901428
residue O 0 0.08866306394338608
362Arg O 1 0.626311182975769
to O 0 0.014154509641230106
362Ser O 1 0.9032677412033081
( O 0 0.03443625941872597
CGT O 1 0.9897114038467407
362Arg O 1 0.984317421913147
to O 0 0.022798312827944756
AGT O 1 0.999798595905304
362Ser O 1 0.9952821135520935
) O 0 0.010647124610841274
, O 0 0.003880138974636793
and O 0 0.0027975912671536207
was O 0 0.005698521155864
responsible O 0 0.013668125495314598
for O 0 0.008155492134392262
deficiency O 1 0.9998831748962402
in O 0 0.006068524904549122
the O 0 0.010860585607588291
sterol O 1 0.9743263721466064
27 O 0 0.034557245671749115
- O 0 0.062007855623960495
hydroxylase O 1 0.8426604270935059
activity O 0 0.018991224467754364
, O 0 0.004663207568228245
as O 0 0.0039049480110406876
confirmed O 0 0.010776287876069546
by O 0 0.005240113940089941
expression O 0 0.02023477293550968
of O 0 0.007962868548929691
mutant O 1 0.9474823474884033
cDNA O 0 0.0809919536113739
into O 0 0.022609954699873924
COS O 1 0.9816935658454895
- O 0 0.06429670006036758
1 O 0 0.03347361832857132
cells O 0 0.09260192513465881
. O 0 0.02592518739402294

Quantitative O 0 0.05904069170355797
analysis O 0 0.019340960308909416
showed O 0 0.013568744994699955
that O 0 0.0043516443111002445
the O 0 0.0057488419115543365
expression O 0 0.02377285622060299
of O 0 0.00919455848634243
CYP27 O 1 0.9956940412521362
gene O 1 0.8207625150680542
mRNA O 0 0.03689894080162048
in O 0 0.007393202278763056
the O 0 0.008317002095282078
patient O 1 0.9442789554595947
represented O 0 0.01791868731379509
52 O 0 0.036347515881061554
. O 0 0.022173527628183365

5 O 0 0.023620091378688812
% O 0 0.008971084840595722
of O 0 0.0044042314402759075
the O 0 0.006327992305159569
normal O 0 0.02561374567449093
level O 0 0.016904117539525032
. O 0 0.01714511029422283

As O 0 0.013024558313190937
the O 0 0.012462669052183628
mutation O 1 0.9914318323135376
occurred O 0 0.02525419555604458
at O 0 0.006712133064866066
the O 0 0.007725914474576712
penultimate O 0 0.09850228577852249
nucleotide O 0 0.05825067311525345
of O 0 0.009431620128452778
exon O 1 0.5313923954963684
6 O 0 0.01749001257121563
( O 0 0.01036282442510128
- O 0 0.015040304511785507
2 O 0 0.007563827093690634
position O 0 0.005782106891274452
of O 0 0.006721989251673222
exon O 0 0.22445490956306458
6 O 0 0.02765405736863613
- O 0 0.055219631642103195
intron O 1 0.7696608901023865
6 O 0 0.031055623665452003
splice O 0 0.11096717417240143
site O 0 0.013459022156894207
) O 0 0.004949107766151428
of O 0 0.002938601654022932
the O 0 0.006032363977283239
gene O 1 0.6138887405395508
, O 0 0.003882712684571743
we O 0 0.004015791695564985
hypothesized O 0 0.03265475481748581
that O 0 0.0035337363369762897
the O 0 0.007662429939955473
mutation O 1 0.9993284940719604
may O 0 0.01627976819872856
partially O 0 0.04003196582198143
affect O 0 0.017106983810663223
the O 0 0.006081480998545885
normal O 0 0.024842049926519394
splicing O 0 0.05511696636676788
efficiency O 0 0.015827123075723648
in O 0 0.006713831331580877
exon O 0 0.4416307210922241
6 O 0 0.013947706669569016
and O 0 0.005913938395678997
cause O 0 0.38219550251960754
alternative O 0 0.022063596174120903
splicing O 0 0.08758872002363205
elsewhere O 0 0.011723843403160572
, O 0 0.00399779574945569
which O 0 0.00448336498811841
resulted O 0 0.018544750288128853
in O 0 0.007040885742753744
decreased O 0 0.05921125039458275
transcript O 0 0.02434181235730648
in O 0 0.006495520938187838
the O 0 0.011636514216661453
patient O 1 0.9886826872825623
. O 0 0.024986470118165016

Transfection O 1 0.7536957859992981
of O 0 0.01123745832592249
constructed O 0 0.020521873608231544
minigenes O 1 0.912574827671051
, O 0 0.0046706791035830975
with O 0 0.003240118734538555
or O 0 0.004436118993908167
without O 0 0.005295312497764826
the O 0 0.00618144404143095
mutation O 1 0.9958010315895081
, O 0 0.005252050701528788
into O 0 0.01162355113774538
COS O 1 0.9962974190711975
- O 0 0.03640783205628395
1 O 0 0.01943216472864151
cells O 0 0.22238413989543915
confirmed O 0 0.015342128463089466
that O 0 0.004591698758304119
the O 0 0.007983801886439323
mutant O 1 0.9878631830215454
minigene O 1 0.8205744624137878
was O 0 0.008051929995417595
responsible O 0 0.01241165678948164
for O 0 0.005492807365953922
a O 0 0.012769227847456932
mRNA O 0 0.052279066294431686
species O 0 0.02522158995270729
alternatively O 0 0.03365572541952133
spliced O 0 0.049528613686561584
at O 0 0.009180307388305664
an O 0 0.010343008674681187
activated O 0 0.41543155908584595
cryptic O 0 0.45772919058799744
5 O 0 0.02377285622060299
splice O 0 0.22956307232379913
site O 0 0.023682884871959686
88 O 0 0.035569578409194946
bp O 0 0.04084501415491104
upstream O 0 0.0252580214291811
from O 0 0.005228199064731598
the O 0 0.00505203427746892
3 O 0 0.009211024269461632
end O 0 0.009321313351392746
of O 0 0.007422971073538065
exon O 0 0.16503016650676727
6 O 0 0.030923737213015556
. O 0 0.021339500322937965

Our O 0 0.013713416643440723
data O 0 0.01062058750540018
suggest O 0 0.011053526774048805
that O 0 0.0031949682161211967
the O 0 0.004936867393553257
C O 0 0.020299900323152542
to O 0 0.0038061642553657293
A O 0 0.013318466953933239
mutation O 1 0.9886415600776672
at O 0 0.006952115334570408
the O 0 0.007028767839074135
penultimate O 0 0.07299362868070602
nucleotide O 0 0.045521531254053116
of O 0 0.007353723980486393
exon O 0 0.13180702924728394
6 O 0 0.010635718703269958
of O 0 0.00430362019687891
the O 0 0.007652710657566786
CYP27 O 1 0.9989004135131836
gene O 1 0.9699203372001648
not O 0 0.005076312925666571
only O 0 0.006172421853989363
causes O 1 0.9824270009994507
the O 0 0.012072890996932983
deficiency B-Disease 1 0.9999603033065796
in I-Disease 0 0.006731952540576458
the I-Disease 0 0.00989334937185049
sterol I-Disease 1 0.9553832411766052
27 I-Disease 0 0.032917872071266174
- I-Disease 0 0.050096578896045685
hydroxylase I-Disease 1 0.9089678525924683
activity I-Disease 0 0.01796826161444187
, O 0 0.00452737882733345
but O 0 0.003479745239019394
also O 0 0.0038037660997360945
partially O 0 0.02677851915359497
leads O 0 0.015958327800035477
to O 0 0.0056952363811433315
alternative O 0 0.022526239976286888
pre O 0 0.0465666726231575
- O 0 0.04079582914710045
mRNA O 0 0.05975588783621788
splicing O 0 0.05577593296766281
of O 0 0.008519596420228481
the O 0 0.012183718383312225
gene O 0 0.3698154389858246
. O 0 0.023572564125061035

To O 0 0.008872383274137974
our O 0 0.008702182210981846
knowledge O 0 0.008510473184287548
, O 0 0.0033519824501127005
this O 0 0.002734718844294548
is O 0 0.0030993197578936815
the O 0 0.0025101283099502325
first O 0 0.0037652491591870785
report O 0 0.0058937580324709415
regarding O 0 0.008532744832336903
effects O 0 0.023221654817461967
on O 0 0.005719061940908432
pre O 0 0.029570503160357475
- O 0 0.033795904368162155
mRNA O 0 0.04609762132167816
splicing O 0 0.04840165376663208
of O 0 0.006401343271136284
a O 0 0.013434180989861488
mutation O 1 0.9804309010505676
at O 0 0.007717511150985956
the O 0 0.006625857669860125
- O 0 0.020105918869376183
2 O 0 0.008456815034151077
position O 0 0.006308386102318764
of O 0 0.0042729158885777
a O 0 0.011594695039093494
5 O 0 0.022491570562124252
splice O 0 0.131001815199852
site O 0 0.029215851798653603
. O 0 0.022239696234464645

ATM O 1 0.870053768157959
germline O 1 0.9963977336883545
mutations O 1 0.9882466197013855
in O 0 0.01641937345266342
classical O 0 0.04371841996908188
ataxia B-Disease 1 0.9999788999557495
- I-Disease 1 0.9985367059707642
telangiectasia I-Disease 1 0.9999899864196777
patients O 1 0.9995251893997192
in O 0 0.009891738183796406
the O 0 0.009665646590292454
Dutch O 0 0.03702380508184433
population O 0 0.031409699469804764
. O 0 0.023632388561964035

Germline O 1 0.9967461824417114
mutations O 1 0.9903234243392944
in O 0 0.00821689609438181
the O 0 0.009170572273433208
ATM O 0 0.27300992608070374
gene O 0 0.24886280298233032
are O 0 0.0038356538861989975
responsible O 0 0.010680397972464561
for O 0 0.006148200016468763
the O 0 0.05345866456627846
autosomal B-Disease 1 0.9999990463256836
recessive I-Disease 1 0.9999998807907104
disorder I-Disease 1 1.0
ataxia B-Disease 1 0.9999992847442627
- I-Disease 1 0.9996906518936157
telangiectasia I-Disease 1 0.9999914169311523
( O 0 0.20197896659374237
A B-Disease 1 0.8299306631088257
- I-Disease 1 0.9754455089569092
T I-Disease 1 0.9986525774002075
) O 0 0.02164841629564762
. O 0 0.021422650665044785

In O 0 0.0085360212251544
our O 0 0.007765509188175201
study O 0 0.00936735700815916
, O 0 0.0036684947554022074
we O 0 0.0031671382021158934
have O 0 0.0032820061314851046
determined O 0 0.008333689533174038
the O 0 0.006436016410589218
ATM O 1 0.6473634243011475
mutation O 1 0.9978132247924805
spectrum O 0 0.03128814697265625
in O 0 0.005060403607785702
19 O 0 0.012044441886246204
classical O 0 0.011785904876887798
A B-Disease 0 0.1683749556541443
- I-Disease 1 0.9967972636222839
T I-Disease 1 0.99993896484375
patients O 1 0.9989485144615173
, O 0 0.005132910329848528
including O 0 0.00551909813657403
some O 0 0.0059443991631269455
immigrant O 0 0.047497764229774475
populations O 0 0.07960616797208786
, O 0 0.003594510955736041
as O 0 0.002797215012833476
well O 0 0.002696858486160636
as O 0 0.0025171679444611073
12 O 0 0.005069363862276077
of O 0 0.0037968140095472336
Dutch O 0 0.024724775925278664
ethnic O 0 0.022135743871331215
origin O 0 0.02585114911198616
. O 0 0.020240256562829018

Both O 0 0.013283634558320045
the O 0 0.013005980290472507
protein O 0 0.05440903455018997
truncation O 0 0.4168522357940674
test O 0 0.023982519283890724
( O 0 0.01360517367720604
PTT O 0 0.08334196358919144
) O 0 0.006003424525260925
and O 0 0.0027905511669814587
the O 0 0.006822274532169104
restriction O 0 0.05532226338982582
endonuclease O 1 0.9837820529937744
fingerprinting O 0 0.11691227555274963
( O 0 0.02373374067246914
REF O 1 0.9339797496795654
) O 0 0.008846543729305267
method O 0 0.0091670798137784
were O 0 0.0022972836159169674
used O 0 0.0028405531775206327
and O 0 0.0021792338229715824
compared O 0 0.006615863181650639
for O 0 0.0027006613090634346
their O 0 0.0048253280110657215
detection O 0 0.030941685661673546
efficiency O 0 0.015300980769097805
, O 0 0.00579042686149478
identifying O 0 0.026055559515953064
76 O 0 0.028303975239396095
% O 0 0.006947021000087261
and O 0 0.003082485869526863
60 O 0 0.008278124034404755
% O 0 0.005886735860258341
of O 0 0.004279073793441057
the O 0 0.010182731784880161
mutations O 1 0.996885359287262
, O 0 0.008059200830757618
respectively O 0 0.02110629715025425
. O 0 0.018943781033158302

Most O 0 0.03424174338579178
patients O 1 0.9912325739860535
were O 0 0.004775443580001593
found O 0 0.0070299021899700165
to O 0 0.004278901498764753
be O 0 0.006463027559220791
compound O 0 0.04358474537730217
heterozygote O 1 0.9407745003700256
. O 0 0.028953364118933678

Seventeen O 0 0.08995319157838821
mutations O 1 0.9492279887199402
were O 0 0.00651887571439147
distinct O 0 0.01365759875625372
, O 0 0.002399249467998743
of O 0 0.002108511747792363
which O 0 0.0023313553538173437
10 O 0 0.0039487965404987335
were O 0 0.0022388764191418886
not O 0 0.003628057660534978
reported O 0 0.01412777230143547
previously O 0 0.015496685169637203
. O 0 0.01841246895492077

Mutations O 1 0.988461971282959
are O 0 0.008299523033201694
small O 0 0.014314097352325916
deletions O 0 0.20499436557292938
or O 0 0.012064742855727673
point O 0 0.020569583401083946
mutations O 1 0.9869491457939148
frequently O 0 0.036276958882808685
affecting O 0 0.24158570170402527
splice O 1 0.5649372935295105
sites O 0 0.028207937255501747
. O 0 0.021762140095233917

Moreover O 0 0.04554631933569908
, O 0 0.011053400114178658
a O 0 0.016571644693613052
16 O 0 0.027343330904841423
. O 0 0.019811447709798813

7 O 0 0.050447117537260056
- O 0 0.0639972984790802
kb O 0 0.4143277704715729
genomic O 0 0.4104865491390228
deletion O 0 0.14060664176940918
of O 0 0.0044212485663592815
the O 0 0.004018144216388464
3 O 0 0.00700317183509469
end O 0 0.0057220966555178165
of O 0 0.002921465551480651
the O 0 0.00592854805290699
gene O 1 0.5796798467636108
, O 0 0.004015896935015917
most O 0 0.004538253415375948
likely O 0 0.007900523953139782
a O 0 0.006172769702970982
result O 0 0.009265762753784657
of O 0 0.004912505391985178
recombination O 0 0.1290459781885147
between O 0 0.004484949167817831
two O 0 0.0032079205848276615
LINE O 0 0.009225194342434406
elements O 0 0.007104267366230488
, O 0 0.0038833883590996265
was O 0 0.006911786273121834
identified O 0 0.022700170055031776
. O 0 0.015430259518325329

The O 0 0.01149984635412693
most O 0 0.008721421472728252
frequently O 0 0.01730324886739254
found O 0 0.0136057548224926
mutation O 1 0.998405396938324
, O 0 0.0047178990207612514
identified O 0 0.009013461880385876
in O 0 0.0031016936991363764
three O 0 0.004327643662691116
unrelated O 0 0.02465820498764515
Turkish O 0 0.023559091612696648
A B-Disease 0 0.4006071388721466
- I-Disease 1 0.9543372392654419
T I-Disease 1 0.9992873072624207
individuals O 0 0.012480182573199272
, O 0 0.00424177898094058
was O 0 0.004657578654587269
previously O 0 0.006004580296576023
described O 0 0.0070441365242004395
to O 0 0.002132150111719966
be O 0 0.0025854744017124176
a O 0 0.007221983280032873
Turkish O 0 0.018376337364315987
A B-Disease 0 0.04333733767271042
- I-Disease 1 0.9452835917472839
T I-Disease 1 0.9986346364021301
founder O 0 0.40460219979286194
mutation O 1 0.9956827163696289
. O 0 0.03321702033281326

The O 0 0.011565539054572582
presence O 0 0.014643385075032711
of O 0 0.0049855755642056465
a O 0 0.01262604258954525
founder O 0 0.29179564118385315
mutation O 1 0.9982092380523682
among O 0 0.011952174827456474
relatively O 0 0.013257615268230438
small O 0 0.00741713447496295
ethnic O 0 0.011728051118552685
population O 0 0.011130612343549728
groups O 0 0.005753268022090197
in O 0 0.003480183193460107
Western O 0 0.007546011824160814
Europe O 0 0.009419340640306473
could O 0 0.005342115182429552
indicate O 0 0.010428667068481445
a O 0 0.008403667248785496
high O 0 0.0134786581620574
carrier O 0 0.05295230820775032
frequency O 0 0.022041605785489082
in O 0 0.005564204417169094
such O 0 0.006811917293816805
communities O 0 0.02109939232468605
. O 0 0.021207820624113083

In O 0 0.020510222762823105
patients O 1 0.9894738793373108
of O 0 0.006791237276047468
Dutch O 0 0.024651676416397095
ethnic O 0 0.016022710129618645
origin O 0 0.0119295259937644
, O 0 0.003529401496052742
however O 0 0.003671770915389061
, O 0 0.0024744209367781878
no O 0 0.0042388890869915485
significant O 0 0.010443007573485374
founder O 0 0.028726980090141296
effect O 0 0.01724032312631607
could O 0 0.006869894452393055
be O 0 0.0053020054474473
identified O 0 0.02430989034473896
. O 0 0.020205793902277946

The O 0 0.017603961750864983
observed O 0 0.036910317838191986
genetic O 1 0.6140283942222595
heterogeneity O 0 0.31740275025367737
including O 0 0.0058365981094539165
the O 0 0.004466772545129061
relative O 0 0.012492128647863865
high O 0 0.008048081770539284
percentage O 0 0.012278610840439796
of O 0 0.006028562784194946
splice O 1 0.9606143236160278
- O 0 0.047280460596084595
site O 0 0.021411478519439697
mutations O 1 0.9916641712188721
had O 0 0.007606002502143383
no O 0 0.0058978586457669735
reflection O 0 0.02172071486711502
on O 0 0.005982535891234875
the O 0 0.013135060667991638
phenotype O 1 0.9980260133743286
. O 0 0.026637639850378036

All O 0 0.023518363013863564
patients O 1 0.9959284663200378
manifested O 1 0.5511316657066345
classical O 0 0.022999826818704605
A B-Disease 0 0.05448543652892113
- I-Disease 1 0.7231165766716003
T I-Disease 1 0.9942926168441772
and O 0 0.007680027280002832
increased O 0 0.028254743665456772
cellular O 0 0.1938934326171875
radioresistant O 1 0.9700930714607239
DNA O 0 0.0798710510134697
synthesis O 0 0.057447098195552826
. O 0 0.025758937001228333

Determination O 0 0.03243071958422661
of O 0 0.0063245175406336784
the O 0 0.009848120622336864
genomic O 0 0.06912564486265182
structure O 0 0.010387266054749489
of O 0 0.004347456619143486
the O 0 0.010750379413366318
COL4A4 O 1 0.9911584258079529
gene O 0 0.37322428822517395
and O 0 0.00452998885884881
of O 0 0.0065798405557870865
novel O 1 0.6173744797706604
mutations O 1 0.9997519850730896
causing O 1 0.9998346567153931
autosomal B-Disease 1 0.9999978542327881
recessive I-Disease 1 0.9999996423721313
Alport I-Disease 1 0.9999990463256836
syndrome I-Disease 1 0.9999997615814209
. O 0 0.06936522573232651

Autosomal B-Disease 1 0.9999896287918091
recessive I-Disease 1 0.9999988079071045
Alport I-Disease 1 0.9999979734420776
syndrome I-Disease 1 0.9999991655349731
is O 0 0.0268380306661129
a O 0 0.0381927490234375
progressive O 1 0.998241662979126
hematuric B-Disease 1 0.9996148347854614
glomerulonephritis I-Disease 1 0.9999569654464722
characterized O 1 0.9559441804885864
by O 0 0.02205718867480755
glomerular B-Disease 1 0.9998254179954529
basement I-Disease 1 0.9377933144569397
membrane I-Disease 1 0.9835669994354248
abnormalities I-Disease 1 0.9996275901794434
and O 0 0.0059923091903328896
associated O 0 0.0123225012794137
with O 0 0.006699003744870424
mutations O 1 0.9914109706878662
in O 0 0.004840606823563576
either O 0 0.006790590938180685
the O 0 0.006207440514117479
COL4A3 O 1 0.9854685664176941
or O 0 0.008441434241831303
the O 0 0.010110215283930302
COL4A4 O 1 0.9981960654258728
gene O 1 0.9272791147232056
, O 0 0.004074568394571543
which O 0 0.0038406020030379295
encode O 0 0.01725957542657852
the O 0 0.007464295253157616
alpha3 O 1 0.8992867469787598
and O 0 0.011415642686188221
alpha4 O 1 0.9889195561408997
type O 1 0.9212258458137512
IV O 1 0.9972862005233765
collagen O 1 0.9991563558578491
chains O 0 0.32597917318344116
, O 0 0.00891534797847271
respectively O 0 0.017593523487448692
. O 0 0.015088960528373718

To O 0 0.011557860299944878
date O 0 0.01720862276852131
, O 0 0.009651096537709236
mutation O 1 0.9947106838226318
screening O 0 0.03022727556526661
in O 0 0.004073146265000105
the O 0 0.003448870964348316
two O 0 0.005152319557964802
genes O 0 0.23877498507499695
has O 0 0.0063990261405706406
been O 0 0.006103876978158951
hampered O 0 0.06860314309597015
by O 0 0.004389380570501089
the O 0 0.004112721420824528
lack O 0 0.012385068461298943
of O 0 0.006552036851644516
genomic O 1 0.7235240936279297
structure O 0 0.01646888628602028
information O 0 0.011549674905836582
. O 0 0.016612127423286438

We O 0 0.007707235403358936
report O 0 0.007606674917042255
here O 0 0.004543100018054247
the O 0 0.003788562258705497
complete O 0 0.008572656661272049
characterization O 0 0.017222685739398003
of O 0 0.0035192989744246006
the O 0 0.004875390324741602
48 O 0 0.015269829891622066
exons O 0 0.04177621379494667
of O 0 0.005260665435343981
the O 0 0.010280919261276722
COL4A4 O 1 0.9990658164024353
gene O 1 0.9326868653297424
, O 0 0.00496564619243145
a O 0 0.00955029297620058
comprehensive O 0 0.027835898101329803
gene O 1 0.9022634625434875
screen O 0 0.020482800900936127
, O 0 0.0035121706314384937
and O 0 0.002453731605783105
the O 0 0.004012305289506912
subsequent O 0 0.015489730052649975
detection O 0 0.023093009367585182
of O 0 0.004812583792954683
10 O 0 0.009979791007936
novel O 0 0.032771673053503036
mutations O 1 0.9870686531066895
in O 0 0.009547721594572067
eight O 0 0.030563369393348694
patients O 1 0.9999430179595947
diagnosed O 1 0.9999967813491821
with O 1 0.8668459057807922
autosomal B-Disease 1 0.9999964237213135
recessive I-Disease 1 0.9999992847442627
Alport I-Disease 1 0.9999990463256836
syndrome I-Disease 1 0.9999995231628418
. O 0 0.0791872963309288

Furthermore O 0 0.03713035583496094
, O 0 0.0067982436157763
we O 0 0.005096891429275274
identified O 0 0.012121087871491909
a O 0 0.00997537188231945
glycine O 0 0.047208625823259354
to O 0 0.007566011510789394
alanine O 0 0.060942210257053375
substitution O 0 0.02437334880232811
in O 0 0.005173301789909601
the O 0 0.007749481126666069
collagenous O 1 0.9945688247680664
domain O 0 0.02289430797100067
that O 0 0.003786648390814662
is O 0 0.006184420082718134
apparently O 0 0.017641454935073853
silent O 0 0.03277383744716644
in O 0 0.005195017904043198
the O 0 0.010330078192055225
heterozygous O 1 0.9793741703033447
carriers O 0 0.07852783054113388
, O 0 0.0063457125797867775
in O 0 0.006511323619633913
11 O 0 0.01829649694263935
. O 0 0.015896406024694443

5 O 0 0.020861167460680008
% O 0 0.008630352094769478
of O 0 0.00352556724101305
all O 0 0.0032149911858141422
control O 0 0.01184000913053751
individuals O 0 0.006367316469550133
, O 0 0.0024041575379669666
and O 0 0.001981601817533374
in O 0 0.0024288438726216555
one O 0 0.004605880472809076
control O 0 0.01753942482173443
individual O 0 0.013951307162642479
homozygous O 1 0.6499171257019043
for O 0 0.006429354194551706
this O 0 0.010725615546107292
glycine O 0 0.08728977292776108
substitution O 0 0.0597231388092041
. O 0 0.020674381405115128

There O 0 0.01120446715503931
has O 0 0.006701224949210882
been O 0 0.004364422522485256
no O 0 0.00427002040669322
previous O 0 0.006599011830985546
finding O 0 0.00785925704985857
of O 0 0.0034660364035516977
a O 0 0.009042470715939999
glycine O 0 0.062385041266679764
substitution O 0 0.022440915927290916
that O 0 0.0038134176284074783
is O 0 0.00413433788344264
not O 0 0.0029405804816633463
associated O 0 0.00783825758844614
with O 0 0.0037536693271249533
any O 0 0.007174724247306585
obvious O 0 0.2616543173789978
phenotype O 1 0.999417781829834
in O 0 0.01229420118033886
homozygous O 1 0.992511510848999
individuals O 0 0.024491600692272186
. O 0 0.020248256623744965

Founder O 1 0.5540102124214172
BRCA1 O 1 0.9991098046302795
and O 0 0.02723129652440548
BRCA2 O 1 0.9999427795410156
mutations O 1 0.9964863061904907
in O 0 0.013341633602976799
French O 0 0.14494933187961578
Canadian O 1 0.9481317400932312
breast B-Disease 1 0.9999897480010986
and I-Disease 1 0.9032695293426514
ovarian I-Disease 1 0.9999994039535522
cancer I-Disease 1 0.9999926090240479
families O 0 0.09269192814826965
. O 0 0.033802974969148636

We O 0 0.00987484771758318
have O 0 0.005792555399239063
identified O 0 0.014345360919833183
four O 0 0.007992341183125973
mutations O 1 0.8573921322822571
in O 0 0.0036799076478928328
each O 0 0.004101995844393969
of O 0 0.005296812858432531
the O 0 0.020140904933214188
breast B-Disease 1 0.9999982118606567
cancer I-Disease 1 0.9999972581863403
- O 1 0.9955114126205444
susceptibility O 1 0.99972003698349
genes O 1 0.9897896647453308
, O 0 0.01689894311130047
BRCA1 O 1 0.9998983144760132
and O 0 0.014537081122398376
BRCA2 O 1 0.9998465776443481
, O 0 0.0069071282632648945
in O 0 0.0073646120727062225
French O 0 0.12121221423149109
Canadian O 1 0.9543547034263611
breast B-Disease 1 0.9999974966049194
cancer I-Disease 1 0.9999903440475464
and O 1 0.6254801154136658
breast B-Disease 1 0.9999982118606567
/ I-Disease 1 0.9999263286590576
ovarian I-Disease 1 0.9999995231628418
cancer I-Disease 1 0.9999932050704956
families O 0 0.03702053800225258
from O 0 0.01783628761768341
Quebec O 0 0.169894278049469
. O 0 0.023143576458096504

To O 0 0.012782826088368893
identify O 0 0.028921937569975853
founder O 0 0.040800441056489944
effects O 0 0.10360908508300781
, O 0 0.005396442487835884
we O 0 0.004783031065016985
examined O 0 0.0252841729670763
independently O 0 0.018408065661787987
ascertained O 0 0.13859079778194427
French O 0 0.060143861919641495
Canadian O 1 0.7871688604354858
cancer B-Disease 1 0.999970555305481
families O 0 0.010335056111216545
for O 0 0.003424848197028041
the O 0 0.004088610876351595
distribution O 0 0.007568164262920618
of O 0 0.003402327885851264
these O 0 0.004421517718583345
eight O 0 0.016577864065766335
mutations O 1 0.9897192716598511
. O 0 0.025391515344381332

Mutations O 1 0.982529878616333
were O 0 0.006936249323189259
found O 0 0.007151653524488211
in O 0 0.004018417093902826
41 O 0 0.01392168365418911
of O 0 0.005777725484222174
97 O 0 0.034584544599056244
families O 0 0.022707968950271606
. O 0 0.022163959220051765

Six O 0 0.013286765664815903
of O 0 0.007502371445298195
eight O 0 0.01487020030617714
mutations O 1 0.9903171062469482
were O 0 0.004994723945856094
observed O 0 0.015387865714728832
at O 0 0.007853860035538673
least O 0 0.014897543005645275
twice O 0 0.027887651696801186
. O 0 0.018709037452936172

The O 0 0.05259270966053009
BRCA1 O 1 0.9997915625572205
C4446T O 1 0.9981877207756042
mutation O 1 0.9973869919776917
was O 0 0.007915787398815155
the O 0 0.0044971550814807415
most O 0 0.006292531732469797
common O 0 0.04077831283211708
mutation O 1 0.9988743662834167
found O 0 0.008862651884555817
, O 0 0.004355451557785273
followed O 0 0.00950356014072895
by O 0 0.0081853698939085
the O 0 0.0184357650578022
BRCA2 O 1 0.9999302625656128
8765delAG O 1 0.9975394010543823
mutation O 1 0.9985358715057373
. O 0 0.03716335818171501

Together O 0 0.011967935599386692
, O 0 0.006122377701103687
these O 0 0.006577577441930771
mutations O 1 0.9887340068817139
were O 0 0.0031306217424571514
found O 0 0.00551395770162344
in O 0 0.0031637391075491905
28 O 0 0.007548898458480835
of O 0 0.004171593580394983
41 O 0 0.017755871638655663
families O 0 0.010433737188577652
identified O 0 0.010015229694545269
to O 0 0.0035271754022687674
have O 0 0.0060197170823812485
a O 0 0.021150121465325356
mutation O 1 0.9900289177894592
. O 0 0.027641523629426956

The O 0 0.01207162719219923
odds O 0 0.02758771926164627
of O 0 0.005322580691426992
detection O 0 0.02025923877954483
of O 0 0.0026077141519635916
any O 0 0.0028373391833156347
of O 0 0.002417593961581588
the O 0 0.004718165844678879
four O 0 0.013798349536955357
BRCA1 O 1 0.999962329864502
mutations O 1 0.9980620741844177
was O 0 0.013555675745010376
18 O 0 0.018774431198835373
. O 0 0.017866101115942

7x O 1 0.9852369427680969
greater O 0 0.02176639810204506
if O 0 0.00767312478274107
one O 0 0.005170416086912155
or O 0 0.005117995198816061
more O 0 0.005440415348857641
cases O 0 0.020011400803923607
of O 0 0.037307802587747574
ovarian B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999951124191284
were O 0 0.005270663183182478
also O 0 0.0036976528353989124
present O 0 0.005099622067064047
in O 0 0.0038576056249439716
the O 0 0.006716512609273195
family O 0 0.024777762591838837
. O 0 0.018600327894091606

The O 0 0.014611329883337021
odds O 0 0.02954120747745037
of O 0 0.0054709454998373985
detection O 0 0.021297544240951538
of O 0 0.003093195613473654
any O 0 0.0028770810458809137
of O 0 0.0026529773604124784
the O 0 0.005181580316275358
four O 0 0.014247897081077099
BRCA2 O 1 0.9999643564224243
mutations O 1 0.9988849759101868
was O 0 0.01773943193256855
5 O 0 0.02352026291191578
. O 0 0.020646456629037857

3x O 1 0.9548176527023315
greater O 0 0.019628014415502548
if O 0 0.006182600744068623
there O 0 0.003315648064017296
were O 0 0.002161709824576974
at O 0 0.0031147138215601444
least O 0 0.006103836465626955
five O 0 0.006466861814260483
cases O 0 0.020612141117453575
of O 0 0.018823660910129547
breast B-Disease 1 0.9999971389770508
cancer I-Disease 1 0.9999682903289795
in O 0 0.00823637843132019
the O 0 0.009141060523688793
family O 0 0.029096238315105438
. O 0 0.020603671669960022

Interestingly O 0 0.0607757642865181
, O 0 0.00635000504553318
the O 0 0.004840109962970018
presence O 0 0.012090960517525673
of O 0 0.006570390425622463
a O 1 0.5769497156143188
breast B-Disease 1 0.9999978542327881
cancer I-Disease 1 0.9999868869781494
case O 0 0.10417278856039047
< O 1 0.9365600347518921
36 O 0 0.015693357214331627
years O 0 0.006066011264920235
of O 0 0.0037762424908578396
age O 0 0.0117791797965765
was O 0 0.0073991809040308
strongly O 0 0.012247797101736069
predictive O 0 0.031501058489084244
of O 0 0.002926900051534176
the O 0 0.003552054986357689
presence O 0 0.007266353815793991
of O 0 0.00233712000772357
any O 0 0.0026833300944417715
of O 0 0.0026769607793539762
the O 0 0.004986380226910114
eight O 0 0.01481629442423582
mutations O 1 0.9954904913902283
screened O 0 0.15525859594345093
. O 0 0.02213446795940399

Carriers O 0 0.05839163437485695
of O 0 0.005791280884295702
the O 0 0.006159997545182705
same O 0 0.012363365851342678
mutation O 1 0.9979436993598938
, O 0 0.004215115215629339
from O 0 0.0038682406302541494
different O 0 0.003589858766645193
families O 0 0.007686431985348463
, O 0 0.0034122520592063665
shared O 0 0.008664117194712162
similar O 0 0.012270557694137096
haplotypes O 1 0.9687012434005737
, O 0 0.004812656901776791
indicating O 0 0.013524512760341167
that O 0 0.003354428568854928
the O 0 0.0064358701929450035
mutant O 1 0.9982056617736816
alleles O 1 0.9982889294624329
were O 0 0.004030853975564241
likely O 0 0.007282810751348734
to O 0 0.0021905163303017616
be O 0 0.002734186826273799
identical O 0 0.009506842121481895
by O 0 0.0049271960742771626
descent O 0 0.01986527442932129
for O 0 0.0045182108879089355
a O 0 0.012478970922529697
mutation O 1 0.99614018201828
in O 0 0.0063614691607654095
the O 0 0.0077048540115356445
founder O 0 0.04050774872303009
population O 0 0.030932676047086716
. O 0 0.02177869901061058

The O 0 0.012046552263200283
identification O 0 0.018628746271133423
of O 0 0.008349443785846233
common O 0 0.12669643759727478
BRCA1 O 1 0.9999542236328125
and O 0 0.0207923986017704
BRCA2 O 1 0.9999856948852539
mutations O 1 0.9993550181388855
will O 0 0.008139427751302719
facilitate O 0 0.022432733327150345
carrier O 0 0.08623795211315155
detection O 0 0.03441004827618599
in O 0 0.008397978730499744
French O 0 0.10011186450719833
Canadian O 1 0.9822618961334229
breast B-Disease 1 0.9999982118606567
cancer I-Disease 1 0.9999964237213135
and O 0 0.46169742941856384
breast B-Disease 1 0.9999972581863403
/ I-Disease 1 0.9998824596405029
ovarian I-Disease 1 0.9999996423721313
cancer I-Disease 1 0.9999904632568359
families O 0 0.05952697619795799
. O 0 0.028382332995533943

Are O 0 0.014491956681013107
Dp71 O 1 0.9804193377494812
and O 0 0.01566050946712494
Dp140 O 1 0.9983078241348267
brain O 1 0.9998499155044556
dystrophin O 1 0.9975960850715637
isoforms O 0 0.4187392592430115
related O 0 0.022749880328774452
to O 0 0.010530129075050354
cognitive B-Disease 1 0.9819230437278748
impairment I-Disease 1 0.9992569088935852
in O 0 0.1723124086856842
Duchenne B-Disease 1 0.9999933242797852
muscular I-Disease 1 0.9999939203262329
dystrophy I-Disease 1 0.9999926090240479
? O 1 0.8750301599502563

Molecular O 0 0.07074689865112305
study O 0 0.02101854793727398
and O 0 0.007076070178300142
neuropsychological O 1 0.7671220898628235
analysis O 0 0.009615170769393444
were O 0 0.0030925823375582695
performed O 0 0.008610743097960949
concurrently O 0 0.009646585211157799
on O 0 0.005846035201102495
49 O 0 0.05377449840307236
patients O 1 0.9988391995429993
with O 0 0.06128796935081482
Duchenne B-Disease 1 0.9999977350234985
muscular I-Disease 1 0.9999982118606567
dystrophy I-Disease 1 0.9999994039535522
( O 1 0.9712929129600525
DMD B-Disease 1 0.9999754428863525
) O 0 0.010967073030769825
in O 0 0.004133458249270916
order O 0 0.004414319526404142
to O 0 0.002945288550108671
find O 0 0.008396683260798454
a O 0 0.008481520228087902
molecular O 0 0.021491479128599167
explanation O 0 0.013853886164724827
for O 0 0.004757547751069069
the O 0 0.009676419198513031
cognitive B-Disease 1 0.9427995681762695
impairment I-Disease 1 0.9976757168769836
observed O 0 0.02977871336042881
in O 0 0.011858354322612286
most O 0 0.03131549432873726
DMD B-Disease 1 0.9999737739562988
patients O 1 0.9991276860237122
. O 0 0.03614507615566254

Complete O 0 0.020226871594786644
analysis O 0 0.013305789791047573
of O 0 0.005080843809992075
the O 0 0.012516417540609837
dystrophin O 1 0.9983987212181091
gene O 1 0.7710126042366028
was O 0 0.008729756809771061
performed O 0 0.009675698354840279
to O 0 0.0031641528476029634
define O 0 0.010708311572670937
the O 0 0.0054188137874007225
localization O 0 0.03305816650390625
of O 0 0.0066605499014258385
deletions O 0 0.061772625893354416
and O 0 0.007188259623944759
duplications O 0 0.45390674471855164
in O 0 0.0055353171192109585
relation O 0 0.012210122309625149
to O 0 0.00401435187086463
the O 0 0.008175693452358246
different O 0 0.02038346789777279
DMD B-Disease 1 0.9998086094856262
promoters O 1 0.840218186378479
. O 0 0.031705234199762344

Qualitative O 0 0.04912938177585602
analysis O 0 0.014965209178626537
of O 0 0.004771885462105274
the O 0 0.008091399446129799
Dp71 O 1 0.855789065361023
transcript O 0 0.02743774838745594
and O 0 0.0049410369247198105
testing O 0 0.011907332576811314
for O 0 0.0028228661976754665
the O 0 0.0034243143163621426
specific O 0 0.0071871024556458
first O 0 0.0074503435753285885
exon O 0 0.058462899178266525
of O 0 0.007031972985714674
Dp140 O 1 0.7108337879180908
were O 0 0.004051339812576771
also O 0 0.004445631522685289
carried O 0 0.009167980402708054
out O 0 0.009148146025836468
. O 0 0.01469888724386692

Neuropsychological O 1 0.8078214526176453
analysis O 0 0.035913269966840744
assessed O 0 0.0411384180188179
verbal O 0 0.042328834533691406
and O 0 0.009536050260066986
visuospatial O 1 0.989246666431427
intelligence O 0 0.018978897482156754
, O 0 0.007426843512803316
verbal O 0 0.08521119505167007
memory O 0 0.11238924413919449
, O 0 0.003946073818951845
and O 0 0.0038466688711196184
reading O 0 0.015605233609676361
skills O 0 0.0275775957852602
. O 0 0.020333893597126007

Comparison O 0 0.03517406806349754
of O 0 0.010303732939064503
molecular O 0 0.035329122096300125
and O 0 0.006602545268833637
psychometric O 0 0.48320645093917847
findings O 0 0.019583113491535187
demonstrated O 0 0.016089679673314095
that O 0 0.004803172312676907
deletions O 0 0.10324726998806
and O 0 0.005134393461048603
duplications O 1 0.5925729870796204
that O 0 0.0035268976353108883
were O 0 0.004340115003287792
localized O 1 0.7184346318244934
in O 0 0.00406116945669055
the O 0 0.008263598196208477
distal O 1 0.9925320744514465
part O 0 0.00708897365257144
of O 0 0.004550850950181484
the O 0 0.007421425078064203
gene O 1 0.9086100459098816
seemed O 0 0.012826732359826565
to O 0 0.004229034762829542
be O 0 0.004975792020559311
preferentially O 0 0.05991501733660698
associated O 0 0.015525265596807003
with O 0 0.011726710014045238
cognitive B-Disease 1 0.9802439212799072
impairment I-Disease 1 0.9979248046875
. O 0 0.03070436231791973

Two O 0 0.018555965274572372
altered O 0 0.05777811259031296
Dp71 O 1 0.7039214372634888
transcripts O 0 0.022066395729780197
and O 0 0.005595549941062927
two O 0 0.00754882674664259
deleted O 0 0.0478411540389061
Dp140 O 1 0.7092776298522949
DNA O 0 0.04480229318141937
sequences O 0 0.021138448268175125
were O 0 0.0033887189347296953
found O 0 0.005167380440980196
in O 0 0.0035943591501563787
four O 0 0.009260769002139568
patients O 1 0.9997289776802063
with O 0 0.04843069240450859
severe O 1 0.9999881982803345
cerebral B-Disease 1 0.9999945163726807
dysfunction I-Disease 1 0.9999412298202515
. O 0 0.04745626822113991

These O 0 0.011214149184525013
findings O 0 0.022184081375598907
suggest O 0 0.012842487543821335
that O 0 0.003649633377790451
some O 0 0.0050602504052221775
sequences O 0 0.018534453585743904
located O 0 0.006774076726287603
in O 0 0.0032863609958440065
the O 0 0.006830265745520592
distal O 1 0.9970104694366455
part O 0 0.006841389462351799
of O 0 0.003908164799213409
the O 0 0.0066463458351790905
gene O 1 0.7574643492698669
and O 0 0.002840041182935238
, O 0 0.0025265503209084272
in O 0 0.00265255244448781
particular O 0 0.00726064620539546
, O 0 0.004531285259872675
some O 0 0.01024104468524456
DMD B-Disease 1 0.9999544620513916
isoforms O 0 0.4989609122276306
expressed O 0 0.014304520562291145
in O 0 0.005448264069855213
the O 0 0.008484352380037308
brain O 1 0.9998094439506531
may O 0 0.00896978285163641
be O 0 0.0028945556841790676
related O 0 0.006854509934782982
to O 0 0.0032972751650959253
the O 0 0.007382124662399292
cognitive B-Disease 1 0.9849201440811157
impairment I-Disease 1 0.9992455244064331
associated O 0 0.029178263619542122
with O 0 0.016426922753453255
DMD B-Disease 1 0.9999231100082397
. O 0 0.01575585827231407
. O 0 0.018329517915844917

I1307K O 1 0.9815655946731567
APC O 1 0.990288496017456
and O 0 0.017992574721574783
hMLH1 O 1 0.9903862476348877
mutations O 1 0.9937964677810669
in O 0 0.006414713338017464
a O 0 0.010541245341300964
non O 0 0.01834796369075775
- O 0 0.024213174358010292
Jewish O 0 0.017968514934182167
family O 0 0.016329262405633926
with O 0 0.009162252768874168
hereditary B-Disease 1 0.999619722366333
non I-Disease 1 0.9896188378334045
- I-Disease 1 0.9996914863586426
polyposis I-Disease 1 0.9999996423721313
colorectal I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999953508377075
. O 0 0.0489487461745739

We O 0 0.01228325068950653
describe O 0 0.01890161633491516
a O 0 0.012025546282529831
French O 0 0.028670189902186394
Canadian O 0 0.055898863822221756
hereditary B-Disease 1 0.9991666078567505
non I-Disease 1 0.9584117531776428
- I-Disease 1 0.9997333884239197
polyposis I-Disease 1 0.9999997615814209
colorectal I-Disease 1 1.0
cancer I-Disease 1 0.9999992847442627
( O 1 0.9346588253974915
HNPCC B-Disease 1 0.9999513626098633
) O 0 0.023765254765748978
kindred O 1 0.9781852960586548
which O 0 0.006245750002563
carries O 0 0.015322592109441757
a O 0 0.014475056901574135
novel O 0 0.06518232077360153
truncating O 1 0.9970968961715698
mutation O 1 0.997734785079956
in O 0 0.01841410994529724
hMLH1 O 1 0.9000496864318848
. O 0 0.026951272040605545

Interestingly O 0 0.07395194470882416
, O 0 0.009052063338458538
the O 0 0.012893371284008026
I1307K O 1 0.9974610805511475
APC O 1 0.998860239982605
polymorphism O 1 0.899807333946228
, O 0 0.006318824365735054
associated O 0 0.00932216364890337
with O 0 0.0034276291262358427
an O 0 0.0048835095949471
increased O 0 0.029336700215935707
risk O 1 0.9973893761634827
of O 1 0.5497178435325623
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
, O 0 0.008078932762145996
is O 0 0.004595337901264429
also O 0 0.0033613834530115128
present O 0 0.004638724960386753
in O 0 0.003758261911571026
this O 0 0.006226229481399059
family O 0 0.021889764815568924
. O 0 0.019890327006578445

The O 0 0.02667062170803547
I1307K O 1 0.9875760078430176
polymorphism O 1 0.9160367250442505
has O 0 0.008675916120409966
previously O 0 0.006829395424574614
only O 0 0.0034719393588602543
been O 0 0.0038832572754472494
identified O 0 0.008782868273556232
in O 0 0.003023511031642556
individuals O 0 0.00602948572486639
of O 0 0.005217278841882944
self O 0 0.04083714261651039
- O 0 0.10049249976873398
reported O 0 0.03944399207830429
Ashkenazi O 1 0.8144321441650391
Jewish O 0 0.043053220957517624
origins O 0 0.05966154858469963
. O 0 0.026655586436390877

In O 0 0.011699977330863476
addition O 0 0.009385011158883572
, O 0 0.0035348462406545877
in O 0 0.0026594006922096014
this O 0 0.003112410893663764
family O 0 0.008731980808079243
, O 0 0.0030467354226857424
there O 0 0.0032408731058239937
appears O 0 0.00976866576820612
to O 0 0.0023673521354794502
be O 0 0.0024263288360089064
no O 0 0.0037869501393288374
relationship O 0 0.010592063888907433
between O 0 0.005647079087793827
the O 0 0.008011679165065289
I1307K O 1 0.9785500764846802
polymorphism O 0 0.49463576078414917
and O 0 0.00394426379352808
the O 0 0.005076815839856863
presence O 0 0.012102534994482994
or O 0 0.008039128966629505
absence O 0 0.022711552679538727
of O 0 0.011012941598892212
cancer B-Disease 1 0.9999278783798218
. O 0 0.01113259606063366
. O 0 0.017215577885508537

Identification O 0 0.03043620102107525
of O 0 0.00785917416214943
a O 0 0.01263034250587225
novel O 0 0.03130972757935524
mutation O 1 0.9800640344619751
of O 0 0.005307402461767197
the O 0 0.008630149066448212
CPO O 1 0.7238169312477112
gene O 0 0.19906164705753326
in O 0 0.005877568386495113
a O 0 0.012060766108334064
Japanese O 0 0.030788378790020943
hereditary B-Disease 1 0.9979299306869507
coproporphyria I-Disease 1 0.9951855540275574
family O 0 0.04375959560275078
. O 0 0.024324804544448853

Hereditary B-Disease 1 0.9990980625152588
coproporphyria I-Disease 1 0.9926717281341553
( O 0 0.04366948455572128
HCP B-Disease 1 0.9820877909660339
) O 0 0.012637092731893063
is O 0 0.007934588938951492
an O 0 0.01457537803798914
autosomal B-Disease 1 0.9999868869781494
dominant I-Disease 1 0.9994485974311829
disease I-Disease 1 0.999996542930603
characterized O 1 0.9594777822494507
by O 0 0.009591619484126568
a O 0 0.04318844899535179
deficiency B-Disease 1 0.9999402761459351
of I-Disease 0 0.01580663025379181
coproporphyrinogen I-Disease 1 0.998162567615509
oxidase I-Disease 1 0.995914876461029
( O 0 0.023476501926779747
CPO O 1 0.5992171764373779
) O 0 0.011410892941057682
caused O 0 0.0783458948135376
by O 0 0.006091201677918434
a O 0 0.013520065695047379
mutation O 1 0.9884774088859558
in O 0 0.006575964391231537
the O 0 0.011356247588992119
CPO O 1 0.5030755400657654
gene O 1 0.8227527737617493
. O 0 0.02415241114795208

Only O 0 0.01583057828247547
11 O 0 0.02049986645579338
mutations O 1 0.9255016446113586
of O 0 0.004911843687295914
the O 0 0.0075566149316728115
gene O 1 0.8248562216758728
have O 0 0.005373569671064615
been O 0 0.007216408383101225
reported O 0 0.020694635808467865
in O 0 0.014524190686643124
HCP B-Disease 1 0.9994775652885437
patients O 1 0.9990697503089905
. O 0 0.02951892651617527

We O 0 0.010856213979423046
report O 0 0.013476020656526089
another O 0 0.01898438110947609
mutation O 1 0.9906080961227417
in O 0 0.007584961596876383
a O 0 0.012109092436730862
Japanese O 0 0.022154798731207848
family O 0 0.026813216507434845
. O 0 0.02062956616282463

Polymerase O 1 0.870083212852478
chain O 0 0.3020600974559784
reaction O 0 0.056758519262075424
- O 0 0.03711605444550514
single O 0 0.0273432657122612
strand O 0 0.08758273720741272
conformational O 1 0.8689054846763611
polymorphism O 0 0.10165204852819443
and O 0 0.005649966187775135
direct O 0 0.014033034443855286
sequence O 0 0.024847490713000298
analyses O 0 0.020571023225784302
demonstrated O 0 0.020547332242131233
a O 0 0.014200728386640549
C O 0 0.035187460482120514
to O 0 0.008315376937389374
T O 0 0.2702590227127075
substitution O 0 0.026203526183962822
in O 0 0.007336843758821487
exon O 0 0.057347238063812256
1 O 0 0.010260497219860554
of O 0 0.004550247918814421
the O 0 0.008468927815556526
CPO O 0 0.17833808064460754
gene O 0 0.24741193652153015
at O 0 0.011544511653482914
nucleotide O 0 0.04107986390590668
position O 0 0.01121144276112318
85 O 0 0.01681237667798996
, O 0 0.0033093541860580444
which O 0 0.003224436193704605
lies O 0 0.010454361326992512
in O 0 0.003973981831222773
the O 0 0.006384247913956642
putative O 1 0.8276223540306091
presequence O 1 0.7466039657592773
for O 0 0.0077237579971551895
targeting O 0 0.025873001664876938
to O 0 0.009966852143406868
mitochondria O 0 0.1364721655845642
. O 0 0.027867641299962997

This O 0 0.02402586303651333
mutation O 1 0.9896201491355896
changes O 0 0.013583586551249027
the O 0 0.007187462877482176
codon O 0 0.06178442761301994
for O 0 0.005232535302639008
glutamine O 0 0.042926203459501266
to O 0 0.0051533677615225315
a O 0 0.013071867637336254
termination O 0 0.3577408790588379
codon O 0 0.09922173619270325
at O 0 0.014265642501413822
amino O 0 0.04173216596245766
acid O 0 0.06417802721261978
position O 0 0.01580154150724411
29 O 0 0.028005404397845268
. O 0 0.019187336787581444

MaeI O 1 0.9358850121498108
restriction O 0 0.04537263885140419
analysis O 0 0.016802212223410606
showed O 0 0.012756268493831158
two O 0 0.004158077761530876
other O 0 0.004251430742442608
carriers O 0 0.02906900644302368
in O 0 0.004782164469361305
the O 0 0.007067551836371422
family O 0 0.022403093054890633
. O 0 0.017828386276960373

The O 0 0.028389619663357735
C O 1 0.5313177108764648
- O 1 0.8173908591270447
T O 1 0.9948311448097229
mutation O 1 0.9950710535049438
is O 0 0.00899066124111414
located O 0 0.009394892491400242
within O 0 0.007236414588987827
a O 0 0.009828676469624043
recently O 0 0.016298914328217506
proposed O 0 0.015273142606019974
putative O 0 0.06802165508270264
alternative O 0 0.02533525414764881
translation O 0 0.0280589759349823
initiation O 0 0.08211449533700943
codon O 1 0.5664032101631165
( O 0 0.03320901468396187
TIC O 1 0.9947879314422607
- O 0 0.04049504175782204
1 O 0 0.01680552214384079
) O 0 0.006548266392201185
, O 0 0.00391697371378541
supporting O 0 0.012091929093003273
that O 0 0.008120175451040268
TIC O 1 0.9977411031723022
- O 0 0.028704321011900902
1 O 0 0.011614898219704628
is O 0 0.005026861093938351
the O 0 0.006617940962314606
real O 0 0.025983743369579315
TIC O 1 0.9852215647697449
rather O 0 0.01789831556379795
than O 0 0.01807241141796112
TIC O 1 0.9903974533081055
- O 0 0.04932131990790367
2 O 0 0.019771955907344818
. O 0 0.010405152104794979
. O 0 0.017711294814944267

Human B-Disease 0 0.05865664407610893
complement I-Disease 0 0.07335768640041351
factor I-Disease 1 0.8601068258285522
H I-Disease 1 0.9988449811935425
deficiency I-Disease 1 0.9999597072601318
associated O 0 0.1466410607099533
with O 0 0.46513086557388306
hemolytic B-Disease 1 0.9999994039535522
uremic I-Disease 1 0.9999996423721313
syndrome I-Disease 1 0.9999994039535522
. O 0 0.07881683111190796

This O 0 0.009426145814359188
study O 0 0.011009255424141884
reports O 0 0.006553275510668755
on O 0 0.002843408612534404
six O 0 0.005624306853860617
cases O 0 0.013133670203387737
of O 0 0.007937975227832794
deficiency B-Disease 1 0.9999771118164062
in I-Disease 0 0.004801604431122541
the I-Disease 0 0.005198301747441292
human I-Disease 0 0.01940273493528366
complement I-Disease 0 0.030497485771775246
regulatory I-Disease 0 0.05900649353861809
protein I-Disease 0 0.07398996502161026
Factor I-Disease 1 0.5691591501235962
H I-Disease 1 0.9909995198249817
( O 0 0.025560175999999046
FH O 1 0.9966644644737244
) O 0 0.007265116088092327
in O 0 0.003193313255906105
the O 0 0.004143507685512304
context O 0 0.010903417132794857
of O 0 0.008183499798178673
an O 0 0.03204119950532913
acute B-Disease 1 0.999996542930603
renal I-Disease 1 0.9999998807907104
disease I-Disease 1 0.999997615814209
. O 0 0.05678090080618858

Five O 0 0.009817912243306637
of O 0 0.0042214770801365376
the O 0 0.005319009535014629
cases O 0 0.01275252178311348
were O 0 0.0033743635285645723
observed O 0 0.012285321950912476
in O 0 0.004698091186583042
children O 0 0.015540892258286476
presenting O 0 0.03693358972668648
with O 0 0.3027181327342987
idiopathic O 1 0.999998927116394
hemolytic B-Disease 1 0.9999998807907104
uremic I-Disease 1 1.0
syndrome I-Disease 1 0.9999998807907104
( O 1 0.9822937846183777
HUS B-Disease 1 0.9999545812606812
) O 0 0.03185718134045601
. O 0 0.02398347668349743

Two O 0 0.007719515822827816
of O 0 0.004096828866750002
the O 0 0.0067366440780460835
children O 0 0.02076098695397377
exhibited O 0 0.05958827584981918
a O 0 0.03316655382514
homozygous O 1 0.9994409680366516
deficiency O 1 0.9999818801879883
characterized O 1 0.6444748640060425
by O 0 0.006800004746764898
the O 0 0.004971562884747982
absence O 0 0.012629835866391659
of O 0 0.0034691866021603346
the O 0 0.00589666748419404
150 O 0 0.019426651298999786
- O 0 0.042345594614744186
kD O 0 0.47106847167015076
form O 0 0.012410535477101803
of O 0 0.006618043873459101
Factor O 0 0.3880433738231659
H O 1 0.8573893308639526
and O 0 0.003763053333386779
the O 0 0.0043000574223697186
presence O 0 0.01095197070389986
, O 0 0.003988171927630901
upon O 0 0.008869510143995285
immunoblotting O 1 0.8598299622535706
, O 0 0.0033946516923606396
of O 0 0.0034150388091802597
the O 0 0.005786396097391844
42 O 0 0.028742430731654167
- O 0 0.06007124111056328
kD O 1 0.916630208492279
Factor O 0 0.22514815628528595
H O 1 0.8992551565170288
- O 0 0.04050050303339958
like O 0 0.01578255370259285
protein O 0 0.04196365177631378
1 O 0 0.01610194519162178
( O 0 0.018709121271967888
FHL O 1 0.9870664477348328
- O 0 0.035253118723630905
1 O 0 0.014394878409802914
) O 0 0.006429373286664486
and O 0 0.00416333694010973
other O 0 0.007157228887081146
FH O 1 0.9980727434158325
- O 0 0.05573742464184761
related O 0 0.03315562382340431
protein O 0 0.07480423897504807
( O 0 0.02800087444484234
FHR O 1 0.9774159789085388
) O 0 0.019440283998847008
bands O 0 0.03857775777578354
. O 0 0.02006116509437561

Southern O 0 0.05406900867819786
blot O 1 0.5292163491249084
and O 0 0.008274747058749199
PCR O 0 0.05860114470124245
analysis O 0 0.010107227601110935
of O 0 0.00481189601123333
DNA O 0 0.018970074132084846
of O 0 0.004120483994483948
one O 0 0.008596504107117653
patient O 1 0.9924046397209167
with O 0 0.016456013545393944
homozygous O 1 0.9997617602348328
deficiency O 1 0.9999845027923584
ruled O 0 0.03165924921631813
out O 0 0.005417737178504467
the O 0 0.004150123801082373
presence O 0 0.00967247225344181
of O 0 0.0037420927546918392
a O 0 0.007535224314779043
large O 0 0.011422360315918922
deletion O 0 0.17540374398231506
of O 0 0.006503952667117119
the O 0 0.011695655062794685
FH O 1 0.9997197985649109
gene O 1 0.9342600703239441
as O 0 0.006015647202730179
the O 0 0.008270014077425003
underlying O 0 0.0855315551161766
defect O 1 0.9606180787086487
for O 0 0.008750664070248604
the O 0 0.01849685050547123
deficiency O 1 0.9999217987060547
. O 0 0.025960152968764305

The O 0 0.0092440415173769
other O 0 0.004862761124968529
four O 0 0.006736662704497576
children O 0 0.014518451876938343
presented O 0 0.010857554152607918
with O 0 0.012225995771586895
heterozygous O 1 0.9995207786560059
deficiency O 1 0.9999843835830688
and O 0 0.0070289308205246925
exhibited O 0 0.024264447391033173
a O 0 0.013704526238143444
normal O 0 0.039136409759521484
immunoblotting O 1 0.7554401159286499
pattern O 0 0.029737452045083046
of O 0 0.005789205431938171
proteins O 0 0.01537508238106966
of O 0 0.004438014701008797
the O 0 0.012028615921735764
FH O 1 0.9995130300521851
family O 0 0.04777545481920242
. O 0 0.022024627774953842

Factor B-Disease 1 0.9546152353286743
H I-Disease 1 0.9984201192855835
deficiency I-Disease 1 0.9998742341995239
is O 0 0.008289935998618603
the O 0 0.00548852002248168
only O 0 0.008740987628698349
complement B-Disease 1 0.9169161319732666
deficiency I-Disease 1 0.9999856948852539
associated O 0 0.03925178945064545
with O 0 0.019700217992067337
HUS B-Disease 1 0.9995489716529846
. O 0 0.033301882445812225

These O 0 0.01085269171744585
observations O 0 0.018845221027731895
suggest O 0 0.014786518178880215
a O 0 0.008588554337620735
role O 0 0.013646291568875313
for O 0 0.01022876612842083
FH O 1 0.999377965927124
and O 0 0.012459442019462585
/ O 0 0.47965848445892334
or O 0 0.026817338541150093
FH O 1 0.9987533092498779
receptors O 0 0.2000272423028946
in O 0 0.008046003058552742
the O 0 0.014205520041286945
pathogenesis O 1 0.9969214797019958
of O 0 0.028592661023139954
idiopathic O 1 0.9999856948852539
HUS B-Disease 1 0.9999154806137085
. O 0 0.02213507704436779
. O 0 0.02180807664990425

Further O 0 0.012948282063007355
evidence O 0 0.006866895593702793
for O 0 0.003488605609163642
a O 0 0.0061003887094557285
major O 0 0.012971192598342896
ancient O 0 0.02160526253283024
mutation O 1 0.9996739625930786
underlying O 1 0.9984531402587891
myotonic B-Disease 1 0.9999969005584717
dystrophy I-Disease 1 0.9999955892562866
from O 0 0.03059706836938858
linkage O 1 0.9714639782905579
disequilibrium O 1 0.9792831540107727
studies O 0 0.018147960305213928
in O 0 0.005771292839199305
the O 0 0.007004787214100361
Japanese O 0 0.01901194266974926
population O 0 0.02696872316300869
. O 0 0.01871693693101406

The O 0 0.09078548848628998
myotonic B-Disease 1 0.999984622001648
dystrophy I-Disease 1 0.9999978542327881
( O 1 0.8971632122993469
DM B-Disease 1 0.9999319314956665
) O 0 0.032679248601198196
mutation O 1 0.9960418939590454
is O 0 0.008765202015638351
an O 0 0.009282385930418968
unstable O 1 0.8664936423301697
( O 0 0.01950005441904068
CTG O 1 0.9682431817054749
) O 0 0.014057605527341366
n O 0 0.030298987403512
repeat O 0 0.03447059541940689
, O 0 0.0037509596440941095
present O 0 0.0043905870988965034
at O 0 0.00409872829914093
a O 0 0.00547316949814558
copy O 0 0.010629167780280113
number O 0 0.004044041968882084
of O 0 0.003957124426960945
5 O 0 0.012666720896959305
- O 0 0.025318345054984093
37 O 0 0.020786400884389877
repeats O 0 0.032302115112543106
on O 0 0.00698666088283062
normal O 0 0.030125096440315247
chromosomes O 0 0.05689471960067749
but O 0 0.007324321195483208
amplified O 0 0.031861163675785065
to O 0 0.005390855949372053
50 O 0 0.013950932770967484
- O 0 0.03067735955119133
3000 O 0 0.053667157888412476
copies O 0 0.020204652100801468
on O 0 0.015502680093050003
DM B-Disease 1 0.9992904663085938
chromosomes O 0 0.3837364912033081
. O 0 0.03119729645550251

Previous O 0 0.027237435802817345
findings O 0 0.022336320951581
in O 0 0.009966009296476841
Caucasian O 0 0.4971681535243988
populations O 0 0.0341174341738224
of O 0 0.007982607930898666
a O 0 0.03051738627254963
DM B-Disease 1 0.9999021291732788
founder O 1 0.8221732378005981
chromosome O 1 0.9973115921020508
raise O 0 0.019965628162026405
a O 0 0.008351883850991726
question O 0 0.008132501505315304
about O 0 0.00536691676825285
the O 0 0.005418682470917702
molecular O 0 0.02182428538799286
events O 0 0.007709860801696777
involved O 0 0.00852192472666502
in O 0 0.004367196001112461
the O 0 0.007097966969013214
expansion O 0 0.03737928345799446
mutation O 1 0.9908730983734131
. O 0 0.025740869343280792

To O 0 0.010849851183593273
investigate O 0 0.023632632568478584
whether O 0 0.009718631394207478
a O 0 0.014515415765345097
founder O 0 0.047433581203222275
chromosome O 1 0.9515080451965332
for O 0 0.00773177295923233
the O 0 0.018063724040985107
DM B-Disease 1 0.999955415725708
mutation O 1 0.9990257024765015
exists O 0 0.016917577013373375
in O 0 0.003940796945244074
the O 0 0.0042191846296191216
Japanese O 0 0.010868304409086704
population O 0 0.011595050804316998
, O 0 0.003941007889807224
we O 0 0.005350079387426376
genotyped O 1 0.762755274772644
families O 0 0.017557643353939056
using O 0 0.01743449456989765
polymorphic O 1 0.9818269610404968
markers O 0 0.03510589897632599
near O 0 0.012727536261081696
the O 0 0.008115645498037338
( O 0 0.016394201666116714
CTG O 1 0.9652839303016663
) O 0 0.014842306263744831
n O 0 0.02916770987212658
repeat O 0 0.03926943242549896
region O 0 0.01815025508403778
and O 0 0.006476353853940964
constructed O 0 0.020767079666256905
haplotypes O 1 0.9675293564796448
. O 0 0.025716286152601242

Six O 0 0.019130531698465347
different O 0 0.011542253196239471
haplotypes O 1 0.6138843894004822
were O 0 0.0049332077614963055
found O 0 0.010394948534667492
and O 0 0.011294162832200527
DM B-Disease 1 0.9999337196350098
alleles O 1 0.9977746605873108
were O 0 0.007488377392292023
always O 0 0.018656395375728607
haplotype O 1 0.9833182096481323
A O 0 0.02376811020076275
. O 0 0.021132763475179672

To O 0 0.01117253489792347
find O 0 0.011202365159988403
an O 0 0.004569238517433405
origin O 0 0.008925165049731731
of O 0 0.0035656974650919437
the O 0 0.005724066402763128
( O 0 0.014958294108510017
CTG O 1 0.9650028944015503
) O 0 0.015904055908322334
n O 0 0.04157304763793945
repeat O 1 0.5455518960952759
mutation O 1 0.9932379722595215
and O 0 0.0035771706607192755
to O 0 0.003155567217618227
investigate O 0 0.011083072982728481
the O 0 0.004429761320352554
mechanism O 0 0.01167929545044899
of O 0 0.00347408140078187
the O 0 0.005644064862281084
expansion O 0 0.021066511049866676
mutation O 1 0.9942407608032227
in O 0 0.004292664583772421
the O 0 0.003885131562128663
Japanese O 0 0.010176485404372215
population O 0 0.010534660890698433
we O 0 0.0031017912551760674
have O 0 0.004233476240187883
studied O 0 0.010952715761959553
90 O 0 0.01989750564098358
Japanese O 0 0.03665080666542053
DM B-Disease 1 0.9995150566101074
families O 0 0.027097640559077263
comprising O 0 0.02233731374144554
190 O 0 0.04039395600557327
affected O 0 0.037915490567684174
and O 0 0.0064618089236319065
130 O 0 0.03176706284284592
unaffected O 1 0.6814394593238831
members O 0 0.016640208661556244
. O 0 0.018746614456176758

The O 0 0.012792830355465412
results O 0 0.014920500107109547
suggest O 0 0.01123278122395277
that O 0 0.003038903931155801
a O 0 0.005471245851367712
few O 0 0.005880243144929409
common O 0 0.01352554839104414
ancestral O 1 0.6475982069969177
mutations O 1 0.9985068440437317
in O 0 0.005671055521816015
both O 0 0.00645474111661315
Caucasian O 1 0.8822479844093323
and O 0 0.005186240654438734
Japanese O 0 0.01351218856871128
populations O 0 0.0358685739338398
have O 0 0.0044752066023647785
originated O 0 0.011278082616627216
by O 0 0.004120403900742531
expansion O 0 0.009235106408596039
of O 0 0.003610394662246108
an O 0 0.0061673810705542564
ancestral O 0 0.044082801789045334
n O 0 0.0410190187394619
= O 0 0.03973668813705444
5 O 0 0.015203863382339478
repeat O 0 0.03157494217157364
to O 0 0.008086119778454304
n O 0 0.037781722843647
= O 0 0.043497078120708466
19 O 0 0.02238498255610466
- O 0 0.03338433802127838
37 O 0 0.032930828630924225
copies O 0 0.02903071790933609
. O 0 0.02488020993769169

These O 0 0.008782540448009968
data O 0 0.011333098635077477
support O 0 0.013472603633999825
multistep O 0 0.13778086006641388
models O 0 0.01748240739107132
of O 0 0.008311414159834385
triplet O 1 0.9914498925209045
repeat O 0 0.09046008437871933
expansion O 0 0.01494541484862566
that O 0 0.004352156538516283
have O 0 0.0035505127161741257
been O 0 0.0044179316610097885
proposed O 0 0.008281292393803596
for O 0 0.005325454752892256
both O 0 0.011865698732435703
DM B-Disease 1 0.9997726082801819
and O 0 0.01665535382926464
Friedreichs B-Disease 1 0.9986780285835266
ataxia I-Disease 1 0.9998118281364441
. O 0 0.01775028556585312
. O 0 0.020250171422958374

The O 0 0.01628699339926243
molecular O 0 0.03680601343512535
basis O 0 0.01189947035163641
of O 0 0.016560839489102364
C6 B-Disease 1 0.9999315738677979
deficiency I-Disease 1 0.999982476234436
in O 0 0.0074448902159929276
the O 0 0.006100039463490248
western O 0 0.013921589590609074
Cape O 0 0.09578388184309006
, O 0 0.00727597763761878
South O 0 0.013894385658204556
Africa O 0 0.028706036508083344
. O 0 0.020811399444937706

Deficiency B-Disease 1 0.9995798468589783
of I-Disease 0 0.00722144590690732
the I-Disease 0 0.006244874093681574
sixth I-Disease 0 0.01783813163638115
component I-Disease 0 0.01915024034678936
of I-Disease 0 0.005779727827757597
human I-Disease 0 0.01840553618967533
complement I-Disease 0 0.033655546605587006
( O 0 0.020130999386310577
C6 O 1 0.9972419738769531
) O 0 0.00874525960534811
has O 0 0.005560712423175573
been O 0 0.004846591502428055
reported O 0 0.008685423992574215
in O 0 0.0025381562300026417
a O 0 0.004599252715706825
number O 0 0.003110863734036684
of O 0 0.0026925229467451572
families O 0 0.007354969624429941
from O 0 0.004399421624839306
the O 0 0.004832848906517029
western O 0 0.012053982354700565
Cape O 0 0.03759850561618805
, O 0 0.006851388607174158
South O 0 0.013534109108150005
Africa O 0 0.02861177735030651
. O 0 0.022220248356461525

Meningococcal B-Disease 1 0.9999878406524658
disease I-Disease 1 0.9999946355819702
is O 0 0.02137071266770363
endemic O 1 0.956670343875885
in O 0 0.005337070673704147
the O 0 0.005394953303039074
Cape O 0 0.025333411991596222
and O 0 0.003218181664124131
almost O 0 0.005716500338166952
all O 0 0.0037446506321430206
pedigrees O 0 0.05529850348830223
of O 0 0.008466728962957859
total O 0 0.054342903196811676
C6 B-Disease 1 0.9999659061431885
deficiency I-Disease 1 0.9999949932098389
( O 0 0.041521571576595306
C6Q0 O 1 0.9930416345596313
) O 0 0.010698823258280754
have O 0 0.0049399277195334435
been O 0 0.007803012616932392
ascertained O 0 0.08679894357919693
because O 0 0.012749342247843742
of O 0 0.014003969728946686
recurrent O 1 0.9999159574508667
disease O 1 0.9999866485595703
. O 0 0.03501679003238678

We O 0 0.010348808951675892
have O 0 0.008051457814872265
sequenced O 0 0.04416300356388092
the O 0 0.005978592671453953
expressed O 0 0.01238409336656332
exons O 0 0.04412810131907463
of O 0 0.005376386921852827
the O 0 0.011996511369943619
C6 O 1 0.9975188970565796
gene O 1 0.5833933353424072
from O 0 0.008370500057935715
selected O 0 0.00812876783311367
cases O 0 0.009795035235583782
and O 0 0.002482688520103693
have O 0 0.0028094076551496983
found O 0 0.005248604342341423
three O 0 0.005026612896472216
molecular O 0 0.04849633947014809
defects O 1 0.9976682066917419
leading O 0 0.011722962372004986
to O 0 0.0064307008869946
total O 0 0.024555910378694534
deficiency O 1 0.9999905824661255
879delG O 1 0.9948554039001465
, O 0 0.005356003064662218
which O 0 0.00399457523599267
is O 0 0.003942737355828285
the O 0 0.004255108535289764
common O 0 0.01804550550878048
defect O 1 0.9842457175254822
in O 0 0.004075305536389351
the O 0 0.004596938844770193
Cape O 0 0.057178135961294174
and O 0 0.0047384146600961685
hitherto O 0 0.39363282918930054
unreported O 0 0.2475263774394989
, O 0 0.004296245519071817
and O 0 0.004311008378863335
1195delC O 1 0.9732968211174011
and O 0 0.006033702287822962
1936delG O 1 0.9806625247001648
, O 0 0.003301778808236122
which O 0 0.0029372689314186573
have O 0 0.003017424140125513
been O 0 0.004113617818802595
previously O 0 0.006712464150041342
reported O 0 0.013313103467226028
in O 0 0.0064580077305436134
African O 0 0.02586982771754265
- O 0 0.043765995651483536
Americans O 0 0.033311877399683
. O 0 0.02006205916404724

We O 0 0.010394630953669548
also O 0 0.006008862052112818
show O 0 0.009438835084438324
that O 0 0.0034930792171508074
the O 0 0.006471370346844196
879delG O 1 0.9616693258285522
and O 0 0.010924979113042355
1195delC O 1 0.9983749389648438
defects O 1 0.9992485642433167
are O 0 0.005112811923027039
associated O 0 0.012114009819924831
with O 0 0.0077505772933363914
characteristic O 1 0.9490967988967896
C6 O 1 0.9997625946998596
/ O 1 0.9925895929336548
C7 O 1 0.9981746673583984
region O 0 0.04244305565953255
DNA O 0 0.2190558910369873
marker O 1 0.6167529225349426
haplotypes O 1 0.9749420285224915
, O 0 0.007739430293440819
although O 0 0.008457447402179241
small O 0 0.009772282093763351
variations O 0 0.01780904270708561
were O 0 0.005532899871468544
observed O 0 0.025295481085777283
. O 0 0.01502576656639576

The O 0 0.02933461219072342
1936delG O 1 0.9928216338157654
defect O 1 0.9853795170783997
was O 0 0.012193639762699604
observed O 0 0.0162680484354496
only O 0 0.003952766768634319
once O 0 0.005950612016022205
in O 0 0.0030873222276568413
the O 0 0.004125264938920736
Cape O 0 0.041311174631118774
, O 0 0.0032539309468120337
but O 0 0.0031884112395346165
its O 0 0.004820984322577715
associated O 0 0.01812129281461239
haplotype O 1 0.9951789379119873
could O 0 0.00855947658419609
be O 0 0.007249923888593912
deduced O 0 0.04418974742293358
. O 0 0.020643867552280426

The O 0 0.00931790191680193
data O 0 0.00858188234269619
from O 0 0.005847753491252661
the O 0 0.0068257516250014305
haplotypes O 1 0.9612347483634949
indicate O 0 0.013612841255962849
that O 0 0.0027239187620580196
these O 0 0.0026640212163329124
three O 0 0.005911057814955711
molecular O 0 0.04058016091585159
defects O 1 0.9905844330787659
account O 0 0.007553397212177515
for O 0 0.0033853964414447546
the O 0 0.006490575149655342
defects O 1 0.9968430995941162
in O 0 0.0032312420662492514
all O 0 0.0025890010874718428
the O 0 0.005016547627747059
38 O 0 0.026104988530278206
unrelated O 0 0.451576828956604
C6Q0 O 1 0.9964507818222046
individuals O 0 0.012842227704823017
we O 0 0.00404296675696969
have O 0 0.0034358403645455837
studied O 0 0.0076596299186348915
from O 0 0.006632640026509762
the O 0 0.008510795421898365
Cape O 0 0.06271474063396454
. O 0 0.020947327837347984

We O 0 0.00868169590830803
have O 0 0.004565847106277943
also O 0 0.004355747252702713
observed O 0 0.01275671273469925
the O 0 0.008533169515430927
879delG O 1 0.991840124130249
defect O 1 0.9159460663795471
in O 0 0.005472839809954166
two O 0 0.00792575441300869
Dutch O 1 0.5021443963050842
C6 B-Disease 1 0.9999402761459351
- I-Disease 1 0.9800646901130676
deficient I-Disease 1 0.999239444732666
kindreds O 1 0.9932491779327393
, O 0 0.006574493832886219
but O 0 0.005341112148016691
the O 0 0.008260578848421574
879delG O 1 0.9947329759597778
defect O 1 0.9817025661468506
in O 0 0.006344137247651815
the O 0 0.007406241726130247
Cape O 0 0.3973780572414398
probably O 0 0.0141581567004323
did O 0 0.005290223751217127
not O 0 0.0027944855391979218
come O 0 0.0042725526727736
from O 0 0.0040192739106714725
The O 0 0.004902519751340151
Netherlands O 0 0.017718473449349403
. O 0 0.009981987997889519
. O 0 0.01616288535296917

Complement B-Disease 1 0.9552557468414307
C7 I-Disease 1 0.9998807907104492
deficiency I-Disease 1 0.9999794960021973
: O 0 0.012754684314131737
seven O 0 0.009586685337126255
further O 0 0.01397672388702631
molecular O 0 0.14801038801670074
defects O 1 0.9864429235458374
and O 0 0.004437936469912529
their O 0 0.008175752125680447
associated O 0 0.026385752484202385
marker O 0 0.40588706731796265
haplotypes O 1 0.9837886095046997
. O 0 0.02880694903433323

Seven O 0 0.018258903175592422
further O 0 0.013193896040320396
molecular O 0 0.034568753093481064
bases O 0 0.01924607716500759
of O 0 0.018007302656769753
C7 B-Disease 1 0.9999436140060425
deficiency I-Disease 1 0.9999850988388062
are O 0 0.012117234990000725
described O 0 0.02891974337399006
. O 0 0.02096431888639927

All O 0 0.0067141298204660416
these O 0 0.005019528325647116
new O 0 0.008847597055137157
molecular O 0 0.07388093322515488
defects O 1 0.995184600353241
involve O 0 0.02195148915052414
single O 0 0.018302643671631813
- O 0 0.03575226292014122
nucleotide O 0 0.05042224004864693
events O 0 0.010463820770382881
, O 0 0.005305864382535219
deletions O 0 0.06897751986980438
and O 0 0.0032147266902029514
substitutions O 0 0.012020708061754704
, O 0 0.0024433715734630823
some O 0 0.0020837855990976095
of O 0 0.002657931763678789
which O 0 0.005098911002278328
alter O 0 0.07145879417657852
splice O 0 0.32009100914001465
sites O 0 0.008056269958615303
, O 0 0.00351329380646348
and O 0 0.0041929734870791435
others O 0 0.015193847939372063
codons O 0 0.10963702201843262
. O 0 0.020325658842921257

They O 0 0.007767559960484505
are O 0 0.0042506251484155655
distributed O 0 0.010387486778199673
along O 0 0.008852406404912472
the O 0 0.013297772966325283
C7 O 1 0.9989997744560242
gene O 1 0.829900860786438
, O 0 0.006154986098408699
but O 0 0.004667920060455799
predominantly O 0 0.013023626990616322
towards O 0 0.008774454705417156
the O 0 0.0061339689418673515
3 O 0 0.014609579928219318
end O 0 0.018689095973968506
. O 0 0.01963954046368599

All O 0 0.007832936011254787
were O 0 0.004653740208595991
found O 0 0.008623852394521236
in O 0 0.006288763135671616
compound O 0 0.033101409673690796
heterozygous O 1 0.9657555818557739
individuals O 0 0.02530078776180744
. O 0 0.021211639046669006

The O 0 0.04958633705973625
C6 O 1 0.9973747730255127
/ O 1 0.9839120507240295
C7 O 1 0.9986035227775574
marker O 1 0.89739990234375
haplotypes O 1 0.988284707069397
associated O 0 0.026578158140182495
with O 0 0.009348498657345772
most O 0 0.01895757019519806
C7 B-Disease 1 0.9996063113212585
defects I-Disease 1 0.9983123540878296
are O 0 0.008001843467354774
tabulated O 0 0.025990759953856468
. O 0 0.011409051716327667
. O 0 0.01869726926088333

A O 0 0.04270077869296074
genome O 0 0.18679724633693695
- O 0 0.03806100785732269
wide O 0 0.021301427856087685
search O 0 0.018003270030021667
for O 0 0.012205797247588634
chromosomal O 1 0.9984402060508728
loci O 1 0.9966885447502136
linked O 0 0.16297271847724915
to O 0 0.013960028998553753
mental O 1 0.9981176853179932
health O 1 0.9872987866401672
wellness O 1 0.9238971471786499
in O 0 0.007552707567811012
relatives O 0 0.020093604922294617
at O 0 0.008068239316344261
high O 0 0.016156941652297974
risk O 1 0.9819090366363525
for O 0 0.03561645746231079
bipolar B-Disease 1 0.9999988079071045
affective I-Disease 1 0.9999853372573853
disorder I-Disease 1 0.9999935626983643
among O 0 0.013164142146706581
the O 0 0.006940310820937157
Old O 0 0.017441390082240105
Order O 0 0.0167840588837862
Amish O 0 0.08406835049390793
. O 0 0.02353711798787117

Bipolar B-Disease 1 0.9999915361404419
affective I-Disease 1 0.9999222755432129
disorder I-Disease 1 0.9999963045120239
( O 1 0.8513246774673462
BPAD B-Disease 1 0.9999240636825562
; O 1 0.653830885887146
manic B-Disease 1 0.9999861717224121
- I-Disease 1 0.9991735816001892
depressive I-Disease 1 0.9999973773956299
illness I-Disease 1 0.9999825954437256
) O 0 0.013272812590003014
is O 0 0.007894380949437618
characterized O 0 0.165336474776268
by O 0 0.006329707335680723
episodes O 0 0.020453253760933876
of O 0 0.008666234090924263
mania B-Disease 1 0.999640941619873
and O 0 0.009877617470920086
/ O 1 0.585861325263977
or O 0 0.02257244661450386
hypomania B-Disease 1 0.9996776580810547
interspersed O 0 0.05189630761742592
with O 0 0.01017955131828785
periods O 0 0.029712682589888573
of O 0 0.016689123585820198
depression B-Disease 1 0.9992678761482239
. O 0 0.02646913006901741

Compelling O 0 0.030956918373703957
evidence O 0 0.013631031848490238
supports O 0 0.016570549458265305
a O 0 0.01048486027866602
significant O 0 0.014695815742015839
genetic O 0 0.12466474622488022
component O 0 0.01869489625096321
in O 0 0.004198412876576185
the O 0 0.007172493264079094
susceptibility O 1 0.9947254061698914
to O 0 0.008758844807744026
develop O 0 0.06636685132980347
BPAD B-Disease 1 0.997886598110199
. O 0 0.029131634160876274

To O 0 0.009880327619612217
date O 0 0.010904122143983841
, O 0 0.004605547990649939
however O 0 0.0049614873714745045
, O 0 0.004483874421566725
linkage O 0 0.030672453343868256
studies O 0 0.008878662250936031
have O 0 0.0030598973389714956
attempted O 0 0.008554033935070038
only O 0 0.0033256630413234234
to O 0 0.004632100462913513
identify O 0 0.03128865361213684
chromosomal O 1 0.999572217464447
loci O 1 0.9949427247047424
that O 0 0.0074917906895279884
cause O 0 0.45924583077430725
or O 0 0.00780700845643878
increase O 0 0.011347438208758831
the O 0 0.006713659502565861
risk O 0 0.2094428539276123
of O 0 0.0072537753731012344
developing O 0 0.07044185698032379
BPAD B-Disease 1 0.9960743188858032
. O 0 0.029276596382260323

To O 0 0.008213849738240242
determine O 0 0.010343956761062145
whether O 0 0.00547400489449501
there O 0 0.0034211233723908663
could O 0 0.005615162197500467
be O 0 0.005195604637265205
protective O 1 0.8982049226760864
alleles O 1 0.9900623559951782
that O 0 0.005884571000933647
prevent O 0 0.04060302674770355
or O 0 0.006525367498397827
reduce O 0 0.016303488984704018
the O 0 0.006779629737138748
risk O 1 0.6000708937644958
of O 0 0.006387918256223202
developing O 0 0.13931414484977722
BPAD B-Disease 1 0.9990270137786865
, O 0 0.005853877868503332
similar O 0 0.006664664950221777
to O 0 0.0024933847598731518
what O 0 0.0037453670520335436
is O 0 0.00451819458976388
observed O 0 0.009607773274183273
in O 0 0.004178379196673632
other O 0 0.006916842423379421
genetic B-Disease 1 0.9998613595962524
disorders I-Disease 1 0.9999935626983643
, O 0 0.005687519442290068
we O 0 0.004315859638154507
used O 0 0.009565888904035091
mental O 1 0.9980922341346741
health O 1 0.9621578454971313
wellness O 1 0.967937707901001
( O 0 0.009848419576883316
absence O 0 0.014062211848795414
of O 0 0.005125975701957941
any O 0 0.016105029731988907
psychiatric B-Disease 1 0.9999767541885376
disorder I-Disease 1 0.9999940395355225
) O 0 0.008570525795221329
as O 0 0.004780804272741079
the O 0 0.00772251607850194
phenotype O 1 0.9982568621635437
in O 0 0.005437260959297419
our O 0 0.010276596993207932
genome O 0 0.29755258560180664
- O 0 0.041167210787534714
wide O 0 0.031240100041031837
linkage O 0 0.11738540977239609
scan O 0 0.13308624923229218
of O 0 0.005854982417076826
several O 0 0.005968600045889616
large O 0 0.013961149379611015
multigeneration O 1 0.9283406734466553
Old O 0 0.0208441112190485
Order O 0 0.016573652625083923
Amish O 0 0.1410578191280365
pedigrees O 1 0.7055071592330933
exhibiting O 0 0.08161897957324982
an O 0 0.009436286054551601
extremely O 0 0.027608027681708336
high O 0 0.02358994446694851
incidence O 1 0.9959509372711182
of O 0 0.015496378764510155
BPAD B-Disease 1 0.998799204826355
. O 0 0.029230758547782898

We O 0 0.007796322461217642
have O 0 0.0049973600544035435
found O 0 0.005906984675675631
strong O 0 0.006531348451972008
evidence O 0 0.004916992504149675
for O 0 0.0037464082706719637
a O 0 0.010700711980462074
locus O 1 0.978442907333374
on O 0 0.015319354832172394
chromosome O 1 0.9978274703025818
4p O 1 0.9913529753684998
at O 0 0.019705425947904587
D4S2949 O 1 0.7861451506614685
( O 0 0.018028398975729942
maximum O 0 0.030068259686231613
GENEHUNTER O 1 0.9693139791488647
- O 0 0.04417373239994049
PLUS O 0 0.045803867280483246
nonparametric O 0 0.11692655086517334
linkage O 0 0.07552750408649445
score O 0 0.02354331873357296
= O 0 0.04127005487680435
4 O 0 0.014387981034815311
. O 0 0.006571016274392605
05 O 0 0.0727330893278122
, O 0 0.010757587850093842
P O 0 0.3086143136024475
= O 0 0.038226041942834854
5 O 0 0.011209381744265556
. O 0 0.005428111646324396
22 O 0 0.0136595843359828
x O 0 0.028855059295892715
10 O 0 0.009188317693769932
( O 0 0.010420333594083786
- O 0 0.021593984216451645
4 O 0 0.014226249419152737
) O 0 0.010402344167232513
; O 0 0.01222501415759325
SIBPAL O 1 0.9836475253105164
Pempirical O 1 0.8037042021751404
value O 0 0.0302455835044384
< O 0 0.33297112584114075
3 O 0 0.017229830846190453
x O 0 0.03144858404994011
10 O 0 0.010448812507092953
( O 0 0.011714198626577854
- O 0 0.022836510092020035
5 O 0 0.013313034549355507
) O 0 0.0068939458578825
) O 0 0.004823798779398203
and O 0 0.0035848882980644703
suggestive O 0 0.029495416209101677
evidence O 0 0.006269815843552351
for O 0 0.004552658647298813
a O 0 0.01355042215436697
locus O 1 0.9450179934501648
on O 0 0.020315414294600487
chromosome O 1 0.9987499713897705
4q O 1 0.9928483963012695
at O 0 0.020228344947099686
D4S397 O 1 0.6758955717086792
( O 0 0.01788991130888462
maximum O 0 0.031017282977700233
GENEHUNTER O 1 0.9799981713294983
- O 0 0.04682710021734238
PLUS O 0 0.041625071316957474
nonparametric O 0 0.1505754590034485
linkage O 0 0.07333197444677353
score O 0 0.022622108459472656
= O 0 0.03643708676099777
3 O 0 0.01132205594331026
. O 0 0.004434471949934959
29 O 0 0.013142479583621025
, O 0 0.007936728186905384
P O 0 0.08927297592163086
= O 0 0.03497018292546272
2 O 0 0.009588337503373623
. O 0 0.005137946456670761
57 O 0 0.02037929929792881
x O 0 0.02882622741162777
10 O 0 0.009803959168493748
( O 0 0.010381619445979595
- O 0 0.020917650312185287
3 O 0 0.013086633756756783
) O 0 0.009969130158424377
; O 0 0.01246710680425167
SIBPAL O 1 0.980811595916748
Pempirical O 1 0.8753092288970947
value O 0 0.024218572303652763
< O 1 0.5016323924064636
1 O 0 0.01795748621225357
x O 0 0.03472251072525978
10 O 0 0.01093916967511177
( O 0 0.011086166836321354
- O 0 0.021778136491775513
3 O 0 0.011537179350852966
) O 0 0.005887199193239212
) O 0 0.004112723283469677
that O 0 0.002480794209986925
are O 0 0.003257350530475378
linked O 0 0.029974620789289474
to O 0 0.00948264915496111
mental O 1 0.9993653893470764
health O 1 0.9804379940032959
wellness O 1 0.9945002794265747
. O 0 0.02440267987549305

These O 0 0.008505735546350479
findings O 0 0.01402244158089161
are O 0 0.002857598941773176
consistent O 0 0.007783223409205675
with O 0 0.002396949799731374
the O 0 0.003977712709456682
hypothesis O 0 0.01970856264233589
that O 0 0.0038411642890423536
certain O 0 0.010012785904109478
alleles O 1 0.9924037456512451
could O 0 0.008878360502421856
prevent O 0 0.03026195988059044
or O 0 0.007561201695352793
modify O 0 0.02420317940413952
the O 0 0.006618755869567394
clinical O 1 0.9719009399414062
manifestations O 1 0.9260013103485107
of O 0 0.007502800785005093
BPAD B-Disease 1 0.99947589635849
and O 0 0.0049644773826003075
perhaps O 0 0.014260160736739635
other O 0 0.006324793677777052
related O 0 0.36777201294898987
affective B-Disease 1 0.9998874664306641
disorders I-Disease 1 0.999961256980896
. O 0 0.03480116277933121

Segregation O 1 0.7017313838005066
distortion O 1 0.5652053952217102
in O 0 0.0589425154030323
myotonic B-Disease 1 0.9999570846557617
dystrophy I-Disease 1 0.9999856948852539
. O 0 0.05203726142644882

Myotonic B-Disease 1 0.9999767541885376
dystrophy I-Disease 1 0.9999966621398926
( O 1 0.5927491784095764
DM B-Disease 1 0.9999421834945679
) O 0 0.0138394171372056
is O 0 0.008497162722051144
an O 0 0.013831544667482376
autosomal B-Disease 1 0.9999945163726807
dominant I-Disease 1 0.9997768998146057
disease I-Disease 1 0.9999979734420776
which O 0 0.0058922297321259975
, O 0 0.003347795456647873
in O 0 0.003566746599972248
the O 0 0.005298667121678591
typical O 0 0.03173824027180672
pedigree O 0 0.43303370475769043
, O 0 0.004598960280418396
shows O 0 0.007298534270375967
a O 0 0.006174460984766483
three O 0 0.005960932932794094
generation O 0 0.03398637846112251
anticipation O 0 0.057217810302972794
cascade O 0 0.1551697701215744
. O 0 0.0270436592400074

This O 0 0.012196159921586514
results O 0 0.019736463204026222
in O 0 0.015616649761795998
infertility B-Disease 1 0.9999587535858154
and O 1 0.7776169180870056
congenital B-Disease 1 0.9999998807907104
myotonic I-Disease 1 0.9999992847442627
dystrophy I-Disease 1 0.9999996423721313
( O 1 0.5085275173187256
CDM B-Disease 1 0.9962245225906372
) O 0 0.009180985391139984
with O 0 0.004193403292447329
the O 0 0.00581668596714735
disappearance O 0 0.08727297931909561
of O 0 0.012409377843141556
DM B-Disease 1 0.9995306730270386
in O 0 0.012150844559073448
that O 0 0.012294230051338673
pedigree O 0 0.49833640456199646
. O 0 0.027466336265206337

The O 0 0.011601670645177364
concept O 0 0.014975011348724365
of O 0 0.007479310035705566
segregation O 0 0.26138320565223694
distortion O 0 0.310456782579422
, O 0 0.004437384661287069
where O 0 0.004341781605035067
there O 0 0.0032947028521448374
is O 0 0.005485511384904385
preferential O 0 0.029735732823610306
transmission O 0 0.032251015305519104
of O 0 0.003306301310658455
the O 0 0.005740057211369276
larger O 0 0.01885814219713211
allele O 1 0.9552704095840454
at O 0 0.011660328134894371
the O 0 0.015646381303668022
DM B-Disease 1 0.9999200105667114
locus O 1 0.9963889122009277
, O 0 0.006570891477167606
has O 0 0.005649408791214228
been O 0 0.0043930974788963795
put O 0 0.0062091234140098095
forward O 0 0.006720843259245157
to O 0 0.0037255208007991314
explain O 0 0.014020781964063644
partially O 0 0.022746412083506584
the O 0 0.006907160859555006
maintenance O 0 0.022093139588832855
of O 0 0.009629604406654835
DM B-Disease 1 0.9996047616004944
in O 0 0.008108777925372124
the O 0 0.008002983406186104
population O 0 0.02288021147251129
. O 0 0.01768122985959053

In O 0 0.010248443111777306
a O 0 0.010450489819049835
survey O 0 0.017515365034341812
of O 0 0.01031499169766903
DM B-Disease 1 0.9997500777244568
in O 0 0.007911194115877151
Northern O 0 0.01540692150592804
Ireland O 0 0.01767997071146965
, O 0 0.007422914728522301
59 O 0 0.029962657019495964
pedigrees O 0 0.25395309925079346
were O 0 0.010124369524419308
ascertained O 0 0.10694976150989532
. O 0 0.02489539235830307

Sibships O 1 0.8576356172561646
where O 0 0.009728704579174519
the O 0 0.004686206113547087
status O 0 0.007167124189436436
of O 0 0.0022526991087943316
all O 0 0.0019128122366964817
the O 0 0.002676216186955571
members O 0 0.004186243284493685
had O 0 0.004594901110976934
been O 0 0.00417874613776803
identified O 0 0.008635551668703556
were O 0 0.00281814974732697
examined O 0 0.01343116071075201
to O 0 0.002946770517155528
determine O 0 0.005360384471714497
the O 0 0.003892167005687952
transmission O 0 0.021461112424731255
of O 0 0.0036741008516401052
the O 0 0.00898945052176714
DM B-Disease 1 0.9998548030853271
expansion O 0 0.024215122684836388
from O 0 0.009498500265181065
affected O 0 0.06719707697629929
parents O 0 0.01510593481361866
to O 0 0.005093024577945471
their O 0 0.010313637554645538
offspring O 1 0.5759041905403137
. O 0 0.02136627584695816

Where O 0 0.014322892762720585
the O 0 0.011011800728738308
transmitting O 0 0.14419029653072357
parent O 1 0.6357210874557495
was O 0 0.012895029969513416
male O 0 0.03686498478055
, O 0 0.009154299274086952
58 O 0 0.03830137476325035
. O 0 0.020278776064515114

3 O 0 0.021305378526449203
% O 0 0.00958781223744154
of O 0 0.003409311408177018
the O 0 0.005674013867974281
offspring O 0 0.497769832611084
were O 0 0.004431782756000757
affected O 0 0.03582737594842911
, O 0 0.0025535307358950377
and O 0 0.0019149200525134802
in O 0 0.0022063092328608036
the O 0 0.002496863016858697
case O 0 0.0046699740923941135
of O 0 0.002786818193271756
a O 0 0.008638442493975163
female O 0 0.03750942274928093
transmitting O 0 0.3549007177352905
parent O 0 0.4216485321521759
, O 0 0.013584793545305729
68 O 0 0.04221690073609352
. O 0 0.022848689928650856

7 O 0 0.033228494226932526
% O 0 0.016208726912736893
were O 0 0.008065049536526203
affected O 0 0.05601521208882332
. O 0 0.022035026922822

Studies O 0 0.02860795520246029
on O 0 0.013384466990828514
meiotic O 1 0.9674867987632751
drive O 0 0.03668888658285141
in O 0 0.015797514468431473
DM B-Disease 1 0.9997546076774597
have O 0 0.0080863106995821
shown O 0 0.012307154946029186
increased O 0 0.016444573178887367
transmission O 0 0.0315512977540493
of O 0 0.003931538667529821
the O 0 0.006369196344166994
larger O 0 0.021682536229491234
allele O 1 0.8246402740478516
at O 0 0.011106212623417377
the O 0 0.016171850264072418
DM B-Disease 1 0.9992840886116028
locus O 1 0.9584960341453552
in O 0 0.013089497573673725
non O 0 0.04822290316224098
- O 1 0.9575923681259155
DM O 1 0.9997559189796448
heterozygotes O 1 0.9947974681854248
for O 0 0.023031985387206078
CTGn O 1 0.9583480358123779
. O 0 0.034026436507701874

This O 0 0.009510884992778301
study O 0 0.011747113429009914
provides O 0 0.009580614976584911
further O 0 0.006404655519872904
evidence O 0 0.0052637699991464615
that O 0 0.0039109354838728905
the O 0 0.010819331742823124
DM B-Disease 1 0.9997223019599915
expansion O 0 0.029379842802882195
tends O 0 0.03026345744729042
to O 0 0.0053064641542732716
be O 0 0.008740081451833248
transmitted O 1 0.7736549973487854
preferentially O 0 0.2927790582180023
. O 0 0.02741299942135811

Diagnosis O 1 0.9970210194587708
of O 0 0.04289921000599861
hemochromatosis B-Disease 1 0.9997627139091492
. O 0 0.047931309789419174

If O 0 0.03876975551247597
untreated O 1 0.9994168281555176
, O 0 0.025889946147799492
hemochromatosis B-Disease 1 0.999994158744812
can O 0 0.07283243536949158
cause O 1 0.9992615580558777
serious O 1 0.999146580696106
illness O 1 0.9999445676803589
and O 0 0.00567288463935256
early B-Disease 0 0.013090101070702076
death I-Disease 0 0.21852868795394897
, O 0 0.003968794830143452
but O 0 0.004290912300348282
the O 0 0.008533995598554611
disease O 1 0.999974250793457
is O 0 0.006927177309989929
still O 0 0.008529535494744778
substantially O 0 0.0418689027428627
under O 0 0.018539495766162872
- O 1 0.9892416596412659
diagnosed O 1 0.9999746084213257
. O 0 0.03139762952923775

The O 0 0.012680659070611
cornerstone O 0 0.03411053493618965
of O 0 0.007595872972160578
screening O 0 0.03437182307243347
and O 0 0.00471732160076499
case O 0 0.011984596028923988
detection O 0 0.027071073651313782
is O 0 0.00463217543438077
the O 0 0.0051900180988013744
measurement O 0 0.01758798584342003
of O 0 0.0101635055616498
serum O 1 0.98894202709198
transferrin O 1 0.9759001135826111
saturation O 0 0.1359788030385971
and O 0 0.0067065744660794735
the O 0 0.011331336572766304
serum O 1 0.9028288125991821
ferritin O 1 0.8722438216209412
level O 0 0.025293854996562004
. O 0 0.021797873079776764

Once O 0 0.029270069673657417
the O 0 0.015949249267578125
diagnosis O 1 0.999471127986908
is O 0 0.010671584866940975
suspected O 0 0.044580258429050446
, O 0 0.0074041918851435184
physicians O 0 0.2087804079055786
must O 0 0.008898699656128883
use O 0 0.014828290790319443
serum O 1 0.9315344095230103
ferritin O 1 0.9747011065483093
levels O 0 0.029021449387073517
and O 0 0.01103541161864996
hepatic O 1 0.9999091625213623
iron O 0 0.15072467923164368
stores O 0 0.024634389206767082
on O 0 0.017551524564623833
liver O 1 0.9999908208847046
biopsy O 1 0.9997321963310242
specimens O 0 0.0905686467885971
to O 0 0.007119325455278158
assess O 0 0.1553838700056076
patients O 1 0.986076831817627
for O 0 0.004082337021827698
the O 0 0.005537225399166346
presence O 0 0.0150308134034276
of O 0 0.009132401086390018
iron B-Disease 0 0.4769814610481262
overload I-Disease 1 0.9914363026618958
. O 0 0.025878068059682846

Liver O 1 0.9999831914901733
biopsy O 1 0.999618411064148
is O 0 0.009024347178637981
also O 0 0.0035278492141515017
used O 0 0.0028519765473902225
to O 0 0.0024751918390393257
establish O 0 0.007501621730625629
the O 0 0.004099736455827951
presence O 0 0.01232885755598545
or O 0 0.006811417639255524
absence O 0 0.01964934729039669
of O 0 0.009018834680318832
cirrhosis B-Disease 1 0.9999537467956543
, O 0 0.005848817992955446
which O 0 0.00480340700596571
can O 0 0.009041134268045425
affect O 0 0.40707382559776306
prognosis O 1 0.9997269511222839
and O 0 0.007970745675265789
management O 0 0.03165658190846443
. O 0 0.021148068830370903

A O 0 0.03538980334997177
DNA O 0 0.049330614507198334
- O 0 0.026239261031150818
based O 0 0.009070534259080887
test O 0 0.011712510138750076
for O 0 0.0048045814037323
the O 0 0.010278090834617615
HFE O 1 0.9996256828308105
gene O 1 0.9166683554649353
is O 0 0.006866323295980692
commercially O 0 0.01260289829224348
available O 0 0.004359187558293343
, O 0 0.002646710490807891
but O 0 0.001950649544596672
its O 0 0.002490486716851592
place O 0 0.0028513313736766577
in O 0 0.002964005107060075
the O 0 0.006716006435453892
diagnosis O 1 0.9997703433036804
of O 0 0.012459020130336285
hemochromatosis B-Disease 1 0.9999940395355225
is O 0 0.010679400525987148
still O 0 0.009638585150241852
being O 0 0.010577064007520676
evaluated O 0 0.047068845480680466
. O 0 0.01968492940068245

Currently O 0 0.014367006719112396
, O 0 0.00541347824037075
the O 0 0.004490703344345093
most O 0 0.004664671141654253
useful O 0 0.007208125665783882
role O 0 0.006464649923145771
for O 0 0.002730649895966053
this O 0 0.0031571518629789352
test O 0 0.007434749510139227
is O 0 0.0030970352236181498
in O 0 0.00306012574583292
the O 0 0.004511942621320486
detection O 0 0.025494851171970367
of O 0 0.008925426751375198
hemochromatosis B-Disease 1 0.9999706745147705
in O 0 0.005104950163513422
the O 0 0.004550066310912371
family O 0 0.009247132577002048
members O 0 0.005112710874527693
of O 0 0.005862997844815254
patients O 1 0.9992121458053589
with O 0 0.004614688456058502
a O 0 0.007700979243963957
proven O 0 0.019774727523326874
case O 0 0.008882717229425907
of O 0 0.006393134593963623
the O 0 0.01729229837656021
disease O 1 0.9999364614486694
. O 0 0.02479221671819687

It O 0 0.007830820046365261
is O 0 0.006477587390691042
crucial O 0 0.015793725848197937
to O 0 0.014844905585050583
diagnose O 1 0.9999741315841675
hemochromatosis B-Disease 1 0.9999943971633911
before O 1 0.7464029788970947
hepatic B-Disease 1 0.9999988079071045
cirrhosis I-Disease 1 0.999997615814209
develops O 1 0.9990839958190918
because O 0 0.43364378809928894
phlebotomy O 1 0.9999197721481323
therapy O 1 0.9998223185539246
can O 0 0.05516074225306511
avert O 1 0.9995961785316467
serious O 1 0.9999090433120728
chronic O 1 0.9999997615814209
disease O 1 0.9999986886978149
and O 0 0.0062015475705266
can O 0 0.005718690808862448
even O 0 0.005157959181815386
lead O 0 0.008886050432920456
to O 0 0.004663973115384579
normal O 0 0.02337261103093624
life O 0 0.018213637173175812
expectancy O 0 0.49012303352355957
. O 0 0.014050157740712166
. O 0 0.019956305623054504

Prevalence O 1 0.9093397259712219
of O 0 0.01435081660747528
the O 0 0.019887760281562805
I1307K O 1 0.9902845025062561
APC B-Disease 1 0.9972051978111267
gene O 1 0.9862192273139954
variant O 1 0.7635077238082886
in O 0 0.0064459918066859245
Israeli O 0 0.010920174419879913
Jews O 0 0.00807996466755867
of O 0 0.0041178627870976925
differing O 0 0.012369970791041851
ethnic O 0 0.0115710673853755
origin O 0 0.012508491985499859
and O 0 0.006041248328983784
risk O 1 0.994231641292572
for O 0 0.19923855364322662
colorectal B-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999932050704956
. O 0 0.041136354207992554

BACKGROUND O 0 0.05795717611908913
& O 0 0.03612030670046806
AIMS O 0 0.033614106476306915
Israeli O 0 0.015889469534158707
Jews O 0 0.010192560032010078
of O 0 0.0039774393662810326
European O 0 0.01019259449094534
birth O 0 0.31240126490592957
, O 0 0.005070521496236324
i O 0 0.007023391779512167
. O 0 0.0049728089943528175
e O 0 0.020137540996074677
. O 0 0.004738359246402979
, O 0 0.004717845004051924
Ashkenazim O 1 0.8061255812644958
, O 0 0.004262696951627731
have O 0 0.003959945403039455
the O 0 0.007363106589764357
highest O 1 0.9765304923057556
colorectal B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999996423721313
incidence O 1 0.9992743134498596
of O 0 0.005284410901367664
any O 0 0.006214471068233252
Israeli O 0 0.013657092116773129
ethnic O 0 0.01757028140127659
group O 0 0.019414685666561127
. O 0 0.019812030717730522

The O 0 0.032066576182842255
I1307K O 1 0.988218367099762
APC B-Disease 1 0.9955863952636719
gene O 1 0.9853361248970032
variant O 1 0.9486559629440308
was O 0 0.01020301878452301
found O 0 0.00919831357896328
in O 0 0.006616454571485519
6 O 0 0.018457982689142227
. O 0 0.015752071514725685

1 O 0 0.020384088158607483
% O 0 0.009434712119400501
of O 0 0.004640358965843916
American O 0 0.009140774607658386
Jews O 0 0.00893185380846262
, O 0 0.0038105458952486515
28 O 0 0.009098504669964314
% O 0 0.006153280846774578
of O 0 0.004883577115833759
their O 0 0.02820172905921936
familial O 1 0.9999985694885254
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999992847442627
cases O 1 0.8271702527999878
, O 0 0.004766251891851425
but O 0 0.0033187884837388992
not O 0 0.002562065841630101
in O 0 0.004665195941925049
non O 0 0.01790706254541874
- O 0 0.03455201908946037
Jews O 0 0.025227751582860947
. O 0 0.02258388325572014

We O 0 0.015550295822322369
assessed O 0 0.032522786408662796
the O 0 0.014803784899413586
I1307K O 1 0.9920071363449097
prevalence O 1 0.9958859086036682
in O 0 0.006733383983373642
Israeli O 0 0.013239020481705666
Jews O 0 0.008276672102510929
of O 0 0.0038358347956091166
differing O 0 0.011974703520536423
ethnic O 0 0.011762329377233982
origin O 0 0.012468886561691761
and O 0 0.006786572281271219
risk O 1 0.9985981583595276
for O 0 0.3391598165035248
colorectal B-Disease 1 0.9999997615814209
cancer I-Disease 1 0.999995231628418
. O 0 0.033679988235235214

METHODS O 0 0.03607402369379997
DNA O 0 0.04421497881412506
samples O 0 0.02247481793165207
from O 0 0.0075257946737110615
500 O 0 0.019343221560120583
unrelated O 0 0.025388961657881737
Jews O 0 0.00956077128648758
of O 0 0.004089283291250467
European O 0 0.008272258564829826
or O 0 0.006750319618731737
non O 0 0.013138187117874622
- O 0 0.014928885735571384
European O 0 0.00793741550296545
origin O 0 0.008017479442059994
, O 0 0.003142737317830324
with O 0 0.0032072572503238916
or O 0 0.0044245533645153046
without O 0 0.005174881312996149
a O 0 0.006290843244642019
personal O 0 0.010085982270538807
and O 0 0.005526816472411156
/ O 0 0.06660011410713196
or O 0 0.007884222082793713
family O 0 0.012289048172533512
history O 0 0.00901772640645504
of O 0 0.008888636715710163
neoplasia B-Disease 1 0.9997079968452454
, O 0 0.0052492935210466385
were O 0 0.0035152225755155087
examined O 0 0.016027290374040604
for O 0 0.00426824064925313
the O 0 0.008188080973923206
I1307K O 1 0.9532995223999023
variant O 1 0.5018163323402405
by O 0 0.007499329280108213
the O 0 0.011808272451162338
allele O 1 0.9795240759849548
- O 0 0.04647698998451233
specific O 0 0.02812032401561737
oligonucleotide O 0 0.4964258074760437
( O 0 0.02763449400663376
ASO O 1 0.7430534362792969
) O 0 0.01816727966070175
method O 0 0.027850555256009102
. O 0 0.02084747701883316

RESULTS O 0 0.03250575810670853
In O 0 0.007898304611444473
persons O 0 0.015032276511192322
at O 0 0.009308786131441593
average O 0 0.02747988887131214
risk O 1 0.988652765750885
for O 0 0.19469690322875977
colorectal B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999979734420776
, O 0 0.015218955464661121
I1307K O 1 0.9935745596885681
was O 0 0.0077427770011126995
found O 0 0.007619086187332869
in O 0 0.005301128141582012
5 O 0 0.01624171994626522
. O 0 0.01628102734684944

0 O 0 0.048265114426612854
% O 0 0.014365891925990582
of O 0 0.005157033912837505
120 O 0 0.013326733373105526
European O 0 0.010135700926184654
and O 0 0.005807655863463879
1 O 0 0.017276214435696602
. O 0 0.01735176146030426

6 O 0 0.029696235433220863
% O 0 0.011992720887064934
of O 0 0.006565250921994448
188 O 0 0.033553387969732285
non O 0 0.021239547058939934
- O 0 0.023484626784920692
European O 0 0.012076138518750668
Jews O 0 0.016546230763196945
( O 0 0.019591161981225014
P O 1 0.6184549331665039
= O 0 0.05412513017654419
0 O 0 0.0276842899620533
. O 0 0.00966231431812048
08 O 0 0.05674941837787628
) O 0 0.016250742599368095
. O 0 0.019106149673461914

It O 0 0.01325216330587864
occurred O 0 0.02941390685737133
in O 0 0.008707251399755478
15 O 0 0.020850442349910736
. O 0 0.020276110619306564

4 O 0 0.028015675023198128
% O 0 0.01210811734199524
of O 0 0.006007814314216375
52 O 0 0.024454403668642044
Ashkenazi O 1 0.8444406390190125
Israelis O 0 0.04099214822053909
with O 0 0.02063465304672718
familial O 1 0.9999890327453613
cancer B-Disease 1 0.9999943971633911
( O 0 0.038236893713474274
P O 1 0.9746143221855164
= O 0 0.0784916952252388
0 O 0 0.02965616062283516
. O 0 0.009250197559595108
02 O 1 0.7153690457344055
) O 0 0.006970126181840897
and O 0 0.0028267723973840475
was O 0 0.005017582792788744
not O 0 0.003938806708902121
detected O 0 0.026869110763072968
in O 0 0.004808454308658838
51 O 0 0.0192912258207798
non O 0 0.018185747787356377
- O 0 0.02171710506081581
European O 0 0.01182000245898962
Jews O 0 0.012848074547946453
at O 0 0.012705374509096146
increased O 1 0.6442389488220215
cancer B-Disease 1 0.999984860420227
risk O 1 0.9897364377975464
. O 0 0.027161944657564163

Colorectal B-Disease 1 0.9999887943267822
neoplasia I-Disease 1 0.9998819828033447
occurred O 0 0.1180235967040062
personally O 0 0.028879541903734207
or O 0 0.006034880876541138
in O 0 0.003379910020157695
the O 0 0.003815465373918414
families O 0 0.0068972441367805
of O 0 0.0033523233141750097
13 O 0 0.007809739094227552
of O 0 0.005379761103540659
20 O 0 0.01776673085987568
Ashkenazi O 1 0.9779274463653564
I1307K O 1 0.9964163303375244
carriers O 0 0.40817388892173767
, O 0 0.005442528519779444
8 O 0 0.0074442001059651375
of O 0 0.0030150869861245155
whom O 0 0.00869758427143097
also O 0 0.002971454756334424
had O 0 0.004244649782776833
a O 0 0.0059006717056035995
personal O 0 0.010538702830672264
or O 0 0.007107163779437542
family O 0 0.01591324433684349
history O 0 0.012511072680354118
of O 0 0.015452072024345398
noncolonic O 1 0.9974385499954224
neoplasia B-Disease 1 0.9989039897918701
. O 0 0.035226479172706604

CONCLUSIONS O 0 0.04420053958892822
The O 0 0.024616625159978867
I1307K O 1 0.9912059903144836
APC O 1 0.9956094622612
variant O 1 0.9817195534706116
may O 0 0.014107231982052326
represent O 0 0.010889711789786816
a O 0 0.019666923210024834
susceptibility O 1 0.9989326596260071
gene O 1 0.9836806058883667
for O 0 0.015208468772470951
colorectal B-Disease 1 0.9999898672103882
, I-Disease 0 0.006885456386953592
or I-Disease 0 0.006635420955717564
other I-Disease 0 0.004934005904942751
, I-Disease 0 0.009017504751682281
cancers I-Disease 1 0.9998844861984253
in O 0 0.008596504107117653
Ashkenazi O 1 0.9214551448822021
Jews O 0 0.010945145040750504
, O 0 0.0035756018478423357
and O 0 0.003907741978764534
partially O 0 0.032915856689214706
explains O 0 0.020638074725866318
the O 0 0.007657489273697138
higher O 0 0.02168928273022175
incidence O 1 0.998538613319397
of O 0 0.06896057724952698
colorectal B-Disease 1 0.9999996423721313
cancer I-Disease 1 0.9999878406524658
in O 0 0.011449874378740788
European O 0 0.01783057488501072
Israelis O 0 0.042419590055942535
. O 0 0.02327260747551918

Systematic O 0 0.05762225762009621
analysis O 0 0.024244222790002823
of O 0 0.014392201788723469
coproporphyrinogen O 1 0.9952743053436279
oxidase O 1 0.9953978657722473
gene O 1 0.9908246397972107
defects O 1 0.9961728453636169
in O 0 0.01642446406185627
hereditary B-Disease 1 0.9995953440666199
coproporphyria I-Disease 1 0.9967064261436462
and O 0 0.016549132764339447
mutation O 1 0.9982921481132507
update O 0 0.08472367376089096
. O 0 0.024181704968214035

Hereditary B-Disease 1 0.9991200566291809
coproporphyria I-Disease 1 0.9929696917533875
( O 0 0.032508280128240585
HC B-Disease 1 0.8883541822433472
) O 0 0.011824075132608414
is O 0 0.00799134373664856
an O 0 0.016242215409874916
acute O 1 0.9999915361404419
hepatic B-Disease 1 0.9999971389770508
porphyria I-Disease 1 0.9999929666519165
with O 0 0.17423616349697113
autosomal O 1 0.9999752044677734
dominant O 1 0.9887324571609497
inheritance O 1 0.9954805374145508
caused O 1 0.9597343802452087
by O 0 0.014400388114154339
deficient B-Disease 1 0.9691565036773682
activity I-Disease 0 0.02145456336438656
of I-Disease 0 0.01023789867758751
coproporphyrinogen I-Disease 1 0.9930279850959778
III I-Disease 1 0.9651205539703369
oxidase I-Disease 1 0.9850192070007324
( O 0 0.03335694596171379
CPO O 0 0.23894084990024567
) O 0 0.02086428925395012
. O 0 0.01965656690299511

Clinical O 1 0.9597052335739136
manifestations O 0 0.2793456017971039
of O 0 0.007212883792817593
the O 0 0.012518827803432941
disease O 1 0.9999833106994629
are O 0 0.007419268134981394
characterized O 1 0.9134461283683777
by O 0 0.014715700410306454
acute O 1 0.999974250793457
attacks O 0 0.43799710273742676
of O 0 0.03522767871618271
neurological B-Disease 1 0.9999974966049194
dysfunction I-Disease 1 0.9999886751174927
often O 0 0.207469180226326
precipitated O 1 0.9970501661300659
by O 0 0.012293354608118534
drugs O 0 0.12202218919992447
, O 0 0.007544980384409428
fasting O 1 0.7670981287956238
, O 0 0.01351099368184805
cyclical O 1 0.9988372921943665
hormonal O 1 0.9996532201766968
changes O 0 0.019763311371207237
, O 0 0.008511391468346119
or O 0 0.047177042812108994
infectious B-Disease 1 0.9999700784683228
diseases I-Disease 1 0.9999760389328003
. O 0 0.02753620035946369

Skin O 1 0.9999827146530151
photosensitivity O 1 0.9997515082359314
may O 0 0.021859722211956978
also O 0 0.005305062048137188
be O 0 0.004393894225358963
present O 0 0.009694714099168777
. O 0 0.015548069961369038

The O 0 0.01388727966696024
seven O 0 0.016125638037919998
exons O 0 0.06239159405231476
, O 0 0.0064215646125376225
the O 0 0.00915293674916029
exon O 1 0.9092219471931458
/ O 0 0.36840954422950745
intron O 1 0.7177892327308655
boundaries O 0 0.011746644042432308
and O 0 0.0037153454031795263
part O 0 0.005644417833536863
of O 0 0.004874446429312229
3 O 0 0.014941427856683731
noncoding O 0 0.09098125249147415
sequence O 0 0.021863894537091255
of O 0 0.004588951822370291
the O 0 0.009011081419885159
CPO O 0 0.3254036605358124
gene O 0 0.32371026277542114
were O 0 0.004300455562770367
systematically O 0 0.019713018089532852
analyzed O 0 0.015066131949424744
by O 0 0.005158526822924614
an O 0 0.0068260976113379
exon O 0 0.10955331474542618
- O 0 0.028456302359700203
by O 0 0.013121492229402065
- O 0 0.07284300029277802
exon O 1 0.770000696182251
denaturing O 1 0.9701438546180725
gradient O 1 0.7594422698020935
gel O 1 0.9622988104820251
electrophoresis O 1 0.8732411861419678
( O 0 0.026763206347823143
DGGE O 1 0.9519466161727905
) O 0 0.012390381656587124
strategy O 0 0.01689978316426277
followed O 0 0.011856305412948132
by O 0 0.005392415914684534
direct O 0 0.012896466068923473
sequencing O 0 0.030022742226719856
in O 0 0.006105305626988411
seven O 0 0.011948746629059315
unrelated O 0 0.32698604464530945
heterozygous O 1 0.9989311099052429
HC B-Disease 1 0.9992128610610962
patients O 1 0.9995342493057251
from O 0 0.011324191465973854
France O 0 0.02432827092707157
, O 0 0.006759264972060919
Holland O 0 0.04673604294657707
, O 0 0.004333891905844212
and O 0 0.004482678137719631
Czech O 0 0.022776002064347267
Republic O 0 0.022268304601311684
. O 0 0.02200843021273613

Seven O 0 0.02900071069598198
novel O 0 0.056081511080265045
mutations O 1 0.9808957576751709
and O 0 0.00490504689514637
two O 0 0.004941871389746666
new O 0 0.01016166340559721
polymorphisms O 1 0.7361979484558105
were O 0 0.011319456622004509
detected O 0 0.08106932789087296
. O 0 0.022346511483192444

Among O 0 0.018525009974837303
these O 0 0.010216742753982544
mutations O 1 0.948456346988678
two O 0 0.006200995296239853
are O 0 0.008037262596189976
missense O 1 0.9917383790016174
( O 0 0.021543093025684357
G197W O 1 0.8781265020370483
, O 0 0.010319996625185013
W427R O 1 0.9536339044570923
) O 0 0.0062777153216302395
, O 0 0.0027954450342804193
two O 0 0.002729981206357479
are O 0 0.0035596289671957493
nonsense O 0 0.12543974816799164
( O 0 0.014271644875407219
Q306X O 1 0.9916748404502869
, O 0 0.00956688728183508
Q385X O 1 0.9646610021591187
) O 0 0.00759935425594449
, O 0 0.0028386383783072233
two O 0 0.002834005979821086
are O 0 0.0033110249787569046
small O 0 0.011144643649458885
deletions O 0 0.3151912987232208
( O 0 0.017599062994122505
662de14bp O 1 0.8879414796829224
; O 0 0.018164103850722313
1168del3bp O 1 0.5468400716781616
removing O 0 0.03809286281466484
a O 0 0.016373271122574806
glycine O 0 0.05660759657621384
at O 0 0.008892822079360485
position O 0 0.011801108717918396
390 O 0 0.0301619004458189
) O 0 0.0056704748421907425
, O 0 0.0025603128597140312
and O 0 0.001915177097544074
one O 0 0.003164697205647826
is O 0 0.004622661042958498
a O 0 0.012764876708388329
splicing O 1 0.7090806365013123
mutation O 1 0.9957555532455444
( O 0 0.032704681158065796
IVS1 O 1 0.9848719239234924
- O 0 0.22600755095481873
15c O 1 0.9586934447288513
- O 0 0.18029801547527313
- O 0 0.25245651602745056
> O 1 0.9572276473045349
g O 0 0.072693832218647
) O 0 0.009643638506531715
which O 0 0.006047677248716354
creates O 0 0.02225634828209877
a O 0 0.012522906996309757
new O 0 0.015125648118555546
acceptor O 0 0.16025222837924957
splice O 0 0.34538111090660095
site O 0 0.041596345603466034
. O 0 0.029052672907710075

The O 0 0.018422212451696396
pathological O 0 0.47918573021888733
significance O 0 0.01245379913598299
of O 0 0.004339104983955622
the O 0 0.006012577563524246
point O 0 0.017624108120799065
mutations O 1 0.9992235898971558
G197W O 1 0.9903918504714966
, O 0 0.008741574361920357
W427R O 1 0.8321385979652405
, O 0 0.0037975460290908813
and O 0 0.002396291820332408
the O 0 0.003202863736078143
in O 0 0.004761455114930868
- O 0 0.025947188958525658
frame O 0 0.03498387709259987
deletion O 1 0.9762061834335327
390delGly O 1 0.840133011341095
were O 0 0.005684001371264458
assessed O 0 0.016792479902505875
by O 0 0.00427871011197567
their O 0 0.003936575725674629
respective O 0 0.010981772094964981
expression O 0 0.017975952476263046
in O 0 0.004449697211384773
a O 0 0.009320010431110859
prokaryotic O 0 0.04958059638738632
system O 0 0.013288510031998158
using O 0 0.0089831268414855
site O 0 0.014969609677791595
- O 0 0.03621384873986244
directed O 0 0.032608553767204285
mutagenesis O 0 0.3978841304779053
. O 0 0.03175106272101402

These O 0 0.02084220200777054
mutations O 1 0.9955042004585266
resulted O 0 0.025335120037198067
in O 0 0.004575301427394152
the O 0 0.0051187193021178246
absence O 0 0.016533108428120613
or O 0 0.0056636743247509
a O 0 0.009229153394699097
dramatic O 0 0.029751740396022797
decrease O 0 0.03883637115359306
of O 0 0.01196396816521883
CPO O 0 0.2970506250858307
activity O 0 0.03919641673564911
. O 0 0.023561591282486916

The O 0 0.012635027058422565
two O 0 0.010094759054481983
polymorphisms O 1 0.5041521787643433
were O 0 0.008700910955667496
localized O 0 0.488892138004303
in O 0 0.009477343410253525
noncoding O 0 0.1990647315979004
part O 0 0.006573861930519342
of O 0 0.004605642054229975
the O 0 0.00817516352981329
gene O 0 0.225066676735878
1 O 0 0.014054082334041595
) O 0 0.008567661046981812
a O 0 0.014179876074194908
C O 0 0.10518045723438263
/ O 1 0.5829097032546997
G O 0 0.3388306200504303
polymorphism O 0 0.06667622923851013
in O 0 0.006865558680146933
the O 0 0.010869771242141724
promotor O 1 0.9555111527442932
region O 0 0.023613395169377327
, O 0 0.00725187361240387
142 O 0 0.037507131695747375
bp O 0 0.043321676552295685
upstream O 0 0.024501914158463478
from O 0 0.005847747437655926
the O 0 0.007953988388180733
transcriptional O 0 0.07622502744197845
initiation O 0 0.05355248972773552
site O 0 0.019167892634868622
( O 0 0.01741786114871502
- O 0 0.14634911715984344
142C O 1 0.9922084212303162
/ O 1 0.7944854497909546
G O 0 0.2896755635738373
) O 0 0.007821105420589447
, O 0 0.0032552240882068872
and O 0 0.0030844267457723618
2 O 0 0.007433873601257801
) O 0 0.0053191534243524075
a O 0 0.007826494053006172
6 O 0 0.01805034838616848
bp O 0 0.065757617354393
deletion O 1 0.8779738545417786
polymorphism O 0 0.07102923095226288
in O 0 0.005231550429016352
the O 0 0.005952130071818829
3 O 0 0.015989508479833603
noncoding O 0 0.08301445841789246
part O 0 0.008412882685661316
of O 0 0.004657169803977013
the O 0 0.009608798660337925
CPO O 1 0.7025499939918518
gene O 1 0.7052426934242249
, O 0 0.009601010009646416
574 O 1 0.5192679166793823
bp O 0 0.04604271799325943
downstream O 0 0.023035097867250443
of O 0 0.0034589841961860657
the O 0 0.0037617343477904797
last O 0 0.006726957857608795
base O 0 0.007123822811990976
of O 0 0.003435080638155341
the O 0 0.006933074444532394
normal O 0 0.03853871673345566
termination O 1 0.7930030226707458
codon O 0 0.44271960854530334
( O 0 0.03191765025258064
+ O 0 0.321319043636322
574 O 1 0.9450139403343201
delATTCTT O 1 0.9614750146865845
) O 0 0.024802938103675842
. O 0 0.022424673661589622

Five O 0 0.04244296997785568
intragenic O 1 0.9893339276313782
dimorphisms O 1 0.9697680473327637
are O 0 0.005622520577162504
now O 0 0.00827203132212162
well O 0 0.005617270711809397
characterized O 0 0.023524656891822815
and O 0 0.0029551968909800053
the O 0 0.0038918121717870235
high O 0 0.007878618314862251
degree O 0 0.010406261309981346
of O 0 0.008140647783875465
allelic O 1 0.980482816696167
heterogeneity O 1 0.6701769232749939
in O 0 0.010157233104109764
HC B-Disease 1 0.9426454901695251
is O 0 0.006680612452328205
demonstrated O 0 0.011270801536738873
with O 0 0.0028840957675129175
seven O 0 0.004205435514450073
new O 0 0.0039772107265889645
different O 0 0.005642924923449755
mutations O 1 0.975832998752594
making O 0 0.004517476074397564
a O 0 0.005157435312867165
total O 0 0.0058862897567451
of O 0 0.004936108831316233
nineteen O 0 0.07190878689289093
CPO O 1 0.9815638065338135
gene B-Disease 1 0.9962671399116516
defects I-Disease 1 0.9981245398521423
reported O 0 0.027441203594207764
so O 0 0.009484530426561832
far O 0 0.011749427765607834
. O 0 0.008144819177687168
. O 0 0.017201809212565422

Coincidence O 0 0.04304031655192375
of O 0 0.005757210310548544
two O 0 0.00624204333871603
novel O 0 0.02811274863779545
arylsulfatase O 1 0.9230940341949463
A O 0 0.0274866484105587
alleles O 1 0.9888928532600403
and O 0 0.012889833189547062
mutation O 1 0.9991777539253235
459 O 1 0.9816601276397705
+ O 1 0.9627879858016968
1G O 1 0.9980039000511169
> O 1 0.5934029221534729
A O 0 0.009932037442922592
within O 0 0.007513162214308977
a O 0 0.008855232037603855
family O 0 0.016615960747003555
with O 0 0.012669773772358894
metachromatic B-Disease 1 0.9996980428695679
leukodystrophy I-Disease 1 0.999824583530426
: O 0 0.018845247104763985
molecular O 0 0.027922838926315308
basis O 0 0.007716496009379625
of O 0 0.009683354757726192
phenotypic O 1 0.988350510597229
heterogeneity O 1 0.8667454123497009
. O 0 0.024263782426714897

In O 0 0.010555656626820564
a O 0 0.011434675194323063
family O 0 0.012546810321509838
with O 0 0.004191373009234667
three O 0 0.005716456100344658
siblings O 0 0.1501867026090622
, O 0 0.004834027495235205
one O 0 0.00713227316737175
developed O 0 0.017239496111869812
classical O 0 0.01922615058720112
late O 0 0.05221650376915932
infantile O 1 0.9998666048049927
metachromatic B-Disease 1 0.9994171857833862
leukodystrophy I-Disease 1 0.9999362230300903
( O 0 0.08143164962530136
MLD B-Disease 1 0.9995935559272766
) O 0 0.017045142129063606
, O 0 0.008915579877793789
fatal O 1 0.9996165037155151
at O 0 0.00823625735938549
age O 0 0.015829818323254585
5 O 0 0.008635486476123333
years O 0 0.005777682177722454
, O 0 0.003947076853364706
with O 0 0.00812109000980854
deficient O 1 0.9840077757835388
arylsulfatase O 1 0.9788333773612976
A O 0 0.024215497076511383
( O 0 0.02158597856760025
ARSA O 1 0.9957887530326843
) O 0 0.01090389583259821
activity O 0 0.012134680524468422
and O 0 0.004703996703028679
increased O 0 0.025229914113879204
galactosylsulfatide O 1 0.9713699221611023
( O 0 0.03274296969175339
GS O 1 0.9947351217269897
) O 0 0.02994224987924099
excretion O 1 0.7747092843055725
. O 0 0.028743328526616096

The O 0 0.010701560415327549
two O 0 0.006651151925325394
other O 0 0.006003029644489288
siblings O 0 0.0970112681388855
, O 0 0.00819097738713026
apparently O 0 0.022974107414484024
healthy O 0 0.35756272077560425
at O 0 0.00824935082346201
12 O 0 0.011082080192863941
( O 0 0.010526458732783794
1 O 0 0.015321562997996807
/ O 0 0.04856465756893158
2 O 0 0.010468072257936
) O 0 0.005217194091528654
and O 0 0.0026862281374633312
15 O 0 0.006678796373307705
years O 0 0.005418595392256975
, O 0 0.0032078216318041086
respectively O 0 0.006605861242860556
, O 0 0.0024991349782794714
and O 0 0.0020492151379585266
their O 0 0.00350850448012352
father O 0 0.014537245966494083
, O 0 0.005768159870058298
apparently O 0 0.022858990356326103
healthy O 1 0.8368093371391296
as O 0 0.004022701643407345
well O 0 0.003959726542234421
, O 0 0.0043938676826655865
presented O 0 0.014737280085682869
ARSA O 1 0.9980114698410034
and O 0 0.011813015677034855
GS O 1 0.9792777895927429
values O 0 0.010678734630346298
within O 0 0.005810663104057312
the O 0 0.005284197628498077
range O 0 0.013037266209721565
of O 0 0.013840901665389538
MLD B-Disease 1 0.9998155236244202
patients O 1 0.9989039897918701
. O 0 0.030564723536372185

Mutation O 1 0.995364785194397
screening O 0 0.06468263268470764
and O 0 0.006877745967358351
sequence O 0 0.021564923226833344
analysis O 0 0.011996488086879253
disclosed O 0 0.01594231277704239
the O 0 0.004435020498931408
involvement O 0 0.014337372966110706
of O 0 0.0032665624748915434
three O 0 0.005261970218271017
different O 0 0.010995122604072094
ARSA O 1 0.9997643828392029
mutations O 1 0.9963488578796387
being O 0 0.006447900552302599
the O 0 0.00566322635859251
molecular O 0 0.021882792934775352
basis O 0 0.0070144482888281345
of O 0 0.009668258018791676
intrafamilial O 1 0.9902521371841431
phenotypic O 1 0.9960004687309265
heterogeneity O 1 0.9232974648475647
. O 0 0.029977137222886086

The O 0 0.018841136246919632
late O 0 0.08720947802066803
infantile O 1 0.999966025352478
patient O 1 0.9998316764831543
inherited O 1 0.9949118494987488
from O 0 0.008772625587880611
his O 0 0.008191806264221668
mother O 0 0.025561271235346794
the O 0 0.007374016102403402
frequent O 0 0.0482366643846035
0 O 0 0.03003358654677868
- O 0 0.06470737606287003
type O 0 0.4424562156200409
mutation O 1 0.9987983703613281
459 O 1 0.9909620881080627
+ O 1 0.9660811424255371
1G O 1 0.9973100423812866
> O 1 0.8563520312309265
A O 0 0.01097747404128313
, O 0 0.004027574323117733
and O 0 0.0027825424913316965
from O 0 0.004873504862189293
his O 0 0.006126098800450563
father O 0 0.01573704183101654
a O 0 0.00975838489830494
novel O 0 0.018854927271604538
, O 0 0.007028062362223864
single O 0 0.022095652297139168
basepair O 1 0.8628768920898438
microdeletion O 1 0.5554231405258179
of O 0 0.008675830438733101
guanine O 0 0.04884416610002518
at O 0 0.010184730403125286
nucleotide O 0 0.04944796487689018
7 O 0 0.014589432626962662
in O 0 0.007832013070583344
exon O 0 0.23703227937221527
1 O 0 0.02293272875249386
( O 0 0.01950717717409134
7delG O 1 0.7368850708007812
) O 0 0.020872976630926132
. O 0 0.024132542312145233

The O 0 0.012667674571275711
two O 0 0.011550216004252434
clinically O 1 0.9943968057632446
unaffected O 1 0.9773763418197632
siblings O 0 0.14471609890460968
carried O 0 0.014632496982812881
the O 0 0.012194368056952953
maternal O 1 0.9978005290031433
mutation O 1 0.9994946718215942
459 O 1 0.9831259846687317
+ O 1 0.9448090195655823
1G O 1 0.9948075413703918
> O 1 0.5517813563346863
A O 0 0.013053757138550282
and O 0 0.004019193351268768
, O 0 0.003681766102090478
on O 0 0.0038582233246415854
their O 0 0.007874672301113605
paternal O 1 0.992638111114502
allele O 1 0.9930972456932068
, O 0 0.007818381302058697
a O 0 0.012267867103219032
novel O 0 0.03205396607518196
cytosine O 0 0.07351884245872498
to O 0 0.010652335360646248
thymidine O 0 0.12070871144533157
transition O 0 0.0345442071557045
at O 0 0.01591150276362896
nucleotide O 0 0.08899367600679398
2435 O 1 0.9558314085006714
in O 0 0.01275295577943325
exon O 0 0.23484981060028076
8 O 0 0.015625743195414543
, O 0 0.005668873433023691
resulting O 0 0.020589061081409454
in O 0 0.004598471336066723
substitution O 0 0.022067006677389145
of O 0 0.008463067002594471
alanine O 0 0.3755981922149658
464 O 0 0.4730965197086334
by O 0 0.017984071746468544
valine O 1 0.9527177214622498
( O 0 0.030448254197835922
A464V O 1 0.790103018283844
) O 0 0.021651998162269592
. O 0 0.022350773215293884

The O 0 0.025604406371712685
fathers O 0 0.2708361744880676
genotype O 1 0.9775050282478333
thus O 0 0.02532258816063404
was O 0 0.02005162462592125
7delG O 1 0.9859657287597656
/ O 1 0.8731266260147095
A464V O 1 0.8646103739738464
. O 0 0.03051314689218998

Mutation O 1 0.9986257553100586
A464V O 1 0.9821316003799438
was O 0 0.010083040222525597
not O 0 0.004387863911688328
found O 0 0.007012602407485247
in O 0 0.0053120385855436325
18 O 0 0.016125235706567764
unrelated O 1 0.8485702276229858
MLD B-Disease 1 0.999927282333374
patients O 1 0.9991301894187927
and O 0 0.008353503420948982
50 O 0 0.020564334467053413
controls O 0 0.040809329599142075
. O 0 0.021756872534751892

A464V O 1 0.9176830649375916
, O 0 0.012854994274675846
although O 0 0.014155999757349491
clearly O 0 0.024226894602179527
modifying O 1 0.5099071264266968
ARSA O 1 0.9977476000785828
and O 0 0.015215305611491203
GS O 1 0.9979351758956909
levels O 0 0.02350909821689129
, O 0 0.006319218780845404
apparently O 0 0.021517129614949226
bears O 0 0.02239672653377056
little O 0 0.012486529536545277
significance O 0 0.013392433524131775
for O 0 0.006798568647354841
clinical O 1 0.5907829999923706
manifestation O 1 0.8676981329917908
of O 0 0.013081036508083344
MLD B-Disease 1 0.9995869994163513
, O 0 0.012037368491292
mimicking O 1 0.7005899548530579
the O 0 0.019029369577765465
frequent O 1 0.6249749064445496
ARSA O 1 0.9986540079116821
pseudodeficiency O 1 0.988577127456665
allele O 1 0.9870432019233704
. O 0 0.044088270515203476

Our O 0 0.01432259101420641
results O 0 0.014079337939620018
demonstrate O 0 0.009661935269832611
that O 0 0.00309485150501132
in O 0 0.004434620030224323
certain O 0 0.01075663510710001
genetic O 1 0.9244089126586914
conditions O 0 0.1642610728740692
MLD B-Disease 1 0.9998272061347961
- O 1 0.60212242603302
like O 0 0.03346816450357437
ARSA O 1 0.9993523955345154
and O 0 0.011268156580626965
GS O 1 0.9937655925750732
values O 0 0.012135457247495651
need O 0 0.00741219986230135
not O 0 0.002884016605094075
be O 0 0.003962792921811342
paralleled O 0 0.04252220690250397
by O 0 0.013163750991225243
clinical O 1 0.9994127750396729
disease O 1 0.9999916553497314
, O 0 0.004692649934440851
a O 0 0.006718115881085396
finding O 0 0.0110635906457901
with O 0 0.006638999097049236
serious O 1 0.9602481722831726
diagnostic O 1 0.9391383528709412
and O 0 0.01128612644970417
prognostic O 1 0.9978489875793457
implications O 1 0.696780264377594
. O 0 0.02455420233309269

Moreover O 0 0.04430192708969116
, O 0 0.011975763365626335
further O 0 0.025648104026913643
ARSA O 1 0.999333918094635
alleles O 1 0.9981970191001892
functionally O 1 0.7608156204223633
similar O 0 0.016049399971961975
to O 0 0.008282169699668884
A464V O 1 0.8983575701713562
might O 0 0.013077681884169579
exist O 0 0.006492475513368845
which O 0 0.0031996078323572874
, O 0 0.0023773915600031614
together O 0 0.003661154303699732
with O 0 0.00509424926713109
0 O 0 0.025959298014640808
- O 0 0.05324859544634819
type O 0 0.28443124890327454
mutations O 1 0.9966149926185608
, O 0 0.007629195228219032
may O 0 0.020052697509527206
cause O 1 0.9932876229286194
pathological O 1 0.9997009038925171
ARSA O 1 0.999717652797699
and O 0 0.015340019017457962
GS O 1 0.998295247554779
levels O 0 0.021596131846308708
, O 0 0.004776534158736467
but O 0 0.0044367192313075066
not O 0 0.006401746068149805
clinical O 1 0.9864547252655029
outbreak O 1 0.9995681643486023
of O 0 0.007720221299678087
the O 0 0.016762416809797287
disease O 1 0.9999765157699585
. O 0 0.014339962042868137
. O 0 0.016237393021583557

Human O 1 0.818031907081604
MLH1 O 1 0.9997523427009583
deficiency O 1 0.9999890327453613
predisposes O 1 0.9994853734970093
to O 0 0.03149355947971344
hematological B-Disease 1 0.9998332262039185
malignancy I-Disease 1 0.9999741315841675
and O 0 0.07316426932811737
neurofibromatosis B-Disease 1 0.9999747276306152
type I-Disease 1 0.6906406283378601
1 I-Disease 0 0.0267535001039505
. O 0 0.021459519863128662

Heterozygous O 1 0.9776715636253357
germ O 1 0.975576639175415
- O 0 0.07585489749908447
line O 0 0.03245243802666664
mutations O 1 0.9750379323959351
in O 0 0.005348392762243748
the O 0 0.007580895908176899
DNA O 0 0.14453186094760895
mismatch O 1 0.9946093559265137
repair O 1 0.9594019651412964
genes O 0 0.3802402913570404
lead O 0 0.023607976734638214
to O 0 0.015365572646260262
hereditary B-Disease 1 0.9997665286064148
nonpolyposis I-Disease 1 0.9999414682388306
colorectal I-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999943971633911
. O 0 0.04203421622514725

The O 0 0.04176781699061394
disease O 1 0.9999891519546509
susceptibility O 1 0.999565064907074
of O 0 0.0067625949159264565
individuals O 0 0.01196843758225441
who O 0 0.00807001069188118
constitutionally O 0 0.03934070095419884
lack O 0 0.013679294846951962
both O 0 0.0068899705074727535
wild O 0 0.07454516738653183
- O 0 0.1825844794511795
type O 1 0.5436756610870361
alleles O 1 0.9935271739959717
is O 0 0.013467584736645222
unknown O 0 0.03429735079407692
. O 0 0.018143078312277794

We O 0 0.009000161662697792
have O 0 0.00581964710727334
identified O 0 0.012605727650225163
three O 0 0.006204828154295683
offspring O 0 0.06826144456863403
in O 0 0.0072851236909627914
a O 0 0.02646050974726677
hereditary B-Disease 1 0.9998134970664978
nonpolyposis I-Disease 1 0.9999595880508423
colorectal I-Disease 1 0.9999997615814209
cancer I-Disease 1 0.999997615814209
family O 0 0.38325783610343933
who O 0 0.0264559518545866
developed O 1 0.8227306604385376
hematological B-Disease 1 0.9999220371246338
malignancy I-Disease 1 0.9999092817306519
at O 0 0.009844955056905746
a O 0 0.008942306973040104
very O 0 0.007252429146319628
early O 0 0.00827773753553629
age O 0 0.010678010061383247
, O 0 0.0028731971979141235
and O 0 0.0021233016159385443
at O 0 0.003268028609454632
least O 0 0.003943315707147121
two O 0 0.0016317516565322876
of O 0 0.00221953890286386
them O 0 0.0033133700489997864
displayed O 0 0.013008564710617065
signs O 0 0.028592227026820183
of O 0 0.013448799960315228
neurofibromatosis B-Disease 1 0.9999490976333618
type I-Disease 0 0.3480738699436188
1 I-Disease 0 0.026675906032323837
( O 0 0.027437563985586166
NF1 B-Disease 1 0.9912775754928589
) O 0 0.020715486258268356
. O 0 0.019273677840828896

DNA O 0 0.07491141557693481
sequence O 0 0.031633954495191574
analysis O 0 0.014495444484055042
and O 0 0.008096295408904552
allele O 1 0.9633819460868835
- O 0 0.028220681473612785
specific O 0 0.012048885226249695
amplification O 0 0.03553682938218117
in O 0 0.004617994651198387
two O 0 0.005907584447413683
siblings O 0 0.04446246102452278
revealed O 0 0.024202466011047363
a O 0 0.024872900918126106
homozygous O 1 0.9973344802856445
MLH1 O 1 0.9998350143432617
mutation O 1 0.999606192111969
( O 0 0.03357050195336342
C676T O 1 0.9921011328697205
- O 0 0.4699442684650421
- O 1 0.5216599106788635
> O 1 0.9671719074249268
Arg226Stop O 1 0.9511095285415649
) O 0 0.020327704027295113
. O 0 0.022249901667237282

Thus O 0 0.02282305620610714
, O 0 0.008507111109793186
a O 0 0.01827879250049591
homozygous O 1 0.9723845720291138
germ O 1 0.9728394746780396
- O 0 0.07645025849342346
line O 0 0.04491870105266571
MLH1 O 1 0.9992759823799133
mutation O 1 0.9989293217658997
and O 0 0.015066931024193764
consequent O 1 0.9975910186767578
mismatch O 1 0.9996685981750488
repair O 1 0.9994650483131409
deficiency O 1 0.9999847412109375
results O 0 0.023249221965670586
in O 0 0.0075484090484678745
a O 0 0.02675054781138897
mutator O 1 0.9998422861099243
phenotype O 1 0.9999568462371826
characterized O 1 0.9917678833007812
by O 0 0.08473608642816544
leukemia B-Disease 1 0.9999982118606567
and O 0 0.013350952416658401
/ O 1 0.9937736988067627
or O 0 0.20603503286838531
lymphoma B-Disease 1 0.9999982118606567
associated O 0 0.04803062602877617
with O 0 0.023177677765488625
neurofibromatosis B-Disease 1 0.9999842643737793
type I-Disease 0 0.2227391004562378
1 I-Disease 0 0.019418571144342422
. O 0 0.009132093749940395
. O 0 0.014363953843712807

Missense O 1 0.996769905090332
mutations O 1 0.9926161766052246
in O 0 0.006378987338393927
the O 0 0.004325811751186848
most O 0 0.004411623347550631
ancient O 0 0.007729790639132261
residues O 0 0.017408333718776703
of O 0 0.0049107735976576805
the O 0 0.010864892043173313
PAX6 O 1 0.9987035989761353
paired O 0 0.28986412286758423
domain O 0 0.04273974895477295
underlie O 0 0.49671614170074463
a O 0 0.012270459905266762
spectrum O 0 0.0327523797750473
of O 0 0.009441567584872246
human O 1 0.9935756325721741
congenital B-Disease 1 0.9999994039535522
eye I-Disease 1 0.9999784231185913
malformations I-Disease 1 0.9999113082885742
. O 0 0.03579457104206085

Mutations O 1 0.9651033878326416
of O 0 0.008708379231393337
the O 0 0.013136133551597595
human O 0 0.0641392171382904
PAX6 O 1 0.999273955821991
gene O 1 0.9967928528785706
underlie O 1 0.9990260601043701
aniridia B-Disease 1 0.9995936751365662
( O 1 0.5014950633049011
congenital B-Disease 1 0.9999933242797852
absence I-Disease 0 0.0300897303968668
of I-Disease 0 0.005543520208448172
the I-Disease 0 0.008703085593879223
iris I-Disease 1 0.9969289898872375
) O 0 0.007344827987253666
, O 0 0.0037664691917598248
a O 0 0.008903578855097294
rare O 0 0.28569677472114563
dominant O 1 0.9648124575614929
malformation B-Disease 1 0.999765932559967
of I-Disease 0 0.008247815072536469
the I-Disease 0 0.013070174492895603
eye I-Disease 1 0.9977136850357056
. O 0 0.024475280195474625

The O 0 0.018151050433516502
spectrum O 0 0.05252116173505783
of O 0 0.0166257806122303
PAX6 O 1 0.9997997879981995
mutations O 1 0.9994646906852722
in O 0 0.02013644576072693
aniridia B-Disease 1 0.9998396635055542
patients O 1 0.9995995163917542
is O 0 0.008852210827171803
highly O 0 0.014620339497923851
biased O 0 0.017796935513615608
, O 0 0.0033424063585698605
with O 0 0.004117170348763466
92 O 0 0.016063405200839043
% O 0 0.005848523695021868
of O 0 0.0028418460860848427
all O 0 0.0041651600040495396
reported O 0 0.02497844398021698
mutations O 1 0.9963865280151367
leading O 0 0.015459394082427025
to O 0 0.007497221231460571
premature O 1 0.8726492524147034
truncation O 0 0.1869075447320938
of O 0 0.005095619708299637
the O 0 0.0068764169700443745
protein O 0 0.03603244572877884
( O 0 0.010888488031923771
nonsense O 0 0.031471069902181625
, O 0 0.007118303794413805
splicing O 0 0.06075459346175194
, O 0 0.007531559094786644
insertions O 0 0.07796690613031387
and O 0 0.007220208644866943
deletions O 0 0.1640385240316391
) O 0 0.005873993970453739
and O 0 0.0029818136245012283
just O 0 0.005023713689297438
2 O 0 0.006673099007457495
% O 0 0.0055711716413497925
leading O 0 0.006508513819426298
to O 0 0.002820946043357253
substitution O 0 0.011317380703985691
of O 0 0.003205387620255351
one O 0 0.005816379562020302
amino O 0 0.026810456067323685
acid O 0 0.036811601370573044
by O 0 0.007727102842181921
another O 0 0.016530640423297882
( O 0 0.022110948339104652
missense O 1 0.9276637434959412
) O 0 0.020740831270813942
. O 0 0.020492108538746834

The O 0 0.013704294338822365
extraordinary O 0 0.02139357477426529
conservation O 0 0.01542101800441742
of O 0 0.006038308143615723
the O 0 0.012109828181564808
PAX6 O 1 0.9959271550178528
protein O 0 0.041294295340776443
at O 0 0.00765696307644248
the O 0 0.007895476184785366
amino O 0 0.03837539628148079
acid O 0 0.05207347869873047
level O 0 0.01393047720193863
amongst O 0 0.02033642865717411
vertebrates O 0 0.27247169613838196
predicts O 0 0.06590411067008972
that O 0 0.009680143557488918
pathological O 1 0.9995296001434326
missense O 1 0.9998237490653992
mutations O 1 0.9995667338371277
should O 0 0.005241931416094303
in O 0 0.0033550183288753033
fact O 0 0.005191446281969547
be O 0 0.0030527273193001747
common O 0 0.008688380010426044
even O 0 0.005239855498075485
though O 0 0.004948800429701805
they O 0 0.002602865919470787
are O 0 0.0027637251187115908
hardly O 0 0.016252238303422928
ever O 0 0.012478159740567207
seen O 0 0.01654956117272377
in O 0 0.014010659419000149
aniridia B-Disease 1 0.9987797141075134
patients O 1 0.9986984729766846
. O 0 0.026144761592149734

This O 0 0.013407498598098755
indicates O 0 0.021049808710813522
that O 0 0.004150906577706337
there O 0 0.003608857747167349
is O 0 0.005437271669507027
a O 0 0.01104567851871252
heavy O 0 0.04207426309585571
ascertainment O 1 0.9842431545257568
bias O 0 0.03989152982831001
in O 0 0.004988024011254311
the O 0 0.004123937338590622
selection O 0 0.010044427588582039
of O 0 0.007388112600892782
patients O 1 0.9978880286216736
for O 0 0.014191338792443275
PAX6 O 1 0.9999077320098877
mutation O 1 0.9995301961898804
analysis O 0 0.01245430950075388
and O 0 0.0028063131030648947
that O 0 0.0027380548417568207
the O 0 0.006411687005311251
missing O 0 0.14698176085948944
PAX6 O 1 0.9997209906578064
missense O 1 0.9993365406990051
mutations O 1 0.9991851449012756
frequently O 0 0.03867337107658386
may O 0 0.03181026875972748
underlie O 1 0.9930312633514404
phenotypes O 1 0.9941670894622803
distinct O 0 0.035287171602249146
from O 0 0.014948729425668716
textbook O 0 0.39152389764785767
aniridia B-Disease 1 0.9936434030532837
. O 0 0.029133304953575134

Here O 0 0.00961342453956604
we O 0 0.004749164916574955
present O 0 0.00682980939745903
four O 0 0.00852096639573574
novel O 0 0.08004153519868851
PAX6 O 1 0.9998303651809692
missense O 1 0.9995835423469543
mutations O 1 0.998291552066803
, O 0 0.005326184444129467
two O 0 0.0035965624265372753
in O 0 0.005275009665638208
association O 0 0.016784412786364555
with O 0 0.012481216341257095
atypical O 1 0.9994136095046997
phenotypes O 1 0.9997015595436096
ectopia B-Disease 1 0.9988934397697449
pupillae I-Disease 1 0.991489052772522
( O 0 0.023555047810077667
displaced B-Disease 0 0.1958109587430954
pupils I-Disease 0 0.04166901111602783
) O 0 0.01350000873208046
and O 0 0.01568501442670822
congenital B-Disease 1 0.9999979734420776
nystagmus I-Disease 1 0.9999538660049438
( O 0 0.022171882912516594
searching B-Disease 0 0.09357592463493347
gaze I-Disease 1 0.9229646921157837
) O 0 0.006479628384113312
, O 0 0.0023197918199002743
and O 0 0.0016735595418140292
two O 0 0.0020475841592997313
in O 0 0.003272097557783127
association O 0 0.00968137476593256
with O 0 0.004900259431451559
more O 0 0.010482382029294968
recognizable O 1 0.9417586922645569
aniridia B-Disease 1 0.9983540773391724
phenotypes O 1 0.9938507080078125
. O 0 0.029939785599708557

Strikingly O 0 0.056513216346502304
, O 0 0.005253201816231012
all O 0 0.003127642208710313
four O 0 0.007267241831868887
mutations O 1 0.9725120663642883
are O 0 0.003459993749856949
located O 0 0.007665432523936033
within O 0 0.00778884207829833
the O 0 0.010238053277134895
PAX6 O 1 0.99895179271698
paired O 0 0.09348804503679276
domain O 0 0.027808859944343567
and O 0 0.0065179625526070595
affect O 0 0.027190590277314186
amino O 0 0.033713165670633316
acids O 0 0.022196706384420395
which O 0 0.00391188682988286
are O 0 0.003109663026407361
highly O 0 0.011520116589963436
conserved O 0 0.015646658837795258
in O 0 0.003663657931610942
all O 0 0.004125545267015696
known O 0 0.0149544021114707
paired O 0 0.04176170378923416
domain O 0 0.04417677968740463
proteins O 0 0.050541479140520096
. O 0 0.023891912773251534

Our O 0 0.013554648496210575
results O 0 0.012172268703579903
support O 0 0.0068662129342556
the O 0 0.004798563662916422
hypothesis O 0 0.018932631239295006
that O 0 0.002692368347197771
the O 0 0.003429328789934516
under O 0 0.0055122035555541515
- O 0 0.017363406717777252
representation O 0 0.011236663907766342
of O 0 0.008702321909368038
missense O 1 0.9988124370574951
mutations O 1 0.9991818070411682
is O 0 0.010104542598128319
caused O 0 0.4788653254508972
by O 0 0.010863364674150944
ascertainment O 1 0.9970844388008118
bias O 0 0.05142781510949135
and O 0 0.004542188253253698
suggest O 0 0.010902301408350468
that O 0 0.003628762438893318
a O 0 0.007079500705003738
substantial O 0 0.01834864169359207
burden O 1 0.5647944808006287
of O 0 0.014000742696225643
PAX6 B-Disease 1 0.9997891783714294
- I-Disease 1 0.9538818001747131
related I-Disease 1 0.9158226847648621
disease I-Disease 1 0.9999865293502808
remains O 0 0.01808277517557144
to O 0 0.004833635874092579
be O 0 0.004804676864296198
uncovered O 0 0.025902755558490753
. O 0 0.009250311180949211
. O 0 0.01573488675057888

The O 0 0.021468939259648323
chromosomal O 1 0.9752331972122192
order O 0 0.009443419054150581
of O 0 0.007242617197334766
genes O 0 0.2263808250427246
controlling O 0 0.053139589726924896
the O 0 0.009174061007797718
major O 0 0.029641043394804
histocompatibility O 1 0.9991936087608337
complex O 0 0.021684588864445686
, O 0 0.009589871391654015
properdin O 1 0.981697142124176
factor O 0 0.1544324904680252
B O 0 0.107738196849823
, O 0 0.004863612353801727
and O 0 0.006176699884235859
deficiency B-Disease 1 0.9997596144676208
of I-Disease 0 0.004097599070519209
the I-Disease 0 0.0039048325270414352
second I-Disease 0 0.007914514280855656
component I-Disease 0 0.019164642319083214
of I-Disease 0 0.007391299586743116
complement I-Disease 0 0.036899030208587646
. O 0 0.018749220296740532

The O 0 0.011803310364484787
relationship O 0 0.01710306480526924
of O 0 0.004348760936409235
the O 0 0.007809117902070284
genes O 0 0.27651247382164
coding O 0 0.08142397552728653
for O 0 0.010042019188404083
HLA O 1 0.995662271976471
to O 0 0.005849189590662718
those O 0 0.006878742016851902
coding O 0 0.04480764642357826
for O 0 0.009029153734445572
properdin O 1 0.9822162389755249
Factor O 0 0.3124288022518158
B O 0 0.4319494366645813
allotypes O 1 0.7819181084632874
and O 0 0.0053637209348380566
for O 0 0.008091824129223824
deficiency B-Disease 1 0.999685525894165
of I-Disease 0 0.004855239763855934
the I-Disease 0 0.004431679844856262
second I-Disease 0 0.008264313451945782
component I-Disease 0 0.016851065680384636
of I-Disease 0 0.0062385862693190575
complement I-Disease 0 0.029161788523197174
( O 0 0.018212629482150078
C2 O 1 0.9973111152648926
) O 0 0.00783709716051817
was O 0 0.004938491154462099
studied O 0 0.006225952412933111
in O 0 0.0036612548865377903
families O 0 0.009454965591430664
of O 0 0.008145255036652088
patients O 1 0.999822199344635
with O 0 0.034312520176172256
connective O 1 0.999983549118042
tissue O 1 0.9999598264694214
disorders O 1 0.999988317489624
. O 0 0.03432922810316086

Patients O 1 0.9972922205924988
were O 0 0.005362266208976507
selected O 0 0.006764690391719341
because O 0 0.005608999170362949
they O 0 0.002875752979889512
were O 0 0.004306507296860218
heterozygous O 1 0.640407383441925
or O 0 0.016354583203792572
homozygous O 1 0.986441969871521
for O 0 0.027319150045514107
C2 B-Disease 1 0.9997637867927551
deficiency I-Disease 1 0.99997878074646
. O 0 0.03446079418063164

12 O 0 0.025107771158218384
families O 0 0.016719279810786247
with O 0 0.008241978473961353
15 O 0 0.019460555166006088
matings O 1 0.5644564032554626
informative O 0 0.04374709725379944
for O 0 0.022477667778730392
C2 B-Disease 1 0.999930739402771
deficiency I-Disease 1 0.9999910593032837
were O 0 0.009870484471321106
found O 0 0.017813879996538162
. O 0 0.015511459670960903

Of O 0 0.014034551568329334
57 O 0 0.03596300631761551
informative O 0 0.03640230372548103
meioses O 1 0.7013461589813232
, O 0 0.005298461299389601
two O 0 0.003963165916502476
crossovers O 0 0.024043133482336998
were O 0 0.0029770059045404196
noted O 0 0.007241849321871996
between O 0 0.006984014995396137
the O 0 0.018201973289251328
C2 B-Disease 1 0.9999779462814331
deficiency I-Disease 1 0.9999953508377075
gene O 1 0.9621076583862305
and O 0 0.007335183210670948
the O 0 0.013761067762970924
HLA O 1 0.9998760223388672
- O 1 0.8908507823944092
B O 1 0.9058487415313721
gene O 1 0.7344845533370972
, O 0 0.004170478321611881
with O 0 0.003988632000982761
a O 0 0.010609898716211319
recombinant O 0 0.06525014340877533
fraction O 0 0.027977867051959038
of O 0 0.009240753017365932
0 O 0 0.0313892662525177
. O 0 0.018681799992918968

035 O 1 0.9543334245681763
. O 0 0.05090989172458649

A O 0 0.04073936492204666
lod O 0 0.10534024983644485
score O 0 0.012989018112421036
of O 0 0.004562400281429291
13 O 0 0.009808785282075405
was O 0 0.005912447813898325
calculated O 0 0.011627156287431717
for O 0 0.006307702045887709
linkage O 0 0.06772277504205704
between O 0 0.027726413682103157
C2 B-Disease 1 0.9999362230300903
deficiency I-Disease 1 0.9999918937683105
and O 0 0.02580386959016323
HLA O 1 0.999868631362915
- O 0 0.31899377703666687
B O 0 0.07464232295751572
at O 0 0.008290030062198639
a O 0 0.009646194986999035
maximum O 0 0.016956256702542305
likelihood O 0 0.02347126044332981
value O 0 0.006185000762343407
of O 0 0.0041504548862576485
the O 0 0.006575023289769888
recombinant O 0 0.06715778261423111
fraction O 0 0.03181080520153046
of O 0 0.01006370596587658
0 O 0 0.036381375044584274
. O 0 0.01816777139902115

04 O 0 0.3579118549823761
. O 0 0.0505916066467762

18 O 0 0.02483096905052662
families O 0 0.015874193981289864
with O 0 0.00637656357139349
21 O 0 0.01703602820634842
informative O 0 0.03317675739526749
matings O 0 0.19212830066680908
for O 0 0.005774184595793486
both O 0 0.008378389291465282
properdin O 1 0.9786754250526428
Factor O 0 0.2948707342147827
B O 1 0.5139495730400085
allotype O 1 0.9515832662582397
and O 0 0.014684276655316353
HLA O 1 0.9994848966598511
- O 0 0.12947194278240204
B O 0 0.05806160345673561
were O 0 0.006431410554796457
found O 0 0.015781177207827568
. O 0 0.016455136239528656

Of O 0 0.016794353723526
72 O 0 0.0438515804708004
informative O 0 0.04740114510059357
meioses O 1 0.7621740698814392
, O 0 0.007005944382399321
three O 0 0.006643402390182018
recombinants O 1 0.7511245012283325
were O 0 0.0040350318886339664
found O 0 0.006779655814170837
, O 0 0.00397436274215579
giving O 0 0.01095499936491251
a O 0 0.0122483866289258
recombinant O 0 0.06588409841060638
fraction O 0 0.03192531317472458
of O 0 0.009371383115649223
0 O 0 0.03437032178044319
. O 0 0.020654598250985146

042 O 1 0.8341614603996277
. O 0 0.04272731393575668

A O 0 0.0350261926651001
lod O 0 0.09175103902816772
score O 0 0.010860176756978035
of O 0 0.004766221158206463
16 O 0 0.011669090948998928
between O 0 0.014820895157754421
HLA O 1 0.9992855191230774
- O 0 0.16294315457344055
B O 0 0.10985949635505676
and O 0 0.008397616446018219
Factor O 0 0.07881031930446625
B O 1 0.5399436950683594
allotypes O 1 0.9036089181900024
was O 0 0.008818366564810276
calculated O 0 0.013400537893176079
at O 0 0.006172819994390011
a O 0 0.007440920453518629
maximum O 0 0.015348131768405437
likelihood O 0 0.022761397063732147
value O 0 0.006344125606119633
of O 0 0.003956564702093601
the O 0 0.007402558345347643
recombinant O 0 0.06677663326263428
fraction O 0 0.03685536980628967
of O 0 0.011403530836105347
0 O 0 0.03792192041873932
. O 0 0.019885163754224777

04 O 0 0.3799353539943695
. O 0 0.04523056000471115

A O 0 0.02953902818262577
crossover O 0 0.04298347607254982
was O 0 0.007409941405057907
shown O 0 0.007678787223994732
to O 0 0.002515437314286828
have O 0 0.003308868268504739
occurred O 0 0.012264855206012726
between O 0 0.006273397710174322
genes O 0 0.06604533642530441
for O 0 0.0063800388015806675
Factor O 0 0.0821661576628685
B O 0 0.12811130285263062
and O 0 0.011936766095459461
HLA O 1 0.9995315074920654
- O 0 0.24170970916748047
D O 0 0.23063595592975616
, O 0 0.005259889177978039
in O 0 0.004938205704092979
which O 0 0.010141165927052498
HLA O 1 0.9991266131401062
- O 0 0.4340660572052002
D O 1 0.8906514048576355
segregared O 1 0.9778062701225281
with O 0 0.019560087472200394
HLA O 1 0.9995046854019165
- O 0 0.044093210250139236
A O 0 0.017966613173484802
and O 0 0.009085066616535187
B O 0 0.06709125638008118
. O 0 0.021331176161766052

These O 0 0.009456832893192768
studies O 0 0.012654567137360573
suggest O 0 0.010306271724402905
that O 0 0.002882672706618905
the O 0 0.004983019083738327
genes O 0 0.043660592287778854
for O 0 0.006608711555600166
Factor O 0 0.2659713923931122
B O 1 0.7083718776702881
and O 0 0.017894739285111427
C2 B-Disease 1 0.9999653100967407
deficiency I-Disease 1 0.9999887943267822
are O 0 0.005343189463019371
located O 0 0.006996834184974432
outside O 0 0.005099097266793251
those O 0 0.003872354980558157
for O 0 0.006487519480288029
HLA O 1 0.999446451663971
, O 0 0.004099452402442694
that O 0 0.0025391075760126114
the O 0 0.0029681690502911806
order O 0 0.004736633971333504
of O 0 0.005247277207672596
genese O 1 0.9849895238876343
is O 0 0.015637729316949844
HLA O 1 0.9991471767425537
- O 0 0.03119887039065361
A O 0 0.01594844087958336
, O 0 0.007391614373773336
- O 0 0.03827283903956413
B O 0 0.08431850373744965
, O 0 0.007857684046030045
- O 0 0.042357187718153
D O 0 0.1242251917719841
, O 0 0.008844800293445587
Factor O 0 0.06188438460230827
B O 1 0.744587242603302
allotype O 1 0.9925422668457031
, O 0 0.03826276212930679
C2 B-Disease 1 0.999970555305481
deficiency I-Disease 1 0.999988317489624
, O 0 0.005113867577165365
that O 0 0.0034574195742607117
the O 0 0.006239260546863079
genes O 0 0.35394665598869324
coding O 0 0.12191455811262131
for O 0 0.01854545809328556
C2 B-Disease 1 0.999970555305481
deficiency I-Disease 1 0.9999896287918091
and O 0 0.012368432246148586
Factor O 0 0.36275890469551086
B O 1 0.5419535636901855
allotypes O 1 0.6796858906745911
are O 0 0.005538916680961847
approximately O 0 0.010973282158374786
3 O 0 0.014956735074520111
- O 0 0.02847425453364849
- O 0 0.02997194044291973
5 O 0 0.016711974516510963
centimorgans O 0 0.13924270868301392
from O 0 0.008220762014389038
the O 0 0.010488428175449371
HLA O 1 0.9988652467727661
- O 0 0.02955315262079239
A O 0 0.01628541760146618
and O 0 0.010618561878800392
HLA O 1 0.9998354911804199
- O 1 0.5801375508308411
B O 1 0.7693249583244324
loci O 1 0.975517749786377
, O 0 0.004437804222106934
and O 0 0.0023605474270880222
that O 0 0.0023060741368681192
the O 0 0.0041675264947116375
apparent O 0 0.029566701501607895
lack O 0 0.011384870857000351
of O 0 0.004947236739099026
recombinants O 1 0.7049933075904846
between O 0 0.007043175864964724
the O 0 0.007746976800262928
Factor O 0 0.1886177957057953
B O 1 0.8645133972167969
gene O 1 0.9737875461578369
and O 0 0.02350369468331337
C2 B-Disease 1 0.9999650716781616
deficiency I-Disease 1 0.9999938011169434
gene O 1 0.9949544072151184
suggests O 0 0.024746637791395187
that O 0 0.0035903137177228928
these O 0 0.003007389372214675
two O 0 0.004111684393137693
genes O 0 0.09170389920473099
lie O 0 0.012242035940289497
in O 0 0.0038991912733763456
close O 0 0.009790798649191856
proximity O 0 0.015977201983332634
to O 0 0.0042244927026331425
one O 0 0.006850739009678364
another O 0 0.017695514485239983
. O 0 0.020854035392403603

Distribution O 0 0.029432663694024086
of O 0 0.01047069113701582
emerin O 1 0.9639773368835449
and O 0 0.00886506773531437
lamins O 1 0.9586539268493652
in O 0 0.0054289717227220535
the O 0 0.007888296619057655
heart O 1 0.9922916293144226
and O 0 0.005127848591655493
implications O 0 0.035749729722738266
for O 0 0.00956093892455101
Emery B-Disease 1 0.9966637492179871
- I-Disease 1 0.9981405735015869
Dreifuss I-Disease 1 0.999967098236084
muscular I-Disease 1 0.9999884366989136
dystrophy I-Disease 1 0.9999920129776001
. O 0 0.05048035457730293

Emerin O 1 0.792374849319458
is O 0 0.01163794007152319
a O 0 0.011528736911714077
nuclear O 0 0.016710970550775528
membrane O 0 0.04158161208033562
protein O 0 0.02981971576809883
which O 0 0.004896311089396477
is O 0 0.005532002542167902
missing O 0 0.01849486492574215
or O 0 0.011551085859537125
defective O 1 0.7921473383903503
in O 0 0.015571932308375835
Emery B-Disease 1 0.9933852553367615
- I-Disease 1 0.9946250319480896
Dreifuss I-Disease 1 0.9999619722366333
muscular I-Disease 1 0.9999921321868896
dystrophy I-Disease 1 0.9999958276748657
( O 0 0.49664831161499023
EDMD B-Disease 1 0.9989719390869141
) O 0 0.028194604441523552
. O 0 0.02063988707959652

It O 0 0.01059695240110159
is O 0 0.006406758446246386
one O 0 0.00507628358900547
member O 0 0.0053670392371714115
of O 0 0.00392351346090436
a O 0 0.009368701837956905
family O 0 0.015390243381261826
of O 0 0.008260133676230907
lamina O 1 0.9958289265632629
- O 0 0.04284566268324852
associated O 0 0.018909413367509842
proteins O 0 0.022214971482753754
which O 0 0.005739088170230389
includes O 0 0.012312366627156734
LAP1 O 1 0.9935572743415833
, O 0 0.01221785880625248
LAP2 O 1 0.9923171997070312
and O 0 0.014836226589977741
lamin O 1 0.9953358769416809
B O 1 0.9147022366523743
receptor O 1 0.9510418772697449
( O 0 0.03952181711792946
LBR O 1 0.9910374879837036
) O 0 0.02476041577756405
. O 0 0.01986447535455227

A O 0 0.023929767310619354
panel O 0 0.017667554318904877
of O 0 0.007467337884008884
16 O 0 0.027371874079108238
monoclonal O 1 0.9953508377075195
antibodies O 1 0.9945297837257385
( O 0 0.02874775603413582
mAbs O 1 0.9840131998062134
) O 0 0.009415457025170326
has O 0 0.005074135959148407
been O 0 0.004299922846257687
mapped O 0 0.013462301343679428
to O 0 0.00277972174808383
six O 0 0.0052693625912070274
specific O 0 0.005855576600879431
sites O 0 0.0071273441426455975
throughout O 0 0.008259320631623268
the O 0 0.008310066536068916
emerin O 1 0.8875826001167297
molecule O 0 0.053101032972335815
using O 0 0.019449617713689804
phage O 1 0.9822024703025818
- O 0 0.04378605633974075
displayed O 0 0.023641491308808327
peptide O 0 0.08269661664962769
libraries O 0 0.010170118883252144
and O 0 0.002844414208084345
has O 0 0.003482050495222211
been O 0 0.0034043642226606607
used O 0 0.0038567958399653435
to O 0 0.005382902920246124
localize O 1 0.812772274017334
emerin O 1 0.8696713447570801
in O 0 0.008292037062346935
human O 0 0.01861935667693615
and O 0 0.01035525742918253
rabbit O 1 0.9986361861228943
heart O 1 0.9981672763824463
. O 0 0.027859393507242203

Several O 0 0.02619795873761177
mAbs O 1 0.7966719269752502
against O 0 0.017553381621837616
different O 0 0.014045469462871552
emerin O 1 0.994877815246582
epitopes O 1 0.9810606241226196
did O 0 0.008668106980621815
not O 0 0.006085419096052647
recognize O 0 0.031183436512947083
intercalated O 1 0.523539125919342
discs O 0 0.023424459621310234
in O 0 0.004687602631747723
the O 0 0.007765766698867083
heart O 1 0.9924465417861938
, O 0 0.005505742970854044
though O 0 0.006742051802575588
they O 0 0.0042214589193463326
recognized O 0 0.019086888059973717
cardiomyocyte O 1 0.9851493835449219
nuclei O 0 0.03946675360202789
strongly O 0 0.013033781200647354
, O 0 0.003224647603929043
both O 0 0.002579193562269211
at O 0 0.0039025614969432354
the O 0 0.004733534995466471
rim O 0 0.022121857851743698
and O 0 0.004835971165448427
in O 0 0.00893879123032093
intranuclear O 1 0.9419499635696411
spots O 0 0.046944111585617065
or O 0 0.01704258657991886
channels O 0 0.03657165914773941
. O 0 0.020190704613924026

A O 0 0.08575446158647537
polyclonal O 1 0.9930451512336731
rabbit O 1 0.9943462014198303
antiserum O 1 0.982521653175354
against O 0 0.023148471489548683
emerin O 1 0.9825716018676758
did O 0 0.010284772142767906
recognize O 0 0.017068756744265556
both O 0 0.005068058613687754
nuclear O 0 0.011072296649217606
membrane O 0 0.02440270595252514
and O 0 0.006105965934693813
intercalated O 1 0.6585158109664917
discs O 0 0.025430917739868164
but O 0 0.00513676879927516
, O 0 0.004013513680547476
after O 0 0.01025761105120182
affinity O 0 0.02987237274646759
purification O 0 0.023342352360486984
against O 0 0.007166244555264711
a O 0 0.009382865391671658
pure O 0 0.0200218316167593
- O 0 0.040541891008615494
emerin O 1 0.9498319625854492
band O 0 0.015595830976963043
on O 0 0.0044100647792220116
a O 0 0.0072143287397921085
western O 0 0.013529239222407341
blot O 1 0.7425475716590881
, O 0 0.005227990914136171
it O 0 0.004325006622821093
stained O 0 0.19180002808570862
only O 0 0.004408306907862425
the O 0 0.005684022791683674
nuclear O 0 0.017095131799578667
membrane O 0 0.057662803679704666
. O 0 0.020837923511862755

These O 0 0.009740297682583332
results O 0 0.01191441435366869
would O 0 0.003696826985105872
not O 0 0.0025138920173048973
be O 0 0.002327386988326907
expected O 0 0.006011873483657837
if O 0 0.006966239307075739
immunostaining O 1 0.8017989993095398
at O 0 0.010093087330460548
intercalated O 0 0.493200421333313
discs O 0 0.021275706589221954
were O 0 0.003455969737842679
due O 0 0.006279107183218002
to O 0 0.0022674244828522205
a O 0 0.004637017380446196
product O 0 0.006244087126106024
of O 0 0.0029805959202349186
the O 0 0.007841340266168118
emerin O 1 0.9972075819969177
gene O 1 0.9254326224327087
and O 0 0.0037988468538969755
, O 0 0.003298601135611534
therefore O 0 0.0046118395403027534
, O 0 0.002872646553441882
cast O 0 0.006027471274137497
some O 0 0.003597675357013941
doubt O 0 0.009752612560987473
upon O 0 0.006510185077786446
the O 0 0.0050419229082763195
hypothesis O 0 0.037725064903497696
that O 0 0.011871985159814358
cardiac B-Disease 1 0.9999864101409912
defects I-Disease 1 0.9998218417167664
in O 0 0.011797428131103516
EDMD B-Disease 1 0.9991387128829956
are O 0 0.0054926443845033646
caused O 0 0.41421186923980713
by O 0 0.005296460352838039
absence O 0 0.015628580003976822
of O 0 0.0075632198713719845
emerin O 1 0.987006664276123
from O 0 0.016231605783104897
intercalated O 1 0.5584179162979126
discs O 0 0.06805827468633652
. O 0 0.02964750863611698

Although O 0 0.03423839434981346
emerin O 1 0.5179203152656555
was O 0 0.011199861764907837
abundant O 0 0.016097156330943108
in O 0 0.00478307856246829
the O 0 0.006462586112320423
membranes O 0 0.08724895119667053
of O 0 0.00805322639644146
cardiomyocyte O 1 0.9930899739265442
nuclei O 0 0.045645467936992645
, O 0 0.004282547160983086
it O 0 0.0029622595757246017
was O 0 0.005409167148172855
absent O 0 0.018323177471756935
from O 0 0.005680862348526716
many O 0 0.00591935683041811
non O 0 0.023634128272533417
- O 1 0.5829334259033203
myocyte O 1 0.9992663264274597
cells O 0 0.49000564217567444
in O 0 0.0076590836979448795
the O 0 0.013987268321216106
heart O 1 0.993050217628479
. O 0 0.023763839155435562

This O 0 0.01307921577244997
distribution O 0 0.01373243611305952
of O 0 0.007097416557371616
emerin O 1 0.9546294808387756
was O 0 0.006899844389408827
similar O 0 0.005448662675917149
to O 0 0.002687370404601097
that O 0 0.0032715904526412487
of O 0 0.005373021122068167
lamin O 1 0.9907009601593018
A O 0 0.011304742656648159
, O 0 0.0042198835872113705
a O 0 0.00833912193775177
candidate O 0 0.022220531478524208
gene O 0 0.4072597026824951
for O 0 0.00698863947764039
an O 0 0.012159042991697788
autosomal O 1 0.9997847676277161
form O 0 0.02010057121515274
of O 0 0.013846884481608868
EDMD B-Disease 1 0.9987521171569824
. O 0 0.02764807641506195

In O 0 0.01784648187458515
contrast O 0 0.03324488177895546
, O 0 0.017612745985388756
lamin O 1 0.9949740171432495
B1 O 1 0.9954310655593872
was O 0 0.018055589869618416
absent O 0 0.04275109991431236
from O 0 0.014173978939652443
cardiomyocyte O 1 0.9171948432922363
nuclei O 0 0.04734927415847778
, O 0 0.007206338457763195
showing O 0 0.021868892014026642
that O 0 0.011551743373274803
lamin O 1 0.9970417618751526
B1 O 1 0.9959815740585327
is O 0 0.006502479314804077
not O 0 0.0035395086742937565
essential O 0 0.007169805001467466
for O 0 0.0037065467331558466
localization O 0 0.0256558358669281
of O 0 0.005682662129402161
emerin O 1 0.7683970928192139
to O 0 0.004995953757315874
the O 0 0.00807736162096262
nuclear O 0 0.026388129219412804
lamina O 1 0.8831396698951721
. O 0 0.026279380545020103

Lamin O 1 0.9936614036560059
B1 O 1 0.9903355836868286
is O 0 0.014208071865141392
also O 0 0.007297038566321135
almost O 0 0.013866320252418518
completely O 0 0.025161419063806534
absent O 0 0.08833956718444824
from O 0 0.018705131486058235
skeletal O 1 0.9992806315422058
muscle O 1 0.9994704127311707
nuclei O 0 0.09575818479061127
. O 0 0.0280680600553751

In O 0 0.02262602001428604
EDMD B-Disease 1 0.9846044182777405
, O 0 0.006759562995284796
the O 0 0.005170105025172234
additional O 0 0.008051206357777119
absence O 0 0.020139873027801514
of O 0 0.012580601498484612
lamin O 1 0.9980748891830444
B1 O 1 0.998683750629425
from O 0 0.016897840425372124
heart O 1 0.9981849789619446
and O 0 0.013687605038285255
skeletal O 1 0.9997631907463074
muscle O 1 0.9996733665466309
nuclei O 0 0.06361429393291473
which O 0 0.006780259311199188
already O 0 0.013803184032440186
lack O 0 0.03175884857773781
emerin O 1 0.99517822265625
may O 0 0.010634665377438068
offer O 0 0.005223514046519995
an O 0 0.0033729153219610453
alternative O 0 0.010255220346152782
explanation O 0 0.009811045601963997
of O 0 0.004023133311420679
why O 0 0.008880630135536194
these O 0 0.00513433525338769
tissues O 1 0.994293749332428
are O 0 0.005039194133132696
particularly O 0 0.01710239052772522
affected O 0 0.07367856055498123
. O 0 0.009944208897650242
. O 0 0.017565663903951645

Genetic O 0 0.1651671677827835
mapping O 0 0.02740407921373844
of O 0 0.006167199928313494
the O 0 0.009870306588709354
copper B-Disease 0 0.06494574248790741
toxicosis I-Disease 1 0.998961329460144
locus O 1 0.9795246720314026
in O 0 0.013854490593075752
Bedlington O 1 0.9979066848754883
terriers O 1 0.9874781370162964
to O 0 0.011120617389678955
dog O 1 0.9965977072715759
chromosome O 1 0.998721182346344
10 O 0 0.007210975978523493
, O 0 0.002410478889942169
in O 0 0.002706129802390933
a O 0 0.006555451545864344
region O 0 0.017345421016216278
syntenic O 1 0.8326303958892822
to O 0 0.007947800680994987
human O 0 0.033039286732673645
chromosome O 1 0.9964536428451538
region O 0 0.060611601918935776
2p13 O 1 0.9884297847747803
- O 1 0.7659741044044495
p16 O 1 0.9919261336326599
. O 0 0.035233765840530396

Abnormal O 1 0.998830258846283
hepatic B-Disease 1 0.99988853931427
copper I-Disease 0 0.272765576839447
accumulation I-Disease 0 0.27379775047302246
is O 0 0.009580885991454124
recognized O 0 0.013679244555532932
as O 0 0.005608398467302322
an O 0 0.011276867240667343
inherited B-Disease 1 0.9999473094940186
disorder I-Disease 1 0.9999967813491821
in O 0 0.008703239262104034
man O 0 0.0877349004149437
, O 0 0.009540888480842113
mouse O 1 0.9925349950790405
, O 0 0.012021473608911037
rat O 1 0.9885177612304688
and O 0 0.012762815691530704
dog O 1 0.8955484628677368
. O 0 0.020841969177126884

The O 0 0.01799492910504341
major O 0 0.02617945894598961
cause O 0 0.20770591497421265
of O 0 0.01411371398717165
hepatic B-Disease 1 0.9999314546585083
copper I-Disease 0 0.13521221280097961
accumulation I-Disease 0 0.33748817443847656
in O 0 0.006769474595785141
man O 0 0.015581627376377583
is O 0 0.007772563025355339
a O 0 0.017017878592014313
dysfunctional O 1 0.9975638389587402
ATP7B O 1 0.9993246793746948
gene O 1 0.9903684854507446
, O 0 0.017332663759589195
causing O 1 0.9971455931663513
Wilson B-Disease 1 0.9965106844902039
disease I-Disease 1 0.9999829530715942
( O 0 0.1293734312057495
WD B-Disease 1 0.9985246062278748
) O 0 0.02165967784821987
. O 0 0.021380387246608734

Mutations O 1 0.9906529188156128
in O 0 0.008371438831090927
the O 0 0.011199872009456158
ATP7B O 1 0.9990113973617554
genes O 1 0.8914832472801208
have O 0 0.005067214835435152
also O 0 0.003521277802065015
been O 0 0.0048058214597404
demonstrated O 0 0.013428330421447754
in O 0 0.006600646767765284
mouse O 1 0.9686444401741028
and O 0 0.01094722654670477
rat O 1 0.9872965812683105
. O 0 0.02758246660232544

The O 0 0.03471118211746216
ATP7B O 1 0.9945631623268127
gene O 1 0.8277615308761597
has O 0 0.008323119953274727
been O 0 0.006309576332569122
excluded O 0 0.014886224642395973
in O 0 0.0038051155861467123
the O 0 0.005141759291291237
much O 0 0.014731091447174549
rarer O 1 0.978188157081604
human O 0 0.06761454045772552
copper B-Disease 1 0.8221756219863892
overload I-Disease 1 0.9995477795600891
disease O 1 0.9999840259552002
non B-Disease 0 0.10426103323698044
- I-Disease 0 0.08810492604970932
Indian I-Disease 0 0.03968317434191704
childhood I-Disease 1 0.9989782571792603
cirrhosis I-Disease 1 0.9999682903289795
, O 0 0.013847424648702145
indicating O 0 0.2715747654438019
genetic O 1 0.9820636510848999
heterogeneity O 1 0.923110842704773
. O 0 0.028899850323796272

By O 0 0.015522518195211887
investigating O 0 0.024676071479916573
the O 0 0.01346009224653244
common O 0 0.49923670291900635
autosomal O 1 0.999975323677063
recessive O 1 0.9999881982803345
copper B-Disease 1 0.9924927353858948
toxicosis I-Disease 1 0.9998724460601807
( O 0 0.15331612527370453
CT B-Disease 1 0.9986339211463928
) O 0 0.014305266551673412
in O 0 0.009635303169488907
Bedlington O 1 0.9987517595291138
terriers O 1 0.9887970685958862
, O 0 0.005971874110400677
we O 0 0.003368191886693239
have O 0 0.0037269792519509792
identified O 0 0.010376776568591595
a O 0 0.006965143606066704
new O 0 0.010059441439807415
locus O 1 0.9585517048835754
involved O 0 0.0216729324311018
in O 0 0.017684023827314377
progressive O 1 0.9996570348739624
liver B-Disease 1 0.9999985694885254
disease I-Disease 1 0.9999934434890747
. O 0 0.04206511750817299

We O 0 0.014919154345989227
examined O 0 0.035527147352695465
whether O 0 0.013654086738824844
the O 0 0.015686705708503723
WD B-Disease 1 0.999384880065918
gene O 1 0.991119921207428
ATP7B O 1 0.9958332777023315
was O 0 0.008510973304510117
also O 0 0.006444702856242657
causative O 1 0.8149829506874084
for O 0 0.008027691394090652
CT B-Disease 1 0.9970988035202026
by O 0 0.007134649902582169
investigating O 0 0.01933796890079975
the O 0 0.011420006863772869
chromosomal O 1 0.9968081116676331
co O 0 0.04631859064102173
- O 0 0.036745455116033554
localization O 0 0.04149855673313141
of O 0 0.008248227648437023
ATP7B O 1 0.9933629035949707
and O 0 0.007975286804139614
C04107 O 1 0.934198796749115
, O 0 0.0061523765325546265
using O 0 0.010231271386146545
fluorescence O 0 0.06792546808719635
in O 0 0.01136190164834261
situ O 1 0.5952290892601013
hybridization O 0 0.08039330691099167
( O 0 0.017774013802409172
FISH O 0 0.034212127327919006
) O 0 0.015165143646299839
. O 0 0.016522442921996117

C04107 O 0 0.4566178321838379
is O 0 0.014538940042257309
an O 0 0.01134540606290102
anonymous O 0 0.042730119079351425
microsatellite O 1 0.9536496996879578
marker O 0 0.06643262505531311
closely O 0 0.024468781426548958
linked O 0 0.05522388592362404
to O 0 0.015125648118555546
CT B-Disease 1 0.9832099676132202
. O 0 0.025529522448778152

However O 0 0.023755589500069618
, O 0 0.014951636083424091
BAC O 1 0.9915649890899658
clones O 1 0.9187923073768616
containing O 0 0.02968539111316204
ATP7B O 1 0.9908389449119568
and O 0 0.008701261132955551
C04107 O 1 0.8264567852020264
mapped O 0 0.025826210156083107
to O 0 0.006292528472840786
the O 0 0.01411033608019352
canine O 1 0.9994075298309326
chromosome O 1 0.9988671541213989
regions O 0 0.043172821402549744
CFA22q11 O 1 0.9796140789985657
and O 0 0.009239021688699722
CFA10q26 O 1 0.9733812212944031
, O 0 0.006373506970703602
respectively O 0 0.009618059732019901
, O 0 0.00444523012265563
demonstrating O 0 0.01669604331254959
that O 0 0.008968786336481571
WD B-Disease 1 0.9993451237678528
cannot O 0 0.012902988120913506
be O 0 0.007111435290426016
homologous O 0 0.18659944832324982
to O 0 0.015612619929015636
CT B-Disease 1 0.985603928565979
. O 0 0.02775130420923233

The O 0 0.017206285148859024
copper O 0 0.043273456394672394
transport O 0 0.02954135462641716
genes O 1 0.7603977918624878
CTR1 O 1 0.9928245544433594
and O 0 0.009285174310207367
CTR2 O 1 0.892495334148407
were O 0 0.004946931730955839
also O 0 0.004297008737921715
excluded O 0 0.014135505072772503
as O 0 0.005399824120104313
candidate O 0 0.01872006431221962
genes O 0 0.49966683983802795
for O 0 0.008654153905808926
CT B-Disease 1 0.9979669451713562
since O 0 0.009348198771476746
they O 0 0.00312261120416224
both O 0 0.004730211570858955
mapped O 0 0.02559836395084858
to O 0 0.011102871969342232
canine O 1 0.9981504082679749
chromosome O 1 0.9966447353363037
region O 0 0.0559622198343277
CFA11q22 O 1 0.9737999439239502
. O 0 0.031639281660318375

2 O 0 0.04541941359639168
- O 0 0.056581977754831314
22 O 0 0.039660509675741196
. O 0 0.025656327605247498

5 O 0 0.06083554029464722
. O 0 0.0345560722053051

A O 0 0.037350211292505264
transcribed O 0 0.055857103317976
sequence O 0 0.03110443241894245
identified O 0 0.018092164769768715
from O 0 0.006555833853781223
the O 0 0.008802979253232479
C04107 O 1 0.7998893857002258
- O 0 0.03309737518429756
containing O 0 0.022927600890398026
BAC O 1 0.9954710006713867
was O 0 0.00828581303358078
found O 0 0.006448215339332819
to O 0 0.0033717104233801365
be O 0 0.003912646789103746
homologous O 0 0.041122715920209885
to O 0 0.005242691840976477
a O 0 0.012203418649733067
gene O 0 0.28877320885658264
expressed O 0 0.014180696569383144
from O 0 0.009612706489861012
human O 0 0.048549871891736984
chromosome O 1 0.9990288019180298
2p13 O 1 0.9968060255050659
- O 1 0.5289261937141418
p16 O 1 0.990128219127655
, O 0 0.007157804910093546
a O 0 0.008899346925318241
region O 0 0.01643264852464199
devoid O 0 0.02266949787735939
of O 0 0.00495215505361557
any O 0 0.008162098936736584
positional O 0 0.06338018923997879
candidate O 0 0.040098514407873154
genes O 1 0.5247504115104675
. O 0 0.02498558722436428

Molecular O 0 0.05466727167367935
analysis O 0 0.015018140897154808
of O 0 0.005176919978111982
the O 0 0.009687300771474838
APC B-Disease 1 0.9976180195808411
gene O 1 0.8496314287185669
in O 0 0.007712181657552719
205 O 0 0.03672748804092407
families O 0 0.015375226736068726
: O 0 0.013676600530743599
extended O 0 0.03555440157651901
genotype O 1 0.9992153644561768
- O 1 0.9565789103507996
phenotype O 1 0.999681830406189
correlations O 0 0.17004898190498352
in O 0 0.012547283433377743
FAP B-Disease 1 0.9991563558578491
and O 0 0.004032944794744253
evidence O 0 0.0047110323794186115
for O 0 0.0023505722638219595
the O 0 0.003555413568392396
role O 0 0.01066901721060276
of O 0 0.008434569463133812
APC B-Disease 1 0.983304500579834
amino O 0 0.06513317674398422
acid O 0 0.2256467193365097
changes O 0 0.03009338490664959
in O 0 0.04406299442052841
colorectal B-Disease 1 0.9999995231628418
cancer I-Disease 1 0.9999985694885254
predisposition O 1 0.9998070597648621
. O 0 0.03804277256131172

BACKGROUND O 0 0.07247152179479599
/ O 0 0.07149277627468109
AIMS O 0 0.028148408979177475
The O 0 0.00736539252102375
development O 0 0.011210105381906033
of O 0 0.024463780224323273
colorectal B-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999946355819702
and O 0 0.0061701759696006775
a O 0 0.010166662745177746
variable O 0 0.030562592670321465
range O 0 0.009325115010142326
of O 0 0.006539180874824524
extracolonic O 1 0.9953798055648804
manifestations O 1 0.9947655200958252
in O 0 0.06986789405345917
familial B-Disease 1 0.9999980926513672
adenomatous I-Disease 1 0.9999997615814209
polyposis I-Disease 1 0.9999996423721313
( O 1 0.87117600440979
FAP B-Disease 1 0.9999037981033325
) O 0 0.011330674402415752
is O 0 0.0047301920130848885
the O 0 0.0032636888790875673
result O 0 0.007509009912610054
of O 0 0.0030272090807557106
the O 0 0.006287595257163048
dominant O 0 0.4021647274494171
inheritance O 1 0.9935088157653809
of O 0 0.18293260037899017
adenomatous B-Disease 1 0.9999994039535522
polyposis I-Disease 1 0.9999990463256836
coli I-Disease 1 0.9999897480010986
( O 1 0.517230212688446
APC B-Disease 1 0.997017502784729
) O 0 0.0407780222594738
gene O 1 0.9905728697776794
mutations O 1 0.9941784143447876
. O 0 0.028780462220311165

In O 0 0.008153051137924194
this O 0 0.004878280218690634
study O 0 0.008592161349952221
, O 0 0.004398861899971962
direct O 0 0.015007028356194496
mutation O 1 0.990776777267456
analysis O 0 0.010916945524513721
of O 0 0.004290330223739147
the O 0 0.009462998248636723
APC B-Disease 1 0.9979105591773987
gene O 1 0.8090355396270752
was O 0 0.00787364412099123
performed O 0 0.009777303785085678
to O 0 0.004689044784754515
determine O 0 0.02105642668902874
genotype O 1 0.9954982995986938
- O 0 0.4211423993110657
phenotype O 1 0.9976968169212341
correlations O 0 0.044837936758995056
for O 0 0.0063917627558112144
nine O 0 0.01429127436131239
extracolonic O 1 0.991713285446167
manifestations O 0 0.4404444396495819
and O 0 0.00357640883885324
to O 0 0.003539585741236806
investigate O 0 0.013174613937735558
the O 0 0.008401700295507908
incidence O 1 0.9929163455963135
of O 0 0.011619990691542625
APC B-Disease 1 0.9981694221496582
mutations O 1 0.9953973889350891
in O 0 0.011019456200301647
non O 0 0.1660575121641159
- O 1 0.9964613318443298
FAP O 1 0.9999839067459106
colorectal B-Disease 1 0.9999994039535522
cancer I-Disease 1 0.999984622001648
. O 0 0.04782608523964882

METHODS O 0 0.03169546276330948
The O 0 0.01613272726535797
APC B-Disease 1 0.9911318421363831
gene O 1 0.5418811440467834
was O 0 0.01035642996430397
analysed O 0 0.028903130441904068
in O 0 0.00808502547442913
190 O 0 0.03592554107308388
unrelated O 0 0.21391648054122925
FAP B-Disease 1 0.9987677335739136
and O 0 0.008041319437325
15 O 0 0.019848236814141273
non O 0 0.09795962274074554
- O 1 0.9962412118911743
FAP O 1 0.9999936819076538
colorectal B-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999979734420776
patients O 1 0.9996408224105835
using O 0 0.031835492700338364
denaturing O 1 0.991412878036499
gradient O 1 0.9700038433074951
gel O 1 0.9894486665725708
electrophoresis O 0 0.37213486433029175
, O 0 0.007418777793645859
the O 0 0.00779672060161829
protein O 0 0.04322117939591408
truncation O 0 0.348334938287735
test O 0 0.014759022742509842
, O 0 0.004188556224107742
and O 0 0.004580568987876177
direct O 0 0.01986299268901348
sequencing O 0 0.07091174274682999
. O 0 0.027045579627156258

RESULTS O 0 0.0760980173945427
Chain O 0 0.3083169460296631
terminating O 0 0.09065315872430801
signals O 0 0.021923711523413658
were O 0 0.003247000277042389
only O 0 0.004357842728495598
identified O 0 0.012524317018687725
in O 0 0.006402656435966492
patients O 1 0.9938609600067139
belonging O 0 0.016559040173888206
to O 0 0.0051805139519274235
the O 0 0.012042638845741749
FAP B-Disease 1 0.999774158000946
group O 0 0.02470201998949051
( O 0 0.020467713475227356
105 O 0 0.07577212899923325
patients O 1 0.9964101910591125
) O 0 0.018400290980935097
. O 0 0.019533246755599976

Amino O 0 0.09620904922485352
acid O 0 0.07529141753911972
changes O 0 0.011951307766139507
were O 0 0.0029626707546412945
identified O 0 0.009140649810433388
in O 0 0.0035493301693350077
four O 0 0.006850070785731077
patients O 1 0.9979146122932434
, O 0 0.0029188983608037233
three O 0 0.002781812334433198
of O 0 0.002963675418868661
whom O 0 0.011976333335042
belonged O 0 0.012333706952631474
to O 0 0.0038135952781885862
the O 0 0.006383885163813829
non O 0 0.02702520601451397
- O 1 0.5132952332496643
FAP O 1 0.9991819262504578
group O 0 0.033762287348508835
of O 0 0.17319782078266144
colorectal B-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999992847442627
patients O 1 0.9999039173126221
. O 0 0.029627420008182526

Genotype O 1 0.9976027607917786
- O 1 0.9414035677909851
phenotype O 1 0.9996601343154907
correlations O 0 0.3322988450527191
identified O 0 0.020018473267555237
significant O 0 0.011061742901802063
differences O 0 0.008498519659042358
in O 0 0.0030105893965810537
the O 0 0.003626246238127351
nature O 0 0.007920338772237301
of O 0 0.004401203244924545
certain O 0 0.015037543140351772
extracolonic O 1 0.9978410005569458
manifestations O 1 0.9907211065292358
in O 0 0.022099671885371208
FAP B-Disease 1 0.9999428987503052
patients O 1 0.9993138313293457
belonging O 0 0.022492241114377975
to O 0 0.006465207785367966
three O 0 0.013635846786201
mutation O 1 0.9933515191078186
subgroups O 0 0.24666664004325867
. O 0 0.026066457852721214

CONCLUSIONS O 0 0.05534253641963005
Extended O 0 0.06484019011259079
genotype O 1 0.9975337982177734
- O 1 0.9058300852775574
phenotype O 1 0.9992510676383972
correlations O 0 0.05222752317786217
made O 0 0.004156456794589758
in O 0 0.0030831745825707912
this O 0 0.0034015451092272997
study O 0 0.007196086924523115
may O 0 0.005822012200951576
have O 0 0.0026147819589823484
the O 0 0.0029053324833512306
potential O 0 0.007922186516225338
to O 0 0.0025479465257376432
determine O 0 0.0050912220031023026
the O 0 0.002782525261864066
most O 0 0.004169214982539415
appropriate O 0 0.008542259223759174
surveillance O 0 0.01924782060086727
and O 0 0.007870151661336422
prophylactic O 1 0.9989859461784363
treatment O 1 0.9974779486656189
regimens O 1 0.9914430975914001
for O 0 0.006032587494701147
those O 0 0.01034145150333643
patients O 1 0.9997027516365051
with O 0 0.011881465092301369
mutations O 1 0.9987165927886963
associated O 0 0.01679101400077343
with O 0 0.007388109341263771
life O 0 0.02374047413468361
threatening O 1 0.9613102078437805
conditions O 0 0.04862894117832184
. O 0 0.02416396327316761

This O 0 0.009794243611395359
study O 0 0.010178253054618835
also O 0 0.003522382350638509
provided O 0 0.003641219576820731
evidence O 0 0.0037415011320263147
for O 0 0.0026165544986724854
the O 0 0.005343886557966471
pathological O 1 0.8608227372169495
nature O 0 0.011600138619542122
of O 0 0.005914813838899136
amino O 0 0.041690558195114136
acid O 0 0.17148268222808838
changes O 0 0.01368239801377058
in O 0 0.007401644252240658
APC O 1 0.9603593945503235
associated O 0 0.013255275785923004
with O 0 0.0057425228878855705
both O 0 0.010376912541687489
FAP B-Disease 1 0.9991312623023987
and O 0 0.011459199711680412
non O 0 0.46930167078971863
- O 1 0.9984149932861328
FAP O 1 0.9999974966049194
colorectal B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999995231628418
patients O 1 0.9998210072517395
. O 0 0.01961674913764
. O 0 0.023124653846025467

Inherited B-Disease 1 0.9998948574066162
colorectal I-Disease 1 0.9999988079071045
polyposis I-Disease 1 0.9999971389770508
and O 0 0.45126980543136597
cancer B-Disease 1 0.9999929666519165
risk O 1 0.986962616443634
of O 0 0.008402871899306774
the O 0 0.015166012570261955
APC O 1 0.9982695579528809
I1307K O 1 0.9926195740699768
polymorphism O 1 0.9642310738563538
. O 0 0.034980617463588715

Germ O 1 0.9439123868942261
- O 0 0.05038481205701828
line O 0 0.019899806007742882
and O 0 0.009776727296411991
somatic O 1 0.9553313851356506
truncating O 1 0.9919241070747375
mutations O 1 0.9614292979240417
of O 0 0.008533609099686146
the O 0 0.011079900898039341
APC B-Disease 1 0.9973799586296082
gene O 1 0.8784066438674927
are O 0 0.0051290118135511875
thought O 0 0.012265192344784737
to O 0 0.009303036145865917
initiate O 1 0.9814066886901855
colorectal B-Disease 1 0.9999974966049194
tumor I-Disease 1 0.999963641166687
formation O 1 0.5912810564041138
in O 0 0.04994521662592888
familial B-Disease 1 0.9999970197677612
adenomatous I-Disease 1 0.9999996423721313
polyposis I-Disease 1 0.9999998807907104
syndrome I-Disease 1 0.9999998807907104
and O 0 0.44657057523727417
sporadic O 1 0.9997228980064392
colorectal O 1 0.999998927116394
carcinogenesis O 1 0.9996139407157898
, O 0 0.014691299758851528
respectively O 0 0.024236733093857765
. O 0 0.021593602374196053

Recently O 0 0.035326726734638214
, O 0 0.009193260222673416
an O 0 0.012289222329854965
isoleucine O 1 0.7781572341918945
- O 0 0.08541467785835266
- O 0 0.12017595022916794
> O 1 0.8385898470878601
lysine O 1 0.5764657855033875
polymorphism O 0 0.31252872943878174
at O 0 0.022578833624720573
codon O 1 0.7749866247177124
1307 O 1 0.9771864414215088
( O 0 0.026857679709792137
I1307K O 0 0.3633772134780884
) O 0 0.007969681173563004
of O 0 0.004198612179607153
the O 0 0.00960080698132515
APC B-Disease 1 0.9984537363052368
gene O 1 0.8575637340545654
has O 0 0.00652335537597537
been O 0 0.004983536899089813
identified O 0 0.010427480563521385
in O 0 0.004617416299879551
6 O 0 0.011789387091994286
% O 0 0.010486720129847527
- O 0 0.019207675009965897
7 O 0 0.01293829083442688
% O 0 0.006557787302881479
of O 0 0.003968553151935339
the O 0 0.008099546656012535
Ashkenazi O 1 0.6724090576171875
Jewish O 0 0.03072824701666832
population O 0 0.031214624643325806
. O 0 0.022943848744034767

To O 0 0.012746135704219341
assess O 0 0.02887592278420925
the O 0 0.007924719713628292
risk O 0 0.040056947618722916
of O 0 0.004811298102140427
this O 0 0.006459852214902639
common O 0 0.044336553663015366
APC B-Disease 1 0.9989401698112488
allelic O 1 0.9973535537719727
variant O 1 0.9921019673347473
in O 0 0.031403109431266785
colorectal O 1 0.9999961853027344
carcinogenesis O 1 0.9996644258499146
, O 0 0.007213082630187273
we O 0 0.003692544298246503
have O 0 0.003984469920396805
analyzed O 0 0.013374703004956245
a O 0 0.007335242815315723
large O 0 0.010330818593502045
cohort O 0 0.06333352625370026
of O 0 0.009138132445514202
unselected O 1 0.8921932578086853
Ashkenazi O 1 0.934650182723999
Jewish O 0 0.024806026369333267
subjects O 0 0.0265780258923769
with O 0 0.030003225430846214
adenomatous B-Disease 1 0.9999970197677612
polyps I-Disease 1 0.9999657869338989
and O 0 0.009246543049812317
. O 0 0.009999120607972145
or O 0 0.4902103543281555
colorectal B-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999939203262329
, I-Disease 0 0.006401006132364273
for O 0 0.005850769579410553
the O 0 0.013793223537504673
APC O 1 0.9976281523704529
I1307K O 1 0.987400472164154
polymorphism O 1 0.8479491472244263
. O 0 0.02836688607931137

The O 0 0.03372560441493988
APC O 1 0.9947273135185242
I1307K O 1 0.9930486679077148
allele O 1 0.9928190112113953
was O 0 0.012585896998643875
identified O 0 0.016455799341201782
in O 0 0.0059020137414336205
48 O 0 0.015523552894592285
( O 0 0.008742627687752247
10 O 0 0.006469595246016979
. O 0 0.00439849216490984
1 O 0 0.00912617240101099
% O 0 0.008147165179252625
) O 0 0.007375056389719248
of O 0 0.009242967702448368
476 O 1 0.9853715300559998
patients O 1 0.9987422823905945
. O 0 0.027052560821175575

Compared O 0 0.03166397288441658
with O 0 0.006402571219950914
the O 0 0.005961560178548098
frequency O 0 0.017275890335440636
in O 0 0.003149299183860421
two O 0 0.0032240315340459347
separate O 0 0.007593177724629641
population O 0 0.012444899417459965
control O 0 0.01409826148301363
groups O 0 0.007877727970480919
, O 0 0.00433421740308404
the O 0 0.01070932112634182
APC O 1 0.9989681243896484
I1307K O 1 0.9974046349525452
allele O 1 0.9956595301628113
is O 0 0.009270557202398777
associated O 0 0.009970476850867271
with O 0 0.003576636780053377
an O 0 0.004532179795205593
estimated O 0 0.014591667801141739
relative O 0 0.020108358934521675
risk O 0 0.1645004004240036
of O 0 0.006166504696011543
1 O 0 0.017889617010951042
. O 0 0.015476691536605358

5 O 0 0.049365658313035965
- O 0 0.0574050210416317
1 O 0 0.03108871355652809
. O 0 0.020253758877515793

7 O 0 0.05187257006764412
for O 0 0.030368119478225708
colorectal B-Disease 1 0.9999819993972778
neoplasia I-Disease 1 0.9995342493057251
( O 0 0.0221300907433033
both O 0 0.01516671758145094
P O 1 0.520802915096283
= O 0 0.06763124465942383
. O 0 0.01641716994345188
01 O 1 0.8277589678764343
) O 0 0.01939959079027176
. O 0 0.01935884729027748

Furthermore O 0 0.03971627354621887
, O 0 0.009390730410814285
compared O 0 0.01862570270895958
with O 0 0.010854881256818771
noncarriers O 1 0.9874171018600464
, O 0 0.016242099925875664
APC O 1 0.9968974590301514
I1307K O 1 0.994436502456665
carriers O 0 0.15840111672878265
had O 0 0.008438489399850368
increased O 0 0.01333641167730093
numbers O 0 0.009550969116389751
of O 0 0.008924768306314945
adenomas B-Disease 1 0.9999001026153564
and O 0 0.07141286879777908
colorectal B-Disease 1 0.9999984502792358
cancers I-Disease 1 0.999975323677063
per O 0 0.030892087146639824
patient O 1 0.9989668130874634
( O 0 0.026784302666783333
P O 1 0.962811291217804
= O 0 0.06935229152441025
. O 0 0.007841872051358223
03 O 1 0.7901664972305298
) O 0 0.005969681311398745
, O 0 0.002880820306017995
as O 0 0.002411486813798547
well O 0 0.002920447615906596
as O 0 0.003623807802796364
a O 0 0.008598970249295235
younger O 0 0.0573873408138752
age O 0 0.02442309446632862
at O 0 0.016846872866153717
diagnosis O 1 0.9985528588294983
. O 0 0.024846360087394714

We O 0 0.011086642742156982
conclude O 0 0.02272147312760353
that O 0 0.005828502122312784
the O 0 0.012545078992843628
APC O 1 0.9952927827835083
I1307K O 1 0.9876817464828491
variant O 1 0.9495459794998169
leads O 0 0.03143993020057678
to O 0 0.00913726445287466
increased O 0 0.06751649081707001
adenoma B-Disease 1 0.9998317956924438
formation O 0 0.03540359437465668
and O 0 0.004144556354731321
directly O 0 0.008296198211610317
contributes O 0 0.029312685132026672
to O 0 0.004199549090117216
3 O 0 0.009907161816954613
% O 0 0.008307776413857937
- O 0 0.016144918277859688
4 O 0 0.008967583999037743
% O 0 0.0057915858924388885
of O 0 0.0036365757696330547
all O 0 0.006733804941177368
Ashkenazi O 1 0.9918191432952881
Jewish O 1 0.9830597639083862
colorectal B-Disease 1 0.9999994039535522
cancer I-Disease 1 0.9999935626983643
. O 0 0.04375288262963295

The O 0 0.01828780397772789
estimated O 0 0.029537443071603775
relative O 0 0.03362336382269859
risk O 1 0.9005249738693237
for O 0 0.008325445465743542
carriers O 0 0.4537694752216339
may O 0 0.012948551215231419
justify O 0 0.023555826395750046
specific O 0 0.013546770438551903
clinical O 1 0.7509804368019104
screening O 0 0.030377613380551338
for O 0 0.0036892422940582037
the O 0 0.005102572496980429
360 O 0 0.02158190682530403
, O 0 0.004981139674782753
000 O 0 0.01969912275671959
Americans O 0 0.012766174972057343
expected O 0 0.006257801316678524
to O 0 0.003779021790251136
harbor O 0 0.01971760205924511
this O 0 0.007587611209601164
allele O 1 0.9876421689987183
, O 0 0.004953956697136164
and O 0 0.004596799612045288
genetic O 0 0.15614165365695953
testing O 0 0.011541659943759441
in O 0 0.002592847915366292
the O 0 0.0025450491812080145
setting O 0 0.005590036511421204
of O 0 0.003902079537510872
long O 0 0.012111813761293888
- O 0 0.024459723383188248
term O 0 0.019603392109274864
- O 0 0.026399239897727966
outcome O 0 0.020534992218017578
studies O 0 0.014806886203587055
may O 0 0.015369526110589504
impact O 0 0.028749626129865646
significantly O 0 0.27788275480270386
on O 0 0.07060534507036209
colorectal B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999991655349731
prevention O 1 0.9985620379447937
in O 0 0.008992972783744335
this O 0 0.009056556038558483
population O 0 0.02529849112033844
. O 0 0.019929369911551476

Localization O 0 0.0756237804889679
of O 0 0.01074988767504692
human O 0 0.09799212217330933
BRCA1 O 1 0.9997947812080383
and O 0 0.005041265394538641
its O 0 0.006175950635224581
loss O 0 0.01985589787364006
in O 0 0.0042370641604065895
high O 0 0.009374842047691345
- O 0 0.022852063179016113
grade O 0 0.02132285200059414
, O 0 0.0077213505282998085
non B-Disease 0 0.036316391080617905
- I-Disease 1 0.9451826810836792
inherited I-Disease 1 0.9997300505638123
breast I-Disease 1 0.9999951124191284
carcinomas I-Disease 1 0.9999082088470459
. O 0 0.038113586604595184

Although O 0 0.015565639361739159
the O 0 0.007622750476002693
link O 0 0.02155931480228901
between O 0 0.009783717803657055
the O 0 0.015587297268211842
BRCA1 O 1 0.9999867677688599
tumour B-Disease 1 0.999995231628418
- O 1 0.9878143072128296
suppressor O 1 0.9995216131210327
gene O 1 0.9936649799346924
and O 0 0.019321268424391747
hereditary B-Disease 1 0.9999741315841675
breast I-Disease 1 0.9999990463256836
and I-Disease 1 0.9759637117385864
ovarian I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999985694885254
is O 0 0.008973581716418266
established O 0 0.007115497253835201
, O 0 0.0030918738339096308
the O 0 0.003572429995983839
role O 0 0.008001957088708878
, O 0 0.003258603159338236
if O 0 0.003319722367450595
any O 0 0.0028694334905594587
, O 0 0.002722483826801181
of O 0 0.0061262790113687515
BRCA1 O 1 0.9997276663780212
in O 0 0.010024812072515488
non B-Disease 0 0.23977169394493103
- I-Disease 1 0.9947282671928406
familial I-Disease 1 0.9999822378158569
cancers I-Disease 1 0.9999691247940063
is O 0 0.019102653488516808
unclear O 0 0.032721973955631256
. O 0 0.02245144173502922

BRCA1 O 1 0.999854326248169
mutations O 1 0.9972348809242249
are O 0 0.009401063434779644
rare O 0 0.03339412808418274
in O 0 0.011003805324435234
sporadic B-Disease 1 0.9968125224113464
cancers I-Disease 1 0.9999440908432007
, O 0 0.00690336711704731
but O 0 0.005387124605476856
loss O 0 0.03725085034966469
of O 0 0.01055881567299366
BRCA1 O 1 0.9999411106109619
resulting O 0 0.09550406038761139
from O 0 0.008834518492221832
reduced O 0 0.03209526464343071
expression O 0 0.02931542694568634
or O 0 0.008802400901913643
incorrect O 0 0.028212448582053185
subcellular O 0 0.08767682313919067
localization O 0 0.040785323828458786
is O 0 0.00697691785171628
postulated O 0 0.02444676123559475
to O 0 0.0027693123556673527
be O 0 0.002464358927682042
important O 0 0.0037132776342332363
in O 0 0.005002861376851797
non B-Disease 0 0.04140731319785118
- I-Disease 1 0.9899880290031433
familial I-Disease 1 0.9999810457229614
breast I-Disease 1 0.9999898672103882
and I-Disease 1 0.6356356739997864
ovarian I-Disease 1 0.9999982118606567
cancers I-Disease 1 0.9999741315841675
. O 0 0.04464103654026985

Epigenetic O 1 0.9795037508010864
loss O 0 0.24334147572517395
, O 0 0.006952325813472271
however O 0 0.006743845529854298
, O 0 0.00345267029479146
has O 0 0.0045931837521493435
not O 0 0.003915166016668081
received O 0 0.010930742137134075
general O 0 0.009797296486794949
acceptance O 0 0.026282621547579765
due O 0 0.009876768104732037
to O 0 0.004099101759493351
controversy O 0 0.015302523039281368
regarding O 0 0.006965556647628546
the O 0 0.005990196950733662
subcellular O 0 0.05755498632788658
localization O 0 0.044751133769750595
of O 0 0.010020909830927849
BRCA1 O 1 0.9999172687530518
proteins O 0 0.028177382424473763
, O 0 0.003670827252790332
reports O 0 0.006109908223152161
of O 0 0.0023758758325129747
which O 0 0.002901525003835559
have O 0 0.003614848479628563
ranged O 0 0.013960967771708965
from O 0 0.0038744008634239435
exclusively O 0 0.009062796831130981
nuclear O 0 0.006745424121618271
, O 0 0.0027978962752968073
to O 0 0.004032381810247898
conditionally O 0 0.03887459635734558
nuclear O 0 0.00832485593855381
, O 0 0.0037675106432288885
to O 0 0.004165967460721731
the O 0 0.010388352908194065
ER O 1 0.9952899217605591
/ O 0 0.48538655042648315
golgi O 1 0.5757855176925659
, O 0 0.006945005618035793
to O 0 0.008180694654583931
cytoplasmic O 0 0.23415575921535492
invaginations O 0 0.3565419912338257
into O 0 0.012084128335118294
the O 0 0.014345468953251839
nucleus O 0 0.07348908483982086
. O 0 0.026258116587996483

In O 0 0.009273523464798927
an O 0 0.005765524692833424
attempt O 0 0.012977968901395798
to O 0 0.004167560022324324
resolve O 0 0.014495096169412136
this O 0 0.0034231070894747972
issue O 0 0.006092812865972519
, O 0 0.0030508702620863914
we O 0 0.0029532446060329676
have O 0 0.004726697225123644
comprehensively O 0 0.04590662196278572
characterized O 0 0.1050289198756218
19 O 0 0.031240388751029968
anti O 1 0.5853728652000427
- O 1 0.9758782982826233
BRCA1 O 1 0.999873161315918
antibodies O 1 0.9900172352790833
. O 0 0.03782312572002411

These O 0 0.017175903543829918
reagents O 0 0.05420709028840065
detect O 0 0.05251563712954521
a O 0 0.016524137929081917
220 O 0 0.03661546856164932
- O 0 0.07312460988759995
kD O 1 0.8676545023918152
protein O 0 0.0854744091629982
localized O 0 0.1042388305068016
in O 0 0.009221660904586315
discrete O 0 0.0267145074903965
nuclear O 0 0.015234965831041336
foci O 0 0.06102265045046806
in O 0 0.005833381321281195
all O 0 0.006769362837076187
epithelial O 1 0.9986704587936401
cell O 0 0.14623799920082092
lines O 0 0.015173263847827911
, O 0 0.003991879988461733
including O 0 0.004622321110218763
those O 0 0.005511652212589979
derived O 0 0.02295152097940445
from O 0 0.021987834945321083
breast B-Disease 1 0.9998770952224731
malignancies I-Disease 1 0.9975396394729614
. O 0 0.03611085191369057

Immunohistochemical O 1 0.9844961166381836
staining O 1 0.9372969269752502
of O 0 0.016710201278328896
human O 1 0.8859872817993164
breast O 1 0.9999701976776123
specimens O 0 0.11306323856115341
also O 0 0.01013325247913599
revealed O 0 0.08511625230312347
BRCA1 O 1 0.9997735619544983
nuclear O 0 0.0261188056319952
foci O 1 0.9158893823623657
in O 0 0.014916813932359219
benign O 1 0.9999386072158813
breast O 1 0.9999918937683105
, O 0 0.2755998373031616
invasive B-Disease 1 0.9999861717224121
lobular I-Disease 1 0.9999946355819702
cancers I-Disease 1 0.9999496936798096
and O 0 0.011320349760353565
low B-Disease 0 0.05357212573289871
- I-Disease 0 0.2844032347202301
grade I-Disease 1 0.7147183418273926
ductal I-Disease 1 0.9999303817749023
carcinomas I-Disease 1 0.9998512268066406
. O 0 0.04806971922516823

Conversely O 1 0.5045760869979858
, O 0 0.02370794117450714
BRCA1 O 1 0.9996194839477539
expression O 0 0.055298373103141785
was O 0 0.010958320461213589
reduced O 0 0.027538415044546127
or O 0 0.009271043352782726
undetectable O 0 0.26404187083244324
in O 0 0.0042098695412278175
the O 0 0.0038200137205421925
majority O 0 0.008453126065433025
of O 0 0.004918571561574936
high O 0 0.01144047174602747
- O 0 0.028800658881664276
grade O 0 0.03132094442844391
, O 0 0.017119118943810463
ductal B-Disease 1 0.9999858140945435
carcinomas I-Disease 1 0.9999628067016602
, O 0 0.007438494823873043
suggesting O 0 0.016961967572569847
that O 0 0.0046083079650998116
absence O 0 0.018710441887378693
of O 0 0.00934314914047718
BRCA1 O 1 0.9999839067459106
may O 0 0.016617456451058388
contribute O 0 0.01364839170128107
to O 0 0.003962002694606781
the O 0 0.005505722016096115
pathogenesis O 1 0.9874683618545532
of O 0 0.004152288660407066
a O 0 0.006822326220571995
significant O 0 0.010412941686809063
percentage O 0 0.01754494570195675
of O 0 0.01207774318754673
sporadic B-Disease 1 0.9982725381851196
breast I-Disease 1 0.9999946355819702
cancers I-Disease 1 0.9999699592590332
. O 0 0.016634656116366386
. O 0 0.022027205675840378

